<?xml version="1.0" encoding="UTF-8"?>
<projectSnippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC3895286/results/search/disease/results.xml">
   <result pre="administer the drug buparvaquone in the treatment of theileriosis, a" exact="parasitic disease" post="affecting cattle. One of the benefits of working in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC4335050/results/search/disease/results.xml">
   <result pre="of motion, such as the &quot;filarial dance&quot; seen in lymphatic" exact="filariasis" post="using ultrasonography [10]; this motility is reduced after administration"/>
   <result pre="Dis. 4, e88510.1371/journal.pntd.000088521103363 4MackenzieCD, HomeidaMM, HopkinsA, LawrenceJC (2012) Elimination of" exact="onchocerciasis" post="from Africa: possible?Trends Parasitol. 28, 16–22. 10.1016/j.pt.2011.10.00322079526 5MarcellinoC, GutJ,"/>
   <result pre="J. Clin.Microbiol. 39, 1025–1031.11230422 18WeilGJ, RamzyRMR (2007) Diagnostic tools for" exact="filariasis" post="elimination programs. Trends Parasitol. 23, 78–82. 17174604 19GardonJ, Gardon-WendelN,"/>
   <result pre="KamgnoJ, ChippauxJ-P, BoussinesqM (1997) Serious reactions after mass treatment of" exact="onchocerciasis" post="with ivermectin in an area endemic for Loa infection."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC4751831/results/search/disease/results.xml">
   <result pre="by using an XhoI/SalI double digest and religation, removing the" exact="tetanus" post="toxin fragment C (TTFC) gene. The following primers were"/>
   <result pre="protein. Previously, L. lactis KP1 (NCK203) was shown to externalize" exact="tetanus" post="toxin fragment C (TTFC) expressed from pTRK617 (24). Plasmid"/>
   <result pre="autolysin-controlled system (38), is selective. While β-Gal (117 kDa) and" exact="tetanus" post="toxin fragment C (47 kDa) were externalized from the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC4791988/results/search/disease/results.xml">
   <result pre="backache, sore eyes, intercostal pain, pulmonary troubles, gout, scrotal elephantiasis," exact="rheumatoid arthritis," post="and external skin diseases.[567891011] The plant has also been"/>
   <result pre="of the genus Markhamia against brine shrimp larvae and HeLa" exact="cervical cancer" post="cell lines. The following section presents a review of"/>
   <result pre="the genus Markhamia against brine shrimp larvae and HeLa cervical" exact="cancer" post="cell lines. The following section presents a review of"/>
   <result pre="of the root bark is used in the treatment of" exact="anemia" post="and diarrhea.[6] Markhamia lutea and Markhamia tomentosa are both"/>
   <result pre="of Markhamia obtusifolia is used in folk medicine to treat" exact="tuberculosis" post="infection of lymph nodes in the neck,[38] convulsion in"/>
   <result pre="tomentosa leaf extract on brine shrimp larvae, HeLa and MCF-7" exact="cancer" post="cell lines, and noncancerous Vero cell lines. In view"/>
   <result pre="on the Belief and Traditional Practices in the Treatment of" exact="sleeping sickness" post="in West AfricaBull Soc Med Afr Noire Lang FR1974194004619047"/>
   <result pre="use in the traditional treatment of gastrointestinal pain, inflammation and" exact="diarrhea" post="in Africa: Future perspectives for integration in modern medicineAnimals2013315822726487315"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC4864485/results/search/disease/results.xml">
   <result pre="et al. [5] showed turmeric extract to have good growth" exact="suppression" post="on earthworm muscle cells. Since nematodes or helminthes are"/>
   <result pre="dividing cells; this activity may have caused the muscle growth" exact="suppression" post="in earthworm. Although the antiparasitic effect of curcumin is"/>
   <result pre="of ethanolic extract of Curcuma longa on thioacetamide induced liver" exact="cirrhosis" post="in ratsBMC Compl. Altern. Med201313156 9HansenJ.WPerryB.DTechniques for parasite assays"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC4913051/results/search/disease/results.xml">
   <result pre="encountered manifestations are anaemia, weakness, emaciation, and sometimes colic and" exact="diarrhea" post="[23]. The intestinal mucosa is damaged where the worms"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC4950832/results/search/disease/results.xml">
   <result pre="apoptosis without PARP or cytokeratin 18 cleavage in non-small cell" exact="lung cancer" post="cell lines AztopalNazlihan1CevatemreBuse1SarimahmutMehmet1AriFerda1DereEgemen1OzelMustafa Zafer2FiratMehmet3UlukayaEngin4[1], [2], [3], [4], Correspondence to:"/>
   <result pre="without PARP or cytokeratin 18 cleavage in non-small cell lung" exact="cancer" post="cell lines AztopalNazlihan1CevatemreBuse1SarimahmutMehmet1AriFerda1DereEgemen1OzelMustafa Zafer2FiratMehmet3UlukayaEngin4[1], [2], [3], [4], Correspondence to:"/>
   <result pre="is known about its biological activity or its effect on" exact="cancer" post="cells. The aim of the present study was to"/>
   <result pre="to determine the cytotoxic activity of P. quercetorum extract on" exact="lung cancer" post="cell lines with varying properties. Following the analyses of"/>
   <result pre="determine the cytotoxic activity of P. quercetorum extract on lung" exact="cancer" post="cell lines with varying properties. Following the analyses of"/>
   <result pre="for further understanding of the effect of this plant on" exact="cancer" post="cells. Pelargonium quercetorum Agnew lung cancer herbal medicine cytotoxicity"/>
   <result pre="effect of this plant on cancer cells. Pelargonium quercetorum Agnew" exact="lung cancer" post="herbal medicine cytotoxicity apoptosis Introduction Lung cancer is an"/>
   <result pre="of this plant on cancer cells. Pelargonium quercetorum Agnew lung" exact="cancer" post="herbal medicine cytotoxicity apoptosis Introduction Lung cancer is an"/>
   <result pre="quercetorum Agnew lung cancer herbal medicine cytotoxicity apoptosis Introduction Lung" exact="cancer" post="is an aggressive and heterogeneous malignancy, and one of"/>
   <result pre="no information regarding the cytotoxic activity of P. quercetorum against" exact="lung cancer" post="cell lines in the literature. In the present study,"/>
   <result pre="information regarding the cytotoxic activity of P. quercetorum against lung" exact="cancer" post="cell lines in the literature. In the present study,"/>
   <result pre="of the methanol extract of P. quercetorum against non-small cell" exact="lung cancer" post="cell lines (A549, PC3 and H1299) were investigated. The"/>
   <result pre="the methanol extract of P. quercetorum against non-small cell lung" exact="cancer" post="cell lines (A549, PC3 and H1299) were investigated. The"/>
   <result pre="Determination of cytotoxic activity Cell culture and chemicals Non-small cell" exact="lung cancer" post="cell lines A549, H1299 (Dr Donner, Walther Oncology Center,"/>
   <result pre="of cytotoxic activity Cell culture and chemicals Non-small cell lung" exact="cancer" post="cell lines A549, H1299 (Dr Donner, Walther Oncology Center,"/>
   <result pre="Collection (Manassas, VA, USA), PC3 is often known as a" exact="prostate cancer" post="cell line (CRL1435), but in the present study, it"/>
   <result pre="(Manassas, VA, USA), PC3 is often known as a prostate" exact="cancer" post="cell line (CRL1435), but in the present study, it"/>
   <result pre="but in the present study, it represents a non-small cell" exact="lung cancer" post="cell line derived from the Japanese Collection Research Resources"/>
   <result pre="in the present study, it represents a non-small cell lung" exact="cancer" post="cell line derived from the Japanese Collection Research Resources"/>
   <result pre="ATP assay The cytotoxic effect of PQE on non-small cell" exact="lung cancer" post="cell lines (A549, PC3 and H1299) were screened by"/>
   <result pre="assay The cytotoxic effect of PQE on non-small cell lung" exact="cancer" post="cell lines (A549, PC3 and H1299) were screened by"/>
   <result pre="considered as incomplete apoptosis, rather than typical apoptosis. Discussion Lung" exact="cancer" post="is the leading cause of cancer-associated mortalities worldwide due"/>
   <result pre="new therapeutic approaches would be instrumental for better management of" exact="lung cancer" post="patients. Since natural products are important in cancer therapy,"/>
   <result pre="therapeutic approaches would be instrumental for better management of lung" exact="cancer" post="patients. Since natural products are important in cancer therapy,"/>
   <result pre="of lung cancer patients. Since natural products are important in" exact="cancer" post="therapy, the present study was conducted to evaluate the"/>
   <result pre="conducted to evaluate the possible anti-growth/cytotoxic activity of PQE on" exact="lung cancer" post="cell lines. Despite the fact that there are several"/>
   <result pre="to evaluate the possible anti-growth/cytotoxic activity of PQE on lung" exact="cancer" post="cell lines. Despite the fact that there are several"/>
   <result pre="demonstrate the cytotoxic activity of P. quercetorum on non-small cell" exact="lung cancer" post="cell lines (A549, PC3 and H1299). In the present"/>
   <result pre="the cytotoxic activity of P. quercetorum on non-small cell lung" exact="cancer" post="cell lines (A549, PC3 and H1299). In the present"/>
   <result pre="exert a significant anti-growth effect against A549, PC3 and H1299" exact="lung cancer" post="cell lines in a dose-dependent manner. According to the"/>
   <result pre="a significant anti-growth effect against A549, PC3 and H1299 lung" exact="cancer" post="cell lines in a dose-dependent manner. According to the"/>
   <result pre="demonstrate the anti-growth/cytotoxic activity of P. quercetorum in non-small cell" exact="lung cancer" post="cells, warranting further evaluation in vivo for proof of"/>
   <result pre="the anti-growth/cytotoxic activity of P. quercetorum in non-small cell lung" exact="cancer" post="cells, warranting further evaluation in vivo for proof of"/>
   <result pre="11Kris-EthertonPMHeckerVKBonanomeACovalSMBinkoskiAEHilpertKFGrielAEEthertonTDBioactive compounds in foods: Their role in the prevention of" exact="cardiovascular disease" post="and cancerAm J Med113Suppl 9B71S88S200210.1016/S0002-9343(01)00995-012566142 12SeidelVTaylorPWIn vitro activity of"/>
   <result pre="platinum(II) saccharinate complexes with 2-(hydroxymethyl) pyridine and 2-(2-hydroxyethyl) pyridine on" exact="cancer" post="cells in vitroBioorg Med Chem2164276434201310.1016/j.bmc.2013.08.05024054490 32UlukayaEAcilanCAriFIkitimurEYilmazYA glance at the"/>
   <result pre="Rev Mol Diagn10353359201010.1586/erm.10.1420370591 36ChiuCCLinCHFangKEtoposide (VP-16) sensitizes p53-deficient human non-small cell" exact="lung cancer" post="cells to caspase-7-mediated apoptosisApoptosis10643650200510.1007/s10495-005-1898-815909125 37DasguptaPKinkadeRJoshiBDeCookCHauraEChellappanSNicotine inhibits apoptosis induced by"/>
   <result pre="Mol Diagn10353359201010.1586/erm.10.1420370591 36ChiuCCLinCHFangKEtoposide (VP-16) sensitizes p53-deficient human non-small cell lung" exact="cancer" post="cells to caspase-7-mediated apoptosisApoptosis10643650200510.1007/s10495-005-1898-815909125 37DasguptaPKinkadeRJoshiBDeCookCHauraEChellappanSNicotine inhibits apoptosis induced by"/>
   <result pre="and the Chinese medical herb complex on cellular immunity of" exact="cancer" post="patients receiving chemotherapy/radiotherapyPhytother Res23785790200910.1002/ptr.262319145638 45CevatemreBUlukayaESarimahmutMOralAYFrameFMThe M30 assay does not"/>
   <result pre="Res23785790200910.1002/ptr.262319145638 45CevatemreBUlukayaESarimahmutMOralAYFrameFMThe M30 assay does not detect apoptosis in epithelial-derived" exact="cancer" post="cells expressing low levels of cytokeratin 18Tumor Biol3668576865201510.1007/s13277-015-3367-5 46UlukayaEAcilanCYilmazYApoptosis:"/>
   <result pre="anti-growth effect of PQE after 48-h treatment in non-small cell" exact="lung cancer" post="cell lines was determined by adenosine triphosphate assay. (B)"/>
   <result pre="effect of PQE after 48-h treatment in non-small cell lung" exact="cancer" post="cell lines was determined by adenosine triphosphate assay. (B)"/>
   <result pre="P. reniforme and P. sidoides Coughs, diarrhoea, hepatic disorders and" exact="tuberculosis" post="(14,15) (roots) Roots Antimycobacterial (12,16) P. graveolens Antiasthmatic, antiallergic,"/>
   <result pre="and IC90 values of Pelargonium quercetorum extract in non-small cell" exact="lung cancer" post="cells lines. Dose (µg/ml) A549 PC3 H1299 IC50 62.13±1.90"/>
   <result pre="IC90 values of Pelargonium quercetorum extract in non-small cell lung" exact="cancer" post="cells lines. Dose (µg/ml) A549 PC3 H1299 IC50 62.13±1.90"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5061482/results/search/disease/results.xml">
   <result pre="for scientific evidence regarding the treatment and control of intestinal" exact="helminthiasis" post="[5]. Acorus calamus Linn. (Araceae), commonly known as &quot;sweet"/>
   <result pre="as well as diarrhea, bronchial catarrh, intermittent fevers, cough, and" exact="asthma" post="[8]. In Indian folk medicines, A. calamus rhizomes are"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5198159/results/search/disease/results.xml">
   <result pre="as 370 million people. This paper explores current methods of" exact="strongyloidiasis" post="treatment, which rely on administration of anthelminthic drugs. However"/>
   <result pre="to control animal and human parasitic nematodes in the environment." exact="strongyloidiasis" post="Strongyloides stercoralis anthelminthic drugs nematicides ivermectin resistance 1. Introduction"/>
   <result pre="stercoralis life-cycle, insensitivity of detection methods and social factors challenge" exact="strongyloidiasis" post="identification, diagnosis and treatment [3,13]. If not diagnosed in"/>
   <result pre="given that we see high disease rates in population sub-groups," exact="strongyloidiasis" post="is not only a personal but a public health"/>
   <result pre="lungs [16,17]. The repeated cycle of this leads to pulmonary" exact="strongyloidiasis" post="[18]. There are no further studies done showing the"/>
   <result pre="larvae maturing into adult worm in the lungs. The pulmonary" exact="strongyloidiasis" post="is believed to occur due to autoinfection and filariform"/>
   <result pre="main constituents, mode of action and toxic effects. To date," exact="strongyloidiasis" post="treatment has tended to be viewed only from a"/>
   <result pre="for drug resistance. Here we suggest a combined approach of" exact="strongyloidiasis" post="treatment; through clinical intervention with drugs once infection has"/>
   <result pre="it has been demonstrated to have a suboptimal effect against" exact="strongyloidiasis" post="(Table 1) [24]. Ivermectin has been shown to be"/>
   <result pre="the most effective and therefore the first choice drug in" exact="strongyloidiasis" post="treatment [25], especially for chronic strongyloidiasis [26,27]. 2.1. Benzimidazoles"/>
   <result pre="first choice drug in strongyloidiasis treatment [25], especially for chronic" exact="strongyloidiasis" post="[26,27]. 2.1. Benzimidazoles (Albendazole and Mebendazole) Benzimidazole is a"/>
   <result pre="nematode paralysis [36,37]. Ivermectin is currently the best treatment for" exact="onchocerciasis" post="and administered at intervals of one year in highly"/>
   <result pre="ability of ivermectin, its oral administration can be impaired in" exact="strongyloidiasis" post="disseminated patients. There is, however, no parenteral administration of"/>
   <result pre="ivermectin licensed currently, which is essential in cases of disseminated" exact="strongyloidiasis" post="[39,40]. 2.3. Anthelminthic Drugs Associated Issues Treatment of soil-transmitted"/>
   <result pre="strongyloidiasis [39,40]. 2.3. Anthelminthic Drugs Associated Issues Treatment of soil-transmitted" exact="helminthiasis" post="is challenging due to development of resistance, as demonstrated"/>
   <result pre="veterinary practice, and reinfection occurrence [41,42]. Among soil-transmitted helminth infections," exact="strongyloidiasis" post="is the most difficult to treat because of its"/>
   <result pre="sensitivity and accuracy, and should be used for not only" exact="strongyloidiasis" post="diagnosis but also follow-up tests [48,49]. The drugs, while"/>
   <result pre="pregnant women who have a high risk of developing iron-deficiency" exact="anemia" post="[54]. Animal-infecting nematode resistance development results in need for"/>
   <result pre="family over the years, as in case of ivermectin against" exact="strongyloidiasis" post="[60]. Studies on benzimidazole drugs against human nematodes have"/>
   <result pre="parasite [60]. A human immune system changes in response to" exact="strongyloidiasis" post="infection, in particular T and B cells. The immune"/>
   <result pre="drugs allows integrating control programs for intestinal helminth infections, lymphatic" exact="filariasis" post="and onchocerciasis with schistosomiasis and food-borne trematode infections. However,"/>
   <result pre="integrating control programs for intestinal helminth infections, lymphatic filariasis and" exact="onchocerciasis" post="with schistosomiasis and food-borne trematode infections. However, MDA could"/>
   <result pre="programs for intestinal helminth infections, lymphatic filariasis and onchocerciasis with" exact="schistosomiasis" post="and food-borne trematode infections. However, MDA could be associated"/>
   <result pre="non-existent in human parasite control. An overlooked environmental approach in" exact="strongyloidiasis" post="control is to kill free-living parasites in environment before"/>
   <result pre="Above we have assessed commercially available drugs used to treat" exact="strongyloidiasis" post="and explored the main issues associated with these drug"/>
   <result pre="used on free-living Strongyloides nematodes. A combined approach to fight" exact="strongyloidiasis" post="should consider environmental control as well as drug treatment."/>
   <result pre="group, against the root-knot nematode meloidogyne javanicaPest Manag. Sci.2009651082108910.1002/ps.179619488996 19.NamisatoS.MotomuraK.HaranagaS.HirataT.ToyamaM.ShinzatoT.HigaF.SaitoA.Pulmonary" exact="strongyloidiasis" post="in a patient receiving prednisolone therapyIntern. Med.20044373173610.2169/internalmedicine.43.73115468976 20.GarrardT.A.RossK.E.TaylorM.J.Biocontrol for"/>
   <result pre="on the efficacy of three anthelmintics on treatment of human" exact="strongyloidiasis" post="in okinawa, JapanSoutheast Asian J. Trop. Med. Public Health20003114715111023084"/>
   <result pre="of veterinary importance: A status reportTrends Parasitol.20042047748110.1016/j.pt.2004.08.00115363441 43.PaulaF.Costa-CruzJ.Epidemiological aspects of" exact="strongyloidiasis" post="in brazilParasitology2011138133110.1017/S003118201100120X21810305 44.VadlamudiR.S.ChiD.S.KrishnaswamyG.Intestinal strongyloidiasis and hyperinfection syndromeClin. Mol. Allergy20064110.1186/1476-7961-4-816478539"/>
   <result pre="status reportTrends Parasitol.20042047748110.1016/j.pt.2004.08.00115363441 43.PaulaF.Costa-CruzJ.Epidemiological aspects of strongyloidiasis in brazilParasitology2011138133110.1017/S003118201100120X21810305 44.VadlamudiR.S.ChiD.S.KrishnaswamyG.Intestinal" exact="strongyloidiasis" post="and hyperinfection syndromeClin. Mol. Allergy20064110.1186/1476-7961-4-816478539 45.ScowdenE.B.SchaffnerW.StoneW.J.Overwhelming strongyloidiasis: An unappreciated"/>
   <result pre="infectionPLoS Negl. Trop. Dis.20159e000349110.1371/journal.pntd.000349125668740 50.ShikiyaK.ZahaO.NiimuraS.UeharaT.OhshiroJ.KinjoF.SaitoA.AsatoR.[clinical study on ivermectin against 125" exact="strongyloidiasis" post="patients]Kansenshogaku Zasshi199468132010.11150/kansenshogakuzasshi1970.68.138138669 51.ZahaO.HirataT.KinjoF.SaitoA.FukuharaH.Efficacy of ivermectin for chronic strongyloidiasis: Two"/>
   <result pre="Two single doses given 2 weeks apartJ. Infect. Chemother.20028949810.1007/s10156020001311957127 52.LichtenbergerP.Rosa-CunhaI.MorrisM.NishidaS.AkpinarE.GaitanJ.TzakisA.Doblecki-LewisS.Hyperinfection" exact="strongyloidiasis" post="in a liver transplant recipient treated with parenteral ivermectinTranspl."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5290783/results/search/disease/results.xml">
   <result pre="10.4103/2249-4863.197306 : Case Report A mixed toxidrome presenting with bilateral" exact="ptosis" post="with normal pupils: The first case in the literature"/>
   <result pre="namely vasculotoxicity and neurotoxicity. Neurotoxic snakebites present mainly with bilateral" exact="ptosis" post="with dilated pupils and/or difficulty in breathing. Jatropha curcas"/>
   <result pre="its diagnosis, symptoms, and treatment modalities. Jatropha curcas normal pupils" exact="ptosis" post="snake bite Introduction Neuroparalytic snake bites are common in"/>
   <result pre="ophthalmologist was consulted for possible causes of toxins causing bilateral" exact="ptosis" post="with normal pupils, and a diagnosis of mixed toxins"/>
   <result pre="include: (i) Preparalytic syndrome (ii) paralysis first appears as bilateral" exact="ptosis" post="followed sequentially by bilateral ophthalmoplegia, paralysis of muscles of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5314823/results/search/disease/results.xml">
   <result pre="mainly used as a folk medicine in the treatment of" exact="diabetes mellitus," post="hypertension, and as an antimicrobial agent. The prime objective"/>
   <result pre="were also found to exhibit the positive activity against Mycobacterium" exact="tuberculosis" post="with MIC of 1600 μg/ml.[24] The leaves extracts have"/>
   <result pre="of antioxidants in diseases associated with oxidative stress (e.g. cancer," exact="diabetes mellitus" post="[DM], and neurodegenerative disorders) has gained much attention in"/>
   <result pre="treated animals also showed minimal signs of histological changes and" exact="dermatitis" post="compared with the untreated group. This finding suggests that"/>
   <result pre="millions of people across the world. DM is a complex" exact="metabolic disorder" post="resulting from either insulin insufficiency or insulin dysfunction. It"/>
   <result pre="are efficaciously used in angina, hepatitis, coronary artery disease, dysmenorrhea," exact="rheumatoid arthritis," post="traumatic injury, tumors, depression, renal failure, stroke prevention, and"/>
   <result pre="disease, dysmenorrhea, rheumatoid arthritis, traumatic injury, tumors, depression, renal failure," exact="stroke" post="prevention, and poststroke syndrome. The anticoagulant activity of A."/>
   <result pre="calcium oxalate crystals in renal tubules which can cause acute" exact="kidney failure." post="Bakul et al. reported a series of cases from"/>
   <result pre="from 5.5 to 12.3 mg/dl, and kidney biopsy showed an" exact="acute tubular necrosis" post="with calcium oxalate crystals. Seven out of the ten"/>
   <result pre="Nair et al. further reported two additional cases of acute" exact="nephropathy" post="with tubular oxalate deposition following ingestion of fruit juice.[47]"/>
   <result pre="these organic solvents have also been feasibly associated to generate" exact="cancer" post="or other deleterious toxicities in the human body. Therefore,"/>
   <result pre="which can be used against the oxidative stress and consecutive" exact="heart disease," post="stroke, cancer, and liver damage. The antihyperlipidemic property can"/>
   <result pre="anticancer agents in the therapeutic managements of DM, hypertension, or" exact="cancer" post="as well as other chronic syndromes. Conclusion A. bilimbi"/>
   <result pre="potent source of thrombolytic compoundsAvicenna J Phytomed20144430625386407 46BakulGUnniVNSeethaleksmyNVMathewARajeshRKurienGet al.Acute oxalate" exact="nephropathy" post="due to ‘Averrhoa bilimbi’ fruit juice ingestionIndian J Nephrol20132329730023960349"/>
   <result pre="to ‘Averrhoa bilimbi’ fruit juice ingestionIndian J Nephrol20132329730023960349 47NairSGeorgeJKumarSGraciousNAcute oxalate" exact="nephropathy" post="following ingestion of Averrhoa bilimbi juiceCase Rep Nephrol 20142014240936"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5327519/results/search/disease/results.xml">
   <result pre="Poverty2049-9957BioMed CentralLondon pmcid: 5327519264 doi: 10.1186/s40249-017-0264-8 : Research Article Urogenital" exact="schistosomiasis" post="and soil-transmitted helminthiasis (STH) in Cameroon: An epidemiological update"/>
   <result pre="5327519264 doi: 10.1186/s40249-017-0264-8 : Research Article Urogenital schistosomiasis and soil-transmitted" exact="helminthiasis" post="(STH) in Cameroon: An epidemiological update at Barombi Mbo"/>
   <result pre="Barombi Mbo and Barombi Kotto are well-known transmission foci of" exact="schistosomiasis" post="and soil-transmitted helminthiasis having had several important control initiatives"/>
   <result pre="Barombi Kotto are well-known transmission foci of schistosomiasis and soil-transmitted" exact="helminthiasis" post="having had several important control initiatives previously. To collect"/>
   <result pre="were characterised by DNA methods. Results Egg-patent prevalence of urogenital" exact="schistosomiasis" post="was 8.7% at Barombi Mbo (all light-intensity infections) and"/>
   <result pre="infections) and 40.1% at Barombi Kotto (21.2% heavy-intensity infections). Intestinal" exact="schistosomiasis" post="was absent. At Barombi Kotto, significantly more women reported"/>
   <result pre="Conclusions STH is currently at very low levels while urogenital" exact="schistosomiasis" post="is of greatest concern at Barombi Kotto. This assessment"/>
   <result pre="available to authorized users. Keywords Schistosoma haematobium Strongyloides Female genital" exact="schistosomiasis" post="WASH Bulinus Indoplanorbis exustus Multilingual abstracts Please see Additional"/>
   <result pre="against NTDs, especially those amenable to preventive chemotherapy, such as" exact="trachoma" post="[2], lymphatic filariasis [3] and onchocerciasis [4]. With regard"/>
   <result pre="those amenable to preventive chemotherapy, such as trachoma [2], lymphatic" exact="filariasis" post="[3] and onchocerciasis [4]. With regard to schistosomiasis and"/>
   <result pre="preventive chemotherapy, such as trachoma [2], lymphatic filariasis [3] and" exact="onchocerciasis" post="[4]. With regard to schistosomiasis and soil-transmitted helminthiasis (STH),"/>
   <result pre="[2], lymphatic filariasis [3] and onchocerciasis [4]. With regard to" exact="schistosomiasis" post="and soil-transmitted helminthiasis (STH), previous mapping initiatives have described"/>
   <result pre="[3] and onchocerciasis [4]. With regard to schistosomiasis and soil-transmitted" exact="helminthiasis" post="(STH), previous mapping initiatives have described the distributions of"/>
   <result pre="has been identified that more than two million people have" exact="schistosomiasis" post="infection, and a further five million live in high"/>
   <result pre="25, 26]. Furthermore, multidisciplinary studies on the transmission of urogenital" exact="schistosomiasis" post="have also included medical malacology [27–30] as well as"/>
   <result pre="Cameroon (see Fig. 1) in seminal attempts to control urogenital" exact="schistosomiasis" post="[35]. The prevalence of egg-patent infection with Sc. haematobium"/>
   <result pre="overall STH prevalence of 46.2% in the South-West Region, with" exact="trichuriasis" post="having highest prevalence (32.9%), followed by ascariasis (24.3%) and"/>
   <result pre="South-West Region, with trichuriasis having highest prevalence (32.9%), followed by" exact="ascariasis" post="(24.3%) and hookworm (15.0%) [37, 38]. The distribution of"/>
   <result pre="programme is developing national strategies to expand preventive chemotherapy against" exact="schistosomiasis" post="and STH, alongside assessing future opportunities to interrupt transmission"/>
   <result pre="objectives were to: (i) describe the prevalence and intensity of" exact="schistosomiasis" post="(Sc. mansoni and Sc. haematobium infections) and STH (inclusive"/>
   <result pre="adults and guardians of children. All participants found infected with" exact="schistosomiasis" post="or STH were offered praziquantel (40 mg/kg) and (or)"/>
   <result pre="(40 mg/kg) and (or) mebendazole (500 mg) treatment. Assessment of" exact="schistosomiasis" post="and soil-transmitted helminth infection A single stool and mid-morning"/>
   <result pre="dipstick (Rapid Medical Diagnostics®, Pretoria, South Africa) for detection of" exact="intestinal schistosomiasis." post="For each urine sample, up to 60 ml but"/>
   <result pre="to females ≥16 years of age to investigate female genital" exact="schistosomiasis" post="(FGS). FGS symptomatology included questions pertaining to intermenstrual bleeding,"/>
   <result pre="FGS symptomatology included questions pertaining to intermenstrual bleeding, genital itching," exact="vaginal discharge," post="dyspareunia and post coital bleeding. Local water and sanitation"/>
   <result pre="study site and cohort age with egg-patent prevalence of urogenital" exact="schistosomiasis" post="Barombi Mbo(n = 126) Barombi Kotto(n = 212) Total(n = 338) Adults &amp;gt;16 yearsPrevalence Population"/>
   <result pre="school-aged children, PSAC pre-school aged children Prevalence and intensity of" exact="schistosomiasis" post="Prevalence of schistosomiasis is shown in Table 1 across"/>
   <result pre="pre-school aged children Prevalence and intensity of schistosomiasis Prevalence of" exact="schistosomiasis" post="is shown in Table 1 across the different demographic"/>
   <result pre="regression analysis of location, demography and behaviour and egg-patent urogenital" exact="schistosomiasis" post="Variable Outcome category Unadjusted OR 95% CI P value"/>
   <result pre="Mbo and Barombi Kotto. b Key symptoms of female genital" exact="schistosomiasis" post="differ between crater lake populations Prevalence and intensity of"/>
   <result pre="diseases it may be able to transmit. In terms of" exact="schistosomiasis" post="and STH, the importance of the former was first"/>
   <result pre="became available and more affordable [73] could large-scale interventions against" exact="schistosomiasis" post="become scalable [74]. This was further enhanced by the"/>
   <result pre="at increasing scales of operation given the endemic zone of" exact="schistosomiasis" post="and STH in Cameroon [9–11, 13, 19, 38, 75–77]."/>
   <result pre="and STH in Cameroon [9–11, 13, 19, 38, 75–77]. Nonetheless" exact="schistosomiasis" post="and STH within these crater lakes have continued to"/>
   <result pre="been confirmed. Even today, however, the disease burden of urogenital" exact="schistosomiasis" post="is not fully appreciated, particularly in reference to FGS"/>
   <result pre="by mitigating reinfection more strongly. Previously the reinfection dynamics of" exact="schistosomiasis" post="have been shown to be variable at mixed infection"/>
   <result pre="mixed infection foci [19], but given that autochthonous transmission of" exact="intestinal schistosomiasis" post="is not possible here as Biomphalaria is absent, future"/>
   <result pre="infection foci [19], but given that autochthonous transmission of intestinal" exact="schistosomiasis" post="is not possible here as Biomphalaria is absent, future"/>
   <result pre="guard against reinfection, broadening the scope of intensified interventions against" exact="schistosomiasis" post="and STH to go beyond that of current anthelminthic"/>
   <result pre="sanitation was relatively similar between locations. Whilst the transmission of" exact="schistosomiasis" post="shares several features with STH, urogenital schistosomiasis sets itself"/>
   <result pre="the transmission of schistosomiasis shares several features with STH, urogenital" exact="schistosomiasis" post="sets itself apart by being transmitted within urine and"/>
   <result pre="for several other reasons outside that of current STH and" exact="schistosomiasis" post="control perspectives. Conclusions Our findings have implications in better"/>
   <result pre="have implications in better tailoring and evaluating future interventions against" exact="schistosomiasis" post="and STH, as several important lake-specific heterogeneities have been"/>
   <result pre="revealed. STH is currently at very low levels while urogenital" exact="schistosomiasis" post="is of greatest concern at Barombi Kotto. The study"/>
   <result pre="intensified control, for example, it is most insightful for urogenital" exact="schistosomiasis" post="in terms of gaining and sustaining control at Barombi"/>
   <result pre="CCA Circulating cathodic antigen DNA Deoxyribonucleic acid FGS Female genital" exact="schistosomiasis" post="GPS Global positioning system ITS Internal transcribed spacer JMP"/>
   <result pre="reaction PSAC Pre-school-aged children SAC School-aged children STH Soil transmitted" exact="helminthiasis" post="WASH Water, sanitation and hygiene Acknowledgements JRS, LATT, SJC"/>
   <result pre="Hien AT, Akame J, Zhang YB, Bella ALF: Prevalence of" exact="trachoma" post="in the North Region of Cameroon: results of a"/>
   <result pre="A, Zhang Y, Njiokou F, et al. Mapping of Bancroftian" exact="filariasis" post="in Cameroon: prospects for elimination. PLoS NTDs. 2015;9(9). 4.Wanji"/>
   <result pre="declaration on adherence to ivermectin treatment and parasitological indicators of" exact="onchocerciasis" post="in an area of persistent transmission despite a decade"/>
   <result pre="disease control in Cameroon, West AfricaPhotogramm Eng Remote Sens2002682175179 6.GreerGJMimpfoundiRMalekEAJokyANgonseuERatardRCHuman" exact="schistosomiasis" post="in Cameroon.2. Distribution of the snail hostsAm J Trop"/>
   <result pre="Trop Med Parasitol199286441341810.1080/00034983.1992.118126861463363 9.RatardRCKouemeniLEBessalaMMENdamkouCNEstimation of the number of cases of" exact="schistosomiasis" post="in a country – the example of CameroonTrans R"/>
   <result pre="the example of CameroonTrans R Soc Trop Med Hyg199286327427610.1016/0035-9203(92)90306-W1412651 10.RatardRCKouemeniLEBessalaMMENdamkouCNGreerGJSpilsburyJClineBLHuman" exact="schistosomiasis" post="in Cameroon.1. Distribution of schistosomiasisAm J Trop Med Hyg19904265615722115306"/>
   <result pre="Cameroon.1. Distribution of schistosomiasisAm J Trop Med Hyg19904265615722115306 11.RatardRCKouemeniLEBessalaMMENdamkouCNSamaMTClineBLAscariasis and" exact="trichuriasis" post="in CameroonTrans R Soc Trop Med Hyg1991851848810.1016/0035-9203(91)90170-42068772 12.Vercruysse J,"/>
   <result pre="soil-transmitted helminths are endemic. PLoS NTDs. 2011;5(3). 13.TchuenteLATN’GoranEKSchistosomiasis and soil-transmitted" exact="helminthiasis" post="control in Cameroon and Cote d’Ivoire: implementing control on"/>
   <result pre="budgetParasitology2009136131739174510.1017/S003118200900598819490723 14.NdamkouNCRatardRCAre sanitation, water-supply and a health-center sufficient to control" exact="schistosomiasis" post="– the case of Douloumi, North CameroonTrop Dr199020417617710.1177/004947559002000415 15.SamaMTRatardRCWater"/>
   <result pre="the case of Douloumi, North CameroonTrop Dr199020417617710.1177/004947559002000415 15.SamaMTRatardRCWater contact and" exact="schistosomiasis" post="infection in Kumba, South-Western CameroonAnn Trop Med Parasitol199488662963410.1080/00034983.1994.118129147893177 16.TchuenteLATSouthgateVRWebsterBLDe"/>
   <result pre="Parasitol199488662963410.1080/00034983.1994.118129147893177 16.TchuenteLATSouthgateVRWebsterBLDe BontJVercruysseJImpact of installation of a water pump on" exact="schistosomiasis" post="transmission in a focus in CameroonTrans R Soc Trop"/>
   <result pre="in CameroonTrans R Soc Trop Med Hyg200195325525610.1016/S0035-9203(01)90228-711490991 17.ClineBLHewlettBSCommunity-based approach to" exact="schistosomiasis" post="controlActa Trop199661210711910.1016/0001-706X(95)00118-X8740889 18.CuninPTchuenteLATPosteBDjibrillaKMartinPMVInteractions between Schistosoma haematobium and Schistosoma mansoni"/>
   <result pre="in single and mixed infection foci for intestinal and urogenital" exact="schistosomiasis" post="in CameroonActa Trop2013128227528310.1016/j.actatropica.2013.06.00723791803 20.WebsterBLTchuenteLATJourdaneJSouthgateVRThe interaction of Schistosoma haematobium and"/>
   <result pre="Soc Trop Med Hyg197165684110.1016/0035-9203(71)90106-45157446 36.ZharaASome notes on the incidence of" exact="schistosomiasis" post="in the southern CameroonsWest Afr Med J1953212629 37.Tchuente LAT,"/>
   <result pre="Kenfack CM, Gipwe NF, Akame J, et al. Mapping of" exact="schistosomiasis" post="and soil-transmitted helminthiasis in the regions of Centre, East"/>
   <result pre="NF, Akame J, et al. Mapping of schistosomiasis and soil-transmitted" exact="helminthiasis" post="in the regions of Centre, East and West Cameroon."/>
   <result pre="Gipwe NF, Dankoni E, Tarini A, Zhang YB. Mapping of" exact="schistosomiasis" post="and soil-transmitted helminthiasis in the regions of Littoral, North-West,"/>
   <result pre="E, Tarini A, Zhang YB. Mapping of schistosomiasis and soil-transmitted" exact="helminthiasis" post="in the regions of Littoral, North-West, South and South-West"/>
   <result pre="C, Dreyfuss G, Dumas M. An epidemiological study of pleuropulmonary" exact="paragonimiasis" post="among pupils in the peri-urban zone of Kumba town,"/>
   <result pre="Parasitol20111751–218719110.1016/j.vetpar.2010.09.02320970258 42.StothardJRKabatereineNBArcherJAl-ShehriHTchuem-TchuentéLAGyapongMBustinduyALA centenary of Robert T. Leiper’s lasting legacy on" exact="schistosomiasis" post="and a COUNTDOWN on control of neglected tropical diseasesParasitology2016111110.1017/S0031182016000998"/>
   <result pre="Feb 2017. 44.SomoRMZukamDTKouamouoJEnyongPRipertCAn epidemiological and radiological study of the vesical" exact="schistosomiasis" post="foci of the Barombi lakes, Meme Division, CameroonBull Soc"/>
   <result pre="the Barombi lakes, Meme Division, CameroonBull Soc Pathol Exot1987805813822 45.RollinsonDKlingerEVMgeniAEKhamisISStothardJRUrinary" exact="schistosomiasis" post="on Zanzibar: application of two novel assays for the"/>
   <result pre="with Schistosoma mansoni infection. PLoS NTDs. 2013;7(11). 49.RudgeJWStothardJRBasanezMGMgeniAFKhamisISKhamisANRollinsonDMicro-epidemiology of urinary" exact="schistosomiasis" post="in Zanzibar: Local risk factors associated with distribution of"/>
   <result pre="parasitic infections in the clinical laboratoryParasitology2014141141863187210.1017/S003118201400041924780241 56.BoissierJGrech-AngeliniSWebsterBLAllienneJFHuyseTMas-ComaSToulzaEBarre-CardiHRollinsonDKincaid-SmithJet al.Outbreak of urogenital" exact="schistosomiasis" post="in Corsica (France): an epidemiological case studyLancet Infect Dis201616897197910.1016/S1473-3099(16)00175-427197551"/>
   <result pre="(Bayluscide (R)), as a molluscicide in the control of human" exact="schistosomiasis" post="in Sahelian CameroonAnn Trop Med Parasitol2007101647948610.1179/136485907X19383317716430 73.SouthgateVRRollinsonDTchuenteLATHaganPTowards control of"/>
   <result pre="schistosomiasis in Sahelian CameroonAnn Trop Med Parasitol2007101647948610.1179/136485907X19383317716430 73.SouthgateVRRollinsonDTchuenteLATHaganPTowards control of" exact="schistosomiasis" post="in sub-Saharan AfricaJ Helminthol200579318118510.1079/JOH200530716153310 74.FenwickAWebsterJPBosque-OlivaEBlairLFlemingFMZhangYGarbaAStothardJRGabrielliAFClementsACAet al.The Schistosomiasis Control Initiative"/>
   <result pre="plans of LQAS sampling in the surveillance of the endemic" exact="schistosomiasis" post="in North-CameroonRevue D Epidemiol Et De Sante Publique201159319719810.1016/j.respe.2010.12.009 77.MassenetDToukourANgassamRIKDjaoRPortalJLTchuenteLATChanges"/>
   <result pre="Et De Sante Publique201159319719810.1016/j.respe.2010.12.009 77.MassenetDToukourANgassamRIKDjaoRPortalJLTchuenteLATChanges in the distribution of human" exact="schistosomiasis" post="in Far North province, Cameroon, since 1986Ann Trop Med"/>
   <result pre="North province, Cameroon, since 1986Ann Trop Med Parasitol2011105432532810.1179/136485911X1298767664974621871169 78.ChristinetVLazdins-HeldsJKStothardJRReinhard-RuppJFemale genital" exact="schistosomiasis" post="(FGS): from case reports to a call for concerted"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5350319/results/search/disease/results.xml">
   <result pre="in developing countries [3]. Despite the public health importance of" exact="schistosomiasis" post="and the risk that the disease might further spread"/>
   <result pre="the risk that the disease might further spread and intensify," exact="schistosomiasis" post="control programs in endemic countries are based mainly on"/>
   <result pre="it is today for some neglected tropical diseases such as" exact="trypanosomiasis" post="and leishmaniasis, the treatment of schistosomiasis was almost as"/>
   <result pre="tropical diseases such as trypanosomiasis and leishmaniasis, the treatment of" exact="schistosomiasis" post="was almost as difficult and toxic until the 1970s"/>
   <result pre="World Health Organization (WHO) for the treatment and control of" exact="schistosomiasis" post="[6]. This drug is safe and effective against all"/>
   <result pre="The growing need for the development of novel drugs against" exact="schistosomiasis" post="mainly from natural sources has, in recent years, led"/>
   <result pre="that roots of R. vomitoria possess antifilarial properties against Onchocerca" exact="volvulus" post="[24]. In this study, we evaluated the root and"/>
   <result pre="weeks after infection. The snails B. pfeifferi, which are the" exact="schistosomiasis" post="intermediate host snails for S. mansoni, were collected from"/>
   <result pre="stem bark seems to be very less toxic to the" exact="cancer" post="liver cell lines but relatively toxic to the normal"/>
   <result pre="line while the roots seem to be more toxic against" exact="cancer" post="cell than the normal cell line. 4. Discussion The"/>
   <result pre="plants as a new approach for the experimental treatment of" exact="schistosomiasis" post="is one of the viable and promising research leads."/>
   <result pre="searches revealed that many plants have been used to treat" exact="schistosomiasis" post="in many African cultures [11, 33–35]. In Mali an"/>
   <result pre="to 30 families to be used for treating urinary and" exact="intestinal schistosomiasis," post="while nine combinations of plants were reported to be"/>
   <result pre="erecta were reported as the plants most frequently used against" exact="schistosomiasis" post="in Mali [34]. Mølgaard et al. (2001) reported that"/>
   <result pre="al. (2001) reported that 21 Zimbabwean plants, traditionally used against" exact="schistosomiasis" post="possess activity against schistosomula worms, with Euclea natalensis having"/>
   <result pre="35]. The results obtained on Zimbabwean plants used to treat" exact="schistosomiasis" post="suggested that extracts made from Abrus precatorius, Pterocarpus angolensis,"/>
   <result pre="Chang liver cell. For the HepG2, which is a human" exact="liver cancer" post="cell, the IC50 values were 490.7 and 72.68, respectively,"/>
   <result pre="liver cell. For the HepG2, which is a human liver" exact="cancer" post="cell, the IC50 values were 490.7 and 72.68, respectively,"/>
   <result pre="roots. This means the roots are more toxic to the" exact="liver cancer" post="cell lines than the stem bark. Based on the"/>
   <result pre="This means the roots are more toxic to the liver" exact="cancer" post="cell lines than the stem bark. Based on the"/>
   <result pre="the above observations, stem bark is less active against the" exact="cancer" post="cell line. In the US NCI plant screening program,"/>
   <result pre="(&amp;lt;1). Although the roots are active against Schistosoma parasites and" exact="liver cancer" post="cells (HepG2), the activity is not specific, and they"/>
   <result pre="Although the roots are active against Schistosoma parasites and liver" exact="cancer" post="cells (HepG2), the activity is not specific, and they"/>
   <result pre="(Euphorbiaceae) and Rauvolfia vomitoria Afzel (Apocynaceae) demonstrate activities against Onchocerca" exact="volvulus" post="Microfilariae in vitroBMC Complementary and Alternative Medicine201313, article 6610.1186/1472-6882-13-66"/>
   <result pre="33NdambaJ.NyazemaN.MakazaN.AndersonC.KaonderaK. C.Traditional herbal remedies used for the treatment of urinary" exact="schistosomiasis" post="in ZimbabweJournal of Ethnopharmacology199442212513210.1016/0378-8741(94)90106-68072305 34BahS.DialloD.DembéléS.PaulsenB. S.Ethnopharmacological survey of plants"/>
   <result pre="34BahS.DialloD.DembéléS.PaulsenB. S.Ethnopharmacological survey of plants used for the treatment of" exact="schistosomiasis" post="in Niono District, MaliJournal of Ethnopharmacology2006105338739910.1016/j.jep.2005.11.02616414223 35SpargS. G.Van StadenJ.JägerA."/>
   <result pre="an updated reviewMini-Reviews in Medicinal Chemistry201313131879190210.2174/1389557511313666009724070206 51HuangM.LuJ.-J.HuangM.-Q.BaoJ.-L.ChenX.-P.WangY.-T.Terpenoids: natural products for" exact="cancer" post="therapyExpert Opinion on Investigational Drugs201221121801181810.1517/13543784.2012.72739523092199 52De MoraesJ.Natural products with"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5371198/results/search/disease/results.xml">
   <result pre="pmcid: 5371198 pmid: 28351414286 doi: 10.1186/s40249-017-0286-2 : Scoping Review Controlling" exact="schistosomiasis" post="with praziquantel: How much longer without a viable alternative?"/>
   <result pre="properties in plants. Here, we summarise recent progress made in" exact="schistosomiasis" post="chemotherapy, placing particular emphasis on repositioning of existing drugs"/>
   <result pre="a disease of poverty [3, 4]. The global burden of" exact="schistosomiasis" post="is estimated at 2.6 million disability-adjusted life years (DALYs)"/>
   <result pre="days lost annually is far below those calculated for HIV/AIDS," exact="malaria" post="and tuberculosis, the perceived importance of schistosomiasis is now"/>
   <result pre="calculated for HIV/AIDS, malaria and tuberculosis, the perceived importance of" exact="schistosomiasis" post="is now more realistic than 10–15 years ago. Indeed,"/>
   <result pre="previously counted by the Global Burden of Disease (GBD) study," exact="schistosomiasis" post="now comes second on the list of 18 (after"/>
   <result pre="Cambodia and Lao People’s Democratic Republic [14]. The pathology characterising" exact="schistosomiasis" post="is primarily the result of immune responses against schistosome"/>
   <result pre="diagnosis [16]. A systematic review and geostatistical analysis pertaining to" exact="schistosomiasis" post="in sub-Saharan Africa suggests that the prevalence and distribution"/>
   <result pre="spectrum against helminth infections, remains the drug of choice for" exact="schistosomiasis" post="chemotherapy since almost 40 years [18, 19]. Thanks to"/>
   <result pre="various ailments since ancient times marked the end of non-specific" exact="schistosomiasis" post="chemotherapy [27, 28]. Schistosomiasis control is at a pivotal"/>
   <result pre="road map for the global control of the NTDs includes" exact="schistosomiasis" post="[30]. However, control – let alone elimination – of"/>
   <result pre="schistosomiasis [30]. However, control – let alone elimination – of" exact="schistosomiasis" post="has proven difficult because of rapid re-infection due to"/>
   <result pre="not dwindle, particularly not in low- and middle-income countries where" exact="schistosomiasis" post="inflicts a disproportionately high burden of disease. Judging from"/>
   <result pre="Judging from the veterinary field, development of drug resistance in" exact="helminthiasis" post="can be swift [35] and the situation with respect"/>
   <result pre="can be swift [35] and the situation with respect to" exact="malaria" post="is a constant reminder of this risk [36]. Laboratory"/>
   <result pre="risk [36]. Laboratory studies The search for new drugs against" exact="schistosomiasis" post="has taken various directions, including testing natural compounds, target-based"/>
   <result pre="also contain compounds with such effect, notably drugs used for" exact="cancer" post="therapy [51]. Table 1 contains a list of candidate"/>
   <result pre="drugs described in some detail with regard to use against" exact="schistosomiasis" post="summarising their effect on adult and juvenile schistosomes, including"/>
   <result pre="played a major role in drug discovery, in particular for" exact="malaria" post="treatment and prophylaxis. While quinine and artemisinin come straight"/>
   <result pre="deemed a strong indication of a novel drug lead for" exact="schistosomiasis" post="[74]. Anticancer drugs It has further been demonstrated that"/>
   <result pre="has so far mainly been used in the treatment of" exact="chronic lymphocytic leukemia," post="low-grade non-Hodgkin’s lymphoma and Hodgkin’s disease, and is on"/>
   <result pre="used in the treatment of chronic lymphocytic leukemia, low-grade non-Hodgkin’s" exact="lymphoma" post="and Hodgkin’s disease, and is on the WHO list"/>
   <result pre="only to reproduction processes, but also to the pathology of" exact="schistosomiasis" post="[79]. Kinases represent therefore attractive targets for new-generation antischistosomal"/>
   <result pre="the plant Artemisia annua recommended in Chinese traditional medicine against" exact="malaria" post="(and other ailments), constituted the starting point for the"/>
   <result pre="including the artemisinins along with praziquantel in areas endemic for" exact="schistosomiasis" post="and co-endemic for malaria [88, 90]. In more detail,"/>
   <result pre="with praziquantel in areas endemic for schistosomiasis and co-endemic for" exact="malaria" post="[88, 90]. In more detail, the antischistosomal effect of"/>
   <result pre="artesunate, however, must be taken seriously as the emergence of" exact="malaria" post="parasites resistant to the artemisinins have shown [99, 100]."/>
   <result pre="assessed as an alternative to ivermectin in the treatment of" exact="onchocerciasis" post="in humans. In the frame of this programme its"/>
   <result pre="the treatment of domestic animals in the context of zoonotic" exact="schistosomiasis" post="[115], increases the risk for development of resistance and"/>
   <result pre="we are still years from potential field application of a" exact="schistosomiasis" post="vaccine. In addition, new drugs are an unconditional necessity"/>
   <result pre="a landmark in the advance towards completely new drugs against" exact="schistosomiasis" post="(and also malaria), ongoing research on repositioning existing drugs"/>
   <result pre="alternatives to praziquantel are necessary for sustaining the control of" exact="schistosomiasis" post="and approaching the goal of eliminating this scourge from"/>
   <result pre="integrated control of schistosomiasisActa Trop2011120Suppl 1S1213710.1016/j.actatropica.2010.08.02020831855 10.LaiYSBiedermannPEkpoUFGarbaAMathieuEMidziNMwinziPN’GoranEKRasoGAssaréRKet al.Spatial distribution of" exact="schistosomiasis" post="and treatment needs in sub-Saharan Africa: a systematic review"/>
   <result pre="review and geostatistical analysisLancet Infect Dis20151589274010.1016/S1473-3099(15)00066-326004859 11.ScholteRGCGosoniuLMaloneJBChammartinFUtzingerJVounatsouPPredictive risk mapping of" exact="schistosomiasis" post="in Brazil using Bayesian geostatistical modelsActa Trop2014132576310.1016/j.actatropica.2013.12.00724361640 12.UtzingerJBergquistROlvedaRZhouXNImportant helminth"/>
   <result pre="27.ShekharKCSchistosomiasis drug therapy and treatment considerationsDrugs199142337940510.2165/00003495-199142030-000041720380 28.KnoppSBeckerSLIngramKJKeiserJUtzingerJDiagnosis and treatment of" exact="schistosomiasis" post="in children in the era of intensified controlExpert Rev"/>
   <result pre="Infect Ther2013111112375810.1586/14787210.2013.84406624127662 29.RollinsonDKnoppSLevitzSStothardJRTchuem TchuentéLAGarbaAMohammedKASchurNPersonBColleyDGet al.Time to set the agenda for" exact="schistosomiasis" post="eliminationActa Trop201312824234010.1016/j.actatropica.2012.04.01322580511 30.collab: WHOAccelerating work to overcome the global"/>
   <result pre="review and meta-analysisPLoS Negl Trop Dis201481210.1371/journal.pntd.000329625474705 32.SokolowSHWoodCLJonesIJSwartzSJLopezMHsiehMHLaffertyKDKurisAMRickardsCDe LeoGAGlobal assessment of" exact="schistosomiasis" post="control over the past century shows targeting the snail"/>
   <result pre="sequence of Schistosoma haematobiumNat Genet2012442221510.1038/ng.106522246508 47.FerreiraLGOlivaGAndricopuloADTarget-based molecular modeling strategies for" exact="schistosomiasis" post="drug discoveryFuture Med Chem2015767536410.4155/fmc.15.2125996068 48.WebsterJPOlivieraGRollinsonDGowerCMSchistosome genomes: a wealth of"/>
   <result pre="Infect Dis200865253810.1016/j.tmaid.2008.06.00618760248 64.SchlagenhaufPAdamcovaMRegepLSchaererMTRheinHGThe position of mefloquine as a 21st century" exact="malaria" post="chemoprophylaxisMalar J2010935710.1186/1475-2875-9-35721143906 65.KeiserJCholletJXiaoSHMeiJYJiaoPYUtzingerJTannerMMefloquine-an aminoalcohol with promising antischistosomal properties in"/>
   <result pre="71.Ingram-SieberKCowanNPanicGVargasMMansourNRBickleQDWellsTNSpangenbergTKeiserJOrally active antischistosomal early leads identified from the open access" exact="malaria" post="boxPLoS Negl Trop Dis20148110.1371/journal.pntd.000261024416463 72.CowanNDatwylerPErnstBWangCVennerstromJLSpangenbergTKeiserJActivities of N, N’-Diarylurea MMV665852"/>
   <result pre="metal complexesAntimicrob Agents Chemother20166095331610.1128/AAC.00778-1627324765 75.EissaMMEl-AzzouniMZAmerEIBaddourNMMiltefosine, a promising novel agent for" exact="schistosomiasis" post="mansoniInt J Parasitol20114122354210.1016/j.ijpara.2010.09.01021055404 76.El-MoslemanyRMEissaMMRamadanAAEl-KhordaguiLKEl-AzzouniMZMiltefosine lipid nanocapsules: intersection of drug"/>
   <result pre="repurposing and nanotechnology for single dose oral treatment of pre-patent" exact="schistosomiasis" post="mansoniActa Trop2016159142810.1016/j.actatropica.2016.03.03827039667 77.EissaMMMossallamSFAmerEIYounisLKRashedHARepositioning of chlorambucil as a potential anti-schistosomal"/>
   <result pre="chemoprophylaxis of major human schistosome parasitesCurr Med Chem200181518416010.2174/092986701337158111772354 87.UtzingerJXiaoSHTannerMKeiserJArtemisinins for" exact="schistosomiasis" post="and beyondCurr Opin Investig Drugs2007821051617328226 88.UtzingerJTannerMKeiserJACTs for schistosomiasis: do"/>
   <result pre="in Plasmodium falciparumCurr Opin Infect Dis2011246570710.1097/QCO.0b013e32834cd3ed22001944 100.TaylorSMJulianoJJArtemisinin combination therapies and" exact="malaria" post="parasite drug resistance: the game is afootJ Infect Dis20142103335710.1093/infdis/jiu14224610873"/>
   <result pre="is afootJ Infect Dis20142103335710.1093/infdis/jiu14224610873 101.ElmorshedyHTannerMBergquistRNSharafSBarakatRProphylactic effect of artemether on human" exact="schistosomiasis" post="mansoni among Egyptian children: a randomized controlled trialActa Trop201615852810.1016/j.actatropica.2016.02.01526921676"/>
   <result pre="107.AwadziKOpokuNOAttahSKLazdins-HeldsJKueselACA randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca" exact="volvulus" post="infectionPLoS Negl Trop Dis20148610.1371/journal.pntd.000295324968000 108.SelimSEl SagheerOEl AmirABarakatRHadleyKBruinsMJEl RidiREfficacy and"/>
   <result pre="Parasitol200319115091510.1016/j.pt.2003.09.00514580962 111.LoNCAddissDGHotezPJKingCHStothardJREvansDSColleyDGLinWCoulibalyJTBustinduyALet al.A call to strengthen the global strategy against" exact="schistosomiasis" post="and soil-transmitted helminthiasis: the time is nowLancet Infect Dis2017172e64910.1016/S1473-3099(16)30535-727914852"/>
   <result pre="al.Efficacy and safety of praziquantel for the treatment of human" exact="schistosomiasis" post="during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trialLancet"/>
   <result pre="in schools and communities targeted for the elimination of urogenital" exact="schistosomiasis" post="in Zanzibar: a cross-sectional surveyParasit Vectors20169510.1186/s13071-015-1244-026727915 115.HongQBYangKHuangYXSunLPYangGJGaoYGaoYZhangLHZhouMSteinmannPet al.Effectiveness of"/>
   <result pre="Zanzibar: a cross-sectional surveyParasit Vectors20169510.1186/s13071-015-1244-026727915 115.HongQBYangKHuangYXSunLPYangGJGaoYGaoYZhangLHZhouMSteinmannPet al.Effectiveness of a comprehensive" exact="schistosomiasis" post="japonica control program in Jiangsu province, China, from 2005"/>
   <result pre="1S151710.1016/j.actatropica.2010.11.00621147056 116.BergquistRUtzingerJMcManusDPTrick or treat: the role of vaccines in integrated" exact="schistosomiasis" post="controlPLoS Negl Trop Dis20082610.1371/journal.pntd.000024418575619 117.TebejeBMHarvieMYouHLoukasAMcManusDPSchistosomiasis vaccines: where do we"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5388655/results/search/disease/results.xml">
   <result pre="been described to be useful against skin diseases, liver troubles," exact="tuberculosis" post="glands, and its use in the treatment of hematemesis,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5426722/results/search/disease/results.xml">
   <result pre="fabago are not the first choices for further evaluations in" exact="cancer" post="researches but it is suggested to isolate and purify"/>
   <result pre="of apigenin and liquiritigenin in rat h4iie hepatoma and c6" exact="glioma" post="cellsFood Chem Toxicol20074511192410.1016/j.fct.2006.08.00817045382 16KumarSPandeyAKChemistry and biological activities of flavonoids:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5441158/results/search/disease/results.xml">
   <result pre="table-count: equation-count: ref-count: page-count: INTRODUCTION Strongyloidiasis is a global emerging" exact="infectious disease" post="with highest prevalence in Southern, Eastern, and Central Europe,"/>
   <result pre="the action of the larvae, preventing reinfection cycles in disseminated" exact="strongyloidiasis" post="and could possibly interfere with parthenogenetic females by preventing"/>
   <result pre="managementPLoS Negl Trop Dis20148e301825121962 2ZueterAMMohamedZAbdullahADMohamadNArifinNOthmanNDetection of Strongyloides stercoralis infection among" exact="cancer" post="patients in a major hospital in Kelantan, MalaysiaSingapore Med"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5456064/results/search/disease/results.xml">
   <result pre="Pneumonia, kidney stone, ulcer, chest pain, external wounds, dysmenorrhea, toothache," exact="asthma" post="0.11 0.43 26◆101∎21◆102●103∎104◆66●105∎80◆ 2 Amaranthus spinosus L. Amaranthaceae, HAF-02"/>
   <result pre="powder; BA. decoction Oral, Gargle Anthelminthic, stomachache, diuretic, cataract, toothache," exact="constipation" post="0.09 0.32 26◆101∎21◆102●103∎104◆66●105∎80◆ 3 Amaranthus viridis L. Amaranthaceae, HAF-03"/>
   <result pre="W H P LE. Juice; ST.FL.RT. decoction Topical, Oral Wounds," exact="peptic ulcer," post="tonic, cough and bronchitis 0.06 0.33 26◆101∎21◆102●103∎104◆66●105∎80◆ 9 Conyza"/>
   <result pre="decoction Oral, Topical Malarial fever, burns, blood purifier, burning urination," exact="liver cancer," post="hair tonic 0.15 0.37 26◆101∎21◆102●103∎104◆66●105∎80◆ 12 Launaea procumbens Roxb."/>
   <result pre="paste; WP. powder Oral, Topical Fever, cough, asthma, constipation, wounds," exact="dyspepsia" post="0.11 0.27 26◆101∎21◆102●103∎104◆66●105∎80◆ 15 Xanthium strumarium L. Asteraceae, HAF-13"/>
   <result pre="juice; FR. infusion; decoction, powder; SD. poultice Oral, Topical Ophthalmia," exact="mumps" post="and measles, dyspepsia, face pimples, cuts and wounds 0.11"/>
   <result pre="decoction, paste; RT. powder Oral, Topical Constipation, gastric, jaundice, cough," exact="urinary tract infection," post="eczema, wounds, rheumatism 0.10 0.38 26◆101∎21◆102●103∎104◆66●105∎80◆ 19 Capparis deciduas"/>
   <result pre="powder; SH. decoction; LE. paste; FL.SD. decoction Oral, Topical Male" exact="sexual dysfunction," post="hemolytic anemia, vermifuge, stomachache, liver tonic, boils and swellings,"/>
   <result pre="decoction; LE. paste; FL.SD. decoction Oral, Topical Male sexual dysfunction," exact="hemolytic anemia," post="vermifuge, stomachache, liver tonic, boils and swellings, sciatic 0.05"/>
   <result pre="ST. decoction, ash; WP. decoction Oral, Topical Diuretic, blood purifier," exact="liver cancer," post="snake bites, kidney stone, hair tonic 0.08 0.41 26◆101∎21◆102●103∎104◆66●105∎80◆"/>
   <result pre="powder, paste, decoction Oral, Topical Diuretic, vermifuge, dermatitis, stomachache, galactagogue," exact="hypersplenism" post="0.12 0.84 26◆101∎21◆102●103∎104◆66●105∎80◆ 28 Chrozophora tinctoria (L.) A.Juss* Euphorbiaceae,"/>
   <result pre="extract; ST. juice Oral, Eye drop Stomachache, sore throat, emetic," exact="cataract" post="0.07 0.20 26◆101∎21◆102●103∎104◆66●105∎80◆ 29 Croton sparsiflorus Morong Euphorbiaceae, HAF-32"/>
   <result pre="powder; ST. juice; WP. juice, decoction Oral, Topical Bone fracture," exact="gastric ulcer," post="hemorrhage, hair tonic, dermatitis, dengue fever, cardiac tonic 0.05"/>
   <result pre="Oral, Topical Bone fracture, gastric ulcer, hemorrhage, hair tonic, dermatitis," exact="dengue fever," post="cardiac tonic 0.05 0.64 26◆101∎21◆102●103∎104◆66●105∎80◆ 30 Euphorbia dracunculoides Lam."/>
   <result pre="juice Oral, Topical Lice killer, headache, skin parasites, snake bite," exact="epilepsy" post="0.09 0.28 26◆101∎21◆102●103∎104◆66●105∎80◆ 31 Euphorbia helioscopia L. Euphorbiaceae, HAF-28"/>
   <result pre="Topical, Toothbrush Toothache, carminative, tonic, cooling agent, back pain, bronchitis," exact="asthma" post="0.06 0.54 26◆101∎21◆102●103∎104◆66●105∎80◆ 35 Acacia nilotica L. Fabaceae, HAF-41"/>
   <result pre="decoction, paste, infusion; BA. decoction; BA. powder; Oral, Topical Emetic," exact="diarrhea" post="and vermifuge, cut and wounds, fever, nosebleed, constipation, hair"/>
   <result pre="boils and blisters, scorpion bite, pancreatic stone, leucorrhoea, chronic dysentery," exact="cataract" post="0.09 0.42 26◆101∎21◆102●103∎104◆66●105∎80◆ 40 Prosopis juliflora Swartz* Fabaceae, HAF-40"/>
   <result pre="powder Oral, Topical and as Toothbrush Galactagogue, kidney stones, toothache," exact="breast cancer," post="asthma, boils 0.07 0.40 26◆101∎21◆102●103∎104◆66●105∎80◆ 41 Trifolium resupinatum L*"/>
   <result pre="Oral, Topical and as Eye drop Diarrhea and dysentery, wounds," exact="hepatitis" post="and jaundice, eye ache, anthelminthic, premature ejaculation 0.09 0.37"/>
   <result pre="Diarrhea and dysentery, wounds, hepatitis and jaundice, eye ache, anthelminthic," exact="premature ejaculation" post="0.09 0.37 26◆101∎21◆102●103∎104◆66●105∎80◆ 43 Hibiscus rosa-sinensis L. Malvaceae, HAF-37"/>
   <result pre="decoction; WP. powder Oral, Topical Sores and wounds, eczema, asthma," exact="diarrhea" post="0.04 0.44 26◆101∎21◆102●103∎104◆66●105∎80◆ 46 Malvaviscus arboreus (Torr. &amp;amp; Gray)"/>
   <result pre="P FR. powder; BA. infusion; ST. latex Oral Diabetes, ulcer," exact="breast cancer" post="0.06 0.25 26◆101∎21◆102●103∎104◆66●105∎80◆ 53 Morus alba L. Moraceae, HAF-48"/>
   <result pre="FR. powder; BA. infusion; ST. latex Oral Diabetes, ulcer, breast" exact="cancer" post="0.06 0.25 26◆101∎21◆102●103∎104◆66●105∎80◆ 53 Morus alba L. Moraceae, HAF-48"/>
   <result pre="infusion; LE. paste; RT. decoction, powder Oral, Topical Dysmenorrheal, snakebite," exact="kidney failure," post="cough, flu and asthma 0.10 0.29 26◆101∎21◆102●103∎104◆66●105∎80◆ 58 Jasminum"/>
   <result pre="powder Oral, Topical Dysmenorrheal, snakebite, kidney failure, cough, flu and" exact="asthma" post="0.10 0.29 26◆101∎21◆102●103∎104◆66●105∎80◆ 58 Jasminum officinale L* Oleaceae, HAF-53"/>
   <result pre="paste; ST. powder Oral, Topical Abortifacient, diarrhea, indigestion, piles, antispasmodic," exact="scabies" post="0.06 0.50 26◆101∎21◆102●103∎104◆66●105∎80◆ 64 Eleusine indica (L.) Gaertn. Poaceae,"/>
   <result pre="FL.LE. decoction; ST. powder Oral, Topical Leprosy, skin ulcer, epilepsy," exact="hepatitis" post="0.09 0.22 26◆101∎21◆102●103∎104◆66●105∎80◆ 72 Ranunculus sceleratus L* Ranunculaceae, HAF-71"/>
   <result pre="decoction Oral, Topical Tonic, diabetes, constipation, cold and sore throat," exact="scabies" post="0.09 0.26 26◆101∎21◆102●103∎104◆66●105∎80◆ 74 Zizyphus mauritiana Lam. Rhamnaceae, HAF-72"/>
   <result pre="Topical and as Inhale Piles, asthma, cough, laxative, lice killer," exact="premature ejaculation," post="sedative and narcotic, rabies 0.07 0.57 26◆101∎21◆102●103∎104◆66●105∎80◆ 78 Solanum"/>
   <result pre="asthma, cough, laxative, lice killer, premature ejaculation, sedative and narcotic," exact="rabies" post="0.07 0.57 26◆101∎21◆102●103∎104◆66●105∎80◆ 78 Solanum nigrum L. Solanaceae, HAF-76"/>
   <result pre="pate; WP. decoction Oral, Topical, Eye drop Cuts and wounds," exact="breast cancer," post="chicken pox, fever, diarrhea, ulcer, piles, cardiac pain, diabetes,"/>
   <result pre="foot cracks, vermifuge, liver tonic, wound healing, rheumatism, kidney stones," exact="asthma" post="0.17 0.86 26◆101∎21◆102●103∎104◆66●105∎80◆ 80 Withania somnifera (L.) Dunnel. Solanaceae,"/>
   <result pre="Oral, Topical and as Snuff Malaria, night mare, stomachache, asthma," exact="breast cancer," post="diabetes, wounds, menstrual flow 0.14 0.86 26◆101∎21◆102●103∎104◆66●105∎80◆ 81 Pterospermum"/>
   <result pre="paste Oral, Topical Dysentery and diarrhea, urodynia, irregular menstruation, wounds," exact="dyspepsia" post="0.13 0.27 26◆101∎21◆102●103∎104◆66●105∎80◆ A Habit/Life forms: W, Wild; C,"/>
   <result pre="= 15), were used to relieve urinary system disorder and" exact="eye disease," post="respectively by the inhabitants of the study area. Novelty"/>
   <result pre="GandhiT. Antiurolithiatic effects of Solanum xanthocarpum fruit extract on ethylene-glycol-induced" exact="nephrolithiasis" post="in rats. Journal of Young Pharmacists. 2012; 4: 164–170."/>
   <result pre="LeeB-H, ShiYC, et al.Anti-cancer activity of Solanum nigrum (AESN) through" exact="suppression" post="of mitochondrial function and epithelial-mesenchymal transition (EMT) in breast"/>
   <result pre="through suppression of mitochondrial function and epithelial-mesenchymal transition (EMT) in" exact="breast cancer" post="cells. Molecules, 2016; 21: 553. 98SrithiK, BalslevH, WangpakapattanawongP, SrisangaP,"/>
   <result pre="suppression of mitochondrial function and epithelial-mesenchymal transition (EMT) in breast" exact="cancer" post="cells. Molecules, 2016; 21: 553. 98SrithiK, BalslevH, WangpakapattanawongP, SrisangaP,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5456238/results/search/disease/results.xml">
   <result pre="spinosa is a spiny shrub used for the management of" exact="arthritis" post="in southwest Nigeria [1]. The fruit is used for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5557511/results/search/disease/results.xml">
   <result pre="ivermectin was observed. Since vaccine and safe macrofilaricidal treatment against" exact="onchocerciasis" post="are still lacking, there is an urgent need to"/>
   <result pre="interest in the prevention and control of those diseases, lymphatic" exact="filariasis" post="(LF) and onchocerciasis continue to spread in the developing"/>
   <result pre="prevention and control of those diseases, lymphatic filariasis (LF) and" exact="onchocerciasis" post="continue to spread in the developing countries causing disabilities"/>
   <result pre="disabilities [2]. Onchocerciasis is a filarial disease caused by Onchocerca" exact="volvulus" post="and transmitted by the blackflies of the genus Simulium"/>
   <result pre="the disease is characterized by cutaneous manifestations such as nodules," exact="dermatitis" post="and ultimately ocular syndrome. Globally, within the 37 million"/>
   <result pre="Adamawa region of Cameroon, the prevalence of human and animal" exact="onchocerciasis" post="has been estimated at 30% and 65% respectively [5]."/>
   <result pre="have high agricultural potential [5]. Thus, a high burden of" exact="onchocerciasis" post="in a country leads primarily to low productivity and"/>
   <result pre="slowdown of development [6]. Several approaches were attempted to control" exact="onchocerciasis" post="in Human. The control started with vector control involving"/>
   <result pre="drugs including ivermectin which is actually the recommended molecule against" exact="onchocerciasis" post="[8]. Although this drug reduces significantly transmission of the"/>
   <result pre="of L. lanceolata by traditional healers in the treatment of" exact="onchocerciasis" post="and other worm infections. Moreover, L. lanceolata possesses significant"/>
   <result pre="goals-why the &quot;other diseases&quot; matter: reality versus rhetoricParasit Vectors2011423410.1186/1756-3305-4-23422166580 2.KeatingJYukichJOMollenkopfbSTediosiFLymphatic" exact="filariasis" post="and onchocerciasis prevention, treatment, and control costs across diverse"/>
   <result pre="&quot;other diseases&quot; matter: reality versus rhetoricParasit Vectors2011423410.1186/1756-3305-4-23422166580 2.KeatingJYukichJOMollenkopfbSTediosiFLymphatic filariasis and" exact="onchocerciasis" post="prevention, treatment, and control costs across diverse settings: a"/>
   <result pre="the Esperanza window trap for the collection of the African" exact="onchocerciasis" post="vector Simulium damnosum sensu latoActa Trop2014137394310.1016/j.actatropica.2014.04.02924794201 4.EzeJMaturBMAssessment of the"/>
   <result pre="damnosum sensu latoActa Trop2014137394310.1016/j.actatropica.2014.04.02924794201 4.EzeJMaturBMAssessment of the epidemiology of Onchocerca" exact="volvulus" post="after treatment with ivermectin in the federal capital territory,"/>
   <result pre="injectionAnn Trop Med Parasit19918532933710.1080/00034983.1991.118125691746982 6.GonzalezRJCruz-OrtizNRizoNRichardsJZea-FloresGDomınguezASauerbreyMCatuEOlivaORichardsFOJLindbladeKASuccessful interruption of transmission of Onchocerca" exact="volvulus" post="in the Escuintla-guatemala focusGuatemala PLOS Negl Trop Dis2009310.1371/journal.pntd.000040419333366 7.BoatinBAThe"/>
   <result pre="volvulus in the Escuintla-guatemala focusGuatemala PLOS Negl Trop Dis2009310.1371/journal.pntd.000040419333366 7.BoatinBAThe" exact="onchocerciasis" post="control Programme in West Africa (OCP)Ann Trop Med Parasitol2008102Suppl"/>
   <result pre="feasibility using ivermectin (Mectizan®) monotherapyActa Trop2011120SS100S10810.1016/j.actatropica.2010.08.009 10.EsumMWanjiSTendongforNEnyongPCo-endemicity of loiasis and" exact="onchocerciasis" post="in the south West Province of Cameroon: implications for"/>
   <result pre="in vitro thrombolysisBMC Complem Altern M.20151512810.1186/s12906-015-0643-2 20.BorsboomGJJJMBoatinBANagelkerkeNJDAgouaHAkpobouaKLBAlleyEWSBissanYRenzAYameogoLRemmeJHFHabbemaJDFImpact of Ivermectin on" exact="onchocerciasis" post="transmission: assessing the empirical evidence that repeated Ivermectin mass"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5566135/results/search/disease/results.xml">
   <result pre="Westhuizen, &amp;amp; Botes, 2007); Conjunctivitis, other eye ailments, internal parasites," exact="infertility" post="in men and women (Grace, Simmonds, Smith, &amp;amp; Van"/>
   <result pre="purgative (Liu (Liu, Van der Kooy, &amp;amp; Verpoorte, 2009); Oesophageal" exact="candidiasis" post="(Otang, Grierson, &amp;amp; Ndip, 2012); Perfume smallpox, stomach-aches (Asres"/>
   <result pre="(0.5) Colds &amp;amp; flues Decongestants of upper respiratory tract in" exact="common cold," post="inflamed mucous membranes of the throat (Dixit, Rohilla, &amp;amp;"/>
   <result pre="cook Qobo Gunnera perpensa L. (Gunneraceae) 2(1) Boost immunity Gonorrhoea," exact="syphilis" post="(Buwa &amp;amp; Van Staden, 2006) Whole plant Cook the"/>
   <result pre="(van Wyk &amp;amp; Gericke, 2000); Treatment of cough, flu and" exact="common cold," post="antimicrobial activity (Dekker, Fourie, Snyckers, &amp;amp; Van der Schyf,"/>
   <result pre="of aqueous extracts of Aloe ferox and Withania somnifera on" exact="herpes simplex" post="virus type 1 in cell culture: research in actionSouth"/>
   <result pre="Hyg77475776317978084 18LawalIGriersonDAfolayanA2014Phytotherapeutic information on plants used for the treatment of" exact="tuberculosis" post="in eastern cape province, South AfricaEvidence-Based Complementary and Alternative"/>
   <result pre="Nepaleseculturalfactors affectadherenceto antiretroviral treatment in Nepal?Health Science Journal513747 47collab: WHO2014Global" exact="tuberculosis" post="report 2014GenevaWHO 48WinkMVan WykB.-E2004Medicinal plants of the worldTimber PressNew"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5622384/results/search/disease/results.xml">
   <result pre="albicans), and protozoa that are responsible for human parasitic infections:" exact="malaria" post="(Plasmodium falciparum), sleeping sickness (Trypanosoma brucei), Chagas disease (T."/>
   <result pre="that are responsible for human parasitic infections: malaria (Plasmodium falciparum)," exact="sleeping sickness" post="(Trypanosoma brucei), Chagas disease (T. cruzi), cutaneous (Leishmania amazonensis)"/>
   <result pre="of deaths is attributed to malaria, leishmaniasis, African and American" exact="trypanosomiasis" post="[36]—protozoal parasites that are included in this study. The"/>
   <result pre="new drugs in this field is a health priority because" exact="malaria" post="is the major parasitic infection in many tropical and"/>
   <result pre="that 40% of the world’s population is at risk of" exact="malaria" post="[37]. In addition to the Plasmodium parasite, flagellated parasitic"/>
   <result pre="this sense, T. brucei is a causative agent of African" exact="trypanosomiasis" post="or sleeping sickness, while T. cruzi causes American trypanosomiasis,"/>
   <result pre="T. brucei is a causative agent of African trypanosomiasis or" exact="sleeping sickness," post="while T. cruzi causes American trypanosomiasis, commonly known as"/>
   <result pre="same concentration range with IC50 values around 2 µg/mL. African" exact="trypanosomiasis" post="invariably leads to coma and death if left untreated,"/>
   <result pre="susceptibilities to P. aduncum EO, with the species that cause" exact="visceral leishmaniasis" post="(L. infantum and L. donovani) showing lower IC50 values."/>
   <result pre="to P. aduncum EO, with the species that cause visceral" exact="leishmaniasis" post="(L. infantum and L. donovani) showing lower IC50 values."/>
   <result pre="epithelial tissues, the EO displayed a higher IC50 value. Currently," exact="leishmaniasis" post="affects 12 million people in 98 countries where the"/>
   <result pre="found against Aedes aegypti mosquitoes, the vector of dengue and" exact="yellow fever." post="Antiparasitic effects were more studied against kinetoplastids, including Trypanosoma"/>
   <result pre="derived therapeutics for the treatment of LeishmaniasisPhytomedicine2011181056106910.1016/j.phymed.2011.03.00421596544 2.TiumanT.S.SantosA.O.Ueda-NakamuraT.FilhoB.P.D.NakamuraC.V.Recent advances in" exact="leishmaniasis" post="treatmentInt. J. Infect. Dis.201115e525e53210.1016/j.ijid.2011.03.02121605997 3.PrandoT.B.L.da BaciqueteT.F.VieiraJ.A.C.BressanJ.GasparottoF.M.JesusD.R.Cardozo JuniorE.L.LourençoE.L.B.Gasparotto JuniorA.Amides from"/>
   <result pre="b. rhodesiense and T. b. gambiense) in vitroActa Trop.19976813914710.1016/S0001-706X(97)00079-X9386789 14.TragerW.JensenJ.B.Human" exact="malaria" post="parasites in continuous cultureJ. Parasitol.20059148448610.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;216108535 15.MaklerM.T.RiesJ.M.WilliamsJ.A.BancroftJ.E.PiperR.C.GibbinsB.L.HinrichsD.J.Parasite lactate dehydrogenase as"/>
   <result pre="Tropical DiseasesWorld Health OrganizationGeneva, Switzerland2015 39.ZuccaM.ScuteraS.SavoiaD.New chemotherapeutic strategies against malaria," exact="leishmaniasis" post="and trypanosomiasesCurr. Med. Chem.20132050252610.2174/092986731132004000323210775 40.BrunR.BlumJ.ChappuisF.BurriC.Human African trypanosomiasisLancet201037514815910.1016/S0140-6736(09)60829-119833383 41.SalomonC.J.First century"/>
   <result pre="heros [53] Antiprotozoal activity against L. amazonensisAntibacterial activity against Mycobacterium" exact="tuberculosis" post="[43] Antiprotozoal activity against T. cruzi [5] Cuba Antioxidant"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5669121/results/search/disease/results.xml">
   <result pre="Sodium carbonate; CH3COONa: Sodium acetate; AlCl3: Aluminum chloride. Zingiberaceae Curcuma" exact="cancer" post="CADD molecular dynamics INTRODUCTION Lack of scientific knowledge to"/>
   <result pre="are previous studies showing β-phellandrene as a potent candidate for" exact="cancer" post="studies.[3031] Song et al.[32] indicated zingerone to ameliorate lipopolysaccharide-induced"/>
   <result pre="Chang et al.[33] showed the potency of linalool oxide against" exact="cancer" post="cell lines. They reported that linalool can promote gene"/>
   <result pre="al.A phenylbutenoid dimer, cis-3-(3¢,4¢-dimethoxyphenyl)-4-[(E)-3¢¢¢,4¢¢¢-dimethoxystyryl] cyclohex-1-ene, exhibits apoptogenic properties in T-acute" exact="lymphoblastic leukemia" post="cells via induction of p53-independent mitochondrial signalling pathwayEvid Based"/>
   <result pre="phenylbutenoid dimer, cis-3-(3¢,4¢-dimethoxyphenyl)-4-[(E)-3¢¢¢,4¢¢¢-dimethoxystyryl] cyclohex-1-ene, exhibits apoptogenic properties in T-acute lymphoblastic" exact="leukemia" post="cells via induction of p53-independent mitochondrial signalling pathwayEvid Based"/>
   <result pre="dockingCurr Protein Pept Sci200674072017073693 30HakkimFLAl-BuloshiMAl-SabahiJFrankincense derived heavy terpene cocktail boosting" exact="breast cancer" post="cell (MDA-MB-231) death in vitroAsian Pacif J Trop Biomed201558248"/>
   <result pre="Protein Pept Sci200674072017073693 30HakkimFLAl-BuloshiMAl-SabahiJFrankincense derived heavy terpene cocktail boosting breast" exact="cancer" post="cell (MDA-MB-231) death in vitroAsian Pacif J Trop Biomed201558248"/>
   <result pre="by supercritical CO2: Chemical composition and cytotoxic activity on CaCo-2" exact="cancer" post="cellsJ Food Sci201277C4485322429024 32SongJFanHJLiHDingHLvQHouSKet al.Zingerone ameliorates lipopolysaccharide-induced acute kidney"/>
   <result pre="J Pharmacol20167721081426698392 33ChangMYShiehDEChenCCYehCSDongHPLinalool induces cell cycle arrest and apoptosis in" exact="leukemia" post="cells and cervical cancer cells through CDKIsInt J Mol"/>
   <result pre="induces cell cycle arrest and apoptosis in leukemia cells and" exact="cervical cancer" post="cells through CDKIsInt J Mol Sci201516281697926703569 34KuzmanicAZagrovicBDetermination of ensemble-average"/>
   <result pre="cell cycle arrest and apoptosis in leukemia cells and cervical" exact="cancer" post="cells through CDKIsInt J Mol Sci201516281697926703569 34KuzmanicAZagrovicBDetermination of ensemble-average"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5703060/results/search/disease/results.xml">
   <result pre="diarrhoea (73%), leg ulcers (51%), loss of appetite (36%) and" exact="gingivitis" post="(32%) in small ruminants [70]. In Mauritania, the powdered"/>
   <result pre="Plant Sciences, 5, 1702-1710. 26HilouA, RappezF, DuezP.2014Ethnoveterinary management of cattle" exact="helminthiasis" post="among the Fulani and the Mossi (Central Burkina Faso):"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5761105/results/search/disease/results.xml">
   <result pre="plant and given for the treatment of dysentery, jaundice, stomachache," exact="hepatitis" post="(B &amp;amp; C), diabetes and high blood pressure. Also"/>
   <result pre="its root is used for cough, cold, fever, pulmonary infections," exact="malaria" post="and hemorrhages. 21 Asteraceae Cichorium intybus L./KOH-0075 Tareezax Herb"/>
   <result pre="sedative, analgesic and antispasmodic. Also used for insomnia, depression, neuralgia," exact="asthma" post="and glaucoma. It works also as cooling agent, stimulant,"/>
   <result pre="Shrub Stem The decoction of stem is used as/for rheumatism," exact="syphilis" post="nasal congestion, bronchial congestion colds cough, flu and asthma."/>
   <result pre="carminative, astringent and anti-rheumatic. It is also used for nausea," exact="diarrhea" post="and dysentery. 43 Lamiaceae Nepeta cataria L./KOH-0080 Chemjanbetai Herb"/>
   <result pre="Whole plant The decoction of the plants is used in" exact="typhoid fever." post="11 Punicaceae Punica granatum L./KOH-0097 Anar Tree Fruit Its"/>
   <result pre="Balmangai Herb Leaves Powder of leaves is used as/in diuretic," exact="diarrhea" post="and dysentery. 13 Sapotaceae Sideroxylon mascatense (A.DC.) T.D.Penn./KOH-0094 Gurgura"/>
   <result pre="plant Whole plant extract is used for the treatment of" exact="diabetes mellitus," post="blood purification, inflammation and abdominal pain. Juice obtained from"/>
   <result pre="was found to be the most potent anti-proliferative fraction against" exact="breast cancer" post="and other tumor cell lines while the steroidal glycosides"/>
   <result pre="found to be the most potent anti-proliferative fraction against breast" exact="cancer" post="and other tumor cell lines while the steroidal glycosides"/>
   <result pre="glycosides were found to possess moderate micromolar cytotoxic activity on" exact="breast cancer" post="and other cells [74]. Ethanolic and aqueous extracts of"/>
   <result pre="were found to possess moderate micromolar cytotoxic activity on breast" exact="cancer" post="and other cells [74]. Ethanolic and aqueous extracts of"/>
   <result pre="the whole plant of F. cretica was utilized for curing" exact="diabetes mellitus," post="blood purification, as anti-inflammatory and for abdominal pain. The"/>
   <result pre="reported the extracts of F. cretica for the treatment of" exact="diabetes mellitus," post="scabies, gastric problems, expulsion of abdomen worms, blood purification"/>
   <result pre="thrombolytic activities [105]. Aqueous extract of F. cretica has anti-breast" exact="cancer" post="effect without common side effects of standard cytotoxic therapy"/>
   <result pre="significant inhibitory potential against Salmonella typhi a causative agent of" exact="typhoid fever" post="[108]. Moreover, it has also shown inhibitory potential against"/>
   <result pre="lanceolata have the potential to combat with multidrug resistant K." exact="pneumonia" post="[114, 115]. Boerhaavia elongata Brandegee and Fumaria officinalis L."/>
   <result pre="utilized for the cure of blood purification, skin problems, and" exact="allergy" post="and as laxative. A detailed and comprehensive literature survey"/>
   <result pre="useful ethno phytomedicinal recipes of angiosperms used against jaundice and" exact="hepatitis" post="in Indo-Pak subcontinentWorld Appl Sci J20121812431252 67.Shinwari ZK, Rehman"/>
   <result pre="acylated steroidal glycosides from Caralluma tuberculata induce caspase-dependent apoptosis in" exact="cancer" post="cellsJ Ethnopharmacol201113731189119610.1016/j.jep.2011.07.04921820042 75.Rizwani GH. Phytochemical and biological studies on"/>
   <result pre="Sci2014312061217 106.Lam M. Cytotoxic activity of Fagonia cretica against human" exact="breast cancer" post="cells. Ph.D diss., Aston University, UK; 2012. 107.RaziTMAsadMHKhanTZabta ChaudharyMTayyab"/>
   <result pre="106.Lam M. Cytotoxic activity of Fagonia cretica against human breast" exact="cancer" post="cells. Ph.D diss., Aston University, UK; 2012. 107.RaziTMAsadMHKhanTZabta ChaudharyMTayyab"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5891877/results/search/disease/results.xml">
   <result pre="It is commonly found in sheep and cattle [1]. Bovine" exact="fasciolosis" post="usually had no visible clinical signs. However, if the"/>
   <result pre="morphological change and DNA fragmentation in a type of human" exact="cancer" post="cell. Conclusion The current study introduced M. oleifera leaf"/>
   <result pre="infection in cattleBJBAS2013245 2SchweizerGBraunUDeplazesPTorgersonP.REstimating the financial losses due to bovine" exact="fasciolosis" post="in SwitzerlandVet. Rec200515718819316100368 3CharlierJDuchateauLClaereboutEWilliamsDVercruysseJAssociations between anti-Fasciola hepaticaantibody levels in"/>
   <result pre="25SreelathaSJeyachitraAPadmaP.RAntiproliferation and induction of apoptosis byMoringa oleiferaleaf extract on human" exact="cancer" post="cellsFood Chem. Toxicol2011491270127521385597"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5930434/results/search/disease/results.xml">
   <result pre="nematodes Funding International Foundation of ScienceB/5498-1OssokomackMarlyse Background Helminth infections or" exact="helminthiasis" post="are among the most pervasive infections distressing a large"/>
   <result pre="a concern and contribute to the prevalence of malnutrition, anemia," exact="eosinophilia" post="and pneumonia [2]. The gastrointestinal helminths mainly subsist in"/>
   <result pre="and contribute to the prevalence of malnutrition, anemia, eosinophilia and" exact="pneumonia" post="[2]. The gastrointestinal helminths mainly subsist in the digestive"/>
   <result pre="Epidemiological studies carried out in Northern Cameroon showed that gastrointestinal" exact="helminthiasis" post="was one of the common diseases of sheep and"/>
   <result pre="drug or combined to food supplements, can help to modulate" exact="helminthiasis" post="by the use of long term treatments of animals"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC5966565/results/search/disease/results.xml">
   <result pre="page-count: word-count: Introduction Malaria, respiratory infections, HIV/AIDS, diarrhoeal diseases, and" exact="tuberculosis" post="are leading transmissible and infectious diseases worldwide. Infections are"/>
   <result pre="et al., 2011). 1.Important antimalarial drug for treatment of severe" exact="malaria" post="and multidrug-resistant malaria.2.Antimalarial, antiarrhythmic, and muscle relaxant drug (Song,"/>
   <result pre="ability of Plasmodium falciparum for the digestion of hemoglobin during" exact="malaria" post="life cycle. Generally vinca alkaloids are known to have"/>
   <result pre="metaphase. Camptothecin (8) Camptotheca acuminate Fusarium solani 1. A potent" exact="cancer" post="chemotherapeutic drug due to its remarkable bioactivity against leukemias"/>
   <result pre="important class of anticancer agents and are used as original" exact="cancer" post="therapies. The potent antineoplastic drug camptothecin (8) which is"/>
   <result pre="of camptothecin (8), which has therapeutic properties against AIDS and" exact="malaria" post="in addition to uterine, colon, cervical, and ovarian cancer"/>
   <result pre="AIDS and malaria in addition to uterine, colon, cervical, and" exact="ovarian cancer" post="(Li et al., 2006). Podophyllotoxin (9), a precursor of"/>
   <result pre="and malaria in addition to uterine, colon, cervical, and ovarian" exact="cancer" post="(Li et al., 2006). Podophyllotoxin (9), a precursor of"/>
   <result pre="the musculoskeletal system.2. Clinical report has delivered its effectiveness for" exact="arthritis" post="and rheumatic disorders.3.A medicine used for liver and kidney"/>
   <result pre="for arteriosclerosis, hypertension and stress (Amusan et al., 2002) and" exact="arthritis" post="and rheumatism (Van Wyk et al., 2009). Aloe-emodin, p-hydroxyacetophenone,"/>
   <result pre="African plants to treat inflammatory conditions (Iwalewa et al., 2007)," exact="diarrhea" post="(Lin et al., 2002; Mathabe et al., 2006; Fawole"/>
   <result pre="compound falcarindiol, which showed potential activity against different types of" exact="cancer" post="in animal models, was isolated from this plant (Setzer"/>
   <result pre="Has importance in traditional medicine to manage diabetes, kidney stones," exact="cancer" post="and hypertension Showed highest significant antimicrobial activity against 6"/>
   <result pre="sample (PDA)BL5 has highest significant anticancer activity against all 5" exact="cancer" post="cell lines at concentrations ranging from 30 to 300"/>
   <result pre="11 and 12 didn't show potential cytotoxic activity against mouse" exact="lymphoma" post="L5178Y cells El-Amrania et al., 2016 6. Pestalotiopsis microspora"/>
   <result pre="mouse lymphoma L5178Y cells El-Amrania et al., 2016 6. Pestalotiopsis" exact="microspora" post="Fungus Drepanocarpus lunatus (L.f.) G.Mey. Fabaceae Pestalotioprolides C (13),"/>
   <result pre="venereal diseasesa. Compounds 14–17 exhibited potent cytotoxicity against the murine" exact="lymphoma" post="cell line L5178Y with IC50 values of 0.7, 5.6,"/>
   <result pre="respectively and compound 16 demonstrated highest activity against the human" exact="ovarian cancer" post="cell line A2780 with an IC50 value of 1.2"/>
   <result pre="and compound 16 demonstrated highest activity against the human ovarian" exact="cancer" post="cell line A2780 with an IC50 value of 1.2"/>
   <result pre="(IC50 &amp;gt;50 μM) in the cytotoxicity test against the murine" exact="cancer" post="cell line L5178Y by the MTT assay Hammerschmidt et"/>
   <result pre="7.5, 17.7, and 15.8 μM against KB, MDA-MB-435, and MRC5" exact="cancer" post="cell lines, respectively. Compound 25 as well was cytotoxic"/>
   <result pre="24 were inactive (IC50 &amp;gt; 30 μM) on all tested" exact="cancer" post="cell lines Mandavid et al., 2015 9. Colletotrichum sp.BS4"/>
   <result pre="the individual compounds showed in vitro cytotoxicity on a human" exact="acute monocytic leukemia" post="cell line (THP-1) Wang et al., 2016 10. Nectria"/>
   <result pre="individual compounds showed in vitro cytotoxicity on a human acute" exact="monocytic leukemia" post="cell line (THP-1) Wang et al., 2016 10. Nectria"/>
   <result pre="compounds showed in vitro cytotoxicity on a human acute monocytic" exact="leukemia" post="cell line (THP-1) Wang et al., 2016 10. Nectria"/>
   <result pre="33 and 34 were in active against the following human" exact="cancer" post="cell; SF-268, MCF-7, NCI-H460, and HepG-2 Sun et al.,"/>
   <result pre="to treat dermatitis, eczema, psoriasis, herpes, sores, abscesses, warts, corns," exact="skin cancer," post="ringworm, scabies, epilepsy, asthma, malaria, and heart disease Isaacs,"/>
   <result pre="warts, corns, skin cancer, ringworm, scabies, epilepsy, asthma, malaria, and" exact="heart disease" post="Isaacs, 2008; Dey and Chaudhuri, 2014. Compound 36 displayed"/>
   <result pre="strains at 200 μg/disc and high anticancer activity against 5" exact="cancer" post="cell lines at concentrations ranging from 30 to 300"/>
   <result pre="7-O-methylnigrosporolide (14) were isolated from the mangrove-derived endophytic fungus Pestalotiopsis" exact="microspora" post="obtained from fresh fruits of the mangrove plant Drepanocarpus"/>
   <result pre="al., 2016). Compounds 14–17 showed significant cytotoxicity against the murine" exact="lymphoma" post="cell line L5178Y with IC50 values of 0.7, 5.6,"/>
   <result pre="respectively, while compound 16 showed potent activity against the human" exact="ovarian cancer" post="cell line A2780 with an IC50 value of 1.2"/>
   <result pre="while compound 16 showed potent activity against the human ovarian" exact="cancer" post="cell line A2780 with an IC50 value of 1.2"/>
   <result pre="&amp;gt; 50 μM) when tested for cytotoxicity against the murine" exact="cancer" post="cell line L5178Y by the MTT assay (Hammerschmidt et"/>
   <result pre="7.5, 17.7, and 15.8 μM against KB, MDA-MB-435, and MRC5" exact="cancer" post="cell lines, respectively. Compound 25 was also cytotoxic to"/>
   <result pre="24 were inactive (IC50 &amp;gt; 30 μM) on all tested" exact="cancer" post="cell lines (Mandavid et al., 2015). Colletotrichones A–C (26–28)"/>
   <result pre="the individual compounds showed in vitro cytotoxicity on a human" exact="acute monocytic leukemia" post="cell line (THP-1) (Wang et al., 2016). Due to"/>
   <result pre="individual compounds showed in vitro cytotoxicity on a human acute" exact="monocytic leukemia" post="cell line (THP-1) (Wang et al., 2016). Due to"/>
   <result pre="compounds showed in vitro cytotoxicity on a human acute monocytic" exact="leukemia" post="cell line (THP-1) (Wang et al., 2016). Due to"/>
   <result pre="S.SoK. F.ChangR. C. (2011). Drug discovery from Chinese medicine against" exact="neurodegeneration" post="in Alzheimer's and vascular dementia. Chinese Med. 6:15. 10.1186/1749-8546-6-1521513513"/>
   <result pre="Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and" exact="vascular dementia." post="Chinese Med. 6:15. 10.1186/1749-8546-6-1521513513 HosseinzadehH.Nassiri-AslM. (2015). Pharmacological effects of"/>
   <result pre="S.FotouhiF.FarahmandB.et al.. (2018). South African medicinal plant extracts active against" exact="influenza" post="A virus. BMC Complement. Altern. Med.18:112. 10.1186/s12906-018-2184-y29587734 MekhailT. M.MarkmanM."/>
   <result pre="BMC Complement. Altern. Med.18:112. 10.1186/s12906-018-2184-y29587734 MekhailT. M.MarkmanM. (2002). Paclitaxel in" exact="cancer" post="therapy. Expert Opin. Pharmacother.3, 755–766. 10.1517/14656566.3.6.75512036415 MekonnenY.GessesseA. (1998). Documentation"/>
   <result pre="Ethnobotanical survey of medicinal plants used for the management of" exact="diabetes mellitus" post="in the Nkonkobe municipality of South Africa. J. Med."/>
   <result pre="(2016). Cytotoxicity of South-African medicinal plants towards sensitive and multidrug-resistant" exact="cancer" post="cells. J. Ethnopharmacol. 186, 209–223. 10.1016/j.jep.2016.04.00527058630 SaeedN.KhanM. R.ShabbirM. (2012)."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6003166/results/search/disease/results.xml">
   <result pre="Northern Ireland [10]. Traditionally in the UK, most cases of" exact="fasciolosis" post="are found in wetter, western areas which provide ideal"/>
   <result pre="areas which provide ideal climatic conditions; however in recent years" exact="fasciolosis" post="has emerged in other areas including East Anglia and"/>
   <result pre="an approximation of the potential impact of climate change on" exact="fasciolosis" post="in the UK predict an overall long term increase"/>
   <result pre="associated with an increased rate of exposure [4]. Control of" exact="fasciolosis" post="is aimed at reducing the prevalence of disease to"/>
   <result pre="meat withhold periods. The drug of choice for treatment of" exact="fasciolosis" post="is the benzamine derivative triclabendazole, because it is effective"/>
   <result pre="If farmers are able to accurately assess the risk of" exact="fasciolosis" post="in their specific location they will be able to"/>
   <result pre="commences 10–12 weeks after ingestion of metacercariae. In the UK" exact="fasciolosis" post="is a seasonal disease, development of the parasite in"/>
   <result pre="Fasciola hepatica, on beef cattleVet Rec.1971892464164310.1136/vr.89.24.6415150810 6.Sanchez-VazquezMJLewisFIInvestigating the impact of" exact="fasciolosis" post="on cattle carcase performanceVet Parasitol20131931–330731110.1016/j.vetpar.2012.11.03023265810 7.CharlierJVercruysseJMorganEvan DijkJWilliamsDJRecent advances in"/>
   <result pre="a large-scale epidemiological investigation utilising surveillance dataParasit Vectors2016920910.1186/s13071-016-1489-227079910 11.PritchardGCForbesABWilliamsDJSalimi-BejestaniMRDanielRGEmergence of" exact="fasciolosis" post="in cattle in east AngliaVet Rec.20051571957858210.1136/vr.157.19.57816272544 12.KenyonFSargisonNDSkucePJJacksonFSheep helminth parasitic"/>
   <result pre="of fasciolosis in cattle in east AngliaVet Rec.20051571957858210.1136/vr.157.19.57816272544 12.KenyonFSargisonNDSkucePJJacksonFSheep helminth" exact="parasitic disease" post="in south eastern Scotland arising as a possible consequence"/>
   <result pre="sensingParassitologia2005471275016044674 15.FuentesMVProposal of a geographic information system for modeling zoonotic" exact="fasciolosis" post="transmission in the AndesParasitol Latinoam200459515510.4067/S0717-77122004000100010 16.BennemaSCDucheyneEVercruysseJClaereboutEHendrickxGCharlierJRelative importance of management,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6024828/results/search/disease/results.xml">
   <result pre="and identifying specific acetylcholine receptors and in the diagnosis of" exact="myasthenia gravis" post="[89]. Aprotinin has been shown clinically effective against flu"/>
   <result pre="chlorotoxin, reached Phase III trials as a treatment for glioblastoma" exact="cancer" post="[92,93]. Finally, Linaclotide, a cystine-stabilized peptide, is licensed for"/>
   <result pre="a cystine-stabilized peptide, is licensed for clinical use orally against" exact="irritable bowel syndrome" post="[94]. 5. Discussion Cystine-stabilized peptides offer a vast opportunity"/>
   <result pre="storyJ. Clin. Neurosci.201633525810.1016/j.jocn.2016.04.01227452128 94.LayerP.StanghelliniV.Review article: Linaclotide for the management of" exact="irritable bowel syndrome" post="with constipationAliment. Pharmacol. Ther.20143937138410.1111/apt.1260424433216 95.WerleM.KolmarH.AlbrechtR.Bernkop-SchnürchA.Characterisation of the barrier caused"/>
   <result pre="bacterial infections Brilacidin Nonpeptide STP mimetic Cellceutix Phase II Ulcerative" exact="proctitis" post="Linclotide STP Ironwood Pharmaceuticals Phase III Irritable bowel syndrome;"/>
   <result pre="Linclotide STP Ironwood Pharmaceuticals Phase III Irritable bowel syndrome; chronic" exact="constipation" post="Ziconotide (Prialt) STP (calcium channel blocker) Azur Pharma FDA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6052623/results/search/disease/results.xml">
   <result pre="the cytotoxicities of the crude extracts were evaluated on the" exact="rhabdomyosarcoma" post="cell line using the MTT assay. The antiviral activity"/>
   <result pre="from various parts of the world have been reported in" exact="encephalitis" post="cases and epidemics [5]. Echoviruses (enteric cytopathic human orphan"/>
   <result pre="of echoviruses include fever of short duration and sometimes a" exact="rash" post="or mild upper respiratory symptoms [6]. Clinical syndromes associated"/>
   <result pre="symptoms [6]. Clinical syndromes associated with infections by echoviruses include" exact="aseptic meningitis," post="paralysis, encephalitis, ataxia, Guillain-Barré syndrome, exanthema, respiratory disease, diarrhoea,"/>
   <result pre="echoviruses include aseptic meningitis, paralysis, encephalitis, ataxia, Guillain-Barré syndrome, exanthema," exact="respiratory disease," post="diarrhoea, pericarditis, myocarditis and hepatic disturbance. Echoviral infection, like"/>
   <result pre="paralysis, encephalitis, ataxia, Guillain-Barré syndrome, exanthema, respiratory disease, diarrhoea, pericarditis," exact="myocarditis" post="and hepatic disturbance. Echoviral infection, like other enteroviruses, occurs"/>
   <result pre="H. Durand Abeere s 108794 1 Hypertension, fever, jaundice, dysmenorrhea," exact="malaria" post="and abdominal discomfort [26]. 5 Asclepiadaceae Secamone afzelii (Roem"/>
   <result pre="Schum Ailu l 109995 1 Diabetes, colic, dysentery, hypertension and" exact="malaria" post="[27]. 6 Asteraceae Ageratum conyzoides L. Imi-esu l 106040"/>
   <result pre="Apari-igun l 110156 10 Wounds, flatulence, inflammation, skin ulcers and" exact="conjunctivitis" post="[29]. 8 Combretaceae Terminalia ivorensis A. Chev. Afara-dudu ba"/>
   <result pre="ivorensis A. Chev. Afara-dudu ba 105432 1 Syphilis, burns, bruises," exact="arthritis" post="and haemorrhoids [30]. 9 Combretaceae Terminalia superba Engl. &amp;amp;"/>
   <result pre="pinnatum (Lam.) Oken Abamoda l 109487 100 Worm expellant, cold," exact="pneumonia" post="and respiratory tract infections [33]. 12 Cucurbitaceae Lagenaria breviflora"/>
   <result pre="Mull. Arg. Agbaasa l 107230 0.01 Gonorrhoea, syphilis, skin infections," exact="cancer" post="and burns [37]. 16 Lamiaceae Hoslundia opposita Vahl Efirin-odan"/>
   <result pre="Vahl Efirin-odan l 100866 10 Burns, skin infections, cough and" exact="malaria" post="[38]. 17 Leguminosae Calliandra portoricensis (Jacq.) Benth Tude r"/>
   <result pre="Mimosa pudica L. Patanmo l 100332 0.1 Fevers, piles, jaundice," exact="leprosy" post="and dysentery [41]. 20 Nyctaginaceae Boerhavia diffusa L. Etipase-erinla"/>
   <result pre="L. Etipase-erinla r 109603 1 Diabetes, cancer, inflammation, infections and" exact="epilepsy" post="[42]. 21 Periplocaceae Mondia whitei (Hook.f.) Skeels Isirigun l"/>
   <result pre="Mondia whitei (Hook.f.) Skeels Isirigun l 110043 100 Malaria, diabetes," exact="infertility" post="and erectile dysfunction [43]. 22 Periplocaceae Parquentina nigrescens (Afzel)"/>
   <result pre="(Hook.f.) Skeels Isirigun l 110043 100 Malaria, diabetes, infertility and" exact="erectile dysfunction" post="[43]. 22 Periplocaceae Parquentina nigrescens (Afzel) Bullock Ogbo l"/>
   <result pre="nigrescens (Afzel) Bullock Ogbo l 108852 1 Abdominal cramps, gonorrhoea," exact="rickets" post="and asthma [44]. 23 Phytolaccaceae Petiveria alliacea L. Awogba"/>
   <result pre="Bullock Ogbo l 108852 1 Abdominal cramps, gonorrhoea, rickets and" exact="asthma" post="[44]. 23 Phytolaccaceae Petiveria alliacea L. Awogba l 100512"/>
   <result pre="alliacea L. Awogba l 100512 100 Pain, influenza, cold, diabetes," exact="malaria" post="and skin infections [45]. 24 Piperaceae Piper guineensis Schumach"/>
   <result pre="Piper guineensis Schumach Iyere l 110051 10 Sickle cell anaemia," exact="male infertility," post="inflammation and skin infections [46]. 25 Poaceae Eleusine indica"/>
   <result pre="E. A. Bruce Egbesi l 109707 10 Epilepsy, diarrhoea, dysentery," exact="malaria" post="and fever [48]. 27 Verbenaceae Lippia multiflora Moldenke Eforomoba"/>
   <result pre="viruses were stored at − 70 °C until use. The human" exact="rhabdomyosarcoma" post="(RD) cells were obtained by Centre for Disease Control,"/>
   <result pre="for various bioactivity observed in the genus, especially against bacteria," exact="cancer" post="cells and Plasmodium falciparum [16, 17]. Fractionation of the"/>
   <result pre="virus, respiratory syncytial virus (RSV), and DNA virus such as" exact="herpes simplex" post="virus (HSV) [21]. The proposed antiviral mechanisms of action"/>
   <result pre="MNTC Maximum non-toxic concentration MTT 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide RD Human" exact="rhabdomyosarcoma" post="cells SI Selectivity index TCID50 50% tissue culture infective"/>
   <result pre="towards the discovery of anticancer agentsJ Med Plant Res2017114062110.5897/JMPR2017.648529152156 5.JainSPatelBBhattGCEnteroviral" exact="encephalitis" post="in children: clinical features, pathophysiology, and treatment advancesPathog Glob"/>
   <result pre="vitro cytotoxic activity of medicinal plants from Nigeria ethnomedicine on" exact="rhabdomyosarcoma" post="cancer cell line and HPLC analysis of active extractsBMC"/>
   <result pre="cytotoxic activity of medicinal plants from Nigeria ethnomedicine on rhabdomyosarcoma" exact="cancer" post="cell line and HPLC analysis of active extractsBMC Complement"/>
   <result pre="OO, Ajaiyeoba EO. Medicinal plants used in the management of" exact="cancer" post="among the Ijebus of Southwestern Nigeria. J Herb Med."/>
   <result pre="effects of plant flavonoids on mammalian cells: implications for inflammation," exact="heart disease," post="and cancerPharmacol Rev20005267375111121513 22.BehbahaniMSayedipourSPourazarAShanehsazzadehMIn vitro anti-HIV-1 activities of kaempferol"/>
   <result pre="cytotoxicity and DNA damaging activity of three plant extracts on" exact="cervical cancer" post="cell linesInt J Pharm Sci Rev Res2015311183189 30.PonouBKTeponnoRBRicciutelliMNguelefackTBQuassintiLBramucciMLupidiGBarboniLTapondjouLANovel 3-Oxo-and"/>
   <result pre="and DNA damaging activity of three plant extracts on cervical" exact="cancer" post="cell linesInt J Pharm Sci Rev Res2015311183189 30.PonouBKTeponnoRBRicciutelliMNguelefackTBQuassintiLBramucciMLupidiGBarboniLTapondjouLANovel 3-Oxo-and"/>
   <result pre="activity of Bryophyllum pinnatum and Detarium microcarpum plants against Mycobacterium" exact="tuberculosis" post="and other bacteriaNat Prod Res Bull201211218 34.OlorunnisolaOSAfolayanAJAdetutuASub-chronic administration of"/>
   <result pre="activities of root methanol extract of Calliandra portoricensis in human" exact="prostate cancer" post="cellsJ Integr Med201513318519310.1016/S2095-4964(15)60175-326006031 40.JohnTAOnabanjoAGastroprotective effects of an aqueous extract"/>
   <result pre="of root methanol extract of Calliandra portoricensis in human prostate" exact="cancer" post="cellsJ Integr Med201513318519310.1016/S2095-4964(15)60175-326006031 40.JohnTAOnabanjoAGastroprotective effects of an aqueous extract"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6100566/results/search/disease/results.xml">
   <result pre="health, having been proven to contribute to decreased rates of" exact="heart disease," post="cancer, and neurodegenerative diseases [1,2,3,4]. Wild and semi-domesticated greens"/>
   <result pre="of Centaurea raphanina was found to be differentially toxic against" exact="cancer" post="metastatic A5 cells (Figure 4). Moreover, the enriched decoction"/>
   <result pre="1 μg/mL (Figure S2) appeared to be differentially cytotoxic to" exact="cancer" post="cells compared to the immortalized non-tumorigenic cells. The water"/>
   <result pre="that the decoction of Centaurea raphanina was differentially toxic against" exact="cancer" post="cells. Yet, given the frequent consumption of chórta, and"/>
   <result pre="Cell Culture Conditions C5N immortalized keratinocytes and A5 aggressive spindle" exact="cancer" post="cells were a kind gift provided by Dr. Zoumpourlis"/>
   <result pre="Selected water decoctions of edible chórta and differential toxicity against" exact="cancer" post="cells. Comparative toxicities as determined by MTT assay of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6130747/results/search/disease/results.xml">
   <result pre="in Eastern Nigeria to treat feverish conditions, and to treat" exact="malaria" post="and sleeping sickness that cause fever. Objective: The current"/>
   <result pre="Nigeria to treat feverish conditions, and to treat malaria and" exact="sleeping sickness" post="that cause fever. Objective: The current study assesses the"/>
   <result pre="on Trypanosoma brucei brucei infected mice. Materials and methods: Delayed" exact="hypersensitivity" post="reaction, humoral antibody response and in-vivo leucocyte mobilization tests"/>
   <result pre="treatment at all the doses tested. The extract inhibited delayed" exact="hypersensitivity" post="reaction by 20.9 and 20.8% at 250 and 500 mg/kg,"/>
   <result pre="methanol extract possesses immunostimulatory activity on trypanosome-infected mice. Keywords Delayed" exact="hypersensitivity" post="reaction antibody response trypanosomosis page-count: word-count: Introduction The immune"/>
   <result pre="approximately 109 red blood cells (Nworu et al. 2007). Delayed" exact="hypersensitivity" post="reaction Delayed hypersensitivity reaction was induced in mice using"/>
   <result pre="blood cells (Nworu et al. 2007). Delayed hypersensitivity reaction Delayed" exact="hypersensitivity" post="reaction was induced in mice using SRBCs as antigen"/>
   <result pre="greater than 1000 mg/kg. The extract was able to inhibit delayed" exact="hypersensitivity" post="reaction at 250 and 500 mg/kg (Table 1). However, at"/>
   <result pre="Effect of methanolic extract of Buchholzia coriacea seeds on delayed" exact="hypersensitivity" post="reaction mice estimated as paw swelling (mm). Treatment Dose"/>
   <result pre="earlier work done by Nweze et al. (2009). The delayed" exact="hypersensitivity" post="reaction was inhibited by the extracts at dose of"/>
   <result pre="500 mg/kg. The ability of the extract to inhibit the delayed" exact="hypersensitivity" post="reaction in this experiment may be due to its"/>
   <result pre="by T cells and monocytes/macrophages rather than by antibodies. Delayed" exact="hypersensitivity" post="reaction is a major mechanism of defence against various"/>
   <result pre="response which appears 48–72 h after antigen exposure from an immediate" exact="hypersensitivity" post="response which generally appears within 12 min of an antigen"/>
   <result pre="Nations, Rome. VojdaniA, O’BryanT, KellermannGH.2008The mmunology of immediate and delayed" exact="hypersensitivity" post="reaction to gluten. Eur J Inflammat. 6:1–10."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6146870/results/search/disease/results.xml">
   <result pre="Chronic disease may manifest as decreased appetite, weight loss, and" exact="anemia" post="[18]. Young animals usually carry heavier burdens than adult"/>
   <result pre="F.MushongaB.GreenE.MuchenjeV.Seasonal prevalence, body condition score and risk factors of bovine" exact="fasciolosis" post="in South AfricaVeterinary and Animal Science201741710.1016/j.vas.2017.06.001 13AbdoB.TesfayeW.ShibbiruT.Prevalence of Haemonchosis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6154738/results/search/disease/results.xml">
   <result pre="nematode infections by traditional healers, herdsmen and pastoralists in Cameroon." exact="onchocerciasis" post="Acacia nilotica Caenorhabditis elegans Onchocerca ochengi proanthocyanidins 1. Introduction"/>
   <result pre="is a tropical insect-borne disease caused by the nematode Onchocerca" exact="volvulus" post="and transmitted through the bite of infected black flies"/>
   <result pre="resistance [9]. Since vaccines and safe macrofilaricidal treatment against Onchocerca" exact="volvulus" post="are still lacking, there is an urgent need to"/>
   <result pre="parasitic nematodes. An online search on medicinal plants used against" exact="onchocerciasis" post="found nine publications since 2002, where a total of"/>
   <result pre="traditionally used in Africa for treating colds, bronchitis, pneumonia, ophthalmia," exact="diarrhea" post="and hemorrhage. Furthermore, A. nilotica was shown to have"/>
   <result pre="Sur les Maladies Tropicales NégligéesOMSGenève, Switzerlands2011124129 2.ZoureH.NomaM.TekleA.AmazigoU.DiggleP.GiorgiE.RemmeJ.H.The geographic distribution of" exact="onchocerciasis" post="in the 20 participating countries of the African Programme"/>
   <result pre="in GhanaAnn. Trop. Med. Parasitol.20049823124910.1179/00034980422500325315119969 6.Osei-AtweneboanaM.Y.EngJ.K.L.BoakyeD.A.GyapongJ.O.PrichardR.K.Prevalence and intensity of Onchocerca" exact="volvulus" post="infection and efficacy of ivermectin in endemic communities in"/>
   <result pre="67.KlägerS.WhitworthJ.A.G.PostR.J.ChavasseD.C.DowhamM.D.How long do the effects of ivermectin on adult Onchocerca" exact="volvulus" post="persist?Trop. Med. Pasatol.199344305310 68.AjaiyeobaE.O.AbiodunO.O.FaladeM.O.OgboleN.O.AshidiJ.S.HappiC.T.AkinboyeD.O.In Vitro cytotoxicity studies of 20"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6161083/results/search/disease/results.xml">
   <result pre="membrane and the blood-brain barrier [10,11,12]. Other ABC transporters include" exact="cystic fibrosis" post="transmembrane conductance regulator (CFTR), transporter associated with antigen processing"/>
   <result pre="transmembrane conductance regulator (CFTR), transporter associated with antigen processing (TAP)," exact="breast cancer" post="resistance protein (BCRP) and multidrug resistance-associated protein 1 (MRP1)"/>
   <result pre="conductance regulator (CFTR), transporter associated with antigen processing (TAP), breast" exact="cancer" post="resistance protein (BCRP) and multidrug resistance-associated protein 1 (MRP1)"/>
   <result pre="it has been discovered that emodin may inhibit migration of" exact="cancer" post="cells, but may not reach clinically significant plasma concentrations"/>
   <result pre="are widely marketed as dietary supplements to be used for" exact="cancer" post="prevention as well as in cardiovascular and chronic inflammatory"/>
   <result pre="serve as beneficial interactions to improve drug levels in the" exact="cancer" post="cells while providing potential synergistic effects. 3.3.3. Green Coffee"/>
   <result pre="efflux transporter inhibitory results were observed in human and mouse" exact="neuroblastoma" post="cells [55]. Ivermectin inhibited the secretory transport of lopinavir"/>
   <result pre="may lead to beneficial pharmacokinetic profiles, resulting in more efficient" exact="cancer" post="treatment. Initial studies with regards to potential pharmacokinetic interactions"/>
   <result pre="inhibit P-gp related efflux of a known substrate, 5-carboxyfluorescien, in" exact="leukemia" post="and lymphoma cells. A concentration dependent trend was identified"/>
   <result pre="related efflux of a known substrate, 5-carboxyfluorescien, in leukemia and" exact="lymphoma" post="cells. A concentration dependent trend was identified where 50,"/>
   <result pre="relatively new direct acting anti-viral, used for the treatment of" exact="hepatitis" post="C. The literature widely reports on the capability of"/>
   <result pre="online: https://www.merriam-webster.com/dictionary/dietary%20supplement(accessed on 24 August 2017) 53.TengY.SheuM.HsiehY.WangR.ChiangY.HungC.β-carotene reverses multidrug resistant" exact="cancer" post="cells by selectively modulating human P-glycoprotein functionPhytomedicine20162331632310.1016/j.phymed.2016.01.00826969385 54.CaterinaP.AntonelloD.P.ChiaraG.ChiaraC.GiacomoL.AntonioS.GiovambiattistaD.S.LucaG.Pharmacokinetic drug-drug"/>
   <result pre="of multidrug transporter-mediated efflux of avermectins in human and mouse" exact="neuroblastoma" post="cell linesToxicol. Lett.201523518919810.1016/j.toxlet.2015.04.00525865432 56.KigenG.EdwardsG.Drug-transporter mediated interactions between anthelminthic and"/>
   <result pre="interaction of anti-HCV telaprevir with the ABC transporters P-glycoprotein and" exact="breast cancer" post="resistance proteinBMC Res. Notes2013644510.1186/1756-0500-6-44524196382 60.WeissJ.BeckerJ.P.HaefeliW.E.Telaprevir is a substrate and"/>
   <result pre="of anti-HCV telaprevir with the ABC transporters P-glycoprotein and breast" exact="cancer" post="resistance proteinBMC Res. Notes2013644510.1186/1756-0500-6-44524196382 60.WeissJ.BeckerJ.P.HaefeliW.E.Telaprevir is a substrate and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6161289/results/search/disease/results.xml">
   <result pre="changes [2]. Acanthamoeba is the causative agent of granulomatous amebic" exact="encephalitis" post="(GAE), a fatal disease most commonly infecting immunocompromised people"/>
   <result pre="against nasopharangeal carcinoma and anti-Inflammatory ActivityJ. Ethnopharmacol.2017198919710.1016/j.jep.2016.12.04528049063 7.FuldaS.Betulinic acid for" exact="cancer" post="treatment and preventionInt. J. Mol. Sci.200891096110710.3390/ijms906109619325847 8.YanM.H.ChengP.JiangZ.Y.MaY.B.ZhangX.M.ZhangF.X.YangL.M.ZhengY.T.ChenJ.J.Periglaucines A–D, Anti-HBV"/>
   <result pre="pediatric parasitic infectionsJ. Pediatr. Infect. Dis.201712264270 15.MirakabadF.S.T.Nejati-KoshkiK.AkbarzadehA.YamchiM.R.MilaniM.ZarghamiN.ZeighamianV.RahimzadehA.AlimohammadiS.HanifehpourS.et al.PLGA-based nanoparticles as" exact="cancer" post="drug delivery systemsAsian Pac. J. Cancer Prev.20141551753510.7314/APJCP.2014.15.2.51724568455 16.DanhierF.AnsorenaE.SilvaJ.M.CocoR.Le BretonA.PreatV.PLGA-Based"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6163712/results/search/disease/results.xml">
   <result pre="associated with the prevention and therapy of cardiovascular diseases and" exact="cancer" post="[33]. Although polyphenolic compounds, such as tannins, have anthelmintic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6165132/results/search/disease/results.xml">
   <result pre="24.KozanE.-AnulS.A.TatliI.I.In vitro anthelmintic effect of Vicia pannonica var. purpurascens on" exact="trichostrongylosis" post="in sheepExp. Parasitol.201313429930310.1016/j.exppara.2013.03.01823562885 25.VillaseñorI.M.AngeladaJ.CanlasA.P.EchegoyenD.Bioactivity studies on beta-sitosterol and its"/>
   <result pre="Majesty’s Stationary Office (HMSO)London, UK19861152 35.SargisonN.D.JacksonJ.GilleardS.Effects of age and immune" exact="suppression" post="of sheep on fecundity, hatching and larval feeding of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6171049/results/search/disease/results.xml">
   <result pre="Hamada et al., reported endophytic fungal isolates were effective in" exact="suppression" post="of the Black-pod rot disease of cacao [12]. Three"/>
   <result pre="and higher yieldProc. Natl. Acad. Sci. U. S. A.1022005133861339116174735 22ClarkeB.B.WhiteJ.F.J.HurleyR.H.TorresM.S.SunS.HuffD.R.Endophyte-mediated" exact="suppression" post="of dollar spot disease in fine fescuesPlant Dis.902006994998 23VarmaA.BakshiM.LouB.G.HartmannA.OelmuellerR.Piriformosporaindica:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6186027/results/search/disease/results.xml">
   <result pre="brain, spinal cord, and eyes, causing cerebrospinal setariosis, conjunctivitis, and" exact="filariasis" post="oculi, respectively [20]. Intriguingly, studies on S. digitata have"/>
   <result pre="host A previous study demonstrated the possibility of in vivo" exact="suppression" post="of the cathepsin L-like cysteine protease gene of B."/>
   <result pre="derived from non-injected, buffer-injected and GFP siRNA-injected mosquitoes. A significant" exact="suppression" post="of the target gene expression was observed in this"/>
   <result pre="to its pharmacodynamics, toxicity, and use in the therapy of" exact="onchocerciasis" post="and other filarial infections1978GenevaWorld Health Organization 24.RodrigoWWPDassanayakeRSVoroninDNovel parasitic nematode-specific"/>
   <result pre="interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca" exact="volvulus" post="confirmed their essential function during L3 moltingMol Biochem Parasitol200413816517010.1016/j.molbiopara.2004.08.00315555728"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6196496/results/search/disease/results.xml">
   <result pre="worms can modulate their host’s immune system and thereby thwart" exact="autoimmune disease." post="In our study, we describe a phenomenon wherein sexually"/>
   <result pre="spore-feeding habit of diplogastrid nematodes may have included the early" exact="suppression" post="of potentially harmful fungi, although the relatively limited molecular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6198547/results/search/disease/results.xml">
   <result pre="of Applied Research in Veterinary Medicine200641p. 51 34QureshiA. W.TanveerA.Seroprevalence of" exact="fasciolosis" post="in buffaloes and humans in some areas of Punjab,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6211212/results/search/disease/results.xml">
   <result pre="J.PittT. L.WinstanleyC. (2007). Widespread pyocyanin overproduction among isolates of a" exact="cystic fibrosis" post="epidemic strain. BMC Microbiol. 7:4510.1186/1471-2180-7-4517521417 GallagherL. A.ManoilC. (2001). Pseudomonas"/>
   <result pre="of the mutational landscape in beta-glucuronidase: a major player of" exact="mucopolysaccharidosis" post="type VII. Gene576(1 Pt 1), 36–44. 10.1016/j.gene.2015.09.06226415878 KhanF. I.WeiD."/>
   <result pre="between citral and MARK4: a newer therapeutic approach to attenuate" exact="cancer" post="cell progression. Int. J. Biol. Macromol.107(Pt B), 2580–2589. 10.1016/j.ijbiomac.2017.10.14329079437"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6243205/results/search/disease/results.xml">
   <result pre="Introduction Gasterophilus intestinalis (Diptera: Oestridae) is a specific obligatory parasitic" exact="myiasis" post="larvae infesting family equidae stomach (equine, donkeys and Zebra)"/>
   <result pre="by gasterointestinal irritation including ulceration, volvulus, looseness of the bowels;" exact="peritonitis" post="may happen which prompts intestinal break (Otranto et al.,"/>
   <result pre="(Otranto et al., 2005). There are numerous reports of human" exact="myiasis" post="caused by Gasterophilus spp. larvae causing ophthalmo-myiasis (Anderson, 2006;"/>
   <result pre="Neem seed oil has been more effective in controlling some" exact="parasitic disease" post="as lice, ticks and many parasites (Okumu et al.,"/>
   <result pre="moulting and inhibits the growth of larval arthropods as in" exact="malaria" post="vector (Dua et al., 2009) from this point which"/>
   <result pre="in Riyadh region of Saudi ArabiaSaudi J. Biol. Sci20111829930323961139 AndersonJ.RColwellDDHallMJRSchollPJAsteroid" exact="myiasis" post="of humansThe Oestrid Flies: Biology, Host-Parasite Relationships, Impact and"/>
   <result pre="OkumuF.OKnolsB.G.JFillingerULarvicidal effects of a neem (Azadirachta indica) oil formulation onthe" exact="malaria" post="vector Anopheles gambiaeMalaria J.2007663 OtrantoDMililloPCapelliGColwellD.DSpecies composition of Gasterophilus spp."/>
   <result pre="OtrantoDMililloPCapelliGColwellD.DSpecies composition of Gasterophilus spp. (Diptera, Oestridae) causing equine gastric" exact="myiasis" post="in southern Italy:parasite biodiversity and risks for extinctionVet. Parasitol200513311111815978726"/>
   <result pre="parasitizing the plumage of poultryParasitol. Res201211062362721750872 YangJ.YZhangDHuD.FChuH.JTaoY.SFanX.ZLiKThe injury caused by" exact="myiasis" post="of Gasterophilus in horseChina Anim. Husb. Vet. Med2013405177180 ZumptT.FMyiasis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6273415/results/search/disease/results.xml">
   <result pre="of purified RIPs to antibodies that recognise tumour antigens for" exact="cancer" post="therapy. ribosome-inactivating proteins plant toxins anticancer drugs folk medicine"/>
   <result pre="stress and its use is suggested for the treatment of" exact="influenza" post="[126]. Mistletoe was recommended by Hippocrates as an emetic"/>
   <result pre="drastic, overturning the stomach excessively. Pounded and applied it cleans" exact="varicose veins" post="and sunburn&quot; [21]. Accordingly, Pliny recognized the therapeutic properties"/>
   <result pre="action in individuals with respiratory infections; (iii) to resolve intestinal" exact="constipation" post="due to dry stools; and (iv) to induce menstruation,"/>
   <result pre="were given both for internal use, in the case of" exact="constipation" post="to induce a laxative effect or as a diuretic"/>
   <result pre="has been used for the cure of inflammatory diseases, including" exact="arthritis" post="and rheumatic pain, skin diseases and fever and for"/>
   <result pre="pain, skin diseases and fever and for the treatment of" exact="cancer" post="[59]. The fruits of the colocynth have been prescribed"/>
   <result pre="for the treatment of gastrointestinal diseases, respiratory infections, diabetes and" exact="cancer" post="(reviewed in [53]). Fresh Stellaria media L. (chickweed) juice"/>
   <result pre="has been administered for the treatment of viral diseases and" exact="dermatitis" post="[132]. A variety of plants that were used in"/>
   <result pre="promoting activities. It was used to treat urticaria, migraine, malaria," exact="tetanus" post="and conjunctivitis due to its anti-pruritic, analgesic, anti-pyretic, anti-spasmodic"/>
   <result pre="It was used to treat urticaria, migraine, malaria, tetanus and" exact="conjunctivitis" post="due to its anti-pruritic, analgesic, anti-pyretic, anti-spasmodic and anti-phlogistic"/>
   <result pre="been suggested for the management of various diseases such as" exact="gastric ulcer," post="diabetes and cancer [5]. Trichosanthes cucumerina L. (snake gourd)"/>
   <result pre="management of various diseases such as gastric ulcer, diabetes and" exact="cancer" post="[5]. Trichosanthes cucumerina L. (snake gourd) is an edible"/>
   <result pre="been mentioned to alleviate the pain induced by chronic knee" exact="osteoarthritis" post="[118]. In Pakistan traditional medicine, some uncommon uses are"/>
   <result pre="of castor bean were administered for external use to cure" exact="gout" post="and rheumatism as well as to treat wounds, boils"/>
   <result pre="the juice of the leaves was given orally to treat" exact="liver disease" post="[22]. In Turkish folk medicine, beet leaves were recommended"/>
   <result pre="diuretic properties in the case of nervous tachycardia and insomnia," exact="arteriosclerosis" post="and hypertension [127]. In Northern Europe, the elderberry has"/>
   <result pre="of kilyambiti plant is used to treat coughs, colds, and" exact="pneumonia" post="and is taken with milk to treat stomach ache"/>
   <result pre="For centuries, the colocynth fruits have also been used for" exact="cancer" post="treatment [53,56,57]. Various parts of Jatropa curcas L. (purging"/>
   <result pre="treat various infections and infestations. Root decoctions are consumed for" exact="gingivitis" post="and toothache, eczema and skin parasites [73]. The stem"/>
   <result pre="[73]. The stem bark is used for the treatment of" exact="infertility" post="and miscarriage [74]. Jequirity roots are used as sedatives"/>
   <result pre="pumpkin, as a flower or fruit decoction, is taken for" exact="measles" post="and small pox, and as leaf poultice, is applied"/>
   <result pre="purgative and as a drug to cure rheumatism, elephantiasis and" exact="leprosy" post="[72]. Jequirity leaves are administered in the Caribbean for"/>
   <result pre="given in different manners: a leaf bath is used for" exact="rash" post="and sprains, leaf poultices for sores and pains and"/>
   <result pre="cells, that also justify its application in the treatment of" exact="choriocarcinoma" post="[166]. Momordica Anti-HIV Protein (MAP30), α- and β-momorcharins are"/>
   <result pre="contained in the Iscador preparations that are marketed to fight" exact="cancer" post="as an alternative and complementary medicine [141]. The anti-tumour"/>
   <result pre="elderberry extract showed promising results in the treatment of viral" exact="influenza" post="infection of chimpanzees. An anti-viral and anti-inflammatory action has"/>
   <result pre="RIP trichosanthin was delivered by a viral vector to human" exact="hepatocellular carcinoma" post="tumour via intra-tumour injection, resulting in a significant inhibition"/>
   <result pre="protein into the target cell to be deleted, such as" exact="cancer" post="cells (reviewed in [157,174]). This perspective was already envisaged"/>
   <result pre="and genotoxicity evaluation of plants used for the treatment of" exact="tuberculosis" post="and related symptoms in South AfricaJ. Ethnopharmacol.201415338639110.1016/j.jep.2014.02.03424576406 9.GulM.Z.AhmadF.KondapiA.K.QureshiI.A.GhaziI.A.Antioxidant and"/>
   <result pre="commercially important African medicinal plantsJ. Ethnopharmacol.201517611813410.1016/j.jep.2015.10.03126498493 12.MoshiM.J.KagasheG.A.MbwamboZ.H.Plants used to treat" exact="epilepsy" post="by Tanzanian traditional healersJ. Ethnopharmacol.20059732733610.1016/j.jep.2004.11.01515707773 13.GaraniyaN.BapodraA.Ethno botanical and Phytophrmacological"/>
   <result pre="colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium" exact="tuberculosis" post="and MOTT clinical isolatesJ. Ethnopharmacol.201314919520010.1016/j.jep.2013.06.02223816500 56.MarzoukB.MarzoukZ.HalouiE.FeninaN.BouraouiA.AouniM.Screening of analgesic and"/>
   <result pre="of edible fruits and spices used for the treatment of" exact="peptic ulcer" post="in traditional Iranian medicineISRN Gastroenterol.2013201313693210.1155/2013/13693224066235 64.DamianoR.CaiT.FornaraP.FranzeseC.A.LeonardiR.MironeV.The role of Cucurbita"/>
   <result pre="dammarane-type saponin from Gynostemma pentaphyllum induces apoptosis in A549 human" exact="lung carcinoma" post="cellsBioorg. Med. Chem. Lett.2016261754175910.1016/j.bmcl.2016.02.04626922140 68.HuyenV.T.PhanD.V.ThangP.HoaN.K.OstensonC.G.Gynostemma pentaphyllum Tea Improves Insulin"/>
   <result pre="remedies of hunters in TrinidadBMC Complement. Altern. Med.200111010.1186/1472-6882-1-1011737880 76.OdonneG.BergerF.StienD.GrenandP.BourdyG.Treatment of" exact="leishmaniasis" post="in the Oyapock basin (French Guiana): A K.A.P. survey"/>
   <result pre="abortionJ. Ethnopharmacol.201113792192510.1016/j.jep.2011.05.02621645605 83.PeterE.L.RumishaS.F.MashotoK.O.MaleboH.M.Ethno-medicinal knowledge and plants traditionally used to treat" exact="anemia" post="in Tanzania: A cross sectional surveyJ. Ethnopharmacol.201415476777310.1016/j.jep.2014.05.00224835027 84.AdeyemiO.O.YemitanO.K.AfolabiL.Inhibition of"/>
   <result pre="utilized by herbalists and traditional practitioner healers for treatments of" exact="diarrhea" post="in the West Bank/PalestineJ. Ethnopharmacol.2016182576610.1016/j.jep.2016.02.01326883246 101.ChusriS.SettharaksaS.ChokpaisarnJ.LimsuwanS.VoravuthikunchaiS.P.Thai herbal formulas used"/>
   <result pre="Ricinus communis L. extractJ. Ethnopharmacol.201314932833410.1016/j.jep.2013.06.04423850709 115.SharmaJ.GairolaS.GaurR.D.PainuliR.M.SiddiqiT.O.Ethnomedicinal plants used for treating" exact="epilepsy" post="by indigenous communities of sub-Himalayan region of Uttarakhand, IndiaJ."/>
   <result pre="L. and Ricinus communis L. leaves extract in treatment of" exact="osteoarthritis" post="using MIA model in ratsDaru2016241210.1186/s40199-016-0152-y27142000 119.AsgarpanahJ.HashemiS.J.HashemiE.AskariK.In vitro antifungal activity"/>
   <result pre="and safety of oral elderberry extract in the treatment of" exact="influenza" post="A and B virus infectionsJ. Int. Med. Res.20043213214010.1177/14732300040320020515080016 127.JarićS.PopovićZ.Macukanović-JocićM.DjurdjevićL.MijatovićM.KaradzićB.MitrovićM.PavlovićP.An"/>
   <result pre="Kars, Igdir provincesEcon. Bot.19975119521110.1007/BF02862090 129.LiuC.DaiL.H.DouD.Q.MaL.Q.SunY.X.A natural food sweetener with anti-pancreatic" exact="cancer" post="propertiesOncogenesis20165e21710.1038/oncsis.2016.2827065453 130.LiC.LinL.M.SuiF.WangZ.M.HuoH.R.DaiL.JiangT.L.Chemistry and pharmacology of Siraitia grosvenorii: A reviewChin."/>
   <result pre="the traditional antidiabetic plant Viscum album (mistletoe)J. Endocrinol.199916040941410.1677/joe.0.160040910076186 141.OstermannT.RaakC.BüssingA.Survival of" exact="cancer" post="patients treated with mistletoe extract (Iscador): A systematic literature"/>
   <result pre="[2,3] India Used for the treatment of anaemia, cancer, diabetes," exact="gastric ulcer," post="gonorrhoea, urethrorrhoea Fruits [4,5,6] Abrus precatorius L. (jequirity) Fabaceaeabrins"/>
   <result pre="menstrual disorders, migraine, muscular skeletal disorders, postpartum complications, spasms, tetanus," exact="urticaria" post="Fruits, leaves, roots, seeds [9,13,14,15,16,17] Caribbean Used for the"/>
   <result pre="Turkey Used as diuretic Used for the treatment of diabetes," exact="malaria" post="Leaves [32,33] Jordan Used for the treatment of inflammation"/>
   <result pre="cancer, diabetes, gas troubles, gastroenteritis, liver and respiratory diseases, toothache," exact="tuberculosis" post="Fruits, roots [22,53,54,55] Africa, China, Middle East Used as"/>
   <result pre="hypertension, indigestion, inflammation, retention of placenta, sore throat, syphilis, toothache," exact="tuberculosis" post="Fruits, roots, seeds [28,29,53,56,57,58] Ancient Egypt Used as abortifacient,"/>
   <result pre="for the treatment of abdominal pain, ascites, intestinal inflammation, oedema," exact="peptic ulcer" post="Fruits, seeds [46,61] Cucurbita maxima Duchesne (autumn squash) Cucurbitaceaecucurmoschin"/>
   <result pre="for the treatment of enlarged prostate gland, irritable bladder, measles," exact="peptic ulcer," post="small pox, sprains, worm infections Flowers, fruits, seeds [18,62,63]"/>
   <result pre="Palestine, Iran, Mediterranean area Used for the treatment of diarrhoea," exact="peptic ulcer" post="Fruits [21,63,100] Thailand Used for the treatment of wound"/>
   <result pre="the treatment of anorexia, diabetes, haemorrhage, hypodynamia, impotence, insomnia, palpitation," exact="shortness" post="of breath Berries, leaves, rhizomes, roots [23,102,103,104] Panax quinquefolium"/>
   <result pre="Japan, Korea Used for the treatment of cancer, diabetes, inflammation," exact="metabolic syndrome" post="Roots [23,104,105] Phytolacca acinosa Roxb (Indian poke) PhytolaccaceaePAP‑S1aci China"/>
   <result pre="ascariasis, eczema, gonorrhoea, jaundice, malaria, rabies, rheumatic pain, sore throat," exact="syphilis" post="pruritus, vitiligo Fruits, roots [108] Pisum sativum L. (pea)"/>
   <result pre="gonorrhoea, jaundice, malaria, rabies, rheumatic pain, sore throat, syphilis pruritus," exact="vitiligo" post="Fruits, roots [108] Pisum sativum L. (pea) Fabaceaepisavins Pakistan"/>
   <result pre="emetic, galactogogue, laxative Used for the treatment of phlegm, sunburn," exact="varicose veins" post="Leaves, seeds [21,35,36,112] China, India, Used as anthelmintic, anti-bacterial,"/>
   <result pre="plant [106,143,144] Turkey Used for the treatment of asthma, atherosclerosis," exact="brain cancer," post="breathing difficulties, bronchitis, cardiovascular diseases, chronic cramps, diabetes, headache,"/>
   <result pre="diseases, sterility, stomach problems, stroke, tachycardia, throat ache, tonic, toothache," exact="tonsillitis" post="Fruits, leafy, leaves branches, twigs [97,145,146,147,148] Ximenia americana L."/>
   <result pre="infection, conjunctivitis, cough, dermatitis, diabetes, dysentery, dysmenorrhoea, fever, food poisoning," exact="gastric ulcer," post="gingivitis, headaches, haemorrhoids, infertility, internal wounds, malaria, measles, mental"/>
   <result pre="snake/scorpion bites, throat infections, tonic, tooth ache, urinary tract infections," exact="uterine cancer," post="uterine prolapse, vaginitis, varicose veins, vomiting, wounds Bark, fruits,"/>
   <result pre="tooth ache, urinary tract infections, uterine cancer, uterine prolapse, vaginitis," exact="varicose veins," post="vomiting, wounds Bark, fruits, leaves, roots, seeds, stems [149,150,151]"/>
   <result pre="Used for the treatment of cough, diabetes, hoarseness, inflammation, obesity," exact="osteoporosis" post="pain, venereal disease, wound healing Bark, fruits, roots [19]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6274040/results/search/disease/results.xml">
   <result pre="to block the action of the acetylcholine neurotransmitter to treat" exact="motion sickness" post="and diseases such as Alzheimer’s and Parkinson’s [8]. The"/>
   <result pre="Pharmacopoeia as an anesthetic and was prescribed to treat cough," exact="asthma" post="and convulsions [13]. Przewalkia tangutica is a rare medicinal"/>
   <result pre="in patients undergoing chemotherapy and radiotherapy for the treatment of" exact="cancer" post="[24]. GAs and TAs have different physiological effects beyond"/>
   <result pre="in the 19th and 20th centuries to treat patients with" exact="asthma" post="or other respiratory conditions [17]. GAs include pelletierine (5),"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6278309/results/search/disease/results.xml">
   <result pre="used to treat tumors and age-related brain disorders such as" exact="dementia" post="and fear [122,123]. It is sold instead of Hypericum"/>
   <result pre="parts fight infections caused by some helminthes and protozoa (e.g.," exact="ascaridiasis" post="and giardiasis) [123,124,125,126]. T. lucida, together with T. erecta"/>
   <result pre="other actions against flu, fever, body pain, rash, sore throat," exact="heart attack," post="and arthritis [130]. Among plants collected for medical purposes"/>
   <result pre="flu, fever, body pain, rash, sore throat, heart attack, and" exact="arthritis" post="[130]. Among plants collected for medical purposes in India,"/>
   <result pre="diseases of the circulatory system, and in the case of" exact="neonatal jaundice" post="for breastfeeding mothers [137]. Indian folk veterinary medicine applies"/>
   <result pre="orally to cattle and sheep affected by anthrax, blackleg, and" exact="amoebiasis" post="[140]. 5. Food Preservative Applications of Tagetes Genus Plants"/>
   <result pre="minuta against mosquitoes of Anopheles gambiae, which are responsible for" exact="malaria" post="transmission. The results were comparable to commercial, synthetic, insecticidal"/>
   <result pre="of this flavonoid and its potential in the control of" exact="diabetes mellitus" post="and obesity were investigated by Wang et al. [184]"/>
   <result pre="and its potential in the control of diabetes mellitus and" exact="obesity" post="were investigated by Wang et al. [184] and compared"/>
   <result pre="Tagetes erecta (Linn.) flower extractJ. Pure Appl. Microbiol.2015925472551 21.Sharifi-RadJ.SalehiB.SchnitzlerP.AyatollahiS.KobarfardF.FathiM.EisazadehM.Sharifi-RadM.Susceptibility of" exact="herpes simplex" post="virus type 1 to monoterpenes thymol, carvacrol, p-cymene and"/>
   <result pre="royleana Benth. and Pulicaria vulgaris GaertnCell. Mol. Biol.201763424710.14715/cmb/2017.63.8.1028886313 22.SalehiB.ZuccaP.Sharifi-RadM.PezzaniR.RajabiS.SetzerW.N.VaroniE.M.IritiM.KobarfardF.Sharifi-RadJ.Phytotherapeutics in" exact="cancer" post="invasion and metastasisPhytother. Res.2018321425144910.1002/ptr.608729672977 23.SalehiB.MishraA.P.ShuklaI.Sharifi-RadM.del Mar ContrerasM.Segura-CarreteroA.FathiH.Nasri NasrabadiN.KobarfardF.Sharifi-RadJ.Thymol, thyme"/>
   <result pre="of Francesc Bolos (1773–1844)J. Ethnopharmacol.201720414216810.1016/j.jep.2017.04.00228412219 135.RasoanaivoP.PetitjeanA.Ratsimamanga-UrvergS.Rakoto-RatsimamangaA.Medicinal plants used to treat" exact="malaria" post="in MadagascarJ. Ethnopharmacol.19923711712710.1016/0378-8741(92)90070-81434686 136.MahomoodallyM.F.A quantitative ethnobotanical study of common"/>
   <result pre="water to wash affected area and to relieve itchiness and" exact="rash" post="[130,187,188,189,190,191,192] Mexico, India, Belize, Bangladesh T. filifolia Severe colic,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6286506/results/search/disease/results.xml">
   <result pre="(STH: Ascaris lumbricoides, Ancylostoma duodenale (hookworm) and Trichuris Trichura) and" exact="schistosomiasis" post="are an important public health concern [1]. These infections"/>
   <result pre="age 4–12 years and informed consent. The exclusion criteria were previous" exact="hypersensitivity" post="to albendazole or pawpaw products, receipt of any anthelminthic"/>
   <result pre="on child growth and nutritionMatern Child Nutr20084Suppl 111823610.1111/j.1740-8709.2007.00127.x18289159 6.AlbonicoMAllenHChitsuloLEngelsDGabrielliAFSavioliLControlling soil-transmitted" exact="helminthiasis" post="in preschool-age children through preventive chemotherapyPLoS Negl Trop Dis20082e12610.1371/journal.pntd.000012618365031"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6313905/results/search/disease/results.xml">
   <result pre="(Euphorbiaceae) and Rauvolfia vomitoria Afzel (Apocynaceae) demonstrate activities against Onchocerca" exact="volvulus" post="microfilariae in vitroMC Complement. Altern. Med.2013136610.1186/1472-6882-13-6623506674 22.UrbanJ.KokoskaL.LangrovaI.MatejkovJ.In vitro anthelmintic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6315057/results/search/disease/results.xml">
   <result pre="copy of this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract Nematodes causing lymphatic" exact="filariasis" post="and onchocerciasis rely on their bacterial endosymbiont, Wolbachia, for"/>
   <result pre="this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract Nematodes causing lymphatic filariasis and" exact="onchocerciasis" post="rely on their bacterial endosymbiont, Wolbachia, for survival and"/>
   <result pre="kill rates (&amp;lt;2 days) than existing anti-Wolbachia drugs that cure" exact="onchocerciasis" post="and lymphatic filariasis. This industrial scale anthelmintic neglected tropical"/>
   <result pre="improved, safer and more selective macrofilaricidal drugs. Parasitic nematodes causing" exact="onchocerciasis" post="and lymphatic filariasis rely on a bacterial endosymbiont, Wolbachia,"/>
   <result pre="more selective macrofilaricidal drugs. Parasitic nematodes causing onchocerciasis and lymphatic" exact="filariasis" post="rely on a bacterial endosymbiont, Wolbachia, which is a"/>
   <result pre="control and elimination of the debilitating neglected tropical diseases (NTDs)" exact="onchocerciasis" post="and lymphatic filariasis are hampered by the lack of"/>
   <result pre="of the debilitating neglected tropical diseases (NTDs) onchocerciasis and lymphatic" exact="filariasis" post="are hampered by the lack of a drug, which"/>
   <result pre="include Wuchereria bancrofti, Brugia malayi and Brugia timori for lymphatic" exact="filariasis" post="whilst Onchocerca volvulus causes onchocerciasis1,2. These diseases afflict 157"/>
   <result pre="Brugia malayi and Brugia timori for lymphatic filariasis whilst Onchocerca" exact="volvulus" post="causes onchocerciasis1,2. These diseases afflict 157 million people worldwide"/>
   <result pre="been shown to be superior to existing regimens for lymphatic" exact="filariasis" post="in a phase II trial5, but there are serious"/>
   <result pre="but there are serious concerns in using these combinations for" exact="onchocerciasis" post="and for lymphatic filariasis in areas of sub-Saharan Africa"/>
   <result pre="concerns in using these combinations for onchocerciasis and for lymphatic" exact="filariasis" post="in areas of sub-Saharan Africa co-endemic for Loa loa."/>
   <result pre="severe adverse events (SAE) induced by rapid killing of O." exact="volvulus" post="microfilariae (Mf) in ocular tissues and Mazzotti reactions in"/>
   <result pre="and Mazzotti reactions in the skin with DEC6 and fatal" exact="encephalopathy" post="in Loiasis following ivermectin, prompting the need for pre-screening"/>
   <result pre="target the Wolbachia bacterial endosymbiont of the nematodes which cause" exact="onchocerciasis" post="and lymphatic filariasis as it is vital for the"/>
   <result pre="bacterial endosymbiont of the nematodes which cause onchocerciasis and lymphatic" exact="filariasis" post="as it is vital for the nematodes’ survival and"/>
   <result pre="policy drug, doxycycline (4–6 weeks regimens) for the treatment of" exact="onchocerciasis" post="and lymphatic filariasis. Furthermore, it is accepted that time-kill"/>
   <result pre="the discovery of novel drugs for the debilitating filarial diseases" exact="onchocerciasis" post="and lymphatic filariasis. Our goals were achieved through a"/>
   <result pre="References References 1.TaylorMJHoeraufATownsonSSlatkoBEWardSAAnti-Wolbachia drug discovery and development: safe macrofilaricides for" exact="onchocerciasis" post="and lymphatic filariasisParasitology201414111912710.1017/S003118201300110823866958 2.BurrowsJNet al.The role of modern drug"/>
   <result pre="ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic" exact="filariasis" post="and onchocerciasis in AfricaPLoS Negl. Trop. Dis.201711e000516310.1371/journal.pntd.000516328056015 7.KamgnoJet al.A"/>
   <result pre="and albendazole (IDA) to accelerate elimination of lymphatic filariasis and" exact="onchocerciasis" post="in AfricaPLoS Negl. Trop. Dis.201711e000516310.1371/journal.pntd.000516328056015 7.KamgnoJet al.A test-and-not-treat strategy"/>
   <result pre="in AfricaPLoS Negl. Trop. Dis.201711e000516310.1371/journal.pntd.000516328056015 7.KamgnoJet al.A test-and-not-treat strategy for" exact="onchocerciasis" post="in loa loa-endemic areasN. Engl. J. Med.20173772044205210.1056/NEJMoa170502629116890 8.WanjiSet al.Relationship"/>
   <result pre="declaration on adherence to ivermectin treatment and parasitological indicators of" exact="onchocerciasis" post="in an area of persistent transmission despite a decade"/>
   <result pre="with Ivermectin non-compliance and its potential role in sustaining Onchocerca" exact="volvulus" post="transmission in the west region of cameroonPLoS Negl. Trop."/>
   <result pre="et al. Macrofilaricidal activity after doxycycline only treatment of Onchocerca" exact="volvulus" post="in an area of Loa loa co-endemicity: a randomized"/>
   <result pre="al.Doxycycline leads to sterility and enhanced killing of female Onchocerca" exact="volvulus" post="worms in an area with persistent microfilaridermia after repeated"/>
   <result pre="high-throughput anti-wolbachia whole-cell screen: a route to macrofilaricidal drugs against" exact="onchocerciasis" post="and lymphatic filariasisJ. Biomol. Screen.201420646910.1177/108705711455151825278497 19.JohnstonKLet al.Identification and prioritization"/>
   <result pre="drugs from the human pharmacopoeia to target Wolbachia endosymbionts of" exact="onchocerciasis" post="and lymphatic filariasisInt. J. Parasitol. Drugs Drug Resist.2014427828610.1016/j.ijpddr.2014.09.00125516838 21.OpreaTIGottfriesJChemography:"/>
   <result pre="depletion predictive of curative outcomes in preclinical models of lymphatic" exact="filariasis" post="and onchocerciasisSci. Rep.2017721010.1038/s41598-017-00322-528303006 30.SharmaRet al.Minocycline as a re-purposed anti-Wolbachia"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6347238/results/search/disease/results.xml">
   <result pre="used this plant for antiparasitic purposes, in tick control and" exact="diarrhea" post="treatment in ruminants (Costa Jr, personal communication). Based on"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6352305/results/search/disease/results.xml">
   <result pre="also been reported to exacerbate other diseases such as malaria," exact="tuberculosis" post="and HIV/AIDS (Fincham et al., 2003; Le Hesran et"/>
   <result pre="Rev.162013173823573938 LamsonP.D.WardC.B.The chemotherapy of helminth infestationsJ. Parasitol.181932173199 Le HesranJ.Y.AkianaJ.Ndiaye elH.M.DiaM.SenghorP.KonateL.Severe" exact="malaria" post="attack is associated with high prevalence of Ascaris lumbricoides"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6357211/results/search/disease/results.xml">
   <result pre="soil-transmitted helminths (STH) or intestinal nematodes, filarial worms, schistosomes and" exact="onchocerciasis" post="worm. The life cycle of a parasite worm could"/>
   <result pre="fatigue, enlarged liver and spleen, gastrointestinal inflammation, pneumonitis, blindness, eosinophilia," exact="bowel obstruction," post="anaemia, vomiting, constipation, lymphedema, weight loss, itchy skin and"/>
   <result pre="reported 90% of the estimated 120 million cases of lymphatic" exact="filariasis" post="was caused by Wuchereria bancrofti in about 83 countries"/>
   <result pre="America Kumar et al. (2014); WHO, 2017 Filarial nematodes Lymphatic" exact="filariasis" post="Brugia malayi; Wuchereria bancrofti 120 Tropical and subtropical regions"/>
   <result pre="Central Africa Hotez et al. (2008) Onchocerciasis (river blindness) Onchocerca" exact="volvulus" post="37 Sub-Saharan Africa, Yemen and isolated areas of South"/>
   <result pre="organism such as increased mucus secretion, cell hyperplasia, muscle contraction," exact="allergy" post="and eosinophil-mediated tissue inflammation (Fig. 2) (Bethony et al.,"/>
   <result pre="response of the helminths to the host immune could cause" exact="suppression" post="of host lymphocytes which ensure the survival of the"/>
   <result pre="2.3 Synthetic anthelminthic drugs and resistance Pathogenic bacteria, parasites or" exact="cancer" post="with initial successful drug treatment may rapidly be tolerant"/>
   <result pre="the 1950s and it is suitable for the treatment of" exact="filariasis" post="and threadworm. Its mode of action; it acts as"/>
   <result pre="et al., 2009). The whole genome sequencing of helminth causing" exact="schistosomiasis" post="was mapped and it confirmed, there was a linkage"/>
   <result pre="development of vaccine antigens for several helminths. The vaccine for" exact="trichuriasis" post="and ascariasis are currently undergoing preclinical testing. Hookworm, schistosomiasis,"/>
   <result pre="vaccine antigens for several helminths. The vaccine for trichuriasis and" exact="ascariasis" post="are currently undergoing preclinical testing. Hookworm, schistosomiasis, onchocerciasis and"/>
   <result pre="trichuriasis and ascariasis are currently undergoing preclinical testing. Hookworm, schistosomiasis," exact="onchocerciasis" post="and other STH infections vaccines are in various stages"/>
   <result pre="Th1 responses are required. For example, the infection of Onchocerca" exact="volvulus" post="and Schistosoma species was reported to decrease the effect"/>
   <result pre="reported to decrease the effect of vaccine used to treat" exact="tetanus" post="and tuberculosis (Moreau and Chauvin, 2010). In a rat"/>
   <result pre="decrease the effect of vaccine used to treat tetanus and" exact="tuberculosis" post="(Moreau and Chauvin, 2010). In a rat model, it"/>
   <result pre="found in the epithelial cells and has excretory roles. It" exact="aids" post="multidrug resistance (MDR) by active transport of drugs using"/>
   <result pre="are known for the health complications; haematuria, kidney damage and" exact="cancer" post="in the bladder, at later stages of infection (Colley"/>
   <result pre="at later stages of infection (Colley et al., 2014). Lymphatic" exact="filariasis" post="and onchocerciasis helminthic diseases are capable of causing permanent"/>
   <result pre="stages of infection (Colley et al., 2014). Lymphatic filariasis and" exact="onchocerciasis" post="helminthic diseases are capable of causing permanent disabilities or"/>
   <result pre="of causing permanent disabilities or even death to host. Furthermore," exact="filariasis" post="and onchocerciasis could cause lymphedema, hydrocoele, elephantiasis, skin disease"/>
   <result pre="permanent disabilities or even death to host. Furthermore, filariasis and" exact="onchocerciasis" post="could cause lymphedema, hydrocoele, elephantiasis, skin disease and blindness"/>
   <result pre="hookworm-endemic areas of developing countries?Can. J. Public Health200622222416827412 Le HesranJ.-Y.Severe" exact="malaria" post="attack is associated with high prevalence of Ascaris lumbricoides"/>
   <result pre="Res.743201332023210Academic Journals OliveiraW.J.Evaluation of diagnostic methods for the detection of" exact="intestinal schistosomiasis" post="in endemic areas with low parasite loads: saline gradient,"/>
   <result pre="Journals OliveiraW.J.Evaluation of diagnostic methods for the detection of intestinal" exact="schistosomiasis" post="in endemic areas with low parasite loads: saline gradient,"/>
   <result pre="Science, University of Nigeria SuZ.SeguraM.StevensonM.M.Reduced protective efficacy of a blood-stage" exact="malaria" post="vaccine by concurrent nematode infectionInfect. Immun.74420062138214416552043 TaylorM.J.HoeraufA.BockarieM.Lymphatic filariasis and"/>
   <result pre="a blood-stage malaria vaccine by concurrent nematode infectionInfect. Immun.74420062138214416552043 TaylorM.J.HoeraufA.BockarieM.Lymphatic" exact="filariasis" post="and onchocerciasisLancet20101175118520739055 TinsleyR.C.Environmental constraints influencing survival of an African"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6359778/results/search/disease/results.xml">
   <result pre="Kidney stone, pneumonia, chest pain, puncture wounds, ulcer, dysmenorrhea, aerodontalgia," exact="asthma" post="42 0.13 26 0.62 0.89 83.3 73 1♦2■3■4●5♦6■7●8♦9♦10■11♦12♦13♦14●15♦16♦17♦18♦19♦20■21♦22♦ 4."/>
   <result pre="ST. decoction Topical, Oral Eye pain, galactagogue, leucorrhea, snake bite," exact="diarrhea" post="25 0.08 10 0.40 0.53 56.0 29 1♦2●3●4♦5♦6♦7♦8♦9♦10♦11♦12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 5."/>
   <result pre="powder; BA. decoction Gargle, Oral Vermifuge, dyspepsia, diuretic, odontalgia, cataract," exact="constipation" post="27 0.08 12 0.44 0.57 59.3 33 1♦2●3♦4■5●6♦7■8●9♦10♦11♦12■13♦14♦15♦16■17♦18♦19♦20♦21♦22♦ 6."/>
   <result pre="Topical Painful urination, eye pain, constipation, piles, snakebite, cough and" exact="asthma" post="35 0.11 19 0.54 0.74 68.6 50 1♦2●3♦4●5♦6●7■8♦9♦10■11●12■13■14■15♦16■17♦18●19♦20♦21♦22■ 7."/>
   <result pre="Painful urination, piles, swelling joint, eczema and leprosy, cough and" exact="asthma" post="37 0.12 22 0.59 0.78 73.0 56 1♦2♦3♦4♦5♦6♦7♦8♦9♦10♦11♦12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 12."/>
   <result pre="A H W SD. oil; FL. Oral Jaundice, obesity, ulcer," exact="male infertility," post="bronchitis, thrombosis 32 0.10 15 0.47 0.68 71.9 48"/>
   <result pre="decoction; ST. Topical, Oral Ringworm, hepatic ulcer, body tonic, cough," exact="asthma" post="34 0.11 15 0.44 0.72 73.5 52 1♦2♦3♦4♦5♦6♦7■8♦9♦10♦11♦12♦13♦14♦15♦16♦17●18♦19♦20♦21♦22♦ 19."/>
   <result pre="H W WP. powder, extract; LE. extract Oral Blood purifier," exact="urinary tract infection," post="liver tonic 31 0.10 16 0.52 0.66 71.0 46"/>
   <result pre="FR. powder, decoction, infusion; WP. juice Topical, Oral Ophthalmia, indigestion," exact="mumps" post="and measles, skin ulcer, wounds 37 0.12 17 0.46"/>
   <result pre="SD and FL. decoction; FR.; RT. powder Topical, Oral Male" exact="sexual dysfunction," post="hemolytic anemia, anthelminthic, indigestion, hepatic disorder, boils, sciatic and"/>
   <result pre="FL. decoction; FR.; RT. powder Topical, Oral Male sexual dysfunction," exact="hemolytic anemia," post="anthelminthic, indigestion, hepatic disorder, boils, sciatic and joint pain"/>
   <result pre="Oral and as Snuff Indigestion, backbone pain, cold and cough," exact="sexual dysfunction," post="anthelminthic 38 0.12 17 0.45 0.80 76.3 60 1●2♦3♦4♦5♦6♦7■8♦9■10♦11●12■13●14■15♦16♦17♦18♦19♦20♦21♦22♦"/>
   <result pre="infusion Topical, Oral Wound healing, dysentery, kidney and pancreatic stone," exact="epilepsy" post="27 0.08 9 0.33 0.57 63.0 35 1♦2♦3♦4♦5♦6■7♦8♦9♦10■11♦12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 42."/>
   <result pre="ST. decoction Topical, Oral Urinary disorder, headache, carminative and anodyne," exact="constipation" post="26 0.08 8 0.31 0.55 61.5 33 1●2■3♦4♦5♦6■7♦8●9♦10●11♦12♦13♦14♦15♦16♦17●18♦19♦20♦21♦22♦ 45."/>
   <result pre="paste; RT. infusion Topical, Oral Urodynia, anthelminthic, dermatitis, indigestion, lactation," exact="hypersplenism" post="47 0.15 32 0.68 0.99 80.9 79 1♦2●3♦4♦5♦6■7●8●9♦10■11♦12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 46."/>
   <result pre="LE. juice, decoction, poultice; ST. juice Topical, Oral Bone Fracture," exact="gastric ulcer," post="hemorrhage, hair tonic, dermatitis, dengue fever, cardiac tonic 31"/>
   <result pre="Topical, Oral Bone Fracture, gastric ulcer, hemorrhage, hair tonic, dermatitis," exact="dengue fever," post="cardiac tonic 31 0.10 21 0.68 0.66 67.7 44"/>
   <result pre="juice Topical, Oral Lice infestation, head ache, snakebite, skin parasites," exact="epilepsy" post="35 0.11 23 0.66 0.74 71.4 52 1♦2♦3♦4●5♦6♦7■8♦9♦10♦11♦12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 49."/>
   <result pre="Oral Dysentery, hepatic ulcer, eczema, blood purifier, hyperglycemia, bladder stone," exact="diarrhea" post="37 0.12 22 0.59 0.78 67.6 52 1♦2●3♦4●5♦6●7■8●9■10■11♦12♦13■14■15♦16♦17♦18■19♦20♦21♦22♦ 52."/>
   <result pre="(Branches); FR. Decoction Oral Sexual disorders, impotencytonic, diuretic, blood purifier," exact="asthma" post="34 0.11 22 0.65 0.72 67.6 48 1♦2♦3●4♦5♦6■7♦8♦9♦10♦11●12●13♦14♦15♦16♦17■18♦19■20■21♦22♦ 55."/>
   <result pre="clover A H W LE. paste; WP. powder Oral Emollient," exact="diarrhea" post="swellings, bowl complaints, carminative, digestive, skin rash 20 0.06"/>
   <result pre="powder Oral Emollient, diarrhea swellings, bowl complaints, carminative, digestive, skin" exact="rash" post="20 0.06 6 0.30 0.42 40.0 17 1♦2♦3♦4♦5■6♦7♦8♦9■10♦11♦12■13♦14■15♦16■17♦18♦19♦20♦21♦22♦ 60."/>
   <result pre="paste, decoction; SD.; WP. powder Topical, Oral Syphilis, laxative, piles,bronchial" exact="asthma" post="40 0.12 26 0.65 0.85 82.5 69 1♦2■3●4♦5♦6●7♦8♦9♦10●11♦12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 69."/>
   <result pre="Oral Sexual dysfunction, leucorrhoea, asthma, skin ulcer, cardiac pain, carminative," exact="diarrhea" post="41 0.13 25 0.61 0.87 80.5 69 1♦2●3♦4♦5♦6●7■8♦9♦10♦11♦12♦13■14■15♦16♦17♦18♦19♦20♦21♦22♦ 70."/>
   <result pre="poultice, decoction, paste Topical, Oral Skin sores, eczema, wounds, diarrhea," exact="asthma" post="40 0.12 23 0.58 0.85 42.5 35 1♦2♦3♦4♦5♦6♦7■8♦9♦10♦11♦12■13●14♦15♦16♦17♦18♦19■20■21♦22♦ 72."/>
   <result pre="P T W ST. latex; LE. decoction Oral Premature ejaculation," exact="syphilis" post="and gonorrhea, male sexual power 73 0.23 53 0.73"/>
   <result pre="Topical, Oral Body tonic, bronchial asthma, heart blockage, leucorrhea, ulcer," exact="hypoglycemia" post="31 0.10 15 0.48 0.66 67.7 44 1♦2●3♦4♦5♦6♦7●8♦9●10♦11♦12■13●14■15♦16♦17●18♦19♦20♦21♦22♦ 80."/>
   <result pre="decoction Topical, Oral Cough, constipation, hepatic ulcer, tonsils, snake bite," exact="hypoglycemia" post="74 0.23 54 0.73 1.00 94.6 95 1♦2♦3♦4♦5♦6♦7■8♦9■10■11♦12■13■14■15■16♦17●18■19♦20♦21■22■ 82."/>
   <result pre="WP. infusion Topical, Oral Dysmenorrhea, cough, snake bite, bronchial asthma," exact="kidney failure," post="flu 21 0.07 6 0.29 0.44 38.1 17 1●2♦3■4♦5♦6♦7●8♦9♦10♦11♦12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦"/>
   <result pre="FL. juice Topical, Oral Conjunctivitis, wound and cuts, emmenagogue, febricity," exact="breast cancer," post="ulcer, insomnia 45 0.14 26 0.58 0.95 86.7 81"/>
   <result pre="cooked Topical, Oral and as Eye drop Diarrhea and dysentery," exact="hepatitis" post="C, wounds, eye inflammation, vermifuge, sexual dysfunction 21 0.07"/>
   <result pre="drop Diarrhea and dysentery, hepatitis C, wounds, eye inflammation, vermifuge," exact="sexual dysfunction" post="21 0.07 9 0.43 0.44 42.9 19 1♦2♦3●4♦5●6●7●8●9♦10■11♦12●13■14●15■16●17●18■19♦20♦21♦22● 91."/>
   <result pre="H W FL. powder; LE. extract Topical, Oral Sexual problems," exact="premature ejaculation," post="spermatoria, emollient, purgative 44 0.14 24 0.55 0.93 86.4"/>
   <result pre="juice, infusion, paste; Topical, Oral Abortifacient, diarrhea, indigestion, piles, antispasmodic," exact="scabies" post="22 0.07 7 0.32 0.47 40.9 19 1♦2♦3♦4♦5♦6♦7■8♦9■10♦11♦12♦13♦14●15♦16♦17♦18♦19♦20♦21♦22♦ 97."/>
   <result pre="Topical, Oral Colon cancer, wound healing, anemia, asthma, late puberty," exact="hyperglycemia" post="37 0.12 21 0.57 0.78 59.5 46 1●2♦3♦4♦5♦6♦7●8●9♦10♦11♦12■13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 105."/>
   <result pre="FL. decoction; WP. juice, paste Topical, Oral Skin ulcer, leprosy," exact="hepatitis" post="C, epilepsy 36 0.11 20 0.56 0.76 63.9 48"/>
   <result pre="WP. juice, paste Topical, Oral Skin ulcer, leprosy, hepatitis C," exact="epilepsy" post="36 0.11 20 0.56 0.76 63.9 48 1♦2♦3●4♦5♦6♦7■8♦9●10♦11♦12■13♦14●15♦16♦17♦18♦19♦20♦21♦22♦ 110."/>
   <result pre="Oral, Inhale and as Topical Rabies, piles, cough, asthma, lice-infestation," exact="premature ejaculation," post="purgative, narcotic and sedative 29 0.09 15 0.52 0.61"/>
   <result pre="febricity, heel cracks, anthelmintic, asthma, wound healing, liver tonic, rheumatic" exact="arthritis" post="90 0.28 74 0.82 1.00 94.4 94 1●2●3●4●5♦6●7■8●9■10■11●12♦13♦14■15■16♦17●18●19♦20♦21♦22● 122."/>
   <result pre="Snuff Malarial fever, stomachache, night mare, hyperglycemia, asthma, irregular menstruation," exact="breast cancer," post="wounds 95 0.30 80 0.84 1.00 100.0 100 1■2♦3♦4■5♦6■7■8♦9■10■11■12■13■14■15♦16♦17♦18♦19♦20♦21♦22♦"/>
   <result pre="P H W RH. paste; FL. Oral Diarrhea and dysentery," exact="mumps" post="and measles, gonorrhea 33 0.10 18 0.55 0.70 69.7"/>
   <result pre="RH. paste; FL. Oral Diarrhea and dysentery, mumps and measles," exact="gonorrhea" post="33 0.10 18 0.55 0.70 69.7 48 1♦2♦3♦4♦5♦6♦7♦8♦9♦10♦11●12♦13♦14♦15♦16♦17♦18♦19♦20♦21♦22♦ 128."/>
   <result pre="juice, decoction, paste Topical, Oral Ringworm, headache, aerodontalgia, malarial fever," exact="rheumatoid arthritis," post="cuts and wounds, injuries, cough, cold, 43 0.13 25"/>
   <result pre="decoction Topical, Oral Dysentery and diarrhea, urodynia, irregular menstruation, wounds," exact="dyspepsia" post="61 0.19 41 0.67 1.00 90.2 90 1■2♦3♦4♦5♦6♦7■8♦9■10■11♦12♦13■14♦15●16♦17■18♦19♦20♦21♦22♦ aLife"/>
   <result pre="e.g., leaves of Withania somnifera were taken orally to treat" exact="asthma" post="and malarial disease, and applied externally to heal wounds."/>
   <result pre="drug preparation [53]. For instance, the treatment of cough and" exact="asthma" post="was done by using a decoction prepared from S."/>
   <result pre="frequently utilized to treat different ailments including gastrointestinal disorders (stomachache," exact="gastric ulcer," post="gas trouble, intestinal worms, vomiting, constipation, dysentery, diarrhea), respiratory"/>
   <result pre="were used in medicinal baths to treat skin diseases, i.e.," exact="allergy" post="and chicken pox. Li et al. [57] reported that"/>
   <result pre="W. somnifera, which were used as blood purifier, to treat" exact="breast cancer" post="and as stomachache, respectively. Comparatively, fidelity levels of these"/>
   <result pre="somnifera, which were used as blood purifier, to treat breast" exact="cancer" post="and as stomachache, respectively. Comparatively, fidelity levels of these"/>
   <result pre="47.EddouksMMaghraniMLemhadriAOuahidiM-LJouadHEthnopharmacological survey of medicinal plants used for the treatment of" exact="diabetes mellitus," post="hypertension and cardiac diseases in the south-east region of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6401159/results/search/disease/results.xml">
   <result pre="Trust (Wellcome) 095778107743ElliottAlison M. Introduction Schistosomiasis is second only to" exact="malaria" post="as a parasitic cause of human morbidity, with over"/>
   <result pre="and LeX (G89) units (Fig. S3). Infection with other helminths," exact="malaria" post="or HIV was not associated with IgE or IgG"/>
   <result pre="after adjusting for age. One of the key challenges in" exact="schistosomiasis" post="vaccine development is the risk of allergic (IgE) sensitisation"/>
   <result pre="Organization (2016). 4.SecorWEMontgomerySPSomething old, something new: is praziquantel enough for" exact="schistosomiasis" post="control?Future Med Chem2015768168410.4155/fmc.15.925996059 5.KingCHThe evolving schistosomiasis agenda 2007–2017-Why we"/>
   <result pre="is praziquantel enough for schistosomiasis control?Future Med Chem2015768168410.4155/fmc.15.925996059 5.KingCHThe evolving" exact="schistosomiasis" post="agenda 2007–2017-Why we are moving beyond morbidity control toward"/>
   <result pre="on the establishment of a controlled human infection model for" exact="schistosomiasis" post="in Uganda: report of a stakeholders’ meeting held in"/>
   <result pre="protein glycosylation in allergyInt Arch Allergy Immunol20071429911510.1159/00009611417033195 23.ComminsSPCarbohydrates as allergensCurrent" exact="allergy" post="and asthma reports20151549210.1007/s11882-014-0492-y25430953 24.KhooK-HChatterjeeDCaulfieldJPMorrisHRDellAStructural mapping of the glycans from"/>
   <result pre="in allergyInt Arch Allergy Immunol20071429911510.1159/00009611417033195 23.ComminsSPCarbohydrates as allergensCurrent allergy and" exact="asthma" post="reports20151549210.1007/s11882-014-0492-y25430953 24.KhooK-HChatterjeeDCaulfieldJPMorrisHRDellAStructural mapping of the glycans from the egg"/>
   <result pre="IgE responses in school children by glycan microarrayThe Journal of" exact="allergy" post="and clinical immunology20181411130113310.1016/j.jaci.2017.09.04029128671 47.Yang, Y. Y., van Diepen, A.,"/>
   <result pre="trialTrials20151618710.1186/s13063-015-0702-525902705 51.Nkurunungi, G. et al. Schistosoma mansoni-specific immune responses and" exact="allergy" post="in Uganda. Parasite immunology40, 10.1111/pim.12506 (2018). 52.Sanya, R. E."/>
   <result pre="glycans and antibody-mediated immune responses in Schistosoma infectionParasitology20121391219123010.1017/s003118201200027322423613 68.DiemertDJet al.Generalized" exact="urticaria" post="induced by the Na-ASP-2 hookworm vaccine: implications for the"/>
   <result pre="implications for the development of vaccines against helminthsThe Journal of" exact="allergy" post="and clinical immunology2012130169176.e16610.1016/j.jaci.2012.04.02722633322 69.MariAet al.Evaluation by double-blind placebo-controlled oral"/>
   <result pre="M.-L.) 181–202 (Springer Vienna, 2012). 71.ComminsSPet al.Delayed anaphylaxis, angioedema, or" exact="urticaria" post="after consumption of red meat in patients with IgE"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6429201/results/search/disease/results.xml">
   <result pre="A. albimanus, and C. quinquefasciatus, vectors of the human diseases," exact="dengue fever," post="malaria, and lymphatic filariasis, respectively. These plant species included"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6436750/results/search/disease/results.xml">
   <result pre="the discovery of new active compounds against diseases such as" exact="cancer" post="or infections, including helminth infections that cause the highest"/>
   <result pre="disability and mortality in humans worldwide [15]. In endemic areas," exact="schistosomiasis" post="occurs as a chronic disease, which derives from the"/>
   <result pre="worm [16]. Approximately 700 million people are at risk of" exact="schistosomiasis" post="[15], and there is no vaccination that might prevent"/>
   <result pre="as possible sources of new drugs in the treatment of" exact="schistosomiasis" post="and further parasitic diseases. Materials &amp;amp; methods Ethics statement"/>
   <result pre="cells or by donezepil in neural stem cells led to" exact="suppression" post="of proliferation, differentiation and self-renewal ability [41, 69]. Therefore,"/>
   <result pre="been studied as an alternative medicine for inflammatory diseases and" exact="cancer" post="[75, 76]. As with propolis, a reduction of worm"/>
   <result pre="causing inflammatory diseases. Toxins. 2015;7(11):4758–72. 10.3390/toxins711475826580653 76OrsolicN. Bee venom in" exact="cancer" post="therapy. Cancer metastasis reviews. 2012;31(1–2):173–94. 10.1007/s10555-011-9339-322109081"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6441754/results/search/disease/results.xml">
   <result pre="dried herb is listed for the treatment of fevers and" exact="malaria" post="(Willcox, 2009). This potent antimalarial activity is due to"/>
   <result pre="a decoction of the leaves and stems externally for colds," exact="asthma" post="and arthritis (Adams, 2012) and a liniment made from"/>
   <result pre="of the leaves and stems externally for colds, asthma and" exact="arthritis" post="(Adams, 2012) and a liniment made from this plant,"/>
   <result pre="and ligament strains, bruises, broken bones, low back pain and" exact="cancer" post="(Adams, 2012). A. californica, was used also by Costanoan"/>
   <result pre="they are responsible for other effects in the prevention of" exact="neurodegeneration" post="(Rodriguez et al., 1976). SLs are also alleged to"/>
   <result pre="is not elucidated, but it may be due to the" exact="suppression" post="of kinin and prostaglandin formation (Al-Harbi et al., 1994)."/>
   <result pre="santonin, sclareolide and their synthetic derivatives on mouse radiation induced" exact="fibrosarcoma" post="cells (RIF-1), following PDT. FP6 turned out to be"/>
   <result pre="Anti-inflammatory active ingredients. Patent PCT/EP01/11055. GhantousA.Gali-MuhtasibH.VuorelaH.SalibaN.DarwicheN.What made sesquiterpene lactones reach" exact="cancer" post="clinical trials?Drug Discov. Today15201066867820541036 GiordanoO.GuerreiroE.PestchankerM.GuzmanJ.PastorD.GuardiaT.The gastric cytoprotective effect of"/>
   <result pre="exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit" exact="osteoarthritis" post="modelInt. J. Clin. Exp. Pathol.83201223652374PMID: 26045743 ZhuX.YangL.LiY.ZhangD.ChenY.KosteckáP.ZídekZ.Effects of sesquiterpene,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6471101/results/search/disease/results.xml">
   <result pre="compounds were evaluated for their in vitro activity against Mycobacterium" exact="tuberculosis" post="and their ability to inhibit NO production by macrophages"/>
   <result pre="medicine for purposes such as earache [9], abdominal pain [10]," exact="constipation" post="[11], coughs [12], etc. Psychotria species have been studied"/>
   <result pre="19) was isolated from this species and evaluated against Mycobacterium" exact="tuberculosis" post="H37Rv and the hypervirulent strain M299 (Table 2). All"/>
   <result pre="M299 (Table 2). All tested substances showed activity against M." exact="tuberculosis" post="H37Rv. The most active compound was strictosidine (18, MIC50"/>
   <result pre="terpenoids have shown moderate to significant biological activity against M." exact="tuberculosis" post="[39]. The common triterpenes—oleanolic acid, ursolic acid, and betulinic"/>
   <result pre="(1) isolated from Acaena pinnatifida showed moderate activity against M." exact="tuberculosis" post="(MIC 64 μM) [40]. In this work, we report"/>
   <result pre="isolated from Voacang globosa (Apocynaceae), showed promising activity against M." exact="tuberculosis" post="H37Rv (MIC 4.0 µg/mL). The other structural analogues tested"/>
   <result pre="monoterpenoid skeleton of indole alkaloids influences their activity against M." exact="tuberculosis" post="H37Rv [42]. In this paper, we report the promising"/>
   <result pre="may be related to its lower inhibitory activity against M." exact="tuberculosis" post="H37Rv and the hypervirulent strain M299. These results suggest"/>
   <result pre="previous study [49] were used in this study—the virulent M." exact="tuberculosis" post="laboratory strain H37Rv (ATCC 27294) and the highly virulent"/>
   <result pre="laboratory strain H37Rv (ATCC 27294) and the highly virulent M." exact="tuberculosis" post="strain Beijing M299 isolated from a TB patient in"/>
   <result pre="20, and 100 µg/mL using an MTT assay [50]. M." exact="tuberculosis" post="H37Rv (ATCC 27294) and the hypervirulent strain Beijing M299"/>
   <result pre="a spectrophotometer at 570 nm. As a positive control, M." exact="tuberculosis" post="treated with the antibiotic rifampicin (95% purity; Sigma-Aldrich) was"/>
   <result pre="was used (ranging from 0.00032 to 1 μg/mL for M." exact="tuberculosis" post="H37Rv and 0.008 to 10 μg/mL for the M."/>
   <result pre="tuberculosis H37Rv and 0.008 to 10 μg/mL for the M." exact="tuberculosis" post="M2b clinical isolate). As a negative control, untreated M."/>
   <result pre="tuberculosis M2b clinical isolate). As a negative control, untreated M." exact="tuberculosis" post="was used. 3.5. Determination of Nitric Oxide Production by"/>
   <result pre="no conflict of interest. References References 1.BarreiraD.The challenges to eliminating" exact="tuberculosis" post="in BrazilEpidemiol. Serv. Saude20182713 2.collab: WHOGlobal Tuberculosis Report 2017World"/>
   <result pre="Mycobacterium tuberculosisPhytomedicine20184610411010.1016/j.phymed.2018.04.02930097109 4.MatsumotoM.HashizumeH.TomishigeT.KawasakiM.TsubouchiH.SasakiH.ShimokawaY.KomatsuM.OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against" exact="tuberculosis" post="in vitro and in micePLos Med.200632131214410.1371/journal.pmed.0030466 5.GaestelM.KotlyarovA.KrachtM.Targeting innate immunity"/>
   <result pre="7.GarlandaC.Di LibertoD.VecchiA.La MannaM.P.BuracchiC.CaccamoN.SalernoA.DieliF.MantovaniA.Damping excessive inflammation and tissue damage in Mycobacterium" exact="tuberculosis" post="infection by Toll IL-1 Receptor 8/Single Ig IL-1-related Receptor,"/>
   <result pre="of pentacyclic triterpenoids from plants of Argentina and ChilePhytomedicine1999634134510.1016/S0944-7113(99)80056-711962541 41.MacabeoA.P.VidarW.S.ChenX.DeckerM.HeilmannJ.WanB.FranzblauS.G.GalvezE.V.AguinaldoM.A.CordellG.A.Mycobacterium" exact="tuberculosis" post="and cholinesterase inhibitors from Voacanga globosaEur. J. Med. Chem.2011463118312310.1016/j.ejmech.2011.04.02521546135"/>
   <result pre="the Extracts and Indole Alkaloids from Alstonia scholaris Against Mycobacterium" exact="tuberculosis" post="H37RvPhillipp Agric. Sci.20089114 43.CastellarA.CoelhoT.S.SilvaP.E.A.RamosD.F.LourençoM.C.S.LageC.L.S.JuliãoL.S.BarbosaY.G.LeitãoS.G.The activity of flavones and oleanolic"/>
   <result pre="oleanolic acid from Lippia lacunosa against susceptible and resistant Mycobacterium" exact="tuberculosis" post="strainsBraz. J. Pharmacogn.20112183584010.1590/S0102-695X2011005000076 44.PalominoJ.C.MartinA.GuerraH.SwingsJ.PortaelsF.Resazurin microtiler assay plate: Simple and"/>
   <result pre="RAW264.7 cells by 7-hydroxyflavone and 7,8-dihydroxyflavoneJ. Pharm. Pharmacol.20176986587410.1111/jphp.1271428295316 49.RibeiroS.C.M.GomesL.L.AmaralE.P.AndradeM.R.M.AlmeidaF.M.RezendeA.L.LanesV.R.CarvalhoE.C.Q.SuffysP.N.MokrousovI.et al.Mycobacterium" exact="tuberculosis" post="Strains of the Modern Subline age of the Beijing"/>
   <result pre="isolated from twigs and leaves of Psychotria nuda against Mycobacterium" exact="tuberculosis" post="strains. Substances MIC (µg/mL) H37Rv M299 Pomolic acid (1)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6471328/results/search/disease/results.xml">
   <result pre="as Trypanosoma brucei, Leishmania donovani and Trypanosoma cruzi, which cause" exact="sleeping sickness," post="visceral leishmaniasis and Chagas disease respectively [1,2,3,4]. Recent studies"/>
   <result pre="brucei, Leishmania donovani and Trypanosoma cruzi, which cause sleeping sickness," exact="visceral leishmaniasis" post="and Chagas disease respectively [1,2,3,4]. Recent studies have also"/>
   <result pre="Leishmania donovani and Trypanosoma cruzi, which cause sleeping sickness, visceral" exact="leishmaniasis" post="and Chagas disease respectively [1,2,3,4]. Recent studies have also"/>
   <result pre="Plasmodium vivax and Plasmodium ovale, the parasite species that cause" exact="malaria" post="[5,6]. Samples of propolis have also been found to"/>
   <result pre="drug treatment on parasite survival was determined as the mean" exact="suppression" post="of fluorescence compared to control values. 4.10. Metabolomics Experiments"/>
   <result pre="the effects of melittin on cisplatin resistant and cisplatin sensitive" exact="ovarian cancer" post="cells using mass spectrometry and biolog microarray technologyMetabolites201663510.3390/metabo604003527754384 31.SumnerL.W.AmbergA.BarrettD.BealeM.H.BegerR.DaykinC.A.FanT.W.FiehnO.GoodacreR.GriffinJ.L.et"/>
   <result pre="effects of melittin on cisplatin resistant and cisplatin sensitive ovarian" exact="cancer" post="cells using mass spectrometry and biolog microarray technologyMetabolites201663510.3390/metabo604003527754384 31.SumnerL.W.AmbergA.BarrettD.BealeM.H.BegerR.DaykinC.A.FanT.W.FiehnO.GoodacreR.GriffinJ.L.et"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6473744/results/search/disease/results.xml">
   <result pre="methanol:water extract were evaluated for their cytotoxicity against the human" exact="cancer" post="cell lines MCF-7, SKBR3, and HCT-116, and normal peripheral"/>
   <result pre="isolated. Compound 6 was the most cytotoxic against the human" exact="cancer" post="lines assessed and showed very low cytotoxicity against PBMCs."/>
   <result pre="of the initial methanol extract, were tested against three human" exact="cancer" post="cell lines: MCF-7 (breast; estrogen receptor positive (ER+), progesterone"/>
   <result pre="Based on the significant cytotoxic activity of compound 6 against" exact="cancer" post="cell lines we further tested whether it may also"/>
   <result pre="3). The good antitumor activity of compound 6 against human" exact="cancer" post="cells and the simultaneous marginal cytotoxicity of the same"/>
   <result pre="O. sanctum extracts and its essential oil with different human" exact="cancer" post="cell lines, clearly suggest that Tulsi may be used"/>
   <result pre="extracts. Taken altogether, (-)-rabdosiin displays an interesting proapoptotic activity against" exact="cancer" post="cell lines and in parallel shows a noticeable selectivity"/>
   <result pre="well as of compound 6 against a series of human" exact="cancer" post="cell lines and its marginal cytotoxicity against PBMCs, give"/>
   <result pre="from Ocimum sanctum Linn. triggers the apoptotic mechanism in human" exact="breast cancer" post="cellsPharmacogn. Mag.201612S327S33127563220 26.MabryT.G.MarkhamK.R.ThomasM.B.The Systematic Identification of FlavonoidsSpringer Science &amp;amp;"/>
   <result pre="Ocimum sanctum Linn. triggers the apoptotic mechanism in human breast" exact="cancer" post="cellsPharmacogn. Mag.201612S327S33127563220 26.MabryT.G.MarkhamK.R.ThomasM.B.The Systematic Identification of FlavonoidsSpringer Science &amp;amp;"/>
   <result pre="Nat. Prod.19955839240010.1021/np50117a0077775984 53.DhandayuthapaniS.AzadH.RathinaveluA.Apoptosis Induction by Ocimum sanctum extract in LNCaP" exact="prostate cancer" post="cellsJ. Med. Food20151877678510.1089/jmf.2014.000825692494 54.BhattacharyyaP.BishayeeA.Ocimum sanctum Linn. (Tulsi): An ethnomedicinal"/>
   <result pre="Prod.19955839240010.1021/np50117a0077775984 53.DhandayuthapaniS.AzadH.RathinaveluA.Apoptosis Induction by Ocimum sanctum extract in LNCaP prostate" exact="cancer" post="cellsJ. Med. Food20151877678510.1089/jmf.2014.000825692494 54.BhattacharyyaP.BishayeeA.Ocimum sanctum Linn. (Tulsi): An ethnomedicinal"/>
   <result pre="O. sanctum. Figure 2 Compound 6 induced apoptosis to human" exact="cancer" post="cells. MCF-7, SKBR3, and HCT-116 cells were exposed to"/>
   <result pre="the methanol extract and isolated compounds from Tulsi on human" exact="cancer" post="cell lines. IC50 ± SD (in μg/mL) a IC50"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6475860/results/search/disease/results.xml">
   <result pre="diabetic patients, decreases insulin resistance, enhances glycaemic control and prevents" exact="diabetic retinopathy" post="(Korkmaz et al., 2013). Table 3 Mineral nutrient composition"/>
   <result pre="patients, decreases insulin resistance, enhances glycaemic control and prevents diabetic" exact="retinopathy" post="(Korkmaz et al., 2013). Table 3 Mineral nutrient composition"/>
   <result pre="through upregulating p53 and p21 in the A549 non-small cell" exact="lung cancer" post="cellsOncol. Rep.31201429830424247527"/>
   <result pre="upregulating p53 and p21 in the A549 non-small cell lung" exact="cancer" post="cellsOncol. Rep.31201429830424247527"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6479000/results/search/disease/results.xml">
   <result pre="women suggested a direct drug effect on the risk of" exact="allergy" post="in infancy (48). In conjunction with prior work, our"/>
   <result pre="LercheNW, McCuneJM, LokeP2012Therapeutic helminth infection of macaques with idiopathic chronic" exact="diarrhea" post="alters the inflammatory signature and mucosal microbiota of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6503787/results/search/disease/results.xml">
   <result pre="that results in demineralization of tooth, pain and discomfort. The" exact="dental caries" post="process starts with microbial adherence on tooth surfaces, after"/>
   <result pre="There are numerous bacteria which cause initiation and progression of" exact="dental caries;" post="however, Streptococcus mutans and Lactobacillus species are considered as"/>
   <result pre="agents which are used for the treatment and prevention of" exact="dental caries," post="of which herbal agents are considered as one of"/>
   <result pre="be used for the treatment of oral diseases such as" exact="gingivitis" post="and stomatitis and was found to have antibacterial activity.[7]"/>
   <result pre="for the treatment of oral diseases such as gingivitis and" exact="stomatitis" post="and was found to have antibacterial activity.[7] Considering the"/>
   <result pre="herbal extracts (GG and TC) against commonly found organism causing" exact="dental caries," post="i.e., S. mutans. MATERIALS AND METHODS Preparation of extract"/>
   <result pre="for the treatment of various oral diseases (periodontal, endodontic and" exact="dental caries" post="infection).[12] In the current study, minimal inhibitory concentration (MIC)"/>
   <result pre="compounds and further developed into products for the prevention of" exact="dental caries." post="This study showed promising results of both the extracts"/>
   <result pre="both GG and TC can help in the reduction of" exact="dental caries." post="However, further studies can be done by incorporation of"/>
   <result pre="Oswaldo Cruz200510039740116113888 4HaidariMAliMWard CasscellsS3rdMadjidMPomegranate (Punica granatum) purified polyphenol extract inhibits" exact="influenza" post="virus and has a synergistic effect with oseltamivirPhytomedicine20091611273619586764 5AluckalEIsmailAPauloseALakshmananSBalakrishnanMSMathewBet"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6526512/results/search/disease/results.xml">
   <result pre="has been used to alleviate jaundice, urethral discharge, and acute" exact="dyspepsia" post="[10]. Vetiveria zizinioides has been used as a cure"/>
   <result pre="11DollR.PetoR.The causes of cancer: quantitative estimates of avoidable risks of" exact="cancer" post="in the United States todayJNCI: Journal of the National"/>
   <result pre="some medicinal plants on Escherichia coli as an agent of" exact="diarrhea" post="in livestockAdvances in Applied Science Research2011243748 20ManachC.ScalbertA.MorandC.RémésyC.JiménezL.Polyphenols: food sources"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6530400/results/search/disease/results.xml">
   <result pre="et al., 2007a,b; WHO, 2016). Currently, therapeutic approaches for controlling" exact="leishmaniasis" post="comprises only five drugs: the pentavalent antimonial, amphotericin B"/>
   <result pre="μg/mLa 5.01 ± 0.12 μg/mLa, Ldo Ageratum conyzoides Treatment of" exact="sleeping sickness," post="bleeding, leprosy, infectious diseases, headaches, allergies, skin diseases and"/>
   <result pre="12.5 μg/mLa, Ldo Aristeguietia glutinosa Treatment of rheumatism, ulcers, headaches," exact="diarrhea" post="and other infectious diseases. (+)-15-hydroxy-labd-7-en-17-al 3.0 μg/mLe NT Varela"/>
   <result pre="dermatological conditions, and stomach pains, as well as malaria, fever," exact="hepatitis" post="and other infectious diseases. 1β, 2α-epoxytagitinin C NT 2.2"/>
   <result pre="evaluated against L. amazonensis in a murine model of experimental" exact="cutaneous leishmaniasis." post="The treatment with this oil (30 mg/kg by intralesional"/>
   <result pre="and seeds of A. annua in a murine model of" exact="visceral leishmaniasis" post="caused by L. donovani. The authors reported that besides"/>
   <result pre="seeds of A. annua in a murine model of visceral" exact="leishmaniasis" post="caused by L. donovani. The authors reported that besides"/>
   <result pre="uncinella was also shown as a potent agent against experimental" exact="visceral leishmaniasis" post="caused by L. infantum. The intraperitoneal injection of ursolic"/>
   <result pre="was also shown as a potent agent against experimental visceral" exact="leishmaniasis" post="caused by L. infantum. The intraperitoneal injection of ursolic"/>
   <result pre="cruzi. The higher SI values (as determined using human monocyte" exact="leukemia" post="THP1 cells) for trypomastigotes were found to deoxymikanolide (SI"/>
   <result pre="20, respectively. These three compounds were efficient in an experimental" exact="cutaneous leishmaniasis" post="model induced by L. amazonensis. The treatment started 15"/>
   <result pre="respectively. These three compounds were efficient in an experimental cutaneous" exact="leishmaniasis" post="model induced by L. amazonensis. The treatment started 15"/>
   <result pre="2016a). Moreover, α-bisabolol was evaluated in a murine model of" exact="visceral leishmaniasis" post="induced by L. infantum. The daily oral treatment with"/>
   <result pre="Moreover, α-bisabolol was evaluated in a murine model of visceral" exact="leishmaniasis" post="induced by L. infantum. The daily oral treatment with"/>
   <result pre="Trop. J. Pharmac. Res.16, 2169–2178. 10.4314/tjpr.v16i9.18 BlumJ.DesjeuxP.SchwartzE.BeckB.HatzC. (2004). Treatment of" exact="cutaneous leishmaniasis" post="among travellers. J. Antimicrob. Chemother.53, 158–166. 10.1093/jac/dkh05814729756 BoraK. S.SharmaA."/>
   <result pre="J. Pharmac. Res.16, 2169–2178. 10.4314/tjpr.v16i9.18 BlumJ.DesjeuxP.SchwartzE.BeckB.HatzC. (2004). Treatment of cutaneous" exact="leishmaniasis" post="among travellers. J. Antimicrob. Chemother.53, 158–166. 10.1093/jac/dkh05814729756 BoraK. S.SharmaA."/>
   <result pre="(-)-alpha-bisabolol is active against the causative agents of Old World" exact="cutaneous leishmaniasis" post="through the induction of mitochondrial-dependent apoptosis. Apoptosis21, 1071–1081. 10.1007/s10495-016-1282-x27539477"/>
   <result pre="is active against the causative agents of Old World cutaneous" exact="leishmaniasis" post="through the induction of mitochondrial-dependent apoptosis. Apoptosis21, 1071–1081. 10.1007/s10495-016-1282-x27539477"/>
   <result pre="(2015). (-)-alpha-Bisabolol, a promising oral compound for the treatment of" exact="visceral leishmaniasis." post="J. Nat. Prod.78, 1202–1207. 10.1021/np500869726076227 CortesS.AlbuquerqueA.CabralL. I.LopesL.CampinoL.CristianoM. L. (2015)."/>
   <result pre="Agents Chemother.59, 5032–5035. 10.1128/AAC.00298-1526014947 CouraJ. R. (2015). Special issue on" exact="chagas disease." post="Mem. Inst. Oswaldo Cruz110, 275–276. 10.1590/0074-027615000125993502 Da Silva FilhoA."/>
   <result pre="robusta, alleviates pain and inflammation in a model of acute" exact="gout" post="arthritis in mice. Front. Pharmacol.9:1076. 10.3389/fphar.2018.0107630319413 FeaseyN.Wansbrough-JonesM.MabeyD. C.SolomonA. W."/>
   <result pre="alleviates pain and inflammation in a model of acute gout" exact="arthritis" post="in mice. Front. Pharmacol.9:1076. 10.3389/fphar.2018.0107630319413 FeaseyN.Wansbrough-JonesM.MabeyD. C.SolomonA. W. (2010)."/>
   <result pre="E TPGS nanoparticles for the treatment of Leishmania donovani infected" exact="visceral leishmaniasis." post="Int. J. Biol. Macromol.93, 961–970. 10.1016/j.ijbiomac.2016.09.01427645930 GirardiC.FabreN.PaloqueL.RamadaniA. P.Benoit-VicalF.González-AspajoG.et al.."/>
   <result pre="extracts from plants of central argentina on sensitive and multidrug-resistant" exact="leukemia" post="cells: isolation of an active principle from gaillardia megapotamica."/>
   <result pre="F.et al. (2017). Therapeutic effect of ursolic acid in experimental" exact="visceral leishmaniasis." post="Int. J. Parasitol. Drugs Drug Resist.7, 1–11. 10.1016/j.ijpddr.2016.12.00227984757 KariotiA.SkaltsaH.KaiserM.TasdemirD."/>
   <result pre="powder and its potential usefulness in the treatment of uncomplicated" exact="cutaneous leishmaniasis" post="in humans. Rev. Soc. Bras. Med. Trop. 50, 52–60."/>
   <result pre="and its potential usefulness in the treatment of uncomplicated cutaneous" exact="leishmaniasis" post="in humans. Rev. Soc. Bras. Med. Trop. 50, 52–60."/>
   <result pre="An. Acad. Bras. Cienc.88, 2319–2330. 10.1590/0001-376520162016012027991965 ReithingerR.BrookerS.KolaczinskiJ. H. (2007a). Visceral" exact="leishmaniasis" post="in eastern Africa–current status. Trans. R. Soc. Trop. Med."/>
   <result pre="in combination with meglumine antimoniate on treatment of Leishmania major-induced" exact="cutaneous leishmaniasis" post="in BALB/c mice. Int. J. Appl. Basic Med. Res.7,"/>
   <result pre="combination with meglumine antimoniate on treatment of Leishmania major-induced cutaneous" exact="leishmaniasis" post="in BALB/c mice. Int. J. Appl. Basic Med. Res.7,"/>
   <result pre="essential oil from Artemisia absinthium L. Formulated in nanocochleates against" exact="cutaneous leishmaniasis." post="Medicines4:38. 10.3390/medicines402003828930253 TarikuY.HymeteA.HailuA.RohloffJ. (2010). Essential-oil composition, antileishmanial, and toxicity"/>
   <result pre="P.et al.. (2017). Nanoliposomal artemisinin for the treatment of murine" exact="visceral leishmaniasis." post="Int. J. Nanomedicine12, 2189–2204. 10.2147/IJN.S10654828356736 WantM. Y.IslamuddinM.ChouhanG.DasguptaA. K.ChattopadhyayA. P.AfrinF."/>
   <result pre="K.et al.. (2015). Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental" exact="visceral leishmaniasis." post="Colloids Surf. B Biointerfaces130, 215–221. 10.1016/j.colsurfb.2015.04.01325936561 collab: WHO (2013)."/>
   <result pre="to programed cell death and presents therapeutic potential in experimental" exact="cutaneous leishmaniasis." post="PLoS ONE10:e0144946. 10.1371/journal.pone.014494626674781 YamamotoE. S.CamposB. L.LaurentiM. D.LagoJ. H.Grecco SdosS.CorbettC."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6533749/results/search/disease/results.xml">
   <result pre="restrictions on herbalists were restored after the end of the" exact="plague" post="[42, 43]. In 1843, a royal edict was issued"/>
   <result pre="venereal diseases: gonorrhoea, syphilis), musculoskeletal ailments (e.g. cramps, gout, rheumatism," exact="scurvy" post="and spasms), neurology (incl. psychosomatic ailments), oral cavity (e.g."/>
   <result pre="(21) and the upper respiratory tract (21) as well as" exact="plague" post="(17). The remedies for these conditions are taxonomically diverse,"/>
   <result pre="of nervous system and psychosomatic disorders (52; Fig. 2) includes" exact="plague" post="(17), stroke (9), pain of the body (5), headache"/>
   <result pre="system and psychosomatic disorders (52; Fig. 2) includes plague (17)," exact="stroke" post="(9), pain of the body (5), headache (3), brain"/>
   <result pre="Carminativae Wedelii bewahret vor dem Schlage und der Schweren-Noth Prevents" exact="stroke" post="INT NERV – Elixir – 5 Elixir Vitrioli Mynsichti"/>
   <result pre="Ess. Pectoralis bewahret vor dem Schlage und der Schweren–Noth Prevents" exact="stroke" post="INT NERV – Animal – 5 Elixir Vitrioli Mynsichti"/>
   <result pre="Mynsichti Corallorum bewahret vor dem Schlage und der Schweren–Noth Prevents" exact="stroke" post="INT NERV – Elixir – 5 Elixir Vitrioli Mynsichti"/>
   <result pre="roth. Schlagwasser bewahret vor dem Schlage und der Schweren–Noth Prevents" exact="stroke" post="INT NERV – Inorganic – 5 Elixir Vitrioli Mynsichti"/>
   <result pre="Sp. Vitrioli bewahret vor dem Schlage und der Schweren–Noth Prevents" exact="stroke" post="INT NERV – Animal – 5 Elixir Vitrioli Mynsichti"/>
   <result pre="vor den Scharbock Sp. Nitri dulcis vor den Scharbock Against" exact="scurvy" post="INT MUSK – Mineral – 7 Elixir anti Scorbutic:"/>
   <result pre="Scorbutic: Elixir vor den Scharbock Pottasche vor den Scharbock Against" exact="scurvy" post="INT MUSK Aloë spp. Asphodelaceae HERB 7 Elixir anti"/>
   <result pre="Scorbutic: Elixir vor den Scharbock Aloe vor den Scharbock Against" exact="scurvy" post="INT MUSK Cochlearia officinalis L. Brassicaceae HERB 7 Elixir"/>
   <result pre="Elixir vor den Scharbock Sp. Cochlear vor den Scharbock Against" exact="scurvy" post="INT MUSK Commiphora spp. Burseraceae EXUD 7 Elixir anti"/>
   <result pre="Scorbutic: Elixir vor den Scharbock Myrrhen vor den Scharbock Against" exact="scurvy" post="INT MUSK Crocus probably sativus L. Iridaceae FLOW 7"/>
   <result pre="Scorbutic: Elixir vor den Scharbock Safran vor den Scharbock Against" exact="scurvy" post="INT MUSK Nasturtium officinale R.Br. Brassicaceae HERB 8 Spirit."/>
   <result pre="HERB 8 Spirit. Cochlear: Löffel-Kraut-Geist Brunnenkresse widersteht dem Scharbock Prevents" exact="scurvy" post="INT MUSK Guaiacum officinale L. Zygophyllaceae WOOD 9 Sp."/>
   <result pre="Lumbricorum, Regenwürmer–Geist Regenwürmer (Gemeine Regenwurm) gegen die Schlagflüss gerühmet Against" exact="stroke" post="INT NERV – Animal – 10 Sp. Lumbricorum, Regenwürmer-Geist"/>
   <result pre="Regenwürmer (Gemeine Regenwurm) gegen die Schmerzlaufende Gicht Against the painful" exact="gout" post="EXT MUSK – Animal – 10 Sp. Lumbricorum, Regenwürmer-Geist"/>
   <result pre="– 16 Ess. Castor, Bibergeil-Essentz Bibergeil curiret den Schlag Heals" exact="stroke" post="INT NERV – Inorganic – 17 Schwarzenberger Gnad und"/>
   <result pre="EXUD 20 Balsamus Copeive Copeive gegen die Franzosen gerühmet Aagainst" exact="syphilis" post="INT ANDR Copaifera officinalis L. Fabaceae EXUD 20 Balsamus"/>
   <result pre="EXUD 20 Balsamus Copeive Copeive gegen die Franzosen gerühmet Aagainst" exact="syphilis" post="INT GYN Copaifera officinalis L. Fabaceae EXUD 20 Balsamus"/>
   <result pre="PARA – Mineral – 25 Zahn-Pulver Bimstein benimmt Scharbock Against" exact="scurvy" post="EXT MUSK – Mineral – 25 Zahn-Pulver gebrannt Alaun"/>
   <result pre="– Mineral – 25 Zahn-Pulver gebrannt Alaun benimmt Scharbock Against" exact="scurvy" post="EXT MUSK – Mineral – 25 Zahn-Pulver Bimstein benimmt"/>
   <result pre="MUSK – Mineral – 25 Zahn-Pulver Bimstein benimmt Mundfäule Against" exact="stomatitis" post="EXT ORAL – Mineral – 25 Zahn-Pulver gebrannt Alaun"/>
   <result pre="– Mineral – 25 Zahn-Pulver gebrannt Alaun benimmt Mundfäule Against" exact="stomatitis" post="EXT ORAL – Mineral – 25 Zahn-Pulver Bimstein schwarze"/>
   <result pre="Hayne Asteraceae SUBT 25 Zahn-Pulver Bertran Wurzel benimmt Scharbock Against" exact="scurvy" post="EXT MUSK Anacyclus pyrethrum (L.) Lag. = Anacyclus officinarum"/>
   <result pre="Hayne Asteraceae SUBT 25 Zahn-Pulver Bertran Wurzel benimmt Mundfäule Against" exact="stomatitis" post="EXT ORAL Anacyclus pyrethrum (L.) Lag. = Anacyclus officinarum"/>
   <result pre="fragrans Houtt. Myristicaceae FLOW 25 Zahn-Pulver Muscat-Blüthen benimmt Scharbock Against" exact="scurvy" post="EXT MUSK Myristica fragrans Houtt. Myristicaceae FLOW 25 Zahn-Pulver"/>
   <result pre="fragrans Houtt. Myristicaceae FLOW 25 Zahn-Pulver Muscat-Blüthen benimmt Mundfäule Against" exact="stomatitis" post="EXT ORAL Myristica fragrans Houtt. Myristicaceae FLOW 25 Zahn-Pulver"/>
   <result pre="officinale R.Br. Brassicaceae HERB 25 08 Brunnenkresse benimmt Scharbock Against" exact="scurvy" post="EXT MUSK Nasturtium officinale R.Br. Brassicaceae HERB 25 Zahn-Pulver"/>
   <result pre="officinale R.Br. Brassicaceae HERB 25 Zahn-Pulver Brunnenkresse benimmt Mundfäule Against" exact="stomatitis" post="EXT ORAL Nasturtium officinale R.Br. Brassicaceae HERB 25 Zahn-Pulver"/>
   <result pre="&amp;amp; L.M.Perry Myrtaceae HERB 25 Zahn-Pulver Nelcken benimmt Scharbock Against" exact="scurvy" post="EXT MUSK Syzygium aromaticum (L.) Merr. &amp;amp; L.M.Perry Myrtaceae"/>
   <result pre="&amp;amp; L.M.Perry Myrtaceae HERB 25 Zahn-Pulver Nelcken benimmt Mundfäule Against" exact="stomatitis" post="EXT ORAL Syzygium aromaticum (L.) Merr. &amp;amp; L.M.Perry Myrtaceae"/>
   <result pre="26 Recept von einem besonderen Elixir Biebergeil In pest Against" exact="plague" post="INT NERV – Animal – 26 Recept von einem"/>
   <result pre="26 Recept von einem besonderen Elixir Biebergeil In pest Against" exact="plague" post="INT RESP – Fungus – 26 Recept von einem"/>
   <result pre="26 Recept von einem besonderen Elixir Lerchenschwamm In pest Against" exact="plague" post="INT NERV – Mineral – 26 Recept von einem"/>
   <result pre="Recept von einem besonderen Elixir Terra Sigill In pest Against" exact="plague" post="INT NERV – Mineral – 26 Recept von einem"/>
   <result pre="Recept von einem besonderen Elixir Potaschen (potash) In pest Against" exact="plague" post="INT NERV – Fungus – 26 Recept von einem"/>
   <result pre="26 Recept von einem besonderen Elixir Lerchenschwamm In pest Against" exact="plague" post="INT RESP – Mineral – 26 Recept von einem"/>
   <result pre="Recept von einem besonderen Elixir Terra Sigill In pest Against" exact="plague" post="INT RESP – Mineral – 26 Recept von einem"/>
   <result pre="Recept von einem besonderen Elixir Potaschen (potash) In pest Against" exact="plague" post="INT RESP – Animal – 26 Recept von einem"/>
   <result pre="antidote to poisons, especially on viper venom] In pest Against" exact="plague" post="INT NERV ? ? ? 26 Recept von einem"/>
   <result pre="antidote to poisons, especially on viper venom] In pest Against" exact="plague" post="INT RESP ? ? ? 26 Recept von einem"/>
   <result pre="26 Recept von einem besonderen Elixir Aloe In pest Against" exact="plague" post="INT NERV Aloë spp. Asphodelaceae HERB 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Aloe In pest Against" exact="plague" post="INT RESP Aloë spp. Asphodelaceae HERB 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Angelica In pest Against" exact="plague" post="INT NERV Angelica spp. Apiaceae HERB 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Angelica In pest Against" exact="plague" post="INT RESP Angelica spp. Apiaceae HERB 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Campher In pest Against" exact="plague" post="INT NERV Cinnamomum camphora (L.) J.Presl Lauraceae OIL 26"/>
   <result pre="26 Recept von einem besonderen Elixir Campher In pest Against" exact="plague" post="INT RESP Cinnamomum camphora (L.) J.Presl Lauraceae OIL 26"/>
   <result pre="26 Recept von einem besonderen Elixir Myrrhen In pest Against" exact="plague" post="INT NERV Commiphora spp. Burseraceae EXUD 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Myrrhen In pest Against" exact="plague" post="INT RESP Commiphora spp. Burseraceae EXUD 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Zittwer In pest Against" exact="plague" post="INT NERV Curcuma zedoaria (Christm.) Roscoe Zingiberaceae SUBT 26"/>
   <result pre="26 Recept von einem besonderen Elixir Zittwer In pest Against" exact="plague" post="INT RESP Curcuma zedoaria (Christm.) Roscoe Zingiberaceae SUBT 26"/>
   <result pre="Recept von einem besonderen Elixir Weiss Diptam In pest Against" exact="plague" post="INT RESP Dictamnus albus L. Rutaceae HERB 26 Recept"/>
   <result pre="Recept von einem besonderen Elixir Weiss Diptam In pest Against" exact="plague" post="INT NERV Dictamnus albus L. Rutaceae HERB 26 Recept"/>
   <result pre="26 Recept von einem besonderen Elixir Entian In pest Against" exact="plague" post="INT NERV Gentiana spp. Gentianaceae HERB 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Entian In pest Against" exact="plague" post="INT RESP Gentiana spp. Gentianaceae HERB 26 Recept von"/>
   <result pre="26 Recept von einem besonderen Elixir Tormentille In pest Against" exact="plague" post="INT NERV Potentilla erecta (L.) Räusch. Rosaceae SUBT 26"/>
   <result pre="26 Recept von einem besonderen Elixir Tormentille In pest Against" exact="plague" post="INT RESP Potentilla erecta (L.) Räusch. Rosaceae SUBT 26"/>
   <result pre="26 Recept von einem besonderen Elixir Rhabarbara In pest Against" exact="plague" post="INT NERV Rheum rhabarbarum L. Polygonaceae HERB 26 Recept"/>
   <result pre="26 Recept von einem besonderen Elixir Rhabarbara In pest Against" exact="plague" post="INT RESP Rheum rhabarbarum L. Polygonaceae HERB 26 Recept"/>
   <result pre="31 Sal. volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Cornu Cervi Pestilenz Against" exact="plague" post="INT NERV – Animal – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="31 Sal. volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Cornu Cervi Pestilenz Against" exact="plague" post="INT RESP – Mineral – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="– 31 Sal. volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Salz Pestilenz Against" exact="plague" post="INT NERV – Mineral – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="– 31 Sal. volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Salz Pestilenz Against" exact="plague" post="INT RESP – Iinctura – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="31 Sal. volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Sp. Vini Pestilenz Against" exact="plague" post="INT NERV – Tinctura – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="31 Sal. volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Sp. Vini Pestilenz Against" exact="plague" post="INT RESP – Mineral – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Cornu Cervi Steck und Schlag-Flüssen Prevents" exact="stroke" post="INT NERV – Mineral – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="Sal. volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Salz Steck und Schlag-Flüssen Prevents" exact="stroke" post="INT NERV – Tinctura – 31 Sal. volatile-Cornu Cervi,"/>
   <result pre="volatile-Cornu Cervi, Flüchtig. Hirschhorn-Salz Sp. Vini Steck und Schlag-Flüssen Prevents" exact="stroke" post="INT NERV – Mineral – 32 Schwarzenberger Heil- und"/>
   <result pre="Tinctur Lunae, Tinktur von Silber Silber in bösen Wesen Against" exact="postpartum depression" post="INT NERV – Organic – 39 Tinctur Lunae, Tinktur"/>
   <result pre="Tinctur Lunae, Tinktur von Silber Urine in bösen Wesen Against" exact="postpartum depression" post="INT NERV – Tinctura – 39 Tinctur Lunae, Tinktur"/>
   <result pre="Lunae, Tinktur von Silber Sp. Vini in bösen Wesen Against" exact="postpartum depression" post="INT NERV – Inorganic – 39 Tinctur Lunae, Tinktur"/>
   <result pre="40 Sp. Tartari, Weinstein-Geist Weinstein (tartar) in der Gicht Against" exact="gout" post="INT MUSK – Organic – 40 Sp. Tartari, Weinstein-Geist"/>
   <result pre="– 40 Sp. Tartari, Weinstein-Geist Weinstein (tartar) in Scharbock Against" exact="scurvy" post="INT MUSK – Organic – 40 Sp. Tartari, Weinstein-Geist"/>
   <result pre="gonorrhoea and syphilis; respiratory ailments including bronchitis, strep throat, haemoptysis," exact="pneumonia" post="and sinusitis; infections in the skin and mucosa such"/>
   <result pre="infections in the skin and mucosa such as dermatitis, eczema," exact="psoriasis" post="and wounds; ulcers and lesions of the uterus; leishmaniasis"/>
   <result pre="eczema, psoriasis and wounds; ulcers and lesions of the uterus;" exact="leishmaniasis" post="and leucorrhea; anaemia; headaches; and snake bites. It is"/>
   <result pre="syphilitic and gouty affections, and specifically for chronic rheumatism and" exact="rheumatoid arthritis" post="[75]. Additional medicinal uses mentioned by Krummhübel herbalists include"/>
   <result pre="and gouty affections, and specifically for chronic rheumatism and rheumatoid" exact="arthritis" post="[75]. Additional medicinal uses mentioned by Krummhübel herbalists include"/>
   <result pre="mentioned by Krummhübel herbalists include the treatment of oedema and" exact="scabies" post="as well as blood purification. Myrrh is a sap-like"/>
   <result pre="it has been used for aphthous ulcers, pharyngitis, respiratory catarrhs," exact="common cold," post="furunculosis, wounds and abrasions, specifically for mouth ulcers, gingivitis"/>
   <result pre="common cold, furunculosis, wounds and abrasions, specifically for mouth ulcers," exact="gingivitis" post="and pharyngitis [75]. It is unknown which Commiphora species"/>
   <result pre="furunculosis, wounds and abrasions, specifically for mouth ulcers, gingivitis and" exact="pharyngitis" post="[75]. It is unknown which Commiphora species was used"/>
   <result pre="but they recommended it, among others, as a remedy for" exact="scurvy" post="and plague as well as to stimulate appetite. Crocus"/>
   <result pre="recommended it, among others, as a remedy for scurvy and" exact="plague" post="as well as to stimulate appetite. Crocus sativus L.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6562550/results/search/disease/results.xml">
   <result pre="injuryPLoS ONE201712e018690410.1371/journal.pone.018690429073178 27.EsmaeelianB.AbbottC.A.Le LeuR.K.BenkendorffK.6-bromoisatin found in muricid mollusc extracts inhibits" exact="colon cancer" post="cell proliferation and induces apoptosis, preventing early stage tumor"/>
   <result pre="ONE201712e018690410.1371/journal.pone.018690429073178 27.EsmaeelianB.AbbottC.A.Le LeuR.K.BenkendorffK.6-bromoisatin found in muricid mollusc extracts inhibits colon" exact="cancer" post="cell proliferation and induces apoptosis, preventing early stage tumor"/>
   <result pre="and induces apoptosis, preventing early stage tumor formation in a" exact="colorectal cancer" post="rodent modelMar. Drugs201412173510.3390/md12010017 28.Gaboriaud-KolarN.MyrianthopoulosV.VougogiannopoulouK.GerolymatosP.HorneD.A.JoveR.MikrosE.NamS.SkaltsounisA.-L.Natural-based indirubins display potent cytotoxicity toward"/>
   <result pre="induces apoptosis, preventing early stage tumor formation in a colorectal" exact="cancer" post="rodent modelMar. Drugs201412173510.3390/md12010017 28.Gaboriaud-KolarN.MyrianthopoulosV.VougogiannopoulouK.GerolymatosP.HorneD.A.JoveR.MikrosE.NamS.SkaltsounisA.-L.Natural-based indirubins display potent cytotoxicity toward"/>
   <result pre="Drugs201412173510.3390/md12010017 28.Gaboriaud-KolarN.MyrianthopoulosV.VougogiannopoulouK.GerolymatosP.HorneD.A.JoveR.MikrosE.NamS.SkaltsounisA.-L.Natural-based indirubins display potent cytotoxicity toward wild-type and t315i-resistant" exact="leukemia" post="cell linesJ. Nat. Prod2016792464247110.1021/acs.jnatprod.6b0028527726390 29.Gaboriaud-KolarN.VougogiannopoulouK.SkaltsounisA.-L.Indirubin derivatives: A patent review"/>
   <result pre="from Dicathais orbita induce apoptosis and cell cycle arrest in" exact="colorectal cancer" post="cell linesMar.Drugs2013113802382210.3390/md1110380224152558 32.CookseyC.J.Tyrian purple: 6,6′-dibromoindigo and related compoundsMolecules (Basel,"/>
   <result pre="Dicathais orbita induce apoptosis and cell cycle arrest in colorectal" exact="cancer" post="cell linesMar.Drugs2013113802382210.3390/md1110380224152558 32.CookseyC.J.Tyrian purple: 6,6′-dibromoindigo and related compoundsMolecules (Basel,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6582913/results/search/disease/results.xml">
   <result pre="as antidote of snake and scorpion sting, and for rheumatism," exact="arthritis" post="and paralysis from Nanda Devi Biosphere reserve [111], and"/>
   <result pre="arthritis and paralysis from Nanda Devi Biosphere reserve [111], and" exact="leprosy" post="[108]. 5. Conclusion The study suggests that while there"/>
   <result pre="plasma and LDL oxidationJournal of Nutrition2010131112837284210.1093/jn/131.11.2837 46CarvalhoM.FerreiraP. J.MendesV. S.et al.Human" exact="cancer" post="cell anti proliferative and antioxidant activities of Juglans regia"/>
   <result pre="Mahendra Pal Singh 73AminA. R. M. R.KucukO.KhuriF. R.ShinD. M.Perspectives for" exact="cancer" post="prevention with natural compoundsJournal of Clinical Oncology200927162712272510.1200/JCO.2008.20.623519414669 74ArunN.SinghD. P.Punica"/>
   <result pre="activity of the Indian medicinal plant extract, Swertia chirata against" exact="herpes simplex" post="viruses: a study by in-vitro and molecular approachIndian Journal"/>
   <result pre="properties of Urtica dioica L. in MCF7 and MDA 231" exact="breast cancer" post="cell linesNew Journal of Medicine201330p. 503 101HarputU. S.SaracogluI.OgiharaY.Stimulation of"/>
   <result pre="of Urtica dioica L. in MCF7 and MDA 231 breast" exact="cancer" post="cell linesNew Journal of Medicine201330p. 503 101HarputU. S.SaracogluI.OgiharaY.Stimulation of"/>
   <result pre="Shrub Root Decoction 1-2 drop Eye ailments 87 Antimicrobial, antidepressant," exact="diabetes mellitus," post="hepatoprotective, immunomodulatory [29] 11 Berberis lycium Royle Berberidaceae HAPPRC ASR"/>
   <result pre="Fruits Raw 1 fruit Anemia 8 Antimicrobial, anti-inflammatory, anti-diabetic, anti" exact="cancer" post="[73, 74] 39 Rheum moorcroftianum Royle Polygonaceae HAPPRC ASR 4160 Figure 5(j)"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6600437/results/search/disease/results.xml">
   <result pre="associated with the reduction of some disease risk such as" exact="cancer" post="and cardiovascular diseases (CVDs) [16]. The Juglans genus or"/>
   <result pre="various biological activities, including excellent antitumoral effects on different human" exact="cancer" post="cell lines [51,52]. In this way, pyrogallol is another"/>
   <result pre="as hazelnuts, almonds, peanuts, etc. [64]. Besides, the lipid autoxidation" exact="suppression" post="attributes are connected to the antioxidants present in the"/>
   <result pre="prepared ethanolic extract obtained from J. regia L. leaf on" exact="hyperglycemia" post="and lipid profiles in type 2 diabetic patients. The"/>
   <result pre="effects of various J. regia L. leaf extracts in human" exact="cancer" post="cell lines. They prepared total extracts with ethanol:water (80:20)"/>
   <result pre="walnut leaf using hot extraction inhibited the growth of human" exact="prostate cancer" post="cells by inducing the apoptosis [205]. The constituents of"/>
   <result pre="leaf using hot extraction inhibited the growth of human prostate" exact="cancer" post="cells by inducing the apoptosis [205]. The constituents of"/>
   <result pre="Bcl-2, Bax, caspases, Tp53, Mdm-2 and TNF-α in MDA-MB-231 human" exact="breast cancer" post="cells. It has been proved that the hydroalcoholic extract"/>
   <result pre="Bax, caspases, Tp53, Mdm-2 and TNF-α in MDA-MB-231 human breast" exact="cancer" post="cells. It has been proved that the hydroalcoholic extract"/>
   <result pre="evaluation of the cytotoxicity of walnut leaf extract on human" exact="cancer" post="cell lines. Using colorimetric methods, they reported that the"/>
   <result pre="riskAm. J. Clin. Nutr.199970504s511s10.1093/ajcn/70.3.504s10479223 40.Kris-EthertonP.M.ZhaoG.BinkoskiA.E.CovalS.M.EthertonT.D.The effects of nuts on coronary" exact="heart disease" post="riskNutr. Rev.20015910311110.1111/j.1753-4887.2001.tb06996.x11368503 41.LavedrineF.ZmirouD.RavelA.BalducciF.AlaryJ.Blood cholesterol and walnut consumption: A cross-sectional"/>
   <result pre="walnut shellBioresources2015101715172910.15376/biores.10.1.1715-1729 102.MeshkiniA.TahmasbiM.Anti-platelet aggregation activity of walnut hull extract via" exact="suppression" post="of ROS generation and caspase activationJ. Acupunct. Meridian Stud.20171019320310.1016/j.jams.2017.02.00728712479"/>
   <result pre="Sci.2014221910.1186/2008-2231-22-19 110.HosseiniS.MehrzadiS.NajmizadehA.R.KazemM.AlimoradiH.Fallah HuseiniH.Effects of Juglans regia L. leaf extract on" exact="hyperglycemia" post="and lipid profiles in type two diabetic patients: A"/>
   <result pre="Juglans regia root extracts and their bactericidal facets against some" exact="urinary tract infection" post="causing bacteriaInt. J. Biol. Med. Res2018963046308 130.WeiQ.MaX.DongJ.Preparation, chemical constituents"/>
   <result pre="pyroligneous acids from walnut tree branchesJ. Anal. Appl. Pyrolysis201087242810.1016/j.jaap.2009.09.006 131.CarvalhoM.FerreiraP.J.MendesV.S.SilvaR.PereiraJ.A.JerónimoC.SilvaB.M.Human" exact="cancer" post="cell antiproliferative and antioxidant activities of Juglans regia L.Food"/>
   <result pre="peel and leaf extract of walnut (Juglans regia l.) on" exact="cutaneous leishmaniasis" post="caused by Leishmania major in BALB/c MiceJ. Chem. Pharm."/>
   <result pre="and leaf extract of walnut (Juglans regia l.) on cutaneous" exact="leishmaniasis" post="caused by Leishmania major in BALB/c MiceJ. Chem. Pharm."/>
   <result pre="effects of various Juglans regia (walnut) leaf extracts in human" exact="cancer" post="cell linesPharm. Biol.2012501416142210.3109/13880209.2012.68211822906313 166.Sharafati-chaleshtoriR.Sharafati-chaleshtoriF.Sharafati-chaleshtoriA.RafieianM.Antibacterial effects of ethanolic extract of"/>
   <result pre="177.LeV.EspositoD.GraceM.H.HaD.PhamA.BortolazzoA.BevensZ.KimJ.OkudaR.KomarnytskyS.et al.Cytotoxic effects of ellagitannins isolated from walnuts in human" exact="cancer" post="cellsNutr. Cancer2014661304131410.1080/01635581.2014.95624625264855 178.Rosales-MartínezP.Arellano-CárdenasS.Dorantes-ÁlvarezL.García-OchoaF.López-CortezM.D.S.Comparison between antioxidant activities of phenolic extracts"/>
   <result pre="root bark of Juglans regia L. (RBJR) on MDA-MB-231 human" exact="breast cancer" post="cells: Role of Bcl-2/Bax, caspases and Tp53Asian Pac. J."/>
   <result pre="bark of Juglans regia L. (RBJR) on MDA-MB-231 human breast" exact="cancer" post="cells: Role of Bcl-2/Bax, caspases and Tp53Asian Pac. J."/>
   <result pre="exerts antitumor effect, apoptosis induction and cell circle arrest in" exact="prostate cancer" post="cells In vitroTrop J. Pharm. Res.20151439940510.4314/tjpr.v14i3.7 206.VieiraV.PereiraC.PiresT.C.CalhelhaR.C.AlvesM.J.FerreiraO.BarrosL.FerreiraI.C.Phenolic profile, antioxidant"/>
   <result pre="antitumor effect, apoptosis induction and cell circle arrest in prostate" exact="cancer" post="cells In vitroTrop J. Pharm. Res.20151439940510.4314/tjpr.v14i3.7 206.VieiraV.PereiraC.PiresT.C.CalhelhaR.C.AlvesM.J.FerreiraO.BarrosL.FerreiraI.C.Phenolic profile, antioxidant"/>
   <result pre="Compos. Anal.20133123223710.1016/j.jfca.2013.06.004 209.EssaM.M.SubashS.DhanalakshmiC.ManivasagamT.Al-AdawiS.GuilleminG.J.ThenmozhiA.J.Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced" exact="neurodegeneration" post="in a mouse model of Parkinson’s diseaseNeurochem. Res.2015401283129310.1007/s11064-015-1593-225944473 210.PellegriniN.SerafiniM.SalvatoreS.Del"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6600640/results/search/disease/results.xml">
   <result pre="tumors, and other pathologies, including migraine, urinary tract dysfunction, dry" exact="eye disease," post="and obesity. Hence, the modulation of the TRPM8 channel"/>
   <result pre="Single Nucleotide Polymorphisms SNPs in the TRPM8 encoding gene and" exact="migraine" post="processes, thus positioning TRPM8 as a potential novel target"/>
   <result pre="a potential novel target for this disabling condition [9,10]. Dry" exact="eye disease" post="(DED), a growing problem today, due to increased pollution"/>
   <result pre="shed light on the real role of these channels in" exact="cancer" post="malignancies. In addition to the above mentioned pathologic processes,"/>
   <result pre="mentioned pathologic processes, TRPM8 channels have also been implicated in" exact="irritable bowel syndrome" post="(SNP increased risks) [16], oropharyngeal dysphagia (OD) [17], and"/>
   <result pre="could be particularly useful in the prevention and treatment of" exact="dry eye syndrome" post="(DES), vaginal dryness, and burning mouth syndrome [34]. In"/>
   <result pre="cream containing only MPO (13, Figure 1) in patients with" exact="atopic dermatitis" post="(AD) in real-life settings. In this clinical study, MPO"/>
   <result pre="containing only MPO (13, Figure 1) in patients with atopic" exact="dermatitis" post="(AD) in real-life settings. In this clinical study, MPO"/>
   <result pre="levels, weight gain, or fat depot levels and treatments for" exact="metabolic syndrome," post="obesity, prediabetes, and type II diabetes. Other applications have"/>
   <result pre="applications have been claimed, such as treating hypercholesterolemia, hypertension, coronary" exact="heart disease," post="diabetic neuropathy and retinopathy, erectile dysfunction, kidney disease, and"/>
   <result pre="been claimed, such as treating hypercholesterolemia, hypertension, coronary heart disease," exact="diabetic neuropathy" post="and retinopathy, erectile dysfunction, kidney disease, and pancreatitis, among"/>
   <result pre="claimed, such as treating hypercholesterolemia, hypertension, coronary heart disease, diabetic" exact="neuropathy" post="and retinopathy, erectile dysfunction, kidney disease, and pancreatitis, among"/>
   <result pre="treating hypercholesterolemia, hypertension, coronary heart disease, diabetic neuropathy and retinopathy," exact="erectile dysfunction," post="kidney disease, and pancreatitis, among others. Several non-menthol derivatives"/>
   <result pre="the topical treatment of patients with mild forms of dry" exact="eye disease" post="(DED) (TR: ISRCTN24802609 and ISRCTN13359367) [50]. Treatment with a"/>
   <result pre="feedback was observed in human corneal epithelial cells [62], and" exact="cancer" post="cells, such as TRPM8 transfected U2osB2 osteosarcoma [63], WERI-Rb1"/>
   <result pre="cells [62], and cancer cells, such as TRPM8 transfected U2osB2" exact="osteosarcoma" post="[63], WERI-Rb1 retinoblastoma, and human uveal melanoma (UM 92-1)"/>
   <result pre="as TRPM8 transfected U2osB2 osteosarcoma [63], WERI-Rb1 retinoblastoma, and human" exact="uveal melanoma" post="(UM 92-1) [64]. The effects observed in these cells"/>
   <result pre="companies, as potential drugs for neuropathic pain, inflammation, migraine, and" exact="cancer" post="[24]. However, most antagonists described in the literature lack"/>
   <result pre="selectivities (1000:1), antiproliferative activity in a LNCap cell line of" exact="prostate cancer" post="(64.3% cellular growth inhibition after three days) and apoptotic"/>
   <result pre="(1000:1), antiproliferative activity in a LNCap cell line of prostate" exact="cancer" post="(64.3% cellular growth inhibition after three days) and apoptotic"/>
   <result pre="in rat models of tactile allodynia and the inflammatory mechanical" exact="hypersensitivity" post="[73]. The same company discovered that the linear urea"/>
   <result pre="was nominated as a clinical candidate for the treatment of" exact="migraine" post="(reached phase I human clinical assays, no news since"/>
   <result pre="be developed as clinical candidates in the treatment of pain" exact="hypersensitivity" post="that was associated with bladder disorders. Due to the"/>
   <result pre="(47, Figure 4) produce considerable antinociceptive effects in orofacial pain" exact="hypersensitivity" post="induced by formalin and in neuropathic pain [90]. In"/>
   <result pre="induced by the well-known AMTB antagonist (50, Figure 4) on" exact="breast cancer" post="cell lines was due to the inhibition of NaV"/>
   <result pre="by the well-known AMTB antagonist (50, Figure 4) on breast" exact="cancer" post="cell lines was due to the inhibition of NaV"/>
   <result pre="drug Riluzole (53, Figure 5), used in the treatment of" exact="amyotrophic lateral sclerosis," post="was able to block cold allodynia alterations and mitigate"/>
   <result pre="12.YangJ.M.WeiE.T.KimS.J.YoonK.C.TRPM8 Channels and Dry EyePharmaceuticals20181112510.3390/ph11040125 13.LiuZ.WuH.WeiZ.WangX.ShenP.WangS.WangA.ChenW.LuY.TRPM8: A potential target for" exact="cancer" post="treatmentJ. Cancer Res. Clin. Oncol.20161421871188110.1007/s00432-015-2112-126803314 14.Hantute-GhesquierA.HaustrateA.PrevarskayaN.Lehen’kyiV.TRPM family channels in"/>
   <result pre="effects of a cream containing menthoxypropanediol, a TRPM8 agonist, in" exact="atopic dermatitis" post="patientsJ. Eur. Acad. Dermatol. Venereol.201933e67e6910.1111/jdv.1519930067875 40.RoggenkampD.WorthmannA.-C.SulzbergerM.WenckH.StaebF.NeufangG.Menthoxypropanediol inhibits nerve growth"/>
   <result pre="of a cream containing menthoxypropanediol, a TRPM8 agonist, in atopic" exact="dermatitis" post="patientsJ. Eur. Acad. Dermatol. Venereol.201933e67e6910.1111/jdv.1519930067875 40.RoggenkampD.WorthmannA.-C.SulzbergerM.WenckH.StaebF.NeufangG.Menthoxypropanediol inhibits nerve growth"/>
   <result pre="regulation by thermosensitive transient receptor potential channels in etoposide-resistant WERI-Rb1" exact="retinoblastoma" post="cellsExp. Eye Res.20129415717310.1016/j.exer.2011.12.00222182671 64.WalcherL.BuddeC.BohmA.LjubojevicN.SchweigerM.W.WaydbrinkH.v.d.ReimersI.MerglerS.ReinachP.S.DhandapaniP.et al.TRPM8 Activation via 3-Iodothyronamine Blunts"/>
   <result pre="ChannelsJ. Neurosci.20193994996910.1523/JNEUROSCI.1726-18.201830545944 67.BasE.NazirogluM.NazirogluM.PeczeL.ADP-Ribose and oxidative stress activate TRPM8 channel in" exact="prostate cancer" post="and kidney cellsSci. Rep.20199410010.1038/s41598-018-37552-030858386 68.JanssensA.GeesM.TothB.I.GhoshD.MulierM.VennekensR.VriensJ.TalaveraK.VoetsT.Definition of two agonist types"/>
   <result pre="Neurosci.20193994996910.1523/JNEUROSCI.1726-18.201830545944 67.BasE.NazirogluM.NazirogluM.PeczeL.ADP-Ribose and oxidative stress activate TRPM8 channel in prostate" exact="cancer" post="and kidney cellsSci. Rep.20199410010.1038/s41598-018-37552-030858386 68.JanssensA.GeesM.TothB.I.GhoshD.MulierM.VennekensR.VriensJ.TalaveraK.VoetsT.Definition of two agonist types"/>
   <result pre="antagonist, is not effective in rat models of inflammatory mechanical" exact="hypersensitivity" post="and neuropathic tactile allodyniaNaunyn. Schmiedebergs. Arch. Pharmacol.201538846547610.1007/s00210-015-1090-925662185 74.HorneD.B.BiswasK.BrownJ.BartbergerM.D.ClarineJ.DavisC.D.GoreV.K.HarriedS.HornerM.KallerM.R.et al.Discovery"/>
   <result pre="Number WO 201721735121122017 93.YapaK.T.D.S.DeuisJ.PetersA.A.KennyP.A.Roberts-ThomsonS.J.VetterI.MonteithG.R.Assessment of the TRPM8 inhibitor AMTB in" exact="breast cancer" post="cells and its identification as an inhibitor of voltage"/>
   <result pre="WO 201721735121122017 93.YapaK.T.D.S.DeuisJ.PetersA.A.KennyP.A.Roberts-ThomsonS.J.VetterI.MonteithG.R.Assessment of the TRPM8 inhibitor AMTB in breast" exact="cancer" post="cells and its identification as an inhibitor of voltage"/>
   <result pre="110.ClemmensenC.JallS.KleinertM.QuartaC.GruberT.SachsS.FischerK.GrandlG.LoherD.Sanchez-QuantE.et al.Coordinated targeting of cold and nicotinic receptors synergistically improves" exact="obesity" post="and type 2 diabetesNat. Commun.20189430410.1038/s41467-018-06769-y30353008 111.AlcaldeI.Íñigo-PortuguésA.González-GonzálezO.AlmarazL.ArtimeE.Morenilla-PalaoC.GallarJ.VianaF.Merayo-LlovesJ.BelmonteC.Morphological and functional changes"/>
   <result pre="114.KhalilM.BabesA.LakraR.FörschS.ReehP.W.WirtzS.BeckerC.NeurathM.F.EngelM.A.Transient receptor potential melastatin 8 ion channel in macrophages modulates" exact="colitis" post="through a balance-shift in TNF-alpha and interleukin-10 productionMucosal Immunol.201691500151310.1038/mi.2016.1626982596"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6630810/results/search/disease/results.xml">
   <result pre="skin diseases, headache, diseases of the nose, internal pains, and" exact="scabies" post="in Indian traditional medicine. The bulbs are administered in"/>
   <result pre="injury, calculous affections, ulcers, sinusitis, and skin diseases such as" exact="leprosy" post="[23]. In addition, they are used as an anthelminthic"/>
   <result pre="used as an anthelminthic and a gastrointestinal stimulant to relieve" exact="constipation" post="and indigestion [24]. Their use in treatments for coughing,"/>
   <result pre="for coughing, bronchitis, asthma, paralytic affection, rheumatism, internal pain, and" exact="scabies" post="is widely known in Asian countries, mainly in India"/>
   <result pre="20 (Table 1, Figure 1) has been proven against few" exact="cancer" post="types. However, more cell lines and different cancer entities"/>
   <result pre="against few cancer types. However, more cell lines and different" exact="cancer" post="entities should be tested to evaluate activity against a"/>
   <result pre="be tested to evaluate activity against a broad variety of" exact="cancer" post="types. In addition, normal cell lines should also be"/>
   <result pre="used to assess whether the cytotoxic effect is restricted to" exact="cancer" post="cells or whether compounds from D. indica exhibit toxicity"/>
   <result pre="skin infections, and urinary tract infections. Gonorrhoea, a sexually transmitted" exact="bacterial disease" post="caused by Neisseria gonorrhoeae, is mainly found in vaginal"/>
   <result pre="potential against 11 clinical isolates from patients with acute gonococcal" exact="urethritis" post="and 7 WHO control strains of N. gonorrhoeae. The"/>
   <result pre="airways. This medication is commonly used for the treatment of" exact="asthma" post="and chronic obstructive pulmonary disease [50]. The D. indica"/>
   <result pre="medication is commonly used for the treatment of asthma and" exact="chronic obstructive pulmonary disease" post="[50]. The D. indica bulb is used to treat"/>
   <result pre="D. indica bulb is used to treat chronic bronchitis and" exact="asthma" post="in traditional medicine. To validate this claim scientifically, Bashir"/>
   <result pre="role of D. indica bulbs in bronchial diseases such as" exact="asthma" post="and bronchitis. However, further studies with in vivo/clinical models"/>
   <result pre="indica is traditionally used as a gastrointestinal stimulant to relieve" exact="constipation" post="and indigestion. Therefore, the gastrointestinal stimulatory activity of an"/>
   <result pre="which provides a rationale for its use in indigestion and" exact="constipation" post="[11]. 6.8. Anti-Inflammatory and Analgesic Activities Nowadays, research on"/>
   <result pre="(9)), which has been clinically proven as a drug for" exact="congestive heart failure" post="and cardiac arrhythmia [60]. Moreover, due to the similarity"/>
   <result pre="laboratory animalsInt. J. Nutr. Pharm. Neurol. Dis.201556368 50.GrossN.J.BarnesP.J.New therapies for" exact="asthma" post="and chronic obstructive pulmonary diseaseAm. J. Respir. Crit. Care"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6631875/results/search/disease/results.xml">
   <result pre="cells [99]. Several cyclotides have shown selective cytotoxicity against several" exact="cancer" post="cell lines, including primary cancer cell lines, when compared"/>
   <result pre="shown selective cytotoxicity against several cancer cell lines, including primary" exact="cancer" post="cell lines, when compared to normal cells [100,101,102]. More"/>
   <result pre="and Pombalia calceolaria have shown cytotoxicity against HeLa [103], several" exact="prostate cancer" post="cell lines [104,105], and breast cancer, respectively [106]. Unfortunately,"/>
   <result pre="Pombalia calceolaria have shown cytotoxicity against HeLa [103], several prostate" exact="cancer" post="cell lines [104,105], and breast cancer, respectively [106]. Unfortunately,"/>
   <result pre="against HeLa [103], several prostate cancer cell lines [104,105], and" exact="breast cancer," post="respectively [106]. Unfortunately, the therapeutic index (i.e., the ratio"/>
   <result pre="deficits associated with several psychiatric and neurodegenerative diseases, such as" exact="schizophrenia" post="and Parkinson’s disease. The cyclotide from Viola odorata, Cycloviolacin"/>
   <result pre="to target bradykinin and melanocortin 4 receptors for pain and" exact="obesity" post="management, respectively [30,115]. The kalata B1-based bradykinin antagonist was"/>
   <result pre="cyclotide also showed oral bioavailability in a mouse model of" exact="multiple sclerosis" post="[31]. The treatment with this cyclotide impeded disease progression"/>
   <result pre="of potent antagonists for the cytokine receptor CXCR4 [116]. Many" exact="cancer" post="cells show overexpression of the CXCR4 receptor, which is"/>
   <result pre="novel peptide-based inhibitors of the breakpoint cluster region protein-Abelson murine" exact="leukemia" post="viral oncogene homolog (BCR-ABL) kinase [122]. In this case"/>
   <result pre="did not show significant growth inhibition in an imatinib-sensitive human" exact="chronic myeloid leukemia" post="(CML) cell line. Although this study did not investigate"/>
   <result pre="not show significant growth inhibition in an imatinib-sensitive human chronic" exact="myeloid leukemia" post="(CML) cell line. Although this study did not investigate"/>
   <result pre="show significant growth inhibition in an imatinib-sensitive human chronic myeloid" exact="leukemia" post="(CML) cell line. Although this study did not investigate"/>
   <result pre="in serum. This cyclotide was cytotoxic to several wild-type p53" exact="cancer" post="cell lines by activating the p53 tumor suppressor pathway"/>
   <result pre="reported to have oral activity in a mouse model of" exact="multiple sclerosis" post="[126]. This cyclotide has been recently shown to be"/>
   <result pre="as a target for the development of checkpoint inhibitors for" exact="cancer" post="treatment [131]. A fully folded cyclotide-based genetically-encoded library was"/>
   <result pre="recently used for the production of potent inhibitors of the" exact="anthrax" post="lethal factor protease (Ki ≈ 40 nM) and TNF-α"/>
   <result pre="challenge for the futureFuture Med. Chem.20091659310.4155/fmc.09.1221426071 3.FryD.C.VassilevL.T.Targeting protein-protein interactions for" exact="cancer" post="therapyJ. Mol. Med.20058395596310.1007/s00109-005-0705-x16283145 4.QianZ.DoughertyP.G.PeiD.Targeting intracellular protein-protein interactions with cell-permeable"/>
   <result pre="sequence amino acid scanning of theta-defensin rtd-1 yields a potent" exact="anthrax" post="lethal factor protease inhibitorJ. Med. Chem.2017601916192710.1021/acs.jmedchem.6b0168928151653 67.YangR.WongY.H.NguyenG.K.T.TamJ.P.LescarJ.WuB.Engineering a catalytically"/>
   <result pre="mitochondria-mediated apoptosis via cytochrome c release and caspases activation in" exact="cervical cancer" post="cellsFitoterapia201610916216810.1016/j.fitote.2015.12.02126751970 104.HuE.WangD.ChenJ.TaoX.Novel cyclotides from hedyotis diffusa induce apoptosis and"/>
   <result pre="apoptosis via cytochrome c release and caspases activation in cervical" exact="cancer" post="cellsFitoterapia201610916216810.1016/j.fitote.2015.12.02126751970 104.HuE.WangD.ChenJ.TaoX.Novel cyclotides from hedyotis diffusa induce apoptosis and"/>
   <result pre="hedyotis diffusa induce apoptosis and inhibit proliferation and migration of" exact="prostate cancer" post="cellsInt. J. Clin. Exp. Med.201584059406526064310 105.ZhangH.SongT.YangY.FuC.LiJ.Exploring the interaction mechanism"/>
   <result pre="diffusa induce apoptosis and inhibit proliferation and migration of prostate" exact="cancer" post="cellsInt. J. Clin. Exp. Med.201584059406526064310 105.ZhangH.SongT.YangY.FuC.LiJ.Exploring the interaction mechanism"/>
   <result pre="dynamics simulations and free energy calculationsFront. Chem.2018611910.3389/fchem.2018.0011929755968 106.PintoM.E.NajasJ.Z.MagalhãesL.G.BobeyA.F.MendonçaJ.N.LopesN.P.LemeF.M.TeixeiraS.P.TrovóM.AndricopuloA.D.et al.Inhibition of" exact="breast cancer" post="cell migration by cyclotides isolated from pombalia calceolariaJ. Nat."/>
   <result pre="simulations and free energy calculationsFront. Chem.2018611910.3389/fchem.2018.0011929755968 106.PintoM.E.NajasJ.Z.MagalhãesL.G.BobeyA.F.MendonçaJ.N.LopesN.P.LemeF.M.TeixeiraS.P.TrovóM.AndricopuloA.D.et al.Inhibition of breast" exact="cancer" post="cell migration by cyclotides isolated from pombalia calceolariaJ. Nat."/>
   <result pre="anti-human immunodeficiency virus (hiv)-1 activityJ. Med. Chem.201255107291073410.1021/jm301468k23151033 117.BalkwillF.The significance of" exact="cancer" post="cell expression of the chemokine receptor cxcr4Semin. Cancer Biol.20041417117910.1016/j.semcancer.2003.10.00315246052"/>
   <result pre="untapped antimicrobial drug targetsJ. Antibiot.20177036637710.1038/ja.2016.13827899793 119.GialeliC.TheocharisA.D.KaramanosN.K.Roles of matrix metalloproteinases in" exact="cancer" post="progression and their pharmacological targetingFEBS J.2011278162710.1111/j.1742-4658.2010.07919.x21087457 120.SommerhoffC.P.AvrutinaO.SchmoldtH.U.Gabrijelcic-GeigerD.DiederichsenU.KolmarH.Engineered cystine knot"/>
   <result pre="Rep.201535e0027010.1042/BSR2015021026464514 139.ChanL.Y.CraikD.J.DalyN.L.Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for" exact="cancer" post="therapySci. Rep.201663534710.1038/srep3534727734947 140.SlazakB.KapustaM.MalikS.BohdanowiczJ.KutaE.MalecP.GoranssonU.Immunolocalization of cyclotides in plant cells, tissues"/>
   <result pre="angiogenesis [129] Kalata B1 Immunomodulator 5 and 6 Protecting against" exact="multiple sclerosis" post="[135] Kalata B1 Immunomodulator 4 Protecting against multiple sclerosis"/>
   <result pre="against multiple sclerosis [135] Kalata B1 Immunomodulator 4 Protecting against" exact="multiple sclerosis" post="[31] Trypsin Inhibitor Subfamily MCoTI-I CXCR4 antagonist 6 Anti-metastatic"/>
   <result pre="diseases [114] MCoTI-II CTLA-4 antagonist 1,3, and 6 Immunotherapy for" exact="cancer" post="[130] MCoTI-II Tryptase inhibitor 1 Anti-cancer [43] MCoTI-II VEGF"/>
   <result pre="libraries [74] MCoTI-II BCR-Abl kinase Inhibitor 1 and 6 Chronic" exact="myeloid leukemia" post="Attempt to graft both a cell penetrating peptide and"/>
   <result pre="[74] MCoTI-II BCR-Abl kinase Inhibitor 1 and 6 Chronic myeloid" exact="leukemia" post="Attempt to graft both a cell penetrating peptide and"/>
   <result pre="and kinase inhibitor [122] MCoTI-I MAS1 receptor agonist 6 Lung" exact="cancer" post="and myocardial infarction [64] MCoTI-II SET antagonist 6 Potential"/>
   <result pre="MCoTI-II FXIIa and FXa inhibitors 1 and 6 Antithrombotic and" exact="cardiovascular disease" post="[137] MCoTI-II Thrombospondin-1 (TSP-1) agonist 6 Microvascular endothelial cell"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6637693/results/search/disease/results.xml">
   <result pre="medium, provided the original work is properly cited. Abstract African" exact="trypanosomiasis" post="is a disease caused by the parasitic protozoa of"/>
   <result pre="Japan Agency for Medical Research and Development 1. Introduction African" exact="trypanosomiasis" post="(AT) is a tsetse-transmitted disease of humans and livestock"/>
   <result pre="livestock caused by the parasitic protozoan genus Trypanosoma. Human African" exact="trypanosomiasis" post="(HAT) and animal African trypanosomiasis (AAT) form the two"/>
   <result pre="protozoan genus Trypanosoma. Human African trypanosomiasis (HAT) and animal African" exact="trypanosomiasis" post="(AAT) form the two main types of AT [1,"/>
   <result pre="effects, and difficulty in regimen application are usually associated with" exact="trypanosomiasis" post="chemotherapy [5–10]. In view of the fact that about"/>
   <result pre="T. b. brucei (GUTat 3.1 strain) and Jurkat cells (acute" exact="lymphoblastic leukemia" post="cells) were cultivated in vitro to the log phase"/>
   <result pre="b. brucei (GUTat 3.1 strain) and Jurkat cells (acute lymphoblastic" exact="leukemia" post="cells) were cultivated in vitro to the log phase"/>
   <result pre="(P. falciparum) (Table 1). The assay also included Jurkat (acute" exact="lymphoblastic leukemia" post="cells) to investigate potential selectivity profiles of Z. zanthoxyloides"/>
   <result pre="falciparum) (Table 1). The assay also included Jurkat (acute lymphoblastic" exact="leukemia" post="cells) to investigate potential selectivity profiles of Z. zanthoxyloides"/>
   <result pre="LZT: Zanthoxylum zanthoxyloides (Lam.) Zepern. &amp;amp; Timler HAT: Human African" exact="trypanosomiasis" post="AAT: African animal trypanosomiasis HPLC: High-performance liquid chromatography ATR-IR:"/>
   <result pre="Zepern. &amp;amp; Timler HAT: Human African trypanosomiasis AAT: African animal" exact="trypanosomiasis" post="HPLC: High-performance liquid chromatography ATR-IR: Attenuated total reflectance infrared"/>
   <result pre="Ethnopharmacology2007109225826310.1016/j.jep.2006.07.02816949231 19FerreiraM. E.Cebrián-TorrejónG.CorralesA. S.et al.Zanthoxylum chiloperone leaves extract: first sustainable" exact="chagas disease" post="treatmentJournal of Ethnopharmacology2011133398699310.1016/j.jep.2010.11.03221134431 20SenR.ChatterjeeM.Plant derived therapeutics for the treatment"/>
   <result pre="cell proliferation through protein phosphatase 2A activation in HA22T human" exact="hepatocellular carcinoma" post="cells in vitro and in vivoInternational Journal of Molecular"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6642907/results/search/disease/results.xml">
   <result pre="Xanthones and phenolics (tannins) skin infections, wounds, dysentery, urinary disorders," exact="cystitis" post="and gonorrhoea 84,85 Impatiens balsamina flavanoids, triterpenoids, glycosides, fatty"/>
   <result pre="throat 90,91 Walsura robusta Sesquiterpenoid 10-nitro-isodauc-3-en-15-al, 10-oxo-isodauc-3-en-15-al Antibacterial, antimicrobial, astringent," exact="diarrhea" post="92,93 Swietenia mahagoni Alkaloids, terpenoids, anthraquinone, cardiac glycosides, saponins,"/>
   <result pre="tannins, saponins, phenols, flavonoids respiratory infections, skin infections, digestive disorders," exact="malaria" post="and other fevers, toothache in humans and eye infections"/>
   <result pre="Mallotus yunnanensis Polyphenols, tannins, flavonoids, coumarins, various terpenoids hepatitis, sore," exact="otitis media," post="stomach and duodenal ulcer, enlarged spleen and boils swelling,"/>
   <result pre="flavonoids, coumarins, various terpenoids hepatitis, sore, otitis media, stomach and" exact="duodenal ulcer," post="enlarged spleen and boils swelling, hematuria leucorrhea and traumatic"/>
   <result pre="70 Cyclobalanopsis austroglauca None astringing sores, carbuncles, dysentery, hemostasis and" exact="vaginal discharge" post="70 Manglietia hongheensis Alkaloids vomiting, diarrhea, dysentery, constipation and"/>
   <result pre="and vaginal discharge 70 Manglietia hongheensis Alkaloids vomiting, diarrhea, dysentery," exact="constipation" post="and geriatric hacking cough 70 Brandisia hancei hydroxytyrosol derivatives"/>
   <result pre="70 Brandisia hancei hydroxytyrosol derivatives and glycosides jaundice, boils, swelling," exact="tuberculosis" post="injury, hematemesis, osteomyelitis, periostitis, rheumatism and pain 70 Evodia"/>
   <result pre="anthelminthic and containing toxic substances 70 Meliosma squamulata Triterpenoids scabies," exact="carbuncle" post="boils swollen poison, hemorrhoids, enterobiasis, beriberi, rheumatoid, and snake"/>
   <result pre="sore pain 70 Schisandra viridis lignans, triterpenoids, organic acids urticaria," exact="herpes zoster," post="rheumatism and analgesia 70 Selaginella tamariscina flavonoids, phenol glycosides,"/>
   <result pre="Polygonum molle tannins, flavonoids, alkaloids carbuncle, swollen abscess, fistula and" exact="scrofula" post="70 Carex prainii alkaloids, polyphenols, flavonoids antipyresis, diuretic and"/>
   <result pre="110,111,112 Dodonaea angustifolia diterpenoids, flavonoids skin infections and irritations, inflammation," exact="tuberculosis" post="and pneumonia 110,113 Withania somnifera withanolides, alkaloids, chlorogenic acid,"/>
   <result pre="angustifolia diterpenoids, flavonoids skin infections and irritations, inflammation, tuberculosis and" exact="pneumonia" post="110,113 Withania somnifera withanolides, alkaloids, chlorogenic acid, glycosides, glucose,"/>
   <result pre="anti-virulence therapyToxins (Basel)2016872 18WeinsteinRAFridkinSKVancomycin-intermediate and –resistant Staphylococcus aureus: What the" exact="infectious disease" post="specialist needs to knowClin Infect Dis20013210811511118389 19AppelbaumPCThe emergence of"/>
   <result pre="aureusJ Clin Diagn Res20106974977 38FridkinSKVancomycin-intermediate and resistant Staphylococcus aureus. What" exact="infectious disease" post="specialists need to knowClin Infect Dis20013210811511118389 39AppelbaumPCReduced glycopeptides susceptibility"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6644182/results/search/disease/results.xml">
   <result pre="(L.) Willd. Asphodelaceae N/A Slimy leaves Applied topically Wound and" exact="rash" post="[3353] Bowiea volubilis Ex Hook.f. subsp. volubilis Hyacinthaceae Umagaqana"/>
   <result pre="umayisake Rhizomes, roots, and leaves Paste Boils, wounds, ulcers, and" exact="syphilis" post="sores [5859] Cissampelos torulosa E. Mey. Ex. Menispermaceae isitorhom"/>
   <result pre="(L.) Radlk. Aquifoliaceae umDuma Ground bark Paste or decoction Skin" exact="rash" post="and sores on the face [71] Kniphofia drepanophylla Baker."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6651730/results/search/disease/results.xml">
   <result pre="recently reported to show low cytotoxic properties for several human" exact="cancer" post="cell lines with median effective concentration (EC50) &amp;gt;30 μM"/>
   <result pre="promising therapeutic candidate for the prevention and treatment of human" exact="colon cancer" post="[247]. 4.3.3. Spergulagenic Acid Derivatives and Their Biological Activities"/>
   <result pre="therapeutic candidate for the prevention and treatment of human colon" exact="cancer" post="[247]. 4.3.3. Spergulagenic Acid Derivatives and Their Biological Activities"/>
   <result pre="as anticoagulant, essential regulator of metabolic processes including inflammation and" exact="cancer" post="in humans [277,278]. Among 4 tocopherols homologues, α-tocopherol (141)"/>
   <result pre="as a nutritional supplement for the prevention and treatment of" exact="obesity" post="and obesity-associated disorders. The findings indicated that the extract"/>
   <result pre="IL-8 expression via the PKCα/ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7" exact="breast cancer" post="cellsPhytomedicine201850354230466990 8.SuttiarpornP.ChumpolsriW.MahatheeranontS.LuangkaminS.TeepsawangS.LeardkamokkarnV.Structures of phytosterols and triterpenoids with potential anti-cancer"/>
   <result pre="expression via the PKCα/ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast" exact="cancer" post="cellsPhytomedicine201850354230466990 8.SuttiarpornP.ChumpolsriW.MahatheeranontS.LuangkaminS.TeepsawangS.LeardkamokkarnV.Structures of phytosterols and triterpenoids with potential anti-cancer"/>
   <result pre="and wheat as affected by sprouting and bakingFood Chem.2010119770778 38.TanakaT.TanakaT.TanakaM.Potential" exact="cancer" post="chemopreventive activity of protocatechuic acidJ. Exp. Clin. Med.201132733 39.LiuK.S.TsaoS.M.YinM.C.In"/>
   <result pre="protocatechuic acid and its pharmacological potentialISRN Pharmacol.2014201495294325006494 43.ZhouZ.ZhangY.DingX.R.ChenS.H.YangJ.WangX.J.WangS.Q.Protocatechuic aldehyde inhibits" exact="hepatitis" post="B virus replication both in vitro and in vivoAntivir."/>
   <result pre="peroxidation and haemolysisPhytochemistry199436579583 59.KwonS.H.LeeH.K.KimJ.A.HongS.I.KimH.C.JoT.H.JangC.G.Neuroprotective effects of chlorogenic acid on scopolamine-induced" exact="amnesia" post="via anti-acetylcholinesterase and anti-oxidative activities in miceEur. J. Pharmacol.201064921021720854806"/>
   <result pre="86.HsuY.L.KuoP.L.LiuC.F.LinC.C.Acacetin-induced cell cycle arrest and apoptosis in human non-small cell" exact="lung cancer" post="A549 cellsCancer Lett.2004212536015246561 87.HayashiK.HayashiT.ArisawaM.MoritaN.Antiviral agents of plant origin. Antiherpetic"/>
   <result pre="cell cycle arrest and apoptosis in human non-small cell lung" exact="cancer" post="A549 cellsCancer Lett.2004212536015246561 87.HayashiK.HayashiT.ArisawaM.MoritaN.Antiviral agents of plant origin. Antiherpetic"/>
   <result pre="oxonate-pretreated ratsBiol. Pharm. Bull.2005282231223416327155 91.ShochetG.E.DruckerL.Pasmanik-ChorM.PomeranzM.FishmanA.MatalonS.T.LishnerM.First trimester human placental factors induce" exact="breast cancer" post="cell autophagyBreast Cancer Res. Treat.201514964565425656679 92.LeeC.Y.ChienY.S.ChiuT.H.HuangW.W.LuC.C.ChiangJ.H.YangJ.S.Apoptosis triggered by vitexin"/>
   <result pre="ratsBiol. Pharm. Bull.2005282231223416327155 91.ShochetG.E.DruckerL.Pasmanik-ChorM.PomeranzM.FishmanA.MatalonS.T.LishnerM.First trimester human placental factors induce breast" exact="cancer" post="cell autophagyBreast Cancer Res. Treat.201514964565425656679 92.LeeC.Y.ChienY.S.ChiuT.H.HuangW.W.LuC.C.ChiangJ.H.YangJ.S.Apoptosis triggered by vitexin"/>
   <result pre="Cancer Res. Treat.201514964565425656679 92.LeeC.Y.ChienY.S.ChiuT.H.HuangW.W.LuC.C.ChiangJ.H.YangJ.S.Apoptosis triggered by vitexin in U937 human" exact="leukemia" post="cells via a mitochondrial signaling pathwayOncol. Rep.2012281883188822941432 93.De OliveiraD.R.ZamberlamC.R.GaiardoR.B.RêgoG.M.CeruttiJ.M.CavalheiroA.J.CeruttiS.M.Flavones"/>
   <result pre="Chenopodium, L.Lett. Bot.19852107113 126.SaudS.M.YoungM.R.Jones-HallY.L.IlevaL.EvbuomwanM.O.WiseJ.BobeG.Chemopreventive activity of plant flavonoid isorhamnetin in" exact="colorectal cancer" post="is mediated by oncogenic Src and β-cateninCancer Res.2013735473548423824743 127.JnawaliH.N.JeonD.JeongM.-C.LeeE.JinB.RyooS.YooJ.JungI.D.LeeS.J.ParkY.M.et"/>
   <result pre="L.Lett. Bot.19852107113 126.SaudS.M.YoungM.R.Jones-HallY.L.IlevaL.EvbuomwanM.O.WiseJ.BobeG.Chemopreventive activity of plant flavonoid isorhamnetin in colorectal" exact="cancer" post="is mediated by oncogenic Src and β-cateninCancer Res.2013735473548423824743 127.JnawaliH.N.JeonD.JeongM.-C.LeeE.JinB.RyooS.YooJ.JungI.D.LeeS.J.ParkY.M.et"/>
   <result pre="of Staphylococcus aureusMicrob. Pathog.201912730431530529513 141.QuY.WangC.LiuN.GaoC.LiuF.Exhibits anti-inflammatory effects on IL-1β-stimulated human" exact="osteoarthritis" post="chondrocytes by activating the Nrf2 signaling pathwayCell. Physiol. Biochem.2018511830183830504721"/>
   <result pre="hydrogen-atom transfer mechanism?Food Res. Int.201910.1016/j.foodres.2018.11.018 145.SitharaT.ArunK.B.SyamaH.P.ReshmithaT.R.NishaP.Morin Inhibits proliferation of SW480" exact="colorectal cancer" post="cells by inducing apoptosis mediated by reactive oxygen species"/>
   <result pre="transfer mechanism?Food Res. Int.201910.1016/j.foodres.2018.11.018 145.SitharaT.ArunK.B.SyamaH.P.ReshmithaT.R.NishaP.Morin Inhibits proliferation of SW480 colorectal" exact="cancer" post="cells by inducing apoptosis mediated by reactive oxygen species"/>
   <result pre="apoptotic and signal transduction effects of hesperidin in non-small cell" exact="lung cancer" post="cellsCell. Oncol.2015381953204 161.MahmoudA.M.Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation"/>
   <result pre="and signal transduction effects of hesperidin in non-small cell lung" exact="cancer" post="cellsCell. Oncol.2015381953204 161.MahmoudA.M.Hesperidin protects against cyclophosphamide-induced hepatotoxicity by upregulation"/>
   <result pre="Pharm.201492717724 162.AgrawalY.O.SharmaP.K.ShrivastavaB.OjhaS.UpadhyaH.M.AryaD.S.GoyalS.N.Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic" exact="heart disease" post="model in diabetic ratsPLoS ONE20149e11121225369053 163.LeeJ.H.LeeS.H.KimY.S.JeongC.S.Protective effects of neohesperidin"/>
   <result pre="rabbitsLife Sci.2001692855286611720089 166.WeiM.YangZ.LiP.ZhangY.SseW.C.Anti-osteoporosis activity of naringin in the retinoic acid-induced" exact="osteoporosis" post="modelAm. J. Chin. Med.20073566366717708632 167.AmaroM.I.RochaJ.Vila-RealH.Eduardo-FigueiraM.Mota-FilipeH.SepodesB.RibeiroM.H.Anti-inflammatory activity of naringin and"/>
   <result pre="naringinase immobilized in microstructured materials in a model of DSS-induced" exact="colitis" post="in miceFood Res. Int.20094210101017 168.HuangS.W.FrankelE.N.Antioxidant activity of tea catechins"/>
   <result pre="fractionation of green tea extract with antiproliferative activity against human" exact="stomach cancer" post="cellsBiol. Pharm. Bull.2002212381240 175.HanZ.WangG.YaoW.ZhuW.Isoflavonic phytoestrogens-new prebiotics for farm animals:"/>
   <result pre="of green tea extract with antiproliferative activity against human stomach" exact="cancer" post="cellsBiol. Pharm. Bull.2002212381240 175.HanZ.WangG.YaoW.ZhuW.Isoflavonic phytoestrogens-new prebiotics for farm animals:"/>
   <result pre="177.FotiP.ErbaD.RisoP.SpadafrancaA.CriscuoliF.TestolinG.Comparison between daidzein and genistein antioxidant activity in primary and" exact="cancer" post="lymphocytesArch. Biochem. Biophys.200543342142715581598 178.ChoK.W.LeeO.H.BanzW.J.Moustaid-MoussaN.ShayN.F.KimY.C.Daidzein and the daidzein metabolite, equol,"/>
   <result pre="on cell growth, cell cycle, and telomerase activity of human" exact="cervical cancer" post="in vitroInt. J. Gynecol. Cancer20041488288815361199 180.PicheritC.DalleM.NeliatG.LebecqueP.DaviccoM.J.BarletJ.P.CoxamV.Genistein and daidzein modulate"/>
   <result pre="cell growth, cell cycle, and telomerase activity of human cervical" exact="cancer" post="in vitroInt. J. Gynecol. Cancer20041488288815361199 180.PicheritC.DalleM.NeliatG.LebecqueP.DaviccoM.J.BarletJ.P.CoxamV.Genistein and daidzein modulate"/>
   <result pre="and genistein may be related to ERα/c-erbB-2 expression in human" exact="breast cancer" post="cellsMol. Med. Rep.2013778178423337939 186.FinkingG.WohlfromM.LenzC.WolkenhauerM.EberleC.HankeH.The phytoestrogens genistein and daidzein, and"/>
   <result pre="genistein may be related to ERα/c-erbB-2 expression in human breast" exact="cancer" post="cellsMol. Med. Rep.2013778178423337939 186.FinkingG.WohlfromM.LenzC.WolkenhauerM.EberleC.HankeH.The phytoestrogens genistein and daidzein, and"/>
   <result pre="pancreatic cancerCancer Res.2005659064907216204081 190.UckunF.M.NarlaR.K.JunX.ZerenT.VenkatachalamT.WaddickK.G.RostostevA.MyersD.E.Cytotoxic activity of epidermal growth factor-genistein against" exact="breast cancer" post="cellsClin. Cancer Res.199849019129563884 191.BüchlerP.ReberH.A.BüchlerM.W.FriessH.LaveyR.S.HinesO.J.Antiangiogenic activity of genistein in pancreatic"/>
   <result pre="cancerCancer Res.2005659064907216204081 190.UckunF.M.NarlaR.K.JunX.ZerenT.VenkatachalamT.WaddickK.G.RostostevA.MyersD.E.Cytotoxic activity of epidermal growth factor-genistein against breast" exact="cancer" post="cellsClin. Cancer Res.199849019129563884 191.BüchlerP.ReberH.A.BüchlerM.W.FriessH.LaveyR.S.HinesO.J.Antiangiogenic activity of genistein in pancreatic"/>
   <result pre="soy isoflavone genisteinJ. Basic Microbiol.20064632933516847837 194.YeF.WuJ.DunnT.YiJ.TongX.ZhangD.Inhibition of cyclooxygenase-2 activity in" exact="head and neck cancer" post="cells by genisteinCancer Lett.2004211394615194215 195.AdityaN.P.ShimM.LeeI.LeeY.ImM.H.KoS.Curcumin and genistein coloaded nanostructured"/>
   <result pre="Basic Microbiol.20064632933516847837 194.YeF.WuJ.DunnT.YiJ.TongX.ZhangD.Inhibition of cyclooxygenase-2 activity in head and neck" exact="cancer" post="cells by genisteinCancer Lett.2004211394615194215 195.AdityaN.P.ShimM.LeeI.LeeY.ImM.H.KoS.Curcumin and genistein coloaded nanostructured"/>
   <result pre="genistein coloaded nanostructured lipid carriers: In vitro digestion and antiprostate" exact="cancer" post="activityJ. Agric. Food Chem.2013611878188323362941 196.RaynalN.J.M.MomparlerL.CharbonneauM.MomparlerR.L.Antileukemic activity of genistein, a"/>
   <result pre="tumor cellsGene. Chromosome Canc.201251961974 199.YangG.HamI.ChoiH.Y.Anti-inflammatory effect of prunetin via the" exact="suppression" post="of NF-κB pathwayFood Chem. Toxicol.20135812413223597450 200.XuX.ZhangS.ZhangL.YanW.ZhengX.The Neuroprotection of puerarin"/>
   <result pre="arrest and disruption of mitochondrial membrane potential in HepG2 human" exact="hepatocellular carcinoma" post="cellsMol. Med. Rep.2015125012501826151733 230.YoshikawaM.MatsudaH.Antidiabetogenic activity of oleanolic acid glycosides"/>
   <result pre="of oleanane disaccharides isolated from Akebia quinata versus cytotoxicity against" exact="cancer" post="cells and NO inhibitionBiol. Pharm. Bull.20042774474715133259 256.DiniI.TenoreG.C.SchettinoO.DiniA.New oleanane saponins"/>
   <result pre="response to activate ASK1-JNK signaling and induce apoptosis in human" exact="bladder cancer" post="T24 cellsCell. Signal.20132520621323000344 274.WangC.M.TsaiS.J.JhanY.L.YehK.L.ChouC.H.Anti-proliferative activity of triterpenoids and sterols"/>
   <result pre="to activate ASK1-JNK signaling and induce apoptosis in human bladder" exact="cancer" post="T24 cellsCell. Signal.20132520621323000344 274.WangC.M.TsaiS.J.JhanY.L.YehK.L.ChouC.H.Anti-proliferative activity of triterpenoids and sterols"/>
   <result pre="of triterpenoids and sterols isolated from Alstonia scholaris against non-small-cell" exact="lung carcinoma" post="cellsMolecules2017222119 275.TangY.LiX.ChenP.X.ZhangB.HernandezM.ZhangH.MarconeM.F.LiuR.TsaoR.Characterisation of fatty acid, carotenoid, tocopherol/tocotrienol compositions and"/>
   <result pre="Bull.1998196170 286.FoucaultA.S.MathéV.LafontR.EvenP.DiohW.VeilletS.ToméD.HuneauJ.F.HermierD.Quignard-BoulangéA.Quinoa extract enriched in 20-hydroxyecdysone protects mice from diet-induced" exact="obesity" post="and modulates adipokines expressionObesity20122027027721869758 287.NsimbaR.Y.KikuzakiH.KonishiY.Ecdysteroids act as inhibitors of"/>
   <result pre="Agric. Food Chem.2003512288229412670172 319.HirakawaN.OkauchiR.MiuraY.YagasakiK.Anti-invasive activity of niacin and trigonelline against" exact="cancer" post="cellsBiosci. Biotech. Biochem.200569653658 320.ShahS.N.BodhankarS.L.BhondeR.MohanV.Hypoglycemic activity of the combination of"/>
   <result pre="adipocyte differentiation and PPARγ transcriptional activities [178] Affected human nonhormone-dependent" exact="cervical cancer" post="cells [179] Modulate in vitro rat uterine contractile activity"/>
   <result pre="differentiation and PPARγ transcriptional activities [178] Affected human nonhormone-dependent cervical" exact="cancer" post="cells [179] Modulate in vitro rat uterine contractile activity"/>
   <result pre="Genistein (63) Seeds - [176] Antiproliferative activity on human breat" exact="cancer" post="cells [185,186] Modulate in vitro rat uterine contractile activity"/>
   <result pre="[191,192] Antibacterial activity [193] Inhibition of cyclooxygenase-2 activity [194] Antiprostate" exact="cancer" post="activity [195] Antileukemic activity [196] Induction of quinone reductase"/>
   <result pre="P-388 mouse lymphoma, L-1210 mouse lymphomatic leukemia, HL-60 human promyelocytic" exact="leukemia" post="and SNU-5 human stomach cancer cells [248,249] Haemolytic activity"/>
   <result pre="mouse lymphomatic leukemia, HL-60 human promyelocytic leukemia and SNU-5 human" exact="stomach cancer" post="cells [248,249] Haemolytic activity [250] Anti-inflammatory activity [244] Antidermatophytic"/>
   <result pre="lymphomatic leukemia, HL-60 human promyelocytic leukemia and SNU-5 human stomach" exact="cancer" post="cells [248,249] Haemolytic activity [250] Anti-inflammatory activity [244] Antidermatophytic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6661349/results/search/disease/results.xml">
   <result pre=": 100119860199: Genetics and Genomics: Research Article Risk alleles for" exact="tuberculosis" post="infection associate with reduced immune reactivity in a wild"/>
   <result pre="activation and pathogen degradation that additively increase risk of bovine" exact="tuberculosis" post="infection by up to ninefold in wild African buffalo."/>
   <result pre="hosts to populations and metapopulations—is a central challenge in understanding" exact="infectious disease" post="processes. Bridging the divide between laboratory-based approaches in genetics"/>
   <result pre="cases annually [20,21]. Mycobacterium bovis, the causative agent of bovine" exact="tuberculosis" post="(bTB), is a broad host range zoonotic pathogen capable"/>
   <result pre="range zoonotic pathogen capable of infecting most mammals. Though human" exact="tuberculosis" post="cases were historically solely attributed to Mycobacterium tuberculosis infections,"/>
   <result pre="Though human tuberculosis cases were historically solely attributed to Mycobacterium" exact="tuberculosis" post="infections, roughly 3% of cases now arise from M."/>
   <result pre="maintenance host populations [23–25]. High worldwide disease burden has made" exact="tuberculosis" post="a main focus of biomedical research over the last"/>
   <result pre="bovis infection resistance within a natural setting, shedding light on" exact="tuberculosis" post="infection dynamics outside the laboratory. 2. Methods (a) Study"/>
   <result pre="excluded animals with fewer than four capture timepoints. (b) Bovine" exact="tuberculosis" post="testing and cytokine stimulations All blood samples for disease"/>
   <result pre="as key cytokines involved in an effective immune response to" exact="tuberculosis" post="infection [33,52]. We used cytokine-specific enzyme-linked immunosorbent assays (ELISAs;"/>
   <result pre="populations can yield discoveries in applied and basic aspects of" exact="infectious disease" post="biology, and build upon laboratory-based studies. For example, foundational"/>
   <result pre="substantiating the important role of IL-12 and phagocyte activation in" exact="tuberculosis" post="progression, even outside of the laboratory. In addition, multiscale"/>
   <result pre="(ROS) to avoid degradation [26]. Highly virulent strains of M." exact="tuberculosis" post="often escape the phagosome (where pathogens are gathered and"/>
   <result pre="[33,34] and is highly upregulated locally in humans with active" exact="pulmonary tuberculosis" post="[83–86]. Additionally, high variability in IL-12 expression has been"/>
   <result pre="and is highly upregulated locally in humans with active pulmonary" exact="tuberculosis" post="[83–86]. Additionally, high variability in IL-12 expression has been"/>
   <result pre="expression has been demonstrated across murine families of varying M." exact="tuberculosis" post="susceptibility [83], mirroring the reduced IL-12 production observed here"/>
   <result pre="ecological and evolutionary dynamics of mycobacterial pathogens that continue to" exact="plague" post="humans, as well as wild and domestic animals. Here,"/>
   <result pre="that substantiate and build upon previous laboratory findings by exploring" exact="tuberculosis" post="resistance within a natural population. We hope that future"/>
   <result pre="35CrossPCet al.2009Disease, predation and demography: assessing the impacts of bovine" exact="tuberculosis" post="on African buffalo by monitoring at individual and population"/>
   <result pre="36RodwellTC, KriekNP, BengisRG, WhyteIJ, ViljoenPC, de VosV, BoyceWM2001Prevalence of bovine" exact="tuberculosis" post="in African buffalo at Kruger National Park. J. Wildl"/>
   <result pre="Wildl Dis.37, 258–264. (10.7589/0090-3558-37.2.258)11310876 37TavalireHet al.2018Context-dependent costs and benefits of" exact="tuberculosis" post="resistance traits in a wild mammalian host. Ecol. Evol.8,"/>
   <result pre="buffalo. Ecology89, 2239–2250. (10.1890/07-0995.1)18724734 40JollesAE, CooperDV, LevinSA2005Hidden effects of chronic" exact="tuberculosis" post="in African buffalo. Ecology86, 2358–2364. (10.1890/05-0038) 41EzenwaVO, JollesAE2015Opposite effects"/>
   <result pre="56BeechlerBR, ManoreCA, ReininghausB, O'NealD, GorsichEE, EzenwaVO, JollesAE2015Enemies and turncoats: bovine" exact="tuberculosis" post="exposes pathogenic potential of Rift Valley fever virus in"/>
   <result pre="mice. Bull. Institut Pasteur. 95, 85–96. (10.1016/S0020-2452(97)83916-4) 78CaiYet al.2016xCT increases" exact="tuberculosis" post="susceptibility by regulating antimicrobial function and inflammation. Oncotarget7, 31"/>
   <result pre="pp. 45–80. New York, NY: Springer. 80KeaneJet al.1997Infection by Mycobacterium" exact="tuberculosis" post="promotes human alveolar macrophage apoptosis. Infect. Immun.65, 298–304.8975927 81EzenwaVO,"/>
   <result pre="(10.1111/j.1365-2249.2004.02328.x)14678260 84TahaRAet al.1999Increased expression of IL-12 receptor mRNA in active" exact="pulmonary tuberculosis" post="and sarcoidosis. Am. J. Respir. Crit. Care Med.160, 1119–1123."/>
   <result pre="84TahaRAet al.1999Increased expression of IL-12 receptor mRNA in active pulmonary" exact="tuberculosis" post="and sarcoidosis. Am. J. Respir. Crit. Care Med.160, 1119–1123."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6680750/results/search/disease/results.xml">
   <result pre="for developing new effective and eco-friendly nematocidal and insecticidal products." exact="anisakiasis" post="contact toxicity enzyme inhibition fumigation toxicity larvicide mosquito control"/>
   <result pre="development of new drugs to fight parasitic infections such as" exact="anisakiasis" post="is highly needed. Anisakiasis, the parasitic infection of the"/>
   <result pre="spread insect species, acting as competent vectors of malaria, dengue," exact="yellow fever," post="West Nile, chikungunya, and Zika virus [8,9]. Among Culex"/>
   <result pre="be industrially exploited with the aim of treating or preventing" exact="anisakiasis" post="or as a fish food additive to avoid larvae"/>
   <result pre="the O. syriacum essential oil is highly effective against the" exact="filariasis" post="vector C. quinquefasciatus and the parasite A. simplex. Notably,"/>
   <result pre="The authors declare no conflict of interest. References References 1.GuardoneL.ArmaniA.NuceraD.CostanzoF.MattiucciS.BruschiF.Human" exact="anisakiasis" post="in Italy: A retrospective epidemiological study over two decadesParasite2018254110.1051/parasite/201803430058531"/>
   <result pre="and epi-β-bisabolol from Hedychium larsenii (Zingiberaceae) essential oil on malaria," exact="chikungunya" post="and St. Louis encephalitis mosquito vectorsEcotoxicol. Environ. Saf.201713714915710.1016/j.ecoenv.2016.11.02827918946 26.GiarratanaF.MuscolinoD.BeninatiC.GiuffridaA.PanebiancoA.Activity"/>
   <result pre="larsenii (Zingiberaceae) essential oil on malaria, chikungunya and St. Louis" exact="encephalitis" post="mosquito vectorsEcotoxicol. Environ. Saf.201713714915710.1016/j.ecoenv.2016.11.02827918946 26.GiarratanaF.MuscolinoD.BeninatiC.GiuffridaA.PanebiancoA.Activity of Thymus vulgaris essential"/>
   <result pre="Anisakis simplexBioMed Res. Int.2014201410.1155/2014/54951024967378 28.RomeroM.C.NavarroM.C.Martín-SánchezJ.ValeroA.Peppermint (Mentha piperita) and albendazole against" exact="anisakiasis" post="in an animal modelTrop. Med. Int. Health2014191430143610.1111/tmi.1239925330410 29.Gómez-Mateos PérezM.Navarro"/>
   <result pre="essential oils and related plant-borne compounds: Larvicidal effectiveness on the" exact="filariasis" post="vector Culex quinquefasciatus SayInd. Crops Prod.20179618619510.1016/j.indcrop.2016.11.059 59.BenelliG.PavelaR.PetrelliR.CappellacciL.CanaleA.Senthil-NathanS.MaggiF.Not just popular"/>
   <result pre="toxicity of eight essential oils of commercial interest against the" exact="filariasis" post="mosquito Culex quinquefasciatus and the housefly Musca domesticaInd. Crop."/>
   <result pre="officinalis, Satureja montana, Aloysia citrodora and Pelargonium graveolens) against the" exact="filariasis" post="vector Culex quinquefasciatus: Synergistic and antagonistic effectsParasitol. Int.20176616617110.1016/j.parint.2017.01.01228110082 65.MarcheseA.OrhanI.E.DagliaM.BarbieriR.Di"/>
   <result pre="(Acmella oleracea (L.) R.K. Jansen) cultivated in central Italy against" exact="filariasis" post="mosquito vectors, houseflies and moth pestsJ. Ethnopharmacol.201922927227910.1016/j.jep.2018.08.03030149065 86.collab: WHOReport"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6702922/results/search/disease/results.xml">
   <result pre="in all continents of the world, except Antarctica. In general," exact="fasciolosis" post="is more common in animals than in humans. Nevertheless,"/>
   <result pre="and weight gain of the animal. The effective control of" exact="fasciolosis" post="currently includes the strategic and tactile use of anthelmintic"/>
   <result pre="measures, the population is dependent on traditional remedies. Treatment of" exact="fasciolosis" post="is more of commercially-manufactured anthelmintic drugs [7], but infrequently"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6716672/results/search/disease/results.xml">
   <result pre="and the potential role of dogs in the maintenance of" exact="strongyloidiasis" post="transmission has been a topic of interest and discussion"/>
   <result pre="topic of interest and discussion for many years. In Australia," exact="strongyloidiasis" post="is prevalent in remote socioeconomically disadvantaged communities in the"/>
   <result pre="Australia, suggesting that dogs represent a potential reservoir of human" exact="strongyloidiasis" post="in remote Australian communities. Author summary Strongyloides stercoralis is"/>
   <result pre="f. kellyi from Papua New Guinea (PNG) [5–7]. In Australia," exact="strongyloidiasis" post="is prevalent in remote communities located across the Northern"/>
   <result pre="Despite initially successful intervention programs targeting treatment to eliminate human" exact="strongyloidiasis" post="in remote Australian communities, the disease remains endemic [13,"/>
   <result pre="infected dogs and their potential role in the maintenance of" exact="strongyloidiasis" post="transmission has been a topic of interest and discussion"/>
   <result pre="dogs should be treated concomitantly in these communities to control" exact="strongyloidiasis" post="[16, 21]. Ultimately, we confirm for the first time"/>
   <result pre="suggest that dogs might represent a potential reservoir of human" exact="strongyloidiasis" post="in remote Australian communities. Supporting information S1 File GenBank"/>
   <result pre="2017;11(5):e000560710.1371/journal.pntd.000560728505198 14PageWA, DempseyK, McCarthyJS. Utility of serological follow-up of chronic" exact="strongyloidiasis" post="after anthelminthic chemotherapy. Transactions of the Royal Society of"/>
   <result pre="16BeknazarovaM, WhileyH, RossK. Mass drug administration for the prevention human" exact="strongyloidiasis" post="should consider concomitant treatment of dogs. PLoS Neglected Tropical"/>
   <result pre="Diseases. 2017;11(8):e000573510.1371/journal.pntd.000573528837662 17GoncalvesA, MachadoG, Goncalves-PiresM, Ferreira-JuniorA, SilvaD, Costa-CruzJ. Evaluation of" exact="strongyloidiasis" post="in kennel dogs and keepers by parasitological and serological"/>
   <result pre="MiyagiK, et al.Molecular identification of the causative agent of human" exact="strongyloidiasis" post="acquired in Tanzania: dispersal and diversity of Strongyloides spp."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6723029/results/search/disease/results.xml">
   <result pre="polymerase-α. This substance has been applied for the treatment of" exact="cancer" post="in preclinical research [14]. An unidentified fungus of the"/>
   <result pre="F (Figure 1H), which displays cytotoxic activity against L5178Y murine" exact="cancer" post="cells [16]. 2.3. Antidiabetic Activity Diabetes mellitus (or diabetes)"/>
   <result pre="and is an anticancer drug candidate with efficacy against L1210" exact="leukemia" post="cells, ovarian carcinoma cells, and drug-resistant breast cancer cells"/>
   <result pre="efficacy against L1210 leukemia cells, ovarian carcinoma cells, and drug-resistant" exact="breast cancer" post="cells [52]. The mechanism of action of cryptophycin involves"/>
   <result pre="against L1210 leukemia cells, ovarian carcinoma cells, and drug-resistant breast" exact="cancer" post="cells [52]. The mechanism of action of cryptophycin involves"/>
   <result pre="from Okeanis sp., showing strong cytotoxicity against HeLa S3 human" exact="cervical cancer" post="cells (IC50 = 26.3 nM) [54]. Hierridin B from"/>
   <result pre="Okeanis sp., showing strong cytotoxicity against HeLa S3 human cervical" exact="cancer" post="cells (IC50 = 26.3 nM) [54]. Hierridin B from"/>
   <result pre="are proposed as anticoagulants, anthelmintic, and in the treatments of" exact="gastritis" post="and diarrhea [69]. The traditional medical uses of green"/>
   <result pre="as anticoagulants, anthelmintic, and in the treatments of gastritis and" exact="diarrhea" post="[69]. The traditional medical uses of green seaweed spans"/>
   <result pre="hypertension, arteriosclerosis, menstrual disorders, skin diseases, gastric ulcers, goiter, and" exact="syphilis" post="and are also used as anticoagulants. Polysaccharides, such as"/>
   <result pre="of carrageenan that has an antiviral property, in particular against" exact="influenza" post="B and mumps virus [88]. Agar and agarose are"/>
   <result pre="has an antiviral property, in particular against influenza B and" exact="mumps" post="virus [88]. Agar and agarose are used for interferon"/>
   <result pre="extracted from Gracilaria corticata, showed activity against both colorectal and" exact="breast cancer" post="[91]. An anthelmintic compound, L-α-kainic acid (Figure 4B), has"/>
   <result pre="from Gracilaria corticata, showed activity against both colorectal and breast" exact="cancer" post="[91]. An anthelmintic compound, L-α-kainic acid (Figure 4B), has"/>
   <result pre="(2017) reported on the possible effects of G. corticata on" exact="cancer" post="treatments, inflammation, and infectious diseases [91]. Some red seaweeds,"/>
   <result pre="the Black Sea. This metabolite inhibited types A and B" exact="influenza" post="viruses, both in vivo and in vitro, followed by"/>
   <result pre="accumulation by stimulating lipolysis, and it can be beneficial for" exact="obesity" post="therapy [117]. Spavieri reported on the antimycobacterial, antiprotozoal, and"/>
   <result pre="pinnatifida sporophylls induced nonoxidative apoptotic damage on human colon or" exact="rectum cancer" post="cells [129]. The derivative of atomaric acid, stypoquinonic acid"/>
   <result pre="sporophylls induced nonoxidative apoptotic damage on human colon or rectum" exact="cancer" post="cells [129]. The derivative of atomaric acid, stypoquinonic acid"/>
   <result pre="acid derivative, dimethoxy-atomaric acid, showed cytotoxic activity against lung and" exact="colon cancer" post="cells [130]. Moreover, fucoidan is known to possess other"/>
   <result pre="derivative, dimethoxy-atomaric acid, showed cytotoxic activity against lung and colon" exact="cancer" post="cells [130]. Moreover, fucoidan is known to possess other"/>
   <result pre="bioactive properties, such as inhibitory effects on the growth of" exact="cancer" post="cells [131]. Sodium alginate (Figure 4J) obtained from brown"/>
   <result pre="of fucoidans in various tumor cell lines, including melanoma cells," exact="colon cancer," post="lymphoma, and breast cancer cells [134]. Antiangiogenic and Anticoagulant"/>
   <result pre="tumor cell lines, including melanoma cells, colon cancer, lymphoma, and" exact="breast cancer" post="cells [134]. Antiangiogenic and Anticoagulant Activities Phlorofucofuroeckol A (Figure"/>
   <result pre="cell lines, including melanoma cells, colon cancer, lymphoma, and breast" exact="cancer" post="cells [134]. Antiangiogenic and Anticoagulant Activities Phlorofucofuroeckol A (Figure"/>
   <result pre="fucoidan from U. pinnatifida and described its defensive effects against" exact="herpes simplex" post="virus (HSV) infections [141]. Also, Queiroz reported on a"/>
   <result pre="showed antiviral activity against HIV-1 infections (EC50= 8.2 nM) and" exact="influenza" post="viruses [158]. The potent anti-HIV-1 activity was related to"/>
   <result pre="Salmonella typhimurium and were proposed for the reduction of the" exact="breast cancer" post="risks [161]. Another carotenoid from green seaweeds, siphonaxanthin (Figure"/>
   <result pre="typhimurium and were proposed for the reduction of the breast" exact="cancer" post="risks [161]. Another carotenoid from green seaweeds, siphonaxanthin (Figure"/>
   <result pre="green seaweeds, siphonaxanthin (Figure 4D), effectively induced apoptosis in human" exact="leukemia" post="(HL-60) cells by caspase-3 activation, accompanied by the modification"/>
   <result pre="seaweedsNat. Prod. Commun.201491934578X140090073710.1177/1934578X1400900737 101.YehC.-C.TsengC.-N.YangJ.-I.HuangH.-W.FangY.TangJ.-Y.ChangF.-R.ChangH.-W.Antiproliferation and induction of apoptosis in ca9-22" exact="oral cancer" post="cells by ethanolic extract of gracilaria tenuistipitataMolecules201217109161092710.3390/molecules17091091622968475 102.YehC.-C.YangJ.-I.LeeJ.-C.TsengC.-N.ChanY.-C.HseuY.-C.TangJ.-Y.ChuangL.-Y.HuangH.-W.ChangF.-R.Anti-proliferative effect"/>
   <result pre="Prod. Commun.201491934578X140090073710.1177/1934578X1400900737 101.YehC.-C.TsengC.-N.YangJ.-I.HuangH.-W.FangY.TangJ.-Y.ChangF.-R.ChangH.-W.Antiproliferation and induction of apoptosis in ca9-22 oral" exact="cancer" post="cells by ethanolic extract of gracilaria tenuistipitataMolecules201217109161092710.3390/molecules17091091622968475 102.YehC.-C.YangJ.-I.LeeJ.-C.TsengC.-N.ChanY.-C.HseuY.-C.TangJ.-Y.ChuangL.-Y.HuangH.-W.ChangF.-R.Anti-proliferative effect"/>
   <result pre="tenuistipitataMolecules201217109161092710.3390/molecules17091091622968475 102.YehC.-C.YangJ.-I.LeeJ.-C.TsengC.-N.ChanY.-C.HseuY.-C.TangJ.-Y.ChuangL.-Y.HuangH.-W.ChangF.-R.Anti-proliferative effect of methanolic extract of gracilaria tenuistipitata on" exact="oral cancer" post="cells involves apoptosis, DNA damage, and oxidative stressBMC Complement."/>
   <result pre="102.YehC.-C.YangJ.-I.LeeJ.-C.TsengC.-N.ChanY.-C.HseuY.-C.TangJ.-Y.ChuangL.-Y.HuangH.-W.ChangF.-R.Anti-proliferative effect of methanolic extract of gracilaria tenuistipitata on oral" exact="cancer" post="cells involves apoptosis, DNA damage, and oxidative stressBMC Complement."/>
   <result pre="from sargassum sp. And fucus vesiculosus reduces cell viability of" exact="lung carcinoma" post="and melanoma cells in vitro and activates natural killer"/>
   <result pre="ethanol extract prepared from sporophyll of undaria pinnatifida on human" exact="colorectal cancer" post="cellsPhytother. Res.20122619119610.1002/ptr.352721604310 130.DortaE.Díaz-MarreroA.R.CuetoM.DariasJ.On the relative stereochemistry of atomaric acid"/>
   <result pre="extract prepared from sporophyll of undaria pinnatifida on human colorectal" exact="cancer" post="cellsPhytother. Res.20122619119610.1002/ptr.352721604310 130.DortaE.Díaz-MarreroA.R.CuetoM.DariasJ.On the relative stereochemistry of atomaric acid"/>
   <result pre="Phytosci.20173510.1186/s40816-017-0042-y 134.KimE.J.ParkS.Y.LeeJ.-Y.ParkJ.H.Y.Fucoidan present in brown algae induces apoptosis of human" exact="colon cancer" post="cellsBMC Gastroenterol.2010109610.1186/1471-230X-10-9620727207 135.FukuyamaY.KodamaM.MiuraI.KinzyoZ.MoriH.NakayamaY.TakahashiM.Anti-plasmin inhibitor. Vi.: Structure of phlorofucofuroeckol a,"/>
   <result pre="134.KimE.J.ParkS.Y.LeeJ.-Y.ParkJ.H.Y.Fucoidan present in brown algae induces apoptosis of human colon" exact="cancer" post="cellsBMC Gastroenterol.2010109610.1186/1471-230X-10-9620727207 135.FukuyamaY.KodamaM.MiuraI.KinzyoZ.MoriH.NakayamaY.TakahashiM.Anti-plasmin inhibitor. Vi.: Structure of phlorofucofuroeckol a,"/>
   <result pre="effects of a fucoidan from brown alga undaria pinnatifida against" exact="herpes simplex" post="virus infectionInt. Immunopharmacol.2008810911610.1016/j.intimp.2007.10.01718068106 142.QueirozK.MedeirosV.QueirozL.AbreuL.RochaH.FerreiraC.JucaM.AoyamaH.LeiteE.Inhibition of reverse transcriptase activity of"/>
   <result pre="boodlea coacta is a potent entry inhibitor of hiv-1 and" exact="influenza" post="virusesJ. Biol. Chem.2011286194461945810.1074/jbc.M110.21665521460211 159.WangR.PaulV.J.LueschH.Seaweed extracts and unsaturated fatty acid"/>
   <result pre="marine carotenoid from green algae, effectively induces apoptosis in human" exact="leukemia" post="(hl-60) cellsBiochim. Biophys. Acta (BBA)-Gen. Subj.2011181049750310.1016/j.bbagen.2011.02.00821371530 163.GanesanP.MatsubaraK.OhkuboT.TanakaY.NodaK.SugawaraT.HirataT.Anti-angiogenic effect of"/>
   <result pre="Mechanism of Action References Salinosporamide A Actinomycete/Salinispora tropica Treatment of" exact="multiple myeloma" post="(anticancer); antimalarial Inhibits proteasome activity by covalently modifying the"/>
   <result pre="of solid tumors and lymphomas Depolymerizes microtubules in A549 human" exact="lung carcinoma" post="cells [21] Alternaramide Ascomycete fungi/Alternaria sp. Anti-inflammatory Inhibits inflammatory"/>
   <result pre="activity in neuro-2a cells and cytotoxic activity in H-460 human" exact="lung carcinoma" post="cells [26] Coibamide A Pantropical cyanobacteria/Caldora penicillata Antitumor cytotoxicity"/>
   <result pre="cells [72] Pheophytin A Green alga/Enteromorpha prolifera Anti-inflammatory Exhibits significant" exact="suppression" post="of TPA-induced inflammatory reaction, such as edema formation in"/>
   <result pre="A Red seaweed/Bryopsis sp. Antibacterial agent Shows in vitroactivity againstMycobacterium" exact="tuberculosis" post="[84,85] Kahalalide F Red seaweed/Bryopsis sp. Antibacterial and anti-HIV"/>
   <result pre="sp. Antibacterial and anti-HIV agent Shows antibacterial activity against M." exact="tuberculosis" post="and proposed for the treatment of lung cancer [84,85]"/>
   <result pre="activity against M. tuberculosis and proposed for the treatment of" exact="lung cancer" post="[84,85]"/>
   <result pre="against M. tuberculosis and proposed for the treatment of lung" exact="cancer" post="[84,85]"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6733712/results/search/disease/results.xml">
   <result pre="in many countries (Mehlhorn, 2014). Weakness due to malnutrition and" exact="anemia" post="is the major complains of the infection with worms"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6746293/results/search/disease/results.xml">
   <result pre="zanthoxyloides Lam (Rutaceae), a medicinal plant used traditionally for treating" exact="malaria" post="in South-Eastern Nigeria, Uganda and Asia. Objectives: To investigate"/>
   <result pre="the application of methanol extracts of F. zanthoxyloides in combating" exact="malaria" post="infection and its associated disorders. Materials and methods: Methanol"/>
   <result pre="for Malaria sets a target to reduce the case of" exact="malaria" post="incidence and mortality rates at least 40% by the"/>
   <result pre="falciparum is responsible for the vast majority of deaths from" exact="malaria" post="especially in unprotected and non-immune populations (Balogun et al."/>
   <result pre="(Ogbuehi et al. 2014). The high mortality rate associated with" exact="malaria" post="infection, especially in tropical and sub-tropical regions of the"/>
   <result pre="Uganda, the plant is widely used for the treatment of" exact="malaria" post="and related conditions (Ogwal-Okeng et al. 2003). Some of"/>
   <result pre="believed that a good antimalarial candidate should not only clear" exact="malaria" post="parasite but also restores aberrations induced by malaria infection;"/>
   <result pre="only clear malaria parasite but also restores aberrations induced by" exact="malaria" post="infection; hence, we monitored the effect of the extract"/>
   <result pre="(normal saline). Group 2 (parasite control) was infected with the" exact="malaria" post="parasite and was untreated. Group 3 (standard control) was"/>
   <result pre="random fields of the microscope using the formula below: Percentage" exact="malaria" post="parasitaemia ( % ) = Number of parasitized RBC"/>
   <result pre="Day 0 MP × 100 where MP is the percentage" exact="malaria" post="parasitaemia Statistical analysis Raw data obtained from the laboratory"/>
   <result pre="standard antimalarial drug (combisunate at 140 mg/kg b.w.). Table 3. Percentage" exact="malaria" post="parasitaemia, chemosuppression, and percentage inhibition in P. berghei passaged"/>
   <result pre="Plasmodium infected mice are presented in Table 4. Infection with" exact="malaria" post="parasite induced significant (p &amp;lt; 0.05) decreases in packed cell volume"/>
   <result pre="implies that the extract normalized the liver damage generated by" exact="malaria" post="infection. Table 5. Effect of the MEFZ on the"/>
   <result pre="mice. Table 6. Effect of MEFZ on antioxidant status of" exact="malaria" post="passaged albino mice. Groups Lipid peroxidation and antioxidant status"/>
   <result pre="extract administration. Effect of MEFZ on some electrolyte concentrations in" exact="malaria" post="passaged mice As shown in Table 8, the concentrations"/>
   <result pre="before and after extract administration. Discussion Malaria remains an overwhelming" exact="infectious disease" post="with significant health challenges in African and other endemic"/>
   <result pre="the present study, MEFZ showed a dose-dependent reduction in percentage" exact="malaria" post="parasitaemia and, hence, an increase in parasite clearance. This"/>
   <result pre="to exhibit antimalarial activity and as well, protect organs of" exact="malaria" post="infected mice (Silikas et al. 1996; Iwasa et al."/>
   <result pre="infections and anaemia is the most common complication associated with" exact="malaria" post="infection (Erhart et al. 2004). The ability of the"/>
   <result pre="This may explain why there was a reduction percentage in" exact="malaria" post="parasitaemia in parasitized-MEFZ-treated mice. In addition, MEFZ significantly (p &amp;lt; 0.05)"/>
   <result pre="agrees with the opinion of Ifeanyichukwu and Esan (2014) that" exact="thrombocytopenia" post="(low platelet count) usually disappears with the treatment of"/>
   <result pre="thrombocytopenia (low platelet count) usually disappears with the treatment of" exact="malaria" post="infection. Malaria has been reported as the major cause"/>
   <result pre="infection. Malaria has been reported as the major cause of" exact="thrombocytopenia" post="in malaria endemic areas (Ifeanyichukwu and Esan 2014). Platelets"/>
   <result pre="has been reported as the major cause of thrombocytopenia in" exact="malaria" post="endemic areas (Ifeanyichukwu and Esan 2014). Platelets engulf malaria"/>
   <result pre="in malaria endemic areas (Ifeanyichukwu and Esan 2014). Platelets engulf" exact="malaria" post="parasites and get damaged in the process and thus"/>
   <result pre="from circulation, leading to a reduction in platelet count during" exact="malaria" post="(Ifeanyichukwu and Esan 2014). The haematopoietic effects observed in"/>
   <result pre="serum increase due to disruption of the liver membrane by" exact="malaria" post="parasite during exo-erythrocytic stage as well as the products"/>
   <result pre="of liver enzymes into circulation. Reduction in RBC destruction by" exact="malaria" post="parasite due to the antiplasmodial effect of MEFZ might"/>
   <result pre="when compared to parasitized-untreated mice (Trampuz et al. 2003). In" exact="malaria" post="infection, free radicals are generated from various sources such"/>
   <result pre="body’s antioxidant defence, oxidative stress – a condition implicated in" exact="malaria" post="complications results (Sandro et al. 2012). The antiplasmodial and"/>
   <result pre="and GSH (Rahman et al. 2012). Infection of mice with" exact="malaria" post="parasite decreased the HDL level when compared with normal"/>
   <result pre="compared with normal control. Kiru et al. (2018) reported that" exact="malaria" post="infected human subjects had higher LDL, TAG, HDL, VLDL,"/>
   <result pre="treated mice when compared with parasitized-untreated mice. In children with" exact="malaria" post="by P. vivax, Dias et al. (2016) reported significantly"/>
   <result pre="TAG and VLDL were not significantly changed in P. falciparum" exact="malaria" post="patients. Changes in serum lipid profile and lipid metabolism"/>
   <result pre="al. 2004). The extent of serum lipid profile changes during" exact="malaria" post="infection and their underlying biological mechanisms remain unclear. A"/>
   <result pre="serum lipids are a characteristic feature of malaria. Patients with" exact="malaria" post="present hypocholesterolemia, decreased HDL level, and elevation in the"/>
   <result pre="al. 2013). The actual mechanisms behind the observed dyslipidaemia in" exact="malaria" post="may be partly host related (i.e., related to an"/>
   <result pre="a combination of these two. However, it was observed that" exact="malaria" post="infection induced dyslipidaemia which was normalized in this study"/>
   <result pre="effect of the extract on the kidney dysfunction generated by" exact="malaria" post="infection, serum electrolyte concentrations of parasitized-MEFZ-extract-treated mice and parasitized-untreated"/>
   <result pre="potassium levels but no significant difference in chloride level when" exact="malaria" post="infected human subjects were compared with control. On the"/>
   <result pre="significant difference when the sodium, chloride and potassium levels of" exact="malaria" post="infected human subjects were compared with the controls. It"/>
   <result pre="controls. It appears that alteration in serum electrolyte indices in" exact="malaria" post="infection is dependent on the species of the malaria"/>
   <result pre="in malaria infection is dependent on the species of the" exact="malaria" post="parasite (Jasani et al. 2012), parasite density (van Wolfswinkel"/>
   <result pre="well as other genetic make-up of the host. In general," exact="malaria" post="infection alters serum electrolyte balance, suggesting that malaria infection"/>
   <result pre="In general, malaria infection alters serum electrolyte balance, suggesting that" exact="malaria" post="infection induces renal dysfunction. Treatment of parasitized mice with"/>
   <result pre="offer protection against oxidative stress and lipid peroxidation associated with" exact="malaria" post="infection. The plant extract also significantly restored altered haematological"/>
   <result pre="J Sci Nat. 3:497–501. AniOC2015. Assessment of the role of" exact="malaria" post="in the aetiology of renal impairment in Isu community"/>
   <result pre="Parasitol. 02(06):123–125. BalogunEA, AkinloyeAA, LasisiA2012Biochemical and histological changes associated with" exact="diabetes mellitus" post="in mice with extracts of Mormodiaca charantia. Biochemistry. 24:34–47."/>
   <result pre="da SilvaIRP, BrasilLMBF, AraújoEDC, de AndradeMA2016Lipid profile of children with" exact="malaria" post="by Plasmodium vivax. J Trop Med. 2016:9052612.28050172 DkhilMA, AlazzouniAS,"/>
   <result pre="BuathongN, LaoboonchaiA, MillerRS, MeshnickSR, GasserRA, WongsrichanalaiC2004Hematologic and clinical indices of" exact="malaria" post="in a semi-immune population of western Thailand. Am J"/>
   <result pre="70(1):8–14.14971691 EsanAJ, OmisakinCT, TitilayoOE, FasakinKA2014Gender difference on stress induced by" exact="malaria" post="parasite infection and effect of anti-malaria drug on stress"/>
   <result pre="3rd edLondon (UK): Chapman and Hall Ltd. HolzJ1977Lipids and the" exact="malaria" post="parasite. Bull World Health Organ. 55(2–3):237–248.412602 HonigGR, FarnsworthNR, FerencC,"/>
   <result pre="HonigGR, FarnsworthNR, FerencC, VidaLN1975Evaluation of Fagara zanthoxyloides root extract in" exact="sickle cell anemia" post="blood in vitro. Lloydia. 38(5):387–390.1202311 IfeanyichukwuMO, EsanA2014Evaluation of blood"/>
   <result pre="FerencC, VidaLN1975Evaluation of Fagara zanthoxyloides root extract in sickle cell" exact="anemia" post="blood in vitro. Lloydia. 38(5):387–390.1202311 IfeanyichukwuMO, EsanA2014Evaluation of blood"/>
   <result pre="IfeanyichukwuMO, EsanA2014Evaluation of blood cells and platelets in Plasmodium falciparum" exact="malaria" post="infected individuals. Int J Hematol Disord. 1:49–54. IkekpeazuEJ, NebohEE,"/>
   <result pre="BelloSY, AdamAL, SuleimanSM, ShamsuA, AbdulkadirML2018Lipid profile and electrolyte level in" exact="malaria" post="patients attending Muhammadu Abdullahi Wuse Specialist Hospital, Kano State."/>
   <result pre="system. *Open Access Sci Rep. 1(8):1–9. NuwahaF2001The challenge of chloroquine-resistant" exact="malaria" post="in sub-Saharan Africa. Health Policy Plan. 16(1):1–12. OdegheOB, UwakweAA,"/>
   <result pre="stem bark. IJAST. 2:58–65. OgbadoyiEO, GabiB2015Assessment of renal function in" exact="malaria" post="patients in Minna, North Central Nigeria. Afr J Infect"/>
   <result pre="ArieyF, WongsrichanalaiC2009Failure of artesunate–mefloquine combination therapy for uncomplicated Plasmodium falciparum" exact="malaria" post="in Southern Cambodia. Malar J. 8:10–18.19138388 RosensonRS, WolffDA, HuskinAL,"/>
   <result pre="and the inflammatory response in subjects with hypertriglyceridemia and the" exact="metabolic syndrome." post="Diabetes Care. 30(8):1945–1951.17483155 SandroP, DaniloRM, BrunoAQ, MichelliES, Ana CarolinaMG,"/>
   <result pre="hematological analyses of ethanol leaf extract of Moringa oleifera on" exact="malaria" post="infected mice. Int J Pharm Biol Sci. 3:360–371. UgwueneMC2011Effect"/>
   <result pre="13:93–103. van WolfswinkelME, HesselinkDA, ZietseR, HoornEJ, van GenderenP2010Hyponatraemia in imported" exact="malaria" post="is common and associated with disease severity. Malar J."/>
   <result pre="of antioxidants. Anal Biochem. 208(1):10–15.8434778 collab: World Health Organization [WHO].2016aWorld" exact="malaria" post="report. Geneva (Switzerland): World Health Organization. collab: World Health"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6749243/results/search/disease/results.xml">
   <result pre="while as anti-inflammatory agents for skin eruptions, rheumatism, bronchitis, and" exact="dermatitis" post="in traditional medicines. The plants of this genus are"/>
   <result pre="nervous disorders [25,26], cough [27], skin disorders, sinusitis, blood disorders," exact="pharyngitis" post="[28], kidney diseases, pneumonia, and bronchitis. The leaves and"/>
   <result pre="liable for the simple ringworm in pets as well as" exact="tinea capitis" post="in humans [43]. Different scientists reported the antimicrobial effect"/>
   <result pre="the CNS [50]. 5.9. Anticonvulsant Activity Epilepsy is third-most common" exact="neurological disorder" post="and is characterized by chronic seizures and disturbances in"/>
   <result pre="relieve gastrointestinal problems such as abdominal discomfort, nausea, vomiting, bloating," exact="constipation" post="and heartburn, gastritis, and gastroparesis. Laxative substances are used"/>
   <result pre="for the medicinal use of V. betonicifolia in indigestion and" exact="constipation" post="[35]. Alcoholic extract of V. odorata at 200 mg/kg"/>
   <result pre="effect [74], while kojic acid is liable to cause pigmented" exact="contact dermatitis." post="Therefore, this is why the thirst to investigate nontoxic"/>
   <result pre="immunity and host defenceRes. Immunol.199814928128810.1016/S0923-2494(98)80752-99720946 43.Ginter-HanselmayerG.SmolleJ.GuptaA.Itraconazole in the treatment of" exact="tinea capitis" post="caused by Microsporum canis: Experience in a large cohortPediatric"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6764475/results/search/disease/results.xml">
   <result pre="CampbellS. J.StothardJ. R.O’HalloranF.SankeyD.DurantT.OmbedeD. E.et al. (2017). Urogenital Schistosomiasis and soil-transmitted" exact="helminthiasis" post="(STH) in Cameroon: an epidemiological update at Barombi Mbo"/>
   <result pre="E.HedtkeS. M.DoyleS. R.KueselA. C.ArmooS.Osei-AtweneboanaM.et al. (2019). Utility of the Onchocerca" exact="volvulus" post="mitochondrial genome for delineation of parasite transmission zones. bioRxiv732446."/>
   <result pre="al. (2019). Entomological assessment of the transmission following recrudescence of" exact="onchocerciasis" post="in the Comoé Valley, Burkina Faso. Parasit. Vectors12 (1),"/>
   <result pre="TrevinoS. G.NkhomaS. C.NairS.DanielB. J.MoncadaK.KhosweS.et al. (2017). High-resolution single-cell sequencing of" exact="malaria" post="parasites. Genome Biol. Evol.9 (12), 3373–3383. 10.1093/gbe/evx25629220419 TsaiI. J.HuntM.HolroydN.HuckvaleT.BerrimanM.KikuchiT."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6779272/results/search/disease/results.xml">
   <result pre="governorate with clinical manifestations of acute fascioliasis. These included high" exact="eosinophilia" post="(&amp;gt; 6% eosinophils in peripheral blood), positive anti-Fasciola antibodies,"/>
   <result pre="the WHO criteria, persistence of symptoms or signs with either" exact="eosinophilia" post="(&amp;gt; 6% eosinophils in peripheral blood) or hepatic focal"/>
   <result pre="clinically assessed for response after 1 month. Resolution of both," exact="eosinophilia" post="in the CBC and/or hepatic focal lesions on US"/>
   <result pre="praziquantel, albendazole, dihydroemetine, or emetine hydrochloride, and patients who showed" exact="hypersensitivity" post="to nitazoxanide were excluded from this study. Statistical analysis"/>
   <result pre="abdominal pain, hepatomegaly, splenomegaly, and ascites. Laboratory data showed mild" exact="anemia" post="(hemoglobin [Hb]: 11.8± 0.7 g/dl), high eosinophilia (41.1 ±"/>
   <result pre="data showed mild anemia (hemoglobin [Hb]: 11.8± 0.7 g/dl), high" exact="eosinophilia" post="(41.1 ± 15.7%), high alanine transaminase (ALT) and aspartate"/>
   <result pre="Hemoglobin are in Male: 14–17 g/dL Female: 12–16 g/dL, for" exact="eosinophilia" post="0–5%, for ALT (0–35 IU/L) and for AST (0–35"/>
   <result pre="Hemoglobin Male: 14–17 g/dL Female: 12–16 g/dL, WBCs 4000–10,000/μL, for" exact="eosinophilia" post="0–5%, Platelet count 150,000–350,000/μL, for Total bilirubin—0.3–1.2 mg/dL, for"/>
   <result pre="tissue without producing eggs; the only evidences of infection are" exact="eosinophilia" post="and HFL, which are observed in early stages of"/>
   <result pre="treatment are defined by resolution of the clinical picture and" exact="eosinophilia" post="during follow up [30]. Therefore, in the current study,"/>
   <result pre="mainly on the persistence of clinical manifestations with either high" exact="eosinophilia" post="with or without radiological signs. In the present study,"/>
   <result pre="GonzalezC, CurtaleF, Munoz-AntoliC, ValeroMA, BarguesMD, et al.Hyperendemic fascioliasis associated with" exact="schistosomiasis" post="in villages in the Nile delta of Egypt. Am"/>
   <result pre="76–79. 10.4269/ajtmh.15-003025870421 28MarcosLA, TerashimaA, GotuzzoE. Update on hepatobiliary flukes: Fascioliasis," exact="opisthorchiasis" post="and clonorchiasis. Curr Opin Infect Dis. 2008;21: 523–530. 10.1097/QCO.0b013e32830f981818725803"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6788095/results/search/disease/results.xml">
   <result pre="and in some cases have been accompanied by anaphylactic shock," exact="asthma" post="and recurrence of the disease [6, 7]. Currently, chemotherapy"/>
   <result pre="but have been accompanied by adverse side effects, such as" exact="sclerosing cholangitis," post="necrosis of the liver and methaemoglobinaemia [6–8]. Two benzimidazoles,"/>
   <result pre="Therefore, it seems necessary to design approaches to induce cyst" exact="infertility" post="in vivo. The innate immunity of humans against the"/>
   <result pre="possible mechanisms for suppressing hydatid cysts as well as the" exact="infertility" post="of fertilized cysts [45–47]. The new pathways of innate"/>
   <result pre="3.GalehTMSpotinAMahami-OskoueiMCarmenaDRahimiMTBaracAet al.The seroprevalence rate and population genetic structure of human" exact="cystic echinococcosis" post="in the Middle East: a systematic review and meta-analysisInt"/>
   <result pre="al.The seroprevalence rate and population genetic structure of human cystic" exact="echinococcosis" post="in the Middle East: a systematic review and meta-analysisInt"/>
   <result pre="J Surg.201851394810.1016/j.ijsu.2018.01.02529367032 4.BudkeCMCarabinHNdimubanziPCNguyenHRainwaterEDickeyMet al.A systematic review of the literature on" exact="cystic echinococcosis" post="frequency worldwide and its associated clinical manifestationsAm J Trop"/>
   <result pre="Surg.201851394810.1016/j.ijsu.2018.01.02529367032 4.BudkeCMCarabinHNdimubanziPCNguyenHRainwaterEDickeyMet al.A systematic review of the literature on cystic" exact="echinococcosis" post="frequency worldwide and its associated clinical manifestationsAm J Trop"/>
   <result pre="consensus for the diagnosis and treatment of cystic and alveolar" exact="echinococcosis" post="in humansActa Trop.201011411610.1016/j.actatropica.2009.11.00119931502 20.BrunettiEJunghanssTUpdate on cystic hydatid diseaseCurr Opin"/>
   <result pre="benzimidazole residues in biological matricesJ Chromatogr.2007845137 22.StojkovicMZwahlenMTeggiAVutovaKCretuCMVirdoneRet al.Treatment response of" exact="cystic echinococcosis" post="to benzimidazoles: a systematic reviewPLoS Negl Trop Dis.20093e52410.1371/journal.pntd.000052419787039 23.Alvela-SuárezLVelasco-TiradoVBelhassen-GarciaMNovo-VeleiroIPardo-LledíasJRomero-AlegríaAet"/>
   <result pre="residues in biological matricesJ Chromatogr.2007845137 22.StojkovicMZwahlenMTeggiAVutovaKCretuCMVirdoneRet al.Treatment response of cystic" exact="echinococcosis" post="to benzimidazoles: a systematic reviewPLoS Negl Trop Dis.20093e52410.1371/journal.pntd.000052419787039 23.Alvela-SuárezLVelasco-TiradoVBelhassen-GarciaMNovo-VeleiroIPardo-LledíasJRomero-AlegríaAet"/>
   <result pre="Med Hyg.20149081982210.4269/ajtmh.13-005924615131 24.GavidiaCMGonzalezAELoperaLJayashiCAngelatsRBarronEAet al.Evaluation of nitazoxanide and oxfendazole efficacy against" exact="cystic echinococcosis" post="in naturally infected sheepAm J Trop Med Hyg.20098036737210.4269/ajtmh.2009.80.36719270283 25.OttesenEACampbellWIvermectin"/>
   <result pre="Hyg.20149081982210.4269/ajtmh.13-005924615131 24.GavidiaCMGonzalezAELoperaLJayashiCAngelatsRBarronEAet al.Evaluation of nitazoxanide and oxfendazole efficacy against cystic" exact="echinococcosis" post="in naturally infected sheepAm J Trop Med Hyg.20098036737210.4269/ajtmh.2009.80.36719270283 25.OttesenEACampbellWIvermectin"/>
   <result pre="disease: current trends in diagnosis and managementSurg Today.20043498799610.1007/s00595-004-2830-515580379 45.DíazÁImmunology of" exact="cystic echinococcosis" post="(hydatid disease)Br Med Bull.201712412113329253150 46.ZhangWRossAGMcManusDPMechanisms of immunity in hydatid"/>
   <result pre="current trends in diagnosis and managementSurg Today.20043498799610.1007/s00595-004-2830-515580379 45.DíazÁImmunology of cystic" exact="echinococcosis" post="(hydatid disease)Br Med Bull.201712412113329253150 46.ZhangWRossAGMcManusDPMechanisms of immunity in hydatid"/>
   <result pre="host and parasite in cystic echinococcosis: a new approach to" exact="suppression" post="and survival of hydatid cystParasitol Res.20121101979198410.1007/s00436-011-2726-422167369 48.ParedesRJimenezVCabreraGIragüenDGalantiNApoptosis as a"/>
   <result pre="of hydatid cystParasitol Res.20121101979198410.1007/s00436-011-2726-422167369 48.ParedesRJimenezVCabreraGIragüenDGalantiNApoptosis as a possible mechanism of" exact="infertility" post="in Echinococcus granulosus hydatid cystsJ Cell Biochem.20071001200120910.1002/jcb.2110817031852 49.HuHKangJChenRMamutiWWuGYuanWDrug-induced apoptosis"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6825121/results/search/disease/results.xml">
   <result pre="to identify genes suited for normalization, applied to bladder and" exact="colon cancer" post="data setsCancer research2004645245525010.1158/0008-5472.Can-04-049615289330 53.SilverNBestSJiangJTheinSLSelection of housekeeping genes for gene"/>
   <result pre="identify genes suited for normalization, applied to bladder and colon" exact="cancer" post="data setsCancer research2004645245525010.1158/0008-5472.Can-04-049615289330 53.SilverNBestSJiangJTheinSLSelection of housekeeping genes for gene"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6826424/results/search/disease/results.xml">
   <result pre="indicated that HMGA2 was mainly overexpressed in gastrointestinal cancers including" exact="colorectal cancer." post="Intriguingly, HMGA2 overexpression had no prognostic impacts on cancer"/>
   <result pre="colorectal cancer. Intriguingly, HMGA2 overexpression had no prognostic impacts on" exact="cancer" post="patients’ overall and disease-free survivals. In addition, HMGA2-overexpressing colorectal"/>
   <result pre="on cancer patients’ overall and disease-free survivals. In addition, HMGA2-overexpressing" exact="colorectal cancer" post="cell lines did not display higher susceptibility to a"/>
   <result pre="cancer patients’ overall and disease-free survivals. In addition, HMGA2-overexpressing colorectal" exact="cancer" post="cell lines did not display higher susceptibility to a"/>
   <result pre="protein A4 (S100A4) may be a druggable vulnerability for HMGA2-overexpressing" exact="colorectal cancer." post="A repurposing S100A4 inhibitor, niclosamide, was found to reverse"/>
   <result pre="was found to reverse the HMGA2-driven gene signature both in" exact="colorectal cancer" post="cell lines and patients’ tissues. In vitro and in"/>
   <result pre="found to reverse the HMGA2-driven gene signature both in colorectal" exact="cancer" post="cell lines and patients’ tissues. In vitro and in"/>
   <result pre="tissues. In vitro and in vivo experiments validated that HMGA2-overexpressing" exact="colorectal cancer" post="cells were more sensitive to niclosamide. However, inhibition of"/>
   <result pre="In vitro and in vivo experiments validated that HMGA2-overexpressing colorectal" exact="cancer" post="cells were more sensitive to niclosamide. However, inhibition of"/>
   <result pre="identified that niclosamide inhibited more cell-cycle-related gene expression in HMGA2-overexpressing" exact="colorectal cancer" post="cells, which may explain its selective anticancer effect. Together,"/>
   <result pre="that niclosamide inhibited more cell-cycle-related gene expression in HMGA2-overexpressing colorectal" exact="cancer" post="cells, which may explain its selective anticancer effect. Together,"/>
   <result pre="our study repurposes an anthelminthic drug niclosamide for treating HMGA2-overexpression" exact="colorectal cancer." post="bioinformatics Connectivity Map colorectal cancer drug repurposing HMGA2 S100A4"/>
   <result pre="drug niclosamide for treating HMGA2-overexpression colorectal cancer. bioinformatics Connectivity Map" exact="colorectal cancer" post="drug repurposing HMGA2 S100A4 1. Introduction High mobility group"/>
   <result pre="niclosamide for treating HMGA2-overexpression colorectal cancer. bioinformatics Connectivity Map colorectal" exact="cancer" post="drug repurposing HMGA2 S100A4 1. Introduction High mobility group"/>
   <result pre="shown to elicit anticancer activity against adenomatous polyposis coli (APC)-mutated" exact="colorectal cancer" post="through downregulating the Wnt signaling pathway [17]. In addition,"/>
   <result pre="to elicit anticancer activity against adenomatous polyposis coli (APC)-mutated colorectal" exact="cancer" post="through downregulating the Wnt signaling pathway [17]. In addition,"/>
   <result pre="is not a suitable prognostic biomarker and therapeutic target in" exact="colorectal cancer." post="However, HMGA2 overexpression in colorectal cancer cells leads to"/>
   <result pre="and therapeutic target in colorectal cancer. However, HMGA2 overexpression in" exact="colorectal cancer" post="cells leads to an increased sensitivity to an anthelminthic"/>
   <result pre="therapeutic target in colorectal cancer. However, HMGA2 overexpression in colorectal" exact="cancer" post="cells leads to an increased sensitivity to an anthelminthic"/>
   <result pre="niclosamide. Our study provides a novel therapeutic strategy for HMGA2-overexpressing" exact="colorectal cancer." post="2. Results 2.1. Pan-Cancer Analyses of HMGA2 Gene Expression"/>
   <result pre="dataset consists of the gene expression profiles from 917 human" exact="cancer" post="cell line spanning 36 cancer types [26]. High expression"/>
   <result pre="expression profiles from 917 human cancer cell line spanning 36" exact="cancer" post="types [26]. High expression of HMGA2 mRNA is found"/>
   <result pre="squamous cell carcinoma (HNSC), lung squamous cell carcinoma (LUSC), ovarian" exact="serous cystadenocarcinoma" post="(OV), rectum adenocarcinoma (READ), skin cutaneous melanoma (SKCM), stomach"/>
   <result pre="was a potential therapeutic target, we established a HMGA2-overexpressing DLD-1" exact="colorectal cancer" post="cell line. The overexpression of HMGA2 mRNA and protein"/>
   <result pre="a potential therapeutic target, we established a HMGA2-overexpressing DLD-1 colorectal" exact="cancer" post="cell line. The overexpression of HMGA2 mRNA and protein"/>
   <result pre="DNA [27,28]. To investigate whether netropsin can selectively kill HMGA2-overexpressing" exact="cancer" post="cells, both DLD-1-Vector and DLD-1-HMGA2 cells were treated with"/>
   <result pre="3D). To further confirm that the effect of netropsin on" exact="colorectal cancer" post="cell viability was not affected by HMGA2 expression, HCT116"/>
   <result pre="To further confirm that the effect of netropsin on colorectal" exact="cancer" post="cell viability was not affected by HMGA2 expression, HCT116"/>
   <result pre="may not a suitable prognosis biomarker and therapeutic target for" exact="colorectal cancer." post="2.3. S100A4 Is a Potential Surrogate Therapeutic Target for"/>
   <result pre="for HMGA2-Overexpressing Colorectal Cancer To identify druggable vulnerability of HGMA2-overexpressing" exact="colorectal cancer," post="microarray analysis was performed and found that 396 gene"/>
   <result pre="tissues. In addition, higher S100A4 expression was observed in various" exact="cancer" post="types compared to MYLK, BDNF, and PCOLCE2 (Figure S2)."/>
   <result pre="PCOLCE2 (Figure S2). S100A4 is a well-known metastasis-inducing gene in" exact="colorectal cancer" post="and S100A4 inhibition for therapeutic intervention is suggested [32,33]."/>
   <result pre="(Figure S2). S100A4 is a well-known metastasis-inducing gene in colorectal" exact="cancer" post="and S100A4 inhibition for therapeutic intervention is suggested [32,33]."/>
   <result pre="a gene related to angiogenesis, but not EMT, in the" exact="cancer" post="hallmark collection of Molecular Signatures Database (MSigDB) [31], it"/>
   <result pre="S100A4 might serve as a potential therapeutic target for HMGA2-overexpressing" exact="colorectal cancer." post="To confirm the S100A4 mRNA was upregulated in HMGA2-overexpressing"/>
   <result pre="prognostic impact of S100A4 on overall and disease-free survivals in" exact="colorectal cancer," post="Kaplan–Meier survival analysis was performed. Although S100A4 expression could"/>
   <result pre="performed. Although S100A4 expression could not predict the overall survival," exact="colorectal cancer" post="patients with high S100A4 expression displayed poor disease-free survival"/>
   <result pre="Although S100A4 expression could not predict the overall survival, colorectal" exact="cancer" post="patients with high S100A4 expression displayed poor disease-free survival"/>
   <result pre="might serve as a suitable molecular target for treating HMGA2-overexpressing" exact="colorectal cancer." post="2.4. Connectivity Map (CMap) Analysis Identified that S100A4 Inhibition"/>
   <result pre="a web-based database consisting of gene expression signatures from human" exact="cancer" post="cell lines treated with small molecules or transfected with"/>
   <result pre="employed CMap analysis to investigate the genetic dependency of HMGA2-overexpressing" exact="colorectal cancer." post="The differentially expressed genes (DEGs) with absolute Log2 fold"/>
   <result pre="further supporting the potency of niclosamide to inhibit S100A4 in" exact="colorectal cancer." post="In addition, we queried the CMap database with the"/>
   <result pre="S100A4 inhibition by niclosamide may exhibit therapeutic benefit for HMGA2-overexpressing" exact="colorectal cancer." post="2.5. Connectivity Map (CMap) Analysis Identified that S100A4 Inhibition"/>
   <result pre="signature provides clinical benefits, the gene expression profile of a" exact="colorectal cancer" post="patient cohort (GSE32323 [46]) was obtained from the GEO"/>
   <result pre="provides clinical benefits, the gene expression profile of a colorectal" exact="cancer" post="patient cohort (GSE32323 [46]) was obtained from the GEO"/>
   <result pre="Figure 6 (the lower part), the HMGA2-driven gene signature in" exact="colorectal cancer" post="patients was reversed by S100A4-knockdown (summary score = −96.55)"/>
   <result pre="6 (the lower part), the HMGA2-driven gene signature in colorectal" exact="cancer" post="patients was reversed by S100A4-knockdown (summary score = −96.55)"/>
   <result pre="demonstrate the in vivo anticancer activity of niclosamide against HMGA2-overexpressing" exact="colorectal cancer," post="DLD-1-Vector and DLD-1-HMGA2 cells were transplanted simultaneously into the"/>
   <result pre="selective in vitro and in vivo anticancer activity against HMGA2-overexpressing" exact="colorectal cancer." post="2.7. Inhibition of S100A4 Is Not Sufficient to Selectively"/>
   <result pre="CMap drugs of 10 μM are usually used to treat" exact="cancer" post="cells and generate gene expression signatures, therefore the inability"/>
   <result pre="examined whether Wnt/β-catenin inhibitors could exhibit selective cytotoxicity against HMGA2-overexpressing" exact="colorectal cancer" post="cells. As shown in Figure 8C, a Wnt/β-catenin inhibitor,"/>
   <result pre="whether Wnt/β-catenin inhibitors could exhibit selective cytotoxicity against HMGA2-overexpressing colorectal" exact="cancer" post="cells. As shown in Figure 8C, a Wnt/β-catenin inhibitor,"/>
   <result pre="indicate that niclosamide is a better therapeutic drug for HMGA2-overexpressing" exact="colorectal cancer" post="than other Wnt/β-catenin pathway inhibitors. In addition, inhibition of"/>
   <result pre="that niclosamide is a better therapeutic drug for HMGA2-overexpressing colorectal" exact="cancer" post="than other Wnt/β-catenin pathway inhibitors. In addition, inhibition of"/>
   <result pre="that S100A4 downregulation was not sufficient to selectively kill HMGA2-overexpressing" exact="colorectal cancer" post="cells. In addition, S100A4 knockdown did not further enhance"/>
   <result pre="S100A4 downregulation was not sufficient to selectively kill HMGA2-overexpressing colorectal" exact="cancer" post="cells. In addition, S100A4 knockdown did not further enhance"/>
   <result pre="the differential effect of niclosamide in HMGA2-low and HMGA2-high expressing" exact="colorectal cancer" post="cells, RNA sequencing for niclosamide-treated DLD-1-Vector and DLD-1-HMGA2 cells"/>
   <result pre="differential effect of niclosamide in HMGA2-low and HMGA2-high expressing colorectal" exact="cancer" post="cells, RNA sequencing for niclosamide-treated DLD-1-Vector and DLD-1-HMGA2 cells"/>
   <result pre="and cell cycle) and DNA repair (homologous recombination and Fanconi" exact="anemia" post="pathway). As a representative, the cell cycle pathway (hsa04114)"/>
   <result pre="with cell cycle progression and DNA repair pathways in HMGA2-overexpressing" exact="colorectal cancer," post="which may account for its higher cytotoxicity. 3. Discussion"/>
   <result pre="because negative prognostic impacts of HMGA2 overexpression in the above" exact="cancer" post="types have been reported previously [54,55,56,57,58,59]. We hypothesized that"/>
   <result pre="that such discrepancy may be resulted from the source of" exact="cancer" post="patients’ data, which can be supported by a recent"/>
   <result pre="be supported by a recent meta-analysis based on literatures (15" exact="cancer" post="types) and TCGA datasets (33 cancer types) [60]. They"/>
   <result pre="based on literatures (15 cancer types) and TCGA datasets (33" exact="cancer" post="types) [60]. They found that high HMGA2 expression is"/>
   <result pre="expression is associated with shorter overall and disease-free survivals in" exact="cancer" post="patients. However, consistent results are only observed in six"/>
   <result pre="cancer patients. However, consistent results are only observed in six" exact="cancer" post="types. For clear cell renal cell carcinoma, head and"/>
   <result pre="are only observed in six cancer types. For clear cell" exact="renal cell carcinoma," post="head and neck cancer, hepatocellular carcinoma, and pancreatic ductal"/>
   <result pre="in six cancer types. For clear cell renal cell carcinoma," exact="head and neck cancer," post="hepatocellular carcinoma, and pancreatic ductal adenocarcinoma, patients with high"/>
   <result pre="For clear cell renal cell carcinoma, head and neck cancer," exact="hepatocellular carcinoma," post="and pancreatic ductal adenocarcinoma, patients with high HMGA2 expression"/>
   <result pre="this study was to identify therapeutic agents selectively targeting HMGA2-overexpressing" exact="colorectal cancer." post="HMGA2 has been considered a therapeutic target in colorectal"/>
   <result pre="colorectal cancer. HMGA2 has been considered a therapeutic target in" exact="colorectal cancer." post="For example, HMGA2 silencing by small interfering (si)RNA, shRNA"/>
   <result pre="shown to inhibit cell growth and induce apoptosis in human" exact="colorectal cancer" post="cells [61,62,63,64]. However, such observations imply that HMGA2 inhibition-based"/>
   <result pre="to inhibit cell growth and induce apoptosis in human colorectal" exact="cancer" post="cells [61,62,63,64]. However, such observations imply that HMGA2 inhibition-based"/>
   <result pre="able to reduce HMGA2 expression and suppress HMGA-mediated EMT in" exact="colorectal cancer" post="cells. Thus, NVP-AUY922 can be viewed as an HMGA2"/>
   <result pre="to reduce HMGA2 expression and suppress HMGA-mediated EMT in colorectal" exact="cancer" post="cells. Thus, NVP-AUY922 can be viewed as an HMGA2"/>
   <result pre="However, knockdown of HMGA2 by siRNA increases the sensitivity of" exact="colorectal cancer" post="cells to NVP-AUY922, whereas HMGA2 overexpression attenuates the anticancer"/>
   <result pre="knockdown of HMGA2 by siRNA increases the sensitivity of colorectal" exact="cancer" post="cells to NVP-AUY922, whereas HMGA2 overexpression attenuates the anticancer"/>
   <result pre="inhibitors is limited by the endogenous expression of HMGA2 in" exact="colorectal cancer" post="cells. Drug repurposing is a promising strategy for the"/>
   <result pre="is limited by the endogenous expression of HMGA2 in colorectal" exact="cancer" post="cells. Drug repurposing is a promising strategy for the"/>
   <result pre="to fight against cancers. There are increasing repurposed drugs for" exact="colorectal cancer," post="including niclosamide [66]. Currently, few clinical trials of niclosamide"/>
   <result pre="niclosamide plus standard-dose enzalutamide (a nonsteroidal antiandrogen) in metastatic castration-resistant" exact="prostate cancer" post="[67]. However, the result is disappointing. The plasma concentration"/>
   <result pre="plus standard-dose enzalutamide (a nonsteroidal antiandrogen) in metastatic castration-resistant prostate" exact="cancer" post="[67]. However, the result is disappointing. The plasma concentration"/>
   <result pre="of niclosamide does not pass the threshold shown to inhibit" exact="prostate cancer" post="growth [67]. The finding that niclosamide inhibits S100A4-driven metastasis"/>
   <result pre="niclosamide does not pass the threshold shown to inhibit prostate" exact="cancer" post="growth [67]. The finding that niclosamide inhibits S100A4-driven metastasis"/>
   <result pre="number: NCT02519582) to evaluate its safety and efficacy in metastatic" exact="colorectal cancer" post="[18,19]. This trial is expected to be completed by"/>
   <result pre="NCT02519582) to evaluate its safety and efficacy in metastatic colorectal" exact="cancer" post="[18,19]. This trial is expected to be completed by"/>
   <result pre="to demonstrate the feasibility of oral niclosamide for treating metastatic" exact="colorectal cancer." post="It has been reported that niclosamide-mediated S100A4 downregulation contributes"/>
   <result pre="involve in the selective anticancer effect of niclosamide against HMGA2-overexpressing" exact="colorectal cancer" post="cells. One limitation of this study is few biological"/>
   <result pre="in the selective anticancer effect of niclosamide against HMGA2-overexpressing colorectal" exact="cancer" post="cells. One limitation of this study is few biological"/>
   <result pre="USA). 4.6. Cell Culture and Transfection DLD-1 and HCT116 human" exact="colorectal cancer" post="cells were cultured in RPMI-1640 medium supplemented with 10%"/>
   <result pre="4.6. Cell Culture and Transfection DLD-1 and HCT116 human colorectal" exact="cancer" post="cells were cultured in RPMI-1640 medium supplemented with 10%"/>
   <result pre="HMGA2 to S100A4 that predicts a poor disease-free survival in" exact="colorectal cancer" post="patients. In addition, niclosamide (a S100A4 inhibitor) exhibits more"/>
   <result pre="to S100A4 that predicts a poor disease-free survival in colorectal" exact="cancer" post="patients. In addition, niclosamide (a S100A4 inhibitor) exhibits more"/>
   <result pre="cannot fully explain the sensitizing effect of niclosamide on HMGA2-overexpressing" exact="colorectal cancer" post="cells, suggesting that additional mechanisms are involved. The results"/>
   <result pre="fully explain the sensitizing effect of niclosamide on HMGA2-overexpressing colorectal" exact="cancer" post="cells, suggesting that additional mechanisms are involved. The results"/>
   <result pre="cells. Nevertheless, our study provides a basis for treating HMGA2-overexpressing" exact="colorectal cancer" post="by niclosamide, and the exact mechanism of action warrants"/>
   <result pre="Nevertheless, our study provides a basis for treating HMGA2-overexpressing colorectal" exact="cancer" post="by niclosamide, and the exact mechanism of action warrants"/>
   <result pre="of HMGA2, MYLK, BDNK, PCOLCE2, and S100A4 in normal and" exact="cancer" post="tissues, Figure S3: Connectivity mapping for the gene signature"/>
   <result pre="Connectivity Map (CMap) analysis, Table S3: The HMGA2-correlated genes in" exact="colorectal cancer" post="patients, Table S4: RNA sequencing for niclosamide-treated DLD-1-Vector cells,"/>
   <result pre="Map (CMap) analysis, Table S3: The HMGA2-correlated genes in colorectal" exact="cancer" post="patients, Table S4: RNA sequencing for niclosamide-treated DLD-1-Vector cells,"/>
   <result pre="cancerMol. Cancer Res.2008674375010.1158/1541-7786.MCR-07-009518505920 7.MalekA.BakhidzeE.NoskeA.SersC.AignerA.SchaferR.TchernitsaO.HMGA2 gene is a promising target for" exact="ovarian cancer" post="silencing therapyInt. J. Cancer200812334835610.1002/ijc.2349118452175 8.MorishitaA.ZaidiM.R.MitoroA.SankarasharmaD.SzabolcsM.OkadaY.D’ArmientoJ.ChadaK.HMGA2 is a driver of"/>
   <result pre="Cancer Res.2008674375010.1158/1541-7786.MCR-07-009518505920 7.MalekA.BakhidzeE.NoskeA.SersC.AignerA.SchaferR.TchernitsaO.HMGA2 gene is a promising target for ovarian" exact="cancer" post="silencing therapyInt. J. Cancer200812334835610.1002/ijc.2349118452175 8.MorishitaA.ZaidiM.R.MitoroA.SankarasharmaD.SzabolcsM.OkadaY.D’ArmientoJ.ChadaK.HMGA2 is a driver of"/>
   <result pre="11.MotoyamaK.InoueH.NakamuraY.UetakeH.SugiharaK.MoriM.Clinical significance of high mobility group A2 in human gastric" exact="cancer" post="and its relationship to let-7 microRNA familyClin. Cancer Res.2008142334234010.1158/1078-0432.CCR-07-466718413822"/>
   <result pre="action of reagents that uncouple oxidative phosphorylationNature19692211016101810.1038/2211016a04180173 15.LiY.LiP.K.RobertsM.J.ArendR.C.SamantR.S.BuchsbaumD.J.Multi-targeted therapy of" exact="cancer" post="by niclosamide: A new application for an old drugCancer"/>
   <result pre="niclosamide in patients with metachronous or sychronous metastases of a" exact="colorectal cancer" post="progressing after therapy: The NIKOLO trialBMC Cancer201818e29710.1186/s12885-018-4197-9 20.WuC.JinX.TsuengG.AfrasiabiC.SuA.I.BioGPS: Building"/>
   <result pre="in patients with metachronous or sychronous metastases of a colorectal" exact="cancer" post="progressing after therapy: The NIKOLO trialBMC Cancer201818e29710.1186/s12885-018-4197-9 20.WuC.JinX.TsuengG.AfrasiabiC.SuA.I.BioGPS: Building"/>
   <result pre="and interactive analysisNucleic Acids Res.20194755656010.1093/nar/gkz43031114875 24.TangZ.LiC.KangB.GaoG.LiC.ZhangZ.GEPIA: A web server for" exact="cancer" post="and normal gene expression profiling and interactive analysesNucleic Acids"/>
   <result pre="and human protein-encoding transcriptomesProc. Natl. Acad. Sci. USA20041016062606710.1073/pnas.040078210115075390 26.BarretinaJ.CaponigroG.StranskyN.VenkatesanK.MargolinA.A.KimS.WilsonC.J.LeharJ.KryukovG.V.SonkinD.et al.The" exact="cancer" post="cell line encyclopedia enables predictive modelling of anticancer drug"/>
   <result pre="signatures database (MSigDB) hallmark gene set collectionCell Syst.2015141742510.1016/j.cels.2015.12.00426771021 32.DahlmannM.KobeltD.WaltherW.MudduluruG.SteinU.S100A4 in" exact="cancer" post="metastasis: Wnt signaling-driven interventions for metastasis restrictionCancers (Basel)20168e5910.3390/cancers806005927331819 33.WeidleU.H.BirzeleF.KrugerA.Molecular"/>
   <result pre="in liver metastasis of colorectal cancerClin. Exp. Metastasis20153262363510.1007/s10585-015-9732-326104118 34.FeiF.QuJ.ZhangM.LiY.ZhangS.S100A4 in" exact="cancer" post="progression and metastasis: A systematic reviewOncotarget20178732197323910.18632/oncotarget.1801629069865 35.LambJ.The connectivity map:"/>
   <result pre="1,000,000 profilesCell201717114371452e141710.1016/j.cell.2017.10.04929195078 38.LiuL.QiL.KnifleyT.PiecoroD.W.RychahouP.LiuJ.MitovM.I.MartinJ.WangC.WuJ.et al.S100A4 alters metabolism and promotes invasion of" exact="lung cancer" post="cells by up-regulating mitochondrial complex I protein NDUFS2J. Biol."/>
   <result pre="profilesCell201717114371452e141710.1016/j.cell.2017.10.04929195078 38.LiuL.QiL.KnifleyT.PiecoroD.W.RychahouP.LiuJ.MitovM.I.MartinJ.WangC.WuJ.et al.S100A4 alters metabolism and promotes invasion of lung" exact="cancer" post="cells by up-regulating mitochondrial complex I protein NDUFS2J. Biol."/>
   <result pre="metastasis is restricted by the Wnt/beta-catenin pathway inhibitor calcimycin in" exact="colon cancer" post="cellsMol. Biol. Cell2011223344335410.1091/mbc.e10-09-073921795396 42.SteinU.ArltF.SmithJ.SackU.HerrmannP.WaltherW.LemmM.FichtnerI.ShoemakerR.H.SchlagP.M.Intervening in beta-catenin signaling by sulindac"/>
   <result pre="is restricted by the Wnt/beta-catenin pathway inhibitor calcimycin in colon" exact="cancer" post="cellsMol. Biol. Cell2011223344335410.1091/mbc.e10-09-073921795396 42.SteinU.ArltF.SmithJ.SackU.HerrmannP.WaltherW.LemmM.FichtnerI.ShoemakerR.H.SchlagP.M.Intervening in beta-catenin signaling by sulindac"/>
   <result pre="Biol. Cell2011223344335410.1091/mbc.e10-09-073921795396 42.SteinU.ArltF.SmithJ.SackU.HerrmannP.WaltherW.LemmM.FichtnerI.ShoemakerR.H.SchlagP.M.Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent" exact="colon cancer" post="metastasisNeoplasia20111313114410.1593/neo.10117221403839 43.GarrettS.C.HodgsonL.RybinA.ToutchkineA.HahnK.M.LawrenceD.S.BresnickA.R.A biosensor of S100A4 metastasis factor activation: Inhibitor"/>
   <result pre="Cell2011223344335410.1091/mbc.e10-09-073921795396 42.SteinU.ArltF.SmithJ.SackU.HerrmannP.WaltherW.LemmM.FichtnerI.ShoemakerR.H.SchlagP.M.Intervening in beta-catenin signaling by sulindac inhibits S100A4-dependent colon" exact="cancer" post="metastasisNeoplasia20111313114410.1593/neo.10117221403839 43.GarrettS.C.HodgsonL.RybinA.ToutchkineA.HahnK.M.LawrenceD.S.BresnickA.R.A biosensor of S100A4 metastasis factor activation: Inhibitor"/>
   <result pre="S100A4 and myosin-IIABiochemistry (Mosc.)2011507218722710.1021/bi200853y21749055 46.KhamasA.IshikawaT.ShimokawaK.MogushiK.IidaS.IshiguroM.MizushimaH.TanakaH.UetakeH.SugiharaK.Screening for epigenetically masked genes in" exact="colorectal cancer" post="Using 5-Aza-2’-deoxycytidine, microarray and gene expression profileCancer Genom. Proteom.201296775"/>
   <result pre="and myosin-IIABiochemistry (Mosc.)2011507218722710.1021/bi200853y21749055 46.KhamasA.IshikawaT.ShimokawaK.MogushiK.IidaS.IshiguroM.MizushimaH.TanakaH.UetakeH.SugiharaK.Screening for epigenetically masked genes in colorectal" exact="cancer" post="Using 5-Aza-2’-deoxycytidine, microarray and gene expression profileCancer Genom. Proteom.201296775"/>
   <result pre="55.NieD.ZhangL.GuoQ.MaoX.High mobility group protein A2 overexpression indicates poor prognosis for" exact="cancer" post="patients: A meta-analysisOncotarget201891237124710.18632/oncotarget.2308529416690 56.PallanteP.SepeR.PucaF.FuscoA.High mobility group a proteins as"/>
   <result pre="human colorectal carcinomaJ. Gastrointest. Cancer20174815616310.1007/s12029-016-9871-z27629422 62.XuX.WangY.DengH.LiuC.WuJ.LaiM.HMGA2 enhances 5-fluorouracil chemoresistance in" exact="colorectal cancer" post="via the Dvl2/Wnt pathwayOncotarget201899963997410.18632/oncotarget.2413329515783 63.WuH.LiangY.ShenL.ShenL.MicroRNA-204 modulates colorectal cancer cell"/>
   <result pre="colorectal carcinomaJ. Gastrointest. Cancer20174815616310.1007/s12029-016-9871-z27629422 62.XuX.WangY.DengH.LiuC.WuJ.LaiM.HMGA2 enhances 5-fluorouracil chemoresistance in colorectal" exact="cancer" post="via the Dvl2/Wnt pathwayOncotarget201899963997410.18632/oncotarget.2413329515783 63.WuH.LiangY.ShenL.ShenL.MicroRNA-204 modulates colorectal cancer cell"/>
   <result pre="chemoresistance in colorectal cancer via the Dvl2/Wnt pathwayOncotarget201899963997410.18632/oncotarget.2413329515783 63.WuH.LiangY.ShenL.ShenL.MicroRNA-204 modulates" exact="colorectal cancer" post="cell sensitivity in response to 5-fluorouracil-based treatment by targeting"/>
   <result pre="in colorectal cancer via the Dvl2/Wnt pathwayOncotarget201899963997410.18632/oncotarget.2413329515783 63.WuH.LiangY.ShenL.ShenL.MicroRNA-204 modulates colorectal" exact="cancer" post="cell sensitivity in response to 5-fluorouracil-based treatment by targeting"/>
   <result pre="mobility group protein A2Biol. Open2016556357010.1242/bio.01500827095441 64.YuF.Y.TuY.DengY.GuoC.NingJ.ZhuY.LvX.YeH.MiR-4500 is epigenetically downregulated in" exact="colorectal cancer" post="and functions as a novel tumor suppressor by regulating"/>
   <result pre="group protein A2Biol. Open2016556357010.1242/bio.01500827095441 64.YuF.Y.TuY.DengY.GuoC.NingJ.ZhuY.LvX.YeH.MiR-4500 is epigenetically downregulated in colorectal" exact="cancer" post="and functions as a novel tumor suppressor by regulating"/>
   <result pre="in the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of" exact="colorectal cancer" post="cellsPeerJ20164e168310.7717/peerj.168326893968 66.FongW.ToK.K.W.Drug repurposing to overcome resistance to various therapies"/>
   <result pre="the regulation of HMGA2-driven growth and epithelial-to-mesenchymal transition of colorectal" exact="cancer" post="cellsPeerJ20164e168310.7717/peerj.168326893968 66.FongW.ToK.K.W.Drug repurposing to overcome resistance to various therapies"/>
   <result pre="prognostic impact of HMGA2 on overall and disease-free survival of" exact="cancer" post="patients. The Kaplan–Meier survival plots for cancer patients with"/>
   <result pre="disease-free survival of cancer patients. The Kaplan–Meier survival plots for" exact="cancer" post="patients with high and low HMGA2 expression were generated"/>
   <result pre="database. TPM, transcript per million. Figure 3 Characterization of HMGA2-overexpressing" exact="colorectal cancer" post="cells. (A) The mRNA and protein expressions of HMGA2"/>
   <result pre="TPM, transcript per million. Figure 3 Characterization of HMGA2-overexpressing colorectal" exact="cancer" post="cells. (A) The mRNA and protein expressions of HMGA2"/>
   <result pre="4 Upregulation of S100 calcium-binding protein A4 (S100A4) in HMGA2-overexpression" exact="colorectal cancer" post="cells. (A) The differentially expressed genes (DEGs) in DLD-1-HMGA2"/>
   <result pre="Upregulation of S100 calcium-binding protein A4 (S100A4) in HMGA2-overexpression colorectal" exact="cancer" post="cells. (A) The differentially expressed genes (DEGs) in DLD-1-HMGA2"/>
   <result pre="enzyme-linked immunosorbent assay (ELISA); (D) the Kaplan–Meier survival plots for" exact="colorectal cancer" post="patients with high and low S100A4 expression were generated"/>
   <result pre="immunosorbent assay (ELISA); (D) the Kaplan–Meier survival plots for colorectal" exact="cancer" post="patients with high and low S100A4 expression were generated"/>
   <result pre="clinical implication of S100 calcium-binding protein A4 (S100A4)-targeting niclosamide for" exact="colorectal cancer." post="The upper part: The most similar and dissimilar genes"/>
   <result pre="map. The lower part: Connections of HMGA2-driven gene signature in" exact="colorectal cancer" post="patients with the HMGA2/S100A4 knockdown and niclosamide were analyzed"/>
   <result pre="The lower part: Connections of HMGA2-driven gene signature in colorectal" exact="cancer" post="patients with the HMGA2/S100A4 knockdown and niclosamide were analyzed"/>
   <result pre="score. Figure 7 Effect of niclosamide on S100A4 expression and" exact="cancer" post="growth in HMGA2-overexpressing colorectal cancer cells. (A) DLD-1-Vector and"/>
   <result pre="of niclosamide on S100A4 expression and cancer growth in HMGA2-overexpressing" exact="colorectal cancer" post="cells. (A) DLD-1-Vector and DLD-1-HMGA2 cells were treated with"/>
   <result pre="niclosamide on S100A4 expression and cancer growth in HMGA2-overexpressing colorectal" exact="cancer" post="cells. (A) DLD-1-Vector and DLD-1-HMGA2 cells were treated with"/>
   <result pre="8 Effect of S100A4 inhibition on cell viability in HMGA2-overexpressing" exact="colorectal cancer" post="cells. (A) DLD-1-Vector and DLD-1-HMGA2 cells were treated with"/>
   <result pre="Effect of S100A4 inhibition on cell viability in HMGA2-overexpressing colorectal" exact="cancer" post="cells. (A) DLD-1-Vector and DLD-1-HMGA2 cells were treated with"/>
   <result pre="polysaccharide biosynthesis domain containing 1 −4.72 NPNT nephronectin −4.57 CFTR" exact="cystic fibrosis" post="transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)"/>
   <result pre="NPTX2 neuronal pentraxin II −4.03 KIT v-kit Hardy-Zuckerman 4 feline" exact="sarcoma" post="viral oncogene homolog −3.99 SH3BGRL SH3 domain binding glutamic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6826867/results/search/disease/results.xml">
   <result pre="Nematodes as model organismsWormBook2017201718428326696 17.KyriakakisE.MarkakiM.TavernarakisN.Caenorhabditis elegans as a model for" exact="cancer" post="researchMol. Cell Oncol.20152e97502710.4161/23723556.2014.97502727308424 18.SommerR.J.BumbargerD.J.Nematode model systems in evolution and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6852960/results/search/disease/results.xml">
   <result pre="References References 1.CaminadeCVan DijkJBaylisMWilliamsDModelling recent and future climatic suitability for" exact="fasciolosis" post="in EuropeGeosp Health.2015930130810.4081/gh.2015.352 2.APHA. Veterinary investigation diagnosis analysis reports"/>
   <result pre="for estimating the intraclass correlation coefficient for binary responses in" exact="cancer" post="prevention cluster randomized trialsContemp Clin Trials.20123386988010.1016/j.cct.2012.05.00422627076 48.PeduzziPConcatoJKemperEHolfordTRFeinsteinARA simulation study"/>
   <result pre="of climatic variables over the United Kingdom2004ExeterMet Office 61.PritchardGCForbesABWilliamsDJLSalimi-BejestaniMRDanielRGEmergence of" exact="fasciolosis" post="in cattle in East AngliaVet Rec.200515757858210.1136/vr.157.19.57816272544 62.InnocentGTGilbertLJonesEOMcLeodJEGunnGMcKendrickIJAlbonSDCombining slaughterhouse surveillance"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6863801/results/search/disease/results.xml">
   <result pre="of target sites/infections obtained in the www.clinicaltrials.gov website: Chronic otitis," exact="diarrhea" post="and gastrointestinal disorders, diabetic foot and venous leg ulcers,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6891569/results/search/disease/results.xml">
   <result pre="L. to treat malaria, while the roots are used for" exact="diarrhea" post="(decoction), rheumatism (rubdown on articulations), and pelvic pain (massage)"/>
   <result pre="cytotoxicity of the GSM and GSC extracts was explored against" exact="neuroblastoma" post="SH-SY5Y utilizing the ATP luminescence assay. The ATP serves"/>
   <result pre="traumatic brain injury (TBI) [16]. The cell viability of the" exact="neuroblastoma" post="SH-SY5Y cells against the GSM extracts may suggest promising"/>
   <result pre="the aggregation of Aβ1–42, cyclooxygenase-1 enzyme, and cell growth of" exact="neuroblastoma" post="SH-SY5Y cells. These biological activities may be ascribed to"/>
   <result pre="in the cytoprotective function in the gastrointestinal system. Moreover, the" exact="suppression" post="of COX-1 can result in side effects, including ulcers"/>
   <result pre="Alzheimer’s disease (AD) is the most common cause of neurodegenerative" exact="dementia" post="in elderly people, often associated witha progressive memory loss"/>
   <result pre="each concentration of each sample. 4.6. Cell Viability Assay The" exact="neuroblastoma" post="cells (SH-SY5Y) were purchased from the American Type Culture"/>
   <result pre="has demonstrated the first therapeutic potential of G. speciosa on" exact="neuroblastoma" post="cytotoxicity, cyclooxygenase-1 inhibition, and the control of Aβ aggregation."/>
   <result pre="odorataActa. Manil.2014624752 16.WuG.-J.ChenW.-F.HungH.-C.JeanY.-H.SungC.-S.ChakrabortyC.LeeH.-P.ChenN.-F.WenZ.-H.Effects of propofol on proliferation and anti-apoptosis of" exact="neuroblastoma" post="SH-SY5Y cell line: New insights into neuroprotectionBrain Res.20111384425010.1016/j.brainres.2011.02.00421315692 17.ChenC.-Y.TCM"/>
   <result pre="a defensive chemical in Catharanthus roseusJ. Chem. Ecol.1996221355136610.1007/BF0202771824226242 26.HanX.-L.LiJ.-D.YangC.LiZ.-Y.Sweroside eradicated" exact="leukemia" post="cells and attenuated pathogenic processes in mice by inducing"/>
   <result pre="MeOH (GSM) and CHCl3 (GSC) extracts on cell viability in" exact="neuroblastoma" post="SH-SY5Y cells. Cell viability was determined using the ATP"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6901230/results/search/disease/results.xml">
   <result pre="such as trichuriasis, ascariasis, hookworm disease, lymphatic filariasis, onchocerciasis, and" exact="dracunculiasis" post="[2,3] These human diseases affect billions of people [4]."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6915161/results/search/disease/results.xml">
   <result pre="anti-inflammation, anticancer, and skin diseases, etc. In recent times, the" exact="diabetes mellitus" post="(DM), a serious physiological disorder all over the world,"/>
   <result pre="communities possess marine life based rich traditional knowledge that also" exact="aids" post="in the sustainable development of the community as well"/>
   <result pre="al. exhibited dichloromethane fraction (DCM-F) of R. mucronata on noninsulin-dependent" exact="diabetes mellitus." post="100 mg/kg of DCM-F treatment in diabetes rats stimulates the"/>
   <result pre="in vitro cytotoxic effects in estrogen receptor-positive (MCF-7) and nonsmall" exact="lung cancer" post="(NCI-H-292) cells [72]. Triterpenoid has been reported to show"/>
   <result pre="vitro cytotoxic effects in estrogen receptor-positive (MCF-7) and nonsmall lung" exact="cancer" post="(NCI-H-292) cells [72]. Triterpenoid has been reported to show"/>
   <result pre="and steroid derivatives are being used for the management of" exact="diabetes mellitus" post="across the globe [27, 28]. Mangroves are woody plants"/>
   <result pre="major public health concerns all over the world. Diabetes or" exact="hyperglycemia" post="is considered to be one of the common public"/>
   <result pre="hazards; optimal control of which is still not possible. Persistent" exact="hyperglycemia" post="or uncontrolled diabetes has the potential to cause serious"/>
   <result pre="to cause serious complications such as kidney disease, vision loss," exact="cardiovascular disease," post="and lower-limb amputations which contributed towards morbidity and mortality"/>
   <result pre="for Conservation of Nature kg: kilogram MCF-7: Michigan Cancer Foundation-7" exact="breast cancer" post="cell line mg: milligram NCI-H-292: Nonsmall lung cancer NIDDM:"/>
   <result pre="Conservation of Nature kg: kilogram MCF-7: Michigan Cancer Foundation-7 breast" exact="cancer" post="cell line mg: milligram NCI-H-292: Nonsmall lung cancer NIDDM:"/>
   <result pre="Cancer Foundation-7 breast cancer cell line mg: milligram NCI-H-292: Nonsmall" exact="lung cancer" post="NIDDM: Noninsulin-dependent diabetes mellitus NIST: National Institute of Standards"/>
   <result pre="Foundation-7 breast cancer cell line mg: milligram NCI-H-292: Nonsmall lung" exact="cancer" post="NIDDM: Noninsulin-dependent diabetes mellitus NIST: National Institute of Standards"/>
   <result pre="cell line mg: milligram NCI-H-292: Nonsmall lung cancer NIDDM: Noninsulin-dependent" exact="diabetes mellitus" post="NIST: National Institute of Standards and Technology PTPase: Protein"/>
   <result pre="Fact Sheet No. 1342008Geneva, SwitzerlandWHOhttp://www.who.int/mediacentre/factsheets/2003/fs134/en/ 11MerriamS.MuhamadM.Roles traditional healers play in" exact="cancer" post="treatment in Malaysia: implications for health promotion and educationAsian"/>
   <result pre="49KimH.HanS.LeeC.LeeK.HongD.Compositions containing polysaccharides from Phellinus linteus and methods for treating" exact="diabetes mellitus" post="using same20046,809,084 B1, US Patent 50LoderJ. W.RussellG. B.Tumour inhibitory"/>
   <result pre="sexangulaMole. for: C15H14O6Mol. wt: 290.271Biological activity: antidiabetic, antioxidant, anti-inflammatory, antimutagenic," exact="cardiovascular disease" post="Kim et al. [49] Bisht et al. [57] Ganeshpurkar"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6928327/results/search/disease/results.xml">
   <result pre="pain pruritus, nausea, abdominal swelling and some severe manifestations as" exact="eosinophilia" post="(Oliveira et al., 2017). Recently, the multicenter clinical trial"/>
   <result pre="not lead to clinical improvements in patients with established Chagas’" exact="cardiomyopathy" post="when compared to the placebo group, even those with"/>
   <result pre="antifungal agent) Patients (human) Possibility of itraconazole to cure the" exact="heart disease" post="associated with T. cruzi, which may interrupt or delay"/>
   <result pre="compound derived from gold, generally prescribed for the treatment of" exact="rheumatoid arthritis," post="showed ability to increase the survival of mice infected"/>
   <result pre="(2019) Sterol 14α-Demethylase (Inhibitor VFV)Benznidazole (Antiprotozoal) Swiss Webster mice parasitemia" exact="suppression" post="and 100% animal survival Coadministration of Bz + VFV"/>
   <result pre="et al., 2018). In a murine model of chronic Chagas" exact="cardiomyopathy" post="the concomitant use of simvastatin, a lipid-lowering medication, and"/>
   <result pre="Phenothiazines and related tricyclics as lead structuresBiochem. J.286119929111355650 BocchiE.A.BestettiR.B.ScanavaccaM.I.Chronic Chagas" exact="heart disease" post="management: from etiology to cardiomyopathy treatmentJ. Am. Coll. Cardiol.20171510152428911515"/>
   <result pre="structuresBiochem. J.286119929111355650 BocchiE.A.BestettiR.B.ScanavaccaM.I.Chronic Chagas heart disease management: from etiology to" exact="cardiomyopathy" post="treatmentJ. Am. Coll. Cardiol.20171510152428911515 BoianiM.PiacenzaL.HernándezP.Mode of action of Nifurtimox"/>
   <result pre="Trypanosoma cruzi in murine modelExp. Parasitol.20174450 Vilar-PereiraG.CarneiroV.C.Mata-SantosH.Resveratrol reverses functional Chagas" exact="heart disease" post="in micePLoS Pathog.2016119 VillaltaF.DobishM.C.N deP.N.KleshchenkoVNI cures acute and chronic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6940947/results/search/disease/results.xml">
   <result pre="allium poly- and oligosaccharides. Lee et al. [46] reported the" exact="influenza" post="A virus inhibitory activity of the fructan from A."/>
   <result pre="in animal proteins are associated with the increased risk of" exact="cardiovascular disease" post="in humans. Several researchers have opined that garlic exhibited"/>
   <result pre="performance, carcass characteristics, and immune response of Coturnix japonica against" exact="avian influenza" post="and Newcastle disease vaccine virusComp. Clin. Pathol.2019281581158810.1007/s00580-019-02970-7 13.SugihartoS.Role of"/>
   <result pre="carcass characteristics, and immune response of Coturnix japonica against avian" exact="influenza" post="and Newcastle disease vaccine virusComp. Clin. Pathol.2019281581158810.1007/s00580-019-02970-7 13.SugihartoS.Role of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6959138/results/search/disease/results.xml">
   <result pre="domestic ruminants [25, 64, 80]. The prophylactic treatment of parasitic" exact="gastroenteritis" post="relies mainly on the use of anthelmintics. However, the"/>
   <result pre="to a complete absence of phospholipid from bile and to" exact="liver disease." post="Cell, 75(3), 451–462.8106172 78SmitJJ, SchinkelAH, MolCA, MajoorD, MooiWJ, JongsmaAP,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6959335/results/search/disease/results.xml">
   <result pre="medicine, is administered to patients to control the symptoms of" exact="irritable bowel syndrome" post="and acute renal colic, in clinical trials. PGL, as"/>
   <result pre="as a medicine to relieve pains and symptoms associated with" exact="irritable bowel syndrome," post="while it is also an anti-spasmodic agent acting on"/>
   <result pre="every other day, in mice, reduced the metastatic ability of" exact="breast cancer" post="cells26. Given the dose-dependent ability of PGL to exert"/>
   <result pre="other day, in mice, reduced the metastatic ability of breast" exact="cancer" post="cells26. Given the dose-dependent ability of PGL to exert"/>
   <result pre="reduction in the viability of HT-29 colon-cancer cells. In general," exact="cancer" post="cells, or immortalized cell lines, seem to differentially respond"/>
   <result pre="syndromeJ. Pak. Med. Assoc.2006565816454126 7.LucakSChangLHalpertAHarrisLACurrent and emergent pharmacologic treatments for" exact="irritable bowel syndrome" post="with diarrhea: evidence-based treatment in practiceTherap. Adv. Gastroenterol.20171025327510.1177/1756283X1666339628203283 8.AnjumNEfficacy"/>
   <result pre="in vivoDNA Repair (Amst)20152813113810.1016/j.dnarep.2015.02.01925766644 26.KimRKet al.Phloroglucinol suppresses metastatic ability of" exact="breast cancer" post="cells by inhibition of epithelial-mesenchymal cell transitionCancer Sci20151069410110.1111/cas.1256225456733 27.KwonYHet"/>
   <result pre="vivoDNA Repair (Amst)20152813113810.1016/j.dnarep.2015.02.01925766644 26.KimRKet al.Phloroglucinol suppresses metastatic ability of breast" exact="cancer" post="cells by inhibition of epithelial-mesenchymal cell transitionCancer Sci20151069410110.1111/cas.1256225456733 27.KwonYHet"/>
   <result pre="LLC-tumor-bearing micePLoS One20127e3361810.1371/journal.pone.003361822496756 28.KimRKet al.Novel anticancer activity of phloroglucinol against" exact="breast cancer" post="stem-like cellsToxicol Appl Pharmacol201528614315010.1016/j.taap.2015.03.02625843036 29.KangMHKimIHNamTJPhloroglucinol induces apoptosis through the"/>
   <result pre="micePLoS One20127e3361810.1371/journal.pone.003361822496756 28.KimRKet al.Novel anticancer activity of phloroglucinol against breast" exact="cancer" post="stem-like cellsToxicol Appl Pharmacol201528614315010.1016/j.taap.2015.03.02625843036 29.KangMHKimIHNamTJPhloroglucinol induces apoptosis through the"/>
   <result pre="of insulin-like growth factor 1 receptor signaling pathways in human" exact="colon cancer" post="HT-29 cellsInt J Oncol2014451036104210.3892/ijo.2014.252124970012 30.KangMHKimIHNamTJPhloroglucinol induces apoptosis via apoptotic"/>
   <result pre="insulin-like growth factor 1 receptor signaling pathways in human colon" exact="cancer" post="HT-29 cellsInt J Oncol2014451036104210.3892/ijo.2014.252124970012 30.KangMHKimIHNamTJPhloroglucinol induces apoptosis via apoptotic"/>
   <result pre="Oncol2014451036104210.3892/ijo.2014.252124970012 30.KangMHKimIHNamTJPhloroglucinol induces apoptosis via apoptotic signaling pathways in HT-29" exact="colon cancer" post="cellsOncol Rep2014321341134610.3892/or.2014.335525070748 31.AnanthakrishnanTNSenrayanRAnnaduraiRSMurugesanSAntibiotic effects of resorcinol, gallic acid and"/>
   <result pre="30.KangMHKimIHNamTJPhloroglucinol induces apoptosis via apoptotic signaling pathways in HT-29 colon" exact="cancer" post="cellsOncol Rep2014321341134610.3892/or.2014.335525070748 31.AnanthakrishnanTNSenrayanRAnnaduraiRSMurugesanSAntibiotic effects of resorcinol, gallic acid and"/>
   <result pre="and nucleic acids in polyacrylamide gelsEur J Biochem197446838810.1111/j.1432-1033.1974.tb03599.x4850204 56.KeramarisKMargaritisLZografouETsiropoulosGEgg laying" exact="suppression" post="in Drosophila melanogaster (Diptera: Drosophilidae) and Dacus (Bactrocera) oleae"/>
   <result pre="of EGTA, GTP gamma S and antifodrin antibodiesFEBS Lett199433912913310.1016/0014-5793(94)80399-48313961 74.NoubissiFKHarknessTAlexanderCMOgleBMApoptosis-induced" exact="cancer" post="cell fusion: a mechanism of breast cancer metastasisFASEB J2015294036404510.1096/fj.15-27109826085132"/>
   <result pre="antifodrin antibodiesFEBS Lett199433912913310.1016/0014-5793(94)80399-48313961 74.NoubissiFKHarknessTAlexanderCMOgleBMApoptosis-induced cancer cell fusion: a mechanism of" exact="breast cancer" post="metastasisFASEB J2015294036404510.1096/fj.15-27109826085132 75.NakanoTet al.Endoplasmic reticulum Ca2+ depletion induces endothelial"/>
   <result pre="antibodiesFEBS Lett199433912913310.1016/0014-5793(94)80399-48313961 74.NoubissiFKHarknessTAlexanderCMOgleBMApoptosis-induced cancer cell fusion: a mechanism of breast" exact="cancer" post="metastasisFASEB J2015294036404510.1096/fj.15-27109826085132 75.NakanoTet al.Endoplasmic reticulum Ca2+ depletion induces endothelial"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6959588/results/search/disease/results.xml">
   <result pre="inflammatory bowel diseases [8–10], type 2 diabetes [11], and atherosclerotic" exact="cardiovascular disease" post="[12]. Helminths and protozoa residing in the gut may"/>
   <result pre="faecal microbiota transplantation for the induction of remission for active" exact="ulcerative colitis." post="Aliment Pharmacol Ther. 2017;00: 1–12. 10.1111/apt.14173 9HeQ, GaoY, JieZ,"/>
   <result pre="ZhongS-L, FengQ, LiS, LiangS, et al.The gut microbiome in atherosclerotic" exact="cardiovascular disease." post="Nat Comm. 2017; 8: 845; 10.1038/s41467-017-00900-1 13LokeP, LimYAL. Helminths"/>
   <result pre="BayL, RiisPT, et al.The follicular skin microbiome in patients with" exact="hidradenitis suppurativa" post="and healthy controls. 2017JAMA Dermatol. 10.1001/jamadermatol.2017.090428538949 55LearR, O'LearyM, O'BrienAL,"/>
   <result pre="et al.Anopheles gambiae PGRPLC-mediated defence against bacteria modulates infections with" exact="malaria" post="parasites. PLoS Path. 2009;5: e100054210.1371/journal.ppat.100054219662170 65AzambujaP, GarciaES, RatcliffeNA. Gut"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6970270/results/search/disease/results.xml">
   <result pre="4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Abstract Purpose Breast" exact="cancer" post="is the most common malignancy among women across the"/>
   <result pre="to improve the prevailing treatment modalities, the overall prognosis of" exact="breast cancer" post="remains unsatisfactory. Recently, antiproliferative activity of Brevilin A (Brv-A),"/>
   <result pre="improve the prevailing treatment modalities, the overall prognosis of breast" exact="cancer" post="remains unsatisfactory. Recently, antiproliferative activity of Brevilin A (Brv-A),"/>
   <result pre="lactone compound of Centipeda minima, has been unveiled in various" exact="cancer" post="types. Here, we have explored anticancer activity of Brv-A"/>
   <result pre="be one of the potential anticancer therapeutics in future. Keywords" exact="breast cancer" post="Brevilin A apoptosis ROS ER stress STAT3 mitochondrial dysfunction"/>
   <result pre="one of the potential anticancer therapeutics in future. Keywords breast" exact="cancer" post="Brevilin A apoptosis ROS ER stress STAT3 mitochondrial dysfunction"/>
   <result pre="ER stress STAT3 mitochondrial dysfunction fig-count: ref-count: page-count: Introduction Currently," exact="cancer" post="research has been privileged over the last century due"/>
   <result pre="privileged over the last century due to multiple factors. All" exact="cancer" post="types including breast cancer have immersed the researcher’s attention"/>
   <result pre="last century due to multiple factors. All cancer types including" exact="breast cancer" post="have immersed the researcher’s attention to the devastating aspects"/>
   <result pre="century due to multiple factors. All cancer types including breast" exact="cancer" post="have immersed the researcher’s attention to the devastating aspects"/>
   <result pre="all female cancers and 18% of total deaths related to" exact="cancer" post="in both males and females.1,2 Incidence and prevalence rate"/>
   <result pre="in both males and females.1,2 Incidence and prevalence rate of" exact="breast cancer" post="is higher in North America, Northern and Western Europe,"/>
   <result pre="both males and females.1,2 Incidence and prevalence rate of breast" exact="cancer" post="is higher in North America, Northern and Western Europe,"/>
   <result pre="to Eastern Asia.3 In China, however, the incidence rate of" exact="breast cancer" post="has increased in last three decades by 20 to"/>
   <result pre="Eastern Asia.3 In China, however, the incidence rate of breast" exact="cancer" post="has increased in last three decades by 20 to"/>
   <result pre="decades by 20 to 30% and, according to Chinese urban" exact="cancer" post="registries, it amounts about 3–5% each year.4,5 This rise"/>
   <result pre="of a patient’s history, characteristics and pathology of the disease," exact="breast cancer" post="is managed by different strategies including surgery, radiation therapy,"/>
   <result pre="a patient’s history, characteristics and pathology of the disease, breast" exact="cancer" post="is managed by different strategies including surgery, radiation therapy,"/>
   <result pre="A lot of potential anticancer drugs are known for killing" exact="cancer" post="cells by enhancing ROS level.13,14 Traditional Chinese Medicines (TCM)"/>
   <result pre="anti-inflammatory and antiproliferative effects and exhibits anticancer activities in multiple" exact="cancer" post="types promoting oxidative stress, mitochondrial dysfunction and more specifically"/>
   <result pre="mechanism and mode of cell fatality is still unknown against" exact="breast cancer." post="The current study aimed to investigate cytotoxic and growth"/>
   <result pre="investigate cytotoxic and growth inhibitory effect of Brv-A in MCF-7" exact="breast cancer" post="cells along with underlying mechanism. In our study, ROS"/>
   <result pre="cytotoxic and growth inhibitory effect of Brv-A in MCF-7 breast" exact="cancer" post="cells along with underlying mechanism. In our study, ROS"/>
   <result pre="multi-pathway targeting property of Brv-A augments its role as potential" exact="breast cancer" post="therapeutics in future. Materials and Methods Chemicals and Reagents"/>
   <result pre="targeting property of Brv-A augments its role as potential breast" exact="cancer" post="therapeutics in future. Materials and Methods Chemicals and Reagents"/>
   <result pre="were obtained from Sigma-Aldrich. Cell Culture Human MCF-7 and MDA-MB-231" exact="breast cancer" post="cell lines were purchased from American Type Culture Collection"/>
   <result pre="obtained from Sigma-Aldrich. Cell Culture Human MCF-7 and MDA-MB-231 breast" exact="cancer" post="cell lines were purchased from American Type Culture Collection"/>
   <result pre="cytotoxic effect of Brv-A in MCF-7 as well as MDA-MB-231" exact="breast cancer" post="cell lines. Following CCK-8 assay, Brv-A was found effective"/>
   <result pre="effect of Brv-A in MCF-7 as well as MDA-MB-231 breast" exact="cancer" post="cell lines. Following CCK-8 assay, Brv-A was found effective"/>
   <result pre="was found effective against both triple positive and triple negative" exact="breast cancer" post="cells (Figure 1A and B). The calculated IC50 value"/>
   <result pre="found effective against both triple positive and triple negative breast" exact="cancer" post="cells (Figure 1A and B). The calculated IC50 value"/>
   <result pre="aimed to explore anticancer effect of Brv-A in triple positive" exact="breast cancer" post="type, we selected MCF-7 cell line as a model"/>
   <result pre="to explore anticancer effect of Brv-A in triple positive breast" exact="cancer" post="type, we selected MCF-7 cell line as a model"/>
   <result pre="Consistent with CCK-8 and live/dead assay results, data demonstrated remarkable" exact="suppression" post="in colony formation in MCF-7 cells. Furthermore, we quantified"/>
   <result pre="data demonstrate that Brv-A induces ROS-dependent mitochondrial apoptosis in MCF-7" exact="breast cancer" post="cells. In earlier studies, it has been verified that"/>
   <result pre="demonstrate that Brv-A induces ROS-dependent mitochondrial apoptosis in MCF-7 breast" exact="cancer" post="cells. In earlier studies, it has been verified that"/>
   <result pre="&amp;lt;0.05, ###p &amp;lt;0.001 vs 15 µM treated group. In various" exact="cancer" post="types, Janus kinase (JAK)-signal transducer and activator of transcription"/>
   <result pre="that Brv-A induced STAT3 inhibition is ROS-dependent and associated with" exact="suppression" post="of upstream tyrosine kinases. However, further study is needed"/>
   <result pre="time period. We measured the expression of well-known markers of" exact="cancer" post="invasion and metastasis including cyclooxygenase-2 (COX-2) and matrix metalloproteinase"/>
   <result pre="Collective data demonstrate that Brv-A has antimetastatic activity in MCF-7" exact="breast cancer" post="cell line. Figure 6 Effect of Brv-A on cell"/>
   <result pre="data demonstrate that Brv-A has antimetastatic activity in MCF-7 breast" exact="cancer" post="cell line. Figure 6 Effect of Brv-A on cell"/>
   <result pre="**p &amp;lt;0.01, ***p &amp;lt;0.001 vs untreated group (control). Discussion Currently," exact="breast cancer" post="has become a serious concern across the whole globe.32"/>
   <result pre="&amp;lt;0.01, ***p &amp;lt;0.001 vs untreated group (control). Discussion Currently, breast" exact="cancer" post="has become a serious concern across the whole globe.32"/>
   <result pre="radiotherapy, and hormonal manipulation are the possible approaches to eradicate" exact="cancer" post="which already has an improved five-year survival rate in"/>
   <result pre="cancer.33 Development of resistance against conventional therapies ultimately leads to" exact="cancer" post="metastasis and recurrence. Most of the primeval antitumor drugs"/>
   <result pre="of the primeval antitumor drugs have limited approach to kill" exact="cancer" post="cells, i.e. development of single drug for single target.34"/>
   <result pre="asthma.15,37 Recently, Brv-A has shown antiproliferative activity in various human" exact="cancer" post="types including CT26, A875, HeLa, HepG2 and A549 cell"/>
   <result pre="cell line.38 However, anticancer activity of Brv-A in triple positive" exact="breast cancer" post="cells has not been investigated so far. Cancer cells"/>
   <result pre="line.38 However, anticancer activity of Brv-A in triple positive breast" exact="cancer" post="cells has not been investigated so far. Cancer cells"/>
   <result pre="cell proliferation, cell survival, angiogenesis, and metastasis.39,40 This property of" exact="cancer" post="cells has been therapeutically exploited for profitable purpose. Recently,"/>
   <result pre="Recently, ROS based drug advancement has become major attribute for" exact="cancer" post="management irrespective of its heterogeneity and genotype.41–43 In this"/>
   <result pre="significantly inhibited viability of both triple positive and triple negative" exact="breast cancer" post="cell types, however, only triple positive MCF-7 cells were"/>
   <result pre="inhibited viability of both triple positive and triple negative breast" exact="cancer" post="cell types, however, only triple positive MCF-7 cells were"/>
   <result pre="study where a sesquiterpene lactone, deoxyelephantopin, inhibited proliferation of HepG2" exact="liver cancer" post="cells by promoting ROS generation.21 Further, we were interested"/>
   <result pre="where a sesquiterpene lactone, deoxyelephantopin, inhibited proliferation of HepG2 liver" exact="cancer" post="cells by promoting ROS generation.21 Further, we were interested"/>
   <result pre="are well-known compounds for inducing apoptotic cell death in various" exact="cancer" post="cell types.44 These compounds have also been confirmed to"/>
   <result pre="stimulus disrupts mitochondrial membrane potential by decreasing Bcl-2/BAX ratio in" exact="cancer" post="cells and releases cytochrome c from mitochondrial inter-membrane space"/>
   <result pre="where Brv-A has been shown to induce apoptosis in various" exact="cancer" post="cells.15,17 ROS generation has been documented to induce ER-stress"/>
   <result pre="documented to induce ER-stress mediated apoptosis in a variety of" exact="cancer" post="types.46 ER is chiefly involved in protein folding, post-translational"/>
   <result pre="the first time in response to Brv-A treatment in any" exact="cancer" post="type. In various cell types, NADPH oxidases are imperative"/>
   <result pre="previously published findings.17 It is previously reported that fate of" exact="cancer" post="cells in case of overproduction of ROS is dependent"/>
   <result pre="wound healing assay and evaluated its effect on biomarkers of" exact="cancer" post="invasion and metastasis, i.e. MMP-2 and COX-2. We found"/>
   <result pre="role of Brv-A in inhibition of constitutive STAT3 activation by" exact="suppression" post="of upstream tyrosine kinases. Brv-A has also been remarked"/>
   <result pre="research paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in" exact="breast cancer" post="cells: synergism with doxorubicin and correlation with physicochemical properties."/>
   <result pre="paper. Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast" exact="cancer" post="cells: synergism with doxorubicin and correlation with physicochemical properties."/>
   <result pre="arrest and apoptosis through activation of ROS/JNK pathway in human" exact="breast cancer" post="cells. Toxicol Lett. 2014;227(1):65–73. doi:10.1016/j.toxlet.2014.03.01524680927 3.FerlayJ, ShinHR, BrayF, FormanD,"/>
   <result pre="and apoptosis through activation of ROS/JNK pathway in human breast" exact="cancer" post="cells. Toxicol Lett. 2014;227(1):65–73. doi:10.1016/j.toxlet.2014.03.01524680927 3.FerlayJ, ShinHR, BrayF, FormanD,"/>
   <result pre="ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of" exact="cancer" post="in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269"/>
   <result pre="Int J Cancer. 2010;127(12):2893–2917. doi:10.1002/ijc.2551621351269 4.PorterP. &quot;Westernizing&quot; women’s risks? Breast" exact="cancer" post="in lower-income countries. N Engl J Med. 2008;358(3):213–216. doi:10.1056/NEJMp070830718199859"/>
   <result pre="Cancer. 2008;113(8 Suppl):2221–2243. doi:10.1002/cncr.2384418816619 6.LiT, Mello-ThomsC, BrennanPC. Descriptive epidemiology of" exact="breast cancer" post="in China: incidence, mortality, survival and prevalence. Breast Cancer"/>
   <result pre="2008;113(8 Suppl):2221–2243. doi:10.1002/cncr.2384418816619 6.LiT, Mello-ThomsC, BrennanPC. Descriptive epidemiology of breast" exact="cancer" post="in China: incidence, mortality, survival and prevalence. Breast Cancer"/>
   <result pre="melatonin: a novel approach in elevating efficacy of tamoxifen in" exact="breast cancer" post="treatment. Colloids Surf B Biointerfaces. 2016;145:64–71. doi:10.1016/j.colsurfb.2016.04.04227137804 8.SkoniecznaM, HejmoT,"/>
   <result pre="a novel approach in elevating efficacy of tamoxifen in breast" exact="cancer" post="treatment. Colloids Surf B Biointerfaces. 2016;145:64–71. doi:10.1016/j.colsurfb.2016.04.04227137804 8.SkoniecznaM, HejmoT,"/>
   <result pre="oxidases: insights into selected functions and mechanisms of action in" exact="cancer" post="and stem cells. Oxid Med Cell Longev. 2017;2017:9420539. doi:10.1155/2017/942053928626501"/>
   <result pre="ShenH, LinH, LiD. Anthelminthic drug niclosamide sensitizes the responsiveness of" exact="cervical cancer" post="cells to paclitaxel via oxidative stress-mediated mTOR inhibition. Biochem"/>
   <result pre="LinH, LiD. Anthelminthic drug niclosamide sensitizes the responsiveness of cervical" exact="cancer" post="cells to paclitaxel via oxidative stress-mediated mTOR inhibition. Biochem"/>
   <result pre="product, inhibits janus kinase activity and blocks STAT3 signaling in" exact="cancer" post="cells. PLoS ONE. 2013;8(5):e63697. doi:10.1371/journal.pone.006369723704931 17.WangJ, LiM, CuiX, et"/>
   <result pre="ChenS. Brevilin A induces cell cycle arrest and apoptosis in" exact="nasopharyngeal carcinoma." post="Front Pharmacol. 2019;10:594. doi:10.3389/fphar.2019.0059431178739 20.DiW, KhanD-M, RasulA, et al."/>
   <result pre="constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in" exact="osteosarcoma" post="U2OS cells through mitochondrial dysfunction. Oncol Rep. 2014;32. 21.MehmoodT,"/>
   <result pre="inhibits NF-кB and STAT3 activation and induces apoptosis in HepG2" exact="liver cancer" post="cells via oxidative stress. J Cancer. 2017;8(18):3707–3717. doi:10.7150/jca.20239 23.LaurindoFRM,"/>
   <result pre="NF-кB and STAT3 activation and induces apoptosis in HepG2 liver" exact="cancer" post="cells via oxidative stress. J Cancer. 2017;8(18):3707–3717. doi:10.7150/jca.20239 23.LaurindoFRM,"/>
   <result pre="induces apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in" exact="prostate cancer" post="cells. Int J Med Sci. 2018;15(8):832–839. doi:10.7150/ijms.2327030008594 31.JingwenZ, SeokAK,"/>
   <result pre="apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in prostate" exact="cancer" post="cells. Int J Med Sci. 2018;15(8):832–839. doi:10.7150/ijms.2327030008594 31.JingwenZ, SeokAK,"/>
   <result pre="model. Antioxid Redox Signal. 2016;24(11):575–589. doi:10.1089/ars.2015.641826649526 32.KariaP, PatelKV, RathodSSP. Breast" exact="cancer" post="amelioration by Butea monosperma in-vitro and in-vivo. J Ethnopharmacol."/>
   <result pre="ATO-induced apoptosis in MCF-7 cells: proposing novel therapeutic potential for" exact="breast cancer." post="Biomed Pharmacother. 2016;83:456–465. doi:10.1016/j.biopha.2016.07.00427427852 34.JiHF, LiXJ, ZhangHY. Natural products"/>
   <result pre="to new and powerful drug combinations in the fight against" exact="cancer" post="and dementia?EMBO Rep. 2009;10(3):194–200. doi:10.1038/embor.2009.1219229284 35.GarrawayLA, JännePA. Circumventing cancer"/>
   <result pre="against cancer and dementia?EMBO Rep. 2009;10(3):194–200. doi:10.1038/embor.2009.1219229284 35.GarrawayLA, JännePA. Circumventing" exact="cancer" post="drug resistance in the era of personalized medicine. Cancer"/>
   <result pre="2012;2(3):214. doi:10.1158/2159-8290.CD-12-001222585993 36.SinghAK, AryaRK, MaheshwariS, et al. Tumor heterogeneity and" exact="cancer" post="stem cell paradigm: updates in concept, controversies and clinical"/>
   <result pre="induces apoptosis through a mitochondrial/caspase and NF-kappaB pathway in human" exact="leukemia" post="HL60 cells. Biomed Pharmacother. 2008;62(6):401–409. doi:10.1016/j.biopha.2007.10.01018077129 39.KhanM, MaryamA, QaziJI,"/>
   <result pre="Targeting apoptosis and multiple signaling pathways with Icariside II in" exact="cancer" post="cells. Int J Biol Sci. 2015;11(9):1100–1112. doi:10.7150/ijbs.1159526221076 40.KhanM, MaryamA,"/>
   <result pre="Biol Sci. 2015;11(9):1100–1112. doi:10.7150/ijbs.1159526221076 40.KhanM, MaryamA, ZhangH, MehmoodT, MaT. Killing" exact="cancer" post="with platycodin D through multiple mechanisms. J Cell Mol"/>
   <result pre="2016;20(3):389–402. doi:10.1111/jcmm.2016.20.issue-326648178 41.AsbyDJ, RadigoisMG, WilsonDC, et al. Triggering apoptosis in" exact="cancer" post="cells with an analogue of cribrostatin 6 that elevates"/>
   <result pre="overload by alantolactone prompts oxidative DNA damage and apoptosis in" exact="colorectal cancer" post="cells. Int J Mol Sci. 2016;17(4):558. doi:10.3390/ijms1704055827089328 45.JiYB, QuZY,"/>
   <result pre="by alantolactone prompts oxidative DNA damage and apoptosis in colorectal" exact="cancer" post="cells. Int J Mol Sci. 2016;17(4):558. doi:10.3390/ijms1704055827089328 45.JiYB, QuZY,"/>
   <result pre="2016;17(4):558. doi:10.3390/ijms1704055827089328 45.JiYB, QuZY, ZouX. Juglone-induced apoptosis in human gastric" exact="cancer" post="SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol."/>
   <result pre="IkappaBalpha and the nuclear translocation of STAT3-NFkappaB complexes in starved" exact="cancer" post="cells. Exp Mol Med. 2016;48:e231. doi:10.1038/emm.2016.1727151455 50.GarciaR, BowmanTL, NiuG,"/>
   <result pre="et al. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231" exact="breast cancer" post="cell invasion and metastasis in vitro and in vivo."/>
   <result pre="al. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast" exact="cancer" post="cell invasion and metastasis in vitro and in vivo."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6983189/results/search/disease/results.xml">
   <result pre="of isoflavones isolated from M. ferruginea were evaluated in human" exact="ovarian cancer" post="cells. We found that isoflavone ferrugone and 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl)isoflavone (DMI)"/>
   <result pre="isoflavones isolated from M. ferruginea were evaluated in human ovarian" exact="cancer" post="cells. We found that isoflavone ferrugone and 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl)isoflavone (DMI)"/>
   <result pre="ferrugone and 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl)isoflavone (DMI) had potent cytotoxic effects on human" exact="ovarian cancer" post="cell A2780 and SKOV3. Ferrugone and DMI treatment increased"/>
   <result pre="and 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl)isoflavone (DMI) had potent cytotoxic effects on human ovarian" exact="cancer" post="cell A2780 and SKOV3. Ferrugone and DMI treatment increased"/>
   <result pre="ROS production, while ferrugone stimulated the extrinsic pathway in human" exact="ovarian cancer" post="cells. Millettia ferruginea 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl) isoflavone ferrugone apoptosis caspase ovarian"/>
   <result pre="production, while ferrugone stimulated the extrinsic pathway in human ovarian" exact="cancer" post="cells. Millettia ferruginea 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl) isoflavone ferrugone apoptosis caspase ovarian"/>
   <result pre="ovarian cancer cells. Millettia ferruginea 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl) isoflavone ferrugone apoptosis caspase" exact="ovarian cancer" post="1. Introduction Ovarian cancer is the most lethal gynecological"/>
   <result pre="cancer cells. Millettia ferruginea 6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl) isoflavone ferrugone apoptosis caspase ovarian" exact="cancer" post="1. Introduction Ovarian cancer is the most lethal gynecological"/>
   <result pre="6,7-dimethoxy-3’,4’-methylenedioxy-8-(3,3-dimethylallyl) isoflavone ferrugone apoptosis caspase ovarian cancer 1. Introduction Ovarian" exact="cancer" post="is the most lethal gynecological disease in the world."/>
   <result pre="are diagnosed and about 140,200 women die each year from" exact="ovarian cancer" post="[1]. Due to the non-specific symptoms, a majority of"/>
   <result pre="diagnosed and about 140,200 women die each year from ovarian" exact="cancer" post="[1]. Due to the non-specific symptoms, a majority of"/>
   <result pre="with poor prognosis [2]. The five-year survival rate of advanced" exact="ovarian cancer" post="is only about 25%. Platinum-taxane chemotherapy following cytoreductive surgery"/>
   <result pre="poor prognosis [2]. The five-year survival rate of advanced ovarian" exact="cancer" post="is only about 25%. Platinum-taxane chemotherapy following cytoreductive surgery"/>
   <result pre="Platinum-taxane chemotherapy following cytoreductive surgery is the standard treatment for" exact="ovarian cancer." post="Although primary therapy may be of therapeutic benefit in"/>
   <result pre="therapy may be of therapeutic benefit in about 80% of" exact="ovarian cancer" post="patients, around 70% of the patients eventually relapse [3]."/>
   <result pre="may be of therapeutic benefit in about 80% of ovarian" exact="cancer" post="patients, around 70% of the patients eventually relapse [3]."/>
   <result pre="urgent to seek for new agents for the treatment of" exact="ovarian cancer." post="Natural products from plants have drawn great attention in"/>
   <result pre="the induction of apoptosis, which is usually abnormal in the" exact="cancer" post="cells [4]. More than 200 species of the Millettia"/>
   <result pre="[7]. M. thonningii is known to treat dysentery, constipation, and" exact="diarrhea" post="while M. carulea has anti-inflammatory effects [8,9]. M. macrophylla"/>
   <result pre="we investigated the anti-cancer effects of the isoflavones using human" exact="ovarian cancer" post="cells. 2. Results 2.1. Ferrugone and DMI Isolated from"/>
   <result pre="investigated the anti-cancer effects of the isoflavones using human ovarian" exact="cancer" post="cells. 2. Results 2.1. Ferrugone and DMI Isolated from"/>
   <result pre="ferrugone, prebarbigerone, and DMI on the viability of two human" exact="ovarian cancer" post="cells A2780 and SKOV3. Ferrugone and DMI had potent"/>
   <result pre="prebarbigerone, and DMI on the viability of two human ovarian" exact="cancer" post="cells A2780 and SKOV3. Ferrugone and DMI had potent"/>
   <result pre="with ferrugone or DMI increased sub G1 phase in the" exact="ovarian cancer" post="cells. After treatment with 0, 0.25, 0.5, and 1"/>
   <result pre="ferrugone or DMI increased sub G1 phase in the ovarian" exact="cancer" post="cells. After treatment with 0, 0.25, 0.5, and 1"/>
   <result pre="ferrugone and DMI dose-dependently induced apoptotic cell death in human" exact="ovarian cancer" post="cells. 2.3. Ferrugone and DMI Induced Caspase-Dependent Apoptotic Cell"/>
   <result pre="and DMI dose-dependently induced apoptotic cell death in human ovarian" exact="cancer" post="cells. 2.3. Ferrugone and DMI Induced Caspase-Dependent Apoptotic Cell"/>
   <result pre="both ferrugone and DMI induced caspase-dependent apoptosis in the human" exact="ovarian cancer" post="cells (Figure 3A,B). To confirm which caspase was associated"/>
   <result pre="ferrugone and DMI induced caspase-dependent apoptosis in the human ovarian" exact="cancer" post="cells (Figure 3A,B). To confirm which caspase was associated"/>
   <result pre="via the caspase-8 and caspase-9 activation, respectively, in the human" exact="ovarian cancer" post="cells. 2.4. Apoptosis-Inducing Effect of DMI Is Associated with"/>
   <result pre="the caspase-8 and caspase-9 activation, respectively, in the human ovarian" exact="cancer" post="cells. 2.4. Apoptosis-Inducing Effect of DMI Is Associated with"/>
   <result pre="oxygen species (ROS) are known to stimulate apoptosis in various" exact="cancer" post="cells [9]. Here, we investigated the involvement of ROS"/>
   <result pre="of ROS in ferrugone or DMI-induced cell death in human" exact="ovarian cancer." post="DCF-DA (2’,7’–dichlorofluorescin diacetate) staining assay showed that ferrugone did"/>
   <result pre="but not ferrugone, induced apoptosis by ROS regulation in the" exact="ovarian cancer" post="cells. 3. Discussion The genus Millettia appears in the"/>
   <result pre="not ferrugone, induced apoptosis by ROS regulation in the ovarian" exact="cancer" post="cells. 3. Discussion The genus Millettia appears in the"/>
   <result pre="[19]. In addition, isoflavones extracted from M. taiwaniana have shown" exact="cancer" post="chemopreventive activities [20]. Durmillone isolated from M. pachyloba Drake"/>
   <result pre="isolated from M. ferruginea, induced apoptotic cell death in human" exact="ovarian cancer" post="cells. In this study, to investigate the effects of"/>
   <result pre="from M. ferruginea, induced apoptotic cell death in human ovarian" exact="cancer" post="cells. In this study, to investigate the effects of"/>
   <result pre="investigate the effects of isoflavones on the viability of human" exact="ovarian cancer" post="cells, we have used two most commonly used human"/>
   <result pre="the effects of isoflavones on the viability of human ovarian" exact="cancer" post="cells, we have used two most commonly used human"/>
   <result pre="we have used two most commonly used human ovarian epithelial" exact="cancer" post="cell lines A2780 and SKOV3 cells. Both DMI and"/>
   <result pre="demonstrated whether p53 mediate DMI- and ferrugone-induced apoptosis in human" exact="ovarian cancer" post="cells. Apoptosis is a natural mechanism of programmed cell"/>
   <result pre="whether p53 mediate DMI- and ferrugone-induced apoptosis in human ovarian" exact="cancer" post="cells. Apoptosis is a natural mechanism of programmed cell"/>
   <result pre="which may not only promote tumorigenesis but also render the" exact="cancer" post="cells resistant to treatment [23,24]. Thus, apoptosis is a"/>
   <result pre="to treatment [23,24]. Thus, apoptosis is a promising target for" exact="cancer" post="therapy. The protease enzymes caspases (cysteinyl aspartate-specific protease) play"/>
   <result pre="activation of an effector caspase-3 and caspases-dependent apoptosis in human" exact="ovarian cancer" post="cells. Notably, ferrugone induced the activation of caspase-8, but"/>
   <result pre="of an effector caspase-3 and caspases-dependent apoptosis in human ovarian" exact="cancer" post="cells. Notably, ferrugone induced the activation of caspase-8, but"/>
   <result pre="involved in multiple diseases, including atherosclerosis, neurodegeneration, diabetes, aging, and" exact="cancer" post="[29]. In cancer therapy, treatment with drugs that induce"/>
   <result pre="diseases, including atherosclerosis, neurodegeneration, diabetes, aging, and cancer [29]. In" exact="cancer" post="therapy, treatment with drugs that induce ROS generation has"/>
   <result pre="has been suggested as an effective strategy to selectively push" exact="cancer" post="cells over the ROS threshold and into cell death"/>
   <result pre="levels of ROS to induce apoptosis and cell death in" exact="cancer" post="cells [34,35]. That is consistent with our finding showing"/>
   <result pre="the isoflavone DMI induced ROS production and apoptosis in human" exact="ovarian cancer" post="cells. In addition, increased levels of ROS have been"/>
   <result pre="isoflavone DMI induced ROS production and apoptosis in human ovarian" exact="cancer" post="cells. In addition, increased levels of ROS have been"/>
   <result pre="ROS have been reported to stimulate apoptotic cell death in" exact="cancer" post="cells by regulating the stress kinase pathways, including PI3K/Akt"/>
   <result pre="isoflavone, ferrugone, was not associated with ROS production in human" exact="ovarian cancer" post="cells. Further research is required to illuminate the upstream"/>
   <result pre="ferrugone, was not associated with ROS production in human ovarian" exact="cancer" post="cells. Further research is required to illuminate the upstream"/>
   <result pre="and DMI, induced apoptosis through a different pathway in human" exact="ovarian cancer" post="cells. The structural differences between two isoflavones are that"/>
   <result pre="DMI, induced apoptosis through a different pathway in human ovarian" exact="cancer" post="cells. The structural differences between two isoflavones are that"/>
   <result pre="Jackson Laboratory (West Grove, PA, USA). 4.3. Cell Culture Ovarian" exact="cancer" post="cells (A2780 and SKOV3) were cultured in RPMI 1640"/>
   <result pre="Assay Cell viability was examined using the MTT assay. Human" exact="ovarian cancer" post="cells (A2780 and SKOV3) were seeded in a 96-well"/>
   <result pre="Cell viability was examined using the MTT assay. Human ovarian" exact="cancer" post="cells (A2780 and SKOV3) were seeded in a 96-well"/>
   <result pre="ROS production, while ferrugone stimulated the extrinsic pathway in human" exact="ovarian cancer" post="cells. This is the first study to demonstrate the"/>
   <result pre="production, while ferrugone stimulated the extrinsic pathway in human ovarian" exact="cancer" post="cells. This is the first study to demonstrate the"/>
   <result pre="The authors declare no conflict of interest. References References 1.JemalA.BrayF.CenterM.M.FerlayJ.WardE.FormanD.Global" exact="cancer" post="statisticsCa. Cancer J. Clin.201161699010.3322/caac.2010721296855 2.DoubeniC.A.DoubeniA.R.MyersA.E.Diagnosis and Management of Ovarian"/>
   <result pre="Clin.201161699010.3322/caac.2010721296855 2.DoubeniC.A.DoubeniA.R.MyersA.E.Diagnosis and Management of Ovarian CancerAm. Fam. Physician20169393794427281838 3.ChristianJ.ThomasH.Ovarian" exact="cancer" post="chemotherapyCancer Treat. Rev.2001279910910.1053/ctrv.2001.021911319848 4.RavishankarD.RajoraA.K.GrecoF.OsbornH.M.Flavonoids as prospective compounds for anti-cancer"/>
   <result pre="millettia taiwaniana: Structure elucidation of five new isoflavonoids and their" exact="cancer" post="chemopreventive activityJ. Nat. Prod.2004671125113010.1021/np030554q15270565 21.YanW.YangJ.TangH.XueL.ChenK.WangL.ZhaoM.TangM.PengA.LongC.et al.Flavonoids from the stems"/>
   <result pre="pachyloba drake mediate cytotoxic activity through apoptosis and autophagy in" exact="cancer" post="cellsJ. Adv. Res.20192011712710.1016/j.jare.2019.06.00231338224 22.DanialN.N.KorsmeyerS.J.Cell death: Critical control pointsCell200411620521910.1016/S0092-8674(04)00046-714744432 23.HanahanD.WeinbergR.A.The"/>
   <result pre="to treatmentJ. Exp. Clin. Cancer Res.2011308710.1186/1756-9966-30-8721943236 28.GhobrialI.M.WitzigT.E.AdjeiA.A.Targeting apoptosis pathways in" exact="cancer" post="therapyCa. Cancer J. Clin.20055517819410.3322/canjclin.55.3.17815890640 29.MillerW.H.Jr.SchipperH.M.LeeJ.S.SingerJ.WaxmanS.Mechanisms of action of arsenic"/>
   <result pre="from the edible brown algae ecklonia cava, induces apoptosis of" exact="ovarian cancer" post="cells and inhibits tumor xenograft growthJ. Cancer Res. Clin."/>
   <result pre="the edible brown algae ecklonia cava, induces apoptosis of ovarian" exact="cancer" post="cells and inhibits tumor xenograft growthJ. Cancer Res. Clin."/>
   <result pre="of ferrugone and DMI on cell cycle distribution in human" exact="ovarian cancer" post="cells. A2780 cells were treated with ferrugone (A) or"/>
   <result pre="ferrugone and DMI on cell cycle distribution in human ovarian" exact="cancer" post="cells. A2780 cells were treated with ferrugone (A) or"/>
   <result pre="of ferrugone and DMI on apoptotic cell death in human" exact="ovarian cancer" post="cells. A2780 cells were treated with ferrugone (A) and"/>
   <result pre="ferrugone and DMI on apoptotic cell death in human ovarian" exact="cancer" post="cells. A2780 cells were treated with ferrugone (A) and"/>
   <result pre="of caspases in ferrugone and DMI-induced cell death in human" exact="ovarian cancer" post="cells. A2780 cells were pretreated with broad caspase inhibitor"/>
   <result pre="caspases in ferrugone and DMI-induced cell death in human ovarian" exact="cancer" post="cells. A2780 cells were pretreated with broad caspase inhibitor"/>
   <result pre="and -9 in ferrugone and DMI-induced cell death in human" exact="ovarian cancer" post="cells. (A,B) A2780 cells were pretreated with caspase-3 inhibitor"/>
   <result pre="-9 in ferrugone and DMI-induced cell death in human ovarian" exact="cancer" post="cells. (A,B) A2780 cells were pretreated with caspase-3 inhibitor"/>
   <result pre="ROS (reactive oxygen species) in DMI-induced cell death in human" exact="ovarian cancer" post="cells. (A) A2780 cells were treated with 0.5 µM"/>
   <result pre="(reactive oxygen species) in DMI-induced cell death in human ovarian" exact="cancer" post="cells. (A) A2780 cells were treated with 0.5 µM"/>
   <result pre="of isoflavones isolated from Millettia ferruginea spp. ferruginea in human" exact="ovarian cancer" post="cells. Compound No Name IC50a A2780 SKOV3 1 6,7-dimethoxy-3′,4′-methylenedioxy-8-(3,3-dimethylallyl)isoflavone"/>
   <result pre="isoflavones isolated from Millettia ferruginea spp. ferruginea in human ovarian" exact="cancer" post="cells. Compound No Name IC50a A2780 SKOV3 1 6,7-dimethoxy-3′,4′-methylenedioxy-8-(3,3-dimethylallyl)isoflavone"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6993401/results/search/disease/results.xml">
   <result pre="sickness, abortion 2 3 0.5 Musculoskeletal system such as sprain," exact="arthritis" post="2 5 0.75 Neurology diseases such as epilepsy, acute"/>
   <result pre="anti-inflammatory, and analgesic [42] Cold Yes Coix lacryma-jobi L. Inhibit" exact="obesity" post="and reduce blood lipids [43] High blood pressure Partial"/>
   <result pre="Salisb. Antioxident, relieving pain and anti-inflammation, contributing flavor, and preventing" exact="cancer" post="[45] Heat stroke, irregular menstruation, and alcoholism Partial Datura"/>
   <result pre="ex C. B. Clarke Anxiety, depression, nerve pain, epilepsy, and" exact="migraine" post="[53] Diarrhea No Equisetum ramosissimum Desf. high blood pressure"/>
   <result pre="Isodon lophanthoides (Buch.-Ham. ex D.Don) H.Hara Enteritis, jaundice, hepatitis, laryngopharyngitis," exact="lepromatous leprosy," post="and ascariasis [38] Intestinal worms Yes Leycesteria formosa Wall."/>
   <result pre="ex D.Don) H.Hara Enteritis, jaundice, hepatitis, laryngopharyngitis, lepromatous leprosy, and" exact="ascariasis" post="[38] Intestinal worms Yes Leycesteria formosa Wall. Traumatic bleeding"/>
   <result pre="is involved in many diseases such as asthma, sinusitis, and" exact="rheumatoid arthritis" post="[59] Allergies Yes Nicotiana tabacum L. Antitumor, detoxification and"/>
   <result pre="involved in many diseases such as asthma, sinusitis, and rheumatoid" exact="arthritis" post="[59] Allergies Yes Nicotiana tabacum L. Antitumor, detoxification and"/>
   <result pre="bite Partial Swertia angustifolia Buch.-Ham. ex D. Don Febrifuge and" exact="epilepsy" post="[71] Anti-malaria Yes Swertia nervosa (Wall. ex G. Don)"/>
   <result pre="rhynchophylla (Miq.) Miq. ex Havil. Treatment of hypertension, headache, and" exact="stroke" post="[75] High blood pressure Yes Uncaria scandens (Sm.) Hutch."/>
   <result pre="Epilepsy Yes Viburnum cylindricum Buch.-Ham. ex D. Don Cough, diarrhea," exact="rheumatoid arthritis," post="and tumefaction [77] Anti-inflammatory, scar and repelling flea Partial"/>
   <result pre="sp. Nu-ru Vine Roots and stems Medicine used for treating" exact="allergy" post="18CS16899 Araceae Alocasia longiloba Miq. Bo-zong-gang-gyi-pa Herb Roots Sliced"/>
   <result pre="Brassaiopsis hainla (Buch.-Ham.) Seem. Bhong-dong-shing Tree Barks Boiled for treating" exact="arthritis" post="0.05 0.05 18CS16883 Araliaceae Hydrocotyle javanica Thunb. Sa-la-meng-ba-ren Herb"/>
   <result pre="Don Pau-sein-po Herb Leaves and roots Medicine used for treating" exact="malaria" post="WangYH0023 Gentianaceae Swertia nervosa (Wall. ex G. Don) C."/>
   <result pre="roots Leaves are boiled in the water used for treating" exact="diarrhea" post="18CS16841 Gnetaceae Gnetum pendulum C. Y. Cheng Gyong-ga-sa Vine"/>
   <result pre="scandens (Sm.) Hutch. Tsae-tsu Liana Leaves Boiled liquid for treating" exact="epilepsy" post="18CS16905 Rubiaceae Wendlandia tinctoria (Roxb.) DC. Mehi-neng-nang-shi Tree or"/>
   <result pre="Shrub Seeds Seed oil with butter is used for treating" exact="epilepsy" post="18CS16961 Rutaceae Zanthoxylum motuoense C. C. Huang Gei Tree"/>
   <result pre="tabacum L. Da-mu-ga Herb Leaves Crushed leaves used for treating" exact="sinusitis" post="18CS16906 Solanaceae Solanum americanum Mill. Gu-ju-shu Herb Burgeons Food"/>
   <result pre="and the leaves of Luffa cylindrica are used for treating" exact="psoriasis" post="18CS16866 Solanaceae Solanum torvum Sw. Kha-lang-gyi Shrub Fruits Food"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6996254/results/search/disease/results.xml">
   <result pre="drug resistanceInt. J. Parasitol4829710510.1016/j.ijpara.2017.08.00929050919 BonelliF.BusechianS.MeuciV.CaporrinoG.BrigantiA.RuecaF.ZapullaF.FeriniE.GhiandaiL.SgorbiniM.2016pHyloGASTRO in the treatment of equine" exact="gastric ulcer" post="lesionsJ. Equine Vet. Sci46697210.1016/j.jevs.2016.06.069 BurkeJ.M.WellsA.CaseyP.KaplanR.M.2009aHerbal dewormer fails to control"/>
   <result pre="and Arsi zones of Oromia region, EthiopiaBMC Vet. Res917910.1186/1746-6148-9-17924025403 SgorbiniM.BonelliF.PapiniR.BusechianS.BrigantiA.LausF.FaillaceV.ZapullaF.RizkA.RuecaF.2017Equine" exact="gastric ulcer" post="syndrome in adult donkeys: investigation on prevalence, anatomical distribution"/>
   <result pre="prevalence, anatomical distribution and severityEquine Vet. Educ30420621010.1111/eve.12747 SgorbiniM.VeronesiF.FratiniM.LausF.2018Tick-borne diseases and" exact="gastric ulcer" post="in the donkeyJ. Equine Vet. Sci65626510.1016/j.jevs.2017.12.014 TariqK.A.ChishtiM.Z.AhmadF.ShawlA.S.2009Anthelmintic activity of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC6997872/results/search/disease/results.xml">
   <result pre="of antibacterial, antioxidant and cytotoxicity effect of Indigofera tinctoria on" exact="lung cancer" post="cell lineInt. J. Pharmacol.72011356362 RodriguesA.B.AthaydeA.C.RodriguesO.G.SilvaW.W.FariaE.B.Evaluation of the efficacy of"/>
   <result pre="antibacterial, antioxidant and cytotoxicity effect of Indigofera tinctoria on lung" exact="cancer" post="cell lineInt. J. Pharmacol.72011356362 RodriguesA.B.AthaydeA.C.RodriguesO.G.SilvaW.W.FariaE.B.Evaluation of the efficacy of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7000416/results/search/disease/results.xml">
   <result pre="which does not comply with these terms. Abstract Background: Cystic" exact="echinococcosis" post="(CE) is a global zoonotic parasitic disease caused by"/>
   <result pre="terms. Abstract Background: Cystic echinococcosis (CE) is a global zoonotic" exact="parasitic disease" post="caused by the larval stage of Echinococcus granulosus and"/>
   <result pre="government support and affiliation with the veterinary sector is essential." exact="cystic echinococcosis" post="Echinococcus granulosus livestock dog public health Pakistan fig-count: table-count:"/>
   <result pre="support and affiliation with the veterinary sector is essential. cystic" exact="echinococcosis" post="Echinococcus granulosus livestock dog public health Pakistan fig-count: table-count:"/>
   <result pre="(NZD) prioritized by the World Health Organization (WHO) (1). Cystic" exact="echinococcosis" post="(CE) is a globally NZD caused by the dog"/>
   <result pre="dogs are not treated with any antiparasitic drug. Discussion Cystic" exact="echinococcosis" post="(CE) is a chronic larval cestode infection caused by"/>
   <result pre="95:213–314. 10.1016/bs.apar.2016.11.00228131364 5.HarandiMFMoazeziSSSabaMGrimmFKamyabiHSheikhzadehFet al.. Sonographical and serological survey of human" exact="cystic echinococcosis" post="and analysis of risk factors associated with seroconversion in"/>
   <result pre="10.1016/bs.apar.2016.11.00228131364 5.HarandiMFMoazeziSSSabaMGrimmFKamyabiHSheikhzadehFet al.. Sonographical and serological survey of human cystic" exact="echinococcosis" post="and analysis of risk factors associated with seroconversion in"/>
   <result pre="Trop Dis. (2016) 10:e0005114. 10.1371/journal.pntd.000511427820824 7.MoshfeASarkariBArefkhahNNikbakhtRShahriariradRRezaeZet al.. Seroepidemiological study of" exact="cystic echinococcosis" post="in nomadic communities in the southwest of Iran: a"/>
   <result pre="Dis. (2016) 10:e0005114. 10.1371/journal.pntd.000511427820824 7.MoshfeASarkariBArefkhahNNikbakhtRShahriariradRRezaeZet al.. Seroepidemiological study of cystic" exact="echinococcosis" post="in nomadic communities in the southwest of Iran: a"/>
   <result pre="the missing opportunities for one health education: the case of" exact="cystic echinococcosis" post="among surgically operated patients in Basrah, Southern Iraq. MDPI."/>
   <result pre="missing opportunities for one health education: the case of cystic" exact="echinococcosis" post="among surgically operated patients in Basrah, Southern Iraq. MDPI."/>
   <result pre="37.AhmedHAliSAfzalMSKhanAARazaHShahZHet al.. Why more research needs to be done on" exact="echinococcosis" post="in Pakistan. Infect Dis Poverty. (2017) 6:90. 10.1186/s40249-017-0309-z28669350 38.collab:"/>
   <result pre="World Health Organization (2010). 39.CraigPSMcManusDPLightowlersMWChabalgoityJAGarciaHHGavidiaCMet al.. Prevention and control of" exact="cystic echinococcosis." post="Lancet Infect Dis. (2007) 7:385–94. 10.1016/S1473-3099(07)70134-217521591 40.GemmellMARobertsMGBeardTCCampano DiazSLawsonJRNonnemakerJMChapter 6:"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7024229/results/search/disease/results.xml">
   <result pre="small ruminants. Infected animals may show reduced growth, cachexia, weakness," exact="anemia" post="and diarrhea, that may lead to poor reproductive and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7027246/results/search/disease/results.xml">
   <result pre="(GNPs) have been used for many applications including drug delivery," exact="cancer" post="diagnostics and therapy, medical imaging and non-optical biosensors [9–18]."/>
   <result pre="Chinese medicine for treating a wide variety of diseases from" exact="rhinitis" post="to fever for centuries [20]. Numerous studies have revealed"/>
   <result pre="chemical properties, their wide applications range from drug delivery to" exact="cancer" post="therapy [46–48]. In the present study, gold nanoprobes were"/>
   <result pre="gold nanoparticles modified with thiol compounds: bioconjugation and application in" exact="cancer" post="cell imagingLangmuir2012284464447110.1021/la204289k22276658 20.ZhaoFWangLLiuKIn vitro anti-inflammatory effects of arctigenin, a"/>
   <result pre="antitumor agent having the ability to eliminate the tolerance of" exact="cancer" post="cells to nutrient starvationCancer Res2006661751175710.1158/0008-5472.CAN-05-314316452235 23.ZhaoZYinYWangZFangRWuHJiangMBaiGLuoGAArctigenin exhibits relaxation effect"/>
   <result pre="structures to multi-functionalityJ Mater Chem B20197348010.1039/C9TB00557A 46.VinesJBYvonJHRyuNELimDJParkHGold nanoparticles for photothermal" exact="cancer" post="therapyFront Chem2019716710.3389/fchem.2019.0016731024882 47.PengJLiangXProgress in research on gold nanoparticles in"/>
   <result pre="cancer therapyFront Chem2019716710.3389/fchem.2019.0016731024882 47.PengJLiangXProgress in research on gold nanoparticles in" exact="cancer" post="managementMedicine201998e1531110.1097/MD.000000000001531131045767 48.BeikJKhateriMKhosraviZKamravaSKKooranifarSGhaznaviHShakeri-ZadehAGold nanoparticles in combinatorial cancer therapy strategiesCoord Chem"/>
   <result pre="on gold nanoparticles in cancer managementMedicine201998e1531110.1097/MD.000000000001531131045767 48.BeikJKhateriMKhosraviZKamravaSKKooranifarSGhaznaviHShakeri-ZadehAGold nanoparticles in combinatorial" exact="cancer" post="therapy strategiesCoord Chem Rev2019387299324 49.BöttcherTPitscheiderMSieberSANatural products and their biological"/>
   <result pre="labelingAdv Healthc Mater201653118312810.1002/adhm.20160089227860428 53.SongKXuPMengYGengFLiJLiZXingJChenJKongBSmart gold nanoparticles enhance killing effect on" exact="cancer" post="cellsInt J Oncol20134259760810.3892/ijo.2012.172123229536 54.ShuklaRBansalVChaudharyMBasuABhondeRRSastryMBiocompatibility of gold nanoparticles and their"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7070545/results/search/disease/results.xml">
   <result pre="Introduction The gastrointestinal nematode (GIN) infection haemonchosis is a prevalent" exact="parasitic disease" post="associated with economic losses, lowered productivity, morbidity and mortality."/>
   <result pre="29.KozanE.AnulS.A.TatliI.I.In vitro anthelmintic effect of Vicia pannonica var. purpurascens on" exact="trichostrongylosis" post="in sheepExp. Parasitol.201313429930310.1016/j.exppara.2013.03.01823562885 30.FerreiraL.E.CastroP.M.ChagasA.C.FrançaS.C.BeleboniR.O.In vitro anthelmintic activity of aqueous"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7079787/results/search/disease/results.xml">
   <result pre="led to remarkable advances in the human–virus interaction, such as" exact="smallpox" post="eradication and the control of measles and poliomyelitis transmission."/>
   <result pre="human–virus interaction, such as smallpox eradication and the control of" exact="measles" post="and poliomyelitis transmission. Nevertheless, viruses still remain one of"/>
   <result pre="such as smallpox eradication and the control of measles and" exact="poliomyelitis" post="transmission. Nevertheless, viruses still remain one of the main"/>
   <result pre="antiviral drug to be considered successful for the treatment of" exact="herpes simplex" post="virus (HSV) and varicella zoster virus (VZV) infections. Because"/>
   <result pre="other stages of the viral cycle, causing, for example, the" exact="suppression" post="of viral gene expression [47, 48]. Fig. 1 Antiviral"/>
   <result pre="involved in human diseases, such as human immunodeficiency virus (HIV)," exact="influenza" post="H1N1, and dengue (DENV) [55–59]. One example is kalata"/>
   <result pre="assay showed that cecropin A also has inhibitory activity against" exact="herpes simplex" post="virus 1 and 2 (HSV) and against Junin virus"/>
   <result pre="was tested against HIV-1 in an assay with infected T" exact="lymphoma" post="cells. Interestingly, the cell culture treated with melittin showed"/>
   <result pre="them. In pre-incubation, in vivo assays performed with Indian vesicular" exact="stomatitis" post="virus (VSV) and MP7-NH2; the peptide made the virus"/>
   <result pre="and Hp1036, which are capable of inhibiting the replication of" exact="hepatitis" post="C virus (HCV), preventing infection installation [77]. Further assays"/>
   <result pre="swimming scorpion (Lychas mucronatus), presented outstanding inhibitory activity against the" exact="measles" post="virus, influenza H5N1, and severe acute respiratory syndrome coronavirus"/>
   <result pre="(Lychas mucronatus), presented outstanding inhibitory activity against the measles virus," exact="influenza" post="H5N1, and severe acute respiratory syndrome coronavirus (SARS-CoV). The"/>
   <result pre="outstanding inhibitory activity against the measles virus, influenza H5N1, and" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV). The difference between mucroporin-M1 and the original"/>
   <result pre="[79]. In a further study, mucroporin-M1 showed activity against the" exact="hepatitis" post="B virus (HBV) both in vitro and in vivo,"/>
   <result pre="showed antitumor activity as well as antiviral activity against two" exact="influenza" post="variants. These peptides were also tested regarding their immunomodulatory"/>
   <result pre="an alanine-substituted magainin-2 amide along with three other peptides against" exact="vaccinia virus" post="to evaluate their virucidal activity, and the magainin-2 variant"/>
   <result pre="dermaseptins S3, S4, and S4 derivatives have been tested against" exact="rabies" post="virus in both in vitro and in vivo assays."/>
   <result pre="also affect early stages of the intracellular infection of the" exact="rabies" post="virus [93]. Moreover, HS-1, an AVP derived from anuran"/>
   <result pre="Indian frog Hydrophylax bahuvistara. Urumin showed strong inhibitory activity against" exact="influenza" post="virus in both in vitro and in vivo tests."/>
   <result pre="a TEM assay was, therefore, conducted, and this showed that" exact="influenza" post="virions were destroyed. In the in vivo assays, BALB/C"/>
   <result pre="al. [104] also showed the activity of HNP-1 against the" exact="influenza" post="A virus and suggested that this peptide inhibits the"/>
   <result pre="most initial stages of the cycle. To establish the infection," exact="influenza" post="uses the PKC signaling pathway of the cell, and"/>
   <result pre="matter. Moreover, HBD-3 also demonstrates the capability of inhibiting the" exact="vaccinia virus," post="demonstrating that the presence of the virus induces the"/>
   <result pre="demonstrates inhibitory activity toward several enveloped viruses, including: VZV; the" exact="vaccinia virus" post="(VV), HSV-1; HIV; the syncytial respiratory virus (RSV); influenza"/>
   <result pre="vaccinia virus (VV), HSV-1; HIV; the syncytial respiratory virus (RSV);" exact="influenza" post="A virus; HCV; dengue virus serotype 2; Zika virus;"/>
   <result pre="virus serotype 2; Zika virus; and, more recently, Venezuelan equine" exact="encephalitis" post="virus (VEEV), which can infect both equines and humans"/>
   <result pre="viral entry in the host cell [131]. AVPs designed from" exact="herpes simplex" post="virus Glycoprotein B is a well-conserved and important surface"/>
   <result pre="candidate for drug development [140]. Influenza virus inspired peptides The" exact="influenza" post="virus presents a major threat to human health as"/>
   <result pre="over the years [16]. Given their segmented single-stranded RNA genome," exact="influenza" post="viruses have a high degree of genomic variation, which"/>
   <result pre="triggered when an animal is infected by different strains of" exact="influenza" post="that can exchange genome segments, thus resulting in a"/>
   <result pre="In addition, the only two classes of antiviral drugs against" exact="influenza" post="are the adamantane and neuraminidase inhibitors, for which there"/>
   <result pre="157]. Based on a conserved region of the HA from" exact="influenza" post="A, several peptides were designed by López-Martinéz et al."/>
   <result pre="them were tested in vitro against four different strains of" exact="influenza" post="from human, swine and avian origin, with HA subtype"/>
   <result pre="that all nine peptides were able to inhibit the four" exact="influenza" post="strains in concentrations ranging from 20 to 74 µM."/>
   <result pre="has activity against multiple HA subtypes, and neutralized distinct human" exact="avian influenza" post="viruses such as H5N1. Furthermore, when tested in mice,"/>
   <result pre="activity against multiple HA subtypes, and neutralized distinct human avian" exact="influenza" post="viruses such as H5N1. Furthermore, when tested in mice,"/>
   <result pre="have been reported to infect humans: HCoV-229E, HCoV-OC43, HCoV-NL63, HCoV-HKU1," exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), and the Middle East respiratory syndrome coronavirus"/>
   <result pre="2 Xenopus laevis HSV-1; HSV-2 [76] Magainin variants – HSV-1;" exact="vaccinia virus" post="[91, 92] Temporin B Rana temporaria HSV-1 [89] Dermaseptins"/>
   <result pre="Temporin B Rana temporaria HSV-1 [89] Dermaseptins Phyllomedusa HSV-1; HSV-2;" exact="rabies" post="virus; HIV-1 [22, 93–96] HS-1 H. semilineatus DENV-2 and"/>
   <result pre="HIV human immunodeficiency virus, HSV Herpes simplex virus, VSV vesicular" exact="stomatitis" post="virus, YFV yellow fever virus, RSV respiratory syncytial virus,"/>
   <result pre="virus, HSV Herpes simplex virus, VSV vesicular stomatitis virus, YFV" exact="yellow fever" post="virus, RSV respiratory syncytial virus, WNV West Nile virus,"/>
   <result pre="virus, RSV respiratory syncytial virus, WNV West Nile virus, HCV" exact="hepatitis" post="C virus, SARS-CoV severe acute respiratory syndrome coronavirus, HBV"/>
   <result pre="virus, WNV West Nile virus, HCV hepatitis C virus, SARS-CoV" exact="severe acute respiratory syndrome" post="coronavirus, HBV hepatitis B virus, DENV dengue virus, CBV-2"/>
   <result pre="hepatitis C virus, SARS-CoV severe acute respiratory syndrome coronavirus, HBV" exact="hepatitis" post="B virus, DENV dengue virus, CBV-2 coxsackievirus B2, VZV"/>
   <result pre="dengue virus, CBV-2 coxsackievirus B2, VZV varicella zoster virus, VV" exact="vaccinia virus," post="CMV cytomegalovirus Despite these molecules’ advantages, some potential problems"/>
   <result pre="type 1 protease inhibitorsArch Intern Med199715795110.1001/archinte.1997.004403000370039140265 5.KiserJJFlexnerCDirect-acting antiviral agents for" exact="hepatitis" post="C virus infectionAnnu Rev Pharmacol Toxicol20135342744910.1146/annurev-pharmtox-011112-14025423140245 6.YuFLuLDuLet al.Approaches for"/>
   <result pre="poliovirus from an immunodeficient patient with poliomyelitisJ Gen Virol2003841215122110.1099/vir.0.18974-012692287 10.ThompsonCWhitleyRNeonatal" exact="herpes simplex" post="virus infections: where are we now?Adv Exp Med Biol201169722123010.1007/978-1-4419-7185-2_1521120729"/>
   <result pre="childrenAIDS Res Hum Retroviruses20132944945510.1089/aid.2012.028323308370 15.DemingPMcNichollIRCoinfection with human immunodeficiency virus and" exact="hepatitis" post="C virus: challenges and therapeutic advances—insights from the society"/>
   <result pre="diseases pharmacistsPharmacotherapy2011435736810.1592/phco.31.4.357 16.HuiDSCLeeNChanPKSA clinical approach to the threat of emerging" exact="influenza" post="viruses in the Asia–Pacific regionRespirology2017221300131210.1111/resp.1311428677861 17.MarstonBJDokuboEKvan SteelandtAet al.Ebola response"/>
   <result pre="antiviral peptides derived from viral fusion proteins potentially active against" exact="herpes simplex" post="and influenza A virusesBioinformation2012887087410.6026/9732063000887023144542 24.ElshabrawyHAFanJHaddadCSet al.Identification of a broad-spectrum"/>
   <result pre="from viral fusion proteins potentially active against herpes simplex and" exact="influenza" post="A virusesBioinformation2012887087410.6026/9732063000887023144542 24.ElshabrawyHAFanJHaddadCSet al.Identification of a broad-spectrum antiviral small"/>
   <result pre="virusesBioinformation2012887087410.6026/9732063000887023144542 24.ElshabrawyHAFanJHaddadCSet al.Identification of a broad-spectrum antiviral small molecule against" exact="severe acute respiratory syndrome" post="coronavirus and ebola, hendra, and nipah viruses by using"/>
   <result pre="simplexAfrican J Pharm Pharmacol20093581584 26.CantatoreARandallSDTraumDAdamsSDEffect of black tea extract on" exact="herpes simplex" post="virus-1 infection of cultured cellsBMC Compl Altern Med20131311010.1186/1472-6882-13-139 27.RothanHABahraniHRahmanNAYusofRIdentification"/>
   <result pre="implications for ice bindingJ Biol Chem2013288122951230410.1074/jbc.m113.45097323486477 31.IshagHZALiCHuangLet al.Inhibition of Japanese" exact="encephalitis" post="virus infection in vitro and in vivo by pokeweed"/>
   <result pre="peptide inhibitors derived from the protein E stem against Japanese" exact="encephalitis" post="and Zika virusesAntiviral Res201714114014910.1016/j.antiviral.2017.02.00928232248 33.ChincharVGBryanLSilphadaungUet al.Inactivation of viruses infecting"/>
   <result pre="inhibits virus replicationJ Gen Virol2004852131213710.1099/vir.0.80051-015269351 38.TiwariVLiuJValyi-NagyTShuklaDAnti-heparan sulfate peptides that block" exact="herpes simplex" post="virus infection in vivoJ Biol Chem2011286254062541510.1074/jbc.m110.20110321596749 39.MooneyCHaslamNJPollastriGShieldsDCTowards the improved"/>
   <result pre="defence peptides: potential as antiviral therapeuticsBioDrugs20132747949310.1007/s40259-013-0039-023649937 46.GaldieroSFalangaATaralloRet al.Peptide inhibitors against" exact="herpes simplex" post="virus infectionsJ Pept Sci20131914815810.1002/psc.248923389903 47.QureshiAThakurNKumarMHIPdb: a database of experimentally"/>
   <result pre="Chem2010181331133610.1016/j.bmc.2009.12.026 59.SencanskiMRadosevicDPerovicVet al.Natural products as promising therapeutics for treatment of" exact="influenza" post="diseaseCurr Pharm Des2015215573558810.2174/138161282166615100211342626429712 60.HenriquesSTHuangYHRosengrenKJet al.Decoding the membrane activity of"/>
   <result pre="MatanicVCCastillaVAntiviral activity of antimicrobial cationic peptides against Junin virus and" exact="herpes simplex" post="virusInt J Antimicrob Agents20042338238910.1016/j.ijantimicag.2003.07.02215081088 73.WachingerMSaermarkTErfleVInfluence of amphipathic peptides on"/>
   <result pre="amphipathic peptides on the HIV-1 production in persistently infected T" exact="lymphoma" post="cellsFEBS Lett199230923524110.1016/0014-5793(92)80780-k1516693 74.HoodJLJalloukAPCampbellNet al.Cytolytic nanoparticles attenuate HIV-1 infectivityAntivir Ther2013189510310.3851/imp234622954649"/>
   <result pre="enveloped virusesPeptides2013489610510.1016/j.peptides.2013.07.01423891650 76.El-BitarAMSarhanMMAokiCet al.Virocidal activity of Egyptian scorpion venoms against" exact="hepatitis" post="C virus Hepatitis virusesVirol J2015121910.1186/s12985-015-0276-625591713 77.YanRZhaoZHeYet al.A new natural"/>
   <result pre="al.Inhibitory activity and mechanism of two scorpion venom peptides against" exact="herpes simplex" post="virus type 1Antiviral Res201410211010.1016/j.antiviral.2013.11.01324315793 79.LiQZhaoZZhouDet al.Virucidal activity of a"/>
   <result pre="a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and" exact="influenza" post="H5N1 virusesPeptides2011321518152510.1016/j.peptides.2011.05.01521620914 80.ZhaoZHongWZengZet al.Mucroporin-M1 inhibits hepatitis B virus replication"/>
   <result pre="against measles, SARS-CoV and influenza H5N1 virusesPeptides2011321518152510.1016/j.peptides.2011.05.01521620914 80.ZhaoZHongWZengZet al.Mucroporin-M1 inhibits" exact="hepatitis" post="B virus replication by activating the mitogen-activated protein kinase"/>
   <result pre="86.MarcocciMEAmatoreDVillaSet al.The amphibian antimicrobial peptide temporin b inhibits in vitro" exact="herpes simplex" post="virus 1 infectionAntimicrob Agents Chemother20186211310.1128/aac.02367-17 87.ShartounyJRJacobJMining the tree of"/>
   <result pre="Dev Biol20188814715510.1016/j.semcdb.2018.03.00129524585 88.EgalMConradMMacDonaldDLet al.Antiviral effects of synthetic membrane-active peptides on" exact="herpes simplex" post="virus, type 1Int J Antimicrob Agents199913576010.1016/S0924-8579(99)00094-110563406 89.DeanREO’BrienLMThwaiteJEet al.A carpet-based"/>
   <result pre="89.DeanREO’BrienLMThwaiteJEet al.A carpet-based mechanism for direct antimicrobial peptide activity against" exact="vaccinia virus" post="membranesPeptides2010311966197210.1016/j.peptides.2010.07.02820705109 90.BelaidAAouniMKhelifaRet al.In vitro antiviral activity of dermaseptins against"/>
   <result pre="virus membranesPeptides2010311966197210.1016/j.peptides.2010.07.02820705109 90.BelaidAAouniMKhelifaRet al.In vitro antiviral activity of dermaseptins against" exact="herpes simplex" post="virus type 1J Med Virol20026622923410.1002/jmv.213411782932 91.LorinCSaidiHBelaidAet al.The antimicrobial peptide"/>
   <result pre="activity of dermaseptin S4 and derivatives from amphibian skin against" exact="herpes simplex" post="virus type 2J Med Virol20138527228110.1002/jmv.2345023161023 93.MechliaMBBelaidACastelGet al.Dermaseptins as potential"/>
   <result pre="amphibian host defense peptide is virucidal for human H1 hemagglutinin-bearing" exact="influenza" post="virusesImmunity20174658759510.1016/j.immuni.2017.03.01828423338 96.YasinBPangMTurnerJSet al.Evaluation of the inactivation of infectious herpes"/>
   <result pre="hemagglutinin-bearing influenza virusesImmunity20174658759510.1016/j.immuni.2017.03.01828423338 96.YasinBPangMTurnerJSet al.Evaluation of the inactivation of infectious" exact="herpes simplex" post="virus by host-defense peptidesEur J Clin Microbiol Infect Dis20001918719410.1007/s10096005045710795591"/>
   <result pre="Dis20001918719410.1007/s10096005045710795591 97.Carriel-GomesMCKratzJMBarraccoMAet al.In vitro antiviral activity of antimicrobial peptides against" exact="herpes simplex" post="virus 1, adenovirus, and rotavirusMem Inst Oswaldo Cruz200710246947210.1590/s0074-0276200700500002817612767 98.LuZVan"/>
   <result pre="One20127e4704710.1371/journal.pone.004704723056574 100.Vilas BoasLCPde LimaLMPMiglioloLet al.Linear antimicrobial peptides with activity against" exact="herpes simplex" post="virus 1 and Aichi virusBiopolymers201710812010.1002/bip.22871 101.HollyMKDiazKSmithJGDefensins in Viral Infection"/>
   <result pre="4 inhibits HIV-1 infection in vitroFEBS Lett200557916216610.1016/j.febslet.2004.11.06215620707 104.SalvatoreMGarcía-SastreARuchalaPet al.α-defensin inhibits" exact="influenza" post="virus replication by cell-mediated mechanism(s)J Infect Dis200719683584310.1086/52102717703413 105.Meyer-HoffertUSchwarzTSchröderJ-MGläserRExpression of"/>
   <result pre="proteinase 3Blood2001973951395910.1182/blood.v97.12.395111389039 109.BarlowPGSvobodaPMackellarAet al.Antiviral activity and increased host defense against" exact="influenza" post="infection elicited by the human cathelicidin LL-37PLoS One201161910.1371/journal.pone.0025333 110.TripathiSWangGWhiteMet"/>
   <result pre="human cathelicidin, LL-37, and derived peptides on seasonal and pandemic" exact="influenza" post="A virusesPLoS One20151011710.1371/journal.pone.0124706 111.MatsumuraTSugiyamaNMurayamaAet al.Antimicrobial peptide LL-37 attenuates infection"/>
   <result pre="A virusesPLoS One20151011710.1371/journal.pone.0124706 111.MatsumuraTSugiyamaNMurayamaAet al.Antimicrobial peptide LL-37 attenuates infection of" exact="hepatitis" post="C virusHepatol Res20164692493210.1111/hepr.1262726606891 112.AlagarasuKPatilPSShilPet al.In-vitro effect of human cathelicidin"/>
   <result pre="cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine" exact="encephalitis" post="virus infectionsAntiviral Res2019164616910.1016/j.antiviral.2019.02.00230738837 114.HeMZhangHLiYet al.Cathelicidin-derived antimicrobial peptides inhibit Zika"/>
   <result pre="trafficking of Herpes simplex virus-1Biochimie20099116016410.1016/j.biochi.2008.05.01618573311 124.ShestakovAJenssenHNordströmIErikssonKLactoferricin but not lactoferrin inhibit" exact="herpes simplex" post="virus type 2 infection in miceAntiviral Res20129334034510.1016/j.antiviral.2012.01.00322269645 125.WangWYWongJHIpDTMet al.Bovine"/>
   <result pre="antiviral peptidesComput Biol Med201910712713010.1016/j.compbiomed.2019.02.01130802694 130.JoseGGLarsenIVGaugerJet al.A cationic peptide, TAT-Cd0, inhibits" exact="herpes simplex" post="virus type 1 ocular infection in vivoInvestig Ophthalmol Vis"/>
   <result pre="inhibitory peptidesPLoS Negl Trop Dis20104e72110.1371/journal.pntd.000072120582308 136.RoizmanBTaddeoBet al.ArvinACampadelli-FiumeGMocarskiEet al.The strategy of" exact="herpes simplex" post="virus replication and takeover of the host cellHuman herpesviruses:"/>
   <result pre="therapy, and immunoprophylaxis2007CambridgeCambridge University Press 137.AkkarawongsaRPocaroNECaseGet al.Multiple peptides homologous to" exact="herpes simplex" post="virus type 1 glycoprotein B inhibit viral infectionAntimicrob Agents"/>
   <result pre="Chemother20095398799610.1128/aac.00793-0819104014 138.Cetina-CoronaALópez-SánchezUSalinas-TrujanoJet al.Peptides derived from glycoproteins H and B of" exact="herpes simplex" post="virus type 1 and herpes simplex virus type 2"/>
   <result pre="H and B of herpes simplex virus type 1 and" exact="herpes simplex" post="virus type 2 are capable of blocking herpetic infection"/>
   <result pre="HIV-2, and Simian immunodeficiencyVirus20179111510.1128/jvi.01839-16 153.HsiehIHartshornKLThe role of antimicrobial peptides in" exact="influenza" post="virus infection and their potential as antiviral and immunomodulatory"/>
   <result pre="A (H1N1) Virus Investigation TeamDawoodFSJainSet al.Emergence of a novel swine-origin" exact="influenza" post="A (H1N1) virus in humansN Engl J Med20093602605261510.1056/nejmoa090381019423869 155.KoszalkaPTilmanisDHurtACInfluenza"/>
   <result pre="trialInfluenza Other Respi Viruses20171124024610.1111/irv.12446 156.VanderlindenENaesensLEmerging antiviral strategies to interfere with" exact="influenza" post="virus entryMed Res Rev20143430133910.1002/med.2128923801557 157.LinDLuoYYangGet al.Potent influenza A virus"/>
   <result pre="to interfere with influenza virus entryMed Res Rev20143430133910.1002/med.2128923801557 157.LinDLuoYYangGet al.Potent" exact="influenza" post="A virus entry inhibitors targeting a conserved region of"/>
   <result pre="inhibitors targeting a conserved region of hemagglutininBiochem Pharmacol2017144355110.1016/j.bcp.2017.07.02328774731 158.López-MartínezRRamírez-SalinasGLCorrea-BasurtoJBarrónBLInhibition of" exact="influenza" post="A virus infection in vitro by peptides designed in"/>
   <result pre="computationally designed hemagglutinin stem-binding protein provides in vivo protection from" exact="influenza" post="independent of a host immune responsePLoS Pathogens201612e100540910.1371/journal.ppat.100540926845438 160.FriedmanNAlterHHindiyehMet al.Human"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7094754/results/search/disease/results.xml">
   <result pre="impediment, and relieving pain, and is mainly indicated for rheumatic" exact="arthritis" post="with pain in the lower back and knees, and"/>
   <result pre="symptoms are common in rheumatic diseases such as rheumatism and" exact="rheumatoid arthritis" post="(RA), with modern medicine ascribing them to an immune"/>
   <result pre="are common in rheumatic diseases such as rheumatism and rheumatoid" exact="arthritis" post="(RA), with modern medicine ascribing them to an immune"/>
   <result pre="clinical practice, APR plays an important role in treating RA," exact="osteoarthritis" post="pain, vascular dementia (VD), Alzheimer's disease (AD) and headache"/>
   <result pre="APR plays an important role in treating RA, osteoarthritis pain," exact="vascular dementia" post="(VD), Alzheimer's disease (AD) and headache (Wang et al.,"/>
   <result pre="plays an important role in treating RA, osteoarthritis pain, vascular" exact="dementia" post="(VD), Alzheimer's disease (AD) and headache (Wang et al.,"/>
   <result pre="as a treatment for wind-cold blows, gold sore pain and" exact="hernia" post="mass in women. In &quot;Ben Cao Gang Mu&quot;, another"/>
   <result pre="high-frequency drug for the treatment of RA, which is an" exact="autoimmune disease" post="requiring the use of analgesics and anti-inflammatory medicines to"/>
   <result pre="water decoction of APR, and several mice died because of" exact="respiratory failure" post="in serious cases. The LD50 of mice (i.g.) was"/>
   <result pre="a novel anti-cancer agent able to eliminate the tolerance of" exact="cancer" post="cells to nutrient starvation. Bioorg. Med. Chem. Lett.37, 581–583."/>
   <result pre="of molecular mechanism of Radix Angelicae Pubescentis in treatment of" exact="rheumatoid arthritis" post="by network pharmacology. J. Liaoning Univ. Tradit. Chin. Med.42,"/>
   <result pre="molecular mechanism of Radix Angelicae Pubescentis in treatment of rheumatoid" exact="arthritis" post="by network pharmacology. J. Liaoning Univ. Tradit. Chin. Med.42,"/>
   <result pre="(2017). A computer simulation study of heracleum for treatment of" exact="osteoarthritis" post="pain. J. Trad. Chin. Orthop. Trauma29, 1–4. 10.3969/j.issn.1001-6015.2017.07.001 ZhengkangM."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7098069/results/search/disease/results.xml">
   <result pre="the epidemics of Middle East respiratory syndrome coronavirus (MERS-CoV) and" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV) caused alarming morbidity and mortality.3 While coronaviruses"/>
   <result pre="repurposed to treat a variety of viral infections, such as" exact="severe acute respiratory syndrome" post="coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), Zika"/>
   <result pre="Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese" exact="encephalitis" post="virus (JEV), hepatitis C virus (HCV), Ebola virus (EBOV),"/>
   <result pre="syndrome coronavirus (MERS-CoV), Zika virus (ZIKV), Japanese encephalitis virus (JEV)," exact="hepatitis" post="C virus (HCV), Ebola virus (EBOV), human rhinoviruses (HRVs),"/>
   <result pre="dengue virus four serotypes (DENV 1–4), West Nile virus (WNV)," exact="yellow fever" post="virus (YFV), and Japanese encephalitis virus (JEV). Many of"/>
   <result pre="West Nile virus (WNV), yellow fever virus (YFV), and Japanese" exact="encephalitis" post="virus (JEV). Many of these viruses are significant human"/>
   <result pre="mosquitoes. ZIKV infection can cause infants to be born with" exact="microcephaly" post="and can trigger neurologic conditions in adults such as"/>
   <result pre="infection. HCV can cause both acute and chronic hepatitis, and" exact="hepatitis" post="C is a major cause of liver cancer. It"/>
   <result pre="chronic hepatitis, and hepatitis C is a major cause of" exact="liver cancer." post="It was estimated that about 71 million people have"/>
   <result pre="infections worldwide.43 At present, there is no effective vaccine against" exact="hepatitis" post="C, although clinically approved therapeutics are available. Niclosamide was"/>
   <result pre="are widespread among humans and the primary cause of the" exact="common cold," post="posing serious health risks for patients with asthma, chronic"/>
   <result pre="risks for patients with asthma, chronic pulmonary disease, and severe" exact="bronchiolitis" post="in infants and children.49 Niclosamide is a weak lipophilic"/>
   <result pre="of their life, resulting in a lymphoproliferative disorder known as" exact="infectious mononucleosis." post="EBV infection was also found to be associated with"/>
   <result pre="to be associated with the development of several types of" exact="cancer" post="such as Burkitt’s lymphoma, Hodgkin’s lymphoma, and nasopharyngeal carcinoma.53"/>
   <result pre="et al. demonstrated that niclosamide inhibits EBV lytic replication in" exact="lymphoma" post="cells and epithelial cells and causes irreversible cell cycle"/>
   <result pre="be effective against a variety of human conditions such as" exact="cancer" post="and viral infections. Currently, there are four ongoing human"/>
   <result pre="there are four ongoing human clinical trials of niclosamide in" exact="ulcerative colitis," post="prostate carcinoma, and colorectal cancer in the ClinicalTrails.gov clinical"/>
   <result pre="clinical trials of niclosamide in ulcerative colitis, prostate carcinoma, and" exact="colorectal cancer" post="in the ClinicalTrails.gov clinical trials registry.56 Of note, niclosamide"/>
   <result pre="trials of niclosamide in ulcerative colitis, prostate carcinoma, and colorectal" exact="cancer" post="in the ClinicalTrails.gov clinical trials registry.56 Of note, niclosamide"/>
   <result pre="2019 novel coronavirus MERS-CoV Middle East respiratory syndrome coronavirus SARS-CoV" exact="severe acute respiratory syndrome" post="coronavirus HCV hepatitis C virus DENV dengue virus ZIKV"/>
   <result pre="respiratory syndrome coronavirus SARS-CoV severe acute respiratory syndrome coronavirus HCV" exact="hepatitis" post="C virus DENV dengue virus ZIKV Zika virus JEV"/>
   <result pre="C virus DENV dengue virus ZIKV Zika virus JEV Japanese" exact="encephalitis" post="virus WNV West Nile virus YFV yellow fever virus"/>
   <result pre="virus JEV Japanese encephalitis virus WNV West Nile virus YFV" exact="yellow fever" post="virus EBOV Ebola virus HRV human rhinovirus CHIKV Chikungunya"/>
   <result pre="C.-C.; ChenH.; HuiC. K.-M.; YuenK.-Y. (2020) A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
   <result pre="ArendR. C.; SamantR. S.; BuchsbaumD. J. (2014) Multi-targeted therapy of" exact="cancer" post="by niclosamide: A new application for an old drug."/>
   <result pre="(2016) Identification of niclosamide as a novel anticancer agent for" exact="adrenocortical carcinoma." post="Clin. Cancer Res.22, 3458–3466. 10.1158/1078-0432.CCR-15-2256.26873959 OsadaT.; ChenM.; YangX. Y.;"/>
   <result pre="of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium" exact="tuberculosis" post="(Beijing). Tuberculosis116, S28–S33. 10.1016/j.tube.2019.04.008. SunZ.; ZhangY. (1999) Antituberculosis activity"/>
   <result pre="ChenS.-C.; HongC.-F.; LinR.-K.; ChaoY.-S.; HsuJ. T. A. (2004) Inhibition of" exact="severe acute respiratory syndrome" post="coronavirus replication by niclosamide. Antimicrob. Agents Chemother.48, 2693–2696. 10.1128/AAC.48.7.2693-2696.2004.15215127"/>
   <result pre="Specific plant terpenoids and lignoids possess potent antiviral activities against" exact="severe acute respiratory syndrome" post="coronavirus. J. Med. Chem.50, 4087–4095. 10.1021/jm070295s.17663539 AnandK.; ZiebuhrJ.; WadhwaniP.;"/>
   <result pre="F.; AnandK.; BartlamM.; HilgenfeldR.; RaoZ. (2003) The crystal structures of" exact="severe acute respiratory syndrome" post="virus main protease and its complex with an inhibitor."/>
   <result pre="WuY.-T.; WongC.-H. (2005) Discovery of potent anilide inhibitors against the" exact="severe acute respiratory syndrome" post="3CL protease. J. Med. Chem.48, 4469–4473. 10.1021/jm050184y.15974598 GassenN. C.;"/>
   <result pre="10.1007/s00234-016-1687-9.27067205 ChambersT. J.; GrakouiA.; RiceC. M. (1991) Processing of the" exact="yellow fever" post="virus nonstructural polyprotein: a catalytically active NS3 proteinase domain"/>
   <result pre="CaoS.; ChenH.; SongY. (2013) Identification of three antiviral inhibitors against" exact="japanese encephalitis" post="virus from library of pharmacologically active compounds 1280. PLoS"/>
   <result pre="ChenH.; SongY. (2013) Identification of three antiviral inhibitors against japanese" exact="encephalitis" post="virus from library of pharmacologically active compounds 1280. PLoS"/>
   <result pre="RossignolJ.-F. (2011) Thiazolides as novel antiviral agents. 2. Inhibition of" exact="hepatitis" post="C virus replication. J. Med. Chem.54, 8670–8680. 10.1021/jm201264t.22059983 KorbaB."/>
   <result pre="KorbaB. E.; ElazarM.; LuiP.; RossignolJ.-F.; GlennJ. S. (2008) Potential for" exact="hepatitis" post="C virus resistance to nitazoxanide or tizoxanide. Antimicrob. Agents"/>
   <result pre="KuoS.-C.; HoY.-J. (2016) Antiviral activities of niclosamide and nitazoxanide against" exact="chikungunya" post="virus entry and transmission. Antiviral Res.135, 81–90. 10.1016/j.antiviral.2016.10.003.27742486 Marrugal-LorenzoJ."/>
   <result pre="LaiH.-C. (2016) Preclinical evaluation of a nanoformulated antihelminthic, niclosamide, in" exact="ovarian cancer." post="Oncotarget.7, 8993–9006. 10.18632/oncotarget.7113.26848771 WrappD.; WangN.; CorbettK. S.; GoldsmithJ. A.;"/>
   <result pre="ChenQ.-J.; DengF.; LiuL.-L.; YanB.; ZhanF.-X.; WangY.-Y.; XiaoG.-F.; ShiZ.-L. (2020) A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7148182/results/search/disease/results.xml">
   <result pre="e1004011.24385919 KotzeAC and BagnallNH (2006) RNA interference in Haemonchus contortus:" exact="suppression" post="of b-tubulin gene expression in L3, L4 and adult"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7168685/results/search/disease/results.xml">
   <result pre="(Taenia solium or Taenia saginata or tapeworm or taeniosis or" exact="taeniasis" post="or cysticercosis), Schistosoma spp. (schistosome or schistosomiasis or bilharzia"/>
   <result pre="or taeniosis or taeniasis or cysticercosis), Schistosoma spp. (schistosome or" exact="schistosomiasis" post="or bilharzia or bilharziasis), Echinococcus spp. (or echinococcosis), STHs"/>
   <result pre="(Taenia solium OR Taenia saginata OR tapeworm OR taeniosis OR" exact="taeniasis" post="OR cysticercosis) AND (surveillance OR surveil OR survey OR"/>
   <result pre="from intermediate snail hosts. Subsequently, the rapid onset of acute" exact="schistosomiasis" post="with symptoms, such as high fever, myalgia and eosinophilia,"/>
   <result pre="chronic schistosome infection may lead to long-term complications, such as" exact="portal hypertension," post="anemia, bladder cancer, and kidney failure. Additionally, various animals,"/>
   <result pre="may lead to long-term complications, such as portal hypertension, anemia," exact="bladder cancer," post="and kidney failure. Additionally, various animals, such as cattle,"/>
   <result pre="long-term complications, such as portal hypertension, anemia, bladder cancer, and" exact="kidney failure." post="Additionally, various animals, such as cattle, dogs, cats, pigs,"/>
   <result pre="at risk. Nevertheless, substantial progress in reducing the burden of" exact="schistosomiasis" post="in many countries has been achieved due to the"/>
   <result pre="to the implementation of these control measurements in a national" exact="schistosomiasis" post="prevention and control plan, transmission control and interruption (i.e.,"/>
   <result pre="identified freshwater bodies) [11,12]. In sum, the M&amp;amp;S indicators for" exact="schistosomiasis" post="include the following: schistosomiasis cases (acute, chronic, and advanced),"/>
   <result pre="In sum, the M&amp;amp;S indicators for schistosomiasis include the following:" exact="schistosomiasis" post="cases (acute, chronic, and advanced), intermediate snail hosts (their"/>
   <result pre="of the Snail Intermediate Host Considering that the transmission of" exact="schistosomiasis" post="is particularly determined by the existence and geographic distribution"/>
   <result pre="to determine its dispersal in the Guangdong province (China), where" exact="schistosomiasis" post="has been eliminated (Figure 2). At 186 sites that"/>
   <result pre="and suspected patients (i.e., people with symptoms of hepatic fibrosis," exact="portal hypertension," post="and splenomegaly) were screened for S. japonicum using immunological"/>
   <result pre="complete cure (i.e., negative fecal examination). Additionally, advanced cases of" exact="schistosomiasis" post="were continuously subjected to supervision and surveillance (i.e., liver"/>
   <result pre="are required to report both acute and chronic cases of" exact="schistosomiasis" post="diagnosed in hospitals to the NIDRS. Contents of this"/>
   <result pre="to facilitate a better understanding of the epidemiology of imported" exact="schistosomiasis" post="and to improve pretravel advice. Every patient with a"/>
   <result pre="to improve pretravel advice. Every patient with a diagnosis of" exact="schistosomiasis" post="is reported to TropNetEurop and further classified according to"/>
   <result pre="changes and to function as an early warning system. Nevertheless," exact="schistosomiasis" post="is a non-notifiable disease in Europe, making data entry"/>
   <result pre="device has played a critical role in the surveillance of" exact="schistosomiasis" post="in China, it is rather time-consuming and impractical on"/>
   <result pre="testing of water samples for environmental schistosome DNA to identify" exact="schistosomiasis" post="transmission areas. A study on such a surveillance system"/>
   <result pre="technologists. In both the settings, acute and advanced cases of" exact="schistosomiasis" post="were regularly examined and interviewed with a standardized questionnaire"/>
   <result pre="PZQ was implemented in infected livestock whenever cattle positive for" exact="schistosomiasis" post="had been detected, and focal mollusciciding was applied in"/>
   <result pre="in these areas were screened (and treated when positive) for" exact="schistosomiasis" post="in case infected snails had been detected. Results from"/>
   <result pre="Results from this system (between 2000 and 2003) confirmed that" exact="schistosomiasis" post="had been successfully controlled in large areas of the"/>
   <result pre="two positive results. Furthermore, migrants from endemic areas and suspected" exact="schistosomiasis" post="cases (i.e., people with fever of unknown cause, symptoms"/>
   <result pre="and case surveys comprise the reporting and investigation of a" exact="schistosomiasis" post="case within 24 h after diagnosis through NIDRS established"/>
   <result pre="final category of surveillance is consolidated surveillance in areas where" exact="schistosomiasis" post="has been eliminated, but where a risk of re-emergence"/>
   <result pre="the important contribution of mobile population to the transmission of" exact="schistosomiasis" post="and the importance of monitoring them. In brief, the"/>
   <result pre="one of the pioneers in the control and elimination of" exact="schistosomiasis" post="with sustained M&amp;amp;S taking place in different parallel systems"/>
   <result pre="systems across the country (Figure 2). Therefore, the epidemiology of" exact="schistosomiasis" post="has shifted over time and place, as did interventions"/>
   <result pre="in Egypt Another pioneer in the control and elimination of" exact="schistosomiasis" post="is Egypt, due to its effective monitoring and treatment"/>
   <result pre="and treatment system. In 2017, this country started a national" exact="schistosomiasis" post="elimination plan supported by the World Health Organization after"/>
   <result pre="endemicity. Since the implementation of different control strategies in 1922," exact="schistosomiasis" post="(S. mansoni) prevalence had substantially decreased to 0.2% in"/>
   <result pre="stage to elimination included the re-mapping of residual distribution of" exact="schistosomiasis" post="in all endemic governorates using both the KK technique"/>
   <result pre="were collected from 100 children per school and tested for" exact="schistosomiasis" post="with the KK technique and CCA test. Based on"/>
   <result pre="Although mostly occurring in developing countries, the geographical range of" exact="schistosomiasis" post="is also spreading toward the Western world due to"/>
   <result pre="the infection externally might in turn introduce local transmission of" exact="schistosomiasis" post="in case a suitable intermediate snail host is present"/>
   <result pre="intervention of migrants should be included and strengthened in any" exact="schistosomiasis" post="control program, as they may form a new source"/>
   <result pre="in the endemic Dongting Lake region of China demonstrated a" exact="schistosomiasis" post="prevalence rate twice as high in immigrants as in"/>
   <result pre="host and further aided in the rapid colonization of urogenital" exact="schistosomiasis" post="in this country [30]. Other threats for the appearance"/>
   <result pre="this area had the potential to aggravate the spread of" exact="schistosomiasis" post="in this region [31]. Another example is the construction"/>
   <result pre="the Diama Dam in Senegal, which instigated the spread of" exact="schistosomiasis" post="in 1989 [32]. The latter specifically resulted in the"/>
   <result pre="human and animal surveillance methods is performed in areas where" exact="schistosomiasis" post="has re-emerged, yet these evaluations are not systematic. Therefore,"/>
   <result pre="be established that enables a systematic evaluation of the current" exact="schistosomiasis" post="surveillance systems in order to improve their accuracy and"/>
   <result pre="they often present with growth retardation, impaired cognitive development, and" exact="anemia" post="as a result [34]. Ideally, the building of decent"/>
   <result pre="and Kenya is the integrated school-based M&amp;amp;S for both lymphatic" exact="filariasis" post="(LF) and STHs. Considering that control interventions for different"/>
   <result pre="two articles were included focusing on surveillance in Sweden (where" exact="echinococcosis" post="is emerging) and Japan for the reason that these"/>
   <result pre="European Union. Among these countries is Sweden, originally free from" exact="echinococcosis" post="(i.e., a prevalence of &amp;lt; 1% in the final"/>
   <result pre="control is on its way since the enforcement of the" exact="echinococcosis" post="control program. The risk for dog-to-human transmission by eggs"/>
   <result pre="bovine or porcine intermediate host after ingestion of eggs (i.e.," exact="cysticercosis" post="(CC)). These eggs are shed by the final human"/>
   <result pre="as a consequence. Furthermore, not only NCC, but also porcine" exact="cysticercosis" post="(PCC), has an enormous economic impact due to many"/>
   <result pre="region (northeastern Italy), where the prevalence of bovine CC and" exact="cystic echinococcosis" post="(CE) is generally low. The data (age, sex, location,"/>
   <result pre="(northeastern Italy), where the prevalence of bovine CC and cystic" exact="echinococcosis" post="(CE) is generally low. The data (age, sex, location,"/>
   <result pre="diagnostic variables as they did not perform well in predicting" exact="schistosomiasis" post="and STH infections. Therefore, the question arises to how"/>
   <result pre="a polio surveillance system for the screening of STHs and" exact="schistosomiasis" post="at the same time. Since the WHO set out"/>
   <result pre="is possible to identify polio as well as STHs and" exact="schistosomiasis" post="from the collected fecal materials. The samples were linked"/>
   <result pre="often lacking. For instance, the SCT for the diagnosis of" exact="echinococcosis" post="was long seen as the golden standard for detection"/>
   <result pre="rely on the determination of eggs in urine for urogenital" exact="schistosomiasis" post="(S. haematobium) [67] and the microscopic detection and counting"/>
   <result pre="eggs in stool samples, such as the KK technique for" exact="intestinal schistosomiasis" post="(S. mansoni and S. japonicum) and STHs [68,69]. These"/>
   <result pre="in stool samples, such as the KK technique for intestinal" exact="schistosomiasis" post="(S. mansoni and S. japonicum) and STHs [68,69]. These"/>
   <result pre="regions with limited available epidemiological data. For the M&amp;amp;S of" exact="schistosomiasis" post="at the post-control/elimination stage, 15 articles obtained in this"/>
   <result pre="PCC prevalence is based on the underestimating MI [120]. Also," exact="echinococcosis" post="remains a huge challenge considering the asymptomatic infection in"/>
   <result pre="Still, control and elimination strategies, especially those for STHs and" exact="schistosomiasis" post="(e.g., large-scale MDA), have striking similarities which provide opportunities"/>
   <result pre="environmental improvement of marshlands: Impact on control and elimination of" exact="schistosomiasis" post="in marshland regions along the Yangtze River, ChinaInfect. Dis."/>
   <result pre="Dis. Poverty201761:11:1010.1186/s40249-017-0287-128160773 11.RollinsonD.KnoppS.LevitzS.StothardJ.R.Tchuem TchuentéL.A.GarbaA.MohammedK.A.SchurN.PersonB.ColleyD.G.et al.Time to set the agenda for" exact="schistosomiasis" post="eliminationAct. Trop.201312842344010.1016/j.actatropica.2012.04.013 12.BergquistR.ZhouX.N.RollinsonD.Reinhard-RuppJ.KloheK.Elimination of schistosomiasis: The tools requiredInfect. Dis."/>
   <result pre="in Guangdong, ChinaInfect. Dis. Poverty20187109:1109:1010.1186/s40249-018-0492-630392469 14.WuW.L.WangJ.R.WenL.Y.HuangY.Y.XuX.F.YuW.M.Surveillance and control of post-transmission" exact="schistosomiasis" post="in Jiaxing prefecture, Zhejiang province, ChinaAct. Trop.20059628228710.1016/j.actatropica.2005.07.02216198300 15.ZhangL.J.LiS.Z.WenL.Y.LinD.D.AbeE.M.ZhuR.DuY.LvS.XuJ.WebsterB.L.et al.The"/>
   <result pre="Zhejiang province, ChinaAct. Trop.20059628228710.1016/j.actatropica.2005.07.02216198300 15.ZhangL.J.LiS.Z.WenL.Y.LinD.D.AbeE.M.ZhuR.DuY.LvS.XuJ.WebsterB.L.et al.The establishment and function of" exact="schistosomiasis" post="surveillance system towards elimination in The People’s Republic of"/>
   <result pre="elimination in The People’s Republic of ChinaAdv. Parasit.20169211714110.1016/bs.apar.2016.03.003 16.GrobuschM.P.MühlbergerN.JelinekT.BisoffiZ.CorachánM.HarmsG.MatteelliA.FryG.HatzC.GjørupE.et al.Imported" exact="schistosomiasis" post="in Europe: Sentinel surveillance data from TropNetEuropJ. Travel Med.20061016416710.2310/7060.2003.3575912757691"/>
   <result pre="TropNetEuropJ. Travel Med.20061016416710.2310/7060.2003.3575912757691 17.AngelesJ.M.M.LeonardoL.R.GotoY.KirinokiM.VillacorteE.A.HakimiH.MoendegK.J.LeeS.RiveraP.T.InoueN.et al.Water buffalo as sentinel animals for" exact="schistosomiasis" post="surveillanceBull. World Health Organ.20159351151210.2471/BLT.14.14306526170512 18.SunL.P.LiangY.S.WuH.H.TianZ.X.DaiJ.R.YangK.HongQ.B.ZhouX.N.YangG.J.A Google Earth-based surveillance system"/>
   <result pre="surveillanceBull. World Health Organ.20159351151210.2471/BLT.14.14306526170512 18.SunL.P.LiangY.S.WuH.H.TianZ.X.DaiJ.R.YangK.HongQ.B.ZhouX.N.YangG.J.A Google Earth-based surveillance system for" exact="schistosomiasis" post="japonica implemented in the lower reaches of the Yangtze"/>
   <result pre="Yangtze River, ChinaParasit. Vectors20114223:1223:810.1186/1756-3305-4-22322117601 19.SunL.P.WangW.HongQ.B.LiS.Z.LiangY.S.YangH.T.ZhouX.N.Approaches being used in the national" exact="schistosomiasis" post="elimination programme in China: A reviewInfect. Dis. Poverty2017655:155:910.1186/s40249-017-0271-928292327 20.McManusD.P.GordonC.WeerakoonK.G.A.D.Testing"/>
   <result pre="schistosome infection in a localityInt. J. Infect. Dis.20187612812910.1016/j.ijid.2018.09.02230266632 21.ZhaoG.M.ZhaoQ.JiangQ.W.ChenX.Y.WangL.Y.YuanH.C.Surveillance for" exact="schistosomiasis" post="japonica in China from 2000 to 2003Act. Trop.20059628829510.1016/j.actatropica.2005.07.023 22.LiangS.YangC.ZhongB.GuoJ.LiH.CarltonE.J.FreemanM.C.RemaisJ.V.Surveillance"/>
   <result pre="systems for neglected tropical diseases: Global lessons from China’s evolving" exact="schistosomiasis" post="reporting systems, 1949–2014Emerg. Themes Epidemiol.20141119:119:1410.1186/1742-7622-11-1926265928 23.WuX.H.Ming-GangC.JiangZ.Surveillance of schistosomiasis in"/>
   <result pre="China’s evolving schistosomiasis reporting systems, 1949–2014Emerg. Themes Epidemiol.20141119:119:1410.1186/1742-7622-11-1926265928 23.WuX.H.Ming-GangC.JiangZ.Surveillance of" exact="schistosomiasis" post="in five provinces of China which have reached the"/>
   <result pre="national criteria for elimination of the diseaseAct. Trop.20059627628110.1016/j.actatropica.2005.07.02116198301 24.QianY.J.LiS.Z.XuJ.YangK.HuangY.X.CaoZ.G.MiuF.DangH.ZhangL.J.WangQ.et al.Potential" exact="schistosomiasis" post="foci in China: A prospective study for schistosomiasis surveillance"/>
   <result pre="24.QianY.J.LiS.Z.XuJ.YangK.HuangY.X.CaoZ.G.MiuF.DangH.ZhangL.J.WangQ.et al.Potential schistosomiasis foci in China: A prospective study for" exact="schistosomiasis" post="surveillance and responseAct. Trop.201514134234810.1016/j.actatropica.2013.08.01724012536 25.DangH.XuJ.LiS.Z.CaoZ.G.HuangY.X.WuC.G.TuZ.W.ZhouX.N.Monitoring the transmission of Schistosoma"/>
   <result pre="China, 2008–2012Int. J. Environ. Res. Public Health2014112278228710.3390/ijerph11020227824566053 26.Abou-El-NagaI.F.Towards elimination of" exact="schistosomiasis" post="after 5000 years of endemicity in EgyptAct. Trop.201818111212110.1016/j.actatropica.2018.02.00529453950 27.HaggagA.A.RabieeA.Abd"/>
   <result pre="antigen urine assayAct. Trop.201716791710.1016/j.actatropica.2016.11.03827965144 28.collab: GeoSentinel Surveillance NetworkSchwartzE.Von SonnenburgF.ReedC.WeldL.H.NicollsD.J.KozarskyP.E.Characteristics of" exact="schistosomiasis" post="in travelers reported to the GeoSentinel Surveillance Network 1997–2008Am."/>
   <result pre="potential impact on control operationAct. Trop.2015145889210.1016/j.actatropica.2015.02.009 30.BoissierJ.Grech-AngeliniS.WebsterB.L.AllienneJ.F.HuyseT.Mas-ComaS.ToulzaE.Barré-CardiH.RollinsonD.Kincaid-SmithJ.et al.Outbreak of urogenital" exact="schistosomiasis" post="in Corsica (France): An epidemiological case studyLancet Infect. Dis.20161697197910.1016/S1473-3099(16)00175-427197551"/>
   <result pre="An epidemiological case studyLancet Infect. Dis.20161697197910.1016/S1473-3099(16)00175-427197551 31.ZengH.YangX.MengS.WangH.TangX.TangW.ZengS.JeschkeS.WangY.Awareness and knowledge of" exact="schistosomiasis" post="infection and prevention in the &quot;Three Gorges Dam&quot; reservoir"/>
   <result pre="33.CarltonE.J.BatesM.N.ZhongB.SetoE.Y.W.SpearR.C.Evaluation of mammalian and intermediate host surveillance methods for detecting" exact="schistosomiasis" post="re-emergence in southwest ChinaPLoS Negl. Trop. Dis.20115e98710.1371/journal.pntd.000098721408127 34.JexA.R.LimY.A.L.BethonyJ.M.HotezP.J.YoungN.D.GasserR.B.Soil-transmitted helminths"/>
   <result pre="SilvaN.R.RanasingheU.B.SamarasekaraS.D.NagodavithanaK.C.RaoR.U.RebelloM.P.et al.Integrated school-based surveillance for soil-transmitted helminth infections and lymphatic" exact="filariasis" post="in Gampaha District, Sri LankaAm. J. Trop. Med. Hyg.20149066166610.4269/ajtmh.13-064124493672"/>
   <result pre="40.SmithJ.L.SturrockH.J.W.AssefaL.NikolayB.NjengaS.M.KiharaJ.MwandawiroC.S.BrookerS.J.Factors associated with the performance and cost-effectiveness of using lymphatic" exact="filariasis" post="transmission assessment surveys for monitoring soil-transmitted helminths: A case"/>
   <result pre="endemic countriesRisk Manag. Health Policy20171010711610.2147/RMHP.S116545 53.FonsecaA.G.TorgalJ.de MeneghiD.GabriëlS.CoelhoA.C.VilhenaM.One Health-ness evaluation of" exact="cysticercosis" post="surveillance design in PortugalFront. Public Health2018674:174:1010.3389/fpubh.2018.0007429594095 54.PriestJ.W.JenksM.H.MossD.M.MaoB.ButhS.WannemuehlerK.SoeungS.C.LucchiN.W.UdhayakumarV.GregoryC.J.et al.Integration of"/>
   <result pre="Taenia soliumPLoS Negl. Trop. Dis.20148e312510.1371/journal.pntd.000312525210748 56.AbuseirS.EpeC.SchniederT.KleinG.KühneM.Visual diagnosis of Taenia saginata" exact="cysticercosis" post="during meat inspection: Is it unequivocal?Parasitol. Res.20069940540910.1007/s00436-006-0158-316583204 57.JansenF.DornyP.BerkvensD.Van HulA.Van"/>
   <result pre="it unequivocal?Parasitol. Res.20069940540910.1007/s00436-006-0158-316583204 57.JansenF.DornyP.BerkvensD.Van HulA.Van den BroeckN.MakayC.PraetN.EichenbergerR.M.DeplazesP.GabriëlS.High prevalence of bovine" exact="cysticercosis" post="found during evaluation of different post-mortem detection techniques in"/>
   <result pre="role of movement history, age and sexPrev. Vet. Med.20161351810.1016/j.prevetmed.2016.10.01527931921 61.BlagojevicB.RobertsonL.J.Vieira-PintoM.JohansenM.V.Laranjo-GonzálezM.GabriëlS.Bovine" exact="cysticercosis" post="in the European Union: Impact and current regulations, and"/>
   <result pre="Cont.201778647110.1016/j.foodcont.2017.02.052 62.CassiniR.MulattiP.ZanardelloC.SimonatoG.SignoriniM.CazzinS.TambaloP.CobianchiM.PietrobelliM.CapelliG.Retrospective and spatial analysis tools for integrated surveillance of" exact="cystic echinococcosis" post="and bovine cysticercosis in hypo-endemic areasGeospat. Health2014850951510.4081/gh.2014.4024893028 63.FürstT.OuattaraM.SiluéK.D.N’GoranD.N.AdiossanL.G.BogochI.I.N’GuessanY.KonéS.UtzingerJ.N’GoranE.K.Scope and"/>
   <result pre="62.CassiniR.MulattiP.ZanardelloC.SimonatoG.SignoriniM.CazzinS.TambaloP.CobianchiM.PietrobelliM.CapelliG.Retrospective and spatial analysis tools for integrated surveillance of cystic" exact="echinococcosis" post="and bovine cysticercosis in hypo-endemic areasGeospat. Health2014850951510.4081/gh.2014.4024893028 63.FürstT.OuattaraM.SiluéK.D.N’GoranD.N.AdiossanL.G.BogochI.I.N’GuessanY.KonéS.UtzingerJ.N’GoranE.K.Scope and"/>
   <result pre="analysis tools for integrated surveillance of cystic echinococcosis and bovine" exact="cysticercosis" post="in hypo-endemic areasGeospat. Health2014850951510.4081/gh.2014.4024893028 63.FürstT.OuattaraM.SiluéK.D.N’GoranD.N.AdiossanL.G.BogochI.I.N’GuessanY.KonéS.UtzingerJ.N’GoranE.K.Scope and limits of an"/>
   <result pre="and limits of an anamnestic questionnaire in a control-induced low-endemicity" exact="helminthiasis" post="setting in South-Central Côte d’IvoirePLoS ONE20138e6438010.1371/journal.pone.006438023755120 64.CunninghamL.J.OdoomJ.PrattD.BoatemaaL.Asante-NtimN.AttikuK.BanaheneB.Osei-AtweneboanaM.VerweijJ.J.MolyneuxD.et al.Expanding molecular"/>
   <result pre="use of the GPLN platform for surveillance of soil transmitted" exact="helminthiasis" post="and schistosomiasis in GhanaPLoS Negl. Trop. Dis.201812e000612910.1371/journal.pntd.000612929370166 65.SpearR.C.SetoE.Y.W.CarltonE.J.LiangS.RemaisJ.V.ZhongB.QiuD.The challenge"/>
   <result pre="the GPLN platform for surveillance of soil transmitted helminthiasis and" exact="schistosomiasis" post="in GhanaPLoS Negl. Trop. Dis.201812e000612910.1371/journal.pntd.000612929370166 65.SpearR.C.SetoE.Y.W.CarltonE.J.LiangS.RemaisJ.V.ZhongB.QiuD.The challenge of effective"/>
   <result pre="effective surveillance in moving from low transmission to elimination of" exact="schistosomiasis" post="in ChinaInt. J. Parasit.2011411243124710.1016/j.ijpara.2011.08.002 66.IsakssonM.HagströmÅ.Armua-FernandezM.T.WahlströmH.ÅgrenE.O.MillerA.HolmbergA.LukacsM.CasulliA.DeplazesP.et al.A semi-automated magnetic capture"/>
   <result pre="fox (Vulpes vulpes) faecal samplesParasit. Vectors20147583:1583:1010.1186/s13071-014-0583-625522844 67.FrenchM.D.RollinsonD.BasáñezM.G.MgeniA.F.KhamisI.S.StothardJ.R.School-based control of urinary" exact="schistosomiasis" post="on Zanzibar, Tanzania: Monitoring micro-haematuria with reagent strips as"/>
   <result pre="approach to the evaluation of circulating cathodic antigen strips for" exact="schistosomiasis" post="diagnosis pre- and post-praziquantel treatment in UgandaPLoS Comput. Biol.20139e100340210.1371/journal.pcbi.100340224367250"/>
   <result pre="support policy decisions related to treatment strategies and surveillance of" exact="schistosomiasis" post="Japonica towards eliminationPLoS Negl. Trop. Dis.20115e140810.1371/journal.pntd.000140822206024 77.YuQ.YangH.FengY.YangX.ZhuY.Magnetic affinity enzyme-linked"/>
   <result pre="based on recombinant 26 kDa glutathione-S-transferase for serological diagnosis of" exact="schistosomiasis" post="japonicaAct. Trop.201212419920210.1016/j.actatropica.2012.08.00622940100 78.MorelN.LassabeG.ElolaS.BondadM.HerreraS.MaríC.LastJ.A.JensenO.Gonzalez-SapienzaG.A monoclonal antibody-based copro-ELISA kit for canine"/>
   <result pre="schistosomiasis japonicaAct. Trop.201212419920210.1016/j.actatropica.2012.08.00622940100 78.MorelN.LassabeG.ElolaS.BondadM.HerreraS.MaríC.LastJ.A.JensenO.Gonzalez-SapienzaG.A monoclonal antibody-based copro-ELISA kit for canine" exact="echinococcosis" post="to support the PAHO effort for hydatid disease control"/>
   <result pre="and optimization of cocktail-ELISA for a unified surveillance of zoonotic" exact="schistosomiasis" post="in multiple host speciesParasitol. Res.20151141225122810.1007/s00436-015-4312-725595656 80.CaldeiraR.L.Jannotti-PassosL.K.Dos Santos CarvalhoO.Use of"/>
   <result pre="Schistosoma mansoniPLoS Negl. Trop. Dis.201812e000654810.1371/journal.pntd.000654829813073 100.WangX.Y.HeJ.YangK.LiangS.Applications of spatial technology in" exact="schistosomiasis" post="control programme in The People’s Republic of ChinaAdv. Parasitol.20169214316310.1016/bs.apar.2016.02.02027137446"/>
   <result pre="The People’s Republic of ChinaAdv. Parasitol.20169214316310.1016/bs.apar.2016.02.02027137446 101.ZhangZ.CarpenterT.E.ChenY.ClarkA.B.LynnH.S.PengW.ZhouY.ZhaoG.JiangQ.Identifying high-risk regions for" exact="schistosomiasis" post="in Guichi, China: A spatial analysisAct. Trop.200810721722310.1016/j.actatropica.2008.04.027 102.NiheiN.KomagataO.KobayashiM.SaitohY.MochizukiK.NakamuraS.Spatial analysis"/>
   <result pre="for monitoring systems of Oncomelania nosophora following the eradication of" exact="schistosomiasis" post="japonica in Yamanashi Prefecture, JapanJpn. J. Infect. Dis.20096212513210.1179/136485906X8629319305052 103.NiheiN.KajiharaN.KirinokiM.ChigusaY.MatsudaH.SaitohY.ShimamuraR.KanetaH.NakamuraS.Establishment"/>
   <result pre="J. Infect. Dis.20096212513210.1179/136485906X8629319305052 103.NiheiN.KajiharaN.KirinokiM.ChigusaY.MatsudaH.SaitohY.ShimamuraR.KanetaH.NakamuraS.Establishment of a GIS monitoring system for" exact="schistosomiasis" post="japonica in Kofu, JapanAnn. Trop. Med. Parasit.200610014315310.1179/136485906X8629316492362 104.TongQ.B.ChenR.ZhangY.YangG.J.KumagaiT.Furushima-ShimogawaraR.LouD.YangK.WenL.Y.LuS.H.et al.A"/>
   <result pre="samplesAct. Trop.201514117017710.1016/j.actatropica.2014.01.006 105.ZhangZ.ClarkA.B.BivandR.ChenY.CarpenterT.E.PengW.ZhouY.ZhaoG.JiangQ.Nonparametric spatial analysis to detect high-risk regions for" exact="schistosomiasis" post="in Guichi, ChinaTrans. R. Soc. Trop. Med. Hyg.20091031045105210.1016/j.trstmh.2008.11.01219117584 106.ScholteR.G.C.GosoniuL.MaloneJ.B.ChammartinF.UtzingerJ.VounatsouP.Predictive"/>
   <result pre="ChinaTrans. R. Soc. Trop. Med. Hyg.20091031045105210.1016/j.trstmh.2008.11.01219117584 106.ScholteR.G.C.GosoniuL.MaloneJ.B.ChammartinF.UtzingerJ.VounatsouP.Predictive risk mapping of" exact="schistosomiasis" post="in Brazil using bayesian geostatistical modelsAct. Trop.2014132576310.1016/j.actatropica.2013.12.00724361640 107.XuJ.F.LvS.WangQ.Y.QianM.B.LiuQ.BergquistR.ZhouX.N.Schistosomiasis japonica:"/>
   <result pre="as a tool to explore transmission patternsAct. Trop.201514121322210.1016/j.actatropica.2014.06.01425004441 108.HuY.WardM.P.XiaC.LiR.SunL.LynnH.GaoF.WangQ.ZhangS.XiongC.et al.Monitoring" exact="schistosomiasis" post="risk in East China over space and time using"/>
   <result pre="data via alignment factorsParasit. Vectors20114142:1142:1010.1186/1756-3305-4-14221774790 110.YangK.SunL.P.HuangY.X.YangG.J.WuF.HangD.R.LiW.ZhangJ.F.LiangY.S.ZhouX.N.A real-time platform for monitoring" exact="schistosomiasis" post="transmission supported by google earth and a web-based geographical"/>
   <result pre="web-based geographical information systemGeospat. Health2012619520310.4081/gh.2012.13722639121 111.FengY.LiuL.XiaS.XuJ.F.BergquistR.YangG.J.Reaching the surveillance-response stage of" exact="schistosomiasis" post="control in The People’s Republic of ChinaAdv. Parasitol.20169216519610.1016/bs.apar.2016.02.00627137447 112.BrookerS.ClementsA.C.A.BundyD.A.P.Global"/>
   <result pre="epidemiology of echinococcosesInfect. Dis. Poverty2016513:113:1310.1186/s40249-016-0109-x26895758 119.SchurN.HürlimannE.GarbaA.TraoréM.S.NdirO.RatardR.C.Tchuem TchuentéL.A.KristensenT.K.UtzingerJ.VounatsouP.Geostatistical model-based estimates of" exact="schistosomiasis" post="prevalence among individuals aged ≤20 years in West AfricaPLoS"/>
   <result pre="Trop. Dis.20115e119410.1371/journal.pntd.000119421695107 120.HandaliS.PawitanY.Verifying elimination programs with a special emphasis on" exact="cysticercosis" post="endpoints and postelimination surveillanceJ. Parasitol. Res.20122012610.1155/2012/974950 121.BasáñezM.G.McCarthyJ.S.FrenchM.D.YangG.J.WalkerM.GambhirM.PrichardR.K.ChurcherT.S.A research agenda"/>
   <result pre="for control and eliminationPLoS Negl. Trop. Dis.20126e154810.1371/journal.pntd.000154822545162 122.StothardJ.R.CampbellS.J.Osei-AtweneboanaM.Y.DurantT.StantonM.C.BiritwumN.K.RollinsonD.OmbedeD.R.E.Tcheum-TchuentéL.A.Towards interruption of" exact="schistosomiasis" post="transmission in sub-Saharan Africa: Developing an appropriate environmental surveillance"/>
   <result pre="the record selection process. Figure 2 Timeline of different, parallel" exact="schistosomiasis" post="surveillance systems in the People’s Republic of China with"/>
   <result pre="climate data. 2016–2017 China [13] S. japonicum Surveillance for human" exact="schistosomiasis" post="cases: Continuous surveillance of advanced human cases in addition"/>
   <result pre="patients. 1995–2002 China [14] All Schistosoma spp. M&amp;amp;S for human" exact="schistosomiasis" post="cases: Reporting of both acute and chronic cases of"/>
   <result pre="schistosomiasis cases: Reporting of both acute and chronic cases of" exact="schistosomiasis" post="diagnosed in hospitals to the National Infectious Diseases Reporting"/>
   <result pre="institutions. 1989–…1 China [15] All Schistosoma spp. M&amp;amp;S for human" exact="schistosomiasis" post="cases: Self-selected data entry of schistosomiasis cases in the"/>
   <result pre="spp. M&amp;amp;S for human schistosomiasis cases: Self-selected data entry of" exact="schistosomiasis" post="cases in the TropNetEurop 2 database. 1999–…1 Europe [16]"/>
   <result pre="plan based on a monitoring and treatment system: Re-mapping residual" exact="schistosomiasis" post="distribution in every governorate of the country with an"/>
   <result pre="Korea [38] Integrated school-based monitoring and surveillance for both lymphatic" exact="filariasis" post="and STHs by fecal examination of school-aged children. 2006"/>
   <result pre="test every individual living in a 100 meter radius for" exact="taeniasis" post="and treatment with niclosamide. 2012–2014 Northern Peru [55] T."/>
   <result pre="of spatial analysis for the integrated surveillance of both bovine" exact="cysticercosis" post="and cystic echinococcosis combined with further actions based on"/>
   <result pre="analysis for the integrated surveillance of both bovine cysticercosis and" exact="cystic echinococcosis" post="combined with further actions based on the outcome. 2006–2010"/>
   <result pre="for the integrated surveillance of both bovine cysticercosis and cystic" exact="echinococcosis" post="combined with further actions based on the outcome. 2006–2010"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7170964/results/search/disease/results.xml">
   <result pre="of possible opportunistic infections associated with HIV-AIDS, respiratory related infections," exact="infertility" post="in partners who could not conceive, gastrointestinal complaints and"/>
   <result pre="Plant part used Medicinal uses Reference(s) South Africa Roots Menorrhagia," exact="infertility" post="if women, tooth ache, scrofula, sexually transmitted infections including"/>
   <result pre="Botswana Stem bark Tooth ache [56] Zimbabwe Roots Abdominal pains," exact="infertility" post="in women, bilharzia, cholera, bladder infections and wounds. [50,"/>
   <result pre="[50, 70, 71, 72] Mozambique Roots Stomach-ache, muscular pains and" exact="constipation" post="[73] Leaves Abdominal pains, infertility in women and wounds."/>
   <result pre="Roots Stomach-ache, muscular pains and constipation [73] Leaves Abdominal pains," exact="infertility" post="in women and wounds. [72] Tanzania Roots Tonic, colds,"/>
   <result pre="and gonorrhoea. [78] Roots Management of HIV-AIDS related infections including" exact="pneumonia" post="and STIs such as syphilis, gonorrhoea and chlamydia [79]"/>
   <result pre="The crushed roots are immersed in water overnight to treat" exact="infertility" post="in women while powdered roots are applied directly on"/>
   <result pre="and the liquid s drunk by adult patients until mild" exact="tuberculosis" post="subsides [60]. 4.4 Whole plant Warm infusions of the"/>
   <result pre="the leaves revealed a positive inhibition against Escherichia coli, Klebsiella" exact="pneumonia" post="and strains of Staphylococcus aureus Positive evidence. [119] Leaves"/>
   <result pre="clinical strains of Enterococcus faecalis, Streptococcus agalactiae, Salmonella enterica, Klebsiella" exact="pneumonia" post="and Escherichia coli. Inconclusive evidence, not dose dependence [150]"/>
   <result pre="extract revealed a MIC value of 0.156 mg/ml against Mycobacterium" exact="tuberculosis" post="(pathogenic strain TB8104) and 2.5 mg/ml against Mycobacterium fortuitum"/>
   <result pre="extract revealed MIC value of &amp;gt;500 μg/ml against pathogenic Mycobacterium" exact="tuberculosis" post="H37 strain. Inconclusive evidence, dose dependence. [150] Antifungal activity"/>
   <result pre="with MIC values much less than 1 mg/ml, against M." exact="tuberculosis" post="and M. smegmatis [136, 144], other authors reported the"/>
   <result pre="clinical isolates of Enterococcus faecalis, Streptococcus agalactiae, Salmonella enterica, Klebsiella" exact="pneumonia" post="and Escherichia coli. The effect of boiling intervals on"/>
   <result pre="most countries and given at a young age to control" exact="poliomyelitis" post="which is a communicable disease [156]. 7.3 Anti-malarial activity"/>
   <result pre="the use of the plant species in the treatment of" exact="malaria" post="and related infections needs to be validated in vivo."/>
   <result pre="mg/ml [188, 189]. Entamoeba histolytica is a pathogenic amoeba causing" exact="amoebiasis" post="in humans and common in homosexual who are sexually"/>
   <result pre="neurotropic viral infections, stroke, paraneoplastic disorders, traumatic brain injury and" exact="multiple sclerosis" post="[203]. Usually, inflammation may be caused by pathogenic microorganisms"/>
   <result pre="sensitive cell lines including MCF-7, CCRF-CEM, CEM-/ADR 5000 and other" exact="cervical cancer" post="cell lines. 7.9 Anti-sickling effect Sickle cell disease (SCD)"/>
   <result pre="cell lines including MCF-7, CCRF-CEM, CEM-/ADR 5000 and other cervical" exact="cancer" post="cell lines. 7.9 Anti-sickling effect Sickle cell disease (SCD)"/>
   <result pre="35 medicinal plants from Sudan towards sensitive and multidrug- resistant" exact="cancer" post="cellsJ. Ethnopharmacol.174201564465826165828 24KhanM.P.Z.AhmadM.ZafarM.SultanaS.AliM.I.SunH.Ethnomedicinal uses of edible wild fruits (EWFs)"/>
   <result pre="Pharmacog.262016268274 55BahS.DialloD.DembéléS.PaulsenB.S.Ethnopharmacological survey of plants used for the treatment of" exact="schistosomiasis" post="in Niono District, MaliJ. Ethnopharmacol.105200638739916414223 56SetshogoM.P.MberekiC.M.Floristic diversity and uses"/>
   <result pre="Ethnopharmacol.14120146171 60LawalI.O.GriersonD.S.AfolayanA.J.Phytotherapeutic information on plants used for the treatment of" exact="tuberculosis" post="in Eastern Cape Province, South AfricaEvid. Base. Compl. Alt."/>
   <result pre="82EtukE.U.BelloS.O.IsezuoS.A.MohammedB.J.Ethnobotanical survey of medicinal plants used for the treatment of" exact="diabetes mellitus" post="in the North West region of NigeriaAsian J. Exp."/>
   <result pre="83OnakpaM.M.OwolekeO.E.A survey of medicinal plants used for the management of" exact="diabetes mellitus" post="in north central NigeriaInt. J. Appl. Biol. Pharmaceut. Technol.120105"/>
   <result pre="J. Pharmaceut. Res. Innovat.5201216 93MativandlelaS.P.N.MeyerJ.J.M.HusseinA.A.HoughtonP.J.HamiltonC.J.LallN.Activity against Mycobacterium smegmatis and M." exact="tuberculosis" post="by extract of South African medicinal plantsPhytother Res.22200884184518412151 94MativandlelaS.P.N.Anti-tuberculosis"/>
   <result pre="cytotoxic activity of medicinal plants from Nigeria ethnomedicine on Rhabdomyosarcoma" exact="cancer" post="cell line and HPLC analysis of active extractsBMC Compl."/>
   <result pre="vitro antiplasmodial activity of selected ethnomedicinal plants used to treat" exact="malaria" post="and associated symptoms in Northern NamibiaInt. Sci. Technol. J."/>
   <result pre="of fourteen medicinal plants used in South Africa to treat" exact="tuberculosis" post="and respiratory infectionsJ. Ethnopharmacol.10220167074 145AkhalwayaS.Van VuurenS.PatelM.An in vitro investigation"/>
   <result pre="ART coverage in the top 30 countries with the highest" exact="aids" post="mortality burden; 1990–2013PloS One102015e0131353 153BessongP.O.ObiC.L.AndréolaM.-L.RojasL.B.PouységuL.IgumborE.MeyerJ.J.M.QuideauS.LitvakS.Evaluation of selected South African"/>
   <result pre="its Burden in the United States. Geneva, Switzerland2017 164KapoorD.BhardwajA.K.KumarD.RainaS.K.Prevalence of" exact="diabetes mellitus" post="and its risk factors among permanently settled tribal individuals"/>
   <result pre="LPS induced macrophage activation and functionBMC Compl. Alternative Med.820081 215BrayF.JemalA.GreyN.FerlayJ.FormanD.Global" exact="cancer" post="transitions according to the Human Development Index (2008–2030): a"/>
   <result pre="plant-based anti-cancer compound-activity-target databaseNucleic Acids Res.412013D1124D112923203877 217FridlenderM.KapulnikY.KoltaiH.Plant-derived substances with anti-" exact="cancer" post="activity: from folklore to practiceFront. Plant Sci.6201579926483815 218ShanthiM.P.BupeshG.MageshS.MeenakurmariK.SaravananK.MuthiahN.S.In vitro"/>
   <result pre="activity of Biophytum sensitivum whole plant extracts against cervical and" exact="liver cancer" post="cell linesInt. J. Pharmaceut. Sci. Res.7201651285135 219VijayarathnaS.SasidharanS.Cytotoxicity of methanol"/>
   <result pre="of Biophytum sensitivum whole plant extracts against cervical and liver" exact="cancer" post="cell linesInt. J. Pharmaceut. Sci. Res.7201651285135 219VijayarathnaS.SasidharanS.Cytotoxicity of methanol"/>
   <result pre="using Ames testJ. Med. Plants Res.5201113451348http://www.academicjournals.org/JMPR 231ShenkelD.M.PillaiS.P.TelikepalliS.MennonS.R.PillaiC.A.MitscheL.A.Role of antimutagens/anticarcinogens in" exact="cancer" post="preventionBiofactors12200011312111216471 232Van WykA.-E.The potential of South African plants in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7175113/results/search/disease/results.xml">
   <result pre="immune system, leading to increased susceptibility to malaria, HIV/AIDS and" exact="tuberculosis" post="[11,12]. In addition, gastro-intestinal nematodes are of major economic"/>
   <result pre="chosen for mass drug administration programs and work best for" exact="ascariasis" post="and hookworm infections [6,10,15]. In the pharmaceutical industry, the"/>
   <result pre="safety and efficacy of the drug in people living with" exact="onchocerciasis" post="(https://www.dndi.org/diseases-projects/portfolio/emodepside/). To the best of our knowledge, no other"/>
   <result pre="fumarate reductase as a target of chemotherapy: From parasites to" exact="cancer" post="cellsBiochim. Biophys. Acta Gen. Subj.2012182064365110.1016/j.bbagen.2011.12.01322226661 Figure 1 Chemical structures"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7179133/results/search/disease/results.xml">
   <result pre="to possess antifungal, antimicrobial properties and cytotoxic activity against different" exact="cancer" post="cell lines. Some examples belonging to this class are"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7191034/results/search/disease/results.xml">
   <result pre="stress and inflammatory status was observed in patients with knee" exact="osteoarthritis" post="treated with A. lappa root tea (Maghsoumi-Norouzabad et al.,"/>
   <result pre="(Mohan, 2008), herpes, dandruff (Parvu, 2000; Ardelean et al., 2008)," exact="cystitis" post="(Bojor and Alexan, 1984), burns (Bojor, 2018), hepatitis, bronchitis,"/>
   <result pre="cystitis (Bojor and Alexan, 1984), burns (Bojor, 2018), hepatitis, bronchitis," exact="scurvy" post="(Milica et al., 2012), corns, typhoid fever, heart pain,"/>
   <result pre="(Bojor, 2018), hepatitis, bronchitis, scurvy (Milica et al., 2012), corns," exact="typhoid fever," post="heart pain, chest pain, rheumatism, STDs, skin rashes (Stanescu"/>
   <result pre="to have a positive impact in ameliorating symptoms of cancer," exact="cardiovascular disease," post="and neurodegenerative disorders (Spencer et al., 2004; Salvamani et"/>
   <result pre="last decade, studies on apigenin use as an adjuvant in" exact="cancer" post="treatment had shown tremendous results, this plant originated flavone"/>
   <result pre="al., 2016), and in Morocco as an alternative to treat" exact="typhoid fever" post="and sterility, and also to ease labor (Kharchoufa et"/>
   <result pre="positive impact on patients with epilepsy, asthma, angina, rheumatism, and" exact="tetanus" post="(Mitich, 1998; Hotti and Rischer, 2017). The chemical composition"/>
   <result pre="appetite-stimulant, and aphrodisiac properties, and to treat hemorrhoids, rheumatism, and" exact="infertility" post="(Küpeli et al., 2006; Belda et al., 2013; Güneş"/>
   <result pre="gonococcal urethritis, ascites, amenorrhea, scurvy, tuberculosis, acne, oliguria, colicky nephritis," exact="seborrheic dermatitis," post="leg edema (Grigore and Grigore, 2007), amenorrhea, constipation, tooth"/>
   <result pre="tooth pain, periodontitis, tooth decay (Milica et al., 2012), and" exact="nephrolithiasis" post="(Ardelean et al., 2008). In the Romanian rural areas"/>
   <result pre="warts and bruises. The aerial parts contribute to amelioration of" exact="diarrhea" post="and stomach disorders in North America and Hungary, while"/>
   <result pre="North America and Hungary, while seeds are used to treat" exact="diarrhea" post="and dysentery in Hungary (Chevalier, 1996; Shale et al.,"/>
   <result pre="while the stilbenoids demonstrated to have a positive impact in" exact="cancer" post="therapy and inflammatory diseases (Wegiera et al., 2007; Vasas"/>
   <result pre="V. album is used to treat rheumatism, toothache, gout, herpes," exact="trigeminal neuralgia," post="and catarrh, and as an hypotensive agent (Furbee, 2009;"/>
   <result pre="fever, mental illnesses, psychiatric disorders, mania, mange, pruritus, psoriasis, and" exact="herpes zoster" post="(Milica et al., 2012). X. spinosum L.—Bathurst Burr, Asteraceae"/>
   <result pre="extended also to antiviral (herpes simplex virus, feline corona virus," exact="influenza" post="A H1N1 and A H3N2, influenza B, repvirus, respiratory"/>
   <result pre="virus, feline corona virus, influenza A H1N1 and A H3N2," exact="influenza" post="B, repvirus, respiratory syncytial virus etc.) and anti-angiogenic activities"/>
   <result pre="in the blood serum, protection of the myocardium, prostate adenoma," exact="nephrolithiasis" post="(Bojor and Pop, 2010), rabies, and hyperthyroidism (Ardelean et"/>
   <result pre="myocardium, prostate adenoma, nephrolithiasis (Bojor and Pop, 2010), rabies, and" exact="hyperthyroidism" post="(Ardelean et al., 2008). X. strumarium L.—Common Cocklebur, Asteraceae"/>
   <result pre="disease, bleeding, insect bite, to treat boils and pimples, against" exact="smallpox" post="and stomach diseases, earache and strumous disease, leprosy, headache,"/>
   <result pre="(Tita et al., 2009) Euphorbia cyparissias L. Aerial parts Alopecia," exact="dermatitis" post="Homeopathic remedies (Parvu, 2000; Gilca et al., 2018) Eryngium"/>
   <result pre="diuretic, cicatrizing, eupeptic, carminative, sedative, abdominal distention, urinary lithiasis, anorexia," exact="gastric ulcer," post="convulsive cough, wounds Decoction (Tita et al., 2009) Rumex"/>
   <result pre="al., 2019) Xanthium spinosum L. Aerial parts Rabies, hyperthyroidism, prostate" exact="adenoma" post="Decoction (Parvu, 2000) Xanthium strumarium L. Diuretic 2% tincture"/>
   <result pre="Xanthium strumarium L. Russia Whole plant Hepatoprotector, pulmonary and uterus" exact="cancer" post="Infusions, decoctions, extracts, tinctures (Spiridonov, 2008) (*)Disclaimer: Mention of"/>
   <result pre="2015). There were an estimated 18.1 million new cases of" exact="cancer" post="and 9.6 million deaths from cancer worldwide in 2018"/>
   <result pre="million new cases of cancer and 9.6 million deaths from" exact="cancer" post="worldwide in 2018 from which in Romania alone been"/>
   <result pre="X. strumarium, as treatments in ethnomedicine for different types of" exact="cancer" post="(e.g. prostatic, pulmonary, endometrial), cancerous ulcerations and tumor development"/>
   <result pre="in Romanian for treatment of cancerous ulcerations (R. acetosella) and" exact="prostate cancer" post="(X. spinosum, and X. strumarium). At least one commercial"/>
   <result pre="Romanian for treatment of cancerous ulcerations (R. acetosella) and prostate" exact="cancer" post="(X. spinosum, and X. strumarium). At least one commercial"/>
   <result pre="flavone apigenin results in senescence and chemotherapeutic effect in human" exact="colorectal cancer" post="cells. Redox Biol.5, 153–162. 10.1016/j.redox.2015.04.00925965143 BaskaranX.-R.Geo VigilaA.-V.ZhangS.-Z.FengS.-X.LiaoW-b (2018). A"/>
   <result pre="apigenin results in senescence and chemotherapeutic effect in human colorectal" exact="cancer" post="cells. Redox Biol.5, 153–162. 10.1016/j.redox.2015.04.00925965143 BaskaranX.-R.Geo VigilaA.-V.ZhangS.-Z.FengS.-X.LiaoW-b (2018). A"/>
   <result pre="from Arctium lappa L. accelerates the healing of acetic acid-induced" exact="gastric ulcer" post="in rats: Involvement of the antioxidant system. Food Chem."/>
   <result pre="Agric.46, 147–173. 10.1002/jsfa.2740460204 FerlayJ.ColombetM.SoerjomataramI.MathersC.ParkinD. M.PiñerosM.et al. (2019). Estimating the global" exact="cancer" post="incidence and mortality in 2018: GLOBOCAN sources and methods."/>
   <result pre="from Euphorbia cyparissias as Pgp inhibitors and cytotoxic agents against" exact="ovarian cancer" post="cell lines. Fitoterapia104, 75–79. 10.1016/j.fitote.2015.05.01226003936 LeporattiM. L.IvanchevaS. (2003). Preliminary"/>
   <result pre="Euphorbia cyparissias as Pgp inhibitors and cytotoxic agents against ovarian" exact="cancer" post="cell lines. Fitoterapia104, 75–79. 10.1016/j.fitote.2015.05.01226003936 LeporattiM. L.IvanchevaS. (2003). Preliminary"/>
   <result pre="a lignan from Arctium lappa L., inhibits metastasis of human" exact="breast cancer" post="cells through the downregulation of MMP-2/-9 and heparanase in"/>
   <result pre="lignan from Arctium lappa L., inhibits metastasis of human breast" exact="cancer" post="cells through the downregulation of MMP-2/-9 and heparanase in"/>
   <result pre="(2014). Observational study of Arctium lappa in the treatment of" exact="acne vulgaris." post="Homeopathy103, 203–207. 10.1016/j.homp.2013.12.00224931753 MilicaC.RomanC. N.TroiaD. (2012). Flora medicinala a"/>
   <result pre="K.Khuda-BukhshA. R. (2014). Anticancer potential of Conium maculatum extract against" exact="cancer" post="cells in vitro: Drug-DNA interaction and its ability to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7193273/results/search/disease/results.xml">
   <result pre="one fungal species: Candida albicans; (2) against three different viruses:" exact="yellow fever," post="chikungunya, and enterovirus; and (3) on the nematode Caenorhabditis"/>
   <result pre="Kalanchoe pinnata, Ampelocissus tomentosa, and Paris polyphylla were active against" exact="chikungunya" post="virus, and Clerodendrum serratum was active against yellow fever"/>
   <result pre="active against chikungunya virus, and Clerodendrum serratum was active against" exact="yellow fever" post="virus (EC50 15.9 μg/mL); Terminalia chebula was active against enterovirus"/>
   <result pre="viral, bacterial, fungal, and protozoal infections, as well as for" exact="cancer" post="[3, 4]. Over the past four decades, natural products"/>
   <result pre="Nepal, selected based on ethnobotanical evidence for their use in" exact="infectious disease." post="2. Methods 2.1. Plant Materials Eighteen plant species were"/>
   <result pre="in Table 1) were tested against three different viruses i.e.," exact="yellow fever," post="chikungunya virus (CHIKV), and enterovirus 71. One-third of the"/>
   <result pre="1) were tested against three different viruses i.e., yellow fever," exact="chikungunya" post="virus (CHIKV), and enterovirus 71. One-third of the plants"/>
   <result pre="SI = 1.75) were active against CHIKV, C. serratum was active against" exact="yellow fever" post="virus, with EC50 of 15.9 μg/mL, and T. chebula (EC50 = 10.6 μg/mL,"/>
   <result pre="study. 4. Discussion 4.1. Antimicrobial Activity In the area of" exact="infectious disease," post="of the 141 small molecules approved between 1981 and"/>
   <result pre="we did not find any prior reports on activity against" exact="yellow fever," post="chikungunya, or enterovirus. Nonetheless, from a member of the"/>
   <result pre="doses are administered for a long time. Similarly, another important" exact="viral disease" post="(yellow fever), transmitted by mosquito bites, causes sporadic outbreaks"/>
   <result pre="have found an interesting activity of C. serratum against the" exact="yellow fever" post="virus for the first time. Though anticonvulsant, antidiabetic, and"/>
   <result pre="C. serratum [45], no one examined its activity against the" exact="yellow fever" post="virus thus far. The development of new anti-yellow fever"/>
   <result pre="to be active against enterovirus. EV71 infections can cause mild" exact="hand, foot, and mouth disease" post="but also lead (more rarely) to severe fatal neurological"/>
   <result pre="against enterovirus. EV71 infections can cause mild hand, foot, and" exact="mouth disease" post="but also lead (more rarely) to severe fatal neurological"/>
   <result pre="that chebulagic acid treatment reduced the viral cytopathic effect on" exact="rhabdomyosarcoma" post="cells with an IC50 of 12.5 μg/mL. Furthermore, in mice"/>
   <result pre="and flower extracts are effective in the control of human" exact="herpes simplex" post="virus [92]. Another study conducted by Ojha et al."/>
   <result pre="[42] isolated (using bioassay-guided purification) luteolin, which was active against" exact="herpes simplex" post="virus type 2 (HSV-2). 4.3. Anthelmintic Activity A search"/>
   <result pre="zeylanicum (vahl ex hornem) thunb. Ex. Lehm. against dalton ascites" exact="lymphoma" post="in Swiss albino miceInternational Journal of Applied Biology and"/>
   <result pre="fruits: effects on cell apoptosis and caspase-3 activation in human" exact="lung carcinoma" post="cellsNatural Product Research20153031459146310.1080/14786419.2015.105428326158392 34BagA.BhattacharyyaS. K.ChattopadhyayR. R.The development of Terminalia"/>
   <result pre="steroidal saponin in Paris polyphylla, in growth inhibition of human" exact="breast cancer" post="cells and in xenograftCancer Biology &amp;amp; Therapy2005 14111248125410.4161/cbt.4.11.213616258257 50NambaT.Medicinal"/>
   <result pre="saponin in Paris polyphylla, in growth inhibition of human breast" exact="cancer" post="cells and in xenograftCancer Biology &amp;amp; Therapy2005 14111248125410.4161/cbt.4.11.213616258257 50NambaT.Medicinal"/>
   <result pre="Life2011304p. 95 61PettitG. R.MukkuV. J. R. V.CraggG.et al.Antineoplastic agents. 558.Ampelocissussp." exact="cancer" post="cell growth inhibitory constituents(1)Journal of Natural Products200871113013310.1021/np068050q18177007 62ThengK.KorpenwarA.Phytochemical analysis"/>
   <result pre="anthelmintic, and antiviral activity of plants traditionally used for treating" exact="infectious disease" post="in the similipal biosphere reserve, Odisha, IndiaFrontiers in Pharmacology20178p."/>
   <result pre="M.AbogeG. O.OkumuM. O.YiaileA. L.Antiviral activity of Dicrocephala integrifolia (kuntze) against" exact="herpes simplex" post="type-1 virus: an in vitro studyPharmacognosy Communications201882818510.5530/pc.2018.2.16 93PandaS. K.LuytenW.Antiparasitic"/>
   <result pre="Kuntze Asteraceae 1123 Treatment of cuts, wounds, malarial fever, and" exact="amoebiasis" post="[18]. It is also put into the nose to"/>
   <result pre="[18]. It is also put into the nose to treat" exact="sinusitis" post="and migraine [19]. Diterpene lactones, sesquiterpene lactones, sterols, dicaffeoylquinic"/>
   <result pre="is also put into the nose to treat sinusitis and" exact="migraine" post="[19]. Diterpene lactones, sesquiterpene lactones, sterols, dicaffeoylquinic acid, and"/>
   <result pre="chebula Retz. Combretaceae 599 Treatment of bleeding piles, ulcers, and" exact="gout" post="[32]. The plant has been demonstrated to possess multiple"/>
   <result pre="IC50 values of 3.4–4.4 μg/mL and confirmed in vivo showing 76%" exact="suppression" post="in Plasmodium berghei-infected mice [43]. Clerodendrum serratum (L.) Moon"/>
   <result pre="Cheilanthes farinosa has shown antiproliferative and apoptotic activity in human" exact="liver cancer" post="cells and is not deleterious for a noncancerous macrophage"/>
   <result pre="farinosa has shown antiproliferative and apoptotic activity in human liver" exact="cancer" post="cells and is not deleterious for a noncancerous macrophage"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7202662/results/search/disease/results.xml">
   <result pre="Trop Dis. 2014;8: e308710.1371/journal.pntd.000308725122037 43collab: WHO. Prevention and control of" exact="schistosomiasis" post="and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser."/>
   <result pre="2018;24: 1551–1554. 10.3201/eid2408.18018430016245 67RalphA, O’SullivanMVN, SangsterNC, WalkerJC. Abdominal pain and" exact="eosinophilia" post="in suburban goat keepers—trichostrongylosis. Med J Aust. 2006;184: 467–469."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7244846/results/search/disease/results.xml">
   <result pre="effect Introduction Human hydatid cyst is a somehow neglected zoonotic" exact="parasitic disease" post="caused by Echinococcus granulosus parasite (dog tapeworm) in its"/>
   <result pre="reported because of chemotherapy including liver enzymes elevation, gastrointestinal discomforts," exact="alopecia" post="etc. by albendazole. Similarly, numerous chemical scolicidal solutions have"/>
   <result pre="the United Nations (FAOSTAT) (13). Effectiveness of pumpkin seeds against" exact="taeniasis" post="(11) and schistosomiasis (14) which both are members of"/>
   <result pre="(FAOSTAT) (13). Effectiveness of pumpkin seeds against taeniasis (11) and" exact="schistosomiasis" post="(14) which both are members of platyhelminths phylum, has"/>
   <result pre="or its components was confirmed on ostrich nematodes (17), mice" exact="schistosomiasis" post="(18), and canine tapeworms (19). Moreover, combination of pumpkin"/>
   <result pre="of pumpkin seed and areca nut effectiveness was investigated in" exact="heterophyiasis" post="in puppies (20) and human taeniasis (11). On the"/>
   <result pre="effectiveness was investigated in heterophyiasis in puppies (20) and human" exact="taeniasis" post="(11). On the other hand, the in vitro anthelmintic"/>
   <result pre="Res Vet Sci. 2003; 74(3):191–202.12726737 3.Fasihi HarandiMBudkeCMRostamiSThe monetary burden of" exact="cystic echinococcosis" post="in Iran. PLoS Negl Trop Dis. 2012; 6(11):e1915.23209857 4.NikmaneshBMirhendiHMahmoudiSet"/>
   <result pre="Vet Sci. 2003; 74(3):191–202.12726737 3.Fasihi HarandiMBudkeCMRostamiSThe monetary burden of cystic" exact="echinococcosis" post="in Iran. PLoS Negl Trop Dis. 2012; 6(11):e1915.23209857 4.NikmaneshBMirhendiHMahmoudiSet"/>
   <result pre="combined with areca nut extract in community-based treatment of human" exact="taeniasis" post="in northwest Sichuan Province, China. Acta Trop. 2012; 124(2):152–7.22910218"/>
   <result pre="urban areas. Rev Gastroenterol Peru. 2004; 24(4):323–7.15614300 20.MahmoudLHBasiounySODawoudHATreatment of experimental" exact="heterophyiasis" post="with two plant extracts, areca nut and pumpkin seed."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7251459/results/search/disease/results.xml">
   <result pre="increase breast milk and used in the treatment of tonsillitis," exact="ulcerative stomatitis," post="and gingivitis [12]. The roots have been suggested to"/>
   <result pre="and used in the treatment of tonsillitis, ulcerative stomatitis, and" exact="gingivitis" post="[12]. The roots have been suggested to be beneficial"/>
   <result pre="the seeds as an anthelmintic agent in the treatment of" exact="helminthiasis" post="or worm infestation. Acknowledgments The authors are grateful to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7277221/results/search/disease/results.xml">
   <result pre="in EgyptRJPBCS2016710941104 33.JaramilloS.LopezS.VarelaL.M.Rodriguez-ArcosR.JimenezA.AbiaR.MurianaF.J.The Flavonol isorhamnetin exhibits cytotoxic effects on human" exact="colon cancer" post="cellsJ. Agric. Food Chem.201058108691087510.1021/jf102669p20923189 34.JnawaliH.N.JeonD.JeongM.-C.LeeE.JinB.RyooS.KimY.Antituberculosis activity of a naturally"/>
   <result pre="EgyptRJPBCS2016710941104 33.JaramilloS.LopezS.VarelaL.M.Rodriguez-ArcosR.JimenezA.AbiaR.MurianaF.J.The Flavonol isorhamnetin exhibits cytotoxic effects on human colon" exact="cancer" post="cellsJ. Agric. Food Chem.201058108691087510.1021/jf102669p20923189 34.JnawaliH.N.JeonD.JeongM.-C.LeeE.JinB.RyooS.KimY.Antituberculosis activity of a naturally"/>
   <result pre="herbal medicine Ginkgo bilobaProc. Natl. Acad. Sci. USA2001986577658010.1073/pnas.11112629811381109 41.LiC.YangX.ChenC.CaiS.HuJ.Isorhamnetin suppresses" exact="colon cancer" post="cell growth through the PI3K-Akt-mTOR pathwayMol. Med. Rep.2014993594010.3892/mmr.2014.188624398569 42.KimT.H.KuS.-K.BaeJ.-S.Anti-inflammatory"/>
   <result pre="medicine Ginkgo bilobaProc. Natl. Acad. Sci. USA2001986577658010.1073/pnas.11112629811381109 41.LiC.YangX.ChenC.CaiS.HuJ.Isorhamnetin suppresses colon" exact="cancer" post="cell growth through the PI3K-Akt-mTOR pathwayMol. Med. Rep.2014993594010.3892/mmr.2014.188624398569 42.KimT.H.KuS.-K.BaeJ.-S.Anti-inflammatory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7284490/results/search/disease/results.xml">
   <result pre="muscle strips (macroscopically-normal human colon obtained following ethical approval at" exact="cancer" post="surgery; Sprague–Dawley rats) were suspended in baths (Krebs solution;"/>
   <result pre="ranging between 43–81 years) undergoing elective surgery for non-obstructing bowel" exact="cancer" post="and 5–10 cm cut from the tumour. No patient"/>
   <result pre="channel blocker pinavarium are, for example, prescribed for treatment of" exact="irritable bowel syndrome" post="[31]. Clearly, further studies are needed to clarify the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7295952/results/search/disease/results.xml">
   <result pre="disease), T. brucei gambiense, and T. b. rhodesiense (human African" exact="trypanosomiasis" post="or sleeping sickness), and Leishmania spp. (different kinds of"/>
   <result pre="The apicomplexan parasite Plasmodium falciparum is the causative agent of" exact="malaria" post="tropica, the most dangerous form of malaria, which—despite the"/>
   <result pre="element of the fight against protozoan neglected tropical diseases and" exact="malaria" post="is the discovery of novel chemotherapeutic agents. While the"/>
   <result pre="of novel chemotherapeutic agents. While the incidence of human African" exact="trypanosomiasis" post="is at a historic low and a new drug,"/>
   <result pre="disease has reached global dimensions (&quot;WHO | Epidemiology&quot; n.d.), and" exact="leishmaniasis" post="as well (&quot;Leishmaniasis&quot; n.d.). Sudan has the highest incidence"/>
   <result pre="as well (&quot;Leishmaniasis&quot; n.d.). Sudan has the highest incidence of" exact="leishmaniasis" post="in sub-Saharan countries, with 15,000–20,000 new cases per annum"/>
   <result pre="per annum (Hotez and Kamath, 2009). The successful treatment of" exact="malaria" post="is threatened by artemisinin-resistant mutants of P. falciparum, first"/>
   <result pre="that are used in traditional medicine, with a focus on" exact="malaria" post="and neglected tropical diseases caused by protozoa. On the"/>
   <result pre="the 62 plants had been recorded for use against leishmaniasis," exact="trypanosomiasis" post="or malaria, including the symptoms related to any of"/>
   <result pre="(DC.) Stapf Poaceae Lemon grass Leaves Kidney stones and infections," exact="malaria" post="(Dike et al., 2012) Cyperus rotundus L. Cyperaceae Rhizome"/>
   <result pre="al., 2007) Guiera senegalensis J.F.Gmel. Combretaceae Gubeish Leaves Jaundice, malaria," exact="hyperglycemia" post="(Suleiman, 2015) Haplophyllum tuberculatum (Forssk.) A.Juss. Rutaceae Haza Leaves"/>
   <result pre="Lupinus termis Forssk. Leguminosae Tormos Seeds Paste for eczema and" exact="herpes zoster" post="(Antoun and Taha, 1981) Moringa oleifera Lam. Moringaceae Shagarat"/>
   <result pre="leiocarpa (DC.) Guill. &amp;amp; Perr.) Combretaceae Sahab Bark Cough, dysentry," exact="giardiasis" post="(Musa et al., n.d.) Typha angustifolia L. Typhaceae Si’da"/>
   <result pre="spina-christi (L.) Desf. Rhamnaceae Sidir Leaves Fever, spasmolytic, and anti-" exact="diarrhea" post="(Khalid et al., 2012) Table 2 Plants investigated in"/>
   <result pre="antiplasmodial activity, the plants that had a reported use against" exact="malaria" post="(n=17; Table 1) were slightly more active against P."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7296102/results/search/disease/results.xml">
   <result pre="vomiting, urinary tract infections, preparation for and/or facilitation of labor," exact="common cold" post="or flu, gastrointestinal problems (e.g., constipation, flatulence), pain conditions,"/>
   <result pre="those intended for the treatment of serious ailments such as" exact="malaria" post="and HIV/AIDS, exclusively residing with traditional healers (International Bioethics"/>
   <result pre="eucalyptus (Eucalyptus globulus Labill.) Management of nausea, vomiting, abdominal pain," exact="common cold" post="Being in the first trimester of pregnancy, having less"/>
   <result pre="G.Don, Vepris heterophylla (Engl.) Letouzey For general well-being, to treat" exact="malaria" post="symptoms, edema, urinary tract infection, tiredness - Sociodemographic characteristics"/>
   <result pre="(Engl.) Letouzey For general well-being, to treat malaria symptoms, edema," exact="urinary tract infection," post="tiredness - Sociodemographic characteristics were not associated with the"/>
   <result pre="al., 2018) Peppermint Mentha piperita L. Nausea, vomiting, flatulence, indigestion," exact="irritable bowel syndrome" post="Heartburn, dry mouth, belching, rash, dizziness, headache Leaf tea;"/>
   <result pre="Laelago, 2018) Pumpkin Cucurbita pepo L. Nutritional supplement, cough, fever," exact="common cold," post="headache, heartburn, gastrointestinal irritation, edema No adverse events were"/>
   <result pre="fever, constipation, increasing appetite, strengthening the pelvic floor muscles, malaria," exact="anemia" post="Stimulation of uterine motility Leaf soup; fresh leaves are"/>
   <result pre="Hochst. ex Benth. Headache, fever, inflammation, joint pain, back pain," exact="common cold," post="cough, eye infections No adverse events were identified in"/>
   <result pre="Juss Inducing labor, malaria, pain, hemorrhoids, enhancing fetal development Vomiting," exact="metabolic acidosis," post="encephalopathy Body smeared with mashed leaves; neem leaf tea;"/>
   <result pre="labor, malaria, pain, hemorrhoids, enhancing fetal development Vomiting, metabolic acidosis," exact="encephalopathy" post="Body smeared with mashed leaves; neem leaf tea; oral"/>
   <result pre="Adam (in Amharic)- Fringed rue Ruta chalepensis L. Nausea, vomiting," exact="common cold," post="abdominal discomfort Sedation, drowsiness Leaf tea; leaf juice (Al-Said"/>
   <result pre="Aloe vera (L.) Burm.f. Digestive problems, constipation, skin treatment Itching," exact="rash" post="Topical gel; lotion; leaf tea; leaf juice (Cuzzolin et"/>
   <result pre="placebo-controlled, double-blind study of bitter kola in patients with knee" exact="osteoarthritis" post="reported a favorable safety profile of bitter kola, with"/>
   <result pre="subcontinent, neem is commonly used across sub-Saharan Africa, particularly for" exact="malaria" post="prevention and treatment (Luong et al., 2012; Kumar and"/>
   <result pre="reported neem oil poisoning incidents causing vomiting, seizures, hepatic toxicity," exact="metabolic acidosis," post="and toxic encephalopathy (Sinniah and Baskaran, 1981; Sundaravalli et"/>
   <result pre="incidents causing vomiting, seizures, hepatic toxicity, metabolic acidosis, and toxic" exact="encephalopathy" post="(Sinniah and Baskaran, 1981; Sundaravalli et al., 1982; Mishra"/>
   <result pre="extracts of the Cucurbita pepo L. on the delay type" exact="hypersensitivity" post="and antibody production. Res. Pharmaceut. Sci.7 (4), 217–224. JamesP."/>
   <result pre="as a sustainable dry season management strategy to control the" exact="malaria" post="vector Anopheles gambiae (DIPTERA: CULICIDAE) in west African villages."/>
   <result pre="leave extract of Ocimum lamiifolium (Damakese) as a treatment for" exact="urinary tract infection." post="Cogent Chem.4 (1), 1440894. 10.1080/23312009.2018.1440894 SaperR. B.KalesS. N.PaquinJ.BurnsM. J.EisenbergD."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7312933/results/search/disease/results.xml">
   <result pre="long time (Table 3). As khat has a known appetite" exact="suppression" post="effect [37,38], it could lead to a poor nutritional"/>
   <result pre="in low birth weight. In addition, khat is associated with" exact="constipation" post="[37]; coupled with the constipation effect of iron supplement,"/>
   <result pre="addition, khat is associated with constipation [37]; coupled with the" exact="constipation" post="effect of iron supplement, khat may hamper treatment adherence"/>
   <result pre="diseases, chronic gastritis/peptic ulcer, hypertension, HIV, chronic renal failure, chronic" exact="liver disease," post="diabetes mellitus, etc. mkhat (Catha edulis) plant leaves are"/>
   <result pre="gastritis/peptic ulcer, hypertension, HIV, chronic renal failure, chronic liver disease," exact="diabetes mellitus," post="etc. mkhat (Catha edulis) plant leaves are chewed by"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7327036/results/search/disease/results.xml">
   <result pre="applied the mouse CCl4-driven liver fibrosis model, the mouse chronic" exact="schistosomiasis" post="liver fibrosis model, as well as novel 2D and"/>
   <result pre="the murine model of established liver fibrosis following chronic experimental" exact="schistosomiasis" post="We further investigated the in vivo effect of PZQ"/>
   <result pre="treated animals. Figure 3 Praziquantel effects in the chronic murine" exact="schistosomiasis" post="model of liver fibrosis. (A) Experimental design. Mice were"/>
   <result pre="of Andrade28 indicating that PZQ suggested antifibrotic potential in chronic" exact="schistosomiasis" post="patients is essentially dependent on its antiparasitic effect. In"/>
   <result pre="pre-existing tissue fibrosis independently from its known antiparasitic effect in" exact="schistosomiasis" post="but harbours a potential in preventing the onset of"/>
   <result pre="markers (i.e. α-SMA and collagen). Phenotypical profiling on the chronic" exact="schistosomiasis" post="model of liver fibrosis Mice and ethics The use"/>
   <result pre="tetrathyridiaJ. Helminthol.20088221121918394210 8.HrckovaGVelebnySDaxnerovaZSolarPPraziquantel and liposomized glucan-treatment modulated liver fibrogenesis and" exact="mastocytosis" post="in mice infected with Mesocestoides vogae (M. corti, Cestoda)"/>
   <result pre="praziquantel on the production of cytokines and morbidity associated with" exact="schistosomiasis" post="mansoniAntimicrob. Agents Chemother.2008522780278618519730 10.RahoudSAet al.Factors controlling the effect of"/>
   <result pre="japonicum-infected miceMed. Sci. Monit.2018241597160329550831 12.OlvedaDUet al.Biennial versus annual treatment for" exact="schistosomiasis" post="and its impact on liver morbidityInt. J. Infect. Dis.20175414514927743969"/>
   <result pre="Xi. Chong. Bing. Fang Zhi. Za Zhi.20162924124229469337 14.CrosbyAet al.Praziquantel reverses" exact="pulmonary hypertension" post="and vascular remodeling in murine schistosomiasisAm. J. Respir. Crit"/>
   <result pre="ultrasonography and two serum biochemical indices for hepatic fibrosis in" exact="schistosomiasis" post="japonica patients one year after praziquantel treatmentChin Med. J."/>
   <result pre="al.Comparative assessment of health benefits of praziquantel treatment of urogenital" exact="schistosomiasis" post="in preschool and primary school-aged childrenBiomed. Res. Int.20162016916263127631011 23.ColleyDGMorbidity"/>
   <result pre="preschool and primary school-aged childrenBiomed. Res. Int.20162016916263127631011 23.ColleyDGMorbidity control of" exact="schistosomiasis" post="by mass drug administration: how can we do it"/>
   <result pre="Dis.201711e000540028222149 26.HarvieMCGet al.Live imaging of collagen deposition during experimental hepatic" exact="schistosomiasis" post="and recovery: a view on a dynamic processLab Invest.20199923124330401957"/>
   <result pre="39.XuDet al.RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune" exact="hypersensitivity" post="responses and arthritis in rodentsJ. Pharmacol. Exp. Ther.20123419010322228807 40.WebbeGJamesCNelsonGSSturrockRFThe"/>
   <result pre="selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and" exact="arthritis" post="in rodentsJ. Pharmacol. Exp. Ther.20123419010322228807 40.WebbeGJamesCNelsonGSSturrockRFThe effect of praziquantel"/>
   <result pre="and ultrasound findings before and after praziquantel treatment among Venezuelan" exact="schistosomiasis" post="patientsRev. Soc. Bras. Med. Trop.20074050551117992403 42.OhmaeHet al.Serologic and ultrasonographic"/>
   <result pre="Hyg.20087822823418256420 53.Abd El-AalNFHamzaRSHarbOPaeoniflorin targets apoptosis and ameliorates fibrosis in murine" exact="schistosomiasis" post="mansoni: A novel insightExp. Parasitol.2017183233229037782 54.BeshayEVNRadyAAAfifiAFMohamedAHSchistosomicidal, antifibrotic and antioxidant"/>
   <result pre="downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental" exact="schistosomiasis" post="mansoniExp. Parasitol.201112915215721762692 57.ElmasryAAladeebNMElkarefAAboulfotouhNSimvastatin exerts antifibrotic effect and potentiates the"/>
   <result pre="Biol.201816e200585030379806 69.NonoJKet al.Host regulation of liver fibroproliferative pathology during experimental" exact="schistosomiasis" post="via interleukin-4 receptor alphaPLoS. Negl. Trop. Dis.201711e000586128827803"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7338903/results/search/disease/results.xml">
   <result pre="medium, provided the original work is properly cited. Abstract Cystic" exact="echinococcosis" post="(CE) is a zoonotic infection caused by Echinococcus granulosus"/>
   <result pre="granulosus encystation process differentially expressed gene protoscolex transcriptome INTRODUCTION Cystic" exact="echinococcosis" post="(CE), also known as hydatid disease, is a chronic"/>
   <result pre="a key trigger of the inflammatory activation of macrophages in" exact="malaria" post="and can damage proteins, carbohydrates, and DNA, which are"/>
   <result pre="and acts as an essential enzyme for the survival of" exact="schistosomiasis" post="in the redox environment. It has therefore been actively"/>
   <result pre="EgPSC_0d and EgPSC_10d. LINK References REFERENCES 1ZhangWZhangZWuWShiBLiJZhouXWenHMcManusDPEpidemiology and control of" exact="echinococcosis" post="in central Asia, with particular reference to the People’s"/>
   <result pre="systematic review and meta-analysis of the genetic characterization of human" exact="echinococcosis" post="in Iran, an endemic countryEpidemiol Health201941e201902431208193 3MahmoudiSMamishiSBanarMPourakbariBKeshavarzHEpidemiology of echinococcosis"/>
   <result pre="human echinococcosis in Iran, an endemic countryEpidemiol Health201941e201902431208193 3MahmoudiSMamishiSBanarMPourakbariBKeshavarzHEpidemiology of" exact="echinococcosis" post="in Iran: a systematic review and meta-analysisBMC Infect Dis20191992931684882"/>
   <result pre="of hydatid cyst fluid antigens on induction of apoptosis on" exact="breast cancer" post="cellsAdv Biomed Res201982731123670 30MandalSDeb MandalMHuman cystic echinococcosis: epidemiologic, zoonotic,"/>
   <result pre="hydatid cyst fluid antigens on induction of apoptosis on breast" exact="cancer" post="cellsAdv Biomed Res201982731123670 30MandalSDeb MandalMHuman cystic echinococcosis: epidemiologic, zoonotic,"/>
   <result pre="ratsOxid Med Cell Longev20192019115 43OzcanCLIZKimGJeevanandamVUrielNMolecular mechanism of the association between" exact="atrial fibrillation" post="and heart failure includes energy metabolic dysregulation due to"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7347746/results/search/disease/results.xml">
   <result pre="nematodes, habronematidosis has been discontinuously studied worldwide. Habronematidosis is a" exact="parasitic disease" post="distributed all over the world. It is caused by"/>
   <result pre="for the comprehension of this widespread—but still not completely understood—intriguing" exact="parasitic disease." post="Here, a broad review of habronematidosis, covering all aspects"/>
   <result pre="hemorrhages or damage of the stomach wall leading to acute" exact="peritonitis" post="and even death (46, 47). There are often congested"/>
   <result pre="end is responsible for the injury and for the local" exact="hypersensitivity" post="reaction. Chest, fetlocks and the inner side of the"/>
   <result pre="in the medial canthus, infected animals present marked conjunctivitis, blepharitis," exact="dermatitis" post="with photophobia and lacrimation (6, 32, 54). This form"/>
   <result pre="may show profuse mucopurulent discharge, and from moderate to evident" exact="blepharospasm" post="and/or epiphora. Some may suffer of ectropion and chemosis."/>
   <result pre="moderate to evident blepharospasm and/or epiphora. Some may suffer of" exact="ectropion" post="and chemosis. Gross lesions are ulcerative and granulomatous with"/>
   <result pre="the lesions are thought to be a result of local" exact="hypersensitivity" post="to dead or dying larvae, the administration of ivermectin"/>
   <result pre="forms (33); in addition, corticosteroids were used to reduce inflammatory" exact="hypersensitivity" post="reactions. These molecules can be used mostly in ocular"/>
   <result pre="the case of &quot;summer sores&quot;. Parassitologia. (2010) 52:329. 54.RebhunWCMirroEJGeorgiMEKernTJ. Habronemic" exact="blepharoconjunctivitis" post="in horses. J Am Vet Med Assoc. (1981) 179:469–72."/>
   <result pre="Elsevier Saunders (2011). pp. 149–50. 56.FinocchioEJMerriamJC. Surgical correction of myiasitic" exact="urethritis" post="granulosa in the horse. Vet Med Small Anim Clin."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7360695/results/search/disease/results.xml">
   <result pre="a new respiratory system disease caused by a novel coronavirus," exact="severe acute respiratory syndrome" post="coronavirus type-2 (SARS-CoV-2) [1]. The World Health Organization (WHO)"/>
   <result pre="type-2 (SARS-CoV-2) [1]. The World Health Organization (WHO) named the" exact="respiratory disease" post="as novel coronavirus disease discovered in 2019 (COVID-19). On"/>
   <result pre="have a variety of symptoms including cough, fever, headache, chills," exact="shortness" post="of breathing, muscle pain, sore throat, and even a"/>
   <result pre="SARS-CoV and MERS-CoV. SARS-CoV and MERS-CoV are coronaviruses that caused" exact="respiratory disease" post="outbreaks in 2003 and 2012 respectively. The genome of"/>
   <result pre="and hydroxychloroquine (HCQ) are used for the treatment of malaria," exact="systemic lupus erythematosus," post="and rheumatoid diseases and are attributed to the anti-inflammatory"/>
   <result pre="hydroxychloroquine (HCQ) are used for the treatment of malaria, systemic" exact="lupus erythematosus," post="and rheumatoid diseases and are attributed to the anti-inflammatory"/>
   <result pre="HCQ-treated group has shown improvements on CT images related to" exact="pneumonia" post="with HCQ (400 mg/day, 5 day, and conventional treatments)"/>
   <result pre="Methodist J.C. Walter Jr. Transplant Center with co-morbidities such as" exact="diabetes mellitus," post="hypertension, and coronary artery disease, 11 patients received a"/>
   <result pre="for 7 weeks (https://icmr.nic.in/sites/default/files/upload_documents/HCQ_Recommendatio n_22March_final_MM_V2.pdf). HCQ and CQ can cause" exact="retinopathy" post="and prolonged QTc (with fatal arrhythmias-tachycardia) [22, 23]. It"/>
   <result pre="of azithromycin per day for 5 days. To prevent an" exact="influenza" post="infection, participants were also treated with 75 mg of"/>
   <result pre="in phase 3. The patients who were diagnosed with COVID-19" exact="pneumonia" post="were included. Participants were above the age of 18."/>
   <result pre="in this trial. Patients who had hearing loss, retinopathy, and" exact="hypersensitivity" post="due to HCQ were also excluded from the study"/>
   <result pre="and retinal loss; prolonged QT syndrome patients, individuals who had" exact="hypersensitivity" post="reactions, those who could not receive CQ, and individuals"/>
   <result pre="patients) and the experimental group (99 patients). Those who had" exact="hypersensitivity" post="reactions, allergy to this drug combination, and liver cirrhosis"/>
   <result pre="the experimental group (99 patients). Those who had hypersensitivity reactions," exact="allergy" post="to this drug combination, and liver cirrhosis were excluded"/>
   <result pre="had hypersensitivity reactions, allergy to this drug combination, and liver" exact="cirrhosis" post="were excluded from this study. The eligible patients were"/>
   <result pre="based on the previous lower EC50 values against Ebola and" exact="influenza" post="infection. Some studies tried dosages ranging from 2400 to"/>
   <result pre="available treatment in Japan but not in the USA for" exact="influenza" post="infection [35–39]. Currently, favipiravir is hardly used in clinical"/>
   <result pre="have adverse effects in DM, hypertension, liver cirrhosis, renal failure," exact="rheumatoid arthritis," post="and CVD patients because of the receptor localization. Tocilizumab"/>
   <result pre="is a monoclonal antibody against IL-6 currently being used for" exact="rheumatoid arthritis," post="giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile"/>
   <result pre="currently being used for rheumatoid arthritis, giant cell arteritis, polyarticular" exact="juvenile idiopathic arthritis," post="systemic juvenile idiopathic arthritis, and cytokine release syndrome therapies."/>
   <result pre="rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic" exact="juvenile idiopathic arthritis," post="and cytokine release syndrome therapies. The COVID-19 infection causes"/>
   <result pre="also used to decrease inflammatory action in SARS-CoV, MERS-CoV, and" exact="influenza" post="infection. Its therapeutic action against SARS-CoV-2 needs to be"/>
   <result pre="around 12–18 months. Remarkably, developing the monovalent form of H1N1" exact="influenza" post="vaccine from existing trivalent vaccines took only 6 months"/>
   <result pre="[28]. When the Ebola virus outbreak occurred in 2014, vesicular" exact="stomatitis" post="virus vector-based vaccine was developed, named Ervebo. The recombinant"/>
   <result pre="vaccine was developed, named Ervebo. The recombinant protein vaccine for" exact="influenza" post="was developed and licensed by the USA as Flublok."/>
   <result pre="as Flublok. The cell culture-based vaccine, Flucelvax, was developed for" exact="influenza" post="virus [47]. These vaccines mimic infectious agents and trigger"/>
   <result pre="vector ChAdOx1 University of Oxford Pre-clinical Chikungunya, plague, TB, Zika," exact="influenza" post="Protein subunit S-Trimmer Clover Biopharmaceuticals Inc./GSK Pre-clinical Zika, influenza"/>
   <result pre="Zika, influenza Protein subunit S-Trimmer Clover Biopharmaceuticals Inc./GSK Pre-clinical Zika," exact="influenza" post="Non-replicating viral vector Ad26 Janssen Pharmaceutical Companies Pre-clinical Ebola"/>
   <result pre="plant-derived VLP on flu, rotavirus, norovirus, West Nile virus, and" exact="cancer" post="platforms to produce a SARS-CoV-2 vaccine. This vaccine is"/>
   <result pre="chainNature19903486006052250716 7.WuSFChangCBHsuJMLuMCLaiNSLiCTungCHHydroxychloroquine inhibits CD154 expression in CD4(+) T lymphocytes of" exact="systemic lupus erythematosus" post="through NFAT, but not STAT5, signalingArthritis Res Ther20171918328793932 8.van"/>
   <result pre="7.WuSFChangCBHsuJMLuMCLaiNSLiCTungCHHydroxychloroquine inhibits CD154 expression in CD4(+) T lymphocytes of systemic" exact="lupus erythematosus" post="through NFAT, but not STAT5, signalingArthritis Res Ther20171918328793932 8.van"/>
   <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci Trends202014727332074550 17.Gautret P, Lagier JC, Parola"/>
   <result pre="of optimized dosing design of hydroxychloroquine for the treatment of" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2). [published online ahead of print, 2020"/>
   <result pre="of chloroquine diphosphate as adjunctive therapy for patients hospitalized with" exact="severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trialJAMA Netw"/>
   <result pre="for coronavirus disease-19 treatment optionJ Med Virol20209255656332104907 30.ChanKSLaiSTChuCMet al.Treatment of" exact="severe acute respiratory syndrome" post="with lopinavir/ritonavir: a multicentre retrospective matched cohort studyHong Kong"/>
   <result pre="for severe COVID-19?J Transl Med20201816432290839 46.KrammerFPalesePAdvances in the development of" exact="influenza" post="virus vaccinesNat Rev Drug Discov20151416718225722244 47.AmanatFKrammerFSARS-CoV-2 vaccines: status reportImmunity20205258358932259480"/>
   <result pre="47.AmanatFKrammerFSARS-CoV-2 vaccines: status reportImmunity20205258358932259480 48.WuFZhaoSYuBChenYMWangWSongZGHuYTaoZWTianJHPeiYYYuanMLZhangYLDaiFHLiuYWangQMZhengJJXuLHolmesECZhangYZA new coronavirus associated with human" exact="respiratory disease" post="in ChinaNature202057926526932015508 49.ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLChenHDChenJLuoYGuoHJiangRDLiuMQChenYShenXRWangXZhengXSZhaoKChenQJDengFLiuLLYanBZhanFXWangYYXiaoGFShiZLA pneumonia outbreak associated with a new"/>
   <result pre="new coronavirus associated with human respiratory disease in ChinaNature202057926526932015508 49.ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLChenHDChenJLuoYGuoHJiangRDLiuMQChenYShenXRWangXZhengXSZhaoKChenQJDengFLiuLLYanBZhanFXWangYYXiaoGFShiZLA" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
   <result pre="Coronavirus Investigating and Research TeamA novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773331978945 51.LanJGeJYuJShanSZhouHFanSZhangQShiXWangQZhangLWangXStructure of the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7388083/results/search/disease/results.xml">
   <result pre="and respiratory problems. Boiled leaves are also used to treat" exact="asthma" post="and tuberculosis. In Tanzania, macerated root bark or leaves"/>
   <result pre="from various parts of the world for the control of" exact="helminthiasis" post="and other ailments. This resulted in increased scientific evidence"/>
   <result pre="of P dodecandra traditionally are used for the treatment of" exact="malaria" post="in North-Western Ethiopia.46,47 A study conducted on the leaf"/>
   <result pre="care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100. 11McCulloughFGayralPDuncanJChristieJMolluscicides in" exact="schistosomiasis" post="control. Bull World Health Organ. 1980;58:681-689.6975179 12WebbeGLambertJSchistosomiasis: plants that"/>
   <result pre="snails and prospects for disease control. Nature. 1983;302:754.6843649 13GollPLemmaADuncanJMazengiaBControl of" exact="schistosomiasis" post="in Adwa, Ethiopia, using the plant molluscicide endod (Phytolacca"/>
   <result pre="extraction. J Parasitol. 1972;58:104-107.5062455 32AbebeFErkoBGemetchuTGundersenSGControl of Biomphalaria pfeifferi population and" exact="schistosomiasis" post="transmission in Ethiopia using the soap berry endod (Phytolacca"/>
   <result pre="Histoplasma capsulatum var. farciminosum and treatment of cases of epizootic" exact="lymphangitis" post="in Ethiopia. Asian Pac J Trop Biomed. 2012;2:505-510.23569960 45WoldeamanuelYAbateGChryssanthouEIn"/>
   <result pre="(Endod) against dermatophytes. Ethiop Med J. 2005;43:31-34.16370528 46GurmuAEKisiTShibruHGrazBWillcoxMTreatments used for" exact="malaria" post="in young Ethiopian children: a retrospective study. Malar J."/>
   <result pre="as a larvicide against Anopheles arabiensis, the principal vector of" exact="malaria" post="in Ethiopia. J Am Mosq Control Assoc. 2016;32:124-129.27280350 51KarunamoorthiKBishawDMulatTLaboratory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7393437/results/search/disease/results.xml">
   <result pre="drugs: the tale of artemisinin derivatives in the elimination of" exact="schistosomiasis" post="japonica in ChinaMolecules19920141505815074Retrieved fromhttps://res.mdpi.com/d_attachment/molecules/molecules-19-15058/article_deploy/molecules-19-15058.pdf25244286 LongC.AussaguesY.MolinierN.MarcourtL.VendierL.SamsonA.MassiotG.Dichapetalins from Dichapetalum species and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7397923/results/search/disease/results.xml">
   <result pre="domestic animals of southern Cameroon: Implications for the control of" exact="brucellosis" post="KAMGA et al. KamgaRolin M. N.1SilatsaBarberine A.1FarikouOumarou2KuiateJules‐Roger3SimoGustavehttps://orcid.org/0000-0002-0449-818X1gsimoca@yahoo.frgustave.simo@univ-dschang.org[1], Molecular Parasitology"/>
   <result pre="animals with the overarching goal of improving our knowledge on" exact="brucellosis" post="in southern Cameroon. During cross‐sectional studies conducted from December"/>
   <result pre="each of them has specific environmental conditions;Understanding the epidemiology of" exact="brucellosis" post="for the overarching objective of designing efficient control measures"/>
   <result pre="on human and animal in different epidemiological settings. Brucella antibodies" exact="brucellosis" post="Cameroon domestic animals Funding University of Dschang of Cameroon"/>
   <result pre="of them has specific environmental conditions; Understanding the epidemiology of" exact="brucellosis" post="for the overarching objective of designing efficient control measures"/>
   <result pre="(Ayayi, Têko‐Agbo, &amp;amp; Koné, 2009; Havelaar et al., 2015). This" exact="infectious disease" post="is one of the major constraints for livestock production"/>
   <result pre="1997; Fyumagwa, Wambura, Mellau, &amp;amp; Hoare, 2009). In sub‐Saharan Africa," exact="brucellosis" post="is considered as a serious public health problem which"/>
   <result pre="Pfeiffer, &amp;amp; Chilonda, 2002). In this sub‐region, the prevalence of" exact="brucellosis" post="ranges from sporadic cases to up to 41% in"/>
   <result pre="In Cameroon, previous studies have generated baseline information on cattle" exact="brucellosis" post="in the northern part of the country (Awah‐Ndukum, Mouiche,"/>
   <result pre="by these studies, no control strategy has been developed for" exact="brucellosis" post="in Cameroon like in most sub‐Saharan countries. The development"/>
   <result pre="sub‐Saharan countries. The development and implementation of control measures against" exact="brucellosis" post="require deep investigations aiming to understand the current epidemiological"/>
   <result pre="this area due to unfavourable climatic conditions and also animal" exact="trypanosomiasis" post="which occurs in these areas (Nimpaye et al., 2011;"/>
   <result pre="was estimated as described by Thrusfield (2007) using the bovine" exact="brucellosis" post="prevalence of 5.2% previously reported by Bayemi et al."/>
   <result pre="dogs for which there is no published data on the" exact="brucellosis" post="prevalence in Cameroon, an expected prevalence of 50% was"/>
   <result pre="DISCUSSION This study was designed to improve our knowledge on" exact="brucellosis" post="by determining the prevalence of Brucella antibodies in domestic"/>
   <result pre="standard and common serological tests recommended for epidemiological study on" exact="brucellosis" post="(Leuenberger et al., 2007). Although i‐ELISA showed higher specificity,"/>
   <result pre="water or marketing figure among the well‐known risk factors of" exact="brucellosis" post="(Berhe, Belihu, &amp;amp; Asfaw, 2007; Kadohira, McDermott, Shoukri, &amp;amp;"/>
   <result pre="pasture zone or water point, the chance of transmission of" exact="brucellosis" post="from infected to uninfected herds increases. At Yoko where"/>
   <result pre="the contact with other infected animals are risk factors for" exact="brucellosis" post="spread. Sharing the same environment constitutes therefore a risk"/>
   <result pre="factor for Brucella infections and can facilitate the dissemination of" exact="brucellosis" post="(Kaindi et al., 2012; Shimeles &amp;amp; Andualem, 2018). Although"/>
   <result pre="Gamble, 1992). In Nigeria for instance, the prevalence of porcine" exact="brucellosis" post="was 0.6% (Nwanta et al., 2011; Onunkwo et al.,"/>
   <result pre="villages. Pig breeding could be probably not too affected by" exact="brucellosis" post="and, like in other African countries, B. suis infections"/>
   <result pre="dogs are the first ones reporting the possibility of dog" exact="brucellosis" post="in Cameroon. If we consider dog as the main"/>
   <result pre="Kaindi et al., 2012). In central Africa, most studies on" exact="brucellosis" post="used serological tests and consequently, information related to Brucella"/>
   <result pre="and small ruminants remains unknown. From data generated on bovine" exact="brucellosis" post="in other parts of sub‐Saharan Africa, it is likely"/>
   <result pre="to identify areas presenting high risk where investigations on human" exact="brucellosis" post="could be undertaken for the overarching objective of designing"/>
   <result pre="varies between animal species and localities. Our results indicate that" exact="brucellosis" post="can affect a variety of domestic animals from different"/>
   <result pre="peasant economy. Investigations aiming to determine the prevalence of human" exact="brucellosis" post="and to identify Brucella genotypes could help to better"/>
   <result pre="structures in the indirect enzyme‐linked immunosorbent assay for diagnosis of" exact="brucellosis" post="in small ruminants and cattle. Clinical and Diagnostic Laboratory"/>
   <result pre="R. D., &amp;amp; Verger, J. M. (1988). Technics for the" exact="brucellosis" post="laboratory, Institut National de la Recherche Agronomique, Paris. 10.12691/ajidm-4-5-1"/>
   <result pre="E., … Pappas, G. (2007). Perspectives for the treatment of" exact="brucellosis" post="in the 21st century: TheIoannina recommendations. PLoS Medicine, 4,"/>
   <result pre="Zoli, P. A. (2018). Seroprevalence and associated risk factors of" exact="brucellosis" post="among indigenous cattle in the Adamawa and North Regions"/>
   <result pre="… Zoli, A. P. (2018). Seroprevalence and risk factors of" exact="brucellosis" post="among slaughtered indigenous cattle, abattoir personnel and pregnant women"/>
   <result pre="A., Têko‐Agbo, A., &amp;amp; Koné, P. (2009). The impact of" exact="brucellosis" post="on the economy and public health in Africa Inter‐State"/>
   <result pre="… Perez, A. (2015). Prevalence and spatial distribution of bovine" exact="brucellosis" post="in San Luis and La Pampa, Argentina. BMC Veterinary"/>
   <result pre="Leinyuy, I., Unger, H., … Luogbou, N. D. (2015). Bovine" exact="brucellosis" post="in cattle production systems in the Western Highlands of"/>
   <result pre="Belihu, K., &amp;amp; Asfaw, Y. (2007). Seroepidemiological investigation of bovine" exact="brucellosis" post="in the extensive cattle production system of Tigray region"/>
   <result pre="H. K., &amp;amp; Stack, J. A. (2006). Serological survey of" exact="brucellosis" post="in livestock animals and workers in Ibadan, Nigeria. African"/>
   <result pre="Dinka, H., &amp;amp; Chala, R. (2009). Sero‐prevalence study of bovine" exact="brucellosis" post="in Pastoral and Agro‐Pastoral Areas of East Showa Zone,"/>
   <result pre="Khan, A., Rizvi, F., &amp;amp; Hussain, I. (2014). Sero‐prevalence of" exact="brucellosis" post="in food animals in the Punjab, Pakistan. Pakistan Veterinary"/>
   <result pre="D. (2007). Prevalence of classical swine fever, Aujeszky’s disease and" exact="brucellosis" post="in a population of wild boar in Switzerland. Veterinary"/>
   <result pre="Jubara, A. S., … Kankya, C. (2018). The sero‐prevalence of" exact="brucellosis" post="in cattle and their herders in Bahrel Ghazal region,"/>
   <result pre="J., Otte, J., Pfeiffer, D., &amp;amp; Chilonda, P. (2002). Bovine" exact="brucellosis" post="in Sub‐Saharan Africa: Estimation of sero‐prevalence and impact on"/>
   <result pre="Regassa, A., Godfroid, J., &amp;amp; Skjerve, E. (2011). Seroprevalence of" exact="brucellosis" post="and its contribution to abortion in cattle, camel, and"/>
   <result pre="F., Rufael, T., Asmare, K., &amp;amp; Skjerve, E. (2011). Cattle" exact="brucellosis" post="in traditional livestock husbandry practice in Southern and Eastern"/>
   <result pre="Shewit, K., &amp;amp; Kyule, M. (2010). Serological survey of bovine" exact="brucellosis" post="in barka and arado breeds (Bosindicus) of western Tigray,"/>
   <result pre="Shuaib, Y. A. (2018). Seroprevalence and risk factors of caprine" exact="brucellosis" post="in Khartoum state, Sudan. Veterinary World, 11(4), 511–518. 10.14202/vetworld.2018.511-51829805218"/>
   <result pre="J., Munyeme, M., &amp;amp; Skjerve, E. (2007). Risk factors for" exact="brucellosis" post="in indigenous cattle reared in livestock‐wildlife interface areas of"/>
   <result pre="forest type and T. simiae: Prevalence in domestic animals of" exact="sleeping sickness" post="foci of Cameroon. Parasite, 18, 171–179. 10.1051/parasite/201118217121678793 Njiokou, F.,"/>
   <result pre="animals as potential reservoir hosts of Trypanosoma brucei gambiense in" exact="sleeping sickness" post="foci in Cameroon. Parasite, 17, 61–66. 10.1051/parasite/201017106120387740 Nwanta, J."/>
   <result pre="Animals (pp. 1–35). collab: OIE . (2013b). Caprine and ovine" exact="brucellosis" post="(excluding Brucella ovis). In Manual of Diagnostic Tests and"/>
   <result pre="Bengal Test and Slow Agglutination Test for the diagnosis of" exact="brucellosis" post="in sheep and goats in Bangladesh. Preventive Veterinary Medicine,"/>
   <result pre="Kang, S. I., &amp;amp; Jung, S. C. (2011). Prevalence of" exact="brucellosis" post="in ruminants in Bangladesh. Veterinary Medicine, 56, 379–385. 10.17221/1555-VETMED"/>
   <result pre="56, 379–385. 10.17221/1555-VETMED Refai, M. (2002). Incidence and control of" exact="brucellosis" post="in the Near East region. Veterinary Microbiology, 90, 81–110."/>
   <result pre="Berkvens, D., &amp;amp; Saegerman, C. (2012). Risk factors associated with" exact="brucellosis" post="seropositivity among cattle in the central savannah‐forest area of"/>
   <result pre="Bronsvoort, B. M. D. C. (2010). Serological patterns of brucellosis," exact="leptospirosis" post="and Q fever in Bos indicus cattle in Cameroon."/>
   <result pre="A. A., &amp;amp; Awan, M. A. (2012). Sero‐prevalence of bovine" exact="brucellosis" post="using indirect ELISA in Quetta Balochistan, Pakistan. Journal of"/>
   <result pre="A., &amp;amp; Andualem, Y. D. (2018). Comparative seroepidemiological study of" exact="brucellosis" post="in sheep under smallholder farming and governmental breeding ranches"/>
   <result pre="&amp;amp; Sanchez‐Gil, L. G. (2007). Seroprevalence and risk factors for" exact="brucellosis" post="of goats in herds of Michoacan Mexico. Preventive Veterinary"/>
   <result pre="W. W. (1956). The diagnosis of human brucellosisThe nature of" exact="brucellosis" post="(pp. 191–215). Minneapolis, MN: The University of Minnesota Press."/>
   <result pre="Snyders, A. J., &amp;amp; Van Heerden, K. M. (1958). Infectious" exact="infertility" post="in sheep. Journal of the South African Veterinary Association,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7400140/results/search/disease/results.xml">
   <result pre="disease manifestations such as abdominal pain, anorexia, vomiting, and bloody" exact="diarrhea" post="[2]. Records of the clinical signs in infected chimpanzees"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7411306/results/search/disease/results.xml">
   <result pre="et al., 2015; Gómez-Dantés et al., 2016). Especially type II" exact="diabetes mellitus" post="and chronic kidney disease of unknown cause (CKDu), now"/>
   <result pre="Gómez-Dantés et al., 2016). Especially type II diabetes mellitus and" exact="chronic kidney disease" post="of unknown cause (CKDu), now also called epidemic of"/>
   <result pre="disease of unknown cause (CKDu), now also called epidemic of" exact="chronic kidney disease" post="of nontraditional origin (CKDnt) pose increasing challenges to the"/>
   <result pre="form of CKDu occurring in MA was previously called Mesoamerican" exact="nephropathy" post="(MeN) and affects above all young male workers of"/>
   <result pre="the treatment of emerging health concerns, specifically anxiety and depression," exact="colorectal cancer," post="diabetes, and obesity (Alonso-Castro et al., 2015a; Cruz and"/>
   <result pre="health concerns, specifically anxiety and depression, colorectal cancer, diabetes, and" exact="obesity" post="(Alonso-Castro et al., 2015a; Cruz and Andrade-Cetto, 2015; Andrade-Cetto"/>
   <result pre="14 days) was statistically superior to treatment with the standard" exact="leishmaniasis" post="drug glucantime (28 mg/kg ID every 4 days for"/>
   <result pre="content in feces, frequency of defecation, enteropooling) of castor oil-induced" exact="diarrhea" post="in rats after treatment with either chloroform or methanol"/>
   <result pre="properties in relation to maternal health (Comerford et al, 2016)," exact="osteoarthritis" post="(Christensen et al., 2008), and wound healing (Nayak et"/>
   <result pre="al., 1992).Antidiarrhea: the efficacy in reducing duration and symptoms of" exact="diarrhea" post="of maize-based oral rehydration solutions has been demonstrated in"/>
   <result pre="(7);Infusion of aromatic leaves used throughout MA for stomachache, cough," exact="common cold," post="and flu. Broad antimicrobial: several preclinical studies demonstrated significant"/>
   <result pre="oil (100–400 μl/kg PO) significantly protected rats from acetic acid-induced" exact="colitis" post="(Rashidian et al., 2015).Analgesic: essential oil (50–200 mg/kg SC)"/>
   <result pre="astringent bark of fruit tree used in lowland MA for" exact="diarrhea" post="and inflammatory skin conditions. Antiinflammatory: significant, dose-dependent effect of"/>
   <result pre="lipophilic bark extract (30–300 μg/cm2 TOP) in croton oil-induced ear" exact="dermatitis" post="in mice (Maldini et al., 2009).Antibacterial: moderate effects of"/>
   <result pre="report significant effects of various rosemary extracts on HI and" exact="herpes simplex" post="virus, as comprehensively reviewed (Ulbricht et al., 2010).Spasmolytic: a"/>
   <result pre="might be effective in the treatment of genital herpes and" exact="psoriasis" post="while several studies suggest topical antiinflammatory properties of aloe"/>
   <result pre="with diarrhea, electrolyte imbalance, kidney dysfunction and drug-drug interaction; further," exact="contact dermatitis," post="erythema, and phototoxicity have been reported from topical applications"/>
   <result pre="antiinflammatory and gastroprotective effects (10 and 20mg/kg IP) in a" exact="gastric ulcer" post="model with rats (Mahmoud-Awny et al., 2015). Mangiferin at"/>
   <result pre="and dyspnea while high doses may result in coma and" exact="respiratory failure" post="(Schep et al., 2009). Possibly effective yet probably unsafe"/>
   <result pre="2012).Antidiarrheal: isolated eugenol significantly reduced various parameters of castor oil-induced" exact="diarrhea" post="in rats (Kamatou et al., 2012).Antiulcer: aqueous leaf extracts"/>
   <result pre="et al., 2012).Anticancer: eugenol’s antiproliferative and cytotoxic effects against different" exact="cancer" post="cell lines were demonstrated in several in vitro and"/>
   <result pre="dose-dependent reduction in fecal output in mice with castor oil-induced" exact="diarrhea" post="(Sagar et al., 2005). Severely hepatotoxic and phototoxic, attributed"/>
   <result pre="al., 1991) and a leaf decoction antidiabetic activity in STZ-induced" exact="hyperglycemia" post="in rats (Aguilar et al., 1993). Several studies reported"/>
   <result pre="et al., 2015) but insufficient evidence for significant prevention from" exact="migraine" post="headache based on several double-blind RCTs against, as comprehensively"/>
   <result pre="respiratory tract as well as for ritual healing. Antiviral (incl." exact="influenza" post="virus) and broad antimicrobial (incl. enteropathogens): several in vitro"/>
   <result pre="extract (200–400 mg/kg PO) significantly reduced defecation in castor oil-induced" exact="diarrhea" post="model on mice (Ganguly et al., 2016).Analgesic: ethanolic leaf"/>
   <result pre="diarrhea; all outcome measures (stool output and consistency, stool weight," exact="diarrhea" post="duration, daily gain in body weight) improved significantly in"/>
   <result pre="significantly reduced the intensity of castor oil- and magnesium sulfate-induced" exact="diarrhea" post="in mice (Rao and Lakshmi, 2012). No serious adverse"/>
   <result pre="2000; Gonzales et al., 2007).The fresh plant and extracts cause" exact="contact dermatitis" post="through phototoxic reactions (Brener and Friedman, 1985; Gonçalo et"/>
   <result pre="Gonzales et al., 2007).The fresh plant and extracts cause contact" exact="dermatitis" post="through phototoxic reactions (Brener and Friedman, 1985; Gonçalo et"/>
   <result pre="extract (25–100 mg/kg PO) significantly and dose-dependently reduced castor oil-induced" exact="diarrhea" post="in mice, as reviewed (Semwal et al., 2014).Gastroprotective: several"/>
   <result pre="In sensitive or allergic persons, the essential oil can cause" exact="contact dermatitis" post="and phototoxic reactions (e.g., Swerdlin et al., 2010). Possibly"/>
   <result pre="sensitive or allergic persons, the essential oil can cause contact" exact="dermatitis" post="and phototoxic reactions (e.g., Swerdlin et al., 2010). Possibly"/>
   <result pre="ml/kg PO) significantly and dose-dependently protected rats from acetic acid-induced" exact="colitis" post="(Heidari et al., 2016).Anthelminthic: in vitro and in vivo"/>
   <result pre="fruits are drunk against different gastrointestinal disorders, incl. dysentery, diarrhea," exact="constipation" post="and pain. Hepatoprotective: the ethyl acetate and dichloromethane fractions"/>
   <result pre="common food plant are topically applied to alleviate fever, against" exact="mumps" post="and folk illnesses of children. Antiinflammatory: methanolic leaf extract"/>
   <result pre="that herbal extracts can be effective in the treatment of" exact="amoebiasis" post="and increase biliary, gastric and intestinal excretion of. Further,"/>
   <result pre="and was also active (30 mg/kg IP) in carrageenan induced" exact="pleurisy" post="in mice (Simão da Silva et al., 2012).Antihyperalgesic: ethanolic"/>
   <result pre="Ramos et al., 2001; Ramos et al., 2002).Known to cause" exact="contact dermatitis" post="(e.g., Sharma and Sethuraman, 2007). Unsafe and limited evidence"/>
   <result pre="et al., 2001; Ramos et al., 2002).Known to cause contact" exact="dermatitis" post="(e.g., Sharma and Sethuraman, 2007). Unsafe and limited evidence"/>
   <result pre="during the first trimester, was also associated with reduced odds" exact="gestational hypertension" post="(Saftlas et al., 2010).Another prospective cohort study found umbilical"/>
   <result pre="(Table 3). Typically, many of the herbal drugs used against" exact="diarrhea" post="(D) are rich in tannins and polyphenols (Heinrich, 1998),"/>
   <result pre="of Punicagranatum. Those used altogether for gastrointestinal plain, cramps and" exact="diarrhea" post="such as the leaves of Eryngium foetidum and Litseaglaucescens,"/>
   <result pre="intriguingly Graz et al. (2005) found that the treatment of" exact="malaria" post="in Mali showed no significant correlation between cultural consensus"/>
   <result pre="ArltV. M.StiborovaM.SchmeiserH. H. (2002). Aristolochic acid as a probable human" exact="cancer" post="hazard in herbal remedies: a review. Mutagenesis17, 265–277. 10.1093/mutage/17.4.26512110620"/>
   <result pre="(2013). Effect of Mirabilis jalapa Linn. flowers in experimentally induced" exact="arthritis" post="and consecutive oxidative stress. Int. J. Pharm. Pharm. Sci.5,"/>
   <result pre="W.GerzoffR. B.WongR.Perez FloresE.Ramirez-ZeaM.et al. (2012). Prevalence of diabetes and intermediate" exact="hyperglycemia" post="among adults from the first multinational study of noncommunicable"/>
   <result pre="Ostomy/wound Manage.59, 20–41. 10.25270/owm.2013.10.2041 Berger-GonzálezM.GharzouziE.RennerC. (2016a). Maya healers’ conception of" exact="cancer" post="as compared to Western medicine. J. Glob. Oncol.2, 56–67."/>
   <result pre="extract of the leaves is effective in the treatment of" exact="migraine" post="in women. Phytomedicine20, 947–950. 10.1016/j.phymed.2013.03.01723639189 CarraraV. S.Cunha-JúniorE. F.Torres-SantosE. C.CorreaA."/>
   <result pre="ChristensenR.BartelsE. M.AstrupA.BliddalH. (2008). Symptomatic efficacy of avocado–soybean unsaponifiables (ASU) in" exact="osteoarthritis" post="(OA) patients: a meta-analysis of randomized controlled trials. Osteoarthr."/>
   <result pre="stem bark of Cedrela odorata has low toxicity and reduces" exact="hyperglycemia" post="induced by an overload of sucrose and glucose. J."/>
   <result pre="2013. Lancet388, 2386–2402. 10.1016/S0140-6736(16)31773-127720260 GonçaloS.CorreiaC.CoutoJ. S.GonçaloM. (1989). Contact and photocontact" exact="dermatitis" post="from Ruta chalepensis contact. Dermatitis21, 200–201. 10.1111/j.1600-0536.1989.tb04740.x GonzalesJ.BenavidesV.RojasR.PinoJ. (2007)."/>
   <result pre="extract and its essential oil on acetic acid- induced acute" exact="colitis" post="in rats. Avicenna J. Phytomed.6, 205–214.27222834 HeimbachJ. T.MaroneP. A.HunterJ."/>
   <result pre="plants used in Mexican traditional medicine for the treatment of" exact="colorectal cancer." post="J. Ethnopharmacol.179, 391–402. 10.1016/j.jep.2015.12.04226721221 Jacobo-SalcedoM. D. R.Alonso-CastroA. J.Salazar-OlivoL. A.Carranza-AlvarezC.Gonzaĺez-EspińdolaL."/>
   <result pre="Use of traditional and complementary/alternative medicine (TCAM) in children with" exact="cancer" post="in Guatemala. Pediatr. Blood Cancer61, 687–692. 10.1002/pbc.2479124504792 LarbieC.Owusu NyarkohC.Owusu"/>
   <result pre="México. Polibotánica29, 213–262. Mahmoud-AwnyM.AttiaA. S.Abd-EllahM. F.El-AbharH. S. (2015). Mangiferin mitigates" exact="gastric ulcer" post="in ischemia/reperfused rats: involvement of PPAR-γ, NF-κB and Nrf2/HO-1"/>
   <result pre="oil from Chenopodium ambrosioides and its main components against experimental" exact="cutaneous leishmaniasis" post="in BALB/c mice. Phytomedicine21, 1048–1052. 10.1016/j.phymed.2014.03.00224768411 Morais-BragaM. F. B.CarneiroJ."/>
   <result pre="from Chenopodium ambrosioides and its main components against experimental cutaneous" exact="leishmaniasis" post="in BALB/c mice. Phytomedicine21, 1048–1052. 10.1016/j.phymed.2014.03.00224768411 Morais-BragaM. F. B.CarneiroJ."/>
   <result pre="and antimalarial activity of plants traditionally used in treatment of" exact="malaria" post="in Msambweni district. Pharm. Biol.53, 588–593. 10.3109/13880209.2014.93586125495507 MyersN.MittermeierR. A.MittermeierC."/>
   <result pre="55–59. 10.1016/j.vetpar.2008.10.01819042088 OoiC. P.YassinZ.HamidT.-A. (2012). Momordica charantia for type 2" exact="diabetes mellitus." post="Cochrane Database Syst. Rev.8:CD007845. 10.1002/14651858.CD007845.pub3 OrdoñezA. A. L.GomezJ. D.CudmaniN."/>
   <result pre="(2019). Momordica charantia L. lowers elevated glycaemia in type 2" exact="diabetes mellitus" post="patients: Systematic review and meta-analysis. J. Ethnopharmacol.231, 311–324. 10.1016/j.jep.2018.10.03330385422"/>
   <result pre="(2016). Anxiolytic effect of Citrus aurantium L. on patients with" exact="chronic myeloid leukemia." post="Phyther. Res.30, 613–617. 10.1002/ptr.5566 PittlerM. H.ErnstE. (2004). Feverfew for"/>
   <result pre="Anxiolytic effect of Citrus aurantium L. on patients with chronic" exact="myeloid leukemia." post="Phyther. Res.30, 613–617. 10.1002/ptr.5566 PittlerM. H.ErnstE. (2004). Feverfew for"/>
   <result pre="Protective effect of Ocimum basilicum essential oil against acetic acid–induced" exact="colitis" post="in rats. J. Evid. Based Integr. Med.21, NP36–NP42. 10.1177/2156587215616550"/>
   <result pre="chocolate intake during pregnancy reduce the risks of preeclampsia and" exact="gestational hypertension?" post="Ann. Epidemiol.20, 584–591. 10.1016/j.annepidem.2010.05.01020609337 SagarL.SehgalR.OjhaS. (2005). Evaluation of antimotility"/>
   <result pre="effects of Capsicum annuum L. and its constituent, capsaicin, in" exact="metabolic syndrome." post="Iran. J. Basic Med. Sci.21, 439–448. 10.22038/ijbms.2018.25200.623829922422 Sánchez-MendozaM. E.Reyes-RamírezA.Cruz"/>
   <result pre="Chemical composition of hexane extract of Citrus aurantifolia and anti-Mycobacterium" exact="tuberculosis" post="activity of some of its constituents. Molecules17, 11173–11184. 10.3390/molecules17091117322992784"/>
   <result pre="418–423. 10.4103/0253-7613.18621227756954 SwerdlinA.RaineyD.StorrsF. J. (2010). Fragrance mix reactions and lime" exact="allergic contact dermatitis." post="Dermatitis21, 214–216. 10.2310/6620.2010.1001420646673 Taddei-BringasG. A.Santillana-MacedoM. A.Romero-CancioJ. A.Romero-TéllezM. B. (1999)."/>
   <result pre="10.4103/0253-7613.18621227756954 SwerdlinA.RaineyD.StorrsF. J. (2010). Fragrance mix reactions and lime allergic" exact="contact dermatitis." post="Dermatitis21, 214–216. 10.2310/6620.2010.1001420646673 Taddei-BringasG. A.Santillana-MacedoM. A.Romero-CancioJ. A.Romero-TéllezM. B. (1999)."/>
   <result pre="survey. J. Ethnopharmacol.32, 37–41. 10.1016/0378-8741(91)90101-I1881165 WesselingC.CroweJ.HogstedtC.JakobssonK.LucasR.WegmanD.H. (2013). The epidemic of" exact="chronic kidney disease" post="of unknown etiology in Mesoamerica: A call for interdisciplinary"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7412011/results/search/disease/results.xml">
   <result pre="range of disorders, including gastrointestinal disturbances, neurological disorders, inflammation, and" exact="diarrhea" post="[12]. Moreover, it is used to treat other diseases,"/>
   <result pre="diseases, like dyspepsia, itching skin, excessive menstrual bleeding, hemorrhoids, and" exact="cancer" post="(particularly colon, breast, and prostate cancer) [13]. Furthermore, sap"/>
   <result pre="leaves is used to treat headache, pain, toothache, liver enlargement," exact="gastric ulcer," post="dysentery, and loss of appetite. The juice of this"/>
   <result pre="toxic and leads to biomolecular damage, which in turn causes" exact="diabetes mellitus," post="cancer, atherosclerosis, and heart and neurodegenerative diseases [24]. In"/>
   <result pre="β-carotene showed a strong association with a lower risk of" exact="lung cancer" post="[33]. β-Carotene along with phenytoin has great antiepileptic activity"/>
   <result pre="showed a strong association with a lower risk of lung" exact="cancer" post="[33]. β-Carotene along with phenytoin has great antiepileptic activity"/>
   <result pre="activity and can be used as a therapeutic agent in" exact="epilepsy" post="management [34]. Tannins have been reported as anticancer and"/>
   <result pre="of lycopene. The intake of lycopene reduces the risk of" exact="prostate cancer" post="[40] and plays a protective role against nephrotoxicity [41]."/>
   <result pre="lycopene. The intake of lycopene reduces the risk of prostate" exact="cancer" post="[40] and plays a protective role against nephrotoxicity [41]."/>
   <result pre="α-glucosidase, have been targeted as a therapeutic approach in postprandial" exact="hyperglycemia" post="[43] because their inhibition can cause reduction in postprandial"/>
   <result pre="hyperglycemia [43] because their inhibition can cause reduction in postprandial" exact="hyperglycemia" post="[44]. Our results indicate that α-amylase activity was inhibited"/>
   <result pre="weight loss and glycemic control in pathological state such as" exact="obesity" post="and diabetesComp. Clin. Path.2016251253126410.1007/s00580-014-1967-x 30.TripathiB.K.SrivastavaA.K.Diabetes mellitus: Complications and therapeuticsMed."/>
   <result pre="and modulate apoptosis-related gene expression in MCF-7 and HepG2 human" exact="cancer" post="cell linesMolecules20192461210.3390/molecules24030612 37.OgawaS.YazakiY.Tannins from acacia mearnsii De Wild. Bark:"/>
   <result pre="J. Nutr.201611622324610.1017/S000711451600188427264638 40.GiovannucciE.RimmE.B.LiuY.StampferM.J.WillettW.C.A prospective study of tomato products, lycopene, and" exact="prostate cancer" post="riskJ. Natl. Cancer Inst.20029439139810.1093/jnci/94.5.39111880478 41.AtessahinA.YilmazS.KarahanI.CeribasiA.O.KaraogluA.Effects of lycopene against cisplatin-induced"/>
   <result pre="Nutr.201611622324610.1017/S000711451600188427264638 40.GiovannucciE.RimmE.B.LiuY.StampferM.J.WillettW.C.A prospective study of tomato products, lycopene, and prostate" exact="cancer" post="riskJ. Natl. Cancer Inst.20029439139810.1093/jnci/94.5.39111880478 41.AtessahinA.YilmazS.KarahanI.CeribasiA.O.KaraogluA.Effects of lycopene against cisplatin-induced"/>
   <result pre="of traditional corn, beans, and pumpkin: In vitro studies for" exact="hyperglycemia" post="and hypertension managementJ. Med. Food20071026627510.1089/jmf.2006.23417651062 45.ChewY.L.ChanE.W.L.TanP.L.LimY.StanslasJ.GohJ.K.Assessment of phytochemical content,"/>
   <result pre="ND 9 11 13 15 17 18 ND 22 K." exact="pneumonia" post="9 10 12 13 14 16 9 10 11"/>
   <result pre="17 9 10 12 14 15 17 ND 22 K." exact="pneumonia" post="7 8 9 13 14 15 9 10 12"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7412399/results/search/disease/results.xml">
   <result pre="gingers in Thailand. Zingiber Curcuma digestive medicinal ethnobotany gingers carminative" exact="gastritis" post="International Classification of Primary Care-2 ICPC-2 1. Introduction Traditional"/>
   <result pre="gastritis. Uses of gingers as a laxative, and to treat" exact="diarrhea" post="and colitis, made up approximately 7% of all use"/>
   <result pre="abdominal pain. The ICF values for treating diarrhea, peptic ulcers," exact="constipation" post="and colitis were also high, and varied between 0.40"/>
   <result pre="The ICF values for treating diarrhea, peptic ulcers, constipation and" exact="colitis" post="were also high, and varied between 0.40 and 0.50"/>
   <result pre="ulcers. Kaempferia species were used to treat flatulence, abdominal pain," exact="diarrhea" post="and peptic ulcer (Table 3). The CI values for"/>
   <result pre="species were used to treat flatulence, abdominal pain, diarrhea and" exact="peptic ulcer" post="(Table 3). The CI values for Zingiber montanum (J.Koenig)"/>
   <result pre="top five for treatments of abdominal pain, colitis, diarrhea, flatulence," exact="constipation" post="and peptic ulcers. Different gingers were used for different"/>
   <result pre="cavity. However, abdominal pain mostly refers to stomach ache or" exact="gastritis" post="(many references in the Supplementary Materials). In such a"/>
   <result pre="digestive system disorders, especially for abdominal pain, colitis, diarrhea, flatulence," exact="constipation" post="and peptic ulcers. Specifically, we suggest the plant taxa"/>
   <result pre="of health conditions, specifically for abdominal pain, colitis, diarrhea, flatulence," exact="constipation" post="and peptic ulcers. We hope that our results will"/>
   <result pre="category of digestive system disorders (abdominal pain, colitis, diarrhea, flatulence," exact="constipation" post="and peptic ulcers) extracted from 62 references covering 104"/>
   <result pre="Burns Plae Fai Mai/Nam Ron Luak Canker Pak Puay Catepillar" exact="allergy" post="Pae Non/Bung Chronic rash Kan Rua Rung Dandruff Rung"/>
   <result pre="Ron Luak Canker Pak Puay Catepillar allergy Pae Non/Bung Chronic" exact="rash" post="Kan Rua Rung Dandruff Rung Kae Dermatophytosis Klak Kluan"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7490686/results/search/disease/results.xml">
   <result pre="dedicated olfactory circuit for detecting harmful microbes in DrosophilaCell20121511345135723217715 52.SeipkeRFLoriaRStreptomyces" exact="scabies" post="87-22 possesses a functional tomatinaseJ. Bacteriol.20081907684769218835993 53.SarwarAet al.Biological control"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7508320/results/search/disease/results.xml">
   <result pre="and in vivo models and by utilizing these constituents and" exact="cancer" post="prevention strategies had emphasized (Bulbul et al., 2013). Again"/>
   <result pre="significant alteration of consciousness (Dewan et al., 2013). In Bangladesh," exact="diarrhea" post="is liable to the death of one third of"/>
   <result pre="that medicinal plants are efficiently used for the treatment of" exact="diarrhea" post="(Dooley et al., 2015). Various antidiarrheal compounds increase its"/>
   <result pre="was used as reference standard. Antidiarrheal activity test Castor oil-induced" exact="diarrhea" post="was induced according to method of Uddin et al."/>
   <result pre="expressed as mean±SEM, N=5 Antidiarrheal activity test In castor oil-induced" exact="diarrhea" post="test, n-hexane fraction showed promising anti-diarrheal effect in mice"/>
   <result pre="of crude extract of seeds of MC on castor oil-induced" exact="diarrhea" post="Groups Treatment(p.o.) Total number of feces % Inhibitionof defecation"/>
   <result pre="feces % Inhibitionof defecation Total number ofdiarrheal feces % Inhibitionof" exact="diarrhea" post="I Saline (2 ml/kg) 21±1.00 - 12±0.57 - II"/>
   <result pre="increasing concentration. Agents which are used for the management of" exact="cancer" post="show toxicity on normal cells in particular rapidly growing"/>
   <result pre="used for the control of diarrhoeal diseases which efficaciously antagonizes" exact="diarrhea" post="precipitated by the castor oil (Al-Taher, 2008). In case"/>
   <result pre="blind trial of holy basil leaves in patients with non-insulin-dependent" exact="diabetes mellitus" post="Int J Clin Pharmacol Ther1996344064098880292 AhmedMShikhaHSadhuSKTMMRDattaBKAnalgesic, diuretic, and anti-inflammatory"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7509998/results/search/disease/results.xml">
   <result pre="doi: 10.4251/wjgo.v12.i9.957 : Review Notch signalling pathway in development of" exact="cholangiocarcinoma" post="RauffBisma[], bisma.rauff@imbb.uol.edu.pkMalikArif[], BhattiYasir Ali[], ChudharyShafiq Ahmad[], QadriIshtiaq[], RafiqShafquat[], Author"/>
   <result pre="the use is non-commercial. Abstract Cholangiocarcinoma (CCA) comprises of extra-hepatic" exact="cholangiocarcinoma" post="and intrahepatic cholangiocarcinoma cancers as a result of inflammation"/>
   <result pre="is non-commercial. Abstract Cholangiocarcinoma (CCA) comprises of extra-hepatic cholangiocarcinoma and" exact="intrahepatic cholangiocarcinoma" post="cancers as a result of inflammation of epithelium cell"/>
   <result pre="non-commercial. Abstract Cholangiocarcinoma (CCA) comprises of extra-hepatic cholangiocarcinoma and intrahepatic" exact="cholangiocarcinoma" post="cancers as a result of inflammation of epithelium cell"/>
   <result pre="chronic damage and inflammation of bile duct epithelium from primary" exact="sclerosing cholangitis," post="chronic hepatitis virus infection, gallstones and liver fluke infection."/>
   <result pre="inflammation of bile duct epithelium from primary sclerosing cholangitis, chronic" exact="hepatitis" post="virus infection, gallstones and liver fluke infection. Various genetic"/>
   <result pre="therapies against CCA. INTRODUCTION Cholangiocarcinoma (CCA) is the most common" exact="biliary tract cancer" post="and the second most common primary liver cancer, which"/>
   <result pre="CCA. INTRODUCTION Cholangiocarcinoma (CCA) is the most common biliary tract" exact="cancer" post="and the second most common primary liver cancer, which"/>
   <result pre="common biliary tract cancer and the second most common primary" exact="liver cancer," post="which is characterized by its late diagnosis and subsequent"/>
   <result pre="based on its anatomical location. CCA are commonly staged into" exact="intrahepatic cholangiocarcinoma" post="(IH-CCA) and extra-hepatic cholangiocarcinoma (EH-CCA) tumours. EH-CCA can further"/>
   <result pre="on its anatomical location. CCA are commonly staged into intrahepatic" exact="cholangiocarcinoma" post="(IH-CCA) and extra-hepatic cholangiocarcinoma (EH-CCA) tumours. EH-CCA can further"/>
   <result pre="CCA are commonly staged into intrahepatic cholangiocarcinoma (IH-CCA) and extra-hepatic" exact="cholangiocarcinoma" post="(EH-CCA) tumours. EH-CCA can further be subdivided into perihilar"/>
   <result pre="and 1.5 per 100000, respectively[4]. The incidence rate of intrahepatic" exact="cancer" post="is reported more than that of the extrahepatic cancer"/>
   <result pre="intrahepatic cancer is reported more than that of the extrahepatic" exact="cancer" post="in the United Kingdom, which is 3.64 vs 3.58"/>
   <result pre="nodes. Hence, adjuvant chemotherapy plays a significant role in delaying" exact="cancer" post="recurrence and prolonging life expectancy in cholangiocarcinomic patients[7]. Apparently,"/>
   <result pre="are bile duct disorders particularly cysts of biliary tract, primary" exact="sclerosing cholangitis," post="hepatolothiasis, cholelithiasis and choledocholithiasis and many liver diseases like"/>
   <result pre="cholelithiasis and choledocholithiasis and many liver diseases like cirrhosis, hemochromatosis," exact="viral hepatitis" post="and Wilson’s disease. Digestive diseases like inflammatory bowel disease,"/>
   <result pre="and choledocholithiasis and many liver diseases like cirrhosis, hemochromatosis, viral" exact="hepatitis" post="and Wilson’s disease. Digestive diseases like inflammatory bowel disease,"/>
   <result pre="and Wilson’s disease. Digestive diseases like inflammatory bowel disease, chronic" exact="pancreatitis" post="and duodenal or gastric ulcer are also among contributing"/>
   <result pre="diseases like inflammatory bowel disease, chronic pancreatitis and duodenal or" exact="gastric ulcer" post="are also among contributing factors. Many parasitic infections have"/>
   <result pre="been reported to modulate risk of CCA. Combined hepatocellular and" exact="cholangiocarcinoma" post="account for around 0.5% to 14% of primary liver"/>
   <result pre="parent phenotypic characteristics and are typically even more aggressive than" exact="hepatocellular carcinoma" post="(HCC) or IH-CCA. Although less well studied, cholangiocarcinomas are"/>
   <result pre="IH-CCA share several recurring risk factors with respect to chronic" exact="liver disease" post="and its causes. Furthermore, despite improved understanding of CCA"/>
   <result pre="growth factors (PDGF, VEGF, and TGFβ etc.)[9]. Molecular pathogenesis of" exact="cholangiocarcinoma" post="is very complicated and involves multiple pathways; out of"/>
   <result pre="a variety of haemopoietic and solid tumours[18], including T-cell leukaemia," exact="prostate cancer," post="lung cancer, colorectal cancer, cancers of central nervous system."/>
   <result pre="of haemopoietic and solid tumours[18], including T-cell leukaemia, prostate cancer," exact="lung cancer," post="colorectal cancer, cancers of central nervous system. Furthermore, it"/>
   <result pre="and solid tumours[18], including T-cell leukaemia, prostate cancer, lung cancer," exact="colorectal cancer," post="cancers of central nervous system. Furthermore, it has also"/>
   <result pre="reported to be in association with the breast and oesophageal" exact="cancer" post="stem cells. Targeting this pathway represent a reasonable approach"/>
   <result pre="intrahepatic bile ducts, a condition that leads to the chronic" exact="cholestasis" post="and hepatic failure[29,30]. In human IH-CCA, the Notch pathway"/>
   <result pre="and might be important for the growth of tumours following" exact="hepatitis" post="B virus infection[41]. In contrast to the complicated functions"/>
   <result pre="activation of Notch signalling pathway and overexpression of v-akt murine" exact="thymoma" post="viral oncogene homolog (AKT) proto-oncogene and inactivation of the"/>
   <result pre="the mouse model manifested by the higher expression of activated" exact="neuroblastoma" post="RAS viral oncogene homolog (NRas) and v-akt murine thymoma"/>
   <result pre="activated neuroblastoma RAS viral oncogene homolog (NRas) and v-akt murine" exact="thymoma" post="viral oncogene homolog (AKT) proto-oncogenes[62]. Another study proposes that"/>
   <result pre="Notch Signalling pathway and their current findings in development of" exact="cholangiocarcinoma" post="Receptors, ligands and downstream signaling molecules Type of model"/>
   <result pre="atypical receptor rather than canonical Notch-RBPJ mechanism. Hepatocarcinogen Thioacetamide induces" exact="cancer" post="in CK19CreERTeYFPp53 mouse model owing constitutive Notch3 deletion that"/>
   <result pre="poor prognosis of IH-CCA [59] Jagged-1 Human cell lines The" exact="suppression" post="of the Jagged-1 results in the reduction of growth"/>
   <result pre="pathway plays an important regulatory role in the development of" exact="liver cancer." post="The function of this pathway has been demonstrated in"/>
   <result pre="are reported to show the cytotoxicity in various types of" exact="cancer" post="cells[81]. Though they have tested in clinical trials of"/>
   <result pre="GSI are being extensively studied in initial clinical trials of" exact="breast cancer," post="T-ALL and other solid tumours[83] but their application in"/>
   <result pre="Phase 2, however, Tarextumab has been more applied on small" exact="lung cancer" post="patients the ones with CCA[87]. Some ligands inhibitors have"/>
   <result pre="2, however, Tarextumab has been more applied on small lung" exact="cancer" post="patients the ones with CCA[87]. Some ligands inhibitors have"/>
   <result pre="completed clinical trials have been mainly conducted in non-small cell" exact="lung cancer," post="ovarian cancer and pancreatic cancer patients; nevertheless, a Phase"/>
   <result pre="trials have been mainly conducted in non-small cell lung cancer," exact="ovarian cancer" post="and pancreatic cancer patients; nevertheless, a Phase 1b trial"/>
   <result pre="have been mainly conducted in non-small cell lung cancer, ovarian" exact="cancer" post="and pancreatic cancer patients; nevertheless, a Phase 1b trial"/>
   <result pre="mainly conducted in non-small cell lung cancer, ovarian cancer and" exact="pancreatic cancer" post="patients; nevertheless, a Phase 1b trial of Demcizumab plus"/>
   <result pre="conducted in non-small cell lung cancer, ovarian cancer and pancreatic" exact="cancer" post="patients; nevertheless, a Phase 1b trial of Demcizumab plus"/>
   <result pre="these two, one follows the inhibition of the growth of" exact="cancer" post="cells and other follows the deregulation of process of"/>
   <result pre="the benefits of using anti Notch receptor monoclonal antibodies for" exact="cancer" post="treatment[90]. RNA interfering antisense oligonucleotide: RNA interfering antisense oligonucleotide,"/>
   <result pre="and miR-429, performs a significant function in suppressing metastasis of" exact="cancer" post="by inhibiting the EMT. Reduced expression levels of miR-200c"/>
   <result pre="to have the potential role of inhibiting the progression of" exact="colon cancer" post="by up-regulating the miR-200 family members and by down-regulating"/>
   <result pre="have the potential role of inhibiting the progression of colon" exact="cancer" post="by up-regulating the miR-200 family members and by down-regulating"/>
   <result pre="on the development of in vivo and in vitro T-Cell" exact="acute leukemia" post="models[96]. Small-molecule inhibitor (SMI), inhibitor (Inhibitor of Mastermind Recruitment-1"/>
   <result pre="the development of in vivo and in vitro T-Cell acute" exact="leukemia" post="models[96]. Small-molecule inhibitor (SMI), inhibitor (Inhibitor of Mastermind Recruitment-1"/>
   <result pre="a second-generation SMI of β-hydroxylase activity has demonstrated a significant" exact="suppression" post="in the tumour growth and progression of CCA without"/>
   <result pre="the treatment of variety of aliments including central nervous system" exact="respiratory disease," post="cardiac diseases and canner. An important component of Chansu"/>
   <result pre="important component of Chansu is Cinobufagin that has an anti" exact="cancer" post="effects including inhibition of prostate cancer cells by inducing"/>
   <result pre="Cinobufagin that has an anti cancer effects including inhibition of" exact="prostate cancer" post="cells by inducing apoptosis[103]. Antitumour effects of cinobufagin on"/>
   <result pre="that has an anti cancer effects including inhibition of prostate" exact="cancer" post="cells by inducing apoptosis[103]. Antitumour effects of cinobufagin on"/>
   <result pre="of cinobufagin on CCA has illustrated that Cinobufagin exhibits significant" exact="suppression" post="on CCA cell proliferation as well as induce the"/>
   <result pre="pathway plays a significant role in the basic processes of" exact="cancer" post="cell proliferation and apoptosis, it has been found that"/>
   <result pre="gene expression in dnMAML cohorts. These findings propose that therapeutic" exact="suppression" post="of osteoclast Notch pathway could lower the osteoclastic resorption"/>
   <result pre="examined in vivo and/or in vitro for the treatment of" exact="cholangiocarcinoma" post="Molecules/Targets and Functions Experiments Results and findings GSI IX"/>
   <result pre="Phase1b/2 study conducted on SCLC (Small Cell Lung Cancer) and" exact="pancreatic cancer." post="Phase1b results showed a greater tumor reduction at high"/>
   <result pre="a partial response and 38% showed a stable disease. In" exact="pancreatic cancer" post="patients, 50% of valuable patients who received Demcizumab showed"/>
   <result pre="partial response and 38% showed a stable disease. In pancreatic" exact="cancer" post="patients, 50% of valuable patients who received Demcizumab showed"/>
   <result pre="significant decrease of tumor burden[94] Niclosamide (An antheliminthic drug) Colon" exact="cancer" post="cell lines (HCT116, LoVo and SW620 cells) Niclosamide results"/>
   <result pre="SW620 cells) Niclosamide results in inhibition of the progression of" exact="colon cancer" post="by up-regulating the miR-200 family members and by down-regulating"/>
   <result pre="cells) Niclosamide results in inhibition of the progression of colon" exact="cancer" post="by up-regulating the miR-200 family members and by down-regulating"/>
   <result pre="growth and progression of CCA. The treatment also results in" exact="suppression" post="of overexpression of Notch1 and Hey1 in the tumors[99]"/>
   <result pre="growth of the cells and stimulates the apoptosis with subsequent" exact="suppression" post="of Notch1 and Hes1 mRNA expression[101] Cinobufagin (Chansu, Toad"/>
   <result pre="(EX-CCA) Cinobufagin causes and cell apoptosis and anti-proliferative effects in" exact="cancer" post="cells[103]. Cinobufagin-derived inactivation of Notch signalling pathway results in"/>
   <result pre="NOTCH receptors and their ligands in the development of hepatoblastoma," exact="cholangiocarcinoma" post="and hepatocellular carcinomaBiol Cell2016108294026621221 13CiglianoAWangJChenXCalvisiDFRole of the Notch signaling"/>
   <result pre="Notch signaling in cholangiocarcinomaExpert Opin Ther Targets20172147148328326864 14WangJDongMXuZSongXZhangSQiaoYCheLGordanJHuKLiuYCalvisiDFChenXNotch2 controls hepatocyte-derived" exact="cholangiocarcinoma" post="formation in miceOncogene2018373229324229545603 15HuangQLiJZhengJWeiAThe Carcinogenic Role of the Notch"/>
   <result pre="CarcinomaJ Cancer2019101570157931031867 16CheLFanBPiloMGXuZLiuYCiglianoACossuAPalmieriGPascaleRMPorcuAVidiliGSerraMDombrowskiFRibbackSCalvisiDFChenXJagged 1 is a major Notch ligand along" exact="cholangiocarcinoma" post="development in mice and humansOncogenesis20165e27427918553 17LuoZShangXZhangHWangGMasseyPABartonSRKevilCGDongYNotch Signaling in Osteogenesis,"/>
   <result pre="Notch ligandsCurr Top Dev Biol2010927312920816393 21NtziachristosPLimJSSageJAifantisIFrom fly wings to targeted" exact="cancer" post="therapies: a centennial for notch signalingCancer Cell20142531833424651013 22JoshiIMinterLMTelferJDemarestRMCapobiancoAJAsterJCSicinskiPFauqAGoldeTEOsborneBANotch signaling"/>
   <result pre="cyclin D3 and its dependent kinasesBlood20091131689169819001083 23LewisHDLeveridgeMStrackPRHaldonCDO'neilJKimHMadinAHannamJCLookATKohlNDraettaGHarrisonTKerbyJAShearmanMSBeherDApoptosis in T cell" exact="acute lymphoblastic leukemia" post="cells after cell cycle arrest induced by pharmacological inhibition"/>
   <result pre="D3 and its dependent kinasesBlood20091131689169819001083 23LewisHDLeveridgeMStrackPRHaldonCDO'neilJKimHMadinAHannamJCLookATKohlNDraettaGHarrisonTKerbyJAShearmanMSBeherDApoptosis in T cell acute" exact="lymphoblastic leukemia" post="cells after cell cycle arrest induced by pharmacological inhibition"/>
   <result pre="and its dependent kinasesBlood20091131689169819001083 23LewisHDLeveridgeMStrackPRHaldonCDO'neilJKimHMadinAHannamJCLookATKohlNDraettaGHarrisonTKerbyJAShearmanMSBeherDApoptosis in T cell acute lymphoblastic" exact="leukemia" post="cells after cell cycle arrest induced by pharmacological inhibition"/>
   <result pre="Natl Acad Sci2006103182611826617114293 25YuanXWuHXuHXiongHChuQYuSWuGSWuKNotch signaling: an emerging therapeutic target for" exact="cancer" post="treatmentCancer Lett2015369202726341688 26GeislerFStrazzaboscoMEmerging roles of Notch signaling in liver"/>
   <result pre="significance in hepatocellular carcinomaNeoplasma20095653354119728763 36QiRAnHYuYZhangMLiuSXuHGuoZChengTCaoXNotch1 signaling inhibits growth of human" exact="hepatocellular carcinoma" post="through induction of cell cycle arrest and apoptosisCancer Res2003638323832914678992"/>
   <result pre="mice with an induced inactivation of Notch1Immunity19991054755810367900 38ViatourPEhmerUSaddicLADorrellCAndersenJBLinCZmoosAFMazurPKSchafferBEOstermeierAVogelHSylvesterKGThorgeirssonSSGrompeMSageJNotch signaling inhibits" exact="hepatocellular carcinoma" post="following inactivation of the RB pathwayJ Exp Med20112081963197621875955 39DillMTTornilloLFritziusTTerraccianoLSemelaDBettlerBHeimMHTchorzJSConstitutive"/>
   <result pre="injured mature hepatocytesCell Stem Cell20141560561825312494 57XueTCZhangBHYeSLRenZGDifferentially expressed gene profiles of" exact="intrahepatic cholangiocarcinoma," post="hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysisTumour"/>
   <result pre="hepatocytesCell Stem Cell20141560561825312494 57XueTCZhangBHYeSLRenZGDifferentially expressed gene profiles of intrahepatic cholangiocarcinoma," exact="hepatocellular carcinoma," post="and combined hepatocellular-cholangiocarcinoma by integrated microarray analysisTumour Biol2015365891589925712376 58Le"/>
   <result pre="signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for" exact="cancer" post="stem cell-like propertiesBMC Cancer20161685427821106 61El KhatibMBozkoPPalaganiVMalekNPWilkensLPlentzRRActivation of Notch signaling"/>
   <result pre="propertiesBMC Cancer20161685427821106 61El KhatibMBozkoPPalaganiVMalekNPWilkensLPlentzRRActivation of Notch signaling is required for" exact="cholangiocarcinoma" post="progression and is enhanced by inactivation of p53 in"/>
   <result pre="and oncogenesisClin Res Hepatol Gastroenterol20133744745423806629 70SingrangNKittisenachaiSRoytrakulSSvastiJKangsamaksinTNOTCH1 regulates the viability of" exact="cholangiocarcinoma" post="cells via 14-3-3 thetaJ Cell Commun Signal20191324525430264361 71BrivioSCadamuroMFabrisLStrazzaboscoMMolecular Mechanisms"/>
   <result pre="in cholangiocarcinomaJ Hepatol20146059960524239776 76FingasCDBronkSFWerneburgNWMottJLGuicciardiMECazanaveSCMertensJCSiricaAEGoresGJMyofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in" exact="cholangiocarcinoma" post="cellsHepatology2011542076208822038837 77JengKSChangCFLinSSSonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor"/>
   <result pre="Exp Clin Cancer Res20193847631775892 85MancarellaSSerinoGDituriFCiglianoARibbackSWangJChenXCalvisiDFGiannelliGCrenigacestat, a selective NOTCH1 inhibitor, reduces" exact="intrahepatic cholangiocarcinoma" post="progression by blocking VEGFA/DLL4/MMP13 axisCell Death Differ2020272330234332042099 86O'RourkeCJMatterMSNepalCCaetano-OliveiraRTonPTFactorVMAndersenJBIdentification of"/>
   <result pre="Clin Cancer Res20193847631775892 85MancarellaSSerinoGDituriFCiglianoARibbackSWangJChenXCalvisiDFGiannelliGCrenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic" exact="cholangiocarcinoma" post="progression by blocking VEGFA/DLL4/MMP13 axisCell Death Differ2020272330234332042099 86O'RourkeCJMatterMSNepalCCaetano-OliveiraRTonPTFactorVMAndersenJBIdentification of"/>
   <result pre="miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with" exact="hepatocellular carcinoma" post="or intrahepatic cholangiocarcinoma and its prognostic significanceMol Carcinog20135229730322213236 93Zakaria"/>
   <result pre="miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or" exact="intrahepatic cholangiocarcinoma" post="and its prognostic significanceMol Carcinog20135229730322213236 93Zakaria MK, Ali A,"/>
   <result pre="miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic" exact="cholangiocarcinoma" post="and its prognostic significanceMol Carcinog20135229730322213236 93Zakaria MK, Ali A,"/>
   <result pre="Impact on Regulation of Notch PathwayAm J Pathol20171872288229928923203 95SulimanMAZhangZNaHRibeiroALZhangYNiangBHamidASZhangHXuLZuoYNiclosamide inhibits" exact="colon cancer" post="progression through downregulation of the Notch pathway and upregulation"/>
   <result pre="on Regulation of Notch PathwayAm J Pathol20171872288229928923203 95SulimanMAZhangZNaHRibeiroALZhangYNiangBHamidASZhangHXuLZuoYNiclosamide inhibits colon" exact="cancer" post="progression through downregulation of the Notch pathway and upregulation"/>
   <result pre="β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and ProgressionPLoS One201611e015033626954680 100GuYXiaoLMingYZhengZLiWCorilagin suppresses" exact="cholangiocarcinoma" post="progression through Notch signaling pathway in vitro and in"/>
   <result pre="ChienEWangPSApoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human" exact="prostate cancer" post="cellsCancer Sci2008992467247619037992 104Ren J, Wang S, Jin L, Ma"/>
   <result pre="signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate" exact="cancer" post="cellsCancer Sci2008992467247619037992 104Ren J, Wang S, Jin L, Ma"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7533268/results/search/disease/results.xml">
   <result pre="results in the progression of serious inflammatory diseases, including asthma," exact="autoimmune disease," post="chronic inflammation, glomerulonephritis, inflammatory bowel diseases, pelvic inflammatory disease,"/>
   <result pre="including asthma, autoimmune disease, chronic inflammation, glomerulonephritis, inflammatory bowel diseases," exact="pelvic inflammatory disease," post="reperfusion injury, hypersensitivities, hay fever, atherosclerosis, and rheumatoid arthritis."/>
   <result pre="pelvic inflammatory disease, reperfusion injury, hypersensitivities, hay fever, atherosclerosis, and" exact="rheumatoid arthritis." post="These devastating conditions are the major cause of disabilities"/>
   <result pre="with many side effects and toxicities, such as gastric irritation," exact="gastric ulcer," post="alterations in renal function, effects on blood pressure, hepatic"/>
   <result pre="the synthesis and release of various endogenous inflammatory mediators and" exact="suppression" post="of sensitivity of peripheral nociceptors in the peritoneal free"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7538544/results/search/disease/results.xml">
   <result pre="wood, instrument making, firewood and skin diseases such as pimples," exact="scabies" post="and inflammation (18, 19). And it is widely distributed"/>
   <result pre="activity against the tick Rhipicephalus microplus; antiviral potential against the" exact="influenza" post="virus; and anthelmintic activity (13–15, 32, 37). Despite the"/>
   <result pre="Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium" exact="tuberculosis" post="strains. Pulm Pharmacol Ther. (2014) 21:114–20. 10.1016/j.pupt.2013.08.001 33.TrongsakulSPanthongAKanjanapothiDTaesotikulT. The"/>
   <result pre="37.Cetina-MontejoLAyora-TalaveraGBorges-ArgáezR. Zeylanone epoxide isolated from Diospyros anisandra stem bark inhibits" exact="influenza" post="virus in vitro. Arch Virol. (2020) 164:1543–52. 10.1007/s00705-019-04223-y30905031 38.LiuZ."/>
   <result pre="plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human" exact="prostate cancer" post="PC-3M-luciferase cells in an orthotopic xenograft mouse model. Mol"/>
   <result pre="(Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate" exact="cancer" post="PC-3M-luciferase cells in an orthotopic xenograft mouse model. Mol"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7548454/results/search/disease/results.xml">
   <result pre="treatment of humans and animals’ opisthorchiasis, clonorchosis, schistosomiasis, echinococcosis, cysticercosis," exact="hymenolepiasis" post="and other intestinal cestodosis (2, 24). Insufficient efficacy of"/>
   <result pre="24). Insufficient efficacy of PZQ in some helminthosis, including schistosomiasis," exact="opisthorchiasis" post="is caused by its low solubility and rapid metabolism"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7553295/results/search/disease/results.xml">
   <result pre="provided the original author and source are credited.pone.0240456.pdf Abstract Cystic" exact="echinococcosis" post="(CE) is a zoonotic helminthiasis caused by different species"/>
   <result pre="source are credited.pone.0240456.pdf Abstract Cystic echinococcosis (CE) is a zoonotic" exact="helminthiasis" post="caused by different species of the genus Echinococcus, and"/>
   <result pre="conditions are infected with one or more helminths [1]. Cystic" exact="echinococcosis" post="is a zoonotic disease caused by the larval stages"/>
   <result pre="and others are related to severe side effects such as" exact="sclerosing cholangitis" post="[11]. In traditional and rural settings, natural compounds from"/>
   <result pre="others are related to severe side effects such as sclerosing" exact="cholangitis" post="[11]. In traditional and rural settings, natural compounds from"/>
   <result pre="(1.49), Myrcene (2.85), α-pinene (2.11) 0.512 N/A Strong Gastralgia, dyspepsia," exact="peptic ulcer," post="anti-inflammatory, antipyretic, antibacterial, antiviral [22] Ethyl acetate Weak Ethyl"/>
   <result pre="(1.67%) 10 30 100 Dysentery, diarrhea, skin diseases, diuretic, leprosy," exact="asthma" post="[39] Buxaceae Buxus wallichiana Baill./ Shamshad/ Shrub Arial parts/"/>
   <result pre="cystitis, symptoms of diabetes, problems with the liver and burns," exact="constipation" post="[40] Aqueous 24, 480 100 Euphorbiaceae Euphorbia heliscopia/ Gandi"/>
   <result pre="Arial parts/ Pakistan Ethanolic N/A 50 50 62.24 Edema, ascites," exact="pulmonary tuberculosis," post="tinea, febrifuge, cathoratic, antihelminthic and purgative [37] Jatropha unicostata"/>
   <result pre="Flavonoids, terpenoids, fatty acids 5 17,280 100 Anti-viral activity against" exact="influenza" post="type A, Herpes simplex 1 [40] Aqueous Mallotus philippinensis/"/>
   <result pre="(8.4), zingiberene (7.5), β-mycrene (7.7) 100 40 100 Arthritis, atherosclerosis," exact="migraine" post="headaches, rheumatoid arthritis, high cholesterol, ulcers, depression, impotence, common"/>
   <result pre="(7.5), β-mycrene (7.7) 100 40 100 Arthritis, atherosclerosis, migraine headaches," exact="rheumatoid arthritis," post="high cholesterol, ulcers, depression, impotence, common cold, antioxidant, antimicrobial,"/>
   <result pre="atherosclerosis, migraine headaches, rheumatoid arthritis, high cholesterol, ulcers, depression, impotence," exact="common cold," post="antioxidant, antimicrobial, anti-inflammatory, antifungal [32] Crude Methanol N/A 25"/>
   <result pre="Mouse is the most commonly used model for in vivo" exact="echinococcosis" post="studies. The reason could be the high similarity of"/>
   <result pre="2008;86(7):657–64. 19472727 7BekeleJ, ButakoB. Occurrence and financial loss assessment of" exact="cystic echinococcosis" post="(hydatidosis) in cattle slaughtered at Wolayita Sodo municipal abattoir,"/>
   <result pre="19472727 7BekeleJ, ButakoB. Occurrence and financial loss assessment of cystic" exact="echinococcosis" post="(hydatidosis) in cattle slaughtered at Wolayita Sodo municipal abattoir,"/>
   <result pre="9StojkovicM, ZwahlenM, TeggiA, VutovaK, CretuCM, VirdoneR, et al.Treatment response of" exact="cystic echinococcosis" post="to benzimidazoles: a systematic review. PLoS Negl Trop Dis."/>
   <result pre="ZwahlenM, TeggiA, VutovaK, CretuCM, VirdoneR, et al.Treatment response of cystic" exact="echinococcosis" post="to benzimidazoles: a systematic review. PLoS Negl Trop Dis."/>
   <result pre="Berberis vulgaris root extract and its main compound, berberine in" exact="cystic echinococcosis." post="Iran J Parasitol. 2014;9(4):50325759731 37HaleemS, NiazS, QureshiNA, UllahR, MahmoodHM,"/>
   <result pre="chuanwu and baishao used separately or in combination on adjuvant" exact="arthritis" post="in rats. China Journal of Chinese Materia Medica. 2000;25(3):175–8."/>
   <result pre="thymol on peripheral blood mononuclear cell PBMC and acute promyelotic" exact="cancer" post="cell line HL-60. Chem-Biol Interact. 2011;193(1):97–106. 10.1016/j.cbi.2011.05.00921640085 105DíazC, QuesadaS,"/>
   <result pre="of thymol on Ca2+ homeostasis and viability in MG63 human" exact="osteosarcoma" post="cells. Pharmacology. 2011;88(3–4):201–12. 10.1159/00033186421986213 108HsuS-S, LinK-L, ChouC-T, ChiangA-J, LiangW-Z,"/>
   <result pre="DenegriG, ElissondoM. Chemoprophylactic and therapeutic efficacy of thymol in murine" exact="cystic echinococcosis." post="Parasitol Int. 2015;64(5):435–40. 10.1016/j.parint.2015.06.00526096310 123RobledoS, OsorioE, MunozD, JaramilloLM, RestrepoA,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7565266/results/search/disease/results.xml">
   <result pre="vaccines are developed, with an example being the licensed recombinant" exact="hepatitis" post="B vaccine (45). The key therefore to an effective"/>
   <result pre="intensively used to develop vaccines against various pathogens (54, 55)," exact="cancer" post="(56), and autoimmune disorders (57). For example, the human"/>
   <result pre="studies have shown promising results against hookworm infections (62, 63)," exact="malaria" post="(64, 65), leishmaniasis (66, 67), and schistosomiasis (68, 69)."/>
   <result pre="promising results against hookworm infections (62, 63), malaria (64, 65)," exact="leishmaniasis" post="(66, 67), and schistosomiasis (68, 69). Even though DNA"/>
   <result pre="infections (62, 63), malaria (64, 65), leishmaniasis (66, 67), and" exact="schistosomiasis" post="(68, 69). Even though DNA vaccines offer several advantages"/>
   <result pre="S (Mosquirix) was the first licensed VLP-based vaccine generated against" exact="parasitic disease" post="(114). It is composed of three tandem repeat (R)"/>
   <result pre="(T) epitopes from the circumsporozoite protein of the P. falciparum" exact="malaria" post="parasite, which are displayed on hepatitis B surface particles"/>
   <result pre="of the P. falciparum malaria parasite, which are displayed on" exact="hepatitis" post="B surface particles (HBs-Ag) (S), co-expressed in Saccharomyces cerevisiae"/>
   <result pre="for use in human vaccines and are being studied in" exact="leishmaniasis" post="(121), schistosomiasis (122), tuberculosis (123), and influenza vaccines (124)."/>
   <result pre="in human vaccines and are being studied in leishmaniasis (121)," exact="schistosomiasis" post="(122), tuberculosis (123), and influenza vaccines (124). The combination"/>
   <result pre="vaccines and are being studied in leishmaniasis (121), schistosomiasis (122)," exact="tuberculosis" post="(123), and influenza vaccines (124). The combination of vaccine"/>
   <result pre="being studied in leishmaniasis (121), schistosomiasis (122), tuberculosis (123), and" exact="influenza" post="vaccines (124). The combination of vaccine antigen with different"/>
   <result pre="the vaccine (125, 126). For example, mice immunized with a" exact="yellow fever" post="vaccine containing antigens combined with TLR4 and TLR7 agonists"/>
   <result pre="a TLR4 ligand contained within a PLGA-based nanoparticle plus a" exact="malaria" post="proteins (Pfs25) noted for its poor immunogenicity, improved vaccine"/>
   <result pre="where the mechanism of action is best unpicked. Peripheral blood" exact="eosinophilia" post="is a hallmark feature of the immune response to"/>
   <result pre="production of reactive oxygen species (162), the lung-stage with an" exact="eosinophilia" post="(163, 164), and expulsion from the gut with increased"/>
   <result pre="products have been shown to suppress of Th1/Th17 responses, with" exact="suppression" post="associated with the production of IL-10, IL-22 and transforming"/>
   <result pre="A. caninum ES products were shown to suppress colitis. The" exact="suppression" post="was associated with potent induction of IL-4 and IL-10"/>
   <result pre="for years in the host's small intestine, causing severe iron-deficiency" exact="anemia" post="in humans (1). Pre-clinical hookworm vaccine studies have focused"/>
   <result pre="immunization with Na-ASP-2. It was hypothesized that the induced immediate-type" exact="hypersensitivity" post="was due to the intrinsic structural or biological properties"/>
   <result pre="Pearson et al. also explored a multi-antigen peptide-based vaccine against" exact="schistosomiasis" post="and hookworm containing A291Y peptide from Na-APR-1, a S."/>
   <result pre="health community have focused their vaccine research on hookworm and" exact="ascariasis" post="and somewhat neglected trichuriasis, despite the fact that trichuriasis"/>
   <result pre="and ascariasis and somewhat neglected trichuriasis, despite the fact that" exact="trichuriasis" post="is the second most common STH infection after ascariasis"/>
   <result pre="that trichuriasis is the second most common STH infection after" exact="ascariasis" post="(13). Around 477 million people are estimated to be"/>
   <result pre="(286). Briggs et al. (91) had developed two vaccines against" exact="trichuriasis" post="based on T. muris whey acidic protein (rTm-WAP49) and"/>
   <result pre="severity higher bacterial burden and elevated plasma matrix metalloproteinases in" exact="pulmonary tuberculosis." post="J Infect Dis. (2020) 222:1021–6. 10.1093/infdis/jiaa19432307511 8.SchärFTrostdorfUGiardinaFKhieuVMuthSMartiHet al.. Strongyloides"/>
   <result pre="4:73. 10.3390/tropicalmed402007331035610 21.BeckerSLLiwanagHJSnyderJSAkogunOBelizarioVJrFreemanMCet al.. Toward the 2020 goal of soil-transmitted" exact="helminthiasis" post="control and elimination. PLoS Negl Trop Dis. (2018) 12:e0006606."/>
   <result pre="trial of a DNA vaccine encoding myelin basic protein for" exact="multiple sclerosis." post="Ann Neurol. (2008) 63:611–20. 10.1002/ana.2137018481290 58.AkulovaEMurashevBVerevochkinSMasharskyAAl-ShekhadatRPoddubnyyVet al.. The increase"/>
   <result pre="58:376–83. 10.2478/s11686-013-0151-923990436 64.BejonPMwacharoJKaiOLoweBTodrykSPeshuNet al.Safety, immunogenicity and efficacy studies of candidate" exact="malaria" post="vaccines FP9 and MVA encoding ME-TRAP in Kenyan children"/>
   <result pre="Acta Tropica. (2005) 95:S84. 65.PennyMACamponovoFChitnisNSmithTATannerM. Future use-cases of vaccines in" exact="malaria" post="control and elimination. Parasite Epidemiol Control. (2020) 2020:e00145. 10.1016/j.parepi.2020.e0014532435704"/>
   <result pre="antibody repertoire to target protective sites of pandemic avian H5N1" exact="influenza" post="virus. Sci Transl Med. (2010) 2:15ra5. 10.1126/scitranslmed.300062420371470 97.DietrichJAndreasenLVAndersenPAggerEM. Inducing"/>
   <result pre="Eng. (2018) 19:1–8. 10.1016/j.coche.2017.11.001 114.HawkesN. European medicines agency approves first" exact="malaria" post="vaccine. BMJ. (2015) 351:h4067. 10.1136/bmj.h406726215922 115.PanceA. How elusive can"/>
   <result pre="vaccine. BMJ. (2015) 351:h4067. 10.1136/bmj.h406726215922 115.PanceA. How elusive can a" exact="malaria" post="vaccine be?Nat RevMicrobiol. (2019) 17:129. 10.1038/s41579-018-0148-330626910 116.GuoJZhouASunXShaWAiKPanGet al.. Immunogenicity"/>
   <result pre="multiple antigenic epitopes of Toxoplasma gondii against acute and chronic" exact="toxoplasmosis" post="in mice. Front Immunol. (2019) 10:592. 10.3389/fimmu.2019.0059230984177 117.LeeS-HKimS-SLeeD-HKimA-RQuanF-S. Evaluation"/>
   <result pre="magnitude and quality of immune responses elicited by the ID93" exact="tuberculosis" post="vaccine: first-in-human trial. NPJ Vaccines. (2018) 3:34. 10.1038/s41541-018-0057-530210819 124.KoE-JLeeY-TKimK-HLeeYJungY-JKimM-Cet"/>
   <result pre="to induce isotype-switched IgG antibody responses and protection by T-dependent" exact="influenza" post="vaccine. J Immunol. (2017) 198:279–91. 10.4049/jimmunol.160017327881702 125.McCluskieMKriegA. Enhancement of"/>
   <result pre="influenza vaccine. J Immunol. (2017) 198:279–91. 10.4049/jimmunol.160017327881702 125.McCluskieMKriegA. Enhancement of" exact="infectious disease" post="vaccines through TLR9-dependent recognition of CpG DNA. In: PulendranBAhmedR,"/>
   <result pre="vaccines differentially influence the quality and longevity of responses to" exact="malaria" post="antigen Pfs25. JCI Insight. (2018) 3:120692. 10.1172/jci.insight.12069229769448 130.HotezPJ. The"/>
   <result pre="10.1053/j.gastro.2010.01.04520138044 160.RichardMGrencisRKHumphreysNERenauldJ-CVan SnickJ. Anti-IL-9 vaccination prevents worm expulsion and blood" exact="eosinophilia" post="in Trichuris muris-infected mice. Proc Natl Acad Sci USA."/>
   <result pre="Transl Med. (2020) 12:eaaw3703. 10.1126/scitranslmed.aaw370331894102 175.HaichouXYanWShuhuaXSenLYongWGuangjinSet al.. Epidemiology of human" exact="ancylostomiasis" post="among rural villagers in Nanlin County (Zhongzhou Village), Anhui"/>
   <result pre="cells are associated with therapeutic trichuris trichiura infection in an" exact="ulcerative colitis" post="patient. Sci Transl Med. (2010) 2:60ra88. 10.1126/scitranslmed.300150021123809 183.SmallwoodTBGiacominPRLoukasAMulvennaJPClarkRJMilesJJ. Helminth"/>
   <result pre="are associated with therapeutic trichuris trichiura infection in an ulcerative" exact="colitis" post="patient. Sci Transl Med. (2010) 2:60ra88. 10.1126/scitranslmed.300150021123809 183.SmallwoodTBGiacominPRLoukasAMulvennaJPClarkRJMilesJJ. Helminth"/>
   <result pre="Sci Transl Med. (2010) 2:60ra88. 10.1126/scitranslmed.300150021123809 183.SmallwoodTBGiacominPRLoukasAMulvennaJPClarkRJMilesJJ. Helminth immunomodulation in" exact="autoimmune disease." post="Front Immunol. (2017) 8:453. 10.3389/fimmu.2017.0045328484453 184.RicciNDFiúzaJABuenoLLCançadoGGGazzinelli-GuimarãesPHMartinsVGet al.. Induction of"/>
   <result pre="al.. IL-22 ameliorates intestinal inflammation in a mouse model of" exact="ulcerative colitis." post="J Clin Invest. (2008) 118:534–44. 10.1172/JCI3319418172556 191.YazdanbakhshMvan den BiggelaarAMaizelsRM."/>
   <result pre="Ac-16. Clin Vaccine Immunol. (2007) 14:281–7. 10.1128/CVI.00404-0617267592 210.DiemertDJPintoAGFreireJJariwalaASantiagoHHamiltonRGet al.. Generalized" exact="urticaria" post="induced by the Na-ASP-2 hookworm vaccine: implications for the"/>
   <result pre="secreted extracellular vesicles interact with host cells and prevent inducible" exact="colitis" post="in mice. Front Immunol. (2018) 9:850. 10.3389/fimmu.2018.0085029760697 283.HansenEPKringelHWilliamsARNejsumP. Secretion"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7565871/results/search/disease/results.xml">
   <result pre="medicine for treating diseases viz. diarrhea, amoebic dysentery, liver disorders," exact="irritable bowel syndrome," post="and bleeding piles. The plant is astringent and bitter"/>
   <result pre="is used for treating anemia, jaundice, dysentery, stomach pains, diarrhea," exact="epilepsy" post="and cholera [33]. It is widely known for the"/>
   <result pre="malaria, against chest infections, for asthma, bronchopneumonia, gastric disorders, dyspepsia," exact="diarrhea" post="and dysentery [38]. 3.2. Leaf In Ayurveda, H. pubescens"/>
   <result pre="[73]. They are also used against venereal diseases, gonorrhea, ascariasis," exact="malaria" post="and severe abscesses [74]. 3.4. Flowers In Ayurveda, flowers"/>
   <result pre="they are reportedly used against diuresis, chronic chest infection, asthma," exact="malaria" post="and vaginitis [81], diabetes [82], arthritis, hematuria, epilepsy, bronchitis,"/>
   <result pre="reportedly used against diuresis, chronic chest infection, asthma, malaria and" exact="vaginitis" post="[81], diabetes [82], arthritis, hematuria, epilepsy, bronchitis, diarrhea, eczema"/>
   <result pre="of α glucosidase is an important approach to limit postprandial" exact="hyperglycemia" post="in diabetes. 4.2. Anti-Diarrheal Property Diarrhea is a condition"/>
   <result pre="extract of H. pubescens seeds when tested on castor oil-induced" exact="diarrhea" post="in rats is reported to cause a significant increase"/>
   <result pre="BW, a significant reduction (p &amp;lt; 0.05) of castor oil-induced" exact="diarrhea" post="is observed [114] (Table 4). In another study on"/>
   <result pre="isolates of enteropathogenic Escherichia coli in vitro, and castor oil-induced" exact="diarrhea" post="in vivo. This successfully reduced diarrhea at a dose"/>
   <result pre="vitro, and castor oil-induced diarrhea in vivo. This successfully reduced" exact="diarrhea" post="at a dose of 200–800 mg/kg [118]. Phytochemicals i.e.,"/>
   <result pre="in vitro activity of H. pubescens seeds aqueous extract against" exact="diarrhea" post="caused by bacteria like Staphylococcus aureus, E. coli, Shigella,"/>
   <result pre="oxide, but an increase in glutathione and superoxide dismutase in" exact="colitis" post="induced in male albino Wistar rats [120] Studies also"/>
   <result pre="of H. pubescens inhibits P. berghei growth with a 43%" exact="suppression" post="rate [140]. 4.10. Stracture Activity Relationship (SAR) Study Currently,"/>
   <result pre="with alkaloids of H. pubescens for the treatment of amoebic" exact="hepatitis" post="was carried out by Chopra and De [153]. However,"/>
   <result pre="out a clinical study with 40 patients suffering from intestinal" exact="amoebiasis" post="and/or giardiasis using H. pubescens. In 70% of patients"/>
   <result pre="clinical study with 40 patients suffering from intestinal amoebiasis and/or" exact="giardiasis" post="using H. pubescens. In 70% of patients a response"/>
   <result pre="carried out another randomized clinical study in 43 patients with" exact="ulcerative colitis;" post="&quot;Kutaja Ghana vati&quot; (H. pubescens, 1 g three times"/>
   <result pre="monoherbal formulation containing H. pubescens extract with mesalamine in chronic" exact="ulcerative colitis" post="patients, with special emphasis on side effects and relapse."/>
   <result pre="formulation containing H. pubescens extract with mesalamine in chronic ulcerative" exact="colitis" post="patients, with special emphasis on side effects and relapse."/>
   <result pre="supports the efficacy of the monoherbal formulation in resolving chronic" exact="ulcerative colitis," post="with fewer chances of relapse and side effects. However,"/>
   <result pre="including H. pubescens; it was tested in patients with polycystic" exact="ovarian disease" post="(n = 34) in a randomized clinical trial, and"/>
   <result pre="mg, along with several other plants) in patients suffering from" exact="osteoarthritis" post="of the knee(s). Three months of treatment with Ayuartis"/>
   <result pre="diseases, diarrhea, dysentery, gastrointestinal infections, stomach-ache, piles, cough and cold," exact="typhoid fever" post="and malaria, etc. Conessine, an active compound of H."/>
   <result pre="36.MariusH.YeteinA.N.HouessouL.G.ToussaintO.Lougbe´gnonA.C.BriceTenteO.K.Ethnobotanical study of medicinal plants used for the treatment of" exact="malaria" post="in plateau of Allada, Benin (West Africa)J. Ethnopharmacol.201314615416323266332 37.GhimireK.A.BastakotiR.R.Ethnomedicinal"/>
   <result pre="medicinal plants used by traditional healers for the treatment of" exact="malaria" post="in the Chipinge District in ZimbabweJ. Ethnopharmacol.201515922423710.1016/j.jep.2014.11.01125449454 44.GelfandM.MaviS.DrummondR.B.NdemeraB.The Traditional"/>
   <result pre="anthelmintic, and antiviral activity of plants traditionally used for treating" exact="infectious disease" post="in the Similipal Biosphere Reserve, Odisha, IndiaFront. Pharmacol.2017865810.3389/fphar.2017.0065829109684 97.PadalS.B.ViyayakumarY.Traditional"/>
   <result pre="Uttarakhand, IndiaJ. Pharmacol.201415814020610.1016/j.jep.2014.10.00425448505 105.GairolaS.SharmaJ.GaurR.D.SiddiqiT.O.PainuliR.M.Plants used for treatment of dysentery and" exact="diarrhea" post="by the Bhoxa community of district Dehradun, Uttarakhand, IndiaJ."/>
   <result pre="of methanolic extract of Holarrhena antidysenterica bark in alloxan induced" exact="diabetes mellitus" post="in ratsPharmacologia201349510610.5567/pharmacologia.2013.95.106 111.HegdeK.JaisalK.K.Anti-diabetic potential of ethanolic extract of Holarrhena"/>
   <result pre="of Holarrhena antidysenterica and Viola canescens, plants traditionally used against" exact="malaria" post="in the Garhwal region of north-west HimalayaMalar. J.2011102010.1186/1475-2875-10-2021288335 141.NondoR.MoshiM.PaulM.P.MachumiF.KidukuliA.HeydenreichM.ZofouD.Anti-plasmodial"/>
   <result pre="effect of Holarrhena antidysenterica seeds and glibenclamide in experimentally induced" exact="diabetes mellitus" post="in albino ratsBiomed. Pharm. J.2015847748310.13005/bpj/637 152.PermpipatU.ChavalittumrongP.AttawishA.ChuntapetP.Toxicity study of Holarrhena"/>
   <result pre="the treatment of amoebic hepatitisIndian Med. Gaz.193065391 154.SinghK.P.Clinical studies on" exact="amoebiasis" post="and giardiasis evaluating the efficacy of kutaja (Holarrhena antidysenterica)"/>
   <result pre="of amoebic hepatitisIndian Med. Gaz.193065391 154.SinghK.P.Clinical studies on amoebiasis and" exact="giardiasis" post="evaluating the efficacy of kutaja (Holarrhena antidysenterica) in Entamoeba"/>
   <result pre="monoherbal formulation containing Holarrhena antidysenterica extract with mesalamine in chronic" exact="ulcerative colitis" post="patientsAnc. Sci. Life201636192710.4103/0257-7941.19540928182023 161.KumariV.SinghB.M.KumarA.SinghG.Assessment of effect of Kutaja (Holarrhena"/>
   <result pre="formulation containing Holarrhena antidysenterica extract with mesalamine in chronic ulcerative" exact="colitis" post="patientsAnc. Sci. Life201636192710.4103/0257-7941.19540928182023 161.KumariV.SinghB.M.KumarA.SinghG.Assessment of effect of Kutaja (Holarrhena"/>
   <result pre="to evaluate efficacy of Ayuartis capsules in patients suffering from" exact="osteoarthritis" post="of the knee(s)AYU201940162231831964 Figure 1 Worldwide distribution of H."/>
   <result pre="Analgesic for backache, body ache, headache, knee pain and rheumatic" exact="arthritis" post="[9] Brain-related disorders Improves depression and other nervous disorders,"/>
   <result pre="dyspepsia, flatulence, cholera, diarrhea, dysentery, food poisoning, gastroenteritis, colic complaints," exact="constipation" post="[7] General health Muscle strength, obesity, tonic [14,15] Gynecological"/>
   <result pre="[24,25] Urogenital disorders Controls urination, cystitis, diuretic, dysuria, urinary problem," exact="urinary tract infection," post="urine tract burning sensation [25] biomolecules-10-01341-t002_Table 2Table 2 Common"/>
   <result pre="Bark Powder Mixed with honey and taken orally Abdominal pain," exact="diarrhea" post="Bark Juice A ½ cup is taken 2–3 times"/>
   <result pre="of Sonbhadra district Stimulate discharge of urine and to remove" exact="constipation" post="10–20 g of root paste is taken orally with"/>
   <result pre="Madhya Pradesh state, tribal communities of chitrakoot region Arthritis and" exact="diarrhea" post="in cattle Leaf decoction twice a day [88,89] Odisha"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7567930/results/search/disease/results.xml">
   <result pre="been reported that ureases are responsible for pathogenicity such as" exact="stomach cancer," post="peptic ulceration, hepatic coma and urinary stones [18]. Besides"/>
   <result pre="are responsible for pathogenicity such as stomach cancer, peptic ulceration," exact="hepatic coma" post="and urinary stones [18]. Besides in agriculture, high urease"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7576349/results/search/disease/results.xml">
   <result pre="[18–23]. Additional redox pathways involved in PD are androgen receptor-induced" exact="neurodegeneration" post="[24], production of oxidatively modified forms of α-synuclein and"/>
   <result pre="and pointed out its importance in the underlying mechanisms of" exact="neurodegeneration" post="in PD. Venkateshappa et al. [39] evaluated the redox"/>
   <result pre="the substantia nigra and consequently lead to oxidative stress and" exact="neurodegeneration" post="[42, 45]. Being rich in this metal, dopaminergic neurons"/>
   <result pre="PD, the use of iron chelators in models of nigral" exact="neurodegeneration" post="induced by proteasome inhibitors showed a decreased loss of"/>
   <result pre="[9]. This was also evidenced in the experimental model of" exact="neurodegeneration" post="proposed by Ebadi and Sharma [107], in which the"/>
   <result pre="and the generation of peroxynitrite were associated with nigrostriatal dopaminergic" exact="neurodegeneration" post="and that animals that overexpressed the genes metallothioneins 1"/>
   <result pre="with a nonselective agonist of cannabinoid receptor. This treatment promoted" exact="suppression" post="of O2•- production by NADPH oxidase in the microglia,"/>
   <result pre="therapeutic treatment of PD, as it is believed that Parkinson's" exact="neurodegeneration" post="is linked to dietary habits and that nutritional deficiency"/>
   <result pre="and dopaminergic axons [156], protection of dopaminergic neurons against excitotoxin-induced" exact="neurodegeneration" post="in PD [157–158], and partial improvement of motor performance"/>
   <result pre="stress and mitochondrial dysfunction, regarded as triggering factors in PD" exact="neurodegeneration" post="[187]. It is also believed that a reduced GSH/GSSG"/>
   <result pre="a dietary monoterpene and was tested to prevent neurotoxicity and" exact="neurodegeneration" post="in rotenone-challenged rats. Rotenone-induced neurodegeneration is a well-established PD"/>
   <result pre="tested to prevent neurotoxicity and neurodegeneration in rotenone-challenged rats. Rotenone-induced" exact="neurodegeneration" post="is a well-established PD model with oxidative stress involvement"/>
   <result pre="reversed several biochemical modifications induced by 6-OHDA, such as the" exact="suppression" post="of inflammatory factors, antioxidant enzymes, and iNOS expression [242]."/>
   <result pre="rotenone-induced PD in rats promoted marked improvement of locomotor activity," exact="suppression" post="of β-amyloid deposition, and inhibition of the NF-ĸB inflammatory"/>
   <result pre="3.5.15. Seaweeds Using the 6-OHDA-induced PD model in SH-SY5Y human" exact="neuroblastoma" post="cells, several studies demonstrated promising anti-PD effects of seaweed"/>
   <result pre="Lancet Neurology20098438239719296921 10LiberatoreG. T.Jackson-LewisV.VukosavicS.et al.Inducible nitric oxide synthase stimulates dopaminergic" exact="neurodegeneration" post="in the MPTP model of Parkinson diseaseNature Medicine19995121403140910.1038/7097810581083 11WuD."/>
   <result pre="iron accumulation in the brain: a possible potential risk of" exact="neurodegeneration" post="in Parkinson’s diseaseJournal of Neural Transmission19971046-764966010.1007/BF012918839444565 127SoficE.PaulusW.JellingerK.Selective increase of"/>
   <result pre="a simple phenol from EVOO, targets multiple pathogenic mechanisms of" exact="neurodegeneration" post="in a C. elegans model of Parkinson’s diseaseNeurobiology of"/>
   <result pre="T. R.JesseC. R.AntunesM. S.et al.Protective role of chrysin on 6-hydroxydopamine-induced" exact="neurodegeneration" post="a mouse model of Parkinson’s disease: involvement of neuroinflammation"/>
   <result pre="F.AnsariS. A.OjhaS.Neuroprotective effects of thymol, a dietary monoterpene against dopaminergic" exact="neurodegeneration" post="in rotenone-induced rat model of Parkinson’s diseaseInternational Journal of"/>
   <result pre="TLR/NF-κB pathwayJournal of Alzheimer's Disease2018643943955 260ArdahM. T.MerghaniM. M.HaqueM. E.Thymoquinone prevents" exact="neurodegeneration" post="against MPTP in vivo and modulates α-synuclein aggregation in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7589639/results/search/disease/results.xml">
   <result pre="colonic leakiness have been demonstrated elsewhere in a model of" exact="colitis" post="in rats [31] and collectively these results support the"/>
   <result pre="been shown to improve GIT health, as demonstrated by lowering" exact="diarrhea" post="scores and Salmonella populations whilst promoting mucosal growth [17,20,32]."/>
   <result pre="ChickensAnimals2020103810.3390/ani10010038 31.VrublovaE.VostalovaJ.EhrmannJ.PalikovaI.VrbkovaJ.VacekJ.CibicekN.VeceraR.UlrichovaJ.SimanekV.The phytogenic feed additive Sangrovit modulates dextran sulfate sodium-induced" exact="colitis" post="in ratsVet. Med. Praha20105561061810.17221/2945-VETMED 32.LiuG.GuanG.FangJ.MartínezY.ChenS.BinP.DuraipandiyanV.GongT.TossouM.C.B.Al-DhabiN.A.et al.Macleaya cordata Extract Decreased"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7591086/results/search/disease/results.xml">
   <result pre="of their infection status [4]. Global control efforts for soil-transmitted" exact="helminthiasis" post="are an essential part of the Sustainable Development Goals"/>
   <result pre="egg production (drug-induced embryostasis), a phenomenon already demonstrated for Onchocerca" exact="volvulus" post="and A. suum [38, 39]. Alternatively, this could also"/>
   <result pre="which has been shown to be effective in lysing Mycobacterium" exact="tuberculosis" post="and even plant cell walls [44, 45]. The fact"/>
   <result pre="(LFIA). Similar LFIA’s have been developed for detection of M." exact="tuberculosis" post="antigens in sputum samples, for the circulating cathodic antigen"/>
   <result pre="References 1[26–3–2020]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/soil-transmitted-helminth-infections. 2WHO. Soil-transmitted helminthiasis: eliminating soil-transmitted" exact="helminthiasis" post="as a public health problem in children. Progress report"/>
   <result pre="VlasSJ, et al.Irreversible effects of ivermectin on adult parasites in" exact="onchocerciasis" post="patients in the Onchocerciasis Control Programme in West Africa."/>
   <result pre="et al.Integrated school-based surveillance for soil-transmitted helminth infections and lymphatic" exact="filariasis" post="in Gampaha district, Sri Lanka. The American journal of"/>
   <result pre="WestNP, WeeEJ, WangY, TrauM. Rapid, Single-Cell Electrochemical Detection of Mycobacterium" exact="tuberculosis" post="Using Colloidal Gold Nanoparticles. Analytical chemistry. 2015;87(20):10613–8. Epub 2015/09/19."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7596660/results/search/disease/results.xml">
   <result pre="health effects similar to those observed in methanol poisoning, i.e.," exact="metabolic acidosis" post="and ocular toxicity (Thompson, 1992). α-Phosphoribosylpyrophosphoric acid is predicted"/>
   <result pre="antimycotic activity was reported for cetrimide, in particular, against fungal" exact="keratitis" post="caused by Fusarium solani, without any negative effect on"/>
   <result pre="a virulence factor and the relevance of enzymatic activity in" exact="cryptococcosis" post="pathogenesis. FEBS J.282, 1406–1418. 10.1111/febs.13229, PMID: 25675897 Fernandez-BeneitezM. J.Ortiz-SantaliestraM."/>
   <result pre="vivo antifungal activity of cetrimide (cetyltrimethyl ammonium bromide) against fungal" exact="keratitis" post="caused by Fusarium solani. Mycoses50, 64–70. 10.1111/j.1439-0507.2006.01313.x, PMID: 17302751"/>
   <result pre="National Academies Press. OhtaT.ShibataH.KawamoriT.IimuroM.SugimuraT.WakabayashiK. (2001). Marked reduction of helicobacter pylori-induced" exact="gastritis" post="by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian"/>
   <result pre="10.1111/jwas.12113 SuroliaN.SuroliaA. (2001). Triclosan offers protection against blood stages of" exact="malaria" post="by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med.7,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7599792/results/search/disease/results.xml">
   <result pre="trigger chronic diseases including liver fibrosis [6,8]. The treatment of" exact="schistosomiasis" post="currently relies on a limited drug repertoire, with praziquantel"/>
   <result pre="43.LiuJ.ZhangY.SunS.ZhangG.JiangK.SunP.ZhangY.YaoB.SuiR.ChenY.et al.Bufalin induces apoptosis and improves the sensitivity of human" exact="glioma" post="stem-like sells to temozolamideOncol. Res.20192747548610.3727/096504018X1527091667692629793559 44.WhiteJ.Bites and stings from"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7601233/results/search/disease/results.xml">
   <result pre="published exclusively for Protozoa in food products. However, after massive" exact="cryptosporidiosis" post="outbreaks, the food industry began to pay attention to"/>
   <result pre="[3,37]. In addition to diarrhea, the general symptoms associated with" exact="cryptosporidiosis" post="include nausea, vomiting, loss of appetite, and cramps. Cryptosporidiosis"/>
   <result pre="within a single host. In immune-competent individuals, the symptoms of" exact="cryptosporidiosis" post="are often self-limiting, but may be chronic when the"/>
   <result pre="such as in children under 5 years of age or" exact="cancer" post="patients [39]. There is currently no effective medication for"/>
   <result pre="cancer patients [39]. There is currently no effective medication for" exact="cryptosporidiosis" post="[40], and so far, nitazoxanide is the only drug"/>
   <result pre="by using recreational waters were caused by 25 outbreaks of" exact="cryptosporidiosis" post="[3,7,37]. The use of proteomics techniques was important during"/>
   <result pre="countries and particularly within young children [22]. Main symptoms of" exact="giardiasis" post="are diarrhea, epigastric pain, nausea, vomiting and weight loss,"/>
   <result pre="and stomach cramps. Amoebic dysentery is a serious form of" exact="amoebiasis" post="and is related to stomach pain, bloody stools and"/>
   <result pre="or plerocercoid larvae of Spirometra tapeworms are the cause of" exact="sparganosis" post="in humans [77]. Humans are an intermediate host for"/>
   <result pre="Humans are an intermediate host for the parasite, who acquire" exact="sparganosis" post="most often by drinking water contaminated with infected copepods"/>
   <result pre="liver is the most common site for cystic and alveolar" exact="echinococcosis" post="[83]. In CE, cysts grow slowly (1–5 cm in"/>
   <result pre="anamnesis, and radiological imaging are used for diagnostic purposes of" exact="echinococcosis" post="where, the steps for diagnosing AE in humans are"/>
   <result pre="up blood, abdominal pain, nausea, vomiting, and diarrhea. In addition," exact="eosinophilic pneumonia" post="(pulmonary ascariasis) or obstruction of the intestinal lumen in"/>
   <result pre="blood, abdominal pain, nausea, vomiting, and diarrhea. In addition, eosinophilic" exact="pneumonia" post="(pulmonary ascariasis) or obstruction of the intestinal lumen in"/>
   <result pre="obstruction of the intestinal lumen in the case of intestinal" exact="ascariasis" post="may occur in case of severe infection. Ascariasis is"/>
   <result pre="immunoproteomic approach using 2-DE-MALDI-TOF MS and sera from pigs with" exact="ascariasis" post="let to identify 24 immunoreactive proteins [111]. Most of"/>
   <result pre="results might help to find effective chemotherapeutic targets for porcine" exact="ascariasis" post="[111]. Different strategy was used to characterize the protein"/>
   <result pre="Trichuris trichiura (T. trichiura) (whipworm) is a nematode that causes" exact="trichuriasis" post="in humans. The larvae infects human cecum and colon"/>
   <result pre="eating contaminated vegetables or drinking water [7]. In pregnant women," exact="toxoplasmosis" post="is generally considered a serious health problem, which can"/>
   <result pre="published research have shown that almost all cases of ocular" exact="toxoplasmosis" post="is caused by acquired diseases, which means that prevention"/>
   <result pre="and myalgia. Many severe complications like myocarditis, thromboembolic disease, and" exact="encephalitis" post="may occur [15,181]. Europe has issued official regulations, which"/>
   <result pre="because the cysticercus stage can also infect humans directly. Human" exact="cysticercosis" post="is acquired by accidental ingestion of T. solium cysticerci"/>
   <result pre="symptoms are mild and non-specific (abdominal pain, weight loss, nausea," exact="diarrhea" post="or constipation and itching cause d by proglottids, which"/>
   <result pre="mild and non-specific (abdominal pain, weight loss, nausea, diarrhea or" exact="constipation" post="and itching cause d by proglottids, which might be"/>
   <result pre="proglottids, which might be passed through the anus) [15,193]. Nevertheless," exact="cysticercosis" post="does have major clinical significance. Intracranial hypertension and epilepsy"/>
   <result pre="Nevertheless, cysticercosis does have major clinical significance. Intracranial hypertension and" exact="epilepsy" post="are the most common clinical manifestations [194]. So far,"/>
   <result pre="source of infection of this parasites to humans [211]. Human" exact="opisthorchiasis" post="is typically asymptomatic and therefore results in chronic inflammatory"/>
   <result pre="chronic inflammatory disease; this chronic inflammation can develop into the" exact="cholangiocarcinoma" post="[212]. Thus, O. viverrini has been classified by the"/>
   <result pre="1 carcinogen. The only way to reduce the percent of" exact="cholangiocarcinoma" post="cases, where the causative agent was O. viverrini, is"/>
   <result pre="agent was O. viverrini, is to reduce the prevalence of" exact="opisthorchiasis" post="through the use of praziquantel—an anthelminthic drug [212]. Unfortunately,"/>
   <result pre="could help develop efficient methods to reduce the prevalence of" exact="opisthorchiasis" post="and induced by O. viverrini cholangiocarcinoma [212]. Comparative 2-DE"/>
   <result pre="reduce the prevalence of opisthorchiasis and induced by O. viverrini" exact="cholangiocarcinoma" post="[212]. Comparative 2-DE analysis was used to highlight proteins"/>
   <result pre="them, the 117 and 145 proteins showed significant differences after" exact="opisthorchiasis" post="in plasma and hemocytes, respectively. Suwannatrai et al. [216],"/>
   <result pre="cantonensis (A. cantonensis) is a parasitic nematode that occasionally causes" exact="angiostrongyliasis" post="in humans. Its main clinical manifestation is eosinophilic meningitis"/>
   <result pre="causes angiostrongyliasis in humans. Its main clinical manifestation is eosinophilic" exact="meningitis" post="[217]. Human infections are acquired by ingestion of raw"/>
   <result pre="the larvae reach the central nervous system, followed by eosinophilic" exact="meningitis" post="and eosinophilia [217,218]. In many patients, the larvae can"/>
   <result pre="reach the central nervous system, followed by eosinophilic meningitis and" exact="eosinophilia" post="[217,218]. In many patients, the larvae can also move"/>
   <result pre="ocular angiostrongyliasis, accompanied by visual disturbances, such as diplopia or" exact="strabismus" post="[219,220]. Detection of A. cantonensis in cerebrospinal fluid or"/>
   <result pre="ducts. In Switzerland, Italy, and France around lakes, reports of" exact="diphyllobothriasis" post="have increased, where raw or undercooked perch was consumed."/>
   <result pre="pain. Other symptoms may also occur, such as fatigue, constipation," exact="pernicious anemia," post="headache, and allergic reactions. Although large-scale infection is not"/>
   <result pre="may cause intestinal obstruction, and the migrating segments can cause" exact="cholecystitis" post="or cholangitis [224]. A single dose of praziquantel is"/>
   <result pre="intestinal obstruction, and the migrating segments can cause cholecystitis or" exact="cholangitis" post="[224]. A single dose of praziquantel is highly effective"/>
   <result pre="[224]. A single dose of praziquantel is highly effective against" exact="diphyllobothriasis" post="[225]. Despite the high prevalence of this disease (about"/>
   <result pre="P. westermani is the most common etiological agent of human" exact="paragonimiasis" post="in Europe [226]. After ingesting raw or undercooked freshwater"/>
   <result pre="snails containing the fully developed cercariae [30]. The presence of" exact="paragonimiasis" post="can cause bleeding, inflammation, lung parenchymal necrosis and fibrotic"/>
   <result pre="Park et al. [228] suggested that a new drug for" exact="paragonimiasis" post="could be designed, focusing on exploring inhibitors of cysteine"/>
   <result pre="inhibitors of cysteine proteases. 2.4.5. Heterophyidae In humans, heterophyidiasis and" exact="metagonimiasis" post="is associated mainly with species of Heterophyes or Metagonimus,"/>
   <result pre="has been applied to investigate the serum biomarkers of African" exact="trypanosomiasis" post="[238], fascioliasis [239], cysticercosis [240], and Chagas disease [241]."/>
   <result pre="investigate the serum biomarkers of African trypanosomiasis [238], fascioliasis [239]," exact="cysticercosis" post="[240], and Chagas disease [241]. These studies have focused"/>
   <result pre="and the disease caused by the Anisakis genus is called" exact="anisakiasis" post="[245,246]. The life cycle of A. simplex is complex"/>
   <result pre="about many foodborne parasites and diseases caused by them, including" exact="heterophyiasis" post="(H. heterophyes), diphyllobothriasis (D. latum), sarcosporidiosis (Sarcocystis spp.), or"/>
   <result pre="parasites and diseases caused by them, including heterophyiasis (H. heterophyes)," exact="diphyllobothriasis" post="(D. latum), sarcosporidiosis (Sarcocystis spp.), or paragonimiasis (P. westermani)."/>
   <result pre="heterophyiasis (H. heterophyes), diphyllobothriasis (D. latum), sarcosporidiosis (Sarcocystis spp.), or" exact="paragonimiasis" post="(P. westermani). Despite this, great attempts have been made"/>
   <result pre="online: https://www.cdc.gov/dpdx/sparganosis/index.html(accessed on 28 July 2020) 78.WiwanitkitV.A review of human" exact="sparganosis" post="in ThailandInt. J. Infect. Dis.2005931231610.1016/j.ijid.2004.08.00316023879 79.KimJ.H.KimY.J.SohnW.M.BaeY.M.HongS.T.ChoiM.H.Differential protein expression in"/>
   <result pre="Microbiol. Rev.20041710713510.1128/CMR.17.1.107-135.200414726458 84.MoroP.SchantzP.M.Echinococcosis: A reviewInt. J. Infect. Dis.20091312513310.1016/j.ijid.2008.03.03718938096 85.MoroP.L.GarciaH.H.GonzalesA.E.BonillaJ.J.VerasteguiM.GilmanMDR.H.Screening for" exact="cystic echinococcosis" post="in an endemic region of Peru using portable ultrasonography"/>
   <result pre="Rev.20041710713510.1128/CMR.17.1.107-135.200414726458 84.MoroP.SchantzP.M.Echinococcosis: A reviewInt. J. Infect. Dis.20091312513310.1016/j.ijid.2008.03.03718938096 85.MoroP.L.GarciaH.H.GonzalesA.E.BonillaJ.J.VerasteguiM.GilmanMDR.H.Screening for cystic" exact="echinococcosis" post="in an endemic region of Peru using portable ultrasonography"/>
   <result pre="on Echinococcosis (IWGE) Guidelines for treatment of cystic and alveolar" exact="echinococcosis" post="in humansBull. World Health Organ.1996742312428789923 87.collab: WHO Informal Working"/>
   <result pre="during infection of its intermediate hostProteomics2010101985199910.1002/pmic.20090050620217864 95.LonguespéeR.CasadonteR.KriegsmannM.WandernothP.LisenkoK.MazzucchelliG.BeckerM.KriegsmannJ.Proteomic investigation of human" exact="cystic echinococcosis" post="in the liverMol. Biochem. Parasitol.201721191410.1016/j.molbiopara.2016.12.00227986452 96.AhnC.S.KimJ.G.HanX.KangI.KongY.Comparison of Echinococcus multilocularis"/>
   <result pre="infection of its intermediate hostProteomics2010101985199910.1002/pmic.20090050620217864 95.LonguespéeR.CasadonteR.KriegsmannM.WandernothP.LisenkoK.MazzucchelliG.BeckerM.KriegsmannJ.Proteomic investigation of human cystic" exact="echinococcosis" post="in the liverMol. Biochem. Parasitol.201721191410.1016/j.molbiopara.2016.12.00227986452 96.AhnC.S.KimJ.G.HanX.KangI.KongY.Comparison of Echinococcus multilocularis"/>
   <result pre="talkJ. Extracell. Vesicles2019810.1080/20013078.2019.1578116 114.RobinsonM.W.DaltonJ.P.Zoonotic helminth infections with particular emphasis on" exact="fasciolosis" post="and other trematodiasesPhilos. Trans. R. Soc. B Biol. Sci.20093642763277610.1098/rstb.2009.0089"/>
   <result pre="for identifying biomarkers of parasitic diseases: The example of porcine" exact="cysticercosis" post="(Taenia solium)Exp. Parasitol.200812032032910.1016/j.exppara.2008.08.01318823977 241.SantamariaC.ChatelainE.JacksonY.MiaoQ.WardB.J.ChappuisF.NdaoM.Serum biomarkers predictive of cure in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7648271/results/search/disease/results.xml">
   <result pre="those of Plasmodium falciparum, human immunodeficiency virus (HIV), and Mycobacterium" exact="tuberculosis" post="[5]. No new drugs have been developed for several"/>
   <result pre="pine (Pinus species) exhibits anticancer activity in vitro against different" exact="cancer" post="cell lines [32]. It was also shown to exhibit"/>
   <result pre="also shown to exhibit immunomodulatory activity by enhancing antiinflammatory response" exact="suppression" post="of NF-κB and MAPK activation, and acetylation of histone"/>
   <result pre="β-sitosterol and campesterol in the blood circulation inhibits proliferation of" exact="cancer" post="cells in mice [37]. Campesterol, β-sitosterol, and stigmasterol are"/>
   <result pre="and stigmasterol are reported to decrease the risk of gastric" exact="cancer" post="[38] and lung cancer [39]. But campesterol and stigmasterol"/>
   <result pre="reported to decrease the risk of gastric cancer [38] and" exact="lung cancer" post="[39]. But campesterol and stigmasterol have no beneficial effect"/>
   <result pre="to decrease the risk of gastric cancer [38] and lung" exact="cancer" post="[39]. But campesterol and stigmasterol have no beneficial effect"/>
   <result pre="[39]. But campesterol and stigmasterol have no beneficial effect in" exact="colon cancer" post="[40]. These compounds are therefore likely cancer-specific and are"/>
   <result pre="But campesterol and stigmasterol have no beneficial effect in colon" exact="cancer" post="[40]. These compounds are therefore likely cancer-specific and are"/>
   <result pre="and cancers [41]. Stigmasterol is further attributed to prevention of" exact="osteoarthritis" post="as it inhibits proteins of chondrocytes [42]. It also"/>
   <result pre="References 1.LoNCAddissDGHotezPJKingCHStothardJREvansDSet al.A call to strengthen the global strategy against" exact="schistosomiasis" post="and soil-transmitted helminthiasis: the time is nowLancet Infect Dis2017172646910.1016/S1473-3099(16)30535-7"/>
   <result pre="range systems in GermanyLivest Sci20111412–318218710.1016/j.livsci.2011.05.015 10.PaulDRDeyARFarhanaBNurjahanBMondalMMEpidemiology and pathology of intestinal" exact="helminthiasis" post="in fowlsEurasian J Vet Sci20122813137 11.KhakiARazaSHKhanRHaoLHosseiniSMAbdelgayedSSKakarMUEpidemiological and pathological studies"/>
   <result pre="can induce cell cycle arrest by blocking the hyper-phosphorylation of" exact="retinoblastoma" post="protein in benzo [a] pyrene-treated NIH3T3 cellsBiochem Biophys Res"/>
   <result pre="cellsBiochem Biophys Res Commun2010400175275710.1016/j.bbrc.2010.08.14220816752 33.JeongJBHongSCJeongHJKooJSAnti-inflammatory effect of 2-methoxy-4-vinylphenol via the" exact="suppression" post="of NF-κB and MAPK activation, and acetylation of histone"/>
   <result pre="37.AwadABDownieAFinkCSKimUDietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human" exact="breast cancer" post="cells grown in SCID miceAnticancer Res200020282182410810360 38.De StefaniEBoffettaPRoncoALBrennanPDeneo-PellegriniHCarzoglioJCet al.Plant"/>
   <result pre="phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast" exact="cancer" post="cells grown in SCID miceAnticancer Res200020282182410810360 38.De StefaniEBoffettaPRoncoALBrennanPDeneo-PellegriniHCarzoglioJCet al.Plant"/>
   <result pre="cancer: a case-control study in UruguayNutr Cancer200037214014410.1207/S15327914NC372_411142085 39.SchabathMBHernandezLMWuXPillowPCSpitzMRDietary phytoestrogens and" exact="lung cancer" post="riskJAMA2005294121493150410.1001/jama.294.12.149316189362 40.StromSSYamamuraYDuphorneCMSpitzMRBabaianRJPillowPCet al.Phytoestrogen intake and prostate cancer: a case-control"/>
   <result pre="a case-control study in UruguayNutr Cancer200037214014410.1207/S15327914NC372_411142085 39.SchabathMBHernandezLMWuXPillowPCSpitzMRDietary phytoestrogens and lung" exact="cancer" post="riskJAMA2005294121493150410.1001/jama.294.12.149316189362 40.StromSSYamamuraYDuphorneCMSpitzMRBabaianRJPillowPCet al.Phytoestrogen intake and prostate cancer: a case-control"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7652247/results/search/disease/results.xml">
   <result pre="laboratorial and instrumental supports, and all laboratory technicians for technical" exact="aids" post="in this project. This research was funded by Universiti"/>
   <result pre="GazianoTAAbrahams-GesselSDenmanCAMontanoCMKhanamMPuoaneTLevittNS2015An assessment of community health workers’ ability to screen for" exact="cardiovascular disease" post="risk with a simple, non-invasive risk assessment instrument in"/>
   <result pre="eight selected medicinal herbs used for the treatment of diabetes," exact="malaria" post="and pneumonia in Kisii region, southwest KenyaEuropean Journal of"/>
   <result pre="medicinal herbs used for the treatment of diabetes, malaria and" exact="pneumonia" post="in Kisii region, southwest KenyaEuropean Journal of Applied Sciences5100106"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7671229/results/search/disease/results.xml">
   <result pre="can be complicated in many neurodegenerative diseases like Parkinson’s disease," exact="multiple sclerosis," post="Alzheimer’s disease, amyotrophic lateral sclerosis, Lewy body dementia, and"/>
   <result pre="many neurodegenerative diseases like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease," exact="amyotrophic lateral sclerosis," post="Lewy body dementia, and vascular dementia. The antioxidant action"/>
   <result pre="sclerosis, Alzheimer’s disease, amyotrophic lateral sclerosis, Lewy body dementia, and" exact="vascular dementia." post="The antioxidant action may be attributed to the presence"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7676924/results/search/disease/results.xml">
   <result pre="[1, 2]. These include people with HIV/AIDS, primary immune deficiency," exact="cancer" post="chemotherapy, hematologic and solid organ transplantation, and prematurity and"/>
   <result pre="in the world: more than 10 million people have mucosal" exact="candidiasis" post="and more than 150 million people have serious fungal"/>
   <result pre="disease is more than 1.6 million, similar to that of" exact="tuberculosis" post="and over 3-fold more than malaria [6]. The major"/>
   <result pre="similar to that of tuberculosis and over 3-fold more than" exact="malaria" post="[6]. The major concern of fungal infections is the"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7677603/results/search/disease/results.xml">
   <result pre="by the accelerated activity of parasites and bleeding from haemorrhagic" exact="gastritis" post="lesions. A concurrent reduction in the concentration of haemoglobin"/>
   <result pre="limitations of evasive grazing as a control measure for parasitic" exact="gastroenteritis" post="in small ruminants in temperate climatesVeterinary Parasitology20051299510410.1016/j.vetpar.2004.12.02215817209 FAOSTAT, 2018."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7697925/results/search/disease/results.xml">
   <result pre="Introduction Fungal infections, such as human invasive aspergillosis, candidiasis, or" exact="cryptococcosis" post="caused by Aspergillus, Candida, or Cryptococcus species, respectively, are"/>
   <result pre="the saprobic/dimorphic Paracoccidioides species, a causative agent of the systemic" exact="mycosis" post="paracoccidioidomycosis, which adopted three additional steps: (a) identification of"/>
   <result pre="various animal models and infection routes, together with various immune" exact="suppression" post="regimens. Examples include, but are not limited to, drug"/>
   <result pre="mucormycosis, persistently neutropenic rabbit model for investigating acute, invasive pulmonary" exact="aspergillosis" post="(IPA), and persistently granulocytopenic rabbit model for characterizing the"/>
   <result pre="to the host (in vivo) and preventing the establishment of" exact="meningoencephalitis" post="[236]. The fact that the in vitro antifungal activity"/>
   <result pre="Overcoming regulatory and financial hurdles in repurposing approved drugs as" exact="cancer" post="therapeuticsFront. Oncol.2017710.3389/fonc.2017.0027329184849 14.collab: National Center for Biotechnology InformationPubMedAvailable online:"/>
   <result pre="online: https://www.ncbi.nlm.nih.gov/pubmed(accessed on 14 August 2020) 15.De OliveiraA.A.NevesB.J.SilvaL.D.C.SoaresC.M.D.A.AndradeC.H.PereiraM.Drug repurposing for" exact="paracoccidioidomycosis" post="through a computational chemogenomics frameworkFront. Microbiol20191010.3389/fmicb.2019.0130131244810 16.KhedrM.A.MassarottiA.MohamedM.E.Rational discovery of"/>
   <result pre="pombe model organismKobe J. Med. Sci.201561E54E6326628015 47.MuthularM.BálsamoF.PasseroP.JewtuchowiczV.MiozzaV.VillalbaM.B.BruscaM.I.PérezC.Effects of tamoxifen on" exact="periodontal disease" post="and Candida albicans of patients with breast cancer and"/>
   <result pre="tamoxifen on periodontal disease and Candida albicans of patients with" exact="breast cancer" post="and other pathologiesFuture Microbiol.20191412913710.2217/fmb-2018-027230672328 48.HaiT.P.VanA.D.NganN.T.T.NhatL.T.H.LanN.P.H.ChauN.V.V.ThwaitesG.E.KrysanD.DayJ.N.The combination of tamoxifen with"/>
   <result pre="on periodontal disease and Candida albicans of patients with breast" exact="cancer" post="and other pathologiesFuture Microbiol.20191412913710.2217/fmb-2018-027230672328 48.HaiT.P.VanA.D.NganN.T.T.NhatL.T.H.LanN.P.H.ChauN.V.V.ThwaitesG.E.KrysanD.DayJ.N.The combination of tamoxifen with"/>
   <result pre="Discovery of new benzocyclane derivatives as potent antifungal agents against" exact="cryptococcosis" post="and candidiasisACS Infect. Dis.2020676878610.1021/acsinfecdis.9b0019731550886 79.StylianouM.KulesskiyE.LopesJ.P.GranlundM.WennerbergK.UrbanC.F.Antifungal application of nonantifungal drugsAntimicrob."/>
   <result pre="for new antifungal agentsMeth. Protoc.201923110.3390/mps202003131164611 105.ClarkA.HemmelgarnT.Danziger-IsakovL.TeusinkA.Intravenous pentamidine for Pneumocystis carinii/jiroveci" exact="pneumonia" post="prophylaxis in pediatric transplant patientsPediatr. Transplant.20151932633110.1111/petr.1244125712369 106.LiW.ZhangZ.-W.LuoY.LiangN.PiX.-X.FanY.-M.Molecular epidemiology, in"/>
   <result pre="against multidrug resistant Candida auris identified in the medicines for" exact="malaria" post="venture’s pathogen boxJ. Fungi201959210.3390/jof5040092 120.WuY.GrossmanN.TottenM.MemonW.FitzgeraldA.YingC.ZhangS.X.Antifungal susceptibility profiles and drug"/>
   <result pre="pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary" exact="aspergillosis" post="and mucormycosisAntimicrob. Agents Chemother.2014586767677210.1128/AAC.03569-1425182639 140.HomaM.GalgóczyL.TóthE.TóthL.PappT.ChandrasekaranM.KadaikunnanS.AlharbiN.S.VágvölgyiC.In vitro antifungal activity of"/>
   <result pre="the antifungal arsenalVirulence2017819821010.1080/21505594.2016.121628327459018 148.JungE.H.MeyersD.J.BoschJ.CasadevallA.Novel antifungal compounds discovered in medicines for" exact="malaria" post="venture’s malaria boxmSphere2018310.1128/mSphere.00537-1729564402 149.MontoyaM.C.DiDoneL.HeierR.F.MeyersM.J.KrysanD.J.Antifungal Phenothiazines: Optimization, characterization of mechanism,"/>
   <result pre="arsenalVirulence2017819821010.1080/21505594.2016.121628327459018 148.JungE.H.MeyersD.J.BoschJ.CasadevallA.Novel antifungal compounds discovered in medicines for malaria venture’s" exact="malaria" post="boxmSphere2018310.1128/mSphere.00537-1729564402 149.MontoyaM.C.DiDoneL.HeierR.F.MeyersM.J.KrysanD.J.Antifungal Phenothiazines: Optimization, characterization of mechanism, and modulation"/>
   <result pre="on 21 August 2020) 173.LawG.L.Tisoncik-GoJ.KorthM.J.KatzeM.G.Drug repurposing: A better approach for" exact="infectious disease" post="drug discovery?Curr. Opin. Immunol.20132558859210.1016/j.coi.2013.08.00424011665 174.AbadioA.K.R.KioshimaE.S.TeixeiraM.M.MartinsN.F.MaigretB.FelipeM.S.S.Comparative genomics allowed the identification"/>
   <result pre="asahii, T. asteroides and T. inkinVirulence2015647648610.1080/21505594.2015.102027325751127 225.PaulussenC.BouletG.A.V.CosP.DelputteP.MaesL.J.R.M.Animal models of invasive" exact="aspergillosis" post="for drug discoveryDrug Discov. Today2014191380138610.1016/j.drudis.2014.06.00624931219 226.collab: National Research Council"/>
   <result pre="female, 4 to 6 weeks old;immunosuppression model of murine oropharyngeal" exact="candidiasis" post="C. albicans Preventive deferasirox treatment significantly reduced the fungal"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7699557/results/search/disease/results.xml">
   <result pre="nicotinamide (120 mg/kg), was given to the rats. The desirable" exact="hyperglycemia" post="(fasting blood glucose level &amp;gt; 200 mg/dL) was checked"/>
   <result pre="reviewAltern. Med. Rev.20081312814418590349 15.KhwairakpamA.D.BordoloiD.ThakurK.K.MonishaJ.ArfusoF.SethiG.MishraS.KumarA.P.KunnumakkaraA.B.Possible use of Punica granatum (Pomegranate) in" exact="cancer" post="therapyPharmacol. Res.2018133536410.1016/j.phrs.2018.04.02129729421 16.ThangaveluA.ElavarasuS.SundaramR.KumarT.RajendranD.PremF.Ancient Seed for Modern Cure—Pomegranate Review of"/>
   <result pre="Therapeutic Applications in PeriodonticsJ. Pharm. Bioallied Sci.20179S11S1410.4103/jpbs.JPBS_101_1729284927 17.MestryS.N.DhodiJ.B.KumbharS.B.JuvekarA.R.Attenuation of diabetic" exact="nephropathy" post="in streptozotocin-induced diabetic rats by Punica granatum Linn. leaves"/>
   <result pre="Food2013161095110010.1089/jmf.2012.271624328701 23.AhangarpourA.OroojanA.A.KhorsandiL.ShabaniR.MojaddamiS.Preventive effects of betulinic acid on streptozotocinnicotinamide induced diabetic" exact="nephropathy" post="in male mouseJ. Nephropathol.2016512813310.15171/jnp.2016.2427921024 24.RaniR.DahiyaS.DhingraD.DilbaghiN.KaushikA.KimK.H.KumarS.Antidiabetic activity enhancement in streptozotocin"/>
   <result pre="Endocrinol. Metab.201216S26723565396 29.YangS.WangS.YangB.ZhengJ.CaiY.YangZ.Weight loss before a diagnosis of type 2" exact="diabetes mellitus" post="is a risk factor for diabetes complicationsMedicine201695e561810.1097/MD.000000000000561827930591 30.RinesA.K.SharabiK.TavaresC.D.PuigserverP.Targeting hepatic"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7701350/results/search/disease/results.xml">
   <result pre="have also been advised not to use in patients with" exact="osteoarthritis" post="or rheumatoid arthritis unless there is no other option."/>
   <result pre="been advised not to use in patients with osteoarthritis or" exact="rheumatoid arthritis" post="unless there is no other option. Therefore, search for"/>
   <result pre="advised not to use in patients with osteoarthritis or rheumatoid" exact="arthritis" post="unless there is no other option. Therefore, search for"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7722406/results/search/disease/results.xml">
   <result pre="health policies willing to address it. Furthermore, the changes in" exact="anemia" post="epidemiology among African preschool children and the late updates"/>
   <result pre="factors, the prevention, and/or control strategies with potential to reduce" exact="anemia" post="that were implemented, and to discuss interventions targeting infections"/>
   <result pre="infections and/or nutrition conducted in other African countries. Keywords Africa" exact="anemia" post="Angola associated factors preschool children prevalence Introduction The prevalence"/>
   <result pre="Angola associated factors preschool children prevalence Introduction The prevalence of" exact="anemia" post="in 2011 for 6- to 59-month children from the"/>
   <result pre="in studies conducted in 2013, showed that the burden of" exact="anemia" post="was more concentrated in western and central sub-Saharan Africa,"/>
   <result pre="et al,9 2014 reported that areas where the prevalence of" exact="anemia" post="is high, may also have higher burden of anemia"/>
   <result pre="of anemia is high, may also have higher burden of" exact="anemia" post="related to infectious and iron-related etiologies. In accordance, the"/>
   <result pre="still need further clarification. Also, the context-specific etiologic profile of" exact="anemia" post="was also suggested to be a crucial factor, influencing"/>
   <result pre="associated mortality.10–15 For instance, in Kenia, malaria, bacteremia, and chronic" exact="diarrhea" post="were reported to be responsible for 12.2%, 8.7%, and"/>
   <result pre="deaths, contrasting with Ghana where nutritional anemia, severe malaria, and" exact="sickle cell anemia" post="caused respectively, 52.1%, 21.6%, and 10.8% of those deaths.11–14"/>
   <result pre="with Ghana where nutritional anemia, severe malaria, and sickle cell" exact="anemia" post="caused respectively, 52.1%, 21.6%, and 10.8% of those deaths.11–14"/>
   <result pre="21.6%, and 10.8% of those deaths.11–14 Furthermore, in Zaire, severe" exact="anemia" post="caused by iron deficiency was reported to be the"/>
   <result pre="than 5 years, and in Gambia, the seasonal variations of" exact="malaria" post="and anemia were similar, with the peak mortality in"/>
   <result pre="years, and in Gambia, the seasonal variations of malaria and" exact="anemia" post="were similar, with the peak mortality in young children"/>
   <result pre="the availability of holistic and public health-relevant data concerning the" exact="anemia" post="associated factors, that could in turn be used to"/>
   <result pre="on the prevalence and factors associated with the occurrence of" exact="anemia" post="in the country and regarding prevention and/or control strategies"/>
   <result pre="that were implemented in national territory with potential to reduce" exact="anemia" post="and (2) to discusses interventions targeting infections and/or nutrition"/>
   <result pre="years, outside of Africa, regarding hereditary or acquired hemolytic or" exact="aplastic anemia," post="nontarget infections (HIV, etc) or in other language than"/>
   <result pre="references were conducted whenever found relevant. Research question: prevalence of" exact="anemia" post="and its associated factors in children younger than 5"/>
   <result pre="in Angola Pubmed search To investigate all studies related to" exact="anemia" post="conducted in Angola we used the MESH &quot;(&quot;anaemia&quot;[All Fields]"/>
   <result pre="documents were excluded because their main scope was unrelated to" exact="anemia" post="or associated etiologies, and data regarding the prevalence of"/>
   <result pre="anemia or associated etiologies, and data regarding the prevalence of" exact="anemia" post="in preschool children was extracted from the remaining 3"/>
   <result pre="is lack of evidence in Angola regarding the prevalence of" exact="anemia" post="and the determinants that influence its occurrence. In addition,"/>
   <result pre="anemia. In this study, the data on what is causing" exact="anemia" post="are almost inexistent, as also the available data on"/>
   <result pre="national territory. The results of studies that include prevalence of" exact="anemia" post="and/or their etiologies and studies of interventions impacting the"/>
   <result pre="children from low social and economic state (in which the" exact="anemia" post="frequency was in turn associated with physical development).18 Later,"/>
   <result pre="moderate public health problem.19 In 2011, the strong relationship between" exact="anemia" post="and malaria was evidenced nationally by the Malaria Indicators"/>
   <result pre="health problem.19 In 2011, the strong relationship between anemia and" exact="malaria" post="was evidenced nationally by the Malaria Indicators Survey conducted"/>
   <result pre="of anemia, and that areas with the highest prevalence of" exact="malaria" post="had higher proportion of severe anemia (4% of the"/>
   <result pre="the highest prevalence of malaria had higher proportion of severe" exact="anemia" post="(4% of the children in the hyperendemic region had"/>
   <result pre="of Luanda had it). Furthermore, associations between the occurrence of" exact="anemia" post="and lower social strata were reinforced.20 Between 2015 and"/>
   <result pre="the Bengo's province in 2010 reported that the prevalence of" exact="anemia" post="in children younger than 5 years was 57% and"/>
   <result pre="in children younger than 5 years was 57% and that" exact="malaria" post="and schistosomiasis were responsible for 16% and 10% of"/>
   <result pre="younger than 5 years was 57% and that malaria and" exact="schistosomiasis" post="were responsible for 16% and 10% of anemia cases,"/>
   <result pre="malaria and schistosomiasis were responsible for 16% and 10% of" exact="anemia" post="cases, whereas ascariasis was associated with undernutrition (in turn"/>
   <result pre="were responsible for 16% and 10% of anemia cases, whereas" exact="ascariasis" post="was associated with undernutrition (in turn responsible for 13%"/>
   <result pre="was associated with undernutrition (in turn responsible for 13% of" exact="anemia" post="cases).22,23 In that area, the distribution of anemia was"/>
   <result pre="13% of anemia cases).22,23 In that area, the distribution of" exact="anemia" post="was found to be heterogeneous and to be influenced"/>
   <result pre="endemic setting of that province in which the prevalence of" exact="anemia" post="at the baseline was very high (76%). In the"/>
   <result pre="The study also reports that, among the children followed, all" exact="anemia" post="cases were infected with S haematobium.24 Interventions with potential"/>
   <result pre="were infected with S haematobium.24 Interventions with potential two reduce" exact="anemia" post="implemented in Angola Using the described methodology, we have"/>
   <result pre="prevalence reductions 1 month after treatment were relevant for urogenital" exact="schistosomiasis" post="and intestinal parasites, but that 6 months later the"/>
   <result pre="was postulated to have been biased by the seasonality of" exact="malaria" post="(which increased 1 month after treatment but decreased 6"/>
   <result pre="decreased 6 months after), whereas the very high prevalence of" exact="anemia" post="was observed to have nonsignificant reduction.24 Those results reiterate"/>
   <result pre="reduction.24 Those results reiterate the high prevalence of infections and" exact="anemia" post="in Angola and suggest that the beneficial effect of"/>
   <result pre="also to be further investigated. The second study reported that" exact="anemia" post="was reduced from 54.1% to 13.4% in malaria-infected children"/>
   <result pre="and followed by 28 days.25 Discussion Main strategies to reduce" exact="anemia" post="Resulting from the review of the evidence available in"/>
   <result pre="that was mentioned above, the prevalence suggests the occurrence of" exact="anemia" post="in children younger than 5 years as a severe"/>
   <result pre="distal determinants. The main immediate determinants reported are infections, mainly" exact="malaria" post="and schistosomiasis. Furthermore, malnutrition has been regionally associated, but"/>
   <result pre="available are very scarce. In fact, designing strategies to reduce" exact="anemia" post="requires previous baseline characterization that includes determining the context-specific"/>
   <result pre="both would comprehend control and preventive dimensions and could tackle" exact="anemia" post="more comprehensively.8,16,27 For the purpose of guiding future strategies"/>
   <result pre="comprehensively.8,16,27 For the purpose of guiding future strategies targeting nutritional" exact="anemia" post="in Angola, the rational for some nutrition-specific and nutrition-sensitive"/>
   <result pre="own diets and are reported as being sustainable for preventing" exact="anemia" post="(mainly Iron Deficiency Anemia) or related micronutrient deficiencies.8,27,31,32 These"/>
   <result pre="bioavailability and absorption of micronutrients.16,28 Nutrition-sensitive approach—preventing and reducing infection-related" exact="anemia" post="Infections can cause anemia indirectly by causing malabsorption of"/>
   <result pre="micronutrients.16,28 Nutrition-sensitive approach—preventing and reducing infection-related anemia Infections can cause" exact="anemia" post="indirectly by causing malabsorption of nutrients or anorexia, but"/>
   <result pre="reducing infection-related anemia Infections can cause anemia indirectly by causing" exact="malabsorption" post="of nutrients or anorexia, but also directly through hemoglobin"/>
   <result pre="haematobium) were reported to be the largest direct contributions to" exact="anemia" post="through blood loss.1,5,54–56 For instance, published report estimates that"/>
   <result pre="published report estimates that one half of moderate-to-severe cases of" exact="anemia" post="in children may occur due to hookworm infection.7,16,57 Nevertheless,"/>
   <result pre="multiple parasites determine the severity of blood loss.16,57 In addition," exact="schistosomiasis" post="may also contribute to anemia through splenic sequestration of"/>
   <result pre="of blood loss.16,57 In addition, schistosomiasis may also contribute to" exact="anemia" post="through splenic sequestration of erythrocytes, increased hemolysis, or inflammation"/>
   <result pre="such as Trichuris trichiura or Giardia lamblia are associated with" exact="malabsorption" post="of micronutrients. Malaria associates with severe anemia by causing"/>
   <result pre="are associated with malabsorption of micronutrients. Malaria associates with severe" exact="anemia" post="by causing acute and chronic hemolysis, subsequent suppression of"/>
   <result pre="with severe anemia by causing acute and chronic hemolysis, subsequent" exact="suppression" post="of erythropoiesis, and possibly secondary folate deficiency.8,16,58,59 Because enteric"/>
   <result pre="Schistosoma was reported to have a multiplicative protective effects on" exact="anemia" post="(in 5–18 years participants), with coinfected children having higher"/>
   <result pre="and influence the pathway by which they will lead to" exact="anemia" post="(dependent on the micronutrient that is lacking).58,59,66 For instance,"/>
   <result pre="the micronutrient that is lacking).58,59,66 For instance, when facing a" exact="malaria" post="infection, pre-established vitamin A deficiency may contribute to anemia"/>
   <result pre="a malaria infection, pre-established vitamin A deficiency may contribute to" exact="anemia" post="by increasing the susceptibility to parasitemia, modulating iron metabolism,"/>
   <result pre="against malarial anemia, specifically, vitamin E deficiency may protect from" exact="anemia" post="by preventing antioxidant activity which increases the susceptibility of"/>
   <result pre="anemia by preventing antioxidant activity which increases the susceptibility of" exact="malaria" post="parasites to oxygen radicals, whereas riboflavin deficiency may reduce"/>
   <result pre="multiplication.58 Nutrition-sensitive approach address mainly underlying and basic causes of" exact="anemia" post="from a wide range of sectors, including disease control,"/>
   <result pre="infections occur, there is an important contribution of micronutrient deficiency" exact="anemia" post="related to infections, potentially refractory to supplementation and requiring"/>
   <result pre="to be considered is malaria, responsible for approximately 35% of" exact="anemia" post="in African children, and whose control in endemic areas"/>
   <result pre="whose control in endemic areas was reported to greatly reduce" exact="anemia" post="and severe anemia (by &amp;gt;25% and by 60%, respectively).16,23,25,77–81"/>
   <result pre="endemic areas was reported to greatly reduce anemia and severe" exact="anemia" post="(by &amp;gt;25% and by 60%, respectively).16,23,25,77–81 When prevention is"/>
   <result pre="the administration of sulfoxide-pyrimethamine, designed to protect children against clinical" exact="malaria" post="and anemia in the first year of life, whereas"/>
   <result pre="of sulfoxide-pyrimethamine, designed to protect children against clinical malaria and" exact="anemia" post="in the first year of life, whereas vector control"/>
   <result pre="life, whereas vector control is the key intervention for global" exact="malaria" post="control, aiming mainly at increasing the use of long-lasting"/>
   <result pre="to be successfully followed by significant decrease in the moderate-to-severe" exact="anemia" post="among children aging between 6 and 23 months of"/>
   <result pre="and 23 months of age.77 Soil-transmitted helminths, schistosomiasis, and environmental/tropical" exact="enteropathy" post="(caused by the ingestion of high amount of fecal"/>
   <result pre="bacteria), should also be considered, as they are associated to" exact="anemia" post="(mainly IDA) as previously reported.16,82–85 Therapeutic approaches, aiming at"/>
   <result pre="assessments, as well as health visits. Combining strategies to reduce" exact="anemia" post="Integrating therapeutic (deworming) and preventive (either food-based or WASH/malaria"/>
   <result pre="instance, deworming plus nutrition education has been reported to reduce" exact="anemia" post="from 82.0% to 55.4%, while increasing green leafy vegetables"/>
   <result pre="than control on their knowledge.86,93 Studies evaluating educational approaches to" exact="malaria" post="prevention showed improved knowledge regarding breeding sites, bed-net use"/>
   <result pre="of maintaining clean environment and, a reduced number of reported" exact="malaria" post="episodes and fever incidence,94,95,99,100 As mentioned, several comprehensive intervention"/>
   <result pre="and Young Child Feeding, concluding that education in nutrition reduce" exact="anemia" post="and stunting, but adding WASH to the intervention had"/>
   <result pre="the effect of combining deworming, nor was the impact of" exact="malaria" post="preventive actions included. Other aspects that need to be"/>
   <result pre="need to be considered when designing interventions Genetic causes of" exact="anemia" post="The normal adult hemoglobin molecule is composed of 4"/>
   <result pre="populations of African ancestry.26 Physiologic and biologic aspects associated with" exact="anemia" post="The proportion of anemia attributable to the nutritional, infectious,"/>
   <result pre="Physiologic and biologic aspects associated with anemia The proportion of" exact="anemia" post="attributable to the nutritional, infectious, and genetic causes discussed"/>
   <result pre="of high heterogeneity regarding the hemoglobin levels that should define" exact="anemia" post="among different countries, particularly in tropical regions.124–126 Health determinants"/>
   <result pre="among different countries, particularly in tropical regions.124–126 Health determinants of" exact="anemia" post="The prevalence and distribution of anemia (particularly IDA) is"/>
   <result pre="regions.124–126 Health determinants of anemia The prevalence and distribution of" exact="anemia" post="(particularly IDA) is considered to have (1) fundamental, (2)"/>
   <result pre="higher risk of anemia.7,27,52 Socioeconomic status affects the prevalence of" exact="anemia" post="through several pathways. For instance, poverty is associated with"/>
   <result pre="dietary practices and poor dietary quality), and inadequate access to" exact="anemia" post="prevention and treatment services (such as iron supplements, deworming,"/>
   <result pre="or religious groups may be at a greater risk of" exact="anemia" post="due to having less opportunities for generating income, accessing"/>
   <result pre="practices may also play a role in the development of" exact="anemia" post="in children, occurring either when mothers face increased physiological"/>
   <result pre="when the child feeding practices lead to differential risk of" exact="anemia" post="between boys and girls.16 Conclusion In Angola, the latest"/>
   <result pre="Conclusion In Angola, the latest data on the prevalence of" exact="anemia" post="in children younger than 5 years is worrisome. In"/>
   <result pre="Zone, Southern Ethiopia?Ann Nutr Metab.2018;72:3–11. [5]NambiemaARobertAYayaIPrevalence and risk factors of" exact="anemia" post="in children aged from 6 to 59 months in"/>
   <result pre="CRC Press LLC; 2001. [9]KassebaumNJJasrasariaRNaghaviMet al.A systematic analysis of global" exact="anemia" post="burden from 1990 to 2010. Blood.2014;123:615–624.24297872 [10]DeMaeyerEAdiels-TegmanMThe prevalence of"/>
   <result pre="in the world. World Health Stat Q.1985;38:302–316.3878044 [11]BrabinBJPremjiZVerhoeffFAn analysis of" exact="anemia" post="and child mortality. J Nutr.2001;131:636S–645S. discussion 646S–648S.11160595 [12]ZuckerJRLackritzEMRuebushTK2ndet al.Childhood"/>
   <result pre="mortality during and after hospitalization in western Kenya: effect of" exact="malaria" post="treatment regimens. Am J Trop Med Hyg.1996;55:655–660.9025694 [13]BwiboNOCommon causes"/>
   <result pre="Desenvolvimento Territorial (MPDT); 2017. [22]OliveiraDFerreiraFSAtouguiaJFortesFGuerraACenteno-LimaSInfection by intestinal parasites, stunting and" exact="anemia" post="in school-aged children from Southern Angola. PLoS One.2015;10:e0137327.26371758 [23]Sousa-FigueiredoJCGamboaDPedroJMet"/>
   <result pre="Southern Angola. PLoS One.2015;10:e0137327.26371758 [23]Sousa-FigueiredoJCGamboaDPedroJMet al.Epidemiology of malaria, schistosomiasis, geohelminths," exact="anemia" post="and malnutrition in the context of a demographic surveillance"/>
   <result pre="C, Moura S, et al. Integrated community-based intervention for urinary" exact="schistosomiasis" post="and soil-transmitted helminthiasis in children from Caxito, Angola. Int"/>
   <result pre="et al. Integrated community-based intervention for urinary schistosomiasis and soil-transmitted" exact="helminthiasis" post="in children from Caxito, Angola. Int Health. 2019.[Epub ahead"/>
   <result pre="[26]BridgesKRPearsonHAAnemias and Other Red Cell Disorders. 2007;McGraw-Hill Professional, [27]PasrichaSRDrakesmithHBlackJHipgraveDBiggsBAControl of" exact="iron deficiency anemia" post="in low- and middle-income countries. Blood.2013;121:2607–2617.23355536 [28]GibsonRSDonovanUMHeathALDietary strategies to"/>
   <result pre="Other Red Cell Disorders. 2007;McGraw-Hill Professional, [27]PasrichaSRDrakesmithHBlackJHipgraveDBiggsBAControl of iron deficiency" exact="anemia" post="in low- and middle-income countries. Blood.2013;121:2607–2617.23355536 [28]GibsonRSDonovanUMHeathALDietary strategies to"/>
   <result pre="of neglected disease burden and control. PLoS Med.2007;4:e231.17696641 [54]StoltzfusRJChwayaHMTielschJMSchulzeKJAlbonicoMSavioliLEpidemiology of" exact="iron deficiency anemia" post="in Zanzibari schoolchildren: the importance of hookworms. Am J"/>
   <result pre="disease burden and control. PLoS Med.2007;4:e231.17696641 [54]StoltzfusRJChwayaHMTielschJMSchulzeKJAlbonicoMSavioliLEpidemiology of iron deficiency" exact="anemia" post="in Zanzibari schoolchildren: the importance of hookworms. Am J"/>
   <result pre="deficiency in African children. Am J Trop Med Hyg.1996;55:399–404.8916795 [56]FriedmanJFKanzariaHKMcGarveySTHuman" exact="schistosomiasis" post="and anemia: the relationship and potential mechanisms. Trends Parasitol.2005;21:386–392.15967725"/>
   <result pre="iron. J Nutr.2007;137:1341–1344.17449603 [62]HurlimannEHoungbedjiCAYapiRBet al.Antagonistic effects of Plasmodium-helminth co-infections on" exact="malaria" post="pathology in different population groups in Cote d’Ivoire. PLoS"/>
   <result pre="Cote d’Ivoire. PLoS Negl Trop Dis.2019;13:e0007086.30629580 [63]ValiceEMWiegandREMwinziPNMet al.Relative contribution of" exact="schistosomiasis" post="and malaria to anemia in Western Kenya. Am J"/>
   <result pre="PLoS Negl Trop Dis.2019;13:e0007086.30629580 [63]ValiceEMWiegandREMwinziPNMet al.Relative contribution of schistosomiasis and" exact="malaria" post="to anemia in Western Kenya. Am J Trop Med"/>
   <result pre="Trop Dis.2019;13:e0007086.30629580 [63]ValiceEMWiegandREMwinziPNMet al.Relative contribution of schistosomiasis and malaria to" exact="anemia" post="in Western Kenya. Am J Trop Med Hyg.2018;99:713–715.29988002 [64]DegaregeADegaregeDVeledarEet"/>
   <result pre="tropical diseases could benefit the poor. PLoS Med.2005;2:e336.16212468 [68]DreyfussMLStoltzfusRJShresthaJBet al.Hookworms," exact="malaria" post="and vitamin A deficiency contribute to anemia and iron"/>
   <result pre="Med.2005;2:e336.16212468 [68]DreyfussMLStoltzfusRJShresthaJBet al.Hookworms, malaria and vitamin A deficiency contribute to" exact="anemia" post="and iron deficiency among pregnant women in the plains"/>
   <result pre="in Selangor, Malaysia. Asia Pac J Clin Nutr.2005;14:188–194.15927939 [70]SuzukiTIron deficiency" exact="anemia" post="refractory to iron preparations. Rinsho Ketsueki.2016;57:1881–1889.27725584 [71]collab: WHOWorldwide Prevalence"/>
   <result pre="Anaemia. Geneva, Switzerland: World Health Organization; 2008. [72]HardingKBNeufeldLMIron deficiency and" exact="anemia" post="control for infants and young children in malaria-endemic areas:"/>
   <result pre="to hospital and mortality in preschool children in a high" exact="malaria" post="transmission setting: community-based, randomised, placebo-controlled trial. Lancet.2006;367:133–143.16413877 [74]ClarkMAGoheenMMCeramiCInfluence of"/>
   <result pre="[75]VeenemansJMilliganPPrenticeAMet al.Effect of supplementation with zinc and other micronutrients on" exact="malaria" post="in Tanzanian children: a randomised trial. PLoS Med.2011;8:e1001125.22131908 [76]PaganiniDZimmermannMBThe"/>
   <result pre="of iron fortification and supplementation on the gut microbiome and" exact="diarrhea" post="in infants and children: a review. Am J Clin"/>
   <result pre="not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and" exact="anemia" post="in Zanzibari preschool children. J Nutr.2004;134:348–356.14747671 [86]GyorkosTWMaheu-GirouxMBlouinBCasapiaMImpact of health"/>
   <result pre="infections among Orang Asli children in Malaysia. Parasit Vectors.2014;7:416.25179100 [88]DawsonEMSousa-FigueiredoJCKabatereineNBDoenhoffMJStothardJRIntestinal" exact="schistosomiasis" post="in pre school-aged children of Lake Albert, Uganda: diagnostic"/>
   <result pre="treatment gap: new steps in epidemiological monitoring and control of" exact="schistosomiasis" post="in African infants and preschool-aged children. Parasitology.2011;138:1593–1606.21861945 [93]AsaoluSOOfoezieIEThe role"/>
   <result pre="infections. Acta Trop.2003;86:283–294.12745145 [94]AlvaradoBEGomezESerraMet al.Evaluation of an educational strategy on" exact="malaria" post="in rural areas of the Colombian Pacific Coast [in"/>
   <result pre="Coast [in Spanish]. Biomedica.2006;26:342–352.17175998 [95]AmoranOEImpact of health education intervention on" exact="malaria" post="prevention practices among nursing mothers in rural communities in"/>
   <result pre="communities in Nigeria. Niger Med J.2013;54:115–122.23798798 [96]LeeYHJeongHGKongWHet al.Reduction of urogenital" exact="schistosomiasis" post="with an integrated control project in Sudan. PLoS Negl"/>
   <result pre="project in Sudan. PLoS Negl Trop Dis.2015;9:e3423.25569278 [97]FooteEMSullivanKMRuthLJet al.Determinants of" exact="anemia" post="among preschool children in rural, western Kenya. Am J"/>
   <result pre="promotion of exclusive breastfeeding. Lancet.2005;366:1094–1100.16182897 [99]TobgayTPemDDophuUet al.Community-directed educational intervention for" exact="malaria" post="elimination in Bhutan: quasi-experimental study in malaria endemic areas"/>
   <result pre="educational intervention for malaria elimination in Bhutan: quasi-experimental study in" exact="malaria" post="endemic areas of Sarpang district. Malar J.2013;12:132.23590625 [100]AbegundeDOrobatonNBassiAet al.The"/>
   <result pre="integrated community case management of childhood diseases interventions to prevent" exact="malaria" post="fever in children less than five years old in"/>
   <result pre="[108]HowesREPielFBPatilAPet al.G6PD deficiency prevalence and estimates of affected populations in" exact="malaria" post="endemic countries: a geostatistical model-based map. PLoS Med.2012;9:e1001339.23152723 [109]NkhomaETPooleCVannappagariVHallSABeutlerEThe"/>
   <result pre="and meta-analysis. Blood Cells Mol Dis.2009;42:267–278.19233695 [110]BriolantSPradinesBBascoLKRole of primaquine in" exact="malaria" post="control and elimination in French-speaking Africa [in French]. Bull"/>
   <result pre="[115]GriffinIJAbramsSAIron and breastfeeding. Pediatr Clin North Am.2001;48:401–413.11339160 [116]Meinzen-DerrJKGuerreroMLAltayeMOrtega-GallegosHRuiz-PalaciosGMMorrowALRisk of infant" exact="anemia" post="is associated with exclusive breast-feeding and maternal anemia in"/>
   <result pre="of infant anemia is associated with exclusive breast-feeding and maternal" exact="anemia" post="in a Mexican cohort. J Nutr.2006;136:452–458.16424127 [117]PizarroFYipRDallmanPROlivaresMHertrampfEWalterTIron status with"/>
   <result pre="during infancy. Pediatrics.2002;110:545–552.12205258 [124]AddoYYuEXWilliamsAet al.Evaluation of hemoglobin cutoffs for defining" exact="anemia" post="in a multinational sample of healthy individuals: the BRINDA"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7727655/results/search/disease/results.xml">
   <result pre="4 (ratio 1:2) showed weak cytotoxic activity against the tested" exact="cancer" post="cell lines with an IC50 of 23 µg/mL. Moreover,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7738434/results/search/disease/results.xml">
   <result pre="immunomodulatory molecules in extracellular vesicles that may be protective in" exact="allergy" post="and inflammatory disease. Collectively, these nematode-derived molecules allow parasites"/>
   <result pre="as vaccine candidates, targets for anthelminthic drugs, and therapeutics for" exact="allergy" post="and inflammatory disease. Last, we evaluate shared virulence and"/>
   <result pre="host immune suppression, or instead exploited for new therapies in" exact="allergy" post="and inflammatory diseases. Nematode-derived products comprise a diverse range"/>
   <result pre="secreted protein-2 (ASP-2) Although effective in animal models, caused generalized" exact="urticaria" post="in clinical trial Diemert et al., 2012 Preclinical Anti-Inflammatory"/>
   <result pre="the immune system, which could be harnessed as therapies for" exact="allergy" post="and inflammatory diseases. For example, in vitro treatment of"/>
   <result pre="the secreted anti-inflammatory protein-2 (AIP-2) suppressed airway inflammation in an" exact="asthma" post="model in mice in a dendritic cell and Treg-dependent"/>
   <result pre="nematode Acanthocheilonema viteae downregulated Th2 cytokine responses in an airway" exact="allergy" post="model in Balb/c mice, including decreased IL-5 and IL-13"/>
   <result pre="Bm cystatin was able to reduce dextran sulfate sodium (DSS)-induced" exact="colitis" post="in mice (Bisht et al., 2019). Specifically, Bm cystatin"/>
   <result pre="MIF isolated from A. simplex increased Treg responses and reduced" exact="colitis" post="severity. Here, mice treated with rAs-MIF regained previously lost"/>
   <result pre="treatment with EVs from T. spiralis and N. brasiliensis suppressed" exact="colitis" post="of mice and protection was associated with reduced proinflammatory"/>
   <result pre="mammals beyond the context of nematode infections, with applications in" exact="allergy" post="and inflammatory diseases, without the risks of infection with"/>
   <result pre="for faster development of anthelminthic drugs, vaccines, and therapies for" exact="allergy" post="and inflammatory disease. Author Contributions MN and SB contributed"/>
   <result pre="parasites suppress the clinical symptoms and pathology of experimentally induced" exact="colitis" post="in mice by inducing T-Regulatory Cells., B1-Cells., and alternatively"/>
   <result pre="Trop.14271–78. 10.1016/j.actatropica.2014.10.00925446175 ChoM. K.LeeC. H.YuH. S. (2011). Amelioration of intestinal" exact="colitis" post="by macrophage migration inhibitory factor isolated from intestinal parasites"/>
   <result pre="Reyes, JiménezM.LechnerA.AlessandriniF.BohnackerS.SchindelaS.et al. (2020). An anti-inflammatory eicosanoid switch mediates the" exact="suppression" post="of type-2 inflammation by helminth larval products.Sci. Transl. Med.12:eaay0605."/>
   <result pre="Trop. Dis.11:e0005574. 10.1371/journal.pntd.000557428464026 DiemertD. J.PintoA. G.FreireJ.JariwalaA.SantiagoH.HamiltonR. G.et al. (2012). Generalized" exact="urticaria" post="induced by the Na-ASP-2 hookworm vaccine: implications for the"/>
   <result pre="secreted extracellular vesicles interact with host cells and prevent inducible" exact="colitis" post="in mice.Front. Immunol.9:850. 10.3389/fimmu.2018.0085029760697 EllisS.MatthewsJ. B.ShawD. J.PatersonS.McWilliamH. E.InglisN. F.et"/>
   <result pre="Helminth parasites and immune regulation.F1000Res7:F1000FacultyRev-1685. GoverseA.SmantG. (2014). The activation and" exact="suppression" post="of plant innate immunity by parasitic nematodes.Annu. Rev. Phytopathol.52243–265."/>
   <result pre="10.3389/fimmu.2018.0176330108588 HondaT.KabashimaK. (2019). Prostanoids and leukotrienes in the pathophysiology of" exact="atopic dermatitis" post="and psoriasis.Int. Immunol.31589–595. 10.1093/intimm/dxy08730715370 HotezP. J.BrindleyP. J.BethonyJ. M.KingC. H.PearceE."/>
   <result pre="HondaT.KabashimaK. (2019). Prostanoids and leukotrienes in the pathophysiology of atopic" exact="dermatitis" post="and psoriasis.Int. Immunol.31589–595. 10.1093/intimm/dxy08730715370 HotezP. J.BrindleyP. J.BethonyJ. M.KingC. H.PearceE."/>
   <result pre="Heterorhabditis bacteriophora excreted-secreted products enable infection by Photorhabdus luminescens through" exact="suppression" post="of the imd pathway.Front. Immunol.10:2372. 10.3389/fimmu.2019.0237231636642 KingT. P.ValentineM. D."/>
   <result pre="peptide antigens.Vaccine233446–3452. 10.1016/j.vaccine.2005.01.09815837368 MaizelsR. M. (2020). Regulation of immunity and" exact="allergy" post="by helminth parasites.Allergy75524–534. 10.1111/all.1394431187881 MaizelsR. M.SartonoE.KurniawanA.PartonoF.SelkirkM. E.YazdanbakhshM. (1995). T-cell"/>
   <result pre="pro-inflammatory signalling.Sci. Rep.8:2123. TaweW.PearlmanE.UnnaschT. R.LustigmanS. (2000). Angiogenic activity of Onchocerca" exact="volvulus" post="recombinant proteins similar to vespid venom antigen 5.Mol. Biochem."/>
   <result pre="Extracellular vesicles derived from trichinella spiralis muscle larvae ameliorate TNBS-induced" exact="colitis" post="in mice.Front. Immunol.11:1174. 10.3389/fimmu.2020.0117432595641 YazdanbakhshM.KremsnerP. G.van ReeR. (2002). Allergy.,"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7755328/results/search/disease/results.xml">
   <result pre="all blood cell lines. Undernourished children with hematological abnormalities like" exact="anemia" post="are at higher risk of mortality. Therefore, this study"/>
   <result pre="mount. Thin and thick blood films were examined to assess" exact="malaria" post="parasite. The data were entered to EpiData version 4.6.0.0"/>
   <result pre="Results The overall magnitude of anemia, leukocytosis, thrombocytosis, thrombocytopenia, and" exact="leukopenia" post="was 53.4%, 26.7%, 23.9%, 8%, and 2.8%, respectively. Being"/>
   <result pre="current study demonstrated the predominant existence of anemia, leukocytosis, and" exact="thrombocytosis" post="among undernourished under-five children. Therefore, early diagnosis, monitoring and"/>
   <result pre="children. Therefore, early diagnosis, monitoring and setting intervention strategies for" exact="anemia" post="especially among children under two years old are required"/>
   <result pre="two years old are required to prevent further complication. Keywords" exact="anemia" post="leukocytosis thrombocytosis leukopenia thrombocytopenia children undernutrition Ethiopia Funding University"/>
   <result pre="old are required to prevent further complication. Keywords anemia leukocytosis" exact="thrombocytosis" post="leukopenia thrombocytopenia children undernutrition Ethiopia Funding University of Gondar10.13039/501100007861"/>
   <result pre="are required to prevent further complication. Keywords anemia leukocytosis thrombocytosis" exact="leukopenia" post="thrombocytopenia children undernutrition Ethiopia Funding University of Gondar10.13039/501100007861 University"/>
   <result pre="required to prevent further complication. Keywords anemia leukocytosis thrombocytosis leukopenia" exact="thrombocytopenia" post="children undernutrition Ethiopia Funding University of Gondar10.13039/501100007861 University of"/>
   <result pre="susceptibility to infections.12 Low red blood cell (RBC) count resulting" exact="anemia" post="has a common feature of PEM. The need for"/>
   <result pre="and energy during erythropoiesis by BM justifies the occurrence of" exact="anemia" post="in malnutrition.13 A decrease in erythropoietin, occurring due to"/>
   <result pre="may also be responsible for anemia.14,15 Amazingly, the prevalence of" exact="anemia" post="among this population reaches to 97%.16 Stunted, underweighted, and"/>
   <result pre="than well-nourished children.17 Studies revealed that severely malnourished children with" exact="anemia" post="are at higher risk (2.62 times) of mortality compared"/>
   <result pre="a leading cause of pediatric morbidity, hospitalization, and mortality. Moreover," exact="anemia" post="affects the cognitive performance and physical growth of the"/>
   <result pre="the associated infection is brought under control.15 The cause of" exact="anemia" post="in PEM children may be due to iron and"/>
   <result pre="impaired phagocytosis by macrophages.29 This in turn may cause immune" exact="suppression" post="and increase susceptibility to infection. This may put a"/>
   <result pre="also be due to platelet activation with an infection like" exact="malaria" post="which shortened the life span of platelet during platelet"/>
   <result pre="renal failure, cancer, and liver diseases were excluded. Children with" exact="tuberculosis" post="and human immunodeficiency virus were also excluded from the"/>
   <result pre="= (Z α/2)2 p (1-p)/d2]. By taking the prevalence of" exact="anemia" post="(61%) among undernourished (stunted) children which was conducted in"/>
   <result pre="than 7 g/dl.36 Morphologically based on mean corpuscular volume (MCV)," exact="anemia" post="is classified as microcytic (MCV &amp;lt;80 fl), normocytic (MCV"/>
   <result pre="fl).37 Thrombocytopenia is defined as platelet count below 150,000/mm3 while" exact="thrombocytosis" post="is defined as platelet count above 450,000/mm3. Moreover, leukopenia"/>
   <result pre="while thrombocytosis is defined as platelet count above 450,000/mm3. Moreover," exact="leukopenia" post="is defined as a WBC count below 4000/mm3 while,"/>
   <result pre="parasites were assessed. Children who were febrile were screened for" exact="malaria" post="parasites. Thick and thin blood smear slides were prepared,"/>
   <result pre="were prepared, stained with Giemsa (10%), and examined microscopically for" exact="malaria" post="parasites. Malaria was excluded when thick blood films were"/>
   <result pre="Among 251 study participants, 138 (55%) and 141 (56.2%) had" exact="diarrhea" post="and fever in the last 2 weeks before data"/>
   <result pre="6 (2.4%) of the children were infected with intestinal and" exact="malaria" post="parasites, respectively. Out of 43 children infected with intestinal"/>
   <result pre="Hospital, Northwest Ethiopia, 2020 Variables Category Frequencies Percentages Presence of" exact="diarrhea" post="Yes 138 55 No 113 45 Presence of fever"/>
   <result pre="(IQR) value of 10.08 g/dl (9.5–11.8). The overall magnitude of" exact="anemia" post="as defined by Hb levels lower than 11 g/dl"/>
   <result pre="76 (56.7%) were from rural dwellers. The highest frequency of" exact="anemia" post="was among children aged groups 6–23 months (73.1%) while"/>
   <result pre="cells/μL. Thrombocytopenia was detected in 8% (95% CI: 4.59–11.34%), whereas" exact="thrombocytosis" post="was detected in 23.9% (95% CI: 18.59–29.22%) of the"/>
   <result pre="2020. Severity and Morphological Classification of Anemia The severity of" exact="anemia" post="was classified based on their Hb levels. Of 134"/>
   <result pre="the complete blood count result, the most common type of" exact="anemia" post="was microcytic anemia (73.1%), followed by normocytic anemia (25.4%)."/>
   <result pre="blood count result, the most common type of anemia was" exact="microcytic anemia" post="(73.1%), followed by normocytic anemia (25.4%). Two children (1.5%)"/>
   <result pre="count result, the most common type of anemia was microcytic" exact="anemia" post="(73.1%), followed by normocytic anemia (25.4%). Two children (1.5%)"/>
   <result pre="type of anemia was microcytic anemia (73.1%), followed by normocytic" exact="anemia" post="(25.4%). Two children (1.5%) had macrocytic anemia (Figure 2)."/>
   <result pre="(73.1%), followed by normocytic anemia (25.4%). Two children (1.5%) had" exact="macrocytic anemia" post="(Figure 2). Figure 2 Type of anemia among undernourished"/>
   <result pre="followed by normocytic anemia (25.4%). Two children (1.5%) had macrocytic" exact="anemia" post="(Figure 2). Figure 2 Type of anemia among undernourished"/>
   <result pre="(1.5%) had macrocytic anemia (Figure 2). Figure 2 Type of" exact="anemia" post="among undernourished under-five children, University of Gondar Specialized Referral"/>
   <result pre="(AOR= 3.13; 95% CI: 1.14–8.55) have remained associated factors with" exact="anemia" post="in undernourished under-five children (Table 4). Table 4 Logistic"/>
   <result pre="95% CI: 1.13–14.55) (Table 5). To assess factors associated with" exact="thrombocytopenia" post="and thrombocytosis, both bi-variable and multi-variable binary logistic regression"/>
   <result pre="production of colony-stimulating factor by macrophages.11 In the current study," exact="anemia" post="was the most prevalent hematological abnormalities in undernourished children"/>
   <result pre="finding was in agreement with previous literature.14,16,30 According to WHO," exact="anemia" post="is considered a severe public health problem if the"/>
   <result pre="problem if the magnitude is ≥40%.36 Accordingly, the magnitude of" exact="anemia" post="in the current study indicates that anemia is a"/>
   <result pre="the magnitude of anemia in the current study indicates that" exact="anemia" post="is a severe public health problem among undernourished under-five"/>
   <result pre="or dietary imbalance may lead to anemia.41 The magnitude of" exact="anemia" post="in this study (53.4% (95% CI: 47.2–59.6)) was in"/>
   <result pre="vegetables and fruits might partly explain the high magnitude of" exact="anemia" post="in this study. The level of severity of anemia"/>
   <result pre="of anemia in this study. The level of severity of" exact="anemia" post="revealed that 44%, 38.8%, and 17.2% had mild, moderate,"/>
   <result pre="mild, moderate, severe anemia, respectively. The magnitude of severe life-threatening" exact="anemia" post="in the current study was comparable to the results"/>
   <result pre="infections (hookworms and malaria) and dietary habits. Morphological classification of" exact="anemia" post="showed that 73.1% had microcytic anemia followed by normocytic"/>
   <result pre="dietary habits. Morphological classification of anemia showed that 73.1% had" exact="microcytic anemia" post="followed by normocytic anemia (25.4%). Similarly, a study done"/>
   <result pre="habits. Morphological classification of anemia showed that 73.1% had microcytic" exact="anemia" post="followed by normocytic anemia (25.4%). Similarly, a study done"/>
   <result pre="anemia showed that 73.1% had microcytic anemia followed by normocytic" exact="anemia" post="(25.4%). Similarly, a study done in India showed that"/>
   <result pre="anemia (25.4%). Similarly, a study done in India showed that" exact="microcytic anemia" post="(55%) was the predominant type of anemia in undernourished"/>
   <result pre="(25.4%). Similarly, a study done in India showed that microcytic" exact="anemia" post="(55%) was the predominant type of anemia in undernourished"/>
   <result pre="showed that microcytic anemia (55%) was the predominant type of" exact="anemia" post="in undernourished children.44 In contrast, Dwivedi et al reported"/>
   <result pre="in undernourished children.44 In contrast, Dwivedi et al reported that" exact="macrocytic anemia" post="was the most common type of anemia in children"/>
   <result pre="undernourished children.44 In contrast, Dwivedi et al reported that macrocytic" exact="anemia" post="was the most common type of anemia in children"/>
   <result pre="reported that macrocytic anemia was the most common type of" exact="anemia" post="in children with SAM.28 The depletion of iron is"/>
   <result pre="increment of leukocyte count may be related to infections like" exact="gastroenteritis" post="and respiratory tract infections which are commonly seen in"/>
   <result pre="which are commonly seen in PEM.9,49 On the other hand," exact="leukopenia" post="occurred in 2.8% (95% CI: 0.74–4.8) of the study"/>
   <result pre="been reported previously in several studies.28,50,51 Experimental studies suggest that" exact="leukopenia" post="in malnutrition occurs due to the spleen and bone"/>
   <result pre="bone marrow hypoplasia which compromise hematopoiesis.52 This may cause immune" exact="suppression" post="and increase susceptibility to infection. As Dwivedi et al"/>
   <result pre="and increase susceptibility to infection. As Dwivedi et al state" exact="leukopenia" post="may also be attributed to vitamin B12 deficiency in"/>
   <result pre="platelet count in children with malnutrition. The possible reason for" exact="thrombocytosis" post="during malnutrition may be associated with infection. For example"/>
   <result pre="inflammatory cytokines which heightens the production of thrombocytes.33 In contrast," exact="thrombocytopenia" post="was observed by 8% (95% CI: 4.59–11.34). The decrement"/>
   <result pre="months was found to be 5.45 times more prone to" exact="anemia" post="as compared to an older age counterpart (AOR= 5.45;"/>
   <result pre="Sri Lanka.42 The possible reason for the high magnitude of" exact="anemia" post="in this age group may be related to the"/>
   <result pre="fourth and above in birth order were also associated with" exact="anemia" post="in this study (AOR= 1.99; 95% CI: 1.10–3.61) and"/>
   <result pre="by intestinal parasites are 2.87 times more likely to have" exact="anemia" post="than children who are free from parasitic infection (AOR="/>
   <result pre="reduced absorption from the gut.15,60 The other factor associated with" exact="anemia" post="in undernourished children was edema (AOR= 5.33; 95% CI:"/>
   <result pre="were found to be related to a risk of acquiring" exact="anemia" post="(AOR= 2.05; 95% CI: 1.03–4.10). This may be related"/>
   <result pre="occupation is daily laborer are 3.13 more likely to have" exact="anemia" post="than children whose father is a non-daily laborer (AOR="/>
   <result pre="experience numerous infectious episodes in their childhood period.65 Unlike anemia," exact="thrombocytopenia" post="and thrombocytosis were not significantly associated with explanatory variables."/>
   <result pre="infectious episodes in their childhood period.65 Unlike anemia, thrombocytopenia and" exact="thrombocytosis" post="were not significantly associated with explanatory variables. The possible"/>
   <result pre="and vitamin B12 which is a major predisposing factor for" exact="anemia" post="was not assessed. The study does not screen children"/>
   <result pre="of testing materials. Conclusion and Recommendation In the current study" exact="anemia" post="was the major hematological abnormality identified, followed by leukocytosis"/>
   <result pre="and fruits, intestinal parasite infection, and edema was associated with" exact="anemia" post="in undernourished children. On the other hand, only age"/>
   <result pre="and strengthen and setting prevention programs, developing treatment protocols for" exact="anemia" post="may help to reduce the burden of anemia, childhood"/>
   <result pre="of lymphocyte subpopulations in bone marrow in a model of" exact="protein–energy malnutrition." post="Nutrition. 2010;26(10):1021–1028. doi:10.1016/j.nut.2009.08.02620036516 13.BorelliP, BlattS, PereiraJ, et al. Reduction"/>
   <result pre="13.BorelliP, BlattS, PereiraJ, et al. Reduction of erythroid progenitors in" exact="protein–energy malnutrition." post="Br J Nutr. 2007;97(2):307–314. doi:10.1017/S000711450717273117298699 14.El NawawyA, BarakatS, El"/>
   <result pre="East Mediterr Health J. 2002;(8):2–3. 15.WarrierR, DoleM, WarrierJ, SuskindR. The" exact="anemia" post="of malnutrition In: Nestle Nutrition Workshop Series (USA). 1990:61–72."/>
   <result pre="not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and" exact="anemia" post="in Zanzibari preschool children. J Nutr. 2004;134(2):348–356. doi:10.1093/jn/134.2.34814747671 25.BuitrónD,"/>
   <result pre="of Severity. World Health Organization; 2011. 37.JanusJ, MoerschelSK. Evaluation of" exact="anemia" post="in children. Am Fam Physician. 2010;81(12):1462–1471.20540485 38.GeletawT, TadesseMZ, DemisseAG."/>
   <result pre="J. 2005;82:625–630.16619706 40.LealLP, Batista FilhoM, LiraP, FigueiroaJN, OsórioMM. Prevalence of" exact="anemia" post="and associated factors in children aged 6–59 months in"/>
   <result pre="2014;59(4):141–143. doi:10.4038/cmj.v59i4.786925556413 43.RahmanMS, MushfiqueeM, MasudMS, HowladerT. Association between malnutrition and" exact="anemia" post="in under-five children and women of reproductive age: evidence"/>
   <result pre="2011. PLoS One. 2019;14(7):e0219170. doi:10.1371/journal.pone.021917031269082 44.NayanaN, SreenivasN, JayaramS. Study of" exact="anemia" post="among protein energy malnourished children in Mysore. Int J"/>
   <result pre="51.FonduP, Hariga-MullerC, MozesN, NeveJ, Van SteirteghemA, MandelbaumI. Protein-energy malnutrition and" exact="anemia" post="in Kivu. Am J Clin Nutr. 1978;31(1):46–56. doi:10.1093/ajcn/31.1.46413429 52.CunhaMCR,"/>
   <result pre="Contemp Pediatr. 2018;3(2):403–408. 56.SantosR, GonzalezESC, AlbuquerqueE, et al. Prevalence of" exact="anemia" post="in under five-year-old children in a children’s hospital in"/>
   <result pre="J Health Dev. 2008;22(1):21–25. doi:10.4314/ejhd.v22i1.10058 64.GebreegziabiherG, EtanaB, NiggusieD. Determinants of" exact="anemia" post="among children aged 6–59 months living in Kilte Awulaelo"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7764037/results/search/disease/results.xml">
   <result pre="pH. Continuous exposure to phenazine affects protein homeostasis and causes" exact="neurodegeneration" post="C. elegans Neuromuscular system, cell mitochondria and protein folding"/>
   <result pre="bank of hidden microbial diversity and functional potentialNat. Commun.20191011010.1038/s41467-019-08463-z30602773 70.ConlanJ.V.ThompsonR.C.A.KhamlomeB.PallantL.FenwickS.ElliotA.SripaB.BlacksellS.D.VongxayK.Soil-transmitted" exact="helminthiasis" post="in Laos: A community-wide cross-sectional study of humans and"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7764245/results/search/disease/results.xml">
   <result pre="[4], penetrate gastrointestinal mucosa and cause mucosal inflammations known as" exact="anisakiasis" post="[5]. Infections caused by A. simplex (s.l.), especially by"/>
   <result pre="nhr-48 gene was highly similar (82%) to daf-12 of Onchocerca" exact="volvulus" post="and nhr-48 of B. malayi. Additionally, the H. contortus"/>
   <result pre="simplex in vitro and in guinea pigsJ. Parasitol.20028839539810.1645/0022-3395(2002)088[0395:EOIAAA]2.0.CO;212054018 12.MooreD.A.GirdwoodR.ChiodiniP.L.Treatment of" exact="anisakiasis" post="with albendazoleLancet20023605410.1016/S0140-6736(02)09333-912114042 13.PaciosE.Arias-DiazJ.ZuloagaJ.Gonzalez-ArmengolJ.VillarroelP.BalibreaJ.L.Albendazole for the Treatment of Anisakiasis IleusClin."/>
   <result pre="in vitroDig. Liver Dis.200638242610.1016/j.dld.2005.09.00416202676 15.RomeroM.C.NavarroM.C.Martín-SánchezJ.ValeroA.Peppermint (Mentha piperita) and albendazole against" exact="anisakiasis" post="in an animal modelTrop. Med. Int. Health2014191430143610.1111/tmi.1239925330410 16.HierroI.ValeroA.PérezP.GonzálezP.CaboM.M.MontillaM.P.NavarroM.C.Action of"/>
   <result pre="fumarate reductase as a target of chemotherapy: From parasites to" exact="cancer" post="cellsBiochim. Biophys. Acta Gen. Subj.2012182064365110.1016/j.bbagen.2011.12.013 22.ShompoleS.YaoC.ChengX.KnoxD.JohnsonS.JasmerD.P.Distinct characteristics of two"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7766728/results/search/disease/results.xml">
   <result pre="Ethnobiol. Ethnomedicine200732310.1186/1746-4269-3-23 20.Bassiri-JahromiS.Punica granaturn (Pomegranate) activity in health promotion and" exact="cancer" post="preventionOncol. Rev.20181234529441150 21.ArunN.RoadR.PradeshU.Punica granatum: A Review on Pharmacological and"/>
   <result pre="sheep from an area considered anthelmintic resistance-freeParasites Vectors20201345710.1186/s13071-020-04329-232907633 37.MinB.HartS.Tannins for" exact="suppression" post="of internal parasitesJ. Anim. Sci.200310.2527/2003.8114_suppl_2E102x 38.HosteH.Torres-AcostaJ.Sandoval-CastroC.Mueller-HarveyI.SotirakiS.LouvandiniH.ThamsborgS.TerrillT.Tannin containing legumes as"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7767097/results/search/disease/results.xml">
   <result pre="women’s medicine, she detailed several recipes involving mints [40]. For" exact="constipation" post="one recipe consisted on cooking mint in honey and"/>
   <result pre="were also much appreciated. Paulus Aegineta provided a recipe for" exact="constipation" post="in children, for which he advised rubbing the abdomen"/>
   <result pre="[55,56]. Their spasmolytic properties are known to relieve symptoms of" exact="irritable bowel syndrome" post="[57,58,59]. They are safe to be used in endoscopic"/>
   <result pre="accordance with Hippocrates’ beliefs, that eating watermint was responsible for" exact="erectile dysfunction" post="[92]. However, the mints’ effect on libido have generated"/>
   <result pre="to prevent Plasmodium protozoa from spreading, the causative agents of" exact="malaria" post="from mosquito bites based on herbs’ insect repellant activity."/>
   <result pre="wide variety of insects, including the mosquitoes responsible for spreading" exact="malaria" post="(Anopheles sp.), yellow fever, dengue (Aedes aegypti), and zika"/>
   <result pre="insects, including the mosquitoes responsible for spreading malaria (Anopheles sp.)," exact="yellow fever," post="dengue (Aedes aegypti), and zika (Culex quinquefasciatus) [94,95,96,97,98]. Mints"/>
   <result pre="France, created by thieves that plundered the dead and dying" exact="plague" post="victims. It is thought that, because they smeared this"/>
   <result pre="theory introduced by Hippocrates and Galen [102]. The discovery that" exact="plague" post="was transmitted by fleas carrying the causative microbe Yersinia"/>
   <result pre="improved inflammatory profile and clinical manifestations in female patients with" exact="interstitial cystitis" post="[113]. As for their cardiac effect, Avicenna wrote of"/>
   <result pre="inflammatory profile and clinical manifestations in female patients with interstitial" exact="cystitis" post="[113]. As for their cardiac effect, Avicenna wrote of"/>
   <result pre="patients with ‘scrophular diseases’, which probably refer to cervical tuberculous" exact="lymphadenitis" post="and rickets [47]. Odo de Magdunensis mentions a mixture"/>
   <result pre="‘scrophular diseases’, which probably refer to cervical tuberculous lymphadenitis and" exact="rickets" post="[47]. Odo de Magdunensis mentions a mixture of mint,"/>
   <result pre="unblocking with a hair pencil [119]. Gout is an inflammatory" exact="arthropathy" post="characterized by the painful swelling of joints resulting from"/>
   <result pre="von Bingen also mentioned the usefulness of mints for treating" exact="gout" post="[39]. Sydenham, having himself been afflicted with gout in"/>
   <result pre="for treating gout [39]. Sydenham, having himself been afflicted with" exact="gout" post="in the last years of his life, made very"/>
   <result pre="that consisted of laudanum and mint in equal quantities for" exact="alopecia" post="[130]. Theophanes also indicates a concoction made of celandine"/>
   <result pre="essential oil in a formula for ameliorating generalized pruritus in" exact="urticaria" post="and papular eczema, which included carbolic acid, glycerin and"/>
   <result pre="Local anesthetic/anti-inflammatory Unknown Theophanes Chryssobalantes (fl.c. 950) Unknown Treatment for" exact="alopecia" post="Avicenna (980–1037) Watermint SpermicideReduce libido Odo de Magdunensis (1070?–1112?)"/>
   <result pre="In vivo Guinea pigs Relaxation of bronchial smooth muscle and" exact="suppression" post="of immunological response to ovalbumin Laude et al. (1994)"/>
   <result pre="use of L-menthol spraying and carbon dioxide insufflation on the" exact="adenoma" post="detection rate during colonoscopy: A prospective randomized trialGastrointest. Endosc.201887AB125AB12610.1016/j.gie.2018.04.1328"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7767326/results/search/disease/results.xml">
   <result pre="by low transport capacity [130,131,132]. In the case of M." exact="tuberculosis" post="and Streptomyces spp., it has been reported that they"/>
   <result pre="is their ability to promote the generation of ROS in" exact="cancer" post="cells, eventually causing cell death. For this situation to"/>
   <result pre="Since an elevated level of Cu2+ is quite common within" exact="cancer" post="tissues and cells, the mobilization of these ions can"/>
   <result pre="nickel ionsJ. Biol. Chem.199827323524110.1074/jbc.273.1.2359417070 133.ColeS.T.BrochR.ParkhillJ.GarnierT.ChurcherC.HarrisD.GordonS.V.EiglmeirK.GasS.BarryC.E.IIIet al.Deciphering the biology of Mycobacterium" exact="tuberculosis" post="from the complete genome sequenceNature199839353754410.1038/311599634230 134.KimE.J.ChungH.J.SuhB.HahY.C.RoeJ.H.Transcriptional and post-transcriptional regulation"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7767343/results/search/disease/results.xml">
   <result pre="of MNPs described to date, such as MarinLit (http://pubs.rsc.org/marinlit/). In" exact="cancer" post="research, for example, NPs are considered very relevant as"/>
   <result pre="vivo in murine models (and others), as well as in" exact="cancer" post="clinical trials [39,42,43]. In fact, marine organisms are still"/>
   <result pre="that cytotoxic, anticancer, and antitumoral compounds are strongly needed, since" exact="cancer" post="remains one of the deadliest diseases worldwide [42]. In"/>
   <result pre="deadliest diseases worldwide [42]. In 2018, about 18 million new" exact="cancer" post="cases were reported globally, producing around 10 million deaths"/>
   <result pre="Many natural compounds present cytotoxic effects against macromolecules expressed by" exact="cancer" post="cells, such as in oncogenic signal transduction pathways, and"/>
   <result pre="modulates the Bcl-2 and p53 oncoproteins in human diffuse large-cell" exact="lymphoma" post="WSU-DLCL2, inducing a decrease in the expression of Bcl-2"/>
   <result pre="well as inducing ubiquitination and proteasome degradation of Bcl-2 in" exact="lymphoblastic leukemia," post="allowing for the growth of progenitor cells from bone"/>
   <result pre="analogues which were tested for growth inhibitory activity against some" exact="cancer" post="cell lines in vitro [506,507,508]. Actinofide (205) and some"/>
   <result pre="(205) and some of its analogues were tested against six" exact="cancer" post="cell lines: two human carcinoma cancer cell lines (MCF-7"/>
   <result pre="were tested against six cancer cell lines: two human carcinoma" exact="cancer" post="cell lines (MCF-7 (breast) and A549 (non–small-cell lung cancer,"/>
   <result pre="human carcinoma cancer cell lines (MCF-7 (breast) and A549 (non–small-cell" exact="lung cancer," post="NSCLC)) of epithelial origin, two human cancer cell lines"/>
   <result pre="A549 (non–small-cell lung cancer, NSCLC)) of epithelial origin, two human" exact="cancer" post="cell lines from glial origin (Hs683 oligodendroglioma and U373"/>
   <result pre="origin, two human cancer cell lines from glial origin (Hs683" exact="oligodendroglioma" post="and U373 glioblastoma of astrocytic origin), and two melanoma"/>
   <result pre="and 11-epivaldiviolide (208), some of them displaying cytotoxicity against murine" exact="leukemia" post="P388 cell lines [87]. In particular, the IC50 values"/>
   <result pre="which show in vitro growth inhibitory activity against four human" exact="cancer" post="cell lines [111]. In particular, this activity was tested"/>
   <result pre="HeLa (cervical), MCF-7 (breast), KB (oral cavity), and HT-29 (colon)" exact="cancer" post="cell lines with IC50 values between 0.05 and 10"/>
   <result pre="values of ~1 μM for both, and against mouse L1210" exact="leukemia" post="cells, with IC50 values of ~2 and ~0.3 μM,"/>
   <result pre="the organization of cell microfilaments, and inhibit the proliferation of" exact="cancer" post="cells due to their strong actin binding properties [153,164,515,516,517]."/>
   <result pre="and B (37) display antimigratory activity against highly metastatic human" exact="prostate cancer" post="PC-3M-CT+ cells and murine brain-metastatic melanoma B16B15b cells [515,518]."/>
   <result pre="B (37) display antimigratory activity against highly metastatic human prostate" exact="cancer" post="PC-3M-CT+ cells and murine brain-metastatic melanoma B16B15b cells [515,518]."/>
   <result pre="values of ~0.5 μM against murine P388 leukemia, human HT-29" exact="colon cancer," post="and human A549 NSCLC, with more than a fivefold"/>
   <result pre="vitro growth inhibitory effects against A549 NSCLC than to P388" exact="leukemia" post="[519]. Latrunculin A (38), coded NSC613011 on the NCI"/>
   <result pre="an IC50 mean value of ~0.7 μM in the 60" exact="cancer" post="cell line panel, with a more than twofold log"/>
   <result pre="magnitude difference between the most sensitive and the most resistant" exact="cancer" post="cell lines, being as active against MDR NCI/ADR-RES as"/>
   <result pre="MDR phenotype [47]. Finally, latrunculin A (38) induces apoptosis in" exact="cancer" post="cells via activation of the caspase-3/caspase-7 pathway and displays"/>
   <result pre="in peritoneal dissemination models of MKN45 and NUGC-4 human gastric" exact="cancer" post="in mice [455]. In vivo anticancer assays using A549"/>
   <result pre="agents [142,523,524]. Laulimalide (39) inhibits growth in more than ten" exact="cancer" post="cell lines at low nanomolar concentrations, while isolaulimalide (40)"/>
   <result pre="molecules [527]. Moreover, laulimalide (39) has an effect in P-gp-overexpressing" exact="cancer" post="cells and against cell lines resistant to paclitaxel and"/>
   <result pre="paclitaxel and epothilones [525,528]. Further studies have shown that in" exact="ovarian cancer" post="cells, the increased expression of βII- and βIII tubulin"/>
   <result pre="and epothilones [525,528]. Further studies have shown that in ovarian" exact="cancer" post="cells, the increased expression of βII- and βIII tubulin"/>
   <result pre="of laulimalide (39) in two xenograft models, the human MDA-MB-435" exact="breast cancer" post="and the human HT-1080 fibrosarcoma models, describing little tumor"/>
   <result pre="laulimalide (39) in two xenograft models, the human MDA-MB-435 breast" exact="cancer" post="and the human HT-1080 fibrosarcoma models, describing little tumor"/>
   <result pre="models, the human MDA-MB-435 breast cancer and the human HT-1080" exact="fibrosarcoma" post="models, describing little tumor growth inhibition accompanied by a"/>
   <result pre="aspersa) and other scalarane terpenoids are cytotoxic against murine L1210" exact="leukemia" post="and human epidermoid carcinoma KB cell lines [156]. Particularly,"/>
   <result pre="Epoxygoniolide-1 (219) shows moderate cytotoxicity to NCIH-460, SW60, and HepG2" exact="cancer" post="cells [532]. G. (Chromodoris) sinensis from China presents aplyroseol-2"/>
   <result pre="together with the ring-closed acetal, both bioactive against P388 mouse" exact="leukemia" post="cells [161,186]. G. reticulatus contains spongian-16-one (221), aplytandiene-3 (222),"/>
   <result pre="(221) [154]. All of these compounds are active against murine" exact="lymphoma" post="L1210 and human epidermoid carcinoma KB cells at IC50"/>
   <result pre="[180,381,383,384,385,386,519,535,538,539,540]. In particular, spongiadiol (35) is active against P388 murine" exact="leukemia" post="cells at an IC50 of 0.5 μg/mL. Other species,"/>
   <result pre="three-dimensional (3D) cell culture model, using spheroids of the MCF-7" exact="breast cancer" post="cell [541,542]. Hypselodoris infucata from Bali presents (–)-furodysinin (48),"/>
   <result pre="(3D) cell culture model, using spheroids of the MCF-7 breast" exact="cancer" post="cell [541,542]. Hypselodoris infucata from Bali presents (–)-furodysinin (48),"/>
   <result pre="Both compounds are reported to display activity against murine L1210" exact="leukemia" post="cells, with IC50 values of ~10 and ~30 nM,"/>
   <result pre="(62) presents growth inhibitory effects in vitro against human MCF-7" exact="breast cancer" post="cells (IC50 ~0.5 μM), ten times higher than for"/>
   <result pre="presents growth inhibitory effects in vitro against human MCF-7 breast" exact="cancer" post="cells (IC50 ~0.5 μM), ten times higher than for"/>
   <result pre="stronger bioselectivity, with IC50 values of 0.02 μM against MCF-7" exact="cancer" post="cells and &amp;gt;2 μM for human fibroblasts [548]. Kabiramides"/>
   <result pre="with IC50 values of ~30 nM, against the murine L1210" exact="leukemia" post="cell line [220]. On the other hand, dihydrohalichondramide (63)"/>
   <result pre="(63) and 33-methylhalichondramide (242) inhibit growth in the murine L1210" exact="leukemia" post="cell line with IC50 values of ~40 and ~60"/>
   <result pre="low concentrations, with an IC50 of 12.5 ng/mL against some" exact="cancer" post="cell lines, such as P388, A549, HT29, and MEL28,"/>
   <result pre="(189) is in phase II clinical studies for endometrial and" exact="cervical cancer," post="as well as solid human tumors and hematological diseases"/>
   <result pre="low nanomolar ranges against human colon (HCT-116) and breast (MDA-MB-435)" exact="cancer" post="cells [561]. Their mechanism of action has been reported"/>
   <result pre="a tumor suppressor gene product that may be involved in" exact="colon cancer" post="[516,561,562,563]. Some structurally related compounds were also found in"/>
   <result pre="tumor suppressor gene product that may be involved in colon" exact="cancer" post="[516,561,562,563]. Some structurally related compounds were also found in"/>
   <result pre="the sponge compounds neopetroformynes and are active against murine P388" exact="leukemia" post="cells with IC50 values of 0.09–0.45 μM [570]. Further"/>
   <result pre="four cell lines, i.e., murine P388 leukemia, A549 NSCLC, HT-29" exact="colon cancer," post="and SKMEL-28, at IC50 ~2 μM [571]. Hydroxy-dehydroisofulvinol (248)"/>
   <result pre="very selective, showing a ~4000-fold differential sensitivity between human Caco-2" exact="colon cancer" post="cells and HeLa cervix cancer cells [229]. Tambjamine C"/>
   <result pre="selective, showing a ~4000-fold differential sensitivity between human Caco-2 colon" exact="cancer" post="cells and HeLa cervix cancer cells [229]. Tambjamine C"/>
   <result pre="sensitivity between human Caco-2 colon cancer cells and HeLa cervix" exact="cancer" post="cells [229]. Tambjamine C (67), instead, is a good"/>
   <result pre="transmembrane anion transporter, similar to prodigiosins, which are relevant in" exact="cancer" post="cell biology and cancer cell migration, and they are"/>
   <result pre="to prodigiosins, which are relevant in cancer cell biology and" exact="cancer" post="cell migration, and they are expressed differently in diverse"/>
   <result pre="cancer cell migration, and they are expressed differently in diverse" exact="cancer" post="cells [581,582,583,584,585,586]. Dendronotida Within this group, several species have"/>
   <result pre="riisei, active at an IC50 of 0.03 µM to mouse" exact="leukemia" post="cells [587]. Dotofide (251) is found in Doto pinnatifida"/>
   <result pre="(251) shows a GI50 value of 18.1 µM for Hs683" exact="oligodendroglioma" post="(ATCC HTB-138), and of 28.8 µM for U373 glioblastoma"/>
   <result pre="values of GI50 around 6–9 μM against WHCO1 and WHCO6" exact="esophageal cancer" post="cell lines, inducing apoptosis via generation of reactive oxygen"/>
   <result pre="of GI50 around 6–9 μM against WHCO1 and WHCO6 esophageal" exact="cancer" post="cell lines, inducing apoptosis via generation of reactive oxygen"/>
   <result pre="IC50 values stand from ~0.4 to &amp;gt;100 μM in three" exact="cancer" post="cell lines, with no selectivity against mouse 3T3-L1 fibroblasts"/>
   <result pre="cardiomyocytes (IC50: ~0.1 and ~5 μM) [592,606]. Human HeLa cervix" exact="cancer" post="cells are very sensitive to the growth inhibitory effects"/>
   <result pre="the growth inhibitory effects of phidianidines (257), contrarily to Caco-2" exact="colon cancer" post="cells [606]. Phidianidines (257) are also selective and potent"/>
   <result pre="growth inhibitory effects of phidianidines (257), contrarily to Caco-2 colon" exact="cancer" post="cells [606]. Phidianidines (257) are also selective and potent"/>
   <result pre="compared to δ- and κ-opiod receptors), which is involved in" exact="cancer" post="progression [593,607]. Virtual screening allowed for the identification of"/>
   <result pre="for CXCR4, a chemokine receptor involved in several diseases, including" exact="cancer" post="progression, metastasis, and immunodeficiency disorders, and competing with natural"/>
   <result pre="migration at 50 μM in a rat cell line of" exact="pituitary adenoma" post="[609]. 3.1.2. Pleurobranchoidea Pleurobranchus albiguttatus and P. forskalii from"/>
   <result pre="at 50 μM in a rat cell line of pituitary" exact="adenoma" post="[609]. 3.1.2. Pleurobranchoidea Pleurobranchus albiguttatus and P. forskalii from"/>
   <result pre="an isoprene residue, which has been reported active against four" exact="cancer" post="cell lines (P388, A549, MEL20, and HT29) with IC50"/>
   <result pre="displays an IC50 value of 5.8 μM against murine P388" exact="leukemia" post="cells [387]. Unfortunately, the low sensitivity of this model"/>
   <result pre="chlorolissoclimide (258) and dichlorolissoclimide (259) were active against murine P388" exact="leukemia" post="cells resistant to adriamycin by blocking the translation elongation"/>
   <result pre="cyclodepsipeptide kulolide-1 (271), which displays potent antitumoral activity against L-1210" exact="leukemia" post="and P388 murine leukemia cell lines, with IC50 values"/>
   <result pre="displays potent antitumoral activity against L-1210 leukemia and P388 murine" exact="leukemia" post="cell lines, with IC50 values of 0.7 and 2.1"/>
   <result pre="effects with an IC50 of ~2 μM in murine P388" exact="leukemia" post="cells, while kulokekahilide-2 (276) presents a higher potency with"/>
   <result pre="(276) also displays activity against human SK-OV-3 ovarian and tMDA-MB-435" exact="breast cancer" post="cell lines, with IC50 values of 7.5 and 14.6"/>
   <result pre="also displays activity against human SK-OV-3 ovarian and tMDA-MB-435 breast" exact="cancer" post="cell lines, with IC50 values of 7.5 and 14.6"/>
   <result pre="an IC50 of 59.1 nM, acting selectively [627]. In other" exact="cancer" post="cell lines, namely, human A549 NSCLC, K562 chronic myelogenous"/>
   <result pre="namely, human A549 NSCLC, K562 chronic myelogenous leukemia, and MCF-7" exact="breast cancer," post="kulokekahilide-2 (276) shows IC50 values of ~0.2 nM [628]."/>
   <result pre="the same, with ~19 and ~4 nM for murine P388" exact="leukemia" post="and human HeLa cervix carcinoma cells, respectively [629]. Some"/>
   <result pre="fatty acids with cytotoxic activity against a range of human" exact="cancer" post="cells lines, including HT-29, MCF7, and A2058, were described"/>
   <result pre="A. dactylomela), which showed growth inhibitory activity against murine lymphocytic" exact="leukemia" post="P338 cells due to the presence of the brominated"/>
   <result pre="(277) showed an IC50 value of ~8 μM for P388" exact="leukemia" post="cells and human KB cancer cells [613,631]. A. dactylomela"/>
   <result pre="of ~8 μM for P388 leukemia cells and human KB" exact="cancer" post="cells [613,631]. A. dactylomela presents a wide variety of"/>
   <result pre="natural product, with IC50 values between 1–10 μM against ten" exact="cancer" post="cell lines in several studies [631,635,636]. Remarkably, elatol (278)"/>
   <result pre="HM02 (gastric carcinoma), HEP-G2 (liver carcinoma), and MCF-7 (breast carcinoma)" exact="cancer" post="cells with IC50 values of ~1 μM [631]. Some"/>
   <result pre="which displays potent IC50 values in the NCI assay (60" exact="cancer" post="cell lines panel), particularly an IC50 of ~0.4 μM"/>
   <result pre="panel), particularly an IC50 of ~0.4 μM in human SNB-19" exact="central nervous system cancer" post="and T-47D breast cancer cells [641]. Aplysqualenol A (287)"/>
   <result pre="IC50 of ~0.4 μM in human SNB-19 central nervous system" exact="cancer" post="and T-47D breast cancer cells [641]. Aplysqualenol A (287)"/>
   <result pre="μM in human SNB-19 central nervous system cancer and T-47D" exact="breast cancer" post="cells [641]. Aplysqualenol A (287) has been described to"/>
   <result pre="in human SNB-19 central nervous system cancer and T-47D breast" exact="cancer" post="cells [641]. Aplysqualenol A (287) has been described to"/>
   <result pre="a strong growth inhibitory in vitro activity against mouse P388" exact="leukemia" post="cells, and only moderate activity in solid tumors cell"/>
   <result pre="of ~0.02 and ~17 μM for P388 and A549 NSCLC" exact="cancer" post="cell lines, respectively [614,648,649]. Apparently, thyrsiferol (288) inhibits hypoxia-induced"/>
   <result pre="with an IC50 value of 2.5 μM for human HCT-116" exact="colorectal cancer" post="cells [606,650,651]. A. fasciata from Spain presents a degraded"/>
   <result pre="an IC50 value of 2.5 μM for human HCT-116 colorectal" exact="cancer" post="cells [606,650,651]. A. fasciata from Spain presents a degraded"/>
   <result pre="~8 μM against mouse P388 leukemia, human A549 NSCLC, HT-29" exact="colon cancer," post="and SKMEl-28 melanoma [397]. A. juliana contains two chlorophyll"/>
   <result pre="being tested in antitumor clinical trials [46,652,653,654,655,656]. For human HeLa-S3" exact="cancer" post="cells, IC50 values were 0.5 nM for aplyronine A"/>
   <result pre="a mean IC50 value of ~0.2 nM in the 60" exact="cancer" post="cell lines, but being selective against some cell lines"/>
   <result pre="selective against some cell lines and most active against MDR" exact="cancer" post="cell line NCI/ADR-RES, with an IC50 value of ~0.2"/>
   <result pre="nM, as well as for P388 murine leukemia, Lewis murine" exact="lung carcinoma," post="Erhlich murine carcinoma, colon 26 murine carcinoma, and B16"/>
   <result pre="cancers) [652]. Aplyronine A (191) also presents proapoptotic effects in" exact="cancer" post="cells [46]. Aplyronine A (191) was in fact suggested"/>
   <result pre="well-known tubulin inhibitors vincristine and vinblastine currently employed in some" exact="cancer" post="treatments [479,659,660]. Later, other studies suggested that aplyronine A"/>
   <result pre="show IC50 values of ~1 μM for human HeLa cervix" exact="cancer" post="cells, while neoaplaminone (296) is active at IC50 ~1"/>
   <result pre="and it shows IC50 values of 4–8 μM for several" exact="cancer" post="cells, with a mean IC50 value of ~30 μM"/>
   <result pre="sensitizer for tumor necrosis factor-related apoptosis, producing TRAIL-induced apoptosis in" exact="cancer" post="cells via the P38 MAPK/survivin pathway [682]. (-)-Aplysin (304)"/>
   <result pre="MAPK/survivin pathway [682]. (-)-Aplysin (304) is also effective against human" exact="glioma" post="cells by increasing miR-181 expression, sensitizing the cytotoxic effects"/>
   <result pre="the PI3K/Akt signaling, which is relevant in the survival of" exact="glioma" post="cells [683]. In Egypt, A. oculifera contains two halogenated"/>
   <result pre="IC50 values between 2 and 8 μM against human PC-3" exact="prostate cancer," post="A549 NSCLC, MCF-7 breast cancer, HepG2 liver cancer, and"/>
   <result pre="8 μM against human PC-3 prostate cancer, A549 NSCLC, MCF-7" exact="breast cancer," post="HepG2 liver cancer, and HCT116 colon cancer [684]. A."/>
   <result pre="human PC-3 prostate cancer, A549 NSCLC, MCF-7 breast cancer, HepG2" exact="liver cancer," post="and HCT116 colon cancer [684]. A. punctata from Spanish"/>
   <result pre="A549 NSCLC, MCF-7 breast cancer, HepG2 liver cancer, and HCT116" exact="colon cancer" post="[684]. A. punctata from Spanish coasts present atypical acetates"/>
   <result pre="NSCLC, MCF-7 breast cancer, HepG2 liver cancer, and HCT116 colon" exact="cancer" post="[684]. A. punctata from Spanish coasts present atypical acetates"/>
   <result pre="1.5 and 2.5 μM against P388, HT-29, A-549, and MEL-28" exact="cancer" post="cell lines [685]. Another sea hare, Dolabella auricularia, is"/>
   <result pre="IC50 values of ~0.2 μM against human HeLa S3 cervix" exact="cancer" post="cells, while auriside B (313) is less potent (IC50"/>
   <result pre="presents IC50 values of ~7 μM against human HeLa S3" exact="cancer" post="cells, and it is structurally similar to enshuol, a"/>
   <result pre="both values of ~2 μM against human HeLa S3 cervix" exact="cancer" post="cells, and synthesis studies are being carried out [692,693,701,702]."/>
   <result pre="cell line panel and was selective for renal, ovarian, and" exact="prostate cancer" post="cell lines. It was active in the in vivo"/>
   <result pre="line panel and was selective for renal, ovarian, and prostate" exact="cancer" post="cell lines. It was active in the in vivo"/>
   <result pre="1 (PHB1) in the mitochondria, activating the proteolytic processing of" exact="optic atrophy" post="1 (OPA1) and resulting in mitochondria-induced apoptosis [707]. Doliculide"/>
   <result pre="Its action mechanism consists of binding to actin and stopping" exact="cancer" post="cells at the G2/M phase of the cell cycle,"/>
   <result pre="and impairs the migratory potential of human MCF-7 and MDA-MB-231" exact="breast cancer" post="cells, while modifying senescence-related genes at non-toxic concentrations in"/>
   <result pre="impairs the migratory potential of human MCF-7 and MDA-MB-231 breast" exact="cancer" post="cells, while modifying senescence-related genes at non-toxic concentrations in"/>
   <result pre="while modifying senescence-related genes at non-toxic concentrations in p53 wild-type" exact="cancer" post="cells by up to 13% [713]. The most famous"/>
   <result pre="synthesized, showing an IC50 &amp;lt; 1 μM in P388 murine" exact="leukemia" post="cells [718,727]. Dolastatin 3 (192) was also found in"/>
   <result pre="78% life extension in vivo in the murine P388 lymphocytic" exact="leukemia" post="model, and a 52% life extension in murine colon"/>
   <result pre="FDA (Food and Drugs Administration) for the treatment of Hodgkin’s" exact="lymphoma" post="[43]. This ADC is composed of a highly toxic"/>
   <result pre="monoclonal antibody (mAb) directed to a particular epitope on the" exact="cancer" post="cell [726]. Dolastatin 10 (326) inhibits microtubule assembly, causing"/>
   <result pre="trials, local irritation at the injection site, and some mild" exact="peripheral neuropathy" post="[733,734]. Dolastatin 10 (326) exhibits cytotoxic effects against human"/>
   <result pre="local irritation at the injection site, and some mild peripheral" exact="neuropathy" post="[733,734]. Dolastatin 10 (326) exhibits cytotoxic effects against human"/>
   <result pre="Dolastatin 10 (326) exhibits cytotoxic effects against human lung and" exact="breast cancer" post="cell lines via both Bcl-2 phosphorylation and caspase-3 protein"/>
   <result pre="10 (326) exhibits cytotoxic effects against human lung and breast" exact="cancer" post="cell lines via both Bcl-2 phosphorylation and caspase-3 protein"/>
   <result pre="activation, and it modulates p53 oncoproteins in human diffuse large-cell" exact="lymphoma" post="[735,736]. Other studies describe dolastatin 10 (326) activity against"/>
   <result pre="leukemia, B16 melanoma, M5076 sarcoma, human LOX melanoma, and MX-1" exact="breast cancer" post="xenografts [736,737,738]. Dolastatin 10 (326) is not only an"/>
   <result pre="B16 melanoma, M5076 sarcoma, human LOX melanoma, and MX-1 breast" exact="cancer" post="xenografts [736,737,738]. Dolastatin 10 (326) is not only an"/>
   <result pre="several models, including murine P388 leukemia, colon 26 cancer, Lewis" exact="lung carcinoma," post="B16 melanoma, and M5076 sarcoma, as well as human"/>
   <result pre="B16 melanoma, and M5076 sarcoma, as well as human MX-1" exact="breast cancer" post="and LX-1 and SBC-3 SCLC xenografts [747,748]. Auristatin PE"/>
   <result pre="melanoma, and M5076 sarcoma, as well as human MX-1 breast" exact="cancer" post="and LX-1 and SBC-3 SCLC xenografts [747,748]. Auristatin PE"/>
   <result pre="for human SF-295 CNS cancer, ~0.1 μM for mouse neuro-2a" exact="neuroblastoma" post="and 1 μM for P388 leukemia cells [750,754,755]. Dolastatin"/>
   <result pre="μM for mouse neuro-2a neuroblastoma and 1 μM for P388" exact="leukemia" post="cells [750,754,755]. Dolastatin 11 (327) produces a massive rearrangement"/>
   <result pre="dolastatin 13 (329) and 14 (330) against the murine P388" exact="leukemia" post="cell line are reported to be 14 and 20"/>
   <result pre="tubulin, and it is a classical inducer of apoptosis in" exact="cancer" post="cells, acting as a conventional proapoptotic cytotoxic agent [762,763,764]."/>
   <result pre="is also a proapoptotic cytotoxic compound, tested against many different" exact="cancer" post="lines, but it did not go beyond phase II"/>
   <result pre="onchidin (121), which has submicromolar values of IC50 against four" exact="cancer" post="cell lines [773,774]. Dolastatin 18 (348) was found in"/>
   <result pre="and shows submicromolar values of IC50 against mouse P388 lymphocytic" exact="leukemia" post="and human NCI-H460 NSCLC cell lines [775]. D. auricularia"/>
   <result pre="in vitro growth inhibition for breast MCF-7 and colon KM20L2" exact="cancer" post="cells with IC50 values of ~1 μM [776]. Similarly,"/>
   <result pre="(335), and iso-dolastatin H (336), also display activity against some" exact="cancer" post="cell lines, such as human HeLa S3 cancer cells"/>
   <result pre="against some cancer cell lines, such as human HeLa S3" exact="cancer" post="cells [721,723,724]. Stylocheilus and Bursatella are also cyanobacterial feeders"/>
   <result pre="Makalikone (100) shows moderate activity against P388, A549, and HTB38" exact="cancer" post="cell lines, with IC50 values between 2.5 and 5"/>
   <result pre="cyanobacterial prey in Hawai’i, displays very potent toxicity against several" exact="cancer" post="cell lines, with IC50 values ~0.05 μg/mL [305]. Furthermore,"/>
   <result pre="O (102) shows IC50 values of 2 μg/mL against the" exact="cancer" post="cell lines P388, A549, and HT29 [123]. In Guam,"/>
   <result pre="B. leachii, possess in vitro growth inhibitory properties against several" exact="cancer" post="cell lines, with IC50 values between ~4 and ~8"/>
   <result pre="IC50 values between ~4 and ~8 μM against murine P388" exact="leukemia" post="and human A549 NSCLC, NCI-H187 (SCLC), HT-29 colon cancer,"/>
   <result pre="murine P388 leukemia and human A549 NSCLC, NCI-H187 (SCLC), HT-29" exact="colon cancer," post="HL60 leukemia, KB and BC breast cancer lines [307,786,787]."/>
   <result pre="NCI-H187 (SCLC), HT-29 colon cancer, HL60 leukemia, KB and BC" exact="breast cancer" post="lines [307,786,787]. Hectochlorin (351) and deacetylhectochlorin (352) show growth"/>
   <result pre="(SCLC), HT-29 colon cancer, HL60 leukemia, KB and BC breast" exact="cancer" post="lines [307,786,787]. Hectochlorin (351) and deacetylhectochlorin (352) show growth"/>
   <result pre="effects in vitro against human KB, NCI-H187 SCLCL, and BC" exact="breast cancer" post="cell lines, with deacetylhectochlorin (352) displaying a mean IC50"/>
   <result pre="in vitro against human KB, NCI-H187 SCLCL, and BC breast" exact="cancer" post="cell lines, with deacetylhectochlorin (352) displaying a mean IC50"/>
   <result pre="its diet of the green algae Caulerpa—is active against several" exact="cancer" post="cell lines at IC50 ~10 μM, while it has"/>
   <result pre="selective for normal (hamster fibroblasts, human keratinocytes, and melanocytes) and" exact="cancer" post="cells [790,791]. Caulerpenyne (155) induces tubulin aggregation, inhibiting the"/>
   <result pre="and tested in phase I trials in patients with hormone-refractory" exact="prostate cancer" post="[797,798]. Treating cancer cells with kahalalide F (194) resulted"/>
   <result pre="tested in phase I trials in patients with hormone-refractory prostate" exact="cancer" post="[797,798]. Treating cancer cells with kahalalide F (194) resulted"/>
   <result pre="I trials in patients with hormone-refractory prostate cancer [797,798]. Treating" exact="cancer" post="cells with kahalalide F (194) resulted in critical changes"/>
   <result pre="Kahalalide F (194) inhibits the PI3K–AKT signaling pathway in the" exact="breast cancer" post="cell lines SKBR3 and BT474 [800]. The IC50 values"/>
   <result pre="F (194) inhibits the PI3K–AKT signaling pathway in the breast" exact="cancer" post="cell lines SKBR3 and BT474 [800]. The IC50 values"/>
   <result pre="line panel were from 0.2 to 10 μM, with hormone-independent" exact="prostate cancer" post="cells being the most sensitive [267]. Kahalalide F (194)"/>
   <result pre="panel were from 0.2 to 10 μM, with hormone-independent prostate" exact="cancer" post="cells being the most sensitive [267]. Kahalalide F (194)"/>
   <result pre="Iso-kahalalide F (354) also entered phase II clinical trials for" exact="liver cancer," post="melanoma, and NSCLC patients, but was also ineffective [807]."/>
   <result pre="IC50 values between 0.4 and ~9 μM in a 23" exact="cancer" post="cell lines, including breast, colon, head and neck, lung,"/>
   <result pre="membrane level, interacting directly with glycosylceramides in the membrane of" exact="cancer" post="cells, while inducing necrosis-like cell death in the yeast"/>
   <result pre="active in vivo against human melanoma, liver, pancreas, breast, and" exact="prostate cancer" post="xenografts [816]. However, in clinical trials, elisidepsin (357) has"/>
   <result pre="in vivo against human melanoma, liver, pancreas, breast, and prostate" exact="cancer" post="xenografts [816]. However, in clinical trials, elisidepsin (357) has"/>
   <result pre="of ~6 μM when tested against human HCT-116 and HT29" exact="colon cancer" post="cells [819]. A secosterol (359) from T. costatus was"/>
   <result pre="~6 μM when tested against human HCT-116 and HT29 colon" exact="cancer" post="cells [819]. A secosterol (359) from T. costatus was"/>
   <result pre="with an IC50 value of ~3 μM against the WHCO1" exact="esophageal cancer" post="cell line [337]. Siphonaria species, S. capensis, S. concinna,"/>
   <result pre="an IC50 value of ~3 μM against the WHCO1 esophageal" exact="cancer" post="cell line [337]. Siphonaria species, S. capensis, S. concinna,"/>
   <result pre="(121) and onchidin B (360) are active against murine P388" exact="leukemia" post="and human KB oral cancer cells at IC50 values"/>
   <result pre="(360) are active against murine P388 leukemia and human KB" exact="oral cancer" post="cells at IC50 values of ~ 7 μM [358,359]."/>
   <result pre="are active against murine P388 leukemia and human KB oral" exact="cancer" post="cells at IC50 values of ~ 7 μM [358,359]."/>
   <result pre="with IC50 between 3 and 9 μM (A549 NSCLC, MCF-7" exact="breast cancer," post="PC-3 prostate cancer, Hs683 oligodendroglioma, U373 glioblastoma, and SKMEL-28"/>
   <result pre="3 and 9 μM (A549 NSCLC, MCF-7 breast cancer, PC-3" exact="prostate cancer," post="Hs683 oligodendroglioma, U373 glioblastoma, and SKMEL-28 melanoma), and being"/>
   <result pre="camptothecin [357]. This compound (362) seems to be active against" exact="cancer" post="cells that present resistance to proapoptotic stimuli [357]. Moreover,"/>
   <result pre="Fiji presents axisonitrile-3 (25), displaying strong growth inhibition against Mycobacterium" exact="tuberculosis" post="(MIC 2 μg/mL) [118,427]. Similarly, Phyllidia picta from Bali"/>
   <result pre="in the sponge Heteronema erecta, displays antibacterial activity towards M." exact="tuberculosis" post="H37Rv, with a MIC of 6.25 μg/mL [85,180,833]. Other"/>
   <result pre="are active against mycobacteria, with kahalalide A (377) inhibiting M." exact="tuberculosis" post="H37Rv by 83% at 12.5 μg/mL, and kahalalide F"/>
   <result pre="IX, producing heme accumulation, which results in toxicity to the" exact="malaria" post="parasite [849]. Pustulosaisonitrile-1 (378) from Phyllidiella pustulosa from Australia"/>
   <result pre="and digestive gland [22,166,380,381,535,536]. Spongiadiol (35) is active against the" exact="herpes simplex" post="virus, showing an IC50 of 0.25 μg/mL against herpes"/>
   <result pre="herpes simplex virus, showing an IC50 of 0.25 μg/mL against" exact="herpes simplex" post="virus type I [535,537]. Chromodoris hamiltoni presents a wide"/>
   <result pre="as reported above. Kahalalide F (194) presents antiviral properties against" exact="herpes simplex" post="virus II, while kahalalides A (377) and G (384)"/>
   <result pre="studied molecule as a potential treatment for many diseases, including" exact="cancer" post="and Alzheimer disease (AD), and it is in phase"/>
   <result pre="signaling pathway is crucial for treating many diseases, such as" exact="cancer" post="and heart failure, as well as neurodegenerative diseases [513]."/>
   <result pre="Lines HEL Human Erythroleukemia cells HeLa Henrietta_Lacks cell line from" exact="cervical cancer" post="cells HIF-1 Hypoxia Inducible Factor 1 HTCLs Human Tumor"/>
   <result pre="HEL Human Erythroleukemia cells HeLa Henrietta_Lacks cell line from cervical" exact="cancer" post="cells HIF-1 Hypoxia Inducible Factor 1 HTCLs Human Tumor"/>
   <result pre="The use of virtual screening for the discovery of small-molecule" exact="cancer" post="drugsMolecules201722103710.3390/molecules22071037 32.NewmanD.J.CraggG.M.Marine natural products and related compounds in clinical"/>
   <result pre="A source of novel anticancer drugsMar. Drugs20191749110.3390/md17090491 43.NewmanD.J.CraggG.M.Marine-sourced anti-cancer and" exact="cancer" post="pain control agents in clinical and late preclinical developmentMar."/>
   <result pre="the Antarctic nudibranch Austrodoris kerguelenensis and inhibition of Jak2/STAT5-dependent HEL" exact="leukemia" post="cellsTetrahedron2012689095910410.1016/j.tet.2012.08.045 68.CutignanoA.ZhangW.AvilaC.CiminoG.FontanaA.Intrapopulation variability in the terpene metabolism of the"/>
   <result pre="effect (on tumor cells) and in vitro antiviral activity against" exact="herpes simplex" post="virus of synthetic spongiane diterpenesJ. Nat. Prod.20026518919210.1021/np010206t11858754 385.KamelH.N.KimY.B.RimoldiJ.M.FronczekF.R.FerreiraD.SlatteryM.Scalarane sesterterpenoids:"/>
   <result pre="481.VinothkumarS.ParameswaranP.S.Recent advances in marine drug researchBiotechnol. Adv.2013311826184510.1016/j.biotechadv.2013.02.00623500952 482.NobiliS.LippiD.WitortE.DonniniM.BausiL.MiniE.CapaccioliS.Natural compounds for" exact="cancer" post="treatment and preventionPharmacol. Res.20095936537810.1016/j.phrs.2009.01.01719429468 483.BrayF.FerlayJ.SoerjomataramI.SiegelR.L.TorreL.A.JemalA.Global cancer statistics 2018: GLOBOCAN"/>
   <result pre="Adv.2013311826184510.1016/j.biotechadv.2013.02.00623500952 482.NobiliS.LippiD.WitortE.DonniniM.BausiL.MiniE.CapaccioliS.Natural compounds for cancer treatment and preventionPharmacol. Res.20095936537810.1016/j.phrs.2009.01.01719429468 483.BrayF.FerlayJ.SoerjomataramI.SiegelR.L.TorreL.A.JemalA.Global" exact="cancer" post="statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide"/>
   <result pre="induces ubiquitination and proteasome degradation of Bcl-2 in the human" exact="acute lymphoblastic leukemia" post="cell line, RehInt. J. Mol. Med.2000516523610.3892/ijmm.5.2.16510639596 504.ManzoE.CarboneM.MolloE.IraceC.Di PascaleA.LiY.CiavattaM.L.CiminoG.GuoY.-W.GavagninM.Structure and"/>
   <result pre="ubiquitination and proteasome degradation of Bcl-2 in the human acute" exact="lymphoblastic leukemia" post="cell line, RehInt. J. Mol. Med.2000516523610.3892/ijmm.5.2.16510639596 504.ManzoE.CarboneM.MolloE.IraceC.Di PascaleA.LiY.CiavattaM.L.CiminoG.GuoY.-W.GavagninM.Structure and"/>
   <result pre="and proteasome degradation of Bcl-2 in the human acute lymphoblastic" exact="leukemia" post="cell line, RehInt. J. Mol. Med.2000516523610.3892/ijmm.5.2.16510639596 504.ManzoE.CarboneM.MolloE.IraceC.Di PascaleA.LiY.CiavattaM.L.CiminoG.GuoY.-W.GavagninM.Structure and"/>
   <result pre="Nat. Prod.2017801339134610.1021/acs.jnatprod.6b0094128406636 506.ParikhM.RiessJ.LaraP.N.Jr.New and emerging developments in extensive-stage small cell" exact="lung cancer" post="therapeuticsCurr. Opin. Oncol.2016289710310.1097/CCO.000000000000026426844984 507.StuppR.HegiM.E.MasonW.P.Van Den BentM.J.TaphoornM.J.JanzerR.C.LudwinS.K.AllgeierA.FisherB.BelangerK.et al.Effects of radiotherapy"/>
   <result pre="Prod.2017801339134610.1021/acs.jnatprod.6b0094128406636 506.ParikhM.RiessJ.LaraP.N.Jr.New and emerging developments in extensive-stage small cell lung" exact="cancer" post="therapeuticsCurr. Opin. Oncol.2016289710310.1097/CCO.000000000000026426844984 507.StuppR.HegiM.E.MasonW.P.Van Den BentM.J.TaphoornM.J.JanzerR.C.LudwinS.K.AllgeierA.FisherB.BelangerK.et al.Effects of radiotherapy"/>
   <result pre="anticancer effect in a peritoneal dissemination model of human gastric" exact="cancer" post="in miceAnticancer Res.2009292091209719528469 521.ProtaA.E.BargstenK.NorthcoteP.T.MarshM.AltmannK.H.MillerJ.H.DıazJ.F.SteinmetzM.O.Structural basis of microtubule stabilization by"/>
   <result pre="trisoxazole macrolide from the marine sponge Chondrosia corticata, on human" exact="prostate cancer" post="cells via modulation of epithelial-to-mesenchymal transitionMar. Drugs2013112472248510.3390/md1107247223860239 552.BaeS.Y.KimG.D.JeonJ.E.ShinJ.LeeS.K.Anti-proliferative effect"/>
   <result pre="macrolide from the marine sponge Chondrosia corticata, on human prostate" exact="cancer" post="cells via modulation of epithelial-to-mesenchymal transitionMar. Drugs2013112472248510.3390/md1107247223860239 552.BaeS.Y.KimG.D.JeonJ.E.ShinJ.LeeS.K.Anti-proliferative effect"/>
   <result pre="Chondrosia corticata, is associated with G2/M cell cycle arrest and" exact="suppression" post="of mTOR signaling in human lung cancer cellsToxicol. In"/>
   <result pre="cell cycle arrest and suppression of mTOR signaling in human" exact="lung cancer" post="cellsToxicol. In Vitro20132769469910.1016/j.tiv.2012.11.00123147639 553.FontanaA.CavaliereP.WahidullaS.NaikC.G.CiminoG.A new antitumor isoquinoline alkaloid from"/>
   <result pre="cycle arrest and suppression of mTOR signaling in human lung" exact="cancer" post="cellsToxicol. In Vitro20132769469910.1016/j.tiv.2012.11.00123147639 553.FontanaA.CavaliereP.WahidullaS.NaikC.G.CiminoG.A new antitumor isoquinoline alkaloid from"/>
   <result pre="renieramycin M-jorunnamycin a analoguesBioorg. Med. Chem.2009174548455810.1016/j.bmc.2009.05.00919457672 562.McPhersonJ.R.OngC.K.NgC.C.Y.RajasegaranV.HengH.L.YuW.S.S.TanB.K.T.MadhukumarP.TeoM.C.C.NgeowJ.et al.Whole-exome sequencing of" exact="breast cancer," post="malignant peripheral nerve sheath tumor and neurofibroma from a"/>
   <result pre="a analoguesBioorg. Med. Chem.2009174548455810.1016/j.bmc.2009.05.00919457672 562.McPhersonJ.R.OngC.K.NgC.C.Y.RajasegaranV.HengH.L.YuW.S.S.TanB.K.T.MadhukumarP.TeoM.C.C.NgeowJ.et al.Whole-exome sequencing of breast cancer," exact="malignant peripheral nerve sheath tumor" post="and neurofibroma from a patient with neurofibromatosis type 1Cancer"/>
   <result pre="sequencing of breast cancer, malignant peripheral nerve sheath tumor and" exact="neurofibroma" post="from a patient with neurofibromatosis type 1Cancer Med.201541871187810.1002/cam4.55126432421 563.StormE.E.DurinckS.e"/>
   <result pre="peripheral nerve sheath tumor and neurofibroma from a patient with" exact="neurofibromatosis" post="type 1Cancer Med.201541871187810.1002/cam4.55126432421 563.StormE.E.DurinckS.e MeloF.D.S.TremayneJ.KljavinN.TanC.YeX.ChiuC.PhamT.HongoJ.A.et al.Targeting PTPRK-RSPO3 colon tumours"/>
   <result pre="expression of organic anion-transporting polypeptides: Transporters as novel targets for" exact="cancer" post="therapyJ. Drug Deliv.2013201311210.1155/2013/863539 585.AbuAliG.GrimmS.Isolation and characterization of the anticancer"/>
   <result pre="(ORCTL3)Anticancer GenesSpringerLondon, UK2014213227 586.LiuT.LiQ.Organic anion-transporting polypeptides: A novel approach for" exact="cancer" post="therapyJ. Drug. Target.201422142210.3109/1061186X.2013.83276723987090 587.BakerB.ScheuerP.The punaglandins: 10-chloroprostanoids from the octocoral"/>
   <result pre="Davies-Coleman, M.T.; Hendricks, D.T. Reactive oxygen species mediated apoptosis of" exact="esophageal cancer" post="cells induced by marine triprenyl toluquinones and toluhydroquinonesMol. Cancer"/>
   <result pre="M.T.; Hendricks, D.T. Reactive oxygen species mediated apoptosis of esophageal" exact="cancer" post="cells induced by marine triprenyl toluquinones and toluhydroquinonesMol. Cancer"/>
   <result pre="602.LukinA.KarapetianR.IvanenkovY.KrasavinM.Privileged 1,2,4-oxadiazoles in anticancer drug design: Novel 5-aryloxymethyl-1,2,4-oxadiazole leads for" exact="prostate cancer" post="therapyLett. Drug Des. Discov.20161319820410.2174/1570180812999150812164251 603.Pitasse-SantosP.Sueth-SantiagoV.LimaM.E.F.1,2,4- and 1,3,4-oxadiazoles as scaffolds"/>
   <result pre="1,2,4-oxadiazoles in anticancer drug design: Novel 5-aryloxymethyl-1,2,4-oxadiazole leads for prostate" exact="cancer" post="therapyLett. Drug Des. Discov.20161319820410.2174/1570180812999150812164251 603.Pitasse-SantosP.Sueth-SantiagoV.LimaM.E.F.1,2,4- and 1,3,4-oxadiazoles as scaffolds"/>
   <result pre="Org. Chem.1990554426443110.1021/jo00301a040 607.SingletonP.A.MossJ.KarpD.D.AtkinsJ.T.JankuF.The mu opioid receptor: A new target for" exact="cancer" post="therapy?Cancer20151212681268810.1002/cncr.2946026043235 608.VitaleR.M.GattiM.CarboneM.BarbieriF.FelicitàV.GavagninM.FlorioT.AmodeoP.Minimalist hybrid ligand/receptor-based pharmacophore model for CXCR4 applied"/>
   <result pre="Quick excursus from basic molecular mechanisms to some implications in" exact="cancer" post="chemotherapyEur. Rev. Med. Pharmacol. Sci.200913132119364082 645.WongD.M.LiL.JuradoS.KingA.BamfordR.WallM.WaliaM.K.KellyG.L.WalkleyC.R.TarlintonD.M.et al.The transcription factor"/>
   <result pre="from the red alga Laurencia okamuraeNat. Prod. Sci.20028103107 682.LiuJ.MaL.WuN.LiuG.ZhengL.LinX.Aplysin sensitizes" exact="cancer" post="cells to TRAIL by suppressing P38 MAPK/survivin pathwayMar. Drugs2014125072508810.3390/md1209507225257790"/>
   <result pre="by suppressing P38 MAPK/survivin pathwayMar. Drugs2014125072508810.3390/md1209507225257790 683.GongA.J.GongL.L.YaoW.C.GeN.LuL.X.LiangH.Aplysin induces apoptosis in" exact="glioma" post="cells through HSP90/AKT pathwayExp. Biol. Med.201524063964410.1177/1535370214555664 684.HegazyM.E.F.MoustfaA.Y.MohamedA.E.H.H.AlhammadyM.A.ElbehairiS.E.I.OhtaS.ParéP.W.New cytotoxic halogenated"/>
   <result pre="Japanese sea hare Dolabella auriculariaTetrahedron Lett.1996376771677410.1016/S0040-4039(96)01464-5 704.HanB.GrossH.GoegerD.E.MooberryS.L.GerwickW.H.Aurilides B and C," exact="cancer" post="cell toxins from a Papua New Guinea collection of"/>
   <result pre="10 analogInt. J. Cancer200310451252110.1002/ijc.1098212584751 736.KalemkerianG.P.OuX.AdilM.R.RosatiR.KhoulaniM.M.MadanS.K.PettitG.R.Activity of dolastatin 10 against small-cell" exact="lung cancer" post="in vitro and in vivo: Induction of apoptosis and"/>
   <result pre="analogInt. J. Cancer200310451252110.1002/ijc.1098212584751 736.KalemkerianG.P.OuX.AdilM.R.RosatiR.KhoulaniM.M.MadanS.K.PettitG.R.Activity of dolastatin 10 against small-cell lung" exact="cancer" post="in vitro and in vivo: Induction of apoptosis and"/>
   <result pre="plasma by radioimmunoassayCancer Chemother. Pharmacol.19963822523210.1007/s0028000504758646796 739.WatanabeJ.NatsumeT.FujioN.MiyasakaK.KobayashiM.Induction of apoptosis in human" exact="cancer" post="cells by TZT-1027, an antimicrotubule agentApoptosis2000534535310.1023/A:100968760933011227216 740.Verdier-PinardP.KeplerJ.A.PettitG.R.HamelE.Sustained intracellular retention"/>
   <result pre="Pharmacol.20005718018710617693 741.DoroninaS.O.TokiB.E.TorgovM.Y.MendelsohnB.A.CervenyC.G.ChaceD.F.DeBlancR.L.GearingR.P.BoveeT.D.SiegallC.B.et al.Development of potent monoclonal antibody auristatin conjugates for" exact="cancer" post="therapyNature Biotech.20032177878410.1038/nbt83212778055 742.SteinmetzM.O.ProtaA.E.Microtubule-targeting agents: Strategies to hijack the cytoskeletonTrends"/>
   <result pre="763.AliM.A.RosatiR.PettitG.KalemkerianG.P.Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell" exact="lung cancer" post="cell linesAnticancer Res.199818102110269615758 764.SatoM.SagawaM.NakazatoT.IkedaY.KizakiM.A natural peptide, dolastatin 15, induces"/>
   <result pre="15 induces apoptosis and BCL-2 phosphorylation in small cell lung" exact="cancer" post="cell linesAnticancer Res.199818102110269615758 764.SatoM.SagawaM.NakazatoT.IkedaY.KizakiM.A natural peptide, dolastatin 15, induces"/>
   <result pre="15, induces G2/M cell cycle arrest and apoptosis of human" exact="multiple myeloma" post="cellsInt. J. Oncol.2007301453145910.3892/ijo.30.6.145317487366 765.BeckwithM.UrbaW.J.LongoD.L.Growth inhibition of human lymphoma cell"/>
   <result pre="human multiple myeloma cellsInt. J. Oncol.2007301453145910.3892/ijo.30.6.145317487366 765.BeckwithM.UrbaW.J.LongoD.L.Growth inhibition of human" exact="lymphoma" post="cell lines by the marine products, dolastatins 10 and"/>
   <result pre="from GuamJ. Nat. Prod.20117491792710.1021/np200076t21446699 770.PettitG.R.XuJ.P.HoganF.WilliamsM.D.DoubekD.L.SchmidtJ.M.CernyR.L.BoydM.R.Isolation and structure of the human" exact="cancer" post="cell growth inhibitory cyclodepsipeptide dolastatin 16J. Nat. Prod.19976075275410.1021/np97002309287413 771.NogleL.M.GerwickW.H.Isolation"/>
   <result pre="a new marine-derived compound, induces oncosis in human prostate and" exact="breast cancer" post="cellsMol. Cancer Ther.2003286387214555705 800.JanmaatM.L.RodriguezJ.A.JimenoJ.KruytF.A.E.GiacconeG.Kahalalide F induces necrosis-like cell death"/>
   <result pre="new marine-derived compound, induces oncosis in human prostate and breast" exact="cancer" post="cellsMol. Cancer Ther.2003286387214555705 800.JanmaatM.L.RodriguezJ.A.JimenoJ.KruytF.A.E.GiacconeG.Kahalalide F induces necrosis-like cell death"/>
   <result pre="linesEur. J. Cancer2005411637164410.1016/j.ejca.2005.04.01515953713 804.Miguel-LilloB.ValenzuelaB.Peris-RiberaJ.E.Soto-MatosA.Pérez-RuixoJ.J.Population pharmacokinetics of kahalalide F in advanced" exact="cancer" post="patientsCancer Chemother. Pharmacol.20157636537410.1007/s00280-015-2800-126093949 805.Martín-AlgarraS.EspinosaE.RubióJ.LópezJ.J.L.ManzanoJ.L.CarriónL.A.PlazaolaA.TanovicA.Paz-AresL.Phase II study of weekly Kahalalide"/>
   <result pre="al.Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal" exact="cancer" post="(IMAGE trial)Cancer Chemother. Pharmacol.20167781982710.1007/s00280-016-2991-026964995 818.CiavattaM.L.VillaniG.TrivelloneE.CiminoG.Two new labdane aldehydes from"/>
   <result pre="HTCLs [491] Polycera atra Bryostatins (203) Cytotoxic to P388 lymphocytic" exact="leukemia" post="and Alzheimer’s disease cells [424,486,487] Actinocyclus papillatus (–)-Actisonitrile (204),"/>
   <result pre="A–N (16, 206), isodrimeninol (207), 11-epivaldiviolide (208) Cytotoxic to murine" exact="leukemia" post="P388 cell lines [86,509] Phyllidiella coelestis 1-Formamido-10(1→2)-abeopupukeanane (209), 2-formamidopupukeanane"/>
   <result pre="1-Formamido-10(1→2)-abeopupukeanane (209), 2-formamidopupukeanane (210) Cytotoxic to HeLa, MCF-7, KB, HT-29" exact="cancer" post="cell lines [111] Phyllidiella pustulosa Axinisothiocyanate K (211), isothiocyanate"/>
   <result pre="B Cytotoxic in vitro to KB cells and mouse L1210" exact="leukemia" post="cells [438,511,512] Cadlina luteomarginata Ansellone A (216) Activation of"/>
   <result pre="lochi Mycothiazole (129) Inhibition of the hypoxia-inducible factor-1 (HIF-1), and" exact="suppression" post="of the mitochondrial respiration at complex I [378,379,825,826] Chromodoris"/>
   <result pre="[142,523,524] Chromodoris inornata Inorolides A–C (217) Cytotoxic to murine L1210" exact="leukemia" post="and human epidermoid carcinoma KB cell lines [156,531] Chromodoris"/>
   <result pre="Dorisenones A–D (229), 11β-hydroxyspongi-12-en-16-one (230), spongian-16-one (221) Cytotoxic to murine" exact="lymphoma" post="L1210 and KB cells [154] Doriprismatica (Glossodoris) atromarginata Spongiadiol"/>
   <result pre="12-deacetoxy-12-oxodeoxoscalarin (136), heteronemin (233), mooloolabene D (234) Cytotoxic to MCF-7" exact="breast cancer" post="cells [180,182,381,828] Felimida (Glossodoris) dalli, Doriprismatica (Glossodoris) sedna, Glossodoris"/>
   <result pre="(136), heteronemin (233), mooloolabene D (234) Cytotoxic to MCF-7 breast" exact="cancer" post="cells [180,182,381,828] Felimida (Glossodoris) dalli, Doriprismatica (Glossodoris) sedna, Glossodoris"/>
   <result pre="(63), 33-methylhalichondramide (242), halichondramide (244), Hurghadin Cytotoxic to murine L1210" exact="leukemia" post="cells, cytotoxic to several HTCLs, and cytotoxic to human"/>
   <result pre="cells, cytotoxic to several HTCLs, and cytotoxic to human MCF-7" exact="breast cancer" post="cells [545] Jorunna funebris Jorumycin (189), jorunnamycins A–C (245),"/>
   <result pre="cytotoxic to several HTCLs, and cytotoxic to human MCF-7 breast" exact="cancer" post="cells [545] Jorunna funebris Jorumycin (189), jorunnamycins A–C (245),"/>
   <result pre="Jorumycin (189), jorunnamycins A–C (245), renieramycin M (246) Cytotoxic to" exact="cancer" post="cell lines P388, A549, HT29, and MEL28, and cytotoxic"/>
   <result pre="MEL28, and cytotoxic to human colon (HCT-116) and breast (MDA-MB-435)" exact="cancer" post="cells [560] Jorunna funebris Fennebricins A and B, N-formyl-1,2-dihydrorenierol"/>
   <result pre="atromaculata Petroformynes (247), hydroxyl-dehydroisofulvinol (248), fulvinol Cytotoxic to murine P388" exact="leukemia" post="cells, A549 NSCLC, HT-29 colon cancer and SKMEL-28 melanoma"/>
   <result pre="fulvinol Cytotoxic to murine P388 leukemia cells, A549 NSCLC, HT-29" exact="colon cancer" post="and SKMEL-28 melanoma cells [567,568] Halgerda aurantiomaculata Zooanemonin (367)"/>
   <result pre="Cytotoxic to murine P388 leukemia cells, A549 NSCLC, HT-29 colon" exact="cancer" post="and SKMEL-28 melanoma cells [567,568] Halgerda aurantiomaculata Zooanemonin (367)"/>
   <result pre="(249), tetrapyrrole (72) Cytotoxic to several tumor cell lines (Caco-2" exact="colon cancer" post="cells, HeLa cervix cancer cells) Tritonia sp. Punaglandins (250)"/>
   <result pre="tetrapyrrole (72) Cytotoxic to several tumor cell lines (Caco-2 colon" exact="cancer" post="cells, HeLa cervix cancer cells) Tritonia sp. Punaglandins (250)"/>
   <result pre="several tumor cell lines (Caco-2 colon cancer cells, HeLa cervix" exact="cancer" post="cells) Tritonia sp. Punaglandins (250) Cytotoxic [587] Doto pinnatifida"/>
   <result pre="[22] Leminda millecra Prenylated hydroquinone (252) Cytotoxic to WHCO1, WHCO6" exact="esophageal cancer" post="cell lines [588,589,590] Hermissenda crassicornis L-6-bromohypaphorine (253) Cytotoxic to"/>
   <result pre="Leminda millecra Prenylated hydroquinone (252) Cytotoxic to WHCO1, WHCO6 esophageal" exact="cancer" post="cell lines [588,589,590] Hermissenda crassicornis L-6-bromohypaphorine (253) Cytotoxic to"/>
   <result pre="Phyllodesmium briareum Brianthein W (254), excavatolide C (255) Cytotoxic to" exact="cancer" post="cell line P-388 [248] Phyllodesmium magnum 11-episinulariolide acetate (256)"/>
   <result pre="line P-388 [248] Phyllodesmium magnum 11-episinulariolide acetate (256) Cytotoxic to" exact="cancer" post="cell line P-388 [248] Phyllodesmium longicirrum Trocheliophorol (84) Cytotoxic"/>
   <result pre="(276) Cytotoxic to L-1210, P388 leukemia, human SK-OV-3 ovarian, tMDA-MB-435" exact="breast cancer," post="human A549 NSCLC, K562 chronic myelogenous leukemia, HeLa cervix"/>
   <result pre="NSCLC, K562 chronic myelogenous leukemia, HeLa cervix carcinoma, and MCF-7" exact="breast cancer" post="cell lines [277,626,627,628] Scaphander lignarius ARA, EPA, HTA (fatty"/>
   <result pre="K562 chronic myelogenous leukemia, HeLa cervix carcinoma, and MCF-7 breast" exact="cancer" post="cell lines [277,626,627,628] Scaphander lignarius ARA, EPA, HTA (fatty"/>
   <result pre="ARA, EPA, HTA (fatty acids) Cytotoxic to a set of" exact="cancer" post="and normal cell lines [630] Anaspidea (11) Aplysia angasi,"/>
   <result pre="(279), iso-obtusol (280), linear halogenated monoterpene (281) Cytotoxic to ten" exact="cancer" post="cell lines, B16F10 melanoma, HM02 gastric carcinoma, HEP-G2 liver"/>
   <result pre="HM02 gastric carcinoma, HEP-G2 liver carcinoma, and MCF-7 breast carcinoma" exact="cancer" post="cells [631,633,632,633] A. dactylomela Parguerol (282), parguerol-16-acetate (283), iso-parguerol"/>
   <result pre="(283), iso-parguerol (284), iso-parguerol-16-acetate (285), deoxyparguerol (286) Cytotoxic to P388" exact="leukemia" post="and Ehrlich ascite carcinoma cells [611,636,640] A. dactylomela Aplysqualenol"/>
   <result pre="cells [611,636,640] A. dactylomela Aplysqualenol A (287) Cytotoxic to 60" exact="cancer" post="cell lines [641,642] A. dactylomela Thyrsiferol (288) Cytotoxic to"/>
   <result pre="cell lines [641,642] A. dactylomela Thyrsiferol (288) Cytotoxic to P388" exact="leukemia" post="and T47D human breast tumor cells, and suppression of"/>
   <result pre="to P388 leukemia and T47D human breast tumor cells, and" exact="suppression" post="of hypoxic induction of HIF-1 target genes [647,648,649] Aplysia"/>
   <result pre="[647,648,649] Aplysia depilans Endoperoxide sterol (289) Cytotoxic to human HCT-116" exact="colorectal cancer" post="cells [650,651] Aplysia fasciata 3-epi-aplykurodinone B (145) Cytotoxic to"/>
   <result pre="Aplysia depilans Endoperoxide sterol (289) Cytotoxic to human HCT-116 colorectal" exact="cancer" post="cells [650,651] Aplysia fasciata 3-epi-aplykurodinone B (145) Cytotoxic to"/>
   <result pre="(145) Cytotoxic to mouse P388 leukemia, human A549 NSCLC, HT-29" exact="colon cancer," post="and SKMEl-28 melanoma [397] Aplysia juliana Pyropheophorbides a and"/>
   <result pre="(303), aplysianin A Induction of growth inhibitory effects in various" exact="cancer" post="cell lines [668,669,670,671,672,673,674] A. kurodai (-)-Aplysin (304), aplysinol (305),"/>
   <result pre="(305), aplykurodins A (306) and B (146) Cytotoxic to various" exact="cancer" post="cell lines, human A549 NSCLC, and human glioma cells"/>
   <result pre="to various cancer cell lines, human A549 NSCLC, and human" exact="glioma" post="cells [680,682,683] Aplysia oculifera Oculiferane (308), epi-obtusane (309) Cytotoxic"/>
   <result pre="PC-3 prostate, A549 NSCLC, MCF-7 breast, HepG2 liver, and HCT116" exact="colon cancer" post="cell lines [684] Aplysia punctata Halogenated monoterpenes (310–312) Cytotoxic"/>
   <result pre="prostate, A549 NSCLC, MCF-7 breast, HepG2 liver, and HCT116 colon" exact="cancer" post="cell lines [684] Aplysia punctata Halogenated monoterpenes (310–312) Cytotoxic"/>
   <result pre="C (322) and D (323) Cytotoxic to human HeLa S3" exact="cancer" post="cells [687,696,701,702] D. auricularia Doliculide (325) Cytotoxic to human"/>
   <result pre="Doliculide (325) Cytotoxic to human HeLa S3, MCF-7, and MDA-MB-231" exact="breast cancer" post="cells [708] D. auricularia Dolastatins 3 (192), 10 (326),"/>
   <result pre="(325) Cytotoxic to human HeLa S3, MCF-7, and MDA-MB-231 breast" exact="cancer" post="cells [708] D. auricularia Dolastatins 3 (192), 10 (326),"/>
   <result pre="PE (344), tasidotin (345) Cytotoxic to renal, ovarian, prostate, hepatobiliary," exact="pancreatic cancer" post="cell lines, P388 murine leukemia, colon 26 cancer, Lewis"/>
   <result pre="(344), tasidotin (345) Cytotoxic to renal, ovarian, prostate, hepatobiliary, pancreatic" exact="cancer" post="cell lines, P388 murine leukemia, colon 26 cancer, Lewis"/>
   <result pre="cancer cell lines, P388 murine leukemia, colon 26 cancer, Lewis" exact="lung carcinoma," post="B16 melanoma, M5076 sarcoma, human MX-1 breast cancer, LX-1,"/>
   <result pre="cancer, Lewis lung carcinoma, B16 melanoma, M5076 sarcoma, human MX-1" exact="breast cancer," post="LX-1, MCF-7, colon KM20L2 cancer, and SBC-3 SCLC cell"/>
   <result pre="and P (103) Cytotoxic to P388, A549, HT29, and HTB38" exact="cancer" post="cell lines, and toxic to mice [302,304,305,307,777,778,779] Bursatella leachii"/>
   <result pre="to murine P388 leukemia, human A549, NSCLC, NCI-H187 (SCLC), HT-29" exact="colon cancer," post="HL60 leukemia, KB, and BC breast cancer [783,784,785,786,787] Sacoglossa"/>
   <result pre="NCI-H187 (SCLC), HT-29 colon cancer, HL60 leukemia, KB, and BC" exact="breast cancer" post="[783,784,785,786,787] Sacoglossa (3) Elysia subornata Caulerpenyne (155) Cytotoxic to"/>
   <result pre="(SCLC), HT-29 colon cancer, HL60 leukemia, KB, and BC breast" exact="cancer" post="[783,784,785,786,787] Sacoglossa (3) Elysia subornata Caulerpenyne (155) Cytotoxic to"/>
   <result pre="cancer [783,784,785,786,787] Sacoglossa (3) Elysia subornata Caulerpenyne (155) Cytotoxic to" exact="neuroblastoma" post="SK-N-SH cell line [316,411,788,789,790] Elysia rufescens Kahalide F (194),"/>
   <result pre="F (354) Cytotoxic to A549 and Hs683 cell lines, and" exact="breast cancer" post="cell lines SKBR3 and BT474 [331,797,800] Elysia ornata Kahalides"/>
   <result pre="(354) Cytotoxic to A549 and Hs683 cell lines, and breast" exact="cancer" post="cell lines SKBR3 and BT474 [331,797,800] Elysia ornata Kahalides"/>
   <result pre="peruvianus Hydroxylated sterol (358) Cytotoxic to human HCT-116 and HT29" exact="colon cancer" post="cell lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to"/>
   <result pre="Hydroxylated sterol (358) Cytotoxic to human HCT-116 and HT29 colon" exact="cancer" post="cell lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to"/>
   <result pre="cell lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to WHCO1" exact="esophageal cancer" post="cell line [337] Siphonaria capensis, S. concinna, S. cristatus,"/>
   <result pre="lines [819] Trimusculus costatus Secosterol (359) Cytotoxic to WHCO1 esophageal" exact="cancer" post="cell line [337] Siphonaria capensis, S. concinna, S. cristatus,"/>
   <result pre="(361), ilikonapyrones (362,363), onchidionol Cytotoxic to murine P388 and KB" exact="oral cancer" post="cells, and regulation of some genes related to tumor"/>
   <result pre="ilikonapyrones (362,363), onchidionol Cytotoxic to murine P388 and KB oral" exact="cancer" post="cells, and regulation of some genes related to tumor"/>
   <result pre="Nudibranchia (21) Phyllidiella pustulosa Axisonitrile-3 (25) Antimycobacterial activity against Mycobacterium" exact="tuberculosis" post="[427] P. pustulosa, P. coelestis Xidaoisocyanate A (24) Antibiotic"/>
   <result pre="Doriorismatica (Glossodoris) atromarginata Scalaranes, heteronemin (233) Antimycobacterial activity against M." exact="tuberculosis" post="H37Rv [833] Glossodoris hikuerensis, G. vespa, G. cincta Heteronemin"/>
   <result pre="and F (194), iso-kahalalide F (354) Antimycobacterial activity against Mycobacterium" exact="tuberculosis" post="and M. intracellulare [794] Elysia ornata, E. grandifolia Kahalalide"/>
   <result pre="ornata, E. grandifolia Kahalalide F (194) Antimycobacterial activity against M." exact="tuberculosis" post="and M. intracellulare [331,411,797] Cyerce nigricans Chlorodesmin (114) Antibacterial"/>
   <result pre="Chromodoris mandapamensis, Glossodoris cincta Spongiadiol (35), epi-spongiadiol (232) Activity against" exact="herpes simplex" post="virus, type 1 (HSV-1) and P388 murine leukemia cells"/>
   <result pre="against herpes simplex virus, type 1 (HSV-1) and P388 murine" exact="leukemia" post="cells [166,535] Chromodoris hamiltoni Latrunculins A (38) and B"/>
   <result pre="E. ornata Kahalalide F (194), iso-kahalalide F (354) Activity against" exact="herpes simplex" post="virus II [331,794,795,797,853] marinedrugs-18-00657-t014_Table 14Table 14 Anti-inflammatory compounds in"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7803949/results/search/disease/results.xml">
   <result pre="humans and animals can lead to inflammatory bowel disease, constipation," exact="colorectal cancer," post="and malnutrition23, 24. The Asian elephant (Elephas maximus) is"/>
   <result pre="monkey (Alouatta pigra)Microb. Ecol.201569243444310.1007/s00248-014-0554-725524570 70.EidHMWrightMLAnil KumarNVQawasmehAHassanSTSMocanAet al.Significance of microbiota in" exact="obesity" post="and metabolic diseases and the modulatory potential by medicinal"/>
   <result pre="bovine gastrointestinal tract Treponema isolates and comparison with bovine digital" exact="dermatitis" post="treponemesAppl. Environ. Microbiol.201177113810.1128/AEM.00993-1021057019 76.KayGLMillardASergeantMJMidziNGwisaiRMduluzaTet al.Differences in the faecal microbiome"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7806132/results/search/disease/results.xml">
   <result pre="the hemoglobin (Hb) measurements. Subsequently, the association of undernutrition and" exact="anemia" post="with STH infections were determined based on univariate and"/>
   <result pre="low (6.8%) but overweight and obese was prominent (26.0%). For" exact="anemia" post="(n = 196), an overall prevalence rate of 68.4%"/>
   <result pre="be healthy and normal [23] with little risk of coronary" exact="heart disease" post="observed amongst the OA [24]. Therefore, the OA’s health"/>
   <result pre="further examined for nutritional status based on anthropometric indices and" exact="anemia" post="status. In brief, the Negritos were divided into two"/>
   <result pre="with portable Diaspect (Sailauf, Germany) Hb measurement device. Nutritional and" exact="anemia" post="profiles For participants ≤19 years old, the anthropometric indices"/>
   <result pre="(NCHS) and WHO standards: overweight (&amp;gt; + 1SD BAZ z-score)," exact="obesity" post="(&amp;gt; + 2SD BAZ z- score), wasting/thinness (&amp;lt; −2SD"/>
   <result pre="30.0 for obesity. We adapted the WHO threshold to define" exact="anemia" post="as our standard reference [30]. Children age below than"/>
   <result pre="then classified into levels of severity; mild, moderate and severe" exact="anemia" post="as shown in Table 1[30]. 10.1371/journal.pone.0245377.t001Table 1 WHO cut-off"/>
   <result pre="shown in Table 1[30]. 10.1371/journal.pone.0245377.t001Table 1 WHO cut-off values for" exact="anemia" post="classification. Hemoglobin values in g/dL Age and gender Non-Anemic"/>
   <result pre="(P ≤ 0.05) was considered significant. Analysis on hemoglobin measurement," exact="anemia" post="status and their association with other variables was conducted"/>
   <result pre="underweight, stunting and wasting (among children and adolescent only) and" exact="anemia" post="(all consented participants regardless of age group) were analysed"/>
   <result pre="the females (&amp;gt;80%) in both communities. Hemoglobin (Hb) concentration and" exact="anemia" post="status (N = 196) Hemoglobin profiles Of the 416"/>
   <result pre="Overall prevalence of 68.4% (134/196; 95% CI: 61.9, 74.9) for" exact="anemia" post="was discovered among the consented Negritos. By community categories,"/>
   <result pre="and female participants in both communities. However, the prevalence of" exact="anemia" post="was found to be the highest among young children"/>
   <result pre="approximately half of the anemic participants had moderate to severe" exact="anemia" post="status (40.5% in the IJV and 47.8% in the"/>
   <result pre="IJV and 47.8% in the RPS). Four children had severe" exact="anemia" post="and all of them were from the RPS community."/>
   <result pre="them were from the RPS community. 10.1371/journal.pone.0245377.t005Table 5 Prevalence of" exact="anemia" post="amongst the IJV and RPS Negritos. Variables Overall (N"/>
   <result pre="22 (34.4) 22.8, 46.0 40 (30.3) 22.5, 38.1 0.57 Overall" exact="anemia" post="134 (68.4) 61.9, 74.9 42 (65.6) 44.9, 77.2 92"/>
   <result pre="30.1, 66.5 0.31 P valuea 0.03* 0.22 0.02* Severity of" exact="anemia" post="0.34 Mild 73 (54.5) 46.7, 67.9 25 (59.5) 46.1,"/>
   <result pre="in both IJV and RPS communities. Potential factors associated with" exact="anemia" post="The association between anemia and thirteen selected factors were"/>
   <result pre="RPS communities. Potential factors associated with anemia The association between" exact="anemia" post="and thirteen selected factors were first analysed independently (univariate"/>
   <result pre="6); P = 0.75]. 10.1371/journal.pone.0245377.t008Table 8 Potential factors associated with" exact="anemia" post="amongst the IJV Negritos (logistic univariate and multivariate regression),"/>
   <result pre="there was no significant relationship between any STH infections and" exact="anemia" post="among RPS Negritos (Table 9). Only stunted individual was"/>
   <result pre="potential risk factor and retained as a significant predictor for" exact="anemia" post="in multivariate analysis in this community [AOR: 7.1 (95%"/>
   <result pre="5); P = 0.44]. 10.1371/journal.pone.0245377.t009Table 9 Potential factors associated with" exact="anemia" post="amongst the RPS Negritos (logistic univariate and multivariate regression),"/>
   <result pre="of P≤0.05. Discussion In this study, the current nutritional and" exact="anemia" post="status, and their associations with STH infections and other"/>
   <result pre="earlier in other tribes [36]. The prevalence of overweight and" exact="obesity" post="among adult females of the Senoi and Proto Malay"/>
   <result pre="versus their IJV counterparts (and 49.4%). Whilst, the prevalence of" exact="anemia" post="was found to be comparable in the RPS (69.7%)"/>
   <result pre="STH-infections was likely associated or has aggravated the undernutrition and" exact="anemia" post="problems. In the IJV, apart from being children aged"/>
   <result pre="trichiura infection contributed to ~4 to 5 times risk of" exact="anemia" post="as compared to those with negative-light infections in the"/>
   <result pre="being stunted was indicated as a significant risk factor for" exact="anemia" post="in the RPS. The inter-relation between these two problems"/>
   <result pre="supply. This indirectly reflects the higher status of undernutrition and" exact="anemia" post="among children and adolescents in this community. Unlike RPS,"/>
   <result pre="community studied, a vital aetiology for low hemoglobin concentration and" exact="anemia" post="which was not measured in this study. This assessment"/>
   <result pre="Al-MekhlafiH, AzlinM, Nor AiniU, ShaikA, Sa’iahA, et al.Malnutrition and soil-transmitted" exact="helminthiasis" post="among Orang Asli children in Selangor, Malaysia. Asia Pac"/>
   <result pre="Ministry of Health of Malaysia. 2008:37–8. 15GendrelD, TreluyerJ, Richard‐LenobleD. Parasitic" exact="diarrhea" post="in normal and malnourished children. Fund Clin Pharmacol. 2003;17(2):189–97."/>
   <result pre="24Burns-CoxC, ChongY, GillmanR. Risk factors and the absence of coronary" exact="heart disease" post="in aborigines in West Malaysia. Br Heart J. 1972;34(9):95310.1136/hrt.34.9.9534116420"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7807783/results/search/disease/results.xml">
   <result pre="all for non-commercial purposes. Abstract Diabetes mellitus is a major" exact="metabolic disorder" post="worldwide. Several herbs are being tested for the management"/>
   <result pre="of the methanolic extract was studied in a diet-induced type-2" exact="diabetes mellitus" post="(T2DM) C57BL/6 mouse model. A significant increase in fasting"/>
   <result pre="in vitro and in vivo. The methanolic extract reduced the" exact="hyperglycemia" post="in the high-fat-diet-fed + STZ-injected type-2 diabetic C57BL/6 mice"/>
   <result pre="and its associated secondary complications like diabetic nephropathy, neuropathy, retinopathy," exact="cardiovascular disease," post="etc. Hence, maintaining the near-normoglycemic condition is a dire"/>
   <result pre="TG and HDL-C. It is considered as an indicator of" exact="dyslipidemia" post="and associated diseases.26 The atherogenic index of diabetic mice"/>
   <result pre="and creatinine, indicating kidney damage in diabetic rats. The prolonged" exact="hyperglycemia" post="in the diabetic condition is known to damage the"/>
   <result pre="Ghats of India. J. Ethnopharmacol.2000, 69, 63–71. 10.1016/S0378-8741(98)00156-1.10661885 PadmalochanaK.Anti-cancer (liver" exact="cancer" post="cell lines) and antioxidant activity of Cassia auriculata flower"/>
   <result pre="SalehiR.Novel high-fat diet formulation and streptozotocin treatment for induction of" exact="prediabetes" post="and type 2 diabetes in rats. Adv. Biomed. Res.2018,"/>
   <result pre="HolmesA.; CoppeyL. J.; DavidsonE. P.; YorekM. A.Rat models of diet-induced" exact="obesity" post="and high fat/low dose streptozotocin type 2 diabetes: effect"/>
   <result pre="JuyaM.; KhodaeeG.; DadgarmoghaddamM.Atherogenic index of plasma (AIP): a marker of" exact="cardiovascular disease." post="Med. J. Islam. Repub. Iran2015, 29, 240.26793631 BaynesJ. W.Role"/>
   <result pre="F.; BurcelinR.; GourdyP.Estrogens protect against high-fat diet-induced insulin resistance and" exact="glucose intolerance" post="in mice. Endrocrinology2009, 150, 2109–2117. 10.1210/en.2008-0971. McDonaldS.; PrenzlerP. D.;"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7821031/results/search/disease/results.xml">
   <result pre="dragon’s blood tree (Croton lechleri Müll.Arg., Euphorbiaceae), used to treat" exact="diarrhea" post="associated with HIV anti-retroviral therapy (Wu et al., 2020)."/>
   <result pre="(30%) were focused on oral health conditions such as periodontitis," exact="gingivitis" post="and dental caries, and 60 (23%) were focused on"/>
   <result pre="focused on oral health conditions such as periodontitis, gingivitis and" exact="dental caries," post="and 60 (23%) were focused on respiratory problems such"/>
   <result pre="the traditional treatment of respiratory problems such as cough, bronchitis," exact="laryngitis" post="and sore throat (Fani and Kohanteb, 2017). EOs exhibited"/>
   <result pre="but most of these focused on non-infectious disorders such as" exact="irritable bowel syndrome" post="and non-ulcer dyspepsia (McKay and Blumberg, 2006). Salvia officinalis"/>
   <result pre="on non-infectious disorders such as irritable bowel syndrome and non-ulcer" exact="dyspepsia" post="(McKay and Blumberg, 2006). Salvia officinalis L. (sage) is"/>
   <result pre="the Mediterranean used traditionally to treat ulcers, gout, rheumatism, diarrhea," exact="dyspepsia" post="and inflammation in the skin and throat (Vokou et"/>
   <result pre="its seeds exhibited an MIC of 25 μg/mL against Mycobacterium" exact="tuberculosis" post="(Gemechu et al., 2013; Ozdikmenli and Demirel Zorba, 2015;"/>
   <result pre="to Africa. Its twigs are used in traditional treatments for" exact="acne vulgaris," post="while leaves and fruits are used for the treatment"/>
   <result pre="used to relieve inflammations, eye diseases, throat infections, peptic ulcers," exact="arthritis" post="and liver conditions (Gupta et al., 2008; Jaiswal et"/>
   <result pre="is used for genitourinary disorders such as gonorrhea, syphilis, urinary" exact="schistosomiasis" post="and venereal diseases (Maroyi, 2017). A methanol extract of"/>
   <result pre="used to treat bacterial and fungal infections, diabetes, skin pruritus," exact="allergic rhinitis" post="and rheumatoid arthritis (Fan et al., 2019). Leaf EO"/>
   <result pre="to treat bacterial and fungal infections, diabetes, skin pruritus, allergic" exact="rhinitis" post="and rheumatoid arthritis (Fan et al., 2019). Leaf EO"/>
   <result pre="bacterial and fungal infections, diabetes, skin pruritus, allergic rhinitis and" exact="rheumatoid arthritis" post="(Fan et al., 2019). Leaf EO demonstrated MICs ranging"/>
   <result pre="and fungal infections, diabetes, skin pruritus, allergic rhinitis and rheumatoid" exact="arthritis" post="(Fan et al., 2019). Leaf EO demonstrated MICs ranging"/>
   <result pre="The root is traditionally used to treat fever, headache, stomachache," exact="malaria" post="and cough (Ameya et al., 2016). Ethanol and methanol"/>
   <result pre="used to treat cough and respiratory disorders as well as" exact="constipation" post="and rheumatism (Bekalo et al., 2009). A leaf methanol"/>
   <result pre="extract exhibited MICs of 6.25 and 12.5 μg/mL against Mycobacterium" exact="tuberculosis" post="and M. bovis, respectively (Gemechu et al., 2013). An"/>
   <result pre="2016), and in Africa, the gum is used to treat" exact="diarrhea" post="and sore throat, while the leaves are used to"/>
   <result pre="is also recommended as a steam inhalation for treating chronic" exact="sinusitis" post="(Ivker, 2018). The European Medicines Agency noted a paucity"/>
   <result pre="into liquor. In India, cashew fruits are used to treat" exact="asthma" post="and headache, while cashew seeds are used for burns"/>
   <result pre="The leaves and bark of A. occidentale are used for" exact="malaria" post="in Nigeria (Dike et al., 2012) and for diarrhea"/>
   <result pre="for malaria in Nigeria (Dike et al., 2012) and for" exact="diarrhea" post="and fever in Peru (Odonne et al., 2013). The"/>
   <result pre="region. It is used to treat asthma, bronchitis, burns, cold," exact="leprosy" post="and urinary afflictions (Bozorgi et al., 2013). The fruit,"/>
   <result pre="is used for the treatment of cough, diarrhea, gastric disorders," exact="syphilis" post="and urinary tract disorders. The leaves are used to"/>
   <result pre="The leaves are used to treat bronchitis, colds, diarrhea, fever," exact="malaria" post="and wounds (Ediriweera et al., 2017). A bark methanol"/>
   <result pre="extract inhibited growth of Mycobacterium smegmatis, M. aurum and M." exact="tuberculosis" post="with MICs ranging from 12–120 μg/mL (Aro et al.,"/>
   <result pre="interacted synergistically with the established antimycobacterial rifampicin, achieving a M." exact="tuberculosis" post="MIC with 2.5 μg/mL extract and 2.25 μg/mL rifampicin"/>
   <result pre="used as a chewing stick for oral conditions such as" exact="dental caries" post="(Tekwu et al., 2012). A methanol extract of the"/>
   <result pre="In vitro anti-mycobacterial activity of selected medicinal plants against Mycobacterium" exact="tuberculosis" post="and Mycobacterium bovis strains. BMC Compl. Alternative Med.13, 29110.1186/1472-6882-13-291"/>
   <result pre="of a mouthwash containing Anacardium occidentale Linn. On plaque and" exact="gingivitis" post="control: a randomized controlled trial. Indian J. Dent. Res.27,"/>
   <result pre="(2017). Chemical composition, anti-biofilm activity and potential cytotoxic effect on" exact="cancer" post="cells of Rosmarinus officinalis L. essential oil from Tunisia."/>
   <result pre="from Mikania glomerata: in vitro activity against bacteria responsible for" exact="dental caries." post="Fitoterapia112, 211–216. 10.1016/j.fitote.2016.06.00727316976 MoretiD. L. C.LeandroL. F.Da Silva MoraesT.MoreiraM."/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7823681/results/search/disease/results.xml">
   <result pre="various ailments including coughs, colds, asthma, fever, influenza, diabetes and" exact="malaria" post="[20], and by certain South African traditional healers to"/>
   <result pre="[20], and by certain South African traditional healers to treat" exact="rhinitis" post="[21]. Artemisia dracunculus L. is widely used in North"/>
   <result pre="the Iranian Traditional Medicine A. vulgaris is used to treat" exact="cervicitis" post="[23], while this species is reported in the ethnobotany"/>
   <result pre="species, that are used traditionally to fight cold fever, fatigue," exact="dyspepsia" post="and respiratory infections, as wound-healing agents and to treat"/>
   <result pre="books, as having a beneficial effect on the nasal bleeding," exact="rheumatoid arthritis," post="headache, sore throat and carbuncle [25] and was used"/>
   <result pre="on the nasal bleeding, rheumatoid arthritis, headache, sore throat and" exact="carbuncle" post="[25] and was used by Mongolian &quot;barefoot&quot; doctors for"/>
   <result pre="and polyunsaturated fatty acids (PUFA), which reduce or inhibit such" exact="cardiovascular disease" post="[104]. Linoleic and linolenic acids are essential for human"/>
   <result pre="desserts. Dietary fiber possesses an ability to prevent or relieve" exact="constipation" post="and foods containing fiber can provide other health benefits"/>
   <result pre="maintain a healthy weight and lowering your risk of diabetes," exact="heart disease" post="and some types of cancer [111]. Few Artemisia species"/>
   <result pre="your risk of diabetes, heart disease and some types of" exact="cancer" post="[111]. Few Artemisia species have been studied for the"/>
   <result pre="allergic subjects revealed that Artemisia pollen can trigger not only" exact="allergic rhinitis" post="but also asthma alone or both [118,119]. Almost half"/>
   <result pre="subjects revealed that Artemisia pollen can trigger not only allergic" exact="rhinitis" post="but also asthma alone or both [118,119]. Almost half"/>
   <result pre="Artemisia pollen can trigger not only allergic rhinitis but also" exact="asthma" post="alone or both [118,119]. Almost half of the patients"/>
   <result pre="both [118,119]. Almost half of the patients with autumnal pollen" exact="allergic rhinitis" post="developed seasonal allergic asthma within 9 years [118]. The"/>
   <result pre="[118,119]. Almost half of the patients with autumnal pollen allergic" exact="rhinitis" post="developed seasonal allergic asthma within 9 years [118]. The"/>
   <result pre="of the patients with autumnal pollen allergic rhinitis developed seasonal" exact="allergic asthma" post="within 9 years [118]. The immunoelectrophoretic comparison of the"/>
   <result pre="the patients with autumnal pollen allergic rhinitis developed seasonal allergic" exact="asthma" post="within 9 years [118]. The immunoelectrophoretic comparison of the"/>
   <result pre="contact with some members of the genus Artemisia can cause" exact="dermatitis" post="or other allergic reactions in some people [125,126,127,128]. Several"/>
   <result pre="other allergic reactions in some people [125,126,127,128]. Several cases of" exact="contact dermatitis" post="are described in the literature [129,130,131,132]. Mugwort (A. vulgaris)"/>
   <result pre="allergic reactions in some people [125,126,127,128]. Several cases of contact" exact="dermatitis" post="are described in the literature [129,130,131,132]. Mugwort (A. vulgaris)"/>
   <result pre="[133]. According to Park [134], nearly 43% of patients with" exact="allergic rhinitis" post="and asthma have positive reactions to mugwort on skin"/>
   <result pre="According to Park [134], nearly 43% of patients with allergic" exact="rhinitis" post="and asthma have positive reactions to mugwort on skin"/>
   <result pre="Park [134], nearly 43% of patients with allergic rhinitis and" exact="asthma" post="have positive reactions to mugwort on skin prick testing."/>
   <result pre="[135]. Erythema multiforme, is probably an expression of a delayed" exact="hypersensitivity" post="reaction and appears clinically as acute or chronic dermatitis"/>
   <result pre="delayed hypersensitivity reaction and appears clinically as acute or chronic" exact="dermatitis" post="of exposed sites [127,128]. Skin contact dermatitis caused by"/>
   <result pre="as acute or chronic dermatitis of exposed sites [127,128]. Skin" exact="contact dermatitis" post="caused by Artemisia species is attributed to the presence"/>
   <result pre="acute or chronic dermatitis of exposed sites [127,128]. Skin contact" exact="dermatitis" post="caused by Artemisia species is attributed to the presence"/>
   <result pre="(artemether, arteether, and sodium artesunate) are successively applied in the" exact="malaria" post="chemotherapy [152]. Extensive studies and meta-analyses of thousands of"/>
   <result pre="were nausea, vomiting, and diarrhea, which are also symptoms of" exact="malaria" post="itself. Efferth and Kaina [157] have summarized the available"/>
   <result pre="agents, there are no reports on their clinical evaluation for" exact="cancer" post="therapy in humans [4]. However, one report by Saeed"/>
   <result pre="in traditional medicine in China for treating fever, inflammation and" exact="malaria" post="[9] have been evaluated in clinical trials for stiffness"/>
   <result pre="in clinical trials for stiffness and functional limitation associated with" exact="osteoarthritis" post="of the hip and knee, pain management, experimental heterophyid"/>
   <result pre="and knee, pain management, experimental heterophyid infection and treatment of" exact="malaria" post="[159,160,161]. Artemisia dracunculus has been used for glycemic control,"/>
   <result pre="A. absinthium can be effective in the treatment of knee" exact="osteoarthritis" post="[165]. Based on the suppressor activity of A. absinthium"/>
   <result pre="with post-burn hypertrophic scars [168]. Recently, the preventive effect on" exact="hepatitis" post="B cirrhosis of A. capillaris decoction combined with the"/>
   <result pre="hypertrophic scars [168]. Recently, the preventive effect on hepatitis B" exact="cirrhosis" post="of A. capillaris decoction combined with the entecavir has"/>
   <result pre="their pollen, being one of the main causes of seasonal" exact="allergic rhinitis" post="(&quot;hayfever&quot;). Lou et al. [170] carried out a phase"/>
   <result pre="pollen, being one of the main causes of seasonal allergic" exact="rhinitis" post="(&quot;hayfever&quot;). Lou et al. [170] carried out a phase"/>
   <result pre="of sublingual immunotherapy (SLI) with drops of A. annua for" exact="allergic rhinitis" post="related to this plant. Results indicated that A. annua"/>
   <result pre="sublingual immunotherapy (SLI) with drops of A. annua for allergic" exact="rhinitis" post="related to this plant. Results indicated that A. annua"/>
   <result pre="and A. afra tea vs. praziquantel for the treatment of" exact="schistosomiasis" post="was documented by Munyangi et al. [173]. Controversially, Gillibert"/>
   <result pre="found scientific and ethical issues such as the article on" exact="schistosomiasis" post="referring to the same ethics committee registration number as"/>
   <result pre="referring to the same ethics committee registration number as the" exact="malaria" post="article [174]. Sensitive skin was initially believed to be"/>
   <result pre="for malaria, as well as in the treatment of leishmaniasis," exact="schistosomiasis" post="and trypanomiasis [188,189,190]. They have also shown efficacy on"/>
   <result pre="and trypanomiasis [188,189,190]. They have also shown efficacy on several" exact="cancer" post="lines, along with anti-inflammatory activity, modulating the immune response"/>
   <result pre="[198], and related to metabolic syndromes, including obesity, diabetes and" exact="atherosclerosis" post="[199,200], being many of the effects mentioned evaluated in"/>
   <result pre="by the WHO estimated a 2 million increase in global" exact="malaria" post="cases with respect to 2017. Examples of growing challenges"/>
   <result pre="of growing challenges are urban malaria, the parasite’s drug resistance," exact="malaria" post="in pregnancy, resistance towards insecticides, etc. [207]. Artemisinin (1)"/>
   <result pre="marked activity against multidrug resistant strains of Plasmodium species and" exact="cerebral malaria" post="both in vivo and in vitro. For this reason,"/>
   <result pre="activity against multidrug resistant strains of Plasmodium species and cerebral" exact="malaria" post="both in vivo and in vitro. For this reason,"/>
   <result pre="(ACT) [208]. Artesunate (1a) is widely used to treat multidrug-resistant" exact="malaria" post="[209,210]. The African Quinine Artesunate Malaria Trial multicenter study"/>
   <result pre="a result of these, the WHO revised the guidelines for" exact="malaria" post="and recommended intravenous artesunate as a choice to treat"/>
   <result pre="and recommended intravenous artesunate as a choice to treat severe" exact="malaria" post="[211,212]. After a cluster-randomized trial carried out in several"/>
   <result pre="reduce parasitemia and affect progression of the disease. Consequently, when" exact="malaria" post="patients cannot be treated orally, rectal artesunate prior to"/>
   <result pre="artesunate (1a) (ASSP) was tested to selectively control timing of" exact="malaria" post="exposure during infancy. It was observed that a balanced"/>
   <result pre="and artemether (1b)–lumefantrine (AL) &quot;first-line treatment of uncomplicated P. falciparum" exact="malaria" post="worldwide&quot; [217]. The benefits of DHA–PQP in children have"/>
   <result pre="uncomplicated falciparum malaria, 16.4% of the participants had a recurrent" exact="malaria" post="episode by day 42. This highlights the need in"/>
   <result pre="42. This highlights the need in this sub-population for additional" exact="malaria" post="prevention measures after treatment [221]. Furthermore, a systematic review"/>
   <result pre="an additional option for treatment of pregnant women with uncomplicated" exact="malaria" post="in the United States during the second and third"/>
   <result pre="and 1c) are very potent anticancer compounds, highly selective on" exact="cancer" post="cells with almost no side effects on normal cells."/>
   <result pre="1 and derivatives inhibit the growth of numerous types of" exact="neoplasm" post="cells, including breast, ovarian, prostate, lung, colon, leukemia, pancreas,"/>
   <result pre="lung, colon, leukemia, pancreas, melanoma, renal, hepatic, gastric, and CNS" exact="cancer" post="cells. Several reviews have been published in the last"/>
   <result pre="of artemisinin (1) and derivatives upon different pathways in human" exact="cancer" post="cells [186,198,226,227]. Therefore, we will only point to the"/>
   <result pre="cleavage of its endoperoxide bridge by the ferrous iron in" exact="cancer" post="cells and formation of ROS. Such free radicals produce"/>
   <result pre="of clinical trials against several cancers such as breast, cervical," exact="hepatocellular carcinoma," post="non-small cell lung, squamous cell laryngeal [229,231,232]. However, insufficient"/>
   <result pre="large-scale clinical studies have been conducted on their applications in" exact="cancer" post="therapy. Artenusate (1a) was used in phase I clinical"/>
   <result pre="was used in phase I clinical trial to treat metastatic" exact="breast cancer" post="(ClinicalTrials.gov identifier: NCT00764036) and concluded that 200 mg per"/>
   <result pre="used in phase I clinical trial to treat metastatic breast" exact="cancer" post="(ClinicalTrials.gov identifier: NCT00764036) and concluded that 200 mg per"/>
   <result pre="trials [233]. This compound (1a) is also being tested regarding" exact="colorectal cancer" post="phase I (ISRCTN registry: ISRCTN05203252) and its safety and"/>
   <result pre="[233]. This compound (1a) is also being tested regarding colorectal" exact="cancer" post="phase I (ISRCTN registry: ISRCTN05203252) and its safety and"/>
   <result pre="and pharmacokinetic properties when administered orally in patients with advanced" exact="hepatocellular carcinoma" post="(ClinicalTrials.gov identifier: NCT02304289) [235]. One double-blind placebo-controlled trial consisted"/>
   <result pre="NCT02304289) [235]. One double-blind placebo-controlled trial consisted of giving human" exact="colorectal cancer" post="patients oral compound 1a prior to surgery. During a"/>
   <result pre="[235]. One double-blind placebo-controlled trial consisted of giving human colorectal" exact="cancer" post="patients oral compound 1a prior to surgery. During a"/>
   <result pre="1 patient in the artesunate group had a recurrence of" exact="colon cancer" post="compared to 6 patients in the placebo group [236]."/>
   <result pre="patient in the artesunate group had a recurrence of colon" exact="cancer" post="compared to 6 patients in the placebo group [236]."/>
   <result pre="showed improvement in the signs and symptoms. This included the" exact="vaginal discharge" post="and pain, with no evidence of severe toxicity. These"/>
   <result pre="improves the anticancer effect of gemcitabine, a drug used in" exact="pancreatic cancer," post="which develops resistance over time. They confirmed by in"/>
   <result pre="they used vincristine and artemisinin (1), in combination, against murine" exact="mastocytoma" post="(P815) cells. A randomized controlled trial with artesunate (1a)"/>
   <result pre="using vinorelbine plus cisplatin, in patients with advanced non-small cell" exact="lung cancer" post="(NSCLL) shown that this treatment can raise the short-term"/>
   <result pre="vinorelbine plus cisplatin, in patients with advanced non-small cell lung" exact="cancer" post="(NSCLL) shown that this treatment can raise the short-term"/>
   <result pre="artesunate (1a) with lenalinomide, commonly used for the treatment of" exact="multiple myeloma," post="caused an impressive enhancement of antineoplastic activity in polyploid"/>
   <result pre="2 weeks of treating a patient diagnosed with stage II" exact="cancer" post="of the larynx with the same compound 1a (50"/>
   <result pre="Additionally, the first long-term treatment of two patients with metastatic" exact="uveal melanoma" post="with artesunate (1a), in combination with standard chemotherapy, was"/>
   <result pre="spleen and lung metastases [245]. Another characteristic of tumors and" exact="cancer" post="cells is their ability to develop resistance to chemotherapy"/>
   <result pre="abundant for santonin derivatives, mainly detailing the synthesis of novel" exact="cancer" post="therapeutic agents. Santonin tumor inhibitory derivatives have included a"/>
   <result pre="in vivo assays. This compound was administered orally to an" exact="arthritis" post="rat model with very similar characteristics to rheumatoid arthritis"/>
   <result pre="to an arthritis rat model with very similar characteristics to" exact="rheumatoid arthritis" post="human patients. Rats were treated with doses of 5"/>
   <result pre="an arthritis rat model with very similar characteristics to rheumatoid" exact="arthritis" post="human patients. Rats were treated with doses of 5"/>
   <result pre="for arthritic disease progression. Results showed a significant improvement of" exact="arthritis" post="symptomatology in the treated rats, with ~40% lower clinical"/>
   <result pre="potential future applications in the development of a new anti-rheumatoid" exact="arthritis" post="(RA) drug. However, some criticism can be levelled at"/>
   <result pre="for immunosuppressant bioactivity, showed one particular compound exhibiting ~75–80% proliferation" exact="suppression" post="rates for B and T lymphocytes. This derivative, a"/>
   <result pre="almost identical activity to theophylline, a widely used medicine for" exact="asthma" post="and chronic obstructive pulmonary disease. The effect seems to"/>
   <result pre="activity to theophylline, a widely used medicine for asthma and" exact="chronic obstructive pulmonary disease." post="The effect seems to be mainly due to a"/>
   <result pre="authors use NMRI infected with Plasmodium berghei, a widely used" exact="malaria" post="animal model organism. The mice were injected daily with"/>
   <result pre="of tehranolide (4) per mouse was injected intratumor in Balb/c" exact="breast cancer" post="mouse models. Results showed this dose significantly inhibited tumor"/>
   <result pre="tehranolide (4) per mouse was injected intratumor in Balb/c breast" exact="cancer" post="mouse models. Results showed this dose significantly inhibited tumor"/>
   <result pre="for novel antimalarials as previously mentioned, as well as rising" exact="cancer" post="rates [302]. We hope to see tehranolide (4) progress"/>
   <result pre="bioactive compounds present in the plant with antiviral effects against" exact="hepatitis" post="B, bovine viral diarrhea, and Epstein–Barr virus [307]. It"/>
   <result pre="Covid-19 is the efficacy of the artesunate to ameliorate bleomycin-induced" exact="pulmonary fibrosis" post="pathology in rats, possibly by inhibiting profibrotic molecules [308]."/>
   <result pre="of Artemisia plants is not risk-free. The allergic reactions, mainly" exact="allergic rhinitis" post="caused by pollens and skin dermatitis caused by the"/>
   <result pre="Artemisia plants is not risk-free. The allergic reactions, mainly allergic" exact="rhinitis" post="caused by pollens and skin dermatitis caused by the"/>
   <result pre="allergic reactions, mainly allergic rhinitis caused by pollens and skin" exact="dermatitis" post="caused by the presence of sesquiterpene lactones, are the"/>
   <result pre="of applications broadened to, for example, the preventive effect on" exact="hepatitis" post="B cirrhosis, treatment of malaria, anti-allergenic and glycemic control."/>
   <result pre="a wide array of clinically established drugs to combat different" exact="cancer" post="are highlighted. The high therapeutic potential is evident in"/>
   <result pre="improve human embryonic development in-vitro fertilization procedures and to treat" exact="asthma" post="and chronic obstructive pulmonary disease, respectively. Nevertheless, although this"/>
   <result pre="embryonic development in-vitro fertilization procedures and to treat asthma and" exact="chronic obstructive pulmonary disease," post="respectively. Nevertheless, although this review shows the great potential"/>
   <result pre="study of curative plants used by traditional healers to treat" exact="rhinitis" post="in the Limpopo Province, South AfricaAfr. Health Sci.2018181076108710.4314/ahs.v18i4.2930766574 22.Native"/>
   <result pre="ordosica Krasch. (traditional Chinese/Mongolian medicine) extracts for the treatment of" exact="allergic rhinitis" post="and nasosinusitisJ. Ethnopharmacol.202024811226210.1016/j.jep.2019.11226231585162 26.XiaoB.BaiJ.J.QiL.LuL.S.TianX.R.YinJ.SuY.X.Research progress on resource distribution, chemical"/>
   <result pre="Krasch. (traditional Chinese/Mongolian medicine) extracts for the treatment of allergic" exact="rhinitis" post="and nasosinusitisJ. Ethnopharmacol.202024811226210.1016/j.jep.2019.11226231585162 26.XiaoB.BaiJ.J.QiL.LuL.S.TianX.R.YinJ.SuY.X.Research progress on resource distribution, chemical"/>
   <result pre="is not just artemisinin: Artemisia sp. for treating diseases including" exact="malaria" post="and schistosomiasisPhytochem. Rev.2019181509152710.1007/s11101-019-09645-9 46.SongX.WenX.HeJ.WangJ.LiS.WangM.Phytochemical components and biological activities of"/>
   <result pre="Trentino-Alto Adige (Northern Italy)Aerobiologia (Bologna)20203666968210.1007/s10453-020-09663-7 116.D’AmatoG.SpieksmaF.T.M.Allergenic pollen in europeGrana199130677010.1080/00173139109427772 117.D’AmatoG.SpieksmaF.T.M.LiccardiG.JägerS.RussoM.NikkelsH.WuthrichB.BoniniS.Kontou-FiliK.Pollen-related" exact="allergy" post="in EuropeAllergy19985356757810.1111/j.1398-9995.1998.tb03932.x9689338 118.TangR.SunJ.-L.YinJ.LiZ.Artemisia Allergy Research in ChinaBioMed Res. Int.201520151910.1155/2015/179426"/>
   <result pre="118.TangR.SunJ.-L.YinJ.LiZ.Artemisia Allergy Research in ChinaBioMed Res. Int.201520151910.1155/2015/179426 119.GaoZ.FuW.-Y.SunY.GaoB.WangH.-Y.LiuM.LuoF.-M.ZhouX.JinJ.ZhaoL.et al.Artemisia pollen" exact="allergy" post="in China: Component-resolved diagnosis reveals allergic asthma patients have"/>
   <result pre="Int.201520151910.1155/2015/179426 119.GaoZ.FuW.-Y.SunY.GaoB.WangH.-Y.LiuM.LuoF.-M.ZhouX.JinJ.ZhaoL.et al.Artemisia pollen allergy in China: Component-resolved diagnosis reveals" exact="allergic asthma" post="patients have significant multiple allergen sensitizationAllergy20197428429310.1111/all.1359730155917 120.BrandysJ.GrimsoenA.NilsenB.M.Smestad PaulsenB.ParkH.S.HongC.S.Cross-reactivity between"/>
   <result pre="119.GaoZ.FuW.-Y.SunY.GaoB.WangH.-Y.LiuM.LuoF.-M.ZhouX.JinJ.ZhaoL.et al.Artemisia pollen allergy in China: Component-resolved diagnosis reveals allergic" exact="asthma" post="patients have significant multiple allergen sensitizationAllergy20197428429310.1111/all.1359730155917 120.BrandysJ.GrimsoenA.NilsenB.M.Smestad PaulsenB.ParkH.S.HongC.S.Cross-reactivity between"/>
   <result pre="a Scientific BasisWichtlM.BissetN.G.CRC PressBoca Raton, FL, USA20040849319617, 9780849319617 127.PaulsenE.Systemic allergic" exact="dermatitis" post="caused by sesquiterpene lactonesContact Derm.20177611010.1111/cod.1267127568784 128.PaulsenE.Contact sensitization from Compositae-containing"/>
   <result pre="128.PaulsenE.Contact sensitization from Compositae-containing herbal remedies and cosmeticsContact Derm.20024718919810.1034/j.1600-0536.2002.470401.x12492516 129.KurzG.RapaportM.J.External/internal" exact="allergy" post="to plants (Artemisia)Contact Derm.1979540740810.1111/j.1600-0536.1979.tb04921.x 130.WuP.HeY.ZengZ.YangZ.LiY.Allergic contact dermatitis by Artemisia:"/>
   <result pre="and cosmeticsContact Derm.20024718919810.1034/j.1600-0536.2002.470401.x12492516 129.KurzG.RapaportM.J.External/internal allergy to plants (Artemisia)Contact Derm.1979540740810.1111/j.1600-0536.1979.tb04921.x 130.WuP.HeY.ZengZ.YangZ.LiY.Allergic" exact="contact dermatitis" post="by Artemisia: Report of two casesContact Derm.202083313210.1111/cod.13495 131.MitchellJ.C.DupuisG.Allergic contact"/>
   <result pre="cosmeticsContact Derm.20024718919810.1034/j.1600-0536.2002.470401.x12492516 129.KurzG.RapaportM.J.External/internal allergy to plants (Artemisia)Contact Derm.1979540740810.1111/j.1600-0536.1979.tb04921.x 130.WuP.HeY.ZengZ.YangZ.LiY.Allergic contact" exact="dermatitis" post="by Artemisia: Report of two casesContact Derm.202083313210.1111/cod.13495 131.MitchellJ.C.DupuisG.Allergic contact"/>
   <result pre="contact dermatitis by Artemisia: Report of two casesContact Derm.202083313210.1111/cod.13495 131.MitchellJ.C.DupuisG.Allergic" exact="contact dermatitis" post="from sesquiterpenoids of the Compositae family of plantsBr. J."/>
   <result pre="dermatitis by Artemisia: Report of two casesContact Derm.202083313210.1111/cod.13495 131.MitchellJ.C.DupuisG.Allergic contact" exact="dermatitis" post="from sesquiterpenoids of the Compositae family of plantsBr. J."/>
   <result pre="sesquiterpenoids of the Compositae family of plantsBr. J. Dermatol.19718413915010.1111/j.1365-2133.1971.tb06857.x5548463 132.HawS.ChoH.-R.LeeM.-H.Allergic" exact="contact dermatitis" post="associated with mugwort (Artemisia vulgaris)Contact Derm.201062616310.1111/j.1600-0536.2009.01672.x 133.ZellerW.de GolsM.HausenB.M.The sensitizing"/>
   <result pre="of the Compositae family of plantsBr. J. Dermatol.19718413915010.1111/j.1365-2133.1971.tb06857.x5548463 132.HawS.ChoH.-R.LeeM.-H.Allergic contact" exact="dermatitis" post="associated with mugwort (Artemisia vulgaris)Contact Derm.201062616310.1111/j.1600-0536.2009.01672.x 133.ZellerW.de GolsM.HausenB.M.The sensitizing"/>
   <result pre="outdoor aeroallergen and month of birthPediatr. Allergy Respir. Dis.20161525726210.1016/j.jaci.2003.12.297 135.LundhK.HindsénM.GruvbergerB.MöllerH.SvenssonÅ.BruzeM.Contact" exact="allergy" post="to herbal teas derived from Asteraceae plantsContact Derm.20065419620110.1111/j.0105-1873.2006.00709.x 136.AmorimM.H.R.Gil"/>
   <result pre="annua for managing pain, stiffness and functional limitation associated with" exact="osteoarthritis" post="of the hip and kneeN. Z. Med. J.20161299710227806033 160.StebbingsS.BeattieE.McNamaraD.HuntS.A"/>
   <result pre="weeks, for managing pain, stiffness, and functional limitation associated with" exact="osteoarthritis" post="of the hip and kneeClin. Rheumatol.2016351829183610.1007/s10067-015-3110-z26631103 161.DaddyN.B.KalisyaL.M.BagireP.G.WattR.L.TowlerM.J.WeathersP.J.Artemisia annua dried"/>
   <result pre="hip and kneeClin. Rheumatol.2016351829183610.1007/s10067-015-3110-z26631103 161.DaddyN.B.KalisyaL.M.BagireP.G.WattR.L.TowlerM.J.WeathersP.J.Artemisia annua dried leaf tablets treated" exact="malaria" post="resistant to ACT and i.v. artesunate: Case reportsPhytomedicine201732374010.1016/j.phymed.2017.04.00628732806 162.MendezV.M.Puebla-PerezA.M.Sanchez-PenaM.J.Gonzalez-OrtizL.J.Martinez-AbundisE.Gonzalez-OrtizM.Effect"/>
   <result pre="safety of Yin Qi San Huang antiviral decoction in chronic" exact="hepatitis" post="B: Study protocol for a randomized, placebo controlled, double-blinded"/>
   <result pre="afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum" exact="malaria" post="in a large scale, double blind, randomized clinical trialPhytomedicine201957495610.1016/j.phymed.2018.12.00230668322"/>
   <result pre="al.Effect of Artemisia annua and Artemisia afra tea infusions on" exact="schistosomiasis" post="in a large clinical trialPhytomedicine20185123324010.1016/j.phymed.2018.10.01430466622 174.GillibertA.StephaneJ.YvesH.XavierA.JordiL.EriceC.Gaudart JeanG.TEMPORARY REMOVAL: Comment"/>
   <result pre="A. afra infusions vs. Artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum" exact="malaria" post="in a large scale, double blind, randomized clinical trialPhytomedicine20195915298110.1016/j.phymed.2019.152981"/>
   <result pre="194.AjeigbeK.O.EmikpeB.O.OlaleyeS.B.Effects of artemisinin, with or without lumefantrine and amodiaquine on" exact="gastric ulcer" post="healing in ratJ. Basic Clin. Physiol. Pharmacol.20182951552410.1515/jbcpp-2017-014529702486 195.DehkordiF.M.KaboutariJ.ZendehdelM.JavdaniM.The antinociceptive"/>
   <result pre="derivatives for the treatment of respiratory diseasesPharmacol. Res.2020158104901210.1016/j.phrs.2020.10490132405226 199.ChenH.DuH.ChangC.LiX.Artemisinin reduces" exact="atherosclerosis" post="in apolipoprotein E deficient miceArterioscler. Thromb. Vasc. Biol.202040Suppl. 1A34610.1161/atvb.40.suppl_1.346"/>
   <result pre="deficient miceArterioscler. Thromb. Vasc. Biol.202040Suppl. 1A34610.1161/atvb.40.suppl_1.346 200.JiangW.CenY.SongY.LiP.QinR.LiuC.ZhaoY.ZhengJ.ZhouH.Artesunate attenuated progression of" exact="atherosclerosis" post="lesion formation alone or combined with rosuvastatin through inhibition"/>
   <result pre="210.NoubiapJ.J.Shifting from quinine to artesunate as first-line treatment of severe" exact="malaria" post="in children and adults: Saving more livesJ. Infect. Public"/>
   <result pre="Groupet al.Artesunate versus quinine in the treatment of severe falciparum" exact="malaria" post="in African children (AQUAMAT): An open-label, randomised trialLancet20103761647165710.1016/S0140-6736(10)61924-121062666 212.FerrariG.F.NtukuH.M.BurriC.TshefuA.K.DuparcS.HugoP.MitemboD.K.RossiA.NgwalaP.L.LuwawuJ.N.et"/>
   <result pre="study of quinine and artesunate for the treatment of severe" exact="malaria" post="in hospitals and health centres in the Democratic Republic"/>
   <result pre="prospective cohortMalar. J.20191841910.1186/s12936-019-3047-931843017 219.LeblancC.VasseC.MinodierP.MornandP.NaudinJ.QuinetB.SiriezJ.Y.SorgedF.de SuremainN.ThellierM.et al.Management and prevention of imported" exact="malaria" post="in children. Update of the French guidelinesMed. Mal. Infect.20205012714010.1016/j.medmal.2019.02.00530885541"/>
   <result pre="of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum" exact="malaria" post="in children: An open label randomized controlled trial in"/>
   <result pre="and safety of artemether–lumefantrine as treatment for Plasmodium falciparum uncomplicated" exact="malaria" post="in adult patients on efavirenz-based antiretroviral therapy in Zambia:"/>
   <result pre="United StatesMorb. Mortal. Wkly. Rep.20186742443110.15585/mmwr.mm6714a4 224.D’AlessandroU.HillJ.TarningJ.PellC.WebsterJ.GutmanJ.SeveneE.Treatment of uncomplicated and severe" exact="malaria" post="during pregnancyLancet Infect. Dis.201818e133e14610.1016/S1473-3099(18)30065-329395998 225.GhantousA.Gali-MuhtasibH.VuorelaN.SalibaA.DarwicheN.What made sesquiterpene lactones reach"/>
   <result pre="malaria during pregnancyLancet Infect. Dis.201818e133e14610.1016/S1473-3099(18)30065-329395998 225.GhantousA.Gali-MuhtasibH.VuorelaN.SalibaA.DarwicheN.What made sesquiterpene lactones reach" exact="cancer" post="clinical trials?Drug Discov. Today20101566867810.1016/j.drudis.2010.06.00220541036 226.ZhangY.XuG.ZhangS.WangD.PrabhaP.S.ZuoZ.Antitumor Research on Artemisinin and"/>
   <result pre="Res.2017375995600310.21873/anticanres.1204629061778 228.Dell’EvaR.PfefferU.VeneR.AnfossoL.ForlaniA.AlbiniA.EfferthT.Inhibition of angiogenesis in vivo and growth of Kaposi’s" exact="sarcoma" post="xenograft tumors by the anti-malarial artesunateBiochem. Pharmacol.2004682359236610.1016/j.bcp.2004.08.02115548382 229.Crespo-OrtizM.WeiM.Antitumor activity"/>
   <result pre="drug?World J. Tradit. Chin. Med.2015122510.15806/j.issn.2311-8571.2015.0036 231.Bhaw-LuximonA.JhurryD.Artemisinin and its derivatives in" exact="cancer" post="therapy: Status of progress, mechanism of action, and future"/>
   <result pre="of oral artesunate as add-on therapy in patients with metastatic" exact="breast cancer" post="(ARTIC M33/2)Breast Cancer Res. Treat.201716435936910.1007/s10549-017-4261-128439738 234.TrimbleC.L.LevinsonK.MaldonadoL.DonovanM.J.ClarkK.T.FuJ.ShayM.E.SauterM.E.SandersS.A.FrantzP.S.et al.A first-in-human proof-of-concept"/>
   <result pre="oral artesunate as add-on therapy in patients with metastatic breast" exact="cancer" post="(ARTIC M33/2)Breast Cancer Res. Treat.201716435936910.1007/s10549-017-4261-128439738 234.TrimbleC.L.LevinsonK.MaldonadoL.DonovanM.J.ClarkK.T.FuJ.ShayM.E.SauterM.E.SandersS.A.FrantzP.S.et al.A first-in-human proof-of-concept"/>
   <result pre="inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on" exact="pancreatic cancer" post="both in vitro and in vivoCancer Lett.20102939910810.1016/j.canlet.2010.01.00120137856 240.TilaouiM.MouseH.A.JaafariA.ZyadA.Differential effect"/>
   <result pre="NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic" exact="cancer" post="both in vitro and in vivoCancer Lett.20102939910810.1016/j.canlet.2010.01.00120137856 240.TilaouiM.MouseH.A.JaafariA.ZyadA.Differential effect"/>
   <result pre="vitro and in vivoCancer Lett.20102939910810.1016/j.canlet.2010.01.00120137856 240.TilaouiM.MouseH.A.JaafariA.ZyadA.Differential effect of artemisinin against" exact="cancer" post="cell linesNat. Prod. Bioprospect.2014418919610.1007/s13659-014-0024-424955301 241.ZhangZ.Y.YuS.-P.MiaoL.-Y.HuanhX.-Y.ZhangX.-P.ZhuY.-P.XiaX.-H.Artesunate combined with vinorelbine plus"/>
   <result pre="form confers the ability to induce differentiation of human promyelocytic" exact="leukemia" post="cells via the down-regulation of NF-kappaB DNA binding activityJ."/>
   <result pre="chemosensitivity to paclitaxel, overcoming resistance and enhancing apoptosis in human" exact="hepatocellular carcinoma" post="cell line resistant to paclitaxel (Hep3B/PTX)Pharmaceutics20191151210.3390/pharmaceutics11100512 284.CastroV.MurilloR.KlaasC.A.MeunierC.MoraG.PahlH.L.MerfortI.Inhibition of the"/>
   <result pre="self and non-selfNat. Immunol.2005634535210.1038/ni117815785760 300.NooriS.HassanZ.M.Tehranolide inhibits proliferation of MCF-7 human" exact="breast cancer" post="cells by inducing G0/G1 arrest and apoptosisFree Radic. Biol."/>
   <result pre="and non-selfNat. Immunol.2005634535210.1038/ni117815785760 300.NooriS.HassanZ.M.Tehranolide inhibits proliferation of MCF-7 human breast" exact="cancer" post="cells by inducing G0/G1 arrest and apoptosisFree Radic. Biol."/>
   <result pre="and artesunateClin. Infect. Dis.20084780481110.1086/59119518699744 308.WangC.XuanX.YaoW.HuangG.JinJ.Anti-profibrotic effects of artesunate on bleomycin-induced" exact="pulmonary fibrosis" post="in Sprague Dawley ratsMol. Med. Rep.2015121291129710.3892/mmr.2015.350025816117 309.LiS.-Y.ChenC.ZhangH.-Q.GuoH.-Y.WangH.WangL.ZhangX.HuaS.-N.YuJ.XiaoP.-G.et al.Identification of"/>
   <result pre="Ethnopharmacol.201214185485910.1016/j.jep.2012.03.02422465592 312.KaramoddiniM.K.EmamiS.A.GhannadM.S.SaniE.A.SahebkarA.Antiviral activities of aerial subsets of Artemisia species against" exact="herpes simplex" post="virus type 1 (HSV1) in vitroAsian Biomed.20115636810.5372/1905-7415.0501.007 313.RoltaR.SalariaD.KumarV.SourirajanA.DevK.Phytocompounds of"/>
  </snippets>
 </snippetsTree>
 <snippetsTree>
  <snippets file="anthelminthic/PMC7823815/results/search/disease/results.xml">
   <result pre="activities, digoxin used in the treatment of heart failure and" exact="atrial fibrillation" post="[5], fusidic acid used as topical antibiotics [6]. Carbenoxolone"/>
   <result pre="[6]. Carbenoxolone enhances peripheral insulin sensitivity [7] and treatment of" exact="gastric ulcer" post="[8] and β-Aescin used in the treatment of human"/>
   <result pre="ulcer [8] and β-Aescin used in the treatment of human" exact="hepatocellular carcinoma" post="SMMC-7721 cells [9]. Steroids and triterpenes possess various potential"/>
   <result pre="[10], anti-hepatitis B activity [11], anti-HIV1 and 2, AIDS, and" exact="hepatitis" post="C virus activities [12]. Steroids class consists of 25"/>
   <result pre="the marine sponge Petrosia weinbergi and showed activities against feline" exact="leukemia" post="virus in vitro (EC50 = 1.0, 1.3, and 1.0"/>
   <result pre="betulinic acid and its derivatives also has been studied against" exact="influenza" post="A, herpes simplex type 1 (HSV-1), and ECHO-6 enterovirus"/>
   <result pre="and its derivatives also has been studied against influenza A," exact="herpes simplex" post="type 1 (HSV-1), and ECHO-6 enterovirus (EC50 1.3 µM;"/>
   <result pre="betulinic acid were more active than betulinic acid against the" exact="influenza" post="A virus with EC50 of 2.8 µM [43], whereas"/>
   <result pre="aldehyde showed antiviral activity against the H9N2 subtype of the" exact="avian influenza" post="virus [48]. Another betulinic acid derivative called 3β,28-di-onicotinoylbetulin is"/>
   <result pre="showed antiviral activity against the H9N2 subtype of the avian" exact="influenza" post="virus [48]. Another betulinic acid derivative called 3β,28-di-onicotinoylbetulin is"/>
   <result pre="RNA viruses such as vaccinia, HSV-1, Newcastle disease, and vesicular" exact="stomatitis" post="virus (VSV) in vitro [64]. Glycyrrhizin has been also"/>
   <result pre="has an inhibitory effect on human flaviviruses, such as Japanese" exact="encephalitis" post="virus (JEV) dengue virus, tick-borne encephalitis virus (TBEV), West"/>
   <result pre="human flaviviruses, such as Japanese encephalitis virus (JEV) dengue virus," exact="tick-borne encephalitis" post="virus (TBEV), West Nile virus (WNV), and many others"/>
   <result pre="flaviviruses, such as Japanese encephalitis virus (JEV) dengue virus, tick-borne" exact="encephalitis" post="virus (TBEV), West Nile virus (WNV), and many others"/>
   <result pre="entry to Vero cells (EC50: 600 mg/L) [70] and H1N1" exact="influenza" post="virus uptake into human bronchial epithelial cells (EC50: 500"/>
   <result pre="KSHV [74]. Additionally, glycyrrhizin showed promising antiviral activity against the" exact="hepatitis" post="C virus with IC50 of 5 µM in hepatic"/>
   <result pre="proved to be active against human immunodeficiency virus (HIV) [85]," exact="measles" post="[86], influenza virus [77,78] HSV, and varicella-zoster virus [65]"/>
   <result pre="be active against human immunodeficiency virus (HIV) [85], measles [86]," exact="influenza" post="virus [77,78] HSV, and varicella-zoster virus [65] Saikosaponin A"/>
   <result pre="betulinic acid and its derivatives also have been studied against" exact="influenza" post="A, herpes simplex type 1 (HSV-1), and ECHO-6 enterovirus."/>
   <result pre="and its derivatives also have been studied against influenza A," exact="herpes simplex" post="type 1 (HSV-1), and ECHO-6 enterovirus. It has been"/>
   <result pre="RNA viruses such as vaccinia, HSV-1, Newcastle disease, and vesicular" exact="stomatitis" post="virus (VSV) in vitro. In vitro studies also showed"/>
   <result pre="obese rats: Potential participation of UBC9 proteinLife Sci.201922915716510.1016/j.lfs.2019.05.01731077719 8.DollR.HillI.HuttonC.Treatment of" exact="gastric ulcer" post="with carbenoxolone sodium and oestrogensGut196561910.1136/gut.6.1.1914259418 9.MingZ.HuY.QiuY.CaoL.ZhangX.Synergistic effects of β-aescin"/>
   <result pre="and oestrogensGut196561910.1136/gut.6.1.1914259418 9.MingZ.HuY.QiuY.CaoL.ZhangX.Synergistic effects of β-aescin and 5-fluorouracil in human" exact="hepatocellular carcinoma" post="SMMC-7721 cellsPhytomedicine20101757558010.1016/j.phymed.2009.12.00920106644 10.ShamsabadipourS.GhanadianM.SaeediH.RahimnejadM.R.Mohammadi-KamalabadiM.AyatollahiS.M.SalimzadehL.Triterpenes and steroids from Euphorbia denticulata Lam."/>
   <result pre="Pharmacother.2016831095110410.1016/j.biopha.2016.08.03027551755 47.ChenP.ZengH.WangY.FanX.XuC.DengR.ZhouX.BiH.HuangM.Low dose of oleanolic acid protects against lithocholic acid–induced" exact="cholestasis" post="in mice: Potential involvement of nuclear factor-E2-related factor 2-mediated"/>
   <result pre="Epstein-Barr virus infection: Structure–activity relationshipsAntivir. Res.20087961110.1016/j.antiviral.2008.01.16018423902 68.TakaharaT.WatanabeA.ShirakiK.Effects of glycyrrhizin on" exact="hepatitis" post="B surface antigen: A biochemical and morphological studyJ. Hepatol.19942160160910.1016/S0168-8278(94)80108-87814808"/>
   <result pre="of liquorice roots, and replication of SARS-associated coronavirusLancet20033612045204610.1016/S0140-6736(03)13615-X12814717 71.WolkerstorferA.KurzH.BachhofnerN.SzolarO.H.Glycyrrhizin inhibits" exact="influenza" post="A virus uptake into the cellAntivir. Res.20098317117810.1016/j.antiviral.2009.04.01219416738 72.SuiX.YinJ.RenX.Antiviral effect"/>
   <result pre="of the human immunodeficiency virus [HIV (HTLV-III/LAV)]Antivir. Res.1987712713710.1016/0166-3542(87)90001-53475037 86.UshioY.AbeH.Inactivation of" exact="measles" post="virus and herpes simplex virus by saikosaponin dPlanta Med.19925817117310.1055/s-2006-9614221529029"/>
   <result pre="immunodeficiency virus [HIV (HTLV-III/LAV)]Antivir. Res.1987712713710.1016/0166-3542(87)90001-53475037 86.UshioY.AbeH.Inactivation of measles virus and" exact="herpes simplex" post="virus by saikosaponin dPlanta Med.19925817117310.1055/s-2006-9614221529029 87.RaoG.S.SinsheimerJ.E.CochranK.W.Antiviral activity of triterpenoid"/>
   <result pre="antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against" exact="herpes simplex" post="virus and poliovirusAntivir. Res.19878132510.1016/0166-3542(87)90084-22825589 89.ChaudhuriS.K.FullasF.BrownD.M.WaniM.C.WallM.E.CaiL.MarW.LeeS.K.LuoY.ZawK.Isolation and structural elucidation of"/>
  </snippets>
 </snippetsTree>
</projectSnippetsTree>
